0001060955-23-000007.txt : 20230224 0001060955-23-000007.hdr.sgml : 20230224 20230224163441 ACCESSION NUMBER: 0001060955-23-000007 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 162 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICON PLC CENTRAL INDEX KEY: 0001060955 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 981067160 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 333-08704 FILM NUMBER: 23667956 BUSINESS ADDRESS: STREET 1: SOUTH COUNTY BUSINESS PARK STREET 2: LEOPARDSTOWN CITY: DUBLIN 18 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00 353 1 291 2000 MAIL ADDRESS: STREET 1: SOUTH COUNTY BUSINESS PARK STREET 2: LEOPARDSTOWN CITY: DUBLIN 18 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ICON PLC /ADR/ DATE OF NAME CHANGE: 20010213 20-F 1 iclr-20221231.htm 20-F iclr-20221231
false2022FY0001060955http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent00010609552022-01-012022-12-310001060955dei:BusinessContactMember2022-01-012022-12-3100010609552022-12-31xbrli:sharesiso4217:USD00010609552021-12-31iso4217:EURxbrli:shares00010609552021-01-012021-12-3100010609552020-01-012020-12-31iso4217:USDxbrli:shares0001060955us-gaap:CommonStockMember2019-12-310001060955us-gaap:AdditionalPaidInCapitalMember2019-12-310001060955iclr:OtherUndenominatedCapitalMember2019-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001060955us-gaap:RetainedEarningsMember2019-12-3100010609552019-12-310001060955iclr:RedeemableNoncontrollingInterestMember2019-12-310001060955us-gaap:RetainedEarningsMember2020-01-012020-12-310001060955iclr:RedeemableNoncontrollingInterestMember2020-01-012020-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310001060955us-gaap:CommonStockMember2020-01-012020-12-310001060955us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001060955iclr:OtherUndenominatedCapitalMember2020-01-012020-12-310001060955us-gaap:CommonStockMember2020-12-310001060955us-gaap:AdditionalPaidInCapitalMember2020-12-310001060955iclr:OtherUndenominatedCapitalMember2020-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001060955us-gaap:RetainedEarningsMember2020-12-3100010609552020-12-310001060955iclr:RedeemableNoncontrollingInterestMember2020-12-310001060955us-gaap:RetainedEarningsMember2021-01-012021-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001060955us-gaap:CommonStockMember2021-01-012021-12-310001060955us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001060955us-gaap:CommonStockMember2021-12-310001060955us-gaap:AdditionalPaidInCapitalMember2021-12-310001060955iclr:OtherUndenominatedCapitalMember2021-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001060955us-gaap:RetainedEarningsMember2021-12-310001060955us-gaap:RetainedEarningsMember2022-01-012022-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001060955us-gaap:CommonStockMember2022-01-012022-12-310001060955us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001060955iclr:OtherUndenominatedCapitalMember2022-01-012022-12-310001060955us-gaap:CommonStockMember2022-12-310001060955us-gaap:AdditionalPaidInCapitalMember2022-12-310001060955iclr:OtherUndenominatedCapitalMember2022-12-310001060955us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001060955us-gaap:RetainedEarningsMember2022-12-31iclr:Employeeiclr:Locationiclr:Country0001060955country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-31xbrli:pure0001060955srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001060955iclr:OtherGeographicLocationsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001060955us-gaap:BuildingMember2022-01-012022-12-310001060955srt:MinimumMembericlr:ComputerEquipmentAndCapitalizedSoftwareMember2022-01-012022-12-310001060955srt:MaximumMembericlr:ComputerEquipmentAndCapitalizedSoftwareMember2022-01-012022-12-310001060955us-gaap:FurnitureAndFixturesMember2022-01-012022-12-310001060955us-gaap:EquipmentMember2022-01-012022-12-310001060955us-gaap:VehiclesMember2022-01-012022-12-310001060955us-gaap:CustomerRelationshipsMember2022-01-012022-12-310001060955us-gaap:OrderOrProductionBacklogMember2022-01-012022-12-310001060955us-gaap:TradeNamesMember2022-01-012022-12-310001060955us-gaap:DatabasesMember2022-01-012022-12-310001060955us-gaap:TechnologyBasedIntangibleAssetsMember2022-01-012022-12-310001060955iclr:MeDiNovaResearchMember2020-03-090001060955iclr:TopClientMember2022-01-012022-12-310001060955iclr:TopClientMember2021-01-012021-12-310001060955iclr:TopClientMember2020-01-012020-12-310001060955iclr:Clients25Member2022-01-012022-12-310001060955iclr:Clients25Member2021-01-012021-12-310001060955iclr:Clients25Member2020-01-012020-12-310001060955iclr:Clients610Member2022-01-012022-12-310001060955iclr:Clients610Member2021-01-012021-12-310001060955iclr:Clients610Member2020-01-012020-12-310001060955iclr:Clients1125Member2022-01-012022-12-310001060955iclr:Clients1125Member2021-01-012021-12-310001060955iclr:Clients1125Member2020-01-012020-12-310001060955iclr:OtherCustomersMember2022-01-012022-12-310001060955iclr:OtherCustomersMember2021-01-012021-12-310001060955iclr:OtherCustomersMember2020-01-012020-12-3100010609552023-01-012022-12-3100010609552022-01-012021-12-3100010609552021-07-010001060955iclr:PRAHealthSciencesIncMember2021-07-010001060955iclr:PRAHealthSciencesIncMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMember2022-01-012022-12-310001060955iclr:PRAHealthSciencesIncMember2021-01-012021-12-310001060955iclr:PRAHealthSciencesIncMember2022-12-310001060955iclr:PRAHealthSciencesIncMemberus-gaap:CustomerRelationshipsMember2021-07-010001060955iclr:PRAHealthSciencesIncMemberus-gaap:CustomerRelationshipsMember2021-07-012021-07-010001060955us-gaap:OrderOrProductionBacklogMembericlr:PRAHealthSciencesIncMember2021-07-010001060955us-gaap:OrderOrProductionBacklogMembericlr:PRAHealthSciencesIncMember2021-07-012021-07-010001060955us-gaap:TradeNamesMembericlr:PRAHealthSciencesIncMember2021-07-010001060955us-gaap:TradeNamesMembericlr:PRAHealthSciencesIncMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMemberus-gaap:DatabasesMember2021-07-010001060955iclr:PRAHealthSciencesIncMemberus-gaap:DatabasesMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMemberus-gaap:TechnologyBasedIntangibleAssetsMember2021-07-010001060955iclr:PRAHealthSciencesIncMemberus-gaap:TechnologyBasedIntangibleAssetsMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMember2021-07-012022-12-310001060955us-gaap:AccountingStandardsUpdate202108Membericlr:PRAHealthSciencesIncMember2022-01-012022-12-310001060955us-gaap:FairValueInputsLevel1Member2022-12-310001060955us-gaap:FairValueInputsLevel2Member2022-12-310001060955us-gaap:FairValueInputsLevel3Member2022-12-310001060955us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel1Membericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Membericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMembericlr:InterestRateCapAndInterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMembericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMembericlr:InterestRateCapAndInterestRateSwapMember2022-12-310001060955us-gaap:FairValueInputsLevel1Member2021-12-310001060955us-gaap:FairValueInputsLevel2Member2021-12-310001060955us-gaap:FairValueInputsLevel3Member2021-12-310001060955us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310001060955us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001060955us-gaap:FairValueMeasurementsNonrecurringMember2022-12-3100010609552020-07-240001060955iclr:OncacareMember2022-12-310001060955iclr:OncacareMember2021-01-012021-12-310001060955iclr:OncacareMember2022-01-012022-12-310001060955iclr:OncacareMember2021-01-012021-12-310001060955iclr:OncacareMember2022-01-012022-12-310001060955iclr:OncacareMember2022-12-310001060955us-gaap:CustomerRelationshipsMember2022-12-310001060955us-gaap:CustomerRelationshipsMember2021-12-310001060955us-gaap:OrderOrProductionBacklogMember2022-12-310001060955us-gaap:OrderOrProductionBacklogMember2021-12-310001060955us-gaap:TradeNamesMember2022-12-310001060955us-gaap:TradeNamesMember2021-12-310001060955us-gaap:DatabasesMember2022-12-310001060955us-gaap:DatabasesMember2021-12-310001060955us-gaap:TechnologyBasedIntangibleAssetsMember2022-12-310001060955us-gaap:TechnologyBasedIntangibleAssetsMember2021-12-310001060955iclr:PRAHealthSciencesIncMembersrt:MinimumMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMembersrt:MaximumMember2021-07-012021-07-010001060955iclr:PRAHealthSciencesIncMember2021-07-022022-12-310001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-12-310001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2021-12-310001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2022-12-310001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2021-12-310001060955iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMemberus-gaap:SecuredDebtMember2021-07-010001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2021-07-010001060955iclr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-07-010001060955iclr:TermLoanFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-07-012021-07-010001060955iclr:TermLoanFacilityMembersrt:MinimumMember2022-01-012022-12-310001060955iclr:SeniorSecuredRevolvingLoanFacilityMembersrt:MaximumMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2022-01-012022-12-310001060955iclr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2022-01-012022-12-310001060955srt:MinimumMembericlr:SeniorSecuredRevolvingLoanFacilityMemberus-gaap:BaseRateMembericlr:VariableRateComponentOneMember2022-01-012022-12-310001060955us-gaap:LondonInterbankOfferedRateLIBORMembericlr:SeniorSecuredRevolvingLoanFacilityMembersrt:MaximumMembericlr:VariableRateComponentTwoMember2022-01-012022-12-310001060955us-gaap:LondonInterbankOfferedRateLIBORMembericlr:SeniorSecuredRevolvingLoanFacilityMembericlr:VariableRateComponentTwoMember2022-01-012022-12-310001060955us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMembericlr:SeniorSecuredRevolvingLoanFacilityMembericlr:VariableRateComponentTwoMember2022-01-012022-12-310001060955iclr:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:SecuredDebtMember2022-12-310001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-12-302022-12-300001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-09-302022-09-300001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-06-302022-06-300001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2022-03-312022-03-310001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2021-12-292021-12-290001060955iclr:TermLoanFacilityMemberus-gaap:SecuredDebtMember2021-09-272021-09-270001060955iclr:SeniorSecuredNotesMemberus-gaap:SeniorSubordinatedNotesMember2021-07-010001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMember2022-11-29iclr:instrument0001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:InterestRateCapMember2022-11-290001060955us-gaap:InterestRateSwapMember2022-11-290001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMember2022-12-310001060955us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2022-12-31iclr:tranche0001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-12-310001060955us-gaap:CostOfSalesMember2022-01-012022-12-310001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-12-310001060955us-gaap:CostOfSalesMember2021-01-012021-12-31iclr:vote0001060955us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-310001060955iclr:PerformanceShareUnitMember2022-01-012022-12-310001060955us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001060955iclr:PerformanceShareUnitMember2021-01-012021-12-310001060955us-gaap:CommonStockMember2021-07-012021-07-010001060955us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-12-310001060955iclr:PerformanceShareUnitMember2020-01-012020-12-310001060955srt:MaximumMembericlr:BuybackProgramMember2016-07-222016-07-220001060955iclr:BuybackProgramMember2016-10-030001060955iclr:BuybackProgramMember2018-01-012018-12-310001060955iclr:BuybackProgramMember2019-01-080001060955iclr:BuybackProgramMember2019-01-012019-12-310001060955iclr:BuybackProgramMember2019-12-312019-12-310001060955iclr:BuybackProgramMember2020-01-012020-12-310001060955iclr:BuybackProgramMember2022-02-182022-02-180001060955iclr:A2021RestructuringPlanMember2022-01-012022-12-310001060955iclr:LeaseLiabilityMember2022-12-310001060955us-gaap:EmployeeSeveranceMember2022-12-310001060955country:IE2022-01-012022-12-310001060955country:IE2021-01-012021-12-310001060955country:IE2020-01-012020-12-310001060955country:US2022-01-012022-12-310001060955country:US2021-01-012021-12-310001060955country:US2020-01-012020-12-310001060955iclr:RestOfEuropeAndOtherCountriesMember2022-01-012022-12-310001060955iclr:RestOfEuropeAndOtherCountriesMember2021-01-012021-12-310001060955iclr:RestOfEuropeAndOtherCountriesMember2020-01-012020-12-310001060955us-gaap:ForeignCountryMembercountry:IE2022-12-310001060955country:USus-gaap:InternalRevenueServiceIRSMember2022-12-310001060955country:USus-gaap:StateAndLocalJurisdictionMember2022-12-310001060955country:US2022-12-310001060955country:USus-gaap:InternalRevenueServiceIRSMembericlr:TaxYear2023To2036Member2022-12-310001060955country:USus-gaap:StateAndLocalJurisdictionMembericlr:TaxYear2023To2036Member2022-12-310001060955iclr:TaxYear20332041Membercountry:USus-gaap:InternalRevenueServiceIRSMember2022-12-310001060955iclr:TaxYear20332041Membercountry:USus-gaap:StateAndLocalJurisdictionMember2022-12-310001060955us-gaap:ForeignCountryMember2022-12-310001060955us-gaap:ForeignCountryMembericlr:TaxYear2022To2028Member2022-12-310001060955us-gaap:ForeignCountryMembericlr:TaxYear2029To2038Member2022-12-310001060955us-gaap:ForeignCountryMembericlr:OtherCountriesMember2022-12-310001060955iclr:IncomeTaxBenefitMember2022-01-012022-12-310001060955us-gaap:OtherComprehensiveIncomeMember2022-01-012022-12-310001060955iclr:AcquiredEntityMember2021-01-012021-12-310001060955iclr:IncomeTaxBenefitMember2021-01-012021-12-310001060955us-gaap:OtherComprehensiveIncomeMember2021-01-012021-12-310001060955country:US2022-01-012022-12-310001060955country:US2021-01-012021-12-310001060955country:US2020-01-012020-12-310001060955country:USus-gaap:PensionPlansDefinedBenefitMember2022-12-310001060955country:USus-gaap:PensionPlansDefinedBenefitMember2021-12-310001060955iclr:OtherRetirementPlansMember2022-12-310001060955iclr:OtherRetirementPlansMember2021-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2020-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-01-012022-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-01-012021-12-310001060955country:GBiclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2020-01-012020-12-310001060955iclr:GovernmentBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955iclr:GovernmentBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955iclr:DiversifiedBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955iclr:DiversifiedBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:DefinedBenefitPlanEquitySecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:DefinedBenefitPlanEquitySecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:CorporateDebtSecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:CorporateDebtSecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-01-012021-12-310001060955iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-01-012022-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:GovernmentBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:GovernmentBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:DiversifiedBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:DiversifiedBondsMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanEquitySecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:DefinedBenefitPlanEquitySecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMembericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2022-12-310001060955us-gaap:FairValueInputsLevel1Membericlr:ICONDevelopmentSolutionsLimitedPensionPlanMember2021-12-310001060955iclr:ICONDevelopmentSolutionsLimitedPensionPlanMembercountry:GB2022-12-310001060955country:CHiclr:AptivSolutionsMembericlr:AptivSolutionsPensionPlanMember2014-05-070001060955country:CHiclr:AptivSolutionsPensionPlanMember2022-12-310001060955country:CHiclr:AptivSolutionsPensionPlanMember2021-12-310001060955iclr:AptivSolutionsPensionPlanMember2022-12-310001060955iclr:AptivSolutionsPensionPlanMember2021-12-310001060955country:CHiclr:AptivSolutionsPensionPlanMember2020-12-310001060955country:CHiclr:AptivSolutionsPensionPlanMember2022-01-012022-12-310001060955country:CHiclr:AptivSolutionsPensionPlanMember2021-01-012021-12-310001060955iclr:PRASwitzerlandAGPensionPlanMembercountry:CH2022-12-310001060955iclr:PRASwitzerlandAGPensionPlanMembercountry:CH2021-12-310001060955iclr:PRASwitzerlandAGPensionPlanMember2022-12-310001060955iclr:PRASwitzerlandAGPensionPlanMember2021-12-310001060955iclr:PRASwitzerlandAGPensionPlanMembercountry:CH2020-12-310001060955iclr:PRASwitzerlandAGPensionPlanMembercountry:CH2022-01-012022-12-310001060955iclr:PRASwitzerlandAGPensionPlanMembercountry:CH2021-01-012021-12-310001060955iclr:ConsultantsStockPlan2008PlanMember2017-02-130001060955iclr:ConsultantsStockPlan2008PlanMember2017-02-140001060955iclr:EmployeeStockPlanTwentyZeroEightPlanMember2017-02-140001060955iclr:ConsultantsStockPlan2008PlanMember2017-02-142017-02-140001060955iclr:EmployeeStockPlanTwentyZeroEightPlanMember2017-02-142017-02-140001060955iclr:OptionPlans2008Membersrt:MinimumMember2017-02-142017-02-140001060955us-gaap:EmployeeStockOptionMembericlr:AwardDateAllYearsExcluding2018Member1997-01-012017-12-310001060955iclr:The2020LegacyPRAPlanMember2020-05-180001060955iclr:The2018LegacyPRAPlanMember2018-05-310001060955iclr:A2013LegacyPRAPlanMember2013-09-230001060955iclr:StockOptionAndAwardPlansMember2019-12-310001060955iclr:StockOptionAndAwardPlansMember2020-01-012020-12-310001060955iclr:StockOptionAndAwardPlansMember2020-12-310001060955iclr:StockOptionAndAwardPlansMember2021-01-012021-12-310001060955iclr:StockOptionAndAwardPlansMember2021-12-310001060955iclr:StockOptionAndAwardPlansMember2022-01-012022-12-310001060955iclr:StockOptionAndAwardPlansMember2022-12-310001060955iclr:Range1Member2022-01-012022-12-310001060955iclr:Range1Membericlr:StockOptionAndAwardPlansMember2022-12-310001060955iclr:Range1Membericlr:StockOptionAndAwardPlansMember2022-01-012022-12-310001060955iclr:Range2Member2022-01-012022-12-310001060955iclr:Range2Membericlr:StockOptionAndAwardPlansMember2022-12-310001060955iclr:Range2Membericlr:StockOptionAndAwardPlansMember2022-01-012022-12-310001060955iclr:Range3Member2022-01-012022-12-310001060955iclr:Range3Membericlr:StockOptionAndAwardPlansMember2022-12-310001060955iclr:Range3Membericlr:StockOptionAndAwardPlansMember2022-01-012022-12-310001060955iclr:Range4Member2022-01-012022-12-310001060955iclr:Range4Membericlr:StockOptionAndAwardPlansMember2022-12-310001060955iclr:Range4Membericlr:StockOptionAndAwardPlansMember2022-01-012022-12-310001060955us-gaap:EmployeeStockOptionMember2021-07-012021-07-010001060955iclr:RestrictedStockUnitsTwentyThirteenMember2015-05-112015-05-110001060955iclr:RestrictedStockUnitsTwentyThirteenMember2015-05-110001060955iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember2019-05-160001060955iclr:NonexecutiveDirectorMembericlr:ConsultantsRestrictedStockUnitsTwentyNineteenMember2019-01-012020-12-310001060955iclr:PerformanceShareUnitMember2021-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2021-12-310001060955iclr:PerformanceShareUnitMember2022-12-310001060955us-gaap:RestrictedStockUnitsRSUMember2022-12-310001060955us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2022-12-310001060955us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2022-12-310001060955us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2021-12-310001060955us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2021-12-310001060955srt:MinimumMembericlr:PerformanceShareUnitMember2022-12-310001060955srt:MaximumMembericlr:PerformanceShareUnitMember2022-12-310001060955srt:MinimumMembericlr:PerformanceShareUnitMember2021-12-310001060955srt:MaximumMembericlr:PerformanceShareUnitMember2021-12-310001060955iclr:PerformanceBasedGrantsMembersrt:MaximumMember2022-12-310001060955us-gaap:CostOfSalesMember2020-01-012020-12-310001060955us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310001060955iclr:TransactionAndIntegrationExpenseMember2022-01-012022-12-310001060955iclr:TransactionAndIntegrationExpenseMember2021-01-012021-12-310001060955iclr:TransactionAndIntegrationExpenseMember2020-01-012020-12-31iclr:segment0001060955iclr:RestOfEuropeMember2022-01-012022-12-310001060955iclr:RestOfEuropeMember2021-01-012021-12-310001060955iclr:RestOfEuropeMember2020-01-012020-12-310001060955iclr:OtherCountriesMember2022-01-012022-12-310001060955iclr:OtherCountriesMember2021-01-012021-12-310001060955iclr:OtherCountriesMember2020-01-012020-12-310001060955country:IE2022-12-310001060955country:IE2021-12-310001060955iclr:RestOfEuropeMember2022-12-310001060955iclr:RestOfEuropeMember2021-12-310001060955country:US2021-12-310001060955iclr:OtherCountriesMember2022-12-310001060955iclr:OtherCountriesMember2021-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:DSBiopharmaLimitedMember2022-01-012022-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:DSBiopharmaLimitedMember2021-01-012021-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:DSBiopharmaLimitedMember2022-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:DSBiopharmaLimitedMember2021-12-310001060955iclr:AfimmuneLimitedMemberus-gaap:SubsidiaryOfCommonParentMember2022-01-012022-12-310001060955iclr:AfimmuneLimitedMemberus-gaap:SubsidiaryOfCommonParentMember2021-01-012021-12-310001060955iclr:AfimmuneLimitedMemberus-gaap:SubsidiaryOfCommonParentMember2022-12-310001060955iclr:AfimmuneLimitedMemberus-gaap:SubsidiaryOfCommonParentMember2021-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:CorvusPharmaceuticalsMember2022-01-012022-12-310001060955us-gaap:SubsidiaryOfCommonParentMembericlr:CorvusPharmaceuticalsMember2022-12-310001060955iclr:OncacareMemberus-gaap:SubsidiaryOfCommonParentMember2022-12-310001060955iclr:OncacareMemberus-gaap:SubsidiaryOfCommonParentMember2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.20549
______________________________________________________________________
FORM 20-F
(Mark One)
Registration statement pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934
OR
Annual report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
For the fiscal year ended: December 31, 2022
OR
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
OR
Shell company report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.
_____________________________________
Commission File Number: 333-08704
ICON PUBLIC LIMITED COMPANY
 (Exact name of Registrant as Specified in its Charter) 
 ICON PLC 
 (Translation of Registrant’s name into English)
 Ireland 
 (Jurisdiction of Incorporation or Organization) 
 South County Business Park, 
 Leopardstown, Dublin 18, D18 X5R3 
 Ireland 
 (Address of principal executive offices) 
Brendan Brennan, Chief Financial Officer
South County Business Park, Leopardstown, Dublin 18, D18 X5R3, Ireland.
Brendan.Brennan@iconplc.com
+353-1-291-2000
_____________________________________
(Name, telephone number, email and/or facsimile number and address of Company contact person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class Trading symbol(s)Name of each exchange on which registered
ORDINARY SHARES, PAR VALUE €0.06 EACHICLRNASDAQ Global Select Market
Securities registered or to be registered pursuant to section 12(g) of the Act:
NONE
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: 
NONE 
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 81,723,555 Ordinary Shares.
Indicate by check mark if the registrant is a well-known seasoned issuer, as determined in Rule 405 of the Securities Act. Yes     No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. Yes     No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes     No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer or an emerging growth company.
Large accelerated filer                                                       Accelerated filer                                                                       Non-accelerated filer
Emerging growth company
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.   
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
U.S. GAAP                                                      International Financial Reporting Standards as issued                                             Other
by the International Accounting Standards Board   
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 Item 18
If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes No



TABLE OF CONTENTS
 
  
PART I
 
PART II 

PART III
 



General Information

As used herein, “ICON plc”, “ICON”, "ICON Group", the “Company” and “we”, "our" or “us” refer to ICON public limited company and its consolidated subsidiaries, unless the context requires otherwise.

Unless otherwise indicated, ICON plc’s financial statements and other financial data contained in this Form 20-F are presented in United States dollars (“$”) and are prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”).

In this Form 20-F, references to "U.S. dollars", "U.S.$" or "$" are to the lawful currency of the United States, references to “euro” or “€” are to the European single currency adopted by nineteen members of the European Union, references to "pound sterling", "sterling", "£", "pence" or "p" are to the lawful currency of the United Kingdom. ICON publishes its consolidated financial statements in U.S. dollars.

On July 1, 2021, the Company completed the Acquisition of PRA Health Sciences, Inc. ("PRA") by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA, the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA and its subsidiaries became wholly owned subsidiaries within the ICON Group. The financial information presented in this Form 20-F reflect the results of the combined Company for the year ended December 31, 2022. The financial information presented for the years ended December 31, 2021 and December 31, 2020  are as previously reported and do not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.

Cautionary Statement Regarding Forward-looking Statements

Statements included herein which are not historical facts are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Forward-looking statements may be identified by the use of future tense or other forward looking words such as “believe”, “expect”, “anticipate”, “should”, “may”, “strategy”, or other variations or comparable terminology. The forward looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, our results could be materially adversely affected. The risks and uncertainties include, but are not limited to, dependence on the pharmaceutical industry and certain clients, the need to regularly win projects and then to execute them efficiently and correctly, the challenges presented by rapid growth, our expectations concerning the ongoing impact of the novel coronavirus identified as 'COVID-19' on our operational results, the challenges associated with the integration of PRA, competition and the continuing consolidation of the industry, the dependence on certain key executives, changes in the regulatory environment, exchange rate fluctuations, inflation and rising labor costs, the conflict in Ukraine, and other factors identified in the Company’s United States Securities and Exchange Commission filings and in the “Risk Factors” included on pages 3 through 21. The Company has no obligation under the PSLRA to update any forward looking statements and does not intend to do so.
1


Part I

Item 1.   Identity of Directors, Senior Management and Advisers.

    Not applicable.

Item 2.  Offer Statistics and Expected Timetable.

    Not applicable.

Item 3.  Key Information.

A.[Reserved]

B. Capitalization and indebtedness
    
The following table presents our capitalization as of December 31, 2022 and December 31, 2021:

December 31,December 31,
20222021
Total debt4,701,213 5,501,213 
Less debt issuance costs and debt discount
(47,026)(64,901)
Total debt, net$4,654,187 $5,436,312 
Share Capital6,649 6,640 
Additional paid-in capital6,840,306 6,733,910 
Other undenominated capital 1,162 1,134 
Accumulated other comprehensive income (171,538)(90,937)
Retained earnings1,821,384 1,416,080 
Total Shareholders’ Equity$8,497,963 $8,066,827 
Total Capitalization$13,152,150 $13,503,139 

On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). The Company drew down debt of $6,015 million in order to finance the cash portion of the Merger consideration. ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities") of which, $1,314 million has been repaid as of December 31, 2022 from cash generated by the Company in the period since the completion of the Merger. In addition to the Senior Secured Credit Facilities, the Company, issued $500 million in aggregate principal amount of 2.875% senior secured notes in a private offering ("Senior Secured Notes").

C. Reasons for the offer and use of proceeds
    
Not applicable.

D. Risk Factors

    Various risk factors that are relevant to our business and the services we provide are outlined below. The occurrence of any of these events may materially and adversely affect our business operations, financial condition and results of operations and future prospects.


2


Summary of Risk Factors

Below is a summary of some of the principal risks that could adversely affect our business, operations and financial results:

Risk Related to Our Business and Operations
The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.
If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected.
We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.
The inability of biotechnology customers to raise adequate financing or funding could affect our business.
Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.
If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected.
If we fail to attract or retain key personnel, our performance may suffer.
We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities which may result in additional costs to the business.
Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.
Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.
Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business.
A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance.
Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations.
Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business.
Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.
We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials.
A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.
We may be unable to realize anticipated cost and tax synergies and expect to incur substantial expenses related to the Merger.
Improper performance of our services could adversely impact our reputation and our financial results.
Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.
We have only a limited ability to protect our intellectual property rights and these rights are important to our success.
The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.
We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction.
We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.
We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.

Risk Related to Our Industry
Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.
Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.
Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.
We operate in a highly competitive and dynamic market.
We may be adversely affected by industry, customer or therapeutic concentration.

3


Risk Related to Our Financial Results and Financial Position
Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.
Our exposure to exchange rate fluctuations could adversely affect our future results of operations.
Inflation and rising labor costs could adversely affect our future results of operations.
Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations.
Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.
The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.
Changes in accounting standards may adversely affect our financial statements.

Risk Related to Our Indebtedness
We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company’s business, financial condition or results of operations.
Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.
Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on the unhedged balance of our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.
Borrowings under our Senior Secured Credit Facilities bear interest at a variable rate that is based on the Secured Overnight Financing Rate (“SOFR”), which may have consequences for us that cannot be reasonably predicted and may adversely affect our liquidity, financial condition, and results of operations.

Risk Related to Political, Legal or Regulatory Environment
We may lose business opportunities as a result of health care reform and the expansion of managed care organizations.
Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.
The conflict in Ukraine could adversely affect our future results of operations.
We may lose business as a result of changes in the regulatory environment.
Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.
We are subject to political, regulatory, operational and legal risks associated with our international operations and any changes or uncertainty in the regulatory regime (including changes in trade compliance laws and regulations as a result of the ongoing conflict in Ukraine) could disrupt our business in the region or the results of our operations as a result of increased compliance costs.
We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.
Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.
Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business.
The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.
Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.
Environmental, social and governance matters may impact our business and reputation.

Risk Related to Our Common Stock
Volatility in the market price of our common stock could lead to losses by investors.
An investor's return may be reduced if we lose our foreign private issuer status.
We do not expect to pay any cash dividends for the foreseeable future.
A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.


4


Risk Related to Our Business and Operations

The potential loss or delay of our large contracts, or of multiple contracts, could adversely affect our results.

Our clients may discontinue using our services completely or cancel some projects either without notice or upon short notice. The termination or delay of a large contract, or of multiple contracts, could have a material adverse effect on our revenue and profitability. Historically, clients have canceled or discontinued projects and may in the future cancel their contracts with us for reasons including, amongst others:
 
the failure of products being tested to satisfy safety or efficacy requirements;
unexpected or undesired clinical results of the product; 
a decision that a particular study is no longer necessary or viable;
poor project performance, quality concerns, insufficient patient enrollment or investigator recruitment; and 
production problems resulting in shortages of the drug.
 
As a result, contract terminations, delays or other changes are part of our clinical services business. In the event of termination, our contracts often provide for fees for winding down the trial but these fees may not be sufficient for us to maintain our margins, and termination may result in lower resource utilization rates. In addition, we may not realize the full benefits of our unsatisfied performance obligation of contractually committed services if our clients cancel, delay or reduce their commitments under our contracts with them. Therefore, the loss, early termination or delay of a large contract or contracts could adversely affect our revenues and profitability.

If we do not generate new business awards, or if new business awards are delayed, terminated, reduced in scope or fail to go to contract, our business, financial conditions, results of operations or cash flows may be materially adversely affected.

Our business is dependent on our ability to generate new business awards from new and existing customers and maintain existing customer contracts. If we were unable to generate new business awards on a timely basis and contract for those awards, that could have a material impact on our business, financial condition, results of operations or cash flows.

We depend on a limited number of customers and a loss of, or significant decrease in, business from one or more of them could affect our business.
 
While no customers individually contributed more than 10% of our revenues during the years ended December 31, 2022 and December 31, 2021, our top five customers represented 28.3% and 31.6% of our revenues, respectively. The loss of, or a significant decrease in, business from one or more of these key customers could have a material adverse impact on our results of operations and financial results.

The inability of biotechnology customers to raise adequate financing or funding could affect our business.

A portion of our revenue is generated from sales and services to the biotechnology industry. The clients we serve are commonly subject to financial pressures, including, but not limited to, the ability to obtain adequate financing or generate sufficient funding. To the extent our clients face such pressures, or they change how they utilize our offerings, the demand for our services, or the prices our clients are willing to pay for those services, may decline. Any such decline could have a material adverse effect on our business, operating results and financial condition.

Our financial results may be adversely impacted if we underprice our contracts, overrun our cost estimates or fail to receive approval for, or experience delays in, documenting change orders.
 
Many of our contracts are long-term fixed price or fixed unit price contracts for services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Revenue recognized on these service contracts are based on an assessment of progress towards completion being the cost of time and other third party costs as a percentage of total estimated time and other third party costs to deliver our services. As a result, variations in the timing and progress of large contracts may materially adversely affect our results of operations. Estimating time and costs to complete requires judgment and includes consideration of the complexity of the study, the number of geographical sites where trials are to be conducted and the number of patients to be recruited at each site. We regularly review the estimated hours on each contract to determine if the budget accurately reflects the agreed tasks to be performed, taking into account the state of progress at the time of review.

We bear the risk of cost overruns unless the scope of activity is revised from the contract specifications and we are able to negotiate a contract modification. We endeavor to ensure that any changes in scope are appropriately monitored and change orders or contract modifications are promptly negotiated and documented for changes in scope. If we fail to successfully negotiate change orders for changes in the resources required or the scope of the work to be performed, and the costs of performance of these contracts exceeded their fixed fees, it could materially adversely affect our operations and financial results.

5


If we are unable to successfully develop and market new services or enter new markets, our growth, results of operations or financial condition could be adversely affected.

A key element of our growth strategy is the successful development and marketing of new services or entering new markets that complement or expand our existing business. As we develop new services or enter new markets, we may not have or be able to adequately build the competencies necessary to perform such services satisfactorily, may not receive market acceptance for such services or may face increased competition. If we are unable to succeed in developing new services, entering new markets or attracting a client base for our new services or in new markets, we will be unable to implement this element of our growth strategy, and our future business, reputation, results of operations could be adversely impacted.

If we fail to attract or retain key personnel, our performance may suffer.
 
Our business, future success and ability to continue to expand operations depends upon our ability to attract, hire, train and retain qualified professional, scientific and technical operating people. We compete for qualified professionals with other Clinical Research Organizations (“CROs”), temporary staffing agencies and the in-house departments of pharmaceutical, biotechnology and medical device companies. An inability to attract and retain a sufficient number of high caliber clinical research professionals (in particular, key personnel and executives) at an acceptable cost would impact our ability to provide our services, our future performance and results of operations.

We may face challenges retaining employees which could cause disruption to our integration plans and day-to-day activities, which may result in additional costs to the business.

The attraction, development and retention of our talent is critical to the success of the Company, and we are working to strengthen processes around these areas to minimize retention risk and support a successful integration. The Company, led by the Chief Human Resource Officer, is taking meaningful action to retain employees. Through our annual Talent Review process we have identified opportunities for improvement as it relates to employee retention. Our People Plans have set specific goals for each functional area in terms of three critical areas: talent attraction, development and retention. However, we can provide no assurances that our efforts in this respect will be successful.

Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business. We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. Our success depends on the knowledge, capabilities, and quality of our people.

Our ability to perform clinical trials is dependent upon the ability to recruit suitable willing patients.

The successful completion of clinical trials is dependent upon the ability to recruit suitable and willing patients on which to test the drug under study. The availability of suitable patients for enrollment in studies is dependent upon many factors including, amongst others, the size of the patient population, the design of the study protocol, eligibility criteria, the referral practices of physicians, the perceived risks and benefits of the drug under study and the availability of alternative medication, including medication undergoing separate clinical trials. Insufficient or inappropriate patient enrollment may result in the termination or delay of a study which could have a material adverse impact on our results of operations.

The Company is focused on continuing to develop its expertise in patient recruitment with the establishment in 2020 of Accellacare, a global clinical research network, offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The focus is on making it easier for the site and the patient to actively participate in a trial to ensure increased predictability, enrollment and retention. Our site and patient solutions group includes upfront planning of site and patient management including identification, enrollment and engagement.

Improved site selection is achieved through:

leading technology to identify where the patients are that match the protocol;
assessment of the qualification of sites based on real data;
partnerships with leading technology vendors and developing the capability to enable EMR interrogation into clinical insights such as sub-populations and larger pre-screened pool where the technology and regulations are enabled.

6


The burden on the site, in ensuring patient enrollment and engagement, is achieved through integrated site networks. ICON has a number of site alliance partners. During 2018, we enhanced our site and patient recruitment capabilities with an expansion of the PMG Research network through a partnership with the DuPage Medical Group. During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, ICON announced the launch of Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research, MeDiNova and CRN. Also in 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions. The new site network is focused on implementing a range of commercial models with specialist oncology healthcare providers in the US and EMEA, to accelerate the recruitment and retention of patients into oncology trials. The oncology site network operates as a joint venture between the Company and a third party company which has extensive experience in developing and running a site network. We also use digital solutions to drive site performance, including pre-screening, eConsent, learning management, document tracking and management with key applications.

Our ability to perform clinical trials is dependent upon our ability to recruit suitable willing investigators.

We contract with physicians located in hospitals, clinics or other similar sites, who serve as investigators in conducting clinical trials to test new drugs on their patients. Investigators supervise administration of the study drug to patients during the course of the clinical trial. The successful conduct of a clinical trial is dependent upon the integrity, experience and capabilities of the investigators conducting the trial. Insufficient investigator recruitment, which in turn may lead to insufficient or inappropriate patient enrollment, may result in the termination or delay of a study which could have a material adverse impact on our results of operations.

Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business.

In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts or floods, or other events that may result from the impact of climate change on the environment, such as sea level rise. As a result, we could experience increased costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions.

A disease outbreak, epidemic or pandemic such as COVID-19, could adversely affect our business performance.

A disease outbreak, such as influenza or coronavirus, could negatively impact our operations. We could experience restrictions on our ability to travel, or the ability of patients or other service providers to travel, to monitor our clinical trials and to ensure laboratory samples are collected and analyzed on time as a result of an outbreak. The potential impact of an epidemic or pandemic may also result in increased operating costs and result in a requirement to increase investment in impact prevention. COVID-19 has affected, and may continue to affect, our business performance and could adversely affect the economies and financial markets worldwide, resulting in an economic downturn that could impact our business, financial condition and results of operations. We may be required, or choose, to take temporary measures intended to help minimize the risk of infection from the virus for our employees, which could negatively affect our business and cannot presently be predicted with confidence.
    
Our business depends on the continued effectiveness and availability of our information systems, including the information systems we use to provide our services to our clients, and any system failures of, security breaches of or cyber attacks to these systems may materially limit our operations or have a material adverse effect on our results of operations.

Due to the global nature of our business and our reliance on information systems to provide our services, we use web-enabled and other integrated information systems in delivering our services. We will continue to increase the use of these systems and such systems will either be developed internally or provided in conjunction with third parties. We also provide access to similar information systems to certain clients in connection with the services we provide them. As the use, scope and complexity of our information systems continue to grow, we are exposed to, and will increasingly be exposed to, the risks inherent in the development, integration and ongoing operation of evolving information systems, including:

disruption or failure of data centers, telecommunications facilities or other key infrastructure platforms;
security breaches, cyber attacks or other failures or malfunctions in our application or information systems or their associated hardware or other systems that we have access to, or that we rely upon, or that have access to our systems;
security breaches, cyber attacks or malfunctions with key suppliers or partners who we rely on to provide services to customers; and
excessive costs, excessive delays or other deficiencies in, or problems with, systems development and deployment.

7


The materialization of any of these risks may impede our ability to provide services, the processing of data, the delivery of databases and services and the day-to-day management of our business and could result in the corruption, loss or unauthorized disclosure of proprietary, confidential or other data, as well as reputational harm.

While we have cybersecurity controls and disaster recovery plans in place, they might not adequately protect us in the event of a system failure, security breach or cyber attack. To date, no cyber attacks have had a material impact on operations or financial reporting. Additionally, despite any precautions we take, damage from fire, floods, hurricanes, power loss, telecommunications failures, computer viruses, information system security breaches, cyber attacks and similar events that impact our various computer facilities could result in interruptions in the flow of data to our servers and from our servers to our clients. Corruption or loss of data may result in the need to repeat a trial at no cost to the client, but at significant cost to us, or result in the termination of one or more contracts, legal proceedings or claims against us or damage to our reputation. Additionally, significant delays in system enhancements or inadequate performance of new or upgraded systems once completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events such as security breaches, cyber attacks, natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities in which we have offices, could adversely affect our business.
 
Unauthorized disclosure of sensitive or confidential data, whether through system failure or employee negligence, fraud or misappropriation, could damage our reputation and cause us to lose clients. Similarly, despite investing in information and cybersecurity controls, there is a risk that unauthorized access to our information systems or those we develop for our clients, whether by our employees or third parties, including a cyber attack by computer programmers and hackers who may attack ICON systems, develop and deploy viruses, worms, ransomware or other malicious software programs, could result in negative publicity, significant remediation costs, legal liability, loss of customers and damage to our reputation and could have a material adverse effect on our results of operations and financial results. In addition, our liability insurance might not be sufficient in type, the cover provided or amount to adequately cover us against claims related to security breaches, cyber attacks and other related breaches.

Our information systems, and those of third parties which we utilize, may face increased cybersecurity risks due to the COVID-19 pandemic, including from the significant number of employees that are working remotely or otherwise impacted by stay-at-home orders. Additional remote access points provide new potential vulnerabilities to cybercriminals. Employees of ICON and third parties may be more susceptible to social engineering efforts, and to phishing attempts which can disguise malware as a legitimate effort to circulate important information relating to COVID-19. 

Additionally, ICON completed the Merger with PRA on July 1, 2021 and, as a result, the IT landscape and physical footprint of the Company has increased significantly. As the organization invests in the consolidation of offices, data centers, IT systems and business services a significant amount of due diligence has been completed to understand the IT landscape and increased attack surface. While the organization continues with substantial integration efforts, a failure to effectively manage these activities in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.

Upgrading the information systems that support our operating processes and evolving the technology platform for our services pose risks to our business.

Continued efficient operation of our business requires that we implement standardized global business processes and evolve our information systems to enable this implementation. We have continued to undertake significant programs to optimize business processes with respect to our services. A failure to effectively manage the implementation and adapt to new processes designed into these new or upgraded systems in a timely and cost-effective manner may result in disruption to our business and negatively affect our operations.

We have entered into agreements with certain vendors to provide systems development and integration services that develop or license to us the IT platform for programs to optimize our business processes. If such vendors fail to perform as required or if there are substantial delays in developing, implementing and updating the IT platform, our customer delivery may be impaired and we may have to make substantial further investments, internally or with third parties, to achieve our objectives. Additionally, our progress may be limited by parties with existing or claimed patents who seek to prevent us from using preferred technology or seek license payments from us.

Meeting our objectives is dependent on a number of factors which may not take place as we anticipate, including obtaining adequate technology-enabled services, creating IT-enabled services that our customers will find desirable and implementing our business model with respect to these services. We are continuing to develop opportunities for automation across ICON using state of the art automation tools including Robotic Process Automation (RPA), the development of new applications and capabilities, and enabling deeper integration across our digital ecosystem. To remain competitive within our industry and keep pace with the rapid evolution of the technological landscape, it is critical that we continue to innovate and expand the capabilities of our current technologies. This applies in particular to our ICONIK, Firecrest, ADDPLAN, Integrated Dataverse (IDV®) and One Search services. Also, increased requirements for investment in information technology may negatively impact our financial condition, including profitability.

8


Failure to meet productivity objectives under our business improvement objectives could adversely impact our competitiveness and therefore our operating results.

We continue to pursue business transformation initiatives to embed technology and innovation and deliver operational efficiencies. As part of these initiatives, we seek to improve our productivity, flexibility, quality, functionality and cost savings by our on-going investment in global technologies, continuous improvement of our business processes and functions to deliver economies of scale. These initiatives may not deliver their intended gains or be completed in a timely manner which may adversely impact our competitiveness and our ability to meet our growth objectives and therefore, could adversely affect our business and operating results, including profitability.

We rely on our interactive response technologies to provide accurate information regarding the randomization of patients and the dosage required for patients enrolled in the trials.

We develop and maintain computer run and web based interactive response technologies to automatically manage the randomization of patients in trials, assign the study drug and adjust the dosage when required for patients enrolled in trials we support. An error in the design, programming or validation of these systems could lead to inappropriate assignment or dosing of patients, which could give rise to patient safety issues and invalidation of the trial and/or liability claims against the Company, amongst other things, any of which could have a material effect on our financial condition and operations.

A failure to identify and successfully close and integrate strategic acquisition targets could adversely impact our ongoing business and financial results.

We have made a number of acquisitions, including the Merger, and continue to review new acquisition opportunities. If we are unable to identify suitable acquisition targets, complete an acquisition or successfully integrate an acquired company or business, our business may be disrupted. The success of an acquisition will depend upon, among other things, our ability to:
 
effectively and quickly assimilate the operations and services or products of the acquired company or business; 
integrate acquired personnel; 
retain and motivate key employees; 
retain customers; and 
minimize the diversion of management's attention from other business concerns.

In the event that the operations of an acquired company or business do not meet our performance expectations, we may have to restructure the acquired company or business or write-off the value of some, or all, of the assets of the acquired company or business.
 
We may be unable to realize anticipated cost and tax synergies and expect to incur substantial expenses related to the Merger.

We expect to generate run rate cost synergies of approximately $150 million and tax savings from the combined target effective tax rate; both to be realized within approximately four years after completion of the Merger. Since completion of the Merger, we have progressed many of our key integration plans including rationalization of our office footprint, targeted headcount reductions to improve efficiency and key system integrations. The actions completed to date are ahead of our original plan such that we now anticipate realizing our run rate cost synergies by the end of 2023. Our ability to achieve such cost and tax synergies in the timeframe described, is subject to various assumptions by management, which may or may not prove to be accurate, as well as the incurrence of costs in our operations that offset all or a portion of such cost synergies. As a consequence, we may not be able to realize all of these cost and tax synergies within the timeframe expected. Failure to achieve the expected cost and tax synergies could significantly reduce the expected benefits associated with the Merger.

We expect to continue to incur non-recurring costs associated with the combination of the two companies and achieving the desired cost synergies. These fees and costs have been, and will continue to be, substantial. Such costs, as well as other unanticipated costs and expenses, could have a material adverse effect on our financial condition and operating results.

Improper performance of our services could adversely impact our reputation and our financial results.

The performance of clinical development services is complex and time-consuming. We may make mistakes in conducting a clinical trial that could negatively impact or damage the usefulness of the clinical trial or cause the results to be reported improperly. If the clinical trial results are compromised, we could be subject to significant costs or liability, which could have an adverse impact on our ability to perform our services. Large clinical trials are costly, and while we endeavor to contractually limit our exposure to such risks, improper performance of our services could have an adverse effect on our financial condition, damage our reputation and result in the cancellation of current contracts or failure to obtain new contracts from affected or other clients.

9


Our relationships with existing or potential customers who are in competition with each other may adversely impact the degree to which other customers or potential customers use our services, which may adversely affect our results of operations.

The biopharmaceutical industry is highly competitive, with biopharmaceutical companies each seeking to persuade payers, providers and patients that their drug therapies are better and more cost-effective than competing therapies marketed or being developed by competing companies. In addition to the adverse competitive interests that biopharmaceutical companies have with each other, biopharmaceutical companies also have adverse interests with respect to drug selection and reimbursement with other participants in the healthcare industry, including payers and providers. Biopharmaceutical companies also compete to be first to market with new drug therapies. We regularly provide services to biopharmaceutical companies who compete with each other and we sometimes provide services to such customers regarding competing drugs in development. Our existing or future relationships with our biopharmaceutical customers may therefore deter other biopharmaceutical customers from using our services or may result in our customers seeking to place limits on our ability to serve other biopharmaceutical industry participants. In addition, our further expansion into the broader healthcare market may adversely impact our relationships with biopharmaceutical customers and such customers may elect not to use our services, reduce the scope of services that we provide to them or seek to place restrictions on our ability to serve customers in the broader healthcare market with interests that are adverse to theirs. Any loss of customers or reductions in the level of revenues from a customer could have a material adverse effect on our results of operations, business and prospects.

We have only a limited ability to protect our intellectual property rights and these rights are important to our success.

Our success depends, in part, upon our ability to develop, use and protect our proprietary methodologies, analytics, systems, technologies and other intellectual property. Existing laws of the various countries in which we provide services or solutions offer only limited protection of our intellectual property rights, and the protection in some countries may be very limited. We rely upon a combination of trade secrets, confidentiality policies, non-disclosure, invention assignment and other contractual arrangements and patent, copyright and trademark laws, to protect our intellectual property rights. These laws are subject to change at any time and certain agreements may not be fully enforceable, which could further restrict our ability to protect our innovations. Intellectual property rights may not prevent competitors from independently developing services similar to, or duplicative of, ours. Further, the steps we take in this regard might not be adequate to prevent or deter infringement or other misappropriation of our intellectual property by competitors, former employees or other third parties and we might not be able to detect unauthorized use of, or take appropriate and timely steps to enforce our intellectual property rights. Enforcing our rights might also require considerable time, money and oversight and we may not be successful in enforcing our rights.

The biopharmaceutical industry has a history of patent and other intellectual property litigation and we might be involved in costly intellectual property lawsuits.

The biopharmaceutical industry has a history of intellectual property litigation, and these lawsuits will likely continue in the future. Accordingly, we may face patent infringement legal proceedings by companies that have patents for similar business processes or other legal proceedings alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive, take significant time and divert management’s attention from other business concerns, regardless of the outcome of the litigation. If we do not prevail in an infringement lawsuit brought against us, we might have to pay substantial damages and we could be required to stop the infringing activity or obtain a license to use technology on unfavorable terms. Any infringement or other legal processing related to intellectual property could have a material adverse effect on our operations and financial condition.

We act as authorized representative or legal representative for some clients pursuant to certain jurisdictional requirements for sponsors of clinical trials to appoint an authorized representative or legal representative with a local presence within the relevant jurisdiction.

We act as authorized representative pursuant to Medical Devices Directive 93/42/EEC (“MDD”), Medical Devices Regulation 2017/745 (“MDR”) and Active Implantable Medical Devices Directive 90/385/EEC (“AIMD”) for certain clients who are located outside of the European Union. As authorized representative, we act on behalf of medical device manufacturers in relation to specified tasks with regard to their obligations under MDR.

We also act as legal representative pursuant to European Clinical Trials Directive (2021/20/EC) (“CTD”), EU Clinical Trials Regulation (No.536/2014) (“CTR”), MDD, MDR and AIMD, for certain clients who are located outside of the European Union with respect to clinical trials being carried out by those clients in the European Union. We also perform similar legal representative services for certain clients in other non-EU jurisdictions where client is located outside the relevant local jurisdiction, ICON has an established local legal entity and analogous local regulations have a similar requirement for a local legal representative for clinical trials being carried out in those jurisdictions. As legal representative, we are responsible for ensuring compliance with the client’s obligations pursuant to CTD, CTR and MDR or analogous local legislation and we are the addressee for all communications with the client provided for under CTD, CTR and MDR or analogous local legislation.

We provide these services subject to certain terms and conditions which are contained in our agreements with clients pertaining to these services. We aim to reduce any potential liability associated with these activities by seeking contractual
10


indemnification from our clients and by maintaining an appropriate level of insurance cover. However, there is no guarantee that the specific insurance will be available or that a client will fulfill its obligations in relation to their indemnity.

We rely on third parties to provide certain data and other information to us. Our suppliers or providers might increase our cost to obtain, restrict our use of or refuse to license data, which could lead to our inability to access certain data or provide certain services and, as a result, materially and adversely affect our operating results and financial condition.

Our services are derived from, or include, the use of data we collect from third parties. We have several data suppliers that provide us with a broad and diverse scope of information that we collect, use in our business and sell.

We generally enter into long-term contractual arrangements with many of our data suppliers. At the time we enter into a new data supply contract or renew an existing contract, suppliers may increase our cost to obtain and use the data provided by such supplier, increase restrictions on our ability to use or sell such data, or altogether refuse to license the data to us. Also, our data suppliers may fail to meet or adhere to our quality control standards or fail to deliver the data to us. Although no single supplier is material to our business, if suppliers that collectively provide a significant amount of the data we receive or use were to increase our costs to obtain or use such data, further restrict our access to or use of such data, fail to meet or adhere to our quality control standards, refuse to provide or fail to deliver data to us, our ability to provide data-dependent services to our clients may be adversely impacted, which could have a material adverse effect on our business, results of operations, financial condition or cash flow.

We rely on third parties for important products, services and licenses to certain technology and intellectual property rights. If there was failure in delivery by these parties, we might not be able to continue to obtain such products, services and licenses.
We depend on certain third parties to provide us with products and services critical to our business. Such services include, among others, suppliers of drugs for patients participating in trials, suppliers of kits for use in our laboratories, suppliers of reagents for use in our testing equipment and providers of maintenance services for our equipment. The failure of any of these third parties to adequately provide the required products or services, or to do so in compliance with applicable regulatory requirements, could have a material adverse effect on our business.

Some of our services rely on intellectual property, technology and other similar property owned and/or controlled by third parties. Our licenses to this property and technology could terminate or expire and we might not be able to replace these licenses in a timely manner. Also, we might not be able to renew these licenses on similar terms and conditions. Failure to renew these licenses, or renewals of these licenses on less advantageous terms, could have a material adverse effect on our business, results of operations, financial condition or cash flow.

Risk Related to Our Industry

Outsourcing trends in the pharmaceutical, biotechnology and medical device industries and changes in spending on research and development could adversely affect our operating results and growth rates.

We are dependent upon the ability and willingness of the pharmaceutical, biotechnology and medical device companies to continue to spend on research and development and to outsource the services that we provide. We are therefore subject to risks, uncertainties and trends that affect companies in these industries that we do not control. We have benefited to date from the tendency of pharmaceutical, biotechnology and medical device companies to outsource clinical research projects. Any downturn in these industries or reduction in spending or outsourcing could materially adversely affect our business. The following could each result in such a downturn:

if pharmaceutical, biotechnology or medical device companies expanded upon their in-house clinical or development capabilities, they would be less likely to utilize our services;
if governmental regulations were changed, it could affect the ability of our clients to operate profitably, which may lead to a decrease in research spending and therefore this could have a material adverse effect on our business; and
if unfavorable economic conditions or disruptions in the credit and capital markets negatively impacted our clients.

Large pharmaceutical companies are increasingly consolidating their vendor base and entering strategic partnership arrangements with a limited number of outsource providers.

Large pharmaceutical companies are continually seeking to drive efficiencies in their development processes to both reduce costs associated with the development of new drug candidates and accelerate time to market. As a result, large pharmaceutical companies, in particular, are increasingly looking to consolidate the number of outsource providers with which they engage, with many entering strategic partnership arrangements with a limited number of outsource providers. The failure to enter strategic partnership arrangements with customers or the loss of existing customers as a result of them entering strategic partnership arrangements with our competitors could have a material adverse impact on our results of operations.

11


Increased collaboration amongst pharmaceutical companies in research and development activities may lead to fewer research opportunities.

Certain pharmaceutical companies have begun to collaborate in seeking to develop new drug candidates. Increased collaboration amongst pharmaceutical companies may lead to fewer research opportunities, which in turn may lead to fewer outsource opportunities for companies within the CRO industry. A reduction in outsource opportunities as a result of this increased collaboration could have a material adverse impact on our results of operations.

We operate in a highly competitive and dynamic market.

The CRO industry is highly competitive. In particular, we compete with other large global CROs for strategic relationships with large pharmaceutical companies. If we are unable to retain and renew existing strategic relationships and win new strategic relationships, there could be a material adverse impact on our results. Similarly, we compete with other CROs for work which comes outside of these strategic relationships and being unable to win work outside of these strategic relationships would have a material adverse impact on our results.

The type and depth of services provided by CROs has changed in recent years. Failure to develop and market new services or expand existing service offerings could adversely affect our business and operations.

New entrants may also enter the market which would further increase competition and could adversely affect our business and operations.

We may be adversely affected by industry, customer or therapeutic concentration.
We provide services to biopharmaceutical, biotechnology, medical device and government organizations and our revenue is dependent on expenditures by these customers. Our business could therefore be adversely impacted by mergers, consolidation, business failures, distress in financial markets or other factors resulting in a decrease in the number of potential customers or therapeutic products being developed through the drug development progress. There has been consolidation in the biopharmaceutical market in recent years. If the number of our potential customers were to decline in the future, they may be able to negotiate price discounts or other terms for services that are less favorable to us than they have been historically.

Risk Related to Our Financial Results and Financial Position

Our quarterly results are dependent upon a number of factors and can fluctuate from quarter to quarter. They may fall short of prior periods, our projections or the expectations of securities analysts or investors, which may adversely affect the market price of our stock.
Our results of operations in any quarter can fluctuate or differ from expected or forecast results depending upon or due to, among other things, the number and scope of ongoing client projects, the commencement, postponement, variation, cancellation or termination of projects in a quarter, the mix of activity, cost overruns, employee hiring, employee attrition and other factors. Our revenue in any period is directly related to the number of employees who were working on billable projects together with investigator activity during that period. We may be unable to compensate for periods of under-utilization during one part of a fiscal period by earning revenue during another part of that period. We believe that operating results for any particular quarter are not necessarily a meaningful indicator of future results.

Also, if in future quarters, we are unable to continue to deliver operational efficiencies and our expenses grow faster than our revenues, our operating margins, profitability and overall financial condition may be materially adversely impacted.

Our exposure to exchange rate fluctuations could adversely affect our future results of operations.

Our contracts with clients are sometimes denominated in currencies other than the currency in which we incur expenses related to such contracts. Where expenses are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material adverse effect on our results of operations.

In addition, we are also subject to translation exposures as our consolidated financial results are presented in U.S. dollars, while the local results of a certain number of our subsidiaries are prepared in currencies other than U.S. dollars, including, amongst others, the pound sterling and the euro. Accordingly, changes in exchange rates between the U.S. dollar and those other currencies will affect the translation of subsidiary companies' financial results into U.S. dollars in reporting our consolidated financial results.



12


Inflation and rising labor costs could adversely affect our future results of operations.

Inflation and rising labor costs may result in significant increases to the cost of our services, which we may not be able to recover from our customers. Our contracts with clients are often fixed price or fixed price-per-unit contracts. If macroeconomic forces, such as inflation, cause the cost of inputs required to deliver these contracts to increase significantly, we may be unable to pass along these cost to our customers. A sustained increase in these costs may require us to increase the price of future service offerings. These actions could adversely affect our future revenue, gross margin, or both.

Our effective tax rate may fluctuate from quarter-to-quarter, which may adversely affect our results of operations.

Our quarterly effective tax rate has depended and will continue to depend on the geographic distribution of our taxable earnings amongst the multiple tax jurisdictions (such as Ireland, United States and United Kingdom) in which we operate and the tax law in those jurisdictions. Changes in the geographic mix of our results of operations amongst these jurisdictions may have a significant impact on our effective tax rate from quarter-to-quarter. Changes in tax law in one or more jurisdictions could also have a significant impact on our tax rate and results. In addition, as we operate in multiple tax jurisdictions, we may be subject to audits in certain jurisdictions. These audits may involve complex issues which could require an extended time period before being resolved. The resolution of audit issues may lead to additional taxes, interest as well as fines and/or penalties being imposed which could have a material adverse impact on our effective tax rate and our consolidated financial results.

Our unsatisfied performance obligation may not convert to revenue and the rate of conversion may slow.

Our unsatisfied performance obligation is the amount of awards that has not yet converted to revenue. This value is not necessarily a meaningful predictor of future results due to the potential for the cancellation or delay of projects included in the unsatisfied performance obligation. No assurances can be given that we will be able to realize this unsatisfied performance obligation in full as revenue. A failure to realize these awards could have a material adverse impact on our results of operations. In addition, as the length and complexity of projects increases, the rate at which awards convert to revenue may be slower than in the past. A significant reduction in the rate of conversion could have a material impact on our results of operations.
 
The Company is exposed to various risks in relation to our cash and cash equivalents and short term investments.
 
The Company’s treasury function manages our available cash resources and invests significant cash balances in various financial institutions to try to ensure optimum returns for our surplus cash balances. These balances are classified as cash and cash equivalents or short term investments depending on the maturity of the related investment. Cash and cash equivalents comprise cash and highly liquid investments with maturities of three months or less. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum “A-” rated fixed and floating rate securities.

     Given the global nature of our business, we are exposed to various risks in relation to these balances including liquidity risk, credit risk associated with the counterparties with whom we invest, interest rate risk on floating rate securities, sovereign risk (our principle sovereign risk relates to investments in U.S. Treasury funds) and other factors.

Although we have not recognized any significant losses to date on our cash and cash equivalents or short term investments, any significant declines in their market values could have a material adverse effect on our financial position and operating results.

Changes in accounting standards may adversely affect our financial statements.

We prepare our financial statements in accordance with generally accepted accounting principles in the United States of America ("US GAAP") which are revised on an on-going basis by the authoritative bodies. It is possible that future accounting standard updates may require changes to the accounting treatment that we apply in preparation of our financial statements. These changes may also require significant changes to our reporting systems. These updates may result in unexpected variability in the timing of recognition of revenue or expenses and therefore in our operating results.




13


Risk Related to Our Indebtedness

We have incurred substantial additional indebtedness in connection with the Merger, which could impair our flexibility and access to capital and could adversely affect the combined Company’s business, financial condition or results of operations.

Following completion of the Merger and the other transactions contemplated by the Merger Agreement, the Company has a substantial amount of debt. ICON borrowed approximately $6,015 million in order to pay PRA stockholders the cash consideration due to them as merger consideration under the Merger Agreement, pay related fees and transaction costs in connection with the transactions, and refinance existing indebtedness. The total remaining transaction related debt balance at December 31, 2022 was $4,701 million. This level of borrowings could adversely affect the Company in a number of ways, including, but not limited to, by placing us at a competitive disadvantage compared to our competitors that have less debt, causing us to incur substantial fees from time to time in connection with debt amendments or refinancing, making it more difficult for the Company to satisfy its obligations with respect to its debt or to its trade or other creditors, requiring a substantial portion of the Company’s cash flows from operations for the payment of interest on the Company’s debt, reducing the Company’s flexibility to respond to changing business and economic conditions, and reducing funds available for the Company’s investments in research and development, capital expenditures and other activities. If ICON cannot service its debt, it may have to take actions such as selling assets, seeking additional debt or equity, or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances.

In addition, ICON’s increased level of indebtedness could adversely affect ICON’s credit rating, which could result in increased borrowing costs for the Company in the future. No assurances can be made that ICON will be able to refinance any indebtedness incurred in connection with the Merger on terms acceptable to it or at all.

Covenants in our credit agreement and the indenture governing the Senior Secured Notes may restrict our business and operations. Our financial condition and results of operations could be adversely affected if we do not comply with those covenants.

The Senior Secured Credit Facilities and the indenture include certain customary covenants that limit our ability to, amongst other things, subject to certain exceptions:
make dividends, investments and other restricted payments;
enter into sale and leaseback transactions;
engage in share buybacks;
incur or assume liens or additional debt;
engage in mergers or reorganizations; or
enter into certain types of transactions with affiliates.

The revolving credit facility also includes a financial covenant that requires us to comply with a maximum consolidated leverage ratio. Our ability to comply with this financial covenant may be affected by events beyond our control.

Interest rate fluctuations may materially adversely affect our results of operations and financial conditions due to the variable interest rate on our senior secured term loan facility, our revolving credit facility or in respect of any future issuances of debt.

Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the original principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.

The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, no amounts were outstanding under the revolving loan facility with the exception of $4.5 million letters of credit given to landlords to guarantee lease arrangements.
14



Because the Company has variable rate debt, fluctuations in interest rates affect our business. We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative financial instruments. We have entered into certain interest rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt. Accordingly, any change in market value associated with these agreements is offset by the opposite market impact on the portion of the debt covered by such agreements. See Note 14 - Derivatives.

Borrowings under our Senior Secured Credit Facilities bear interest at a variable rate that is based on the Secured Overnight Financing Rate (“SOFR”), which may have consequences for us that cannot be reasonably predicted and may adversely affect our liquidity, financial condition, and results of operations.

On July 27, 2017, the U.K. Financial Conduct Authority (the “FCA”) announced that it intended to end the use of LIBOR effective after December 31, 2021 as the benchmark rate that many banks and issuers use to set interest rates for loans, securities, derivative contracts and other financial instruments. Recognizing the need to replace LIBOR, authorities in the United States convened the Alternative Reference Rates Committee (“ARRC”) in 2014 to identify a replacement for LIBOR with respect to indebtedness denominated in U.S. Dollars. In 2017, the ARRC identified SOFR, and in April 2018, the Federal Reserve Bank of New York began publishing SOFR.

SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. Although the U.S. Treasury-backed overnight repo market is highly liquid, there is currently no robust market for determining forward-looking SOFR term rates. Because SOFR is an overnight risk-free rate, whereas LIBOR has various terms and an embedded credit charge, the transition from LIBOR to SOFR will require adjustments, which may continue to vary for certain forms of indebtedness and financial instruments as the relevant markets adapt to SOFR’s implementation. Similar alternative benchmark replacements will be required to be implemented in respect of indebtedness and other financial instruments that are currently based on LIBOR quotes for currencies other than the U.S. Dollar.

The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or other base rate (as elected by the borrower), plus an applicable margin. The credit agreement also provides that LIBOR may be replaced by a SOFR-based rate for borrowings in U.S. Dollars upon (i) the FCA ceasing to provide LIBOR for U.S. Dollars or announcing that LIBOR is no longer representative or (ii) an early election by the Company and the administrative agent under our credit agreement to transition from LIBOR. On November 29, 2022, the Company agreed with its lenders to the adoption of SOFR as the benchmark rate within the Credit Agreement. The possible volatility of and uncertainty around SOFR as a LIBOR replacement rate and the applicable credit adjustment could result in higher borrowing costs for us, which would adversely affect our liquidity, financial condition, and results of operations.

Risk Related to Political, Legal or Regulatory Environment

We may lose business opportunities as a result of healthcare reform and the expansion of managed care organizations.
 
Numerous governments, including the U.S. government, have undertaken efforts to control growing healthcare costs through legislation, regulation and voluntary agreements with medical care providers and drug companies. If these efforts are successful, pharmaceutical, biotechnology and medical device companies may react by spending less on research and development and therefore this could have a material adverse effect on our business.

In addition to healthcare reform proposals, the expansion of managed care organizations in the health care market may result in reduced spending on research and development. Managed care organizations' efforts to cut costs by limiting expenditures on pharmaceuticals and medical devices could result in pharmaceutical, biotechnology and medical device companies spending less on research and development. If this were to occur, we would have fewer business opportunities and our revenues could decrease, possibly materially.

Healthcare reform legislation, other changes in the healthcare industry and in healthcare spending could adversely affect our business model, financial condition or results of operations.

Our results of operations and financial conditions could be affected by changes in healthcare spending and policy.  The healthcare industry is subject to changing political, regulatory and other influences. It is possible that legislation will be introduced and passed in the United States repealing, modifying or invalidating the current healthcare reform legislation, in whole or in part, and signed into law. Because of the continued uncertainty about the implementation of the current healthcare reform legislation, including the potential for further legal challenges or repeal of that legislation, we cannot quantify or predict with any certainty the likely impact of the current healthcare reform legislation or its repeal on the healthcare sector, on our customers and ultimately on our financial condition or results of operations.

On August 16, 2022, the U.S. government enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and
15


several tax incentives to promote clean energy, which will go into effect in 2023. The Company is continuing to assess the potential impact of these changes.

The conflict in Ukraine could adversely affect our future results of operations.

The current conflict in Ukraine has led to, among other things, hardship and the imposition of international economic sanctions aimed at the region. While the situation is subject to change, there remains the possibility of additional and harsher sanctions if the conflict intensifies. If that were to happen, our operations in the region may be severely curtailed or eliminated, which could adversely affect our results of operations. In addition, if the current unrest broadens or further escalates, our operations may be severely curtailed, which could adversely affect our results of operations.

We may lose business as a result of changes in the regulatory environment.

Various regulatory bodies throughout the world may enact legislation, rules and guidance which could introduce changes to the regulatory environment for drug development and research. The adoption and implementation of such legislation, rules and guidance is difficult to predict and therefore could have a material adverse effect on our business.

Failure to comply with the regulations and requirements of the U.S. Food and Drug Administration and other regulatory authorities could result in substantial penalties and/or loss of business.
The U.S. Food and Drug Administration, ("FDA"), and other regulatory and government authorities and agencies inspect and audit us from time to time to ensure that we comply with their regulations and guidelines, including environmental, health and safety matters, and other requirements imposed in connection with the performance of government contracts.  We must comply with the applicable regulatory requirements governing the conduct of clinical trials and contracting with the government in all countries in which we operate.
If we fail to comply with any of these requirements we could suffer some or all of: 
termination of or delay in any research;
disqualification of data;
denial of the right to conduct business;
criminal penalties;
financial penalties;
other enforcement actions including debarment from government contracts;
loss of clients and/or business; and
litigation from clients and/or patients and/or regulatory authorities and/or other affected third parties, and resulting material penalties, damages and costs.

We are subject to political, regulatory, operational and legal risks associated with our international operations.

We are one of a small group of organizations with the capability and expertise to conduct clinical trials on a global basis. We believe that this capability to provide our services globally in most major and developing pharmaceutical markets enhances our ability to compete for new business from large multinational pharmaceutical, biotechnology and medical device companies. We have expanded geographically in the past and intend to continue expanding in regions that have the potential to increase our client base or increase our investigator and patient populations. We expect that revenues earned in emerging markets will continue to account for an increasing portion of our total revenues. However, emerging market operations may present several risks, including civil disturbances, health concerns, cultural differences such as employment, regulatory and business practices, compliance with economic sanctions, laws and regulations, volatility in gross domestic product, economic and governmental instability, the potential for nationalization of private assets and the imposition of exchange controls. In addition, operating globally means the Company faces the challenges associated with coordinating its services across different countries, time zones and cultures.

Changes in the political and regulatory environment in the international markets in which we operate such as price or exchange controls could impact our revenue and profitability and could lead to penalties, sanctions and reputational damages if we are not compliant with those regulations. Political uncertainty and a lack of institutional continuity in some of the emerging, developing or other countries in which we operate could affect the orderly operation of markets in these economies. In addition, in countries with a large and complicated structure of government and administration, national, regional, local and other governmental bodies may issue inconsistent decisions and opinions that could increase our cost of regulatory compliance and/or have a material adverse effect on our business. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states. These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations.

Uncertainty of the legal environment in some emerging countries could also limit our ability to enforce our rights. In certain emerging and developing countries we enjoy less comprehensive protection for some of our rights, including intellectual
16


property rights, which could undermine our competitive position. Proceedings to enforce our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business.

If any of the above risks or similar risks associated with our international operations were to materialize, our results of operations and financial condition could be materially adversely affected.

We operate in many different jurisdictions and we could be adversely affected by violations of anti-corruption laws, including the United States Foreign Corrupt Practices Act of 1977 ("FCPA"), UK Bribery Act of 2010 ("Bribery Act") and similar anti-corruption laws in other jurisdictions as well as laws and regulations relating to trade compliance and economic sanctions.

The FCPA, UK Bribery Act of 2010 and similar anti-corruption laws in other jurisdictions prohibit us and our officers, directors, employees and third parties acting on our behalf, including agents, from corruptly offering, promising, authorizing, or providing anything of value to a "foreign official" for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. In addition, the FCPA imposes certain books, records and accounting control obligations on public companies and other issuers. The UK Bribery Act also prohibits "commercial" bribery and accepting bribes.

Our global business operations also must be conducted in compliance with applicable export controls and economic sanctions laws and regulations, including those administered by the U.S. Department of the Treasury’s (the “U.S. Treasury”) Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the European Union, His Majesty’s Treasury and other relevant trade compliance authorities.

Our internal policies mandate compliance with these anti-corruption and trade compliance laws and regulations. We also operate in many jurisdictions in which bribery or corruption can be common and compliance with anti-bribery laws may conflict with local customs and practices. Despite our training and compliance program safeguards, we cannot assure that our internal control policies, procedures and safeguards will protect us from acts in violation of anti-corruption and trade compliance laws and regulations committed by employees or other third parties associated with us and our continued expansion, including in developing countries, could increase such risk in the future. Violations of anti-corruption, economic sanctions and trade control laws and regulations, or even allegations of such violations, could disrupt our business and result in a material adverse effect on our financial condition, results of operations, cash flows and reputation. For example, violations of anti-corruption and trade compliance laws can result in restatements of, or irregularities in, our financial statements, disgorgement of profits, related stockholder lawsuits as well as severe criminal or civil sanctions. In some cases, companies that violate anti-corruption and trade compliance laws might be debarred by the U.S. government and/or lose their U.S. export privileges. In addition, the U.S. government or other governments may seek to hold us liable based on successor liability for violations of anti-corruption and trade compliance laws committed by companies that we acquire or in which we invest. Changes in anti-corruption and trade compliance laws or enforcement priorities could also result in increased compliance requirements and related costs which could materially adversely affect our business, financial condition, results of operations and cash flows. The recent increase in economic sanctions and trade controls, particularly relating to our ongoing operations in Russia, Ukraine and Belarus, has increased the amount of resources necessary to ensure compliance in this area.

Current and proposed laws and regulations regarding the protection of personal data could result in increased risks of liability or increased costs to us or could limit our service offerings.

ICON has a strong privacy posture, driven by the implementation of a core privacy governance strategy and the adoption of policies and procedures designed to help ensure that ICON, including our employees and contractors, can comply with applicable data protection laws (including, but not limited to, the General Data Protection Regulation (“GDPR”) (EU) 2016/679). Notwithstanding these measures, failure to comply with applicable data protection laws may occur and could result in increased risk of liability or increased costs to us or could limit our service offerings.

Administrative fines. The GDPR introduced a new regime of administrative fines for data protection infringements and provided for a tiered penalty structure based on the nature of the infringement. The EU supervisory authorities for the GDPR can directly impose fines on organizations found to be in breach of the GDPR. Lower tier administrative fines allow for fines of up to 2% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines allow for fines of up to 4% of worldwide turnover of the group in the preceding financial year. Higher tier administrative fines are more likely to be levied for major infringements of the GDPR and core data protection principles (e.g. transparency, data retention, accountability).

Penalties. The GDPR also permits Member States to implement rules on other penalties applicable to infringements of the GDPR, in particular, for infringements which are not subject to administrative fines under the GDPR itself. Therefore, Member States may legislate for further fines or penalties that may be criminal in nature.

Any fines levied under the GDPR must be effective, proportionate, and dissuasive. Supervisory authorities have been strengthening enforcement activities across the EU in recent years in respect of breaches of GDPR. The risk of fines and
17


penalties under the GDPR carries increased risk of liability to ICON and can result in increased costs and disruption to the delivery of our services.

Right to compensation of data subjects. In addition to the risk of administrative and criminal penalties, the GDPR also provides that any person who has suffered material or non-material damage as a result of an infringement of the GDPR shall have the right to receive compensation for the damage suffered, from the controller or processor responsible for the infringement. The level of award of damages is set by the competent court in the applicable EU Member State. This carries increased risk of liability for ICON.

Corrective Powers of the supervisory authorities. Each supervisory authority across the Member States of the EU also has corrective powers. Supervisory authorities have the power to order ICON to bring processing operations into compliance with the provisions of the GDPR in a specified manner within a specified time period, or to impose a temporary or definitive limitation including a ban on processing, and to order the suspension of data flows to a recipient in a third country or to an international organization. Supervisory authorities also have powers to conduct audits and investigations of ICON and instruct ICON to take certain actions. The exercise of these powers by supervisory authorities has the potential to increase costs for ICON and cause disruption to the business and delivery of our services.

From a US perspective, the confidentiality, collection, use and disclosure of personal data, including clinical trial patient-specific information, is subject to governmental regulation generally in the country that the personal data was collected or used. For example, United States federal regulations under the Health Insurance Portability and Accountability Act of 1996, or ("HIPAA"), and as amended in 2014 by the Health Information Technology for Economic and Clinical Health (“HITECH”) Act, require individuals’ written authorization, in addition to any required informed consent, before Protected Health Information may be used for research. HIPAA specifies standards for de-identifications and for limited data sets. We are both directly and indirectly affected by the privacy provisions surrounding individual authorizations because many investigators and organizations with whom we are involved in clinical trials and in our services are directly subject to them as a HIPAA “covered entity” and because we obtain identifiable health information from third parties that are subject to such regulations. As there are some instances where we are a HIPAA “business associate” of a “covered entity”, we can also be directly liable to the covered entity contractually for mishandling protected health information and, under HIPAA’s enforcement scheme, we can be subject to up to $1.9 million per year in civil money penalties for identical HIPAA violations. The per violation penalties and calendar year cap on penalties are adjusted annually for inflation under the Federal Civil Penalties Inflation Adjustment Act.

The foundational principles of the GDPR have helped shape the development of many other privacy laws globally. Internationally, data protection laws continue to be introduced at a rapid rate, with greater protections afforded to personal data than ever before, and greater risk of liability to organizations processing that personal data. As a global organization, ICON must ensure that our privacy posture continues to adapt to these new laws and regulations.

Additional legislation or regulation of this type might, among other things, require us to implement new security measures and processes which may require substantial expenditures or limit our ability to offer some of our services. Additionally, if we violate applicable laws, regulations or duties relating to the use, processing or security of personal data, we could be subject to civil liability or criminal prosecution, be forced to alter our business practices or suffer reputational harm.

Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business.

We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with governmental regulations, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical studies or data or documentation fraud or manipulation, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant fines or other sanctions.

18


The failure to comply with our government contracts or applicable laws and regulations could result in, among other things, fines or other liabilities, and changes in procurement regulations could adversely impact our business, results of operations or cash flows.
 
Revenues from our government customers are derived from sales to federal, state and local governmental departments and agencies through various contracts. Sales to public segment customers are highly regulated. Noncompliance with contract provisions, government procurement regulations or other applicable laws or regulations (including but not limited to the False Claims Act) could result in civil, criminal and administrative liability, including substantial monetary fines or damages, termination of government contracts or other public segment customer contracts, and suspension, debarment or ineligibility from doing business with the government and other customers in the public segment. In addition, generally contracts in the public segment are terminable at any time for convenience of the contracting agency or upon default. The effect of any of these possible actions by any governmental department or agency could adversely affect our business, results of operations or cash flows. In addition, the adoption of new or modified procurement regulations and other requirements may increase our compliance costs and reduce our gross margins, which could have a negative effect on our business, results of operations or cash flows.

Liability claims brought against us could result in payment of substantial damages, costs and liabilities and decrease our profitability.

We may face legal claims involving stockholders, consumers, clinical trial subjects, competitors, regulators and other parties. See 'Legal Proceedings' in Part A, Item 8 of this Form 20-F. Litigation and other legal proceedings are inherently uncertain, and adverse rulings could occur, including monetary damages, or an injunction stopping us from engaging in business practices, or requiring other remedies, including, but not limited to, compulsory licensing of patents. In addition, the combined Company may be exposed to increased litigation from stockholders, customers, suppliers, consumers and other third parties due to the combination of ICON’s business and PRA’s business following the Merger.

    Customer Claims

If we breach the terms of an agreement with a customer (for example if we fail to comply with the agreement, all applicable regulations or Good Clinical Practice) this could result in claims against us for substantial damages which could have a material adverse effect on our business. As we provide staff to deliver our services, there is a risk that our management, quality and control structures fail to quickly detect a failure by one or more employees or contractors to comply with all applicable regulations and Good Clinical Practice and our internal requirements and standard operating procedures thereby exposing us to the risk of claims by customers.

    Claims relating to Investigators

We contract with physicians who serve as investigators in conducting clinical trials to test new drugs on their patients. These patients will generally have underlying health conditions and this testing creates the risk of liability for personal injury to the patient or the risk of a serious adverse event occurring. Although investigators are generally required by law to maintain their own liability insurance, we could be named in lawsuits and incur expenses arising from any professional malpractice or other actions brought against the investigators with whom we contract.

    Indemnification from Customers

Indemnifications provided by our customers against the risk of liability for personal injury to or death of the patients arising from a study drug vary from customer to customer and from trial to trial and may not be sufficient in scope or amount, or our customer may not have the financial ability to fulfill their indemnification obligations. Furthermore, we would be liable for our own negligence and negligence of our employees which could lead to litigation from customers or action or enforcement by regulatory authorities.

    Insurance

We maintain what we believe is an appropriate level of worldwide Professional Liability/Error and Omissions Insurance. In the future we may be unable to maintain or continue our current insurance coverage on the same or similar terms. If we are liable for a claim or settlement that is beyond the level of insurance coverage, we may be responsible for paying all or part of any award or settlement amount. Also, the insurance policies contain exclusions which mean that the policy will not respond or provide cover in certain circumstances.

    Claims to Date

To date, we have not been subject to any liability claims that are expected to have a material effect on our business; however, there can be no assurance that we will not become subject to such claims in the future or that such claims will not have a material effect on our business.


19


Environmental, social and governance matters may impact our business and reputation.

Increasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance ('ESG') matters, which are considered to contribute to the long-term sustainability of companies’ performance. A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. Customers may have specific ESG related requirements or targets and if we fail to meet these targets we may lose business. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the Company’s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the Company’s board of directors in supervising various sustainability issues. We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of investors’ increased focus on ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society’s perceived expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.

Risk Related to Our Common Stock

Volatility in the market price of our common stock could lead to losses by investors.

The market price of our common stock has experienced volatility in the past and may experience volatility in the future which could lead to losses for investors. Factors impacting volatility in the market price of our common stock include, amongst others:

general market and economic conditions;
our results of operations;
issuance of new or changed securities analysts’ reports or recommendations;
developments impacting the industry or our competitors;
declines in the market prices of stocks generally;
strategic actions by us or our competitors;
announcements by us or our competitors of significant contracts, new products, acquisitions, joint marketing relationships, joint ventures, other strategic relationships or capital commitments;
the public's reaction to press releases, other public announcements by us or third parties, including our filings with the SEC;
guidance, if any, that we provide to the public, any changes in this guidance or failure to meet this guidance;
changes in the credit rating of our debt;
sale, or anticipated sale, of large blocks of our stock;
additions or departures of key personnel;
regulatory or political developments;
our performance on ESG matters
litigation and governmental investigations;
changing economic conditions;
exchange rate fluctuations;
changes in accounting principles; and
other events or factors, including those resulting from natural disasters, war, acts of terrorism or responses to those events.                        

In addition, stock markets have from time to time experienced significant price and volume fluctuations unrelated to the operating performance of particular companies. Future fluctuations in stock markets may lead to volatility in the market price of our common stock which could lead to losses by investors.

Investment returns may be reduced if we lose our foreign private issuer status.

We are a “foreign private issuer,” as such term is defined in Rule 405 under the U.S. Securities Act 1933, and, therefore, we are not required to file quarterly reports on Form 10-Q or current reports on Form 8-K with the SEC. In addition, the proxy rules and Section 16 reporting and short-swing profit recapture rules are not applicable to us. If we lose our status as a foreign private issuer by our election or otherwise and we become subject to the full reporting regime of the United States securities laws, we will be subject to additional reporting obligations and proxy solicitation obligations under the Exchange Act and our officers, directors and 10% shareholders would become subject to the short-swing profit rules. The imposition of these reporting rules would increase our costs and the obligations of those affected by the short-swing rules.

20


We do not expect to pay any cash dividends for the foreseeable future.

We currently do not expect to declare dividends on our common stock and have not done so in the past. We continue to anticipate that our earnings will be used to provide working capital, to support operations, to make debt repayments and to finance the growth and development of our business. They may also be used to continue our share repurchase program. Any determination to declare or pay dividends in the future will be at the discretion of our board of directors, subject to relevant laws and dependent on a number of factors, including our earnings, capital requirements and overall financial condition. Therefore, the only opportunity for stockholders to achieve a return on their investment may be if the market price of our common stock appreciates and shares are sold at a profit. The market price for our common stock may not appreciate and may fall below the price stockholders paid for such common stock.

A future transfer of ICON ordinary shares, other than one effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC"), may be subject to Irish stamp duty.

Transfers of ICON ordinary shares effected by means of the transfer of book entry interests in the Depositary Trust Company ("DTC") should not be subject to Irish stamp duty where ICON ordinary shares are traded through DTC, either directly or through brokers that hold such shares on behalf of customers through DTC. However, if ICON ordinary shares are held as of record rather than beneficially through DTC, any transfer of ICON ordinary shares could be subject to Irish stamp duty (currently at the rate of 1% of the higher of the price paid or the market value of the shares acquired). Payment of Irish stamp duty is generally a legal obligation of the transferee. The potential for Irish stamp duty to arise could adversely affect the price of ICON ordinary shares.








































21


Item 4.   Information on the Company.

A.History and development

ICON public limited company (“ICON plc”) is a clinical research organization (“CRO”), founded in Dublin, Ireland in 1990. Over thirty years we have grown significantly to become a leading global provider of outsourced development and      services to pharmaceutical, biotechnology, medical device and government and public health organizations. Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.

We are a public limited company in Ireland and operate under the Irish Companies Acts. Our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000. Our website is www.iconplc.com. Additionally, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

Our service offering includes clinical development, functional outsourcing and laboratory services. Our clinical development services include all phases of development (Phases I-IV), peri and post approval, data solutions and site and patient access services. Our laboratory services include a range of high value testing services, including bionanalytical, biomarker, vaccine, good manufacturing practice ('GMP') and central laboratory services. We also offer full-service and functional service partnerships to our customers.

Since ICON was founded, the Company has expanded through organic growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process and to broaden the service portfolio and add scale to existing services.

iclr-20221231_g1.jpg

Recent investments, which continue to strengthen our service offerings to meet the needs of our customers include:

On July 1, 2021, the Company completed the acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of PRA Health Sciences ("the Acquisition" and "the Merger"). Upon completion of the Acquisition, PRA became a wholly owned subsidiary within the ICON Group. The Acquisition has transformed the scale and capabilities of the Company. The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers’ commercial success through the development of much needed medicines and medical devices. The combined Company retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating one of the world’s most advanced healthcare intelligence and clinical research organizations.

The Acquisition has brought together two high-quality, innovative, growing organizations with similar cultures and values to create the world's leading clinical research organization with a singular focus on clinical research and commercialization. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The total value of the Merger consideration is $12.0 billion and has resulted in the recognition of goodwill of $8.1 billion, intangible assets of $4.9 billion and an associated deferred tax liability of $1.1 billion. The accounting for the Merger was final as of June 30, 2022.

In conjunction with the completion of the Merger, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal
22


amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA’s existing credit facilities and (ii) the Company's private placement notes outstanding and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on the London Interbank Offered Rate ("LIBOR") or other base rate (as elected by the borrower), plus an applicable margin. On November 29, 2022, the Company agreed with its lenders to the adoption of the Secured Overnight Financing Rate ("SOFR") as the benchmark rate within the Senior Secured Credit Facilities, thus LIBOR is no longer the benchmark rate available to the Company under the terms of the Senior Secured Credit Facilities.

The Company repaid $800 million and $513.8 million of the senior secured term loan facility for the years ended December 31, 2022 and 2021, respectively. At December 31, 2022 and 2021, no amounts were outstanding under the senior secured revolving loan facility with the exception of $4.5 million letters of credit given to landlords to guarantee lease arrangements.

The financial information presented in this Form 20-F reflect the results of the combined Company for the year ended December 31, 2022. The financial information presented for the years ended December 31, 2021 and December 31, 2020  are as previously reported and do not reflect the pre-Merger results of PRA before July 1, 2021, other than where clearly stated and required by GAAP.

During 2019, we further enhanced our site and patient recruitment abilities through the strategic acquisitions of MeDiNova and CRN. In 2020, ICON announced the launch of Accellacare, a global clinical research network offering patients easier and faster access to innovative treatments and offering customers the option to deploy decentralized trials. The site network includes previously acquired PMG Research, MeDiNova and CRN. Also in 2020, we entered into an agreement to jointly establish a new company, Oncacare Limited ("Oncacare"), with a third party. Oncacare operates as a specialized oncology site network in the US and EMEA regions.

With approximately 41,100 employees across the globe, the new ICON has established relationships with a majority of the world’s top pharmaceutical and biotech companies. We believe the Company now has the expertise, technology, and data assets to lead the industry into a new paradigm for bringing clinical research to more patients and enabling expanded capabilities for customers. We believe the Merger will deliver a transformational effect on ICON through:

Scale: With a deeper clinical, commercialization and consulting services portfolio, a broader geographic footprint, depth in therapeutic expertise, and data-driven healthcare technology, the Company can deliver enhanced globally scaled expertise & solutions for all customers and patients.

Focus: The Company will have a singular focus on clinical research and commercialization, leveraging transformational technology and innovation to execute clinical trials from Phase 1 to post-approval studies with the highest quality, expertise and speed.

Speed to market: Our extensive services portfolio, digital and data technology capabilities, and enhanced access to more diverse patient populations, have been combined with flexible delivery approaches and partnership models – all with the aim of reducing development time and costs.

Flexible partnership models: ICON has partnerships with a majority of world’s top biopharma and biotech companies worldwide. ICON is a global leader in Functional Service Provision and a top global provider of full service clinical research.

Differentiated DCT platform, healthcare intelligence & technology: The new ICON can deliver differentiated decentralized and hybrid trial solutions through a suite of capabilities, including mobile health, commercial connected health platforms, real world data and information solutions, a global site network, home health services and wearables expertise.

Access to patients: The new ICON offers customers enhanced access to a larger global pool of more diverse patients through its global site network (Accellacare), specialized oncology network (Oncacare), a pediatric site network, in-home clinical services and a network of six Phase I clinical research units across the United States and Europe.

Interest Rate Risk Management

The Company has entered into derivative financial instruments to manage exposures to interest rate fluctuations. On November 29, 2022, the Company entered into two interest rate cap agreements and one interest rate swap agreement with notional amounts of $2,100.6 million and $1,100.6 million, respectively. These derivative financial instruments are used to limit the Company's exposure to changes in the variable interest rate on its Senior Secured Credit Facilities by fixing the interest rates on approximately 48% of ICON's term loan facility at that date.
23


Share Repurchase Program

On February 18, 2022, the Board authorized the repurchase of up to $100 million of the Company's common stock. The share repurchase program was completed during the year ended December 31, 2022 with a total of 420,530 ordinary shares redeemed by the Company for a total consideration of $100.0 million. All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required by Irish Company law.

Ukraine

On February 24, 2022 Russia invaded Ukraine, creating significant instability and unrest in the region. Since that time, the Company's key focus has been on the safety of our employees and their families, patients, investigators and on the mitigation of adverse impacts on ongoing clinical trials. The Company has worked to ensure the safety of employees and their families based in Ukraine through the implementation of a number of employee assistance programs. These programs aim to provide affected employees and their families with transportation, accommodation in neighboring countries, financial assistance, communications and other support services as needed.

The Company's operations in these affected regions have been significantly curtailed as a result of these events. The ongoing conflict in Ukraine has resulted in an increasingly complex economic sanctions and export controls environment applicable to our business operations in the region (including Russia and Belarus) as a result of additional trade compliance measures enacted by the United States, United Kingdom and European Union member states. These economic sanctions and export controls restrict our ability to do business with sanctioned entities, require additional compliance resources, and could have a material adverse effect on the results of our operations. The financial impact of the conflict was not material to the Company during the year ended December 31, 2022.

Foreign exchange

The Company prepares its financial statements in United States dollars while the local results of a certain number of our subsidiaries are prepared in currencies other than United States dollars, including, amongst others, the pound sterling and the euro. In addition, the Company's contracts with clients are sometimes denominated in currencies other than the United States dollar. Finally, the Company is exposed to a wider variety of currencies in the expenses line due to most expenses being incurred in the local currencies of where our global operations are based. Accordingly, changes in exchange rates between the United States dollar and those other currencies could have a material adverse effect on the Company’s financial results. In the year ended December 31, 2022, the Company recorded foreign currency gains of $26.0 million.

B.Business Overview

ICON is a leading global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations.

We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization.

ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services.

We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process, from compound selection to Phase I-IV clinical studies. We earn revenue by providing a number of different services to our customers. Those services are integral components of the clinical development process and include clinical trial management, consulting, contract staffing, data solutions and laboratory services.
24



iclr-20221231_g2.jpg

Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development. We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in the major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full-service solution. In order to achieve this vision, we are capitalizing on the enhanced scale, technology and data analytics capabilities that the recent acquisition of PRA Health Sciences delivered.

ICON maintains a sustained focus on research and development and developing industry-leading technologies and processes to support our clients. We continue to enhance our portfolio of data solutions and decentralized clinical trial technology. ICON is leading the industry transformation through four key levers: transforming clinical trials, site and patient centricity, healthcare intelligence and applied innovation, and seamless, integrated service delivery.

At December 31, 2022, we employed approximately 41,100 employees in 111 locations in 53 countries. During the year ended December 31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.

The ICON strategy

We have achieved strong growth since our foundation in 1990, as a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations. We focus our innovation on those factors that are critical to our clients - reducing time to market, reducing cost and increasing quality. Our global team has extensive experience in a broad range of therapeutic areas. ICON has been recognized as one of the world's leading Contract Research Organizations (''CROs") through a number of high-profile industry awards (see www.iconplc.com/awards).

As our market has evolved, biopharmaceutical companies are tackling productivity challenges, increasing budget constraints and greater demands to demonstrate product value; all of which are placing increased pressure on their revenues and levels of profitability. However, these trends have generally been positive for CROs, as increased outsourcing has been adopted by these companies as they seek to create greater efficiencies in their development processes, convert previously fixed costs to variable, and accelerate time to market for new treatments.

Regulatory and reimbursement pressures will increase the emphasis on late stage (post marketing) research, while increasing requirements to demonstrate the economic value of new treatments. As a result, outcomes and comparative effectiveness research will most likely be required in order to secure on-going product reimbursement. Furthermore, we believe advances in molecular biology and genetics will drive further growth in innovation in the long term which in turn should create further growth opportunities for both biopharma companies and their outsource development partners.

We expect that continued outsourcing will be a core strategy of clients in the near term as they respond to the increased pressures on their revenues and profitability. Larger clients were the first to form strategic partnerships with global CROs in an effort to reduce the number of outsource partners with whom they engage and to reduce inefficiencies in their current drug
25


development models. More recently we have seen the increasing adoption of this partner model with mid-tier pharmaceutical and biotechnology firms as they also seek to drive development efficiencies. As outsourcing penetration increases, we believe clients may seek a greater level of integration of service offerings from CROs, although some will continue to purchase services on a stand-alone basis. Creating greater connectivity and “seamlessness” between our services and the sharing of “real-time” clinical, operational and “real world” data with clients will therefore become increasingly important for CROs. ICON will seek to benefit from this increased outsourcing by clients to grow our business by increasing market share with our existing client base and adding new clients within the Phase I-IV outsourced development services market; the aim being to ensure we will be considered for all major Phase I-IV projects.

Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access & Engagement (ii) Career Development & Employer of choice (iii) Enduring Customer Partnerships and (iv) Healthcare Intelligence & Applied Innovation.

iclr-20221231_g3.jpg
Patient Access & Engagement

ICON has a focused patient, site and data strategy, which is helping us to improve site identification, study placement and patient recruitment and retention.

Accellacare is ICON's global clinical research network offering customers a wide range of stand-alone and integrated solutions at the site or in patients' homes as part of decentralized trials. Our patient centric approach accelerates study start-up and increases patient recruitment and retention for pharmaceutical, biotechnology and medical device industries.

The Accellacare Site Network encompasses more than 76 sites across 6 countries covering the United States and Europe. Accellacare offers a quality focused clinical research infrastructure delivering value and benefits to sponsors. Accellacare supports customers with faster start-up. The time from site selected to site initiation visit is on average 30% faster when compared to other sites. Also, Accellacare achieves an average of 40% more patients per site when compared to other sites.

Accellacare In-Home Services takes study visits directly to patients where they live, work, study or play in all phases and therapeutic areas of clinical trials. By bringing trial visits directly to patients, we ease the burden of participating in clinical research to increase patient recruitment, retention and diversity. Accellacare In-Home Services has experience in more than 400 clinical trials, tailoring our services to fit each study's specific requirements across more than 55 countries. This cohesive approach is leading to higher patient recruitment and retention rates. Accellacare is also achieving faster study start-up for its customers through efficiencies gained in central process management including budget and contracting, which can otherwise be a source of delay. This combined with a finely tuned feasibility approach allows the network to identify and recruit more patients to studies, in a wide range of therapeutic areas, in a shorter time frame. Accellacare is an important part of the integrated patient, site and data strategy, helping us to improve patient recruitment and retention. Through Accellacare we are committed to delivering on the promise of patient centricity in clinical research. It is also providing investigators with innovative treatments for their patients with a quality-focused clinical research infrastructure supported by experienced professionals globally.
26



In 2021, Accellacare entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities. Agreements with Asclepes Research and Olympian Clinical Research in the U.S., Curiositas ad Sanum and Intermed in Germany, Quironsalud in Spain, and KO-MED in Poland. Through these new partnerships, Accellacare is also enhancing its capability in the central nervous system (CNS) and immune-inflammation therapeutic areas.

In 2022 the continued expansion of the Accellacare Site Network increases access and engagement with investigative sites and its patients, with the goal of faster recruitment and reducing the overall time and cost associated with drug development for customers. Accellacare now has access to more than 9 million patients.

Finding and engaging suitable patients to conduct clinical trials is one of the biggest issues facing the drug development industry today. Less than 1% of the US population participates in clinical trials and the performance of investigative sites that do take part in research is uneven, hard to predict and many trials do not meet the initial recruitment goals. The current market challenge in patient enrollment creates an opportunity for ICON to differentiate its service offering and we are working to reduce patient recruitment times through enhanced site and investigator selection based on key performance metrics and through use of our proprietary FIRECREST technology which is used to train and support sites during the development process. Our Accellacare and Oncacare site network alliances enhances our ability to enroll patients onto the clinical studies we perform. We have also developed strategic alliances with investigator site groups and healthcare systems in all major global research markets. In partnership with others, we are pioneering patient recruitment solutions that leverage cognitive computing to transform clinical trial matching and allow a data-driven approach to deliver the right patients for trials. One Search is our intuitive, integrated workflow and interrogation tool that enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.

Career development and employer of choice

People have long been central to our mission to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader.

Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.

We aim to be an industry leader: a company where talented people come to do important work, a place where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people’s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.

Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.

To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs.

Enduring customer partnerships

We continue to focus on expanding and deepening our partnerships with existing customers, while also developing new customer relationships.

Strategic client relationships will increasingly manifest themselves in many different forms. Many of these relationships will require innovative forms of collaboration across ICON service areas and departments and will therefore require increased flexibility to offer services on both a standalone functional basis and as part of a fully integrated service solution. To support this objective, we continue to evolve our collaboration and delivery models, invest in technology that will enable closer data integration across our service areas and enhance our project and program management capabilities.

To meet the evolving needs of both our existing and new clients we continue to enhance our capabilities through both organic service development and targeted acquisitions.
During the year, we continued to enhance our scientific and therapeutic expertise to support our customers in specific areas including oncology, orphan and rare diseases, CNS, dermatology, infectious disease and women's health.
27


ICON has extensive experience in vaccine clinical development for commercial businesses, governments and NGOs, having participated in over 160 vaccine studies in the past five years. This experience enabled us to play a significant role in the search for vaccines and treatments for COVID-19. ICON is currently or has already conducted a total of over 130 COVID-19 related trials.

Of particular note was our work in partnering with Pfizer and BioNTech on their investigational COVID-19 vaccine program - the first to announce positive efficacy results from a Phase 3, late-stage study of a COVID-19 vaccine and to receive Emergency Use Authorization in individuals 16 years of age or older from the U.S. Food and Drug Administration.
ICON mobilized a large global team of therapeutic and operational specialists to partner on the implementation of Pfizer‘s and BioNTech’s strategic plan and framework for the monitoring of the trial, which included a high level of remote clinical monitoring and source data verification in addition to on-site monitoring, safeguarding data quality and integrity in the evolving pandemic environment. The team combined the benefits of full service and functional service provider clinical operating models to increase efficiency and ensure rapid study start-up.
ICON worked with 153 sites in the US, Europe, South Africa and Latin America to ensure the recruitment of more than 44,000 trial participants over a four-month period in late 2020. ICON provided site training, document management and operational support for patient Informed Consent Form review, coordinated eConsent in most countries, and assisted with clinical supply management services. Achieving the unprecedented trial timelines, while maintaining high standards of quality, undertaken in response to the pandemic required collaboration and strong communication between the ICON and companies’ project teams.

We continue to target growth in under-penetrated CRO market segments. Penetration within medical device companies has lagged that of bio-pharma firms but is beginning to accelerate. EU regulatory reform enacted in 2017 is a further catalyst to growth in this segment as it included stricter requirements to perform clinical evaluations and post-sale surveillance. In early 2020, ICON acquired MedPass which has further enhanced our value offering in this area.

We also invested significantly in our site and patient network (Accellacare), and consider our expertise and offering in this area as one of our strategic pillars effective from 2021.

Healthcare intelligence and applied innovation
Innovation at ICON is focused on the factors that are critical to our clients. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs, providing true transparency across all areas of a study.

ICON is focused on applying innovation that can help our customers improve their development outcomes. We are focusing this innovation in three critical areas: improving clinical trial design and execution; faster and more predictable patient recruitment; and evolving clinical trials to be more patient centric which includes data collection and analysis directly from patient’s digital devices. Our approach to developing solutions to these challenges incorporates partnering with best-in-class technology providers but is also supported by a suite of differentiated ICON proprietary technologies.

We have continued to invest in building our capabilities in the gathering, analysis and application of real world patient data within both the clinical trial and post-trial observational study environments. Alongside expanding internal capabilities, we continue to develop innovative partnerships with providers of real world data including TriNetX. During 2018, we signed an agreement with Intel to deploy the Intel® Pharma Analytics Platform for use in clinical trials. The Intel platform is an artificial intelligence solution that enables remote monitoring and continuous capture of clinical data from study subjects using sensors and wearable devices and can apply machine learning techniques to objectively measure symptoms and quantify the impact of new therapies.

ICON’s proprietary One Search tool helps identify optimum trial sites the first time. It synthesizes multiple data sources, applying AI machine learning and rich data visualization for optimum site identification, resulting in improved study start-up and site cycle times, significant reductions in the percentage of low performing sites and increasing the percentage of studies meeting planned First Patient In (FPI).

FIRECREST is ICON’s proprietary comprehensive site performance management system. It is a web-based solution which enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to investigative sites. It allows site behavior to be tracked to ensure training is understood, procedures are being followed and that timelines and study parameters are met. It can significantly reduce the number of data queries originated from investigator sites. FIRECREST is now integrated into the ICON Safety Reporting Solution and provides a Site Question Management Tool.

ICON has also developed a patient engagement platform to support improved patient experience and enrollment in clinical trials. The web-based patient engagement platform, provides patients with study specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases visibility of potential
28


study participants for sponsors and sites. An easy to navigate, user friendly interface guides the patient to new and ongoing studies in their particular indication and a pre-qualification questionnaire helps to determine if the study is a right fit for them. If the patient decides to register interest, they are given the option to select their nearest investigative site. This establishes connection with the site and the patient can then choose to contact the site or ask to be contacted for pre-screening.

We positively impact patients’ lives by understanding their journeys and how they can benefit from drugs currently in development and on the market. We do this by developing a holistic, global data environment across pharmaceutical and biotech companies (development to commercial) that gives insights into patients, and how best to serve them. Alongside the application of these technology solutions we are also focused on innovation through the redesign and where appropriate the automation of current clinical trial processes.

Operational excellence, quality and delivery

Quality is the foundation of our success. The quality of our work is vital to our mission of bringing better medications to patients around the world. We are committed to maintaining, supporting, checking and improving our quality systems to meet or exceed the quality standards demanded by our clients, patients and regulatory authorities. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Quality project execution underpins all that we do and we have an ongoing focus on developing our people and processes to continue to enhance our service delivery. We also deploy supporting technologies which we believe will enable faster and deeper insights into the quality of trial data.

We are focused on operational excellence across our support functions, and we operate a global business support infrastructure across functions including finance, information technology, facilities, human resources and legal. This enables us to enhance the service levels across these support areas whilst driving down the costs of the service provision.

Capabilities and service offerings

ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives.    


29


With an expansive portfolio of integrated clinical, commercialization and consulting services, global presence, depth in therapeutic expertise, and data-driven healthcare technology, we deliver globally scaled expertise & solutions for all customers and patients. Solutions span the Clinical Development lifecycle from compound selection to Phase I-IV clinical studies and post approval outcome research and market access consulting solutions, and can be adapted to suit local trials or large global programs: iclr-20221231_g4.jpg
30


Industry overview

The CRO industry provides independent product development solutions and services for the pharmaceutical, biotechnology and medical device industries. Companies in these industries outsource services to CROs in order to manage the drug and device development process more efficiently and to bring both patent-protected bio-similars and medical devices to market faster to enhance patient well-being and maximize their return on investment. The CRO industry has evolved since the 1970s from a small number of companies that provided limited clinical development services to a larger number of CROs that offer a range of services that encompass the entire research and development process, including pre-clinical development, clinical trials management, clinical data management, study design, bio statistical analyses, post market surveillance, regulatory affairs, central laboratory and market access services. CROs are required to provide services in accordance with good clinical and laboratory practices, as governed by the applicable regulatory authorities.
    
The CRO industry is highly fragmented, consisting of several hundred small, limited-service providers, medium sized CROs and a small number of large CROs with global operations. Although there are few barriers to entry for small, specialist service providers, we believe there are significant barriers to becoming a CRO with global capabilities and expertise. These barriers include the infrastructure and experience necessary to serve the global demands of clients (sponsors), the ability to recruit sites and patients globally, the simultaneous management of complex clinical trials, the ability to offer customers a variety of delivery models, broad therapeutic expertise and the development and maintenance of the complex information technology systems required to integrate these capabilities. In recent years, the CRO industry has experienced consolidation, resulting in the emergence of a select group of CROs that have the capital, technical resources, integrated global capabilities, data and expertise to manage the development programs of pharmaceutical, biotechnology and medical device companies. We believe that large and medium-sized pharmaceutical companies are selecting a limited number of CRO service providers with which they deal rather than utilizing many, in order to form strategic partnerships with global CROs in an effort to drive incremental development efficiencies and leverage the scientific and medical expertise. We believe that this trend will continue to concentrate the market share among the larger CROs with a track record of quality, speed, flexibility, responsiveness, global capabilities and access to patients and overall development experience and expertise.

New drug development overview ethical pharmaceuticals and biologics

Before a new drug or biologic may be marketed, it must undergo extensive testing and regulatory review to determine that it is safe and effective. The following discussion primarily relates to the FDA approval process for such products. Similar procedures must be followed for product development with other global regulatory agencies. The stages of this development process are as follows:

Preclinical Research “In vitro” (test tube) and animal studies must be conducted in accordance with applicable regulations to establish the relative toxicity of the drug over a wide range of doses and to detect any potential to cause birth defects, affect vital organs, cause mutations or cancer. Many of these tests must be performed before a new investigational therapy can progress into human studies. If results warrant continuing development of the drug or biologic, the sponsor or owner of the asset will file for an Investigational New Drug Application, or ("IND"), which must be approved by the FDA before starting the proposed clinical trials. However, preclinical studies will continue to be conducted in parallel with the clinical trials, some of which can take up to 3 years to complete. Preclinical research is not commonly provided by ICON as a service to its customers.

Clinical trials (approximately 3.5 to 7 years)

Exploratory development

Phase I (approximately 6 months to 1 year) consists of basic safety and tolerability testing in small numbers of human subjects, initially in healthy volunteers, and includes studies which may show the drug is having an effect on the body, if it is safe, how it is affected by other drugs, where it goes in the body, how long it remains active and how it is broken down by and eliminated from the body. After single and multiple dose studies have been conducted, the asset can progress into Phase II, however, Phase I studies will continue to be done to help support the development of the asset in new populations such as children or the elderly.

Phase II (approximately 2 to 3 years) includes basic efficacy and dose-range testing in a limited patient population (usually) 100 to 200 patients to help provide preliminary safety and evidence that the drug is likely to be effective in the target disease. If the Phase II results are satisfactory the sponsor may decide to proceed to Phase III studies.

Confirmatory development

Phase III (2 years or greater) consists of efficacy and safety studies in several hundred to a few thousand patients at multiple investigational sites (hospitals and clinics), often in multiple geographies.

FDA approval, through submission of an IND, is necessary for all clinical trials, regardless of the phase of development. In addition, parallel independent committee approval is also required.
31


NDA or BLA Preparation and Submission. Upon completion of Phase III trials, the sponsor assembles the statistically analyzed data from all phases of development into a single large submission along with the Chemistry, Manufacturing and Controls (CMC) and preclinical data and the proposed labelling into the New Drug Application (NDA), or Biologics License Application (BLA) and submits them for assessment and approval by the relevant division of the FDA.

Expanded Access Programs (EAPs). Sometimes a study drug may continue to be provided to subjects after completion of a clinical trial, also called compassionate use. EAPs refer to the regulated use of a study drug outside of a clinical trial by patients with serious or life-threatening conditions where there is no alternative therapy available. In this context the FDA may allow the sponsor to make the study drug available to a larger number of patients for treatment use.
FDA review and approval of NDA or BLA (1 to 1.5 years). Data from all phases of development is scrutinized to confirm that the applicant company has complied with all applicable regulations and that the benefit to risk ratio for the drug or biologic is positive for the specific use (or “indication”) under study. The FDA may refuse to accept the NDA or BLA if the application has administrative or content criteria which do not meet FDA standards. The FDA may also deny approval of the drug or biologic product if applicable regulatory requirements are not satisfied, if the drug has not adequately shown to be effective or if there are safety concerns. Often a company will be required to conduct specific studies after the approval of a drug. These are called post approval commitments.

Post-market surveillance, Phase IV studies and health outcomes. Once approved by the FDA, it requires the drug or biologic license holder to collect and periodically report to them additional safety (and perhaps efficacy) data on the drug or biologic for as long as the license holder markets it (post-market surveillance, including pharmacovigilance). If the product is marketed outside the U.S., these reports must include data from all countries in which the drug is sold. Additional studies (Phase III and Phase IV) may be undertaken after initial approval to find new uses for the drug, to test new dosage formulations, or to confirm selected non-clinical benefits, e.g., increased cost-effectiveness or improved quality of life. Additionally, the FDA and other regulatory agencies require license holders of drugs or biologics to prepare risk management plans that are aimed at assessing areas of product risk and actively managing such risks throughout the product lifecycle.

Key trends affecting the CRO industry
 
CROs derive substantially all their revenue from the research and development expenditures of pharmaceutical, biotechnology and medical device companies. We believe that the following trends create further growth opportunities for global CROs, although there is no assurance that growth will materialize.

Continued innovation and development of enabling technologies

Innovation driving new drug development activity

New technologies together with improved understanding of disease pathology (driven by scientific advances such as the mapping of the human genome) have increased the number of new drug candidates being investigated in early development. This has greatly broadened the number of biological mechanisms being targeted, which increasingly include rare or orphan diseases that currently have no effective treatments.

These developments should lead to increased activity in both preclinical and Phase I development and in turn lead to more treatments in Phase II-III clinical trials. As the number of trials that need to be performed increases and these trials become focused in indications where finding suitable patients is increasingly challenging, we believe that drug developers will increasingly rely on CROs to manage these trials to leverage their global expertise and to continue to focus their own competences on drug discovery and sales and marketing.

Decentralized and hybrid trials

Decentralized and hybrid trials have existed for quite some time, but the coronavirus pandemic accelerated the demand when the pharma industry was challenged to move to remote models to protect patient safety and ensure data integrity for COVID-19 vaccine trials and other ongoing trials. The pandemic has provided an opportunity to move many technologies and remote patient care solutions from pilot phase to supporting patients and research.

As an industry, we have an opportunity to make decentralized and hybrid the standard moving forward. The ways the industry have been conducting clinical research in a traditional site-based approach need to flex so we can implement these tools, techniques and processes in everyday research to bring about a more patient-centric approach. Each new element needs to be evaluated to assess the impact for the individual patients and study sites. Recent experiences in the industry have shown:
Using fewer countries and fewer sites can reduce costs, decrease timelines for start-up and minimize the risk of disruption during and post pandemic.
Hybrid studies, utilizing digital health, in-home health, and telehealth, can reduce the number and frequency of onsite patient visits and therefore reduce patient burden.
Home-based patient visits and direct-to-patient contacts can increase patient satisfaction, compliance and retention, providing greater trial resilience.
32


Harmonizing data from disparate data sources will provide real-time access and consistent data visibility, helping to improve safety monitoring and enabling the visualization of data trends.

Regulatory easement has resulted in a number of positive changes to clinical trial procedures, enabling studies to continue and in some case progress at a faster pace, and improvements to the process of CTA and IND approvals despite the restrictions imposed by the current COVID-19 pandemic. However, the regulatory authorities have been clear that regulatory easement will be discontinued once the pandemic recedes so it remains to be seen how many of these improvements will endure and become standard practice in the longer term. It is hoped that we can hold on to some of the improvements for the benefit of the patient and healthcare advancement.

Ultimately, we are trying to increase the speed at which drugs can meet approval guidelines and help treatable populations. By using decentralized tools, technologies and processes, we will reduce the burden on patients, increase satisfaction and provide them with the same standard of care during a virtual or home visit that they would receive in a clinic, thereby fulfilling the promise of clinical research as a care option. While reduced costs may not be seen in the early phase of adoption (in fact investment may be required initially) choosing the right solution for the specific study characteristics has the potential to increase patient recruitment and retention which can result in reduced overall research costs and quicker time to market. To find the best clinical trial design to suit their needs, sponsors will need to take patient centricity into consideration from the outset and at every step along the way, because what benefits the patient will ultimately benefit the sponsor in outcomes.

New technology enabling more efficient development

Technology innovation is playing an increasingly important role in helping to support more efficient drug development. Leveraging differentiated technology solutions and data collaborations drives better execution in clinical trials. The larger CROs have been at the forefront of this innovation developing technology solutions that support the integration of trial data across multiple systems, data repositories that enable sponsors to get real time clinical insights on the performance of their drugs and tools that support better trial designs and operation.

The emergence of modern healthcare technologies ("mHealth") that build on the global prevalence of mobile and digital technologies also have an influence on drug development. It is now possible to capture health data using mobile devices and wearables. This enables sponsors to gather new clinical and “real-world” patient insights and will also be used to enhance patient engagement and adherence throughout the development process. As these devices mature it will also be possible to complete more “decentralized and hybrid trials” based on remote monitoring of patients in their home environment which may drive further efficiencies in the trial process.

Social media is also becoming an important platform for life sciences companies to strengthen patient engagement programs and collaborate with other stakeholders in the healthcare system. Many sufferers of specific diseases are forming patient groups and actively collaborating using social media. These groups represent an important potential source of patients for new clinical studies but can also provide valuable insights into effectiveness and safety of new treatments.

As the influence of technology on drug development grows, it broadens the potential number of partners that CROs will work with in the future.

Expanded use of new patient data sources

Pharmaceutical companies are looking to access a variety of new healthcare data sources containing medical and prescribing records to help improve development programs and to get better evidence of the value their treatments are bringing to patients once they are launched in the market. The larger global CROs have significant data management experience which can be leveraged to support these efforts and have invested in analytics capabilities to help deliver better insights for customers during the product lifecycle. Global CROs are also forging collaborations to access specific data sets that can provide further patient insights to support better matching of patients to the clinical trial process.

Improving productivity and operating efficiencies

Continuing focus on productivity within research and development programs

Pharmaceutical and biotechnology companies continue to seek ways to improve the productivity of their development efforts and increasingly see the use of CROs as a strategic component of these efforts. They are leveraging the expertise with CROs to help identify the most promising drug candidates in early development and discontinue developing those that have safety issues, limited efficacy or that will have significant reimbursement challenges. These companies are also initiating programs to drive more efficiency in their development programs. One example of this has been the efforts to achieve a more seamless transition across development phases, particularly Phase I-III. In parallel, regulatory initiatives such as the 21st Century Cures Act and the emergence of clinical trial techniques such as adaptive trial design, risk based clinical trial monitoring, decentralized and hybrid trials are enhancing development, allowing effective treatments to get to patients quicker at reduced development costs.

33


Cost containment pressures

Over the past several years, drug companies have sought more efficient ways of conducting business due to margin pressures stemming from patent expirations, greater acceptance of generic drugs, pricing pressures caused by the impact of managed care, purchasing alliances and regulatory consideration of the economic benefit of new drugs. Consequently, drug companies are centralizing research and development, streamlining their internal structures and outsourcing certain functions to CROs, thereby converting previously fixed costs to variable costs. Larger companies (and more recently medium sized companies) are actively entering strategic partnerships with a limited number of CROs in an effort to drive increased efficiencies. The CRO industry and, in particular, large CROs with global capabilities, considerable scientific knowledge and expertise are often able to perform the needed services with greater focus and at a lower cost than the client could perform internally, although CRO companies themselves are facing increased cost containment pressures as drug companies seek to further reduce their cost base.

Global trends influencing the CRO industry

Pressure to accelerate time to markets and globalization of the marketplace

Reducing product development time maximizes the client’s potential period of patent exclusivity, which in turn maximizes potential economic returns. We believe that clients are increasingly using CROs that have the appropriate expertise and innovation to improve the speed of product development to assist them in improving economic returns. In addition, applying for regulatory approval in multiple markets and for multiple indications simultaneously, rather than sequentially, reduces product development time and thereby maximizes economic returns. We believe that CROs with global capabilities, considerable knowledge and experience in a broad range of therapeutic areas are key resources to support a global regulatory approval strategy. Alongside this, the increasing need to access pools of new patients is leading to the conduct of clinical trials in new “emerging regions” such as Eastern Europe, Latin America, Asia-Pacific and South America. We believe that having access to both traditional and emerging clinical research markets gives global CROs a competitive advantage.

Growth within the biotechnology sector

The nature of the drugs being developed is continuing to change. Biotechnology is enabling the development of targeted drugs with diagnostic tests to determine whether a drug will be effective given a patient’s genomic profile. An increasing proportion of research and development expenditure is being spent on the development of highly technical drugs to treat very specific therapeutic areas in sectors of unmet medical need. Much of this discovery expertise is found in biotechnology firms. We believe that it is to these organizations that the large pharmaceutical companies will look for an increasing proportion of their new drug pipelines. Whether it is through licensing agreements, joint ventures or equity investment, we believe we may see the emergence of more strategic relationships between small discovery firms and the larger pharmaceutical groups. As the majority of these biotechnology companies do not have a clinical development infrastructure, we believe that the services offered by CROs will continue to be in demand from such companies providing they have the necessary funding. ICON has over 8,000 staff exclusively dedicated to working with biotech clients.

Increasing number of large long-term studies and an increasing requirement to show the economic value of new treatments

We believe that to establish competitive claims and demonstrate product value, to obtain reimbursement authorization from bodies such as the National Institute for Health and Clinical Excellence in the UK, and to encourage drug prescription by physicians in some large and competitive categories, more clients need to conduct outcome studies to demonstrate, for example, that mortality rates are reduced by certain drugs. To verify such outcomes, very large patient numbers are required, and they must be monitored over long time periods. We believe that as these types of studies increase there will be a commensurate increase in demand for the services of CROs who have the ability to quickly assemble large patient populations, globally if necessary, and manage this complex process throughout its duration.

The rising costs of healthcare in most developed countries also means there is an increasing pressure to show that new medical treatments are more cost effective and deliver better patient outcomes than existing treatment regimes. This also means that sponsors need to increasingly generate outcome data both as part of the product approval submissions and as part of post-approval research programs. This is creating opportunities for CROs who can offer support in developing and interpreting this data.
34



A focus on long-term product safety

The clinical trial approval process can only detect major and common adverse side effects of drugs; less common but no less serious side effects may only become apparent after many years of use. As a result, there is an increase in the number of drugs given “conditional approvals” where further ‘post-approval’ studies are being mandated. In addition, prudent sponsors undertake similar studies to detect early warning signs of any potential problems with their products. Such studies may take the form of prospective long-term safety studies, simpler observational studies or registries where patients meeting specific criteria for disease or drug use are followed for long periods to detect any safety issues. CROs are well positioned to perform these studies on behalf of sponsors.

Increasing regulatory demands

Regulatory agencies increasingly require more data to support new drug approvals and are seeking more evidence that new drugs are safer and more effective than existing products. As a result, the complexity of clinical trials, the number of procedures required to be conducted in these trials and the size of regulatory submissions are driving the demand for services provided by CROs.

Environment, Social and Governance ('ESG')

Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions. We are passionate about providing innovative solutions for customers, we are better together working as one team, we value diversity and care about the success of our people, and we care about doing the right thing. We are advancing clinical research while offering customers broader and deeper experience, scale, and focus, complemented by continuity of delivery and speed to market. Our business model is described in the preceding sections. Consistent with our values, we seek to not only operate in compliance with applicable laws but also to positively influence our global workforce, the communities that we operate in, the environment and society as a whole. Doing so makes us a stronger, more resilient organization by every measure.

Our core values underpin our mission and drive a culture and mind-set of ownership at ICON. "OwnIt@ICON", as set out below, is a statement of values that has remained at the very heart of ICON’s culture, encouraging our people to seize the opportunity and bring flexibility, innovation, and determination to every situation. We believe our culture of ownership personifies who we are as a company — it also helps us apply our expertise, collaborate to get things done, and succeed at our mission.
iclr-20221231_g5.jpg

35



Our values underpin how we work together to deliver on our mission to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions. These values and our Code of Ethical Conduct, which underpins these values, form the core of what we do, and how we do it. It applies to all of our officers, directors, employees, consultants and agents globally. All employees and temporary workers are mandated to complete global ethics training.

At ICON, we care about conducting business sustainably. We care about our people, patients, and the communities in which we live. We care about doing the right thing and we are committed to working to the highest ethical standards and demonstrating our commitment to honesty, transparency, and quality. As a testament to our commitment, we launched our “ICON Cares” program at the start of 2023 which incorporates all our Environment, Social and Governance (ESG), Diversity, Inclusion and Belonging (DIB), and CSR initiatives into one program. ICON’s Environment, Social, and Governance Committee ('ESG Committee') brings together all these initiatives and efforts under one umbrella to ensure consistency, enhance monitoring, reveal areas for development and facilitate reporting to the Board. The ESG Committee is chaired by the Chief Administrative Officer and General Counsel (CAO), who is responsible for reporting to the ICON executive leadership team, the Nominating, Sustainability and Governance Committee and the Board on ESG matters. In February 2022, the Board delegated oversight responsibilities of the Company's strategies, activities, and risks in respect to ESG matters to the Nominating and Governance Committee, which was renamed the “Nominating, Sustainability and Governance Committee” in April 2022. Accordingly, the CAO reports on ESG matters to the Nominating, Sustainability and Governance Committee and reports to the Board on an annual basis whilst also providing periodic ESG updates to the executive leadership team.

The ESG Committee is focused on developing our strategy and initiatives relating to the environment, social matters, health and safety, community engagement, corporate governance, sustainability, and other public policy matters relevant to the Company. The ESG Committee is a cross-functional management committee of the Company including representation from facilities, health and safety, corporate communications, finance, legal, investor relations, procurement, commercial, marketing, and human resources departments. The Committee assists and supports executive management and the Nominating, Sustainability and Governance Committee of the Company in:

determining and setting the strategy relating to ESG matters;
developing, implementing and monitoring initiatives and policies based on that strategy; and
communicating these strategies, initiatives, and their results.

We are committed to building and developing our ESG strategies and reporting. In 2020 we launched our ESG page on the ICON website and have an internal ESG page on our MyICON intranet portal to engage with our employees and provide information and updates relating to ESG matters and our commitment to sustainability. In 2021, as a testament to our commitment to managing ICON responsibly and sustainably, we became a participant in the United Nations Global Compact (UNGC), a set of Ten Principles covering the areas of human rights, labor, environment, and anti-corruption. In our 2021 ESG report, released in 2022, we reported under the newest Global Reporting Initiative (GRI) standards and the Task Force on Climate-Related Financial Disclosures (TCFD). Our report summarizes our current policies, priorities, and commitments in respect to ESG matters. During 2022, ICON received a silver medal from EcoVadis in recognition of our environment, social and governance efforts throughout ICON. The ESG page on our website is available at https://www.iconplc.com/about/esg/.

The global landscape in respect to regulatory and legislative requirements relating to ESG reporting and disclosure requirements is rapidly evolving, and we are monitoring potential requirements so that we are positioned to adhere to any additional requirements in due course.

Building a sustainable future – our commitment to the United Nations Sustainable Development Goals

As a global company, we maintain an ethical and sustainable presence in hundreds of locations worldwide. At its core, ICON’s mission is to improve health and lives. We are also committed to contributing to the 2030 United Nations Sustainable Development Goals (SDGs) and are proud that our work contributes to their advancement.

Our research, our work with customers and patients and our on-the-ground efforts to meet the diverse needs across our communities align with the SDGs. These efforts, however, focus on a subset of themes where we have the greatest opportunity to effect change and further details are set out in our ESG Report.

Environment: Conducting business sustainably

ICON is committed to delivering excellence in care to our communities. To improve our overall sustainability, this commitment means tracking and improving our environmental performance across all business activities. We achieve this by pursuing sustainability strategies that recognize the impact of our operations as a CRO on the environment, addressing greenhouse gas (GHG) emissions, energy use, waste generation and procurement-related activities. Our employees, directors, officers, contractors, and temporary workers are expected to support our sustainability objectives.

36


Our Global Environmental Management Policy and Environmental Management Plan is our program for managing environmental sustainability initiatives. The implementation of the program is led by our facilities team, reporting to our Chief Administrative Officer and General Counsel (CAO). The CAO is responsible for reporting on the program to the ICON executive leadership team and Nominating, Sustainability and Governance Committee and the Board.

ICON set environmental goals around the use of renewable energy and carbon emissions in 2019 and we are working towards achieving these goals which are as follows:
100% renewable electricity by 2025
20% reduction in kilowatt hours (kWh) of electricity by 2030
Net zero carbon emissions on Scope 1 & 2 by 2030

We have programs in place to manage and minimize climate impacts of business activities. To continue to improve processes and reduce our environmental impact, we track, calculate, and report our GHG footprint. We apply the GHG Protocol Corporate Standard, which is the global corporate accounting and reporting standard for calculating carbon emissions. Carbon Trust provides annual verification of our emissions data.

In line with carbon reduction targets, ICON’s combined Scope 1 and 2 GHG emissions, relative to revenue and the number of employees, have fallen year on year since 2018. Since 2018, following our reduction efforts, the pandemic-related closure of many of our facilities and a reduction in business travel, GHG emissions across our operations declined significantly. Since 2021, as more normal operations resumed, we have seen a decrease in combined Scope 1 and 2 emissions with an overall increase in our total GHG emissions due to an increase in business travel (Scope 3). As the pandemic recovery continues, and we have resumed more normal operations, we are evaluating additional opportunities to continue to reduce our carbon emissions across our organization to develop and improve our environment program.

CDP (formerly the Carbon Disclosure Project) provides a globally recognized system that enables companies to measure and manage their environmental impacts. ICON continues to be committed to improving its current scoring of a C.

We are focused on reducing energy use across our global operations. For example, reducing energy use and shifting to renewable energy are components of our specific environment goals. Waste reduction is embedded into our environment policies and practices and is one of the objectives of ICON’s Environmental Management Policy. We will seek new opportunities to reduce waste by increasing recycling volumes, reducing consumption of primary materials, and decreasing use of disposable products in our offices and facilities.

The majority of our sites are leased, and we work closely with our landlords and leasing agents to implement measures to ensure we operate in an environmentally sustainable manner. The Acquisition of PRA expanded our global real estate footprint and our real estate group worked with other business leaders to understand the sustainability implications and opportunities of this new footprint and find ways to continue to advance our collective sustainability goals. During 2022, we continued to integrate offices and reduce our footprint which resulted in downsizing or closing 31 locations to align with new working styles and business needs. When selecting new locations for offices and planning building modifications, experts from our real estate team factor in environmental considerations. In addition, we have implemented a series of measures globally to reduce the local footprint of our offices, such as installing energy-efficient LED lighting, using motion detectors to reduce energy use, purchasing recycled office supplies, and reducing paper consumption by promoting paperless office processes, or where printing is necessary, enabling double-sided output.

Our office design has efficiency in mind, utilizing space to provide the maximum number of desks and functional provisions while still providing comfortable, safe spaces for our employees. Our strategies include:
Perimeter glazing of meeting rooms, offices, and other spaces which allow in natural light.
Recycling areas built into business centers and kitchen/ canteens which reduce waste sent to landfills.
Planted green spaces which contribute to internal air quality, temperature, and humidity.
Building materials and vendors which we select for low environmental impact.

We also require our suppliers to abide by our Global Supplier Code of Conduct which includes a commitment to comply with applicable environment laws and regulations, our expectations around waste management and sustainable use of resources.
Community Engagement

We are committed to making a positive impact on the communities in which we work and live and we have aligned our community efforts to a broader vision for social impact, including by aligning priorities with our organizational goals of diversity, inclusion, and belonging.
    
Our community engagement activities are focused on two core areas:
Supporting education and building closer ties between industry and academia.
Improving the welfare of people in the communities in which we live.

37


Supporting education and building closer ties between industry and academia
A core area of community support includes building ties between industry and academia to inspire the next generation of leaders in business and science. Our existing partnerships continue with the following organizations:

The ICON-McKeon Research Fellowship in Motor Neuron Disease ('MND') in honor of Mr. Declan McKeon, former Board member, acting Chairman, Lead Independent Director and Chair of the ICON Audit committee. The ICON-McKeon Research Fellow in MND carries out research in the areas of machine-learning and artificial intelligence to derive insights from multimodal clinical, imaging neuro-electric signaling, in the context of the neurodegenerative disease of ALS.

Partnership with Trinity Centre for People with Intellectual Disabilities ('TCPID') - TCPID situated within the School of Education, Trinity College Dublin, aims to promote the inclusion of people with intellectual disabilities in education and society. The Centre provides people who have intellectual disabilities with the opportunity to participate in a higher education program designed to enhance their capacity to fully participate in society as independent adults. The 2-year education program includes work placements and internships to enable students to experience and participate in the work environment. In 2022, ICON facilitated a 12-month internship in our Laboratory and Facilities departments for one of the TCPID graduates and our aim is to continue to offer work placements and internships as part of this partnership in 2023.

Partnership with Junior Achievement to inspire schoolchildren. Junior Achievement encourages young people to remain in education and teaches them the skills they need to succeed in a changing world. ICON volunteers take time out of their working day to deliver Junior Achievement programs, teaching primary and secondary-level students valuable business, STEM and entrepreneurship skills that will serve them throughout their professional lives. ICON expanded its partnership with Junior Achievement to include an additional three locations in the United States and the United Kingdom in 2022.

In 2022, we further expanded our industry-academia partnerships through the creation of a new ICON scholarship program to provide increased opportunities for underrepresented groups to study STEM (Science, Technology, Engineering & Mathematics) courses and to build a more diverse graduate pool of talented and ambitious STEM professionals who can help to ensure the future success of the life sciences industry. Through the program, ICON is partnering with three universities in Ireland – Dublin City University (DCU), Trinity College Dublin (TCD) and the University of Limerick (UL) – as well as with the Thurgood Marshall College Fund (TMCF) in the US, to fund 33 scholarships for students of STEM courses. TMCF is a not-for-profit organization that supports nearly 300,000 students attending its 47 member-schools that include publicly-supported Historically Black Colleges and Universities (HBCUs).

Improving the welfare of people in the communities in which we live

Through volunteering, donations and other charitable initiatives, our employees across the world are making a positive difference to their communities. We support causes that are important to our employees and have several programs that support the welfare of people in our local communities. In 2022, 540 employees across the world participated in Run in the Dark, an annual event organized by the Mark Pollock Foundation to bring people together and fundraise to help find a cure for paralysis. ICON was the largest global corporate team to participate in the event and helped to raise $10,000 for the cause. A team of 90 ICON cyclists from 19 countries also participated in our annual ICON cycle challenge, which raised funds for the International Committee for the Red Cross.

Since 2012, ICON’s annual employee-nominated charity donation program has supported over 90 charities, donating $10,000 to each organization. The selected organizations focus on a range of critical issues, from relieving poverty and homelessness to improving child welfare through education and enhancing the lives of people living with a variety of diseases. The organizations were chosen to align with our ESG goals. In addition, to support ongoing humanitarian efforts in Ukraine, we also made a donation to the Children of Heroes charity fund in Ukraine to support children who have been severely impacted by the war in that region.

Talent and People

Our people are core to our ability to deliver our services and drive better patient outcomes. Through diversity, inclusion and belonging, industry-leading talent management practices, a sincere attention to our employees’ needs, well-being and health and safety, we continue to power the potential of together.

At the core of our strategy is our people
    
People have long been central to our mission to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions. We encourage our people to bring flexibility, innovation, and determination to every situation. By doing so, our people can build exciting and rewarding careers, and deliver results to bring life-changing medicines to market and to maintain our success as an industry leader.
38



Learning and development of our staff is a key focus for us

Our leadership and talent programs contribute to the enhanced retention of our employees, better project deliverables for our customers and the enhanced financial performance of the business.

We aim to be an industry leader where talented people come to do important work and where our employees can shape the future of healthcare, grow their careers, and reach their full potential. We have long held a deep commitment to cultivating strong people practices. This includes competitive total rewards packages along with a focus on continuous learning. We nurture a culture of development and aim to boost engagement by supporting our people’s growth, both personally and professionally. We are dedicated to finding opportunities for our employees to grow and develop.

Our success depends on the knowledge, capabilities, and quality of our people. To improve their skills, we are committed to providing continuous learning. This commitment is underpinned by clearly defined competencies, which offer employees a clear path along which to develop skills and advance their careers.

To support employees at every stage of their career journeys, training and development programs are aimed at advancing scientific, technical, and business knowledge. Programs include tailored CRA academies and a range of project management curricula, therapeutic-focused programs, and people leader development programs. During 2022, this also included diversity, inclusion and belonging training for everyone on our talent acquisition team and many of our People Leaders.

Our People Leader development program focuses on providing our People Leaders with the relevant skills to effectively manage themselves, their team and their business, including psychometrics to raise their awareness of their behavioral preferences and the preference of others. ICON also invested in Harvard Manage Mentor, an online learning platform providing People Leaders with access to learning available at any time with topics ranging from change management, diversity & inclusion, retaining employees and developing employees.

We provide our people with a personalized and flexible learning experience, delivered through a combination of in-person and technology-driven programs that suit their learning styles and can flex to suit their schedules. Through our industry leading CareerHub, ICON employees are encouraged to broaden their scientific, technical, leadership, and business knowledge. By tapping into development programs and partnerships with leading academic institutions, team members can use the hub to develop competencies that advance their careers. We also collaborate with UCD Smurfit School Executive Development to deliver customized leadership development programs for global employees.

As an organization we are keen to hear directly from our employees

To attract and retain the best talent, we must listen and respond to employees’ needs. This begins with a focus on diversity, inclusion and belonging, and extends to every aspect of our work, from recruitment and onboarding, to training, engagement, enablement, and reward. We pursue best-in-class approaches to building employee engagement and these include, among others:

Comprehensive global employee surveys, which measure how people feel about their work and whether they feel they have the tools to do their jobs well. Feedback from these studies informs detailed action plans at the group, function, and team level.
Pulse check surveys, which are smaller-scale studies designed to measure employee sentiment on specific topics and initiatives.
Fostering an environment of diversity, inclusion and belonging where everyone is valued.
Stay interviews to help managers understand why staff stay and to uncover what might put them at risk of departing.
Skip-level meetings to develop trust and rapport between senior leaders and employees.

Our listening strategy supports our efforts to reduce employee turnover, which we monitor closely through analytics. Qualitative information is collected through formal exit interviews and, where we believe they’ll make an impact, we intervene via retention plans and related efforts.

Employee well-being

ICON’s commitment to improving health and enriching lives extends beyond the work we do with our customers. Employees across the globe have direct access to locally relevant information and resources to support every facet of their well-being, including physical, social, psychological, and environmental.

39


Our global Employee Assistance Program (EAP) ensures that all employees, and their families, have access to a range of different, confidential resources and experts to help them better manage their working life and personal life. The EAP also delivers a web-based and mobile app platform with access to toolkits providing advice and resources in local languages.

Health and safety

At ICON, the health and safety of our employees, customers and clinical trial patients are our most important priorities. We take guidance from global and regional health authorities and governments to protect the safety and welfare of employees, as well as abide by government directives. Our global health and safety management system ensures we deliver on all local and national requirements. Our priority objectives are the safety of our staff, clinical trial patients, protecting the environment, maintaining business continuity, and ensuring all sensitive health and safety data is protected.

We are committed to providing a safe working environment for our people. We achieve this goal by working in ways that protect the safety, health, and welfare of all our employees, clinical trial patients, and visitors. Risk assessment is the basis of the safety management system, and we work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities. We work to identify, mitigate, and monitor existing and emerging health or environment risks that may be associated with our business activities.

Fostering diversity, inclusion and belonging

We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow, whether at work, at home or in their communities. The diversity of our teams is critical to our success. As a global operation, we deliberately structure teams to be diverse to support the delivery of our customers’ clinical development programs across multiple geographies and communities.

Diversity, inclusion, and belonging (DIB) are fundamental to our culture and values. Diversity makes us more innovative and more creative, which helps us better serve our patients, our customers, and our communities. We recognize the critical importance of diversity in clinical trials ensuring all types of patients who will eventually receive therapies are represented on clinical trials, as well as offering clinical trials as a care option for those who may not otherwise have access to medical treatment.

We are committed to being a workplace where all employees are included and feel a sense of belonging. To achieve this, we acknowledge and celebrate our differences in gender, ethnicity, culture, and abilities. As a values-driven organization, respect for diverse points is foundational to how we interact with each other, as well as with customers, patients, and suppliers.

ICON’s approach to DIB is a key focus area. To reflect this, inclusion is one of our core values and our DIB strategy is now organized into four key ambitions:

iclr-20221231_g6.jpg

ICON’s DIB practices and programs are viewed through the lens of our four DIB ambitions. Each ambition has sponsors from our executive leadership team to support and drive the agenda and provide leadership.

40


We believe in a workplace culture that embraces diverse perspectives and empowers our team members to grow — at work, at home and in their communities. The key areas of focus for our diversity, inclusion, and belonging agenda include talent management, country-level inclusion policies, rewards, training, and communications.

We established a Diversity, Inclusion & Belonging Steering Committee in 2019 which brings together individuals from across ICON to develop and execute work streams under each of the four ambitions, with a central team overseeing the overarching efforts. ICON has Diversity, Inclusion & Belonging advocates from across our global employee population to better understand local needs, build local presence and awareness, and to give a voice to every corner of the company across the world. These individuals play a key role in supporting the Diversity, Inclusion & Belonging Steering Committee and in aligning activities across the organization.

The DIB community groups we have at ICON are:

iclr-20221231_g7.jpg
DAWN:
The Disability Awareness Network is a community group striving to develop and foster a mindset towards creating an inclusive workplace and working environment where everyone is treated equally with respect and dignity, irrespective of any visible or hidden disabilities.
iclr-20221231_g8.jpg
EmbRACE:
Supporting all race and ethnic backgrounds in creating an inclusive workplace culture.
iclr-20221231_g9.jpg
NOW@ICON:
Networking Organization for Women at ICON is committed to inspiring and connecting current and potential leaders through an inclusive environment of targeted initiatives and supportive mentorship.
iclr-20221231_g10.jpg
Pride@ICON:
Supporting LGBTQ+ colleagues and allies, ensuring that no matter where employees are in the world, our offices are a safe space where they are welcomed, respected, and valued.
iclr-20221231_g11.jpg
SPACE:
Supporting Parents and Carers Everywhere to create a workplace where stepping out of careers due to personal commitments for a period is wholly accepted and not career limiting, and where stepping back into their career is an organic and positive process.
As a testament to our commitment to diversity, ICON are aiming for gender parity at the VP level and above by 2025. As at February 24, 2023, women represent 44% of the positions at the VP level and above.

ICON is focused on building an inclusive culture where employees feel supported by a fair system supporting pay equity. We have a long track record of developing talent and filling vacancies through internal hires. Using best-in-class analysis, we conduct regular reviews of salary ranges to ensure fair pay, irrespective of gender, race, or ethnicity whilst considering legitimate business factors that explain differences such as performance, tenure, and experience.

We continuously monitor and seek to maintain pay equity for our employees. We have structured our pay principles so that individual differences not related to tenure, experience or performance criteria are not a factor in how we deliver rewards. ICON has made significant investments in organizational design structures, tools and education that uphold and support our pay principles.

We are committed to ensuring fair employment practices. For every jurisdiction in which we operate, we act in compliance with relevant laws relating to labor rights and labor relations as well as market competitive benefits. We believe in fair and equal treatment for all our people, without regard to gender, race, ethnicity, sexual orientation, marital status, physical or mental disability, age, pregnancy, veteran status, nationality, religion, or any other legally protected status. We do not tolerate our employees being subjected to physical, sexual, racial, psychological, verbal, or any other form of harassment. We encourage our
41


employees to report any issues of harassment or discrimination. We prohibit retaliation against any employee who rejects, protests, or complains about unlawful discrimination or harassment.

Human rights

ICON is committed to human rights and in 2021, ICON became a participant in the UN Global Compact (UNGC), signaling our commitment to uphold the UNGC’s 10 Principles, including those related to human rights across our global operations. Our business model and our policies, including our Global Code of Ethical Conduct and Global Supplier Code of Conduct, are intended to fully comply with applicable human rights legislation in the countries where we operate. Our zero-tolerance policy on forced labor, slavery, and human trafficking is defined clearly in these policies, which are available to employees, suppliers, customers, and the public.

We are opposed to forced labor, slavery, and human trafficking. We will not knowingly support or conduct business with any organization involved in such activities. We do not employ anyone below the minimum employment age in the jurisdictions in which we operate.

Our Global Supplier Code of Conduct incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for responsible supply chain management, including for labor. Before doing business with ICON, suppliers must certify that they will comply with the ICON Global Supplier Code of Conduct or their own materially equivalent internal code, which includes human rights protections. We perform pre-engagement due diligence on our suppliers, including in relation to labor issues, which we support through periodic re-screening. We hold our suppliers accountable for meeting their contractual obligations. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business.

Ethics and Compliance

ICON’s commitment to ethics and integrity is embedded in our company values. We act with integrity and integrate ethical principles into our business practices and culture. ICON’s Global Code of Ethical Conduct (the Code) establishes our core principles and standards for honest, fair, and ethical behavior. This Code addresses the core values expected of our people in our internal interactions with each other as well as in external dealings with patients, customers, healthcare professionals, regulators, investors, vendors and other third parties.

Our Ethics and Compliance program builds on the principles established in the Code to define and drive business conduct consistent with company values and the laws, rules and regulations that apply to our business. The Ethics & Compliance Team (E&C) provides day-to-day independent oversight for the program. The team is independent of the business and reports to the Chief Administrative Officer and General Counsel (CAO). The CAO reports on the program to ICON’s executive leadership team, the Nominating, Sustainability and Governance Committee and the Board. The program supports all functional areas globally and is dedicated to the implementation of standardized global policies, procedures, training, guidance, communications, monitoring, investigations, issue management, assessing compliance-related risk and mitigations, and reporting to ensure the overall compliance program is effectively functioning.

ICON has incorporated a third-party system, Ethics Line, for employees and third parties to confidentially report ethics and compliance questions, as well as concerns, and to track reports through follow-up and resolution. These tools also provide visibility into our risks while highlighting opportunities to address them. ICON’s compliance and ethics program will continue to grow and evolve in response to changes in our business and in the global business climate.

All employees are required to complete mandatory training in key areas which support our values and our ways of working. The training incorporates the key principles of our policies and codes and includes interactive scenarios where applicable.

At ICON, we promote a Speak Up culture that encourages compliance, openness, and accountability without retaliation. The Speak Up Policy aims to support our culture and values and seeks to encourage the prompt reporting or surfacing of concerns or violations. Reported ethics concerns and other ethics and compliance-related data are reported via the CAO to the Board as appropriate.

Anti-bribery and Corruption

ICON is guided by the foundational principle that we do not tolerate bribery or any other form of corruption or fraud. Our anti-bribery and anti-corruption (ABAC) program is a key element of our Ethics and Compliance Program. ICON and all ICON directors, employees, consultants, agents and all third parties acting on ICON's behalf must act in compliance with international laws and regulations relating to bribery, corruption, and illicit payments, including the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.

ICON maintains the ISO 37001:2016 certification for our Anti-Bribery Management System, which establishes the framework for the controls that prevent, detect and mitigate the risk of bribery. Our program is designed to ensure our compliance with anti-corruption laws, including due diligence, training, policies, procedures, and internal controls.
42



Bribery and corruption remain a business risk as we conduct our business across the globe and enter partnerships and collaborations. There is no certainty that all employees and third-party business partners (including our vendors, suppliers, agents, contractors, and other partners) will comply with anti-bribery laws. When working with third parties, we are committed to working with only those who embrace high standards of ethical behavior consistent with our own. Bribery and corruption risks are a focus of our third-party diligence and management process. We hold our suppliers accountable for meeting their contractual obligations with ICON, including commitments that are made with regard to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship with the supplier and exclusion from future business with ICON.

ICON's internal audit teams conduct ABAC Program audits. Internal Audit focuses on testing for compliance and design effectiveness of the overall ABAC Program. Internal Audit incorporates an assessment of ABAC measures in all audits, as appropriate. In this approach, bribery and corruption risks are incorporated into the risk assessment and scoping process of each audit.

Information Security and Privacy

Data privacy and information security are fundamental to our business and key to retaining customers, building investors’ trust, protecting patients, and complying with global and regional regulations. We recognize and respect that our customers, employees, patients, and all those who do business with us expect that we will protect their personal information in accordance with our legal obligations and policy commitments.

Our cybersecurity strategy and program protect our systems and data from an evolving threat landscape. The cybersecurity program, overseen by the Chief Information Officer (CIO), has the support of executive leadership and the Board, and we have invested heavily in cybersecurity technologies to protect our environment. Our processes and range of information security policies are certified to ISO 27001 and are independently audited twice annually. ICON also maintains the Cyber Essentials certification. During an acquisition process, we conduct security and privacy due diligence and risk assessments, implement policies, deliver employee training, and securely integrate IT systems.

Our Global Data Protection Policy regulates the processing of personal data in accordance with the applicable data protection laws of the countries where we operate, including Europe’s General Data Protection Regulation (GDPR) framework. This policy governs ICON’s and its employees’ obligations concerning the processing of personal data, including core privacy issues such as how we address data subject rights, data protection impact assessments and our obligations to maintain records of processing activities (ROPAs).

ICON has a separate Personal Data Incident and Breach Response Policy and Process that governs the management of personal data incidents and breaches within ICON. The policy requires incidents to be reported to ICON’s Global Data Protection Officer (DPO) and Privacy Team, who manage them in collaboration with relevant internal stakeholders (e.g., IT Security, Quality & Compliance), to ensure we comply with our legal and contractual obligations, including our reporting obligations. Our privacy program is overseen by the CAO.

Our people and partners play a critical role in safeguarding data. ICON has training in place for all employees and contingent workers on information security and privacy practices so that they understand their responsibilities with respect to data security and privacy.

Sustainable procurement

ICON maintains policies and practices to support responsible, sustainable, and ethical business practices. Our goal is to source from suppliers whose values align with our own, including suppliers who are committed to diversity and inclusion, and are socially and environmentally responsible and conscious.

We manage our suppliers through our Global Procurement department. The onboarding of new suppliers is completed through a centrally managed due diligence process. Environmental sustainability, bribery, and corruption risks are a focus of our collective third-party diligence and management process. We require our suppliers to abide by our Global Supplier Code of Conduct which incorporates the Pharmaceutical Supply Chain Initiative (PSCI) principles for Responsible Supply Chain Management and sets out our standards and expectations regarding:
Ethics and compliance
Labor and human rights
Health and safety
Environmental stewardship

ICON performs pre-engagement due diligence on our suppliers. This includes screening of sanctions lists, debarment, and adverse media. Suppliers are continuously monitored against sanctions and debarment lists and are periodically re-screened. Suppliers deemed higher risk are subject to enhanced due diligence and controls, which may include periodic training, auditing, and assessments.
43



We hold our suppliers accountable for meeting their contractual obligations, including commitments relating to our Global Supplier Code of Conduct and regulatory compliance. Contract non-compliance can result in termination of the business relationship and exclusion from future business with our company.

We have also engaged with EcoVadis, CDP and Supplier IO to assess our key suppliers and allow us to take ESG status into our decision making on vendor selection.

Sales and Marketing

Our marketing strategy is focused on building a differentiated brand position for ICON and supporting our business development efforts to develop and build relationships with pharmaceutical, biotechnology, medical device, and government and public health organizations. Our marketing activities are coordinated centrally to ensure a consistent and differentiated market positioning for ICON and to ensure all marketing efforts align to the overall strategic objectives of the business. Our business development teams are located throughout the Americas, Europe and Asia Pacific regions. Business development activities are carried out by account executives with assigned territories and global account directors supporting our large accounts. Specialized business development teams focus on growing each of our business areas. Collectively, our business development team, senior executives and project team leaders share responsibility for the maintenance of key client relationships. Our aim is to develop deeper relationships within our client base to gain repeat business and enable us new opportunities to penetrate into other therapeutic indications and adjacent service lines.

Competition
The CRO industry is fragmented, consisting of many small, niche service providers, a declining number of medium-sized providers and a smaller number of large CROs, including ICON, that are differentiated by the scale of their global operations, breadth of service portfolios and supporting technology infrastructure. The need to conduct complex research and access patients on a global basis is driving market share to these global CROs. When competing for large development programs, ICON competes primarily with IQVIA, PAREXEL, the PPD clinical research services brand of Thermo Fisher Scientific Inc., the Covance Drug Development business of LabCorp and Syneos Health. In some specific markets, for example biotech and mid-tier pharma, ICON may also compete against mid-tier CROs. Competition also exists for acquisition candidates in addition to competition for customers.

CROs generally compete on the basis of previous product experience, the ability to recruit patients on a global basis, the depth of therapeutic and scientific expertise, the strength of project teams, price and increasingly on the ability to apply new innovation that can drive significant time and cost savings throughout the development process. An evolving area of competition is the need to provide services that can help generate the evidence of the economic value of new treatments that payers and regulators require. This requires access to new data sources which includes information to support the identification of suitable investigator sites and patient populations as well as data on the value delivered by new products following marketing approval.

We believe that we compete favorably in all these areas and we continue to invest in our capabilities to ensure that we remain competitive in the future.

Customers

During the year ended December 31, 2022, revenue was earned from a wide range of clients. During the year ended December 31, 2022, 28.3% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.8% of revenue for the year. 

During the year ended December 31, 2021, 31.6% of our revenues were derived from our top five customers, with no one customer individually contributing more than 10% of our revenues during the period. Our largest customer represented a strategic partnership with a large global pharmaceutical company and contributed 8.0% of revenue for the year ended December 31, 2022.  

During the year ended December 31, 2020, 39.1% of our revenues were derived from our top five customers, with one customers individually contributing more than 10% of our revenues during the period (12.1%). No other customer contributed more than 10% of our revenues during this period.  

The loss of, or a significant decrease in business from one or more of these key customers could have a material adverse impact on our results of operations.

44


Unsatisfied Performance Obligation

Our unsatisfied performance obligation consists of contracted revenue yet to be earned from projects awarded by clients. At December 31, 2022 we had contracted unsatisfied performance obligations of $13.7 billion. We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize this unsatisfied performance obligation as revenue.

Information Systems

Having access to accurate and timely information is critical in the management, delivery and quality of all aspects of drug development. ICON utilizes an extensive range of both on premise and cloud based applications that support its services including clinical trial design and planning, site and patient identification and recruitment, site start-up, patient consent, site payments, content management, clinical data analysis and real world evidence generation, customer relationship management (CRM), performance management, compliance and safety reporting and master data management. These solutions are to allow healthcare companies to manage, optimize and execute their clinical and commercial strategies in an orchestrated manner while addressing their regulatory obligations.

ICON has developed an informatics strategy built around key platforms including ICONIK and Health Cloud, web-based information platforms that enable the management, reporting, analysis and visualization of all data relating to drug development. The ICONIK and Health Cloud platforms collect, manage and standardize study data from multiple sources, including Electronic Data Capture (EDC), patient engagement, EMR/EHR, mobile health, Telehealth, Wearables, central laboratories, Symphony Health and Imaging platforms to provide a single view of study information. ICONIK and Health Cloud enable ICON to deliver services such as Risk Based Monitoring (RBM) which uses near-real time clinical data to drive monitoring visit schedules, enabling better decision making and the successful implementation of clinical trial strategies that significantly improve efficiency in clinical trials thereby reducing overall cost and time to market whilst better protecting patient safety.

In addition to managing clinical data, ICONIK and Health Cloud collect operational data, such as project management, clinical trials management system (CTMS) and metrics information to drive trial efficiency and transparency. Investigator data, such as payments, site details and performance, can also be incorporated. ICONIK and Health Cloud can be accessed via a portal that allows clients access to study-related information via a secure web-based environment. Data analysis from ICONIK and Health Cloud Informatics Hubs and CDRP allows us to enhance the design and delivery of our projects, through stronger engagement with investigators and patients.

Data management and collection is a key business process for Symphony Health through its Integrated Dataverse (IDV®) platform. Integrated Dataverse (IDV®) is a comprehensive and longitudinal source of healthcare data in the industry, bringing together our vast claims resources – medical, hospital, and prescription – with our rich point-of-sale prescription data, non-retail invoice data, and demographic data.

Firecrest, our site management and training technology, is another important component of our informatics strategy. Firecrest provides an on-line web-based portal to access visit by visit study guides which drive site performance and quality.

ICON also utilizes a range of enterprise applications that enable the delivery of our business services in a global environment. The focus is to provide ease of access and capture of study information for our staff and clients globally. Our current information systems are built on open standards and leading commercial business applications from vendors including Microsoft, Amazon, Oracle, Dell, SAS, Veeva, Dassault, Salesforce and BOX. IT expenditure is authorized by strict IT governance policies requiring senior level approval of all strategic IT expenditure based on defined business strategy and measurable business benefits.

In Clinical Operations, we have deployed a suite of software applications that assist in the management and tracking of our clinical trial activities. These software applications are both internally developed and commercially available applications from external vendors. These include a clinical trial management application that tracks all relevant data in a trial and automates all management and reporting processes. In our Data Management function, we have both leading clinical data management solutions including EDC and Clinical Data Warehouse solutions from external vendors as well as our proprietary EDC capability NEXTrials Prism eClinical. This allows us to guarantee the integrity of client data and provide consolidated information across client studies.

Within Clinical Operations, we also provide the ICON Digital Platform enabling the delivery of Decentralized and Hybrid Clinical Trial services, maximizing patient recruitment and retention and at the same time expanding access to diverse and remote patient populations. We develop strategic, flexible approaches that leverage clinical informatics, state-of-the-art technologies, and our global reach to maximize safety and efficiency and make data-driven decisions for every study.

In our clinical trials management area, Firecrest Clinical provides a comprehensive site performance management system that improves compliance, consistency and efficient execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out
45


quickly and simultaneously to sites. Site behavior can then be tracked to ensure training is understood, procedures are being followed, timelines are met and study parameters are maintained. As well as meeting day to day operational requirements, this system feeds data into the ICONIK and Health Cloud platforms.

We provide interactive response technology (IXR) to enable centralized patient randomization, drug inventory management, patient diary collection, providing our clients with a fully flexible multi-channel data retrieval solution which can be utilized via telephone, internet browser or a mobile device. In our central laboratory business, we utilize a comprehensive suite of software, including a laboratory information management system (LIMS), a kit / sample management system and a web interface system to allow clients to review results online. Our Laboratory also utilizes IMRA, a web based laboratory review application that allows global access to the latest laboratory data on a study. IMRA facilitates detailed analysis of any trends, signals, alerts or patient-specific data on a real-time basis. ICON provides imaging services through the use of its internally developed MIRA platform and also utilizes Medidata’s Rave Commercial Imaging for collecting, managing and processing data to support its imaging capabilities.

ICON provides its Pharmacovigilance Services using Oracle’s ARGUS safety database. The system is FDA regulation 21 CFR Part 11 compliant and generates all the standard regulatory required reports, as well the periodic reports required to support operations.

ICON supports Population Pharmacokinetics and Pharmacokinetic Pharmacodynamic modeling through the use of its proprietary software NONMEM®. NONMEM® is a nonlinear mixed effects modeling tool that can be used to fit models to many different types of data. Statistical analysis with NONMEM® using the appropriate model helps pharmaceutical companies determine appropriate dosing strategies for their products, and increase their understanding of drug mechanisms and interactions. NONMEM® can also be accompanied with PDx-Pop proprietary software. PDx-Pop software is a graphical interface for NONMEM® which has its own automation methodology which expedites the iterative process of population pharmacokinetic modeling and analysis. ICON also utilizes PREDPP, which is a powerful package of subroutines handling population PK data, as well as general linear and nonlinear models, which can free the user from coding standard kinetic-type equations while simultaneously allowing complicated patient-type data to be easily analyzed. Finally, ICON utilizes NM-TRAN, which is a preprocessor allowing control and other needed inputs to be specified in a user-friendly manner.

ICON's configurable Real World Data “Evidence” platform is a fit-for-purpose solution to support and enhance observational research. The platform gathers disparate real world data assets into a common data model, provides analytics to support multiple audiences across the product lifecycle, and serves as a central repository and analytic platform for all Real World Data assets.

ICON’s Integrated Dataverse (IDV®) is one of the largest integrated repositories of healthcare data consisting of 280 million patient lives, 1.8 million prescribers and 16 thousand health plans provides powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market. We transform data into decisions and give deeper insight into the relationships that sponsor brands have with the market by allowing a holistic view of the impacts of payer, prescriber, and patient behavior. Our proprietary Tokenisation technology Synoma® simplifies the anonymization, exchange and connection of industry data sources to provide an integrated view of a patient’s data.

The Company’s strategy of using technology to enhance our global processes is evident from our deployment of platforms like ICONIK, Health Cloud, Veeva EDMS/QMS (our global SOP Document Management system), iLearn and Cornerstone (our Web-based training delivery solution), ServiceNow (workflow and automation platform), Sailpoint (identity management and governance), and Pega and ARGUS (pharmacovigilance). The Electronic Trial Master File is delivered via ICON’s proprietary software ICOMaster or the Wingspan and PhlexGlobal software platforms.

The Company’s global finance operations utilize Oracle’s eBusiness suite, with the integrated Excel4Apps reporting tool, to serve the organization’s financial and project accounting requirements. Workday is used to fulfill our HR people management requirements. Our business development and contracting teams use Salesforce CRM.

Our IT systems are operated from two data center hubs in Europe (Dublin, Ireland; Groningen, Netherlands), four in North America (Philadelphia, Pennsylvania; Lenexa, Kansas; Charlottesville, Virginia; Dallas, Texas) and one in Asia (Singapore). These hubs reside within purpose-built data center facility locations. Other offices are linked to these hubs through a network managed by Verizon, a tier one global telecommunications provider. This network provides global connectivity for our applications and allows collaboration and communication using tools like Microsoft Teams, Cisco Jabber, Sharepoint and Box. Mobile staff can also access all systems via secure remote access facilities. A global corporate intranet portal provides access to all authorized data and applications for our internal staff as well as providing an internal platform for company-wide communication. IT systems are protected with robust information security controls which are independently audited biannually as part of maintaining ICON’s ISO27001:2013 certification.

ICON enables its patient site and data strategy through the services delivered via Accellacare and through our partnerships with Oncacare and Veradigm Allscripts. We also work with biopharmaceutical companies and other life science providers (e.g. medical devices companies) to develop and deploy bespoke stakeholder engagement solutions. ICON’s patient
46


engagement services enable site staff to engage directly with patients to help improve their disease and medication understanding through interventional and non-interventional support.

ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology.

ICON is the leading provider of Functional Service Provision (FSP) globally. Our team of operational, functional and therapeutic specialists offer a range of FSP models. We offer FSP solutions across all major functions from clinical monitoring and project management through data management, statistical programming and beyond. Our teams leverage either Sponsor or ICON’s IT Infrastructure to deliver services. Our team has extensive experience managing the migration of systems and can support system upgrades as part of the ramp-up phase.

ICON provides molecular diagnostic laboratory capabilities that enables the development and commercialization of precision medicines in oncology.

Other key innovations and new technologies include:

FLEX ADVANTAGE, our interactive response technology platform (accessible through the web and web-enabled mobile devices) for managing patient randomization, investigator sites and clinical suppliers.
PubsHub brings speed and efficiency to medical teams by delivering easy-to-use, web-based solutions that bridge process gaps for system harmonization across companies. ICON utilizes PubsHub to automate medical and scientific communications and publications management.
The ICON Patient Engagement Platform features an easy to navigate, user friendly website enabling patients to explore new and ongoing studies available, opt-in and connect with their nearest clinical research site.
One Search, an intuitive, integrated workflow and interrogation tool from ICON, enables access to multiple data sources and provides the visualization and tools necessary for optimum site identification based on ICON and industry data of capability, experience and performance. Scoring on enrollment performance, speed of start-up and quality supports better site selection.
ADDPLAN for simulation and design of exploratory/pilot and confirmatory/pivotal adaptive clinical trials (ADDPLAN® DF (Dose Finder), ADDPLAN® Base, ADDPLAN® MC (Multiple Comparison) and ADDPLAN® PE (Population Enrichment)).
AptivAdvantage which is an integrated platform comprising EDC, randomization and drug supply management specifically created for execution of adaptive clinical trials and used to deliver risk-based monitoring; and Aptiv Insite which is a novel approach to risk-based monitoring, using Verification by Statistical Sampling (VSS) to manage data quality and site related risks.
Sample Inventory Management System (SIMS) is an interactive reporting module in ICOLabs for use by sponsors and study teams. It offers near real time, high level traceability of all patient samples in a clinical trial as they move from accessioning through disposition. SIMS provides detailed sample inventory reports and summaries of sample status and location with drill down capabilities. It helps locate samples more rapidly, particularly at critical study junctures.
APECS for Investigator Payments ensures timely and accurate payments to sites for the work performed in the care and management of patients as they participate within clinical trials.
The PredictivvTM platform is a fully integrated solution for designing, planning, managing and optimizing the execution of global clinical studies. Designed around a unified Sales Force platform that harmonizes data, processes, and people across every aspect of a clinical study, PredictivvTM enables unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.
EXACT™ allows users quickly to construct re-usable programs for data extraction, data transformation, statistical reporting and electronic publishing, in a visual environment with limited code writing. The EXACT™ system is used to simplify and automate the production of multiple Clinical Data Interchange Standards Consortium (CDISC) guidelines as well as tables, figures and listings in trial reports.

Contractual Arrangements

We are generally awarded projects based upon our responses to requests for proposals received from companies in the pharmaceutical, biotechnology and medical device industries, or through strategic partnership agreements.

Revenues on long term contracts are recognized based on an assessment of progress towards completion. Payment terms usually provide either for payments based on the delivery of certain identified milestones, units delivered or monthly payments, according to a contracted payment schedule over the life of the contract. Where there are changes in the scope of a trial or in the services to be provided by us, a change order or amendment is issued which may result either in an increase or decrease in the contract value. We also contract on a "fee-for-service" or "time and materials" basis.

47


Contract periods may range from several weeks to several years depending on the nature of the work to be performed. In most cases, an upfront portion of the contract fee is paid at the time the study or trial is started. The balance of the contract fee is generally payable in installments over the study or trial duration and may be based on the completion of certain performance targets or "milestones", on units delivered, or on a fixed monthly payment schedule. For instance, installment payments may be based on patient enrollment progress or delivery of the study database.

The progress towards completion for clinical service contracts is measured based on total project costs (direct fees are therefore inclusive of third party costs). Reimbursable costs include payments to investigators, travel and accommodation costs and various other expenses incurred over the course of the clinical trial which are fully reimbursable by the client. Reimbursable expenses are included within the contract and are invoiced on a monthly basis based on actual expenses incurred. Expenses incurred are determined by reference to activity.

As the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred, we usually negotiate currency fluctuation clauses in our contracts which allow for price adjustments if changes in the relative value of those currencies exceed predetermined tolerances.

Most of our contracts are terminable immediately by the client with justifiable cause or with 30 to 90 days’ notice without cause. In the event of termination, we are usually entitled to all sums owed for work performed and expenses incurred through the notice of termination and certain costs associated with termination of the study. Termination or delay in the performance of a contract occurs for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client's decision to de-emphasize a particular trial, inadequate patient enrollment or investigator recruitment.

Risk Management

Our Chief Executive Officer and other members of the executive management team are responsible for day-to-day risk management of the Company and our Board oversees management's activities through both the full Board and its committees. Our Chief Executive Officer and other members of the executive management team are members of ICON’s Quality and Risk Forum, which reviews risk. Our executive management team regularly reports to the Board and its Committees to ensure effective and efficient oversight of our activities and to assist in proper risk management and the ongoing evaluation of management controls. The Board oversees general business and market risk management, our Audit Committee oversees risk management with respect to financial statements, accounting and financial controls and our Compensation and Organization Committee oversees risk management with respect to our compensation plans, policies and procedures and our Nominating, Sustainability and Governance Committee oversees risks relating to ESG matters. Internal audit reports functionally and administratively to our Chief Financial Officer and directly to the Audit Committee. With respect to non-financial risk management, including cybersecurity, legal compliance, privacy and enterprise risk, the Board and its Committees receive updates from the appropriate executives on the primary risks facing the Company and the measures the Company is taking to mitigate such risks.

Government Regulation

The clinical investigation of new drugs is highly regulated by government agencies. The standard for the conduct of clinical research and development studies is Good Clinical Practice (“GCP”), which stipulates procedures designed to ensure the quality and integrity of data obtained from clinical testing and to protect the rights and safety of clinical subjects.

The FDA and other prominent regulators have promulgated regulations and guidelines that pertain to applications to initiate trials of products, the approval and conduct of studies, report and record retention, informed consent, applications for the approval of drugs and post-marketing requirements. Pursuant to these regulations and guidelines, service providers that assume the obligations of a drug sponsor are required to comply with applicable regulations and are subject to regulatory action for failure to comply with such regulations and guidelines. In the United States and Europe, the trend has been in the direction of increased regulation and enforcement by the applicable regulatory authority.

In providing services in the United States, we are obligated to comply with FDA requirements governing such activities. These include ensuring that the study is approved by an appropriate Independent Review Board (“IRB”) and Ethics Committee, obtaining patient informed consents, verifying qualifications of investigators, reporting patients’ adverse reactions to drugs and maintaining thorough and accurate records. We must maintain critical documents for each study for specified periods, and such documents may be reviewed by the study sponsor and the FDA.

The services we provide outside the United States are ultimately subject to similar regulation by the relevant regulatory authority. In addition, our activities in Europe are affected by the European Medicines Agency.

We must retain records for each study for specified periods for inspection by the client and by the applicable regulatory authority during audits. If we fail to comply with applicable regulations and guidelines, it could result in a material adverse effect. In addition, our failure to comply with applicable regulations and guidelines, depending on the extent of the failure, could result in fines, debarment, termination or suspension of ongoing research, the disqualification of data or litigation by clients, any of which could also result in a material adverse effect.
48


Potential Liability and Insurance  
The nature of our business exposes us to potential liability including, but not limited to, potential liability for (i) breach of contract or negligence claims by our customers; and, (ii) third party (such as patients) claims in respect of our performance of services.
 
In addition, although we do not believe we are legally responsible for acts of third party investigators (physicians running trials), we could be subject to claims arising as a result of the actions of these investigators.
 
We try to reduce this potential liability by:

Seeking contractual indemnification from customers in relation to certain activities. However, the terms and scope of indemnification varies from customer to customer and project to project and the performance of these indemnities is not secured. As a result, we bear the risk that indemnification may not be relevant or sufficient or that the indemnifying party may not have the financial ability to fulfill its indemnification obligations. This indemnification does not protect us against our own acts or omissions such as our negligence or where our performance does not reach the required contractual, industry or regulatory standard.
Maintaining worldwide professional liability insurance. While we maintain the types and amounts of insurance we view as customary in the industries and countries in which we operate, there is no guarantee that we will continue to be able to maintain such insurance coverage on terms acceptable to us, if at all, or that the relevant policy will respond and provide cover when we want it to.

We could be materially adversely affected if ICON is required to pay damages or bear the costs of defending or settling any claim which a) is outside the scope of or in excess of a contractual indemnification provision, b) an indemnifying party does not fulfill its indemnification obligations, c) the claim is in excess of the level of our insurance coverage or d) the relevant circumstances are not covered by our insurance policies.


49


C.Organizational Structure

    Details of the Company’s significant subsidiaries or entities under the Company's control at December 31, 2022 are as follows: 
CompanyCountryGroup ownership
ICON Clinical Research S.A.Argentina100%
RPS Research S.A.Argentina100%
ICON Clinical Research PTY LimitedAustralia100%
Medpass International Pty LtdAustralia100%
Pharmaceutical Research Associates Pty LimitedAustralia100%
ICON Clinical Research Austria GmbH Austria100%
RPS Research Austria GmbHAustria100%
IMP-Logistics Bel, FLLCBelarus100%
DOCS International Belgium N.V.Belgium100%
Pharmaceutical Research Associates Belgium B.V. Belgium100%
RPS Bermuda, Ltd.Bermuda100%
ICON Pesquisas Clínicas LTDA.Brazil100%
Pharmaceutical Research Associates Ltda.Brazil100%
RPS do Brasil Serviços de Pesquisas LTDA.Brazil100%
RPS China Inc.British Virgin Islands100%
ICON Clinical Research EOODBulgaria100%
Pharmaceutical Research Associates Bulgaria EOODBulgaria100%
ICON Clinical Research (Canada) Inc.Canada100%
3065613 Nova Scotia CompanyCanada100%
Pharmaceutical Research Associates ULCCanada100%
Services de Recherche Pharmaceutique SrlCanada100%
Oxford Outcomes LTD.Canada100%
ICON Life Sciences Canada Inc.Canada100%
ICON Chile LimitadaChile100%
PRA Health Sciences Chile SpAChile100%
ICON Clinical Research (Beijing No.2) Co., Ltd China100%
ICON Clinical Research (Beijing) Co., LtdChina100%
PRA Health Sciences China, Inc.China100%
PRA Health Sciences Colombia Ltda.Colombia100%
Research Pharmaceutical Services Costa Rica, LTDA.Costa Rica100%
Ispitivanja ICON d.o.o
ICON Research Ltd.
Croatia100%
Pharm Research Associates d.o.o. za klinicka ispitivanjaCroatia100%
ICON Clinical Research s.r.o.Czech Republic100%
Pharmaceutical Research Associates CZ, s.r.o.Czech Republic100%
DOCS International Nordic Countries A/SDenmark100%
Pharmaceutical Research Associates Denmark ApSDenmark100%
RPS Egypt (Limited Liability Company)Egypt100%
RPS Estonia OÜEstonia100%
DOCS International Finland OyFinland100%
Pharmaceutical Research Associates Finland OyFinland100%
ICON Clinical Research S.A.R.L.France100%
Mapi Research Trust*France100%
ReSearch Pharmaceutical Services France S.A.S.France100%
IMP Logistics Georgia LLCGeorgia100%
50


CompanyCountryGroup ownership
Pharmaceutical Research Associates Georgia LLCGeorgia100%
Averion Europe GmbH Germany100%
ICON Clinical Research Germany GmbHGermany100%
ICON Clinical Research GmbHGermany100%
Pharmaceutical Research Associates GmbHGermany100%
Pharmaceutical Research Associates Greece A.E.Greece100%
RPS Guatemala, S.A.Guatemala100%
ICON Clinical Research Hong Kong LimitedHong Kong100%
PRA Health Sciences (Hong Kong) LimitedHong Kong100%
ICON Klinikai Kutató Korlátolt Felelősségű Társaság (ICON Clinical Research Limited Liability Company)Hungary100%
Pharmaceutical Research Associates Magyarország Kutatás-Fejlesztési Korlátolt Felelősségű Társaság (Pharmaceutical Research Associates Hungary Research and Development Ltd.)Hungary100%
RPS Iceland ehf.Iceland100%
ICON Clinical Research India Private LimitedIndia100%
Pharmaceutical Research Associates India Private LimitedIndia100%
Accellacare LimitedIreland100%
DOCS Resourcing LimitedIreland100%
ICON (LR) LimitedIreland100%
ICON Clinical Global Holdings Unlimited Company Ireland100%
ICON Clinical International Unlimited Company Ireland100%
ICON Clinical Research LimitedIreland100%
ICON Clinical Research Property Development (Ireland) LimitedIreland100%
ICON Clinical Research Property Holdings (Ireland) LimitedIreland100%
ICON Holdings Clinical Research International LimitedIreland100%
ICON Holdings Unlimited Company Ireland100%
ICON Investments Five Unlimited CompanyIreland100%
ICON Investments Four Unlimited CompanyIreland100%
ICON Operational Financing Unlimited Company Ireland100%
ICON Operational Holdings Unlimited Company Ireland100%
Research Pharmaceutical Services (Outsourcing Ireland) LimitedIreland100%
ICON Global Treasury Unlimited CompanyIreland 100%
PRA Clinical Limited Ireland 100%
ICON Clinical Research Holdings (Ireland) Unlimited CompanyIreland100%
ICON Clinical Research Israel LTD.Israel100%
Pharmaceutical Research Associates Israel Ltd.Israel100%
Pharmaceutical Research Associates Italy S.r.l.Italy100%
PRA Development Center KKJapan100%
PRA Health Sciences KKJapan100%
ICON Japan K.K.Japan 100%
ICON Investments Limited Jersey100%
PRA Health Sciences Kenya LimitedKenya100%
RPS Latvia SIALatvia100%
UAB RPS LithuaniaLithuania100%
ICON Luxembourg S.à r.l.Luxembourg100%
ICON CRO Malaysia SDN. BHD.Malaysia100%
RPS Malaysia Sdn. Bhd.Malaysia100%
ICON Clinical Research México, S.A. de C.V.México100%
51


CompanyCountryGroup ownership
Pharmaceutical Research Associates Mexico S. de R.L. de C. V.México100%
RPS Research México, S. de R.L. de C.V.México100%
RPS Research Servicios, S. de R.L. de C.V.México100%
DOCS International B.V. Netherlands100%
Pharmaceutical Research Associates Group B.V.Netherlands100%
PRA International Operations B.V.Netherlands100%
ReSearch Pharmaceutical Services Netherlands B.V.Netherlands100%
ICON Clinical Research (New Zealand) LimitedNew Zealand100%
Pharmaceutical Research Associates New Zealand LimitedNew Zealand100%
RPS Research Norway ASNorway100%
RPS Panama Inc.Panama100%
ICON Clinical Research Perú S.A.Perú100%
RPS Perú S.A.C.Perú100%
ICON Clinical Research Services Philippines, Inc.Philippines100%
RPS Research Philippines, Inc.Philippines100%
DOCS International Poland Sp. z o.o.Poland100%
Symphony Clinical Research Sp zooPoland100%
Pharmaceutical Research Associates Sp. z o.o.Poland100%
PRA International Portugal, Unipessoal, Lda.Portugal100%
Research Pharmaceutical Services Puerto Rico, Inc.Puerto Rico100%
ICON Clinical Research S.R.L. Romania100%
Pharmaceutical Research Associates Romania S.R.L.Romania100%
ICON Clinical Research (Rus) LLCRussia100%
Joint Stock Company IMP Logistics Russia100%
ICON Clinical Research d.o.o. BeogradSerbia100%
Pharmaceutical Research Associates doo BelgradeSerbia100%
ICON Clinical Research (Pte) LimitedSingapore100%
Mapi Life Sciences Singapore Pte. Ltd.Singapore100%
Pharmaceutical Research Associates Singapore Pte. Ltd.Singapore100%
ICON Clinical Research Slovakia, s.r.o.Slovakia100%
Pharmaceutical Research Associates SK s.r.o.Slovakia100%
PRA Pharmaceutical S A (Proprietary) LimitedSouth Africa100%
RPS Research South Africa (Proprietary) LimitedSouth Africa100%
Accellacare South Africa (PTY) LTDSouth Africa 100%
ICON Clinical Research Korea Yuhan Hoesa/ ICON Clinical Research Korea Ltd.South Korea100%
Pharmaceutical Research Associates Korea LimitedSouth Korea100%
ICON Clinical Research España, S.L. Spain100%
Pharmaceutical Research Associates España, S.A.U.Spain100%
RPS ReSearch Ibérica, S.L.U.Spain100%
RPS Spain S.L.Spain100%
Accellacare España S.L.Spain 100%
DOCS International Sweden ABSweden100%
PRA International Sweden ABSweden100%
DOCS International Switzerland GmbHSwitzerland100%
ICON Clinical Research (Switzerland) GmbHSwitzerland100%
52


CompanyCountryGroup ownership
PRA Switzerland AGSwitzerland100%
ICON Clinical Research Taiwan LimitedTaiwan100%
Pharmaceutical Research Associates Taiwan, Inc.Taiwan100%
ICON Clinical Research (Thailand) Limited Thailand100%
RPS Research (Thailand) Co., Ltd.Thailand100%
ICON Ankara Klinik Arastirma Dis Ticaret Anonim SirketiTurkey100%
Pra Turkey Sağlik Araştirma Ve Geliştirme Limited Şirketi Turkey100%
DOCS Ukraine LLCUkraine100%
ICON Clinical Research LLCUkraine100%
IMP-Logistics Ukraine, LLC Ukraine100%
Pharmaceutical Research Associates Ukraine, LLCUkraine100%
Accellacare UK LimitedUnited Kingdom100%
Aptiv Solutions (UK) LtdUnited Kingdom100%
DOCS International UK LimitedUnited Kingdom100%
ICON (LR) LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) No. 2 LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) No. 3 LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) No. 4 LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) No. 5 LimitedUnited Kingdom100%
ICON Development Solutions LimitedUnited Kingdom100%
ICON Investments (UK) LtdUnited Kingdom100%
Improving Treatments Limited United Kingdom100%
Medeval Group LimitedUnited Kingdom100%
MeDiNova Lakeside Clinical Research Limited United Kingdom100%
MeDiNova Merc (UK) Limited United Kingdom100%
VSK (Kenilworth) Limited United Kingdom100%
IMP Logistics UK LimitedUnited Kingdom100%
Pharm Research Associates (UK) LimitedUnited Kingdom100%
Sterling Synergy Systems LimitedUnited Kingdom100%
ICON Clinical Research Holdings (U.K.) LimitedUnited Kingdom100%
ICON Clinical Research (U.K.) No. 6 LimitedUnited Kingdom 100%
RPS Global S.A.Uruguay100%
RPS Latin America S.AUruguay100%
ICON Early Phase Services, LLC USA100%
Pharmaceutical Research Associates, Inc.USA100%
ClinStar LLCUSA100%
Nextrials, Inc.USA100%
Pharmaceutical Research Associates CIS, LLC USA100%
Pharmaceutical Research Associates Eastern Europe, LLC USA100%
CRN North America, LLCUSA100%
ICON Clinical Research, LPUSA100%
Addplan, Inc.USA100%
Beacon Bioscience, Inc USA100%
C4 MedSolutions, LLC USA100%
CHC Group, LLCUSA100%
53


CompanyCountryGroup ownership
CRN Holdings, LLCUSA100%
Global Pharmaceutical Strategies Group, LLC USA100%
ICON Clinical Investments, LLCUSA100%
ICON Clinical Research LLCUSA100%
ICON Laboratory Services, Inc.USA100%
ICON Tennessee, LLCUSA100%
ICON US Holdings Inc. USA100%
MMMM Consulting, LLCUSA100%
MMMM Group, LLC USA100%
MolecularMD Corp.USA100%
PriceSpective LLCUSA100%
PubsHub LLC USA100%
Care Innovations, Inc.USA100%
Care Innovations, LLCUSA100%
CRI NewCo, Inc.USA100%
CRI Worldwide, LLCUSA100%
International Medical Technical Consultants, LLCUSA100%
Parallel 6, Inc.USA100%
PRA Early Development Research, Inc. USA100%
PRA Health Sciences, Inc.USA100%
PRA Holdings, Inc.USA100%
PRA International, LLCUSA100%
PRA Receivables, LLCUSA100%
ReSearch Pharmaceutical Services, LLCUSA100%
ReSearch Pharmaceutical Services, Inc.USA100%
Roy RPS Holdings LLCUSA100%
RPS Global Holdings, LLCUSA100%
RPS Parent Holding LLCUSA100%
Source Healthcare Analytics, LLCUSA100%
Sunset Hills, LLCUSA100%
Symphony Health Solutions CorporationUSA100%
Accellacare of Christie Clinic, LLCUSA100%
Clinical Resource Network, LLCUSA100%
DOCS Global, Inc.USA100%
Managed Care Strategic Solutions, L.L.C. USA100%
CRI International, LLCUSA100%
Accellacare of Charlotte, LLCUSA100%
Accellacare of Hickory, LLCUSA100%
Accellacare of Raleigh, LLCUSA100%
Accellacare of Rocky Mount, LLCUSA100%
Accellacare of Salisbury, LLCUSA100%
Accellacare of Wilmington, LLCUSA100%
Accellacare of Winston-Salem, LLCUSA100%
Accellacare US Inc. USA100%
Complete Healthcare Communications LLCUSA100%
Complete Publication Solutions, LLC USA100%
54


CompanyCountryGroup ownership
Accellacare of Charleston, LLCUSA100%
Accellacare of Bristol, LLCUSA100%
Lifetree Clinical Research, LCUSA100%
ICON Government and Public Health Solutions, Inc.USA100%
*Mapi Research Trust is an association, its members are ICON Subsidiary entities.

D. Description of Property

Our principal executive offices are located in South County Business Park, Leopardstown, Dublin, Republic of Ireland, where we own an office facility of approximately 15,000 square meters. We lease all other properties.

We maintain fifty-three offices in Europe; ten of our offices are in the UK, seven in Germany, five in The Netherlands, four in Spain, two in each of the Czech Republic, France, Hungary, Ireland, Poland, Russia, Sweden, Turkey and Ukraine, and one in each of Belarus, Belgium, Bulgaria, Georgia, Israel, Italy, Latvia, Romania, and Slovakia. We maintain thirty-three offices in North America; twenty-nine in the United States, two in Canada and two in Mexico. We have sixteen offices in Asia; five in China (including one in Hong Kong), three in India, two in each of Japan and Singapore, and one in each of South Korea, Taiwan, Thailand and The Philippines. We have two offices in Australia and one in New Zealand. We have five offices in South America; one in each of Argentina, Brazil, Chile, Columbia and Peru. We maintain one office in South Africa.

Item 4A.   Unresolved Staff Comments.

Not applicable.








































55


Item 5.   Operating and Financial Review and Prospects.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with our consolidated financial statements, accompanying notes and other financial information, appearing in Item 18. The consolidated financial statements have been prepared in accordance with U.S. GAAP. The information included in the discussion and analysis below provides details on the information for the years ended December 31, 2022 and December 31, 2021. Information related to the year ended December 31, 2020 has not been included. It can be found in the Company's filing of the form 20-F for the year ended December 31, 2021.

Overview

We are a CRO, providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Our vision is to be the healthcare intelligence partner of choice by delivering industry leading solutions and best in class performance in clinical development.

We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full-service” solution. At December 31, 2022, we employed approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December 31, 2022 we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe, and the rest of the world, respectively.

Revenue consists of fees earned under contracts with third-party clients. In most cases, a portion of the contract fee is paid at the time the study or trial is started, with the balance of the contract fee generally payable in installments over the study or trial duration, based on the delivery of certain performance targets or milestones. Revenue from long term contracts is recognized on a proportional performance method based on the relationship between cost incurred and the total estimated costs of the trial or on a fee-for-service basis according to the particular circumstances of the contract. As is customary in the CRO industry, we contract with third party investigators in connection with clinical trials. Investigator costs and certain other third party costs are included in our assessment of progress towards completion and costs incurred in measuring revenue. Where these costs are reimbursed by clients, they are included in the total contract value recognized over time, based on our assessment of progress towards completion.

As the nature of our business involves the management of projects, the majority of which have a duration of one to four years, the commencement or completion of projects in a fiscal year can have a material impact on revenues earned with the relevant clients in such years. In addition, as we typically work with some, but not all divisions of a client, fluctuations in the number and status of available projects within such divisions can also have a material impact on revenues earned from such clients from year to year.

Termination or delay in the performance of an individual contract may occur for various reasons, including, but not limited to, unexpected or undesired results, production problems resulting in shortages of the drug, adverse patient reactions to the drug, the client’s decision to de-emphasize a particular trial or inadequate patient enrollment or investigator recruitment. In the event of termination the Company is usually entitled to all sums owed for work performed through the notice of termination and certain costs associated with the termination of the study. In addition, contracts generally contain provisions for renegotiation in the event of changes in the scope, nature, duration, or volume of services of the contract.

Our unsatisfied performance obligation comprises our assessment of contracted revenue yet to be earned from projects awarded by clients. At December 31, 2022 we had unsatisfied performance obligations of approximately $13.7 billion. We believe that our unsatisfied performance obligation as of any date is not necessarily a meaningful predictor of future results, due to the potential for cancellation or delay of the projects included in the unsatisfied performance obligation, and no assurances can be given on the extent to which we will be able to realize the unsatisfied performance obligation.

On July 1, 2021, ICON announced the completion of its Merger with PRA creating one of the world’s most advanced healthcare intelligence and clinical research organizations. The management's discussion and analysis below reflects the operating results of the Group for the year ended December 31, 2022 which incorporates the results of PRA and results in large variances when comparing to the year ended December 31, 2021. The results of PRA prior to July 1, 2021 are not reflected. Where applicable, management have included commentary on specific one-time charges related to the Merger in order to provide an understanding of the normal operations of the Group.

Although we are domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be materially affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.

56


In addition to translation exposures, we are also subject to transaction exposures because the currency in which contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of our revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts are usually priced in a single currency, most often U.S. dollars or euros, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging, due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our currency exposures.

As we conduct operations on a global basis, our effective tax rate has depended and will depend on the geographic distribution of our revenue and earnings among locations with varying tax rates. Our results therefore may be affected by changes in the tax rates of the various jurisdictions. In particular, as the geographic mix of our results of operations among various tax jurisdictions changes, our effective tax rate may vary significantly from period to period.

A.    Operating Results

The following table sets forth, for the periods indicated, certain financial data as a percentage of revenue and the percentage change in these items compared to the prior comparable period. The trends illustrated in the following table may not be indicative of future results.
Year Ended December 31,
202220212022
Percentage of RevenuePercentage Increase/(Decrease)
Revenue100.0 %100.0 %41.2 %
Costs and expenses:
Direct costs71.4 %72.5 %39.1 %
Selling, general and administrative expense10.0 %10.7 %33.0 %
Depreciation1.4 %1.4 %41.0 %
Amortization6.0 %4.4 %93.4 %
Transaction and integration-related expenses0.5 %3.6 %(80.0)%
Restructuring0.4 %0.5 %0.1 %
Income from operations 10.3 %6.9 %110.1 %

Year ended December 31, 2022 compared to year ended December 31, 2021

Revenue    
Year Ended
December 31,
Change
(dollars in thousands)20222021$%
Revenue$7,741,386 $5,480,826 $2,260,560 41.2 %

Revenue for the year ended December 31, 2022 increased by $2,260.6 million, or 41.2%, to $7,741.4 million, compared to $5,480.8 million for the year ended December 31, 2021. Revenue increased by 45.4% in constant currency terms. The increase in revenues in the year ended December 31, 2022 is due to the Merger and continued organic growth across the Company's markets.
 
During the year ended December 31, 2022 the Company derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World respectively. Revenues from our top five customers amounted to $2,189.6 million in the year ended December 31, 2022 compared to $1,733.1 million in the year ended December 31, 2021 or 28.3% and 31.6% respectively.

Revenue in Ireland increased by $618.7 million in the year ended December 31, 2022, to $1,984.6 million, compared to $1,365.9 million for the year ended December 31, 2021. Revenue in Ireland during the year ended December 31, 2022 increased by 45.3% compared to an overall increase in Group revenue of 41.2%. Revenue in Ireland is principally a function of our global contracting model.

57


Revenue in the Rest of Europe increased by $442.8 million or 37.7%, to $1,618.4 million, compared to $1,175.5 million for the year ended December 31, 2021. Revenue in the U.S. increased by $993.6 million or 38.5%, to $3,574.6 million, compared to $2,581.0 million for the year ended December 31, 2021. Revenue in our Rest of World (‘Other’) region increased by $205.5 million or 57.3%, to $563.9 million, compared to $358.4 million for the year ended December 31, 2021. Revenue has increased across all regions due to the completion of the Merger and continued organic growth across the Company's markets.

Direct costs
Year Ended
December 31,
(dollars in thousands)20222021Change
Direct costs$5,527,045 $3,972,612 $1,554,433 
% of revenue71.4 %72.5 %39.1 %

Direct costs for the year ended December 31, 2022 increased by $1,554.4 million, or 39.1%, to $5,527.0 million, compared to $3,972.6 million for the year ended December 31, 2021. Direct costs consist primarily of investigator and other reimbursable costs, compensation, associated fringe benefits and share based compensation expense for project-related employees and other direct project driven costs. The increase in direct costs during the year ended December 31, 2022 arose due to an increase in headcount and an increase in personnel related expenditure of $926.5 million combined with an increase in other direct project related costs of $179.7 million, an increase in laboratory costs of $10.0 million and an increase in travel related costs of $5.6 million. There was an increase in third party investigator and other reimbursable costs of $434.5 million. The decrease in direct costs as a percentage of revenue reflect the different activity mix for the year ended December 31, 2022 compared to the year ended December 31, 2021, as well as the realization of integration synergies.

Selling, general and administrative expenses
Year Ended
December 31,
(dollars in thousands)20222021Change
Selling, general and administrative expenses$778,753 $585,330 $193,423 
% of revenue10.0 %10.7 %33.0 %

Selling, general and administrative expenses for the year ended December 31, 2022 increased by $193.4 million, or 33.0%, to $778.8 million, compared to $585.3 million for the year ended December 31, 2021. Selling, general and administrative expenses comprise primarily of compensation, related fringe benefits and routine share based compensation expense for non-project-related employees, recruitment expenditures, professional service costs, advertising costs and all costs related to facilities and information systems. As a percentage of revenue, selling, general and administrative expenses decreased to 10.0% of revenue during the year ended December 31, 2022, compared to 10.7% of revenue for the year ended December 31, 2021. During the year ended December 31, 2022, the increase in selling, general and administrative expenses relates to an increase in general overhead costs of $47.3 million, an increase of $42.9 million in facilities related costs, an increase of $88.0 million in personnel related expenditure, an increase of $24.0 million in professional fees and an increase of $3.7 million in marketing fees. These increases were partly offset by foreign exchange gains for the year ended December 31, 2022 of $26.0 million ($14.3 million for the year ended December 31, 2021) driven mainly by the movement in the Euro to U.S. dollar exchange rate. Finally, share based compensation expense recognized during the years ended December 31, 2022 and December 31, 2021 were $70.5 million and $133.8 million, respectively. Share based compensation expenses are part of personnel related expenditure in direct costs and selling, general and administrative expenses.

Depreciation and amortization
Year Ended
December 31,
(dollars in thousands)20222021Change
Depreciation$106,426 $75,484 $30,942 
% of revenue1.4 %1.4 %41.0 %
Amortization$463,087 $239,503 $223,584 
% of revenue6.0 %4.4 %93.4 %

58


Depreciation expense for the year increased by $30.9 million or 41.0%, to $106.4 million, compared to $75.5 million for the year ended December 31, 2021. The depreciation charge reflects the impact of the acquisition and investments in facilities, information systems and equipment supporting the Company’s continued growth. As a percentage of revenue, the depreciation expense remained consistent at 1.4% of revenues, for the year ended December 31, 2022 and December 31, 2021. The increase in the depreciation charge for the years ended December 31, 2022 is due to the increase in our depreciable asset base acquired through the Merger as well as additional spend related to computer hardware and software.

Amortization expense for the year ended December 31, 2022 increased by $223.6 million or 93.4%, to $463.1 million, compared to $239.5 million for the year ended December 31, 2021. The amortization expense represents the amortization of intangible assets acquired during business combinations. The increase in amortization expense for the year reflects the amortization of newly acquired intangibles resulting from the Merger. As a percentage of revenue, the amortization expense increased to 6.0% for the year ended December 31, 2022, compared to 4.4% of revenue for the year ended December 31, 2021.

Restructuring, transaction and integration-related expenses associated with the Merger
Year Ended
December 31,
(dollars in thousands)20222021Change
Transaction and integration-related expenses$39,695 $198,263 $(158,568)
% of revenue0.5 %3.6 %(80.0)%
Restructuring costs$31,143 $31,105 $38 
% of revenue0.4 %0.5 %0.1 %

During the year ended December 31, 2022, the Company incurred $70.8 million for restructuring, transaction and integration-related expenses primarily associated with the Merger. The charge includes transaction and integration costs of $39.7 million associated with advisory costs, severance arrangements, retention agreements and ongoing integration activities.

The Company has also undertaken a restructuring program following the announcement of the Merger to review its global office footprint, optimize its locations to best fit the requirements of the Company and reorganize its workforce to drive future growth. This program has resulted in a charge of $31.1 million in the year ended December 31, 2022. In the year ended December 31, 2021, a restructuring charge of $31.1 million was recognized.

We expect to incur some additional expenses associated with the Merger; however, the timing and the amount of these expenses depends on various factors such as, but not limited to, the execution of integration activities and the aggregate amount of synergies we achieve from these activities.

Income from operations
Year Ended
December 31,
(dollars in thousands)20222021Change
Income from operations$795,237 $378,529 $416,708 
% of revenue10.3 %6.9 %110.1 %

Income from operations increased by $416.7 million, or 110.1%, to $795.2 million, compared to $378.5 million for the year ended December 31, 2021. As a percentage of revenue, income from operations increased to 10.3% of revenues compared to 6.9% of revenues for year ended December 31, 2021.

Income from operations in Ireland increased to $218.1 million compared to $132.0 million for the year ended December 31, 2021.

In the Rest of Europe region, income from operations increased to $253.8 million compared to $177.9 million for the year ended December 31, 2021. As a percentage of revenues, income from operations in the Rest of Europe region increased to 15.7% compared to 15.1% for the year ended December 31, 2021.

In the U.S. region, income from operations increased by $215.7 million, to $254.8 million, compared to $39.1 million for the year ended December 31, 2021. As a percentage of revenues, income from operations in the U.S. region increased to 7.1% compared to 1.5% for the year ended December 31, 2021.

59


In other regions, income from operations increased by $38.9 million to $68.5 million compared to $29.6 million for the year ended December 31, 2021. As percentage of revenues, income from operations in the other regions increased to 12.1% compared to 8.3% for the year ended December 31, 2021.

Interest income and expense
Year Ended
December 31,
Change
(dollars in thousands)20222021$%
Interest income$2,345 $574 $1,771 308.5 %
Interest expense$(229,731)$(182,423)$(47,308)25.9 %

Interest expense increased to $229.7 million compared to $182.4 million for the year ended December 31, 2021. The increase in the year reflects the impact of financing costs associated with the Merger and the average gross amount of outstanding borrowing and the impact of rising interest rates during the year. Interest income for the year ended December 31, 2022 increased to $2.3 million, compared to $0.6 million for the year ended December 31, 2021.

Income tax expense
Year Ended
December 31,
Change
(dollars in thousands)20222021$%
Income tax expense $59,411 $41,334 $18,077 43.7 %
Effective income tax rate 10.5 %21.0 %

Provision for income taxes for the year increased to $59.4 million compared to $41.3 million for the year ended December 31, 2021. The Company’s effective tax rate for the year ended December 31, 2022 was 10.5% compared to 21.0% for the year ended December 31, 2021 primarily due to the full year amortization impact of acquired intangible assets and non-deductive expenditures incurred in 2021 related to the Merger. The Company’s effective tax rate remains principally a function of the distribution of pre-tax profits amongst the territories in which it operates.

B.     Liquidity and Capital Resources

The CRO industry is generally not capital intensive. The Group’s principal operating cash needs are payment of salaries, office rents, travel expenditures and payments to investigators. Investing activities primarily reflect capital expenditures for facilities and information systems enhancements, the purchase and sale of short term investments and acquisitions. Financing activities primarily reflect the servicing of the Company's external debt.

Our clinical research and development contracts are generally fixed price with some variable components and range in duration from a few weeks to several years. Revenue from contracts is generally recognized as income on the basis of the relationship between costs incurred and the total estimated contract costs. The cash flow from contracts typically consists of a small down payment at the time the contract is entered into, with the balance paid in installments over the contract duration, in some cases on the achievement of certain milestones. Therefore, cash receipts do not correspond to costs incurred and revenue recognized on contracts.

Cash and cash equivalents and net borrowings
Balance December 31, 2021(Drawn
down)/
repaid
Net cash inflow/
(outflow)
Other non-cash adjustmentsEffect of exchange ratesBalance December 31, 2022
dollars in thousands
Cash and equivalents
Cash and cash equivalents752,213 — (446,725)— (16,720)288,768 
Available for sale investments1,712 — — — 1,713 
Senior Secured Credit Facilities & Senior Secured Notes(5,436,312)800,000 — (17,875)— (4,654,187)
Net cash and cash equivalents and borrowings (4,682,387)800,000 (446,724)(17,875)(16,720)(4,363,706)

The Company’s cash and cash equivalents and available for sale investments at December 31, 2022 amounted to $290.5 million compared with cash and available for sale investments of $753.9 million at December 31, 2021. The Company’s
60


cash and available for sale investments at December 31, 2022 comprised cash and cash equivalents of $288.8 million and available for sale investments of $1.7 million. The Company’s cash and available for sale investments at December 31, 2021 comprised cash and cash equivalents of $752.2 million and available for sale investments of $1.7 million.

In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a Senior Secured Credit Facilities providing for a senior secured term loan facility of $5,515.0 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300.0 million. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026. At December 31, 2022 and December 31, 2021, no amounts were outstanding under the revolving loan facility with the exception of $4.5 million letters of credit given to landlords to guarantee lease arrangements.

In addition to the Senior Secured Credit Facilities, on July 1, 2021, the Company, issued $500.0 million in aggregate principal amount of 2.875% senior secured notes in a private offering. The senior secured notes will mature on July 15, 2026.

On March 31, 2022 the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $35.1 million. On June 30, 2022 the Company repaid $100.0 million of the senior secured term loan facility and made a quarterly interest payment of $39.4 million. On September 30, 2022 the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $53.6 million. On December 30, 2022 the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $66.1 million.

The Company has contractual liabilities for lease arrangements of $189.7 million which will be predominantly settled over the next five year period through cash payments.

Cash flows

Net cash from operating activities

Net cash provided by operating activities decreased by $265.8 million to $563.3 million for the year ended December 31, 2022 as compared to net cash provided by operating activities of $829.1 million for the year ended December 31, 2021. The decrease in net cash provided by operating activities of $265.8 million is due to changes in working capital of $685.2 million, offset by increases in cash inflows from net income of $419.4 million.

The change in working capital is primarily attributable to increases in Accounts Receivable of $534.2 million and Unbilled Revenue of $314.9 million, offset by increases in Unearned Revenue of $262.1 million. These changes result from differences in timing of revenue recognition and billing on clinical trials. The days’ revenue outstanding at December 31, 2022 was 54 days compared to 31 days at December 31, 2021. Cash generated from working capital and days’ revenue outstanding may be positively or negatively impacted by, amongst others, the scheduling of contractual milestones over a study or trial duration, the achievement of a particular milestone during the period, the timing of receipt of invoices from third parties for reimbursable costs and the timing of cash receipts from customers. Contract fees are generally payable in installments based on the achievement of certain performance targets or “milestones” (e.g. target patient enrollment rates, clinical testing sites initiated or case report forms completed), such milestones being specific to the terms of each individual contract, while revenues on contracts are recognized as contractual obligations are performed. A decrease in the number of days’ revenue outstanding during a period will result in cash inflows to the Company while an increase in days revenue outstanding will lead to cash outflows.

Net cash used in investing activities

Net cash used in investing activities was $145.9 million for the year ended December 31, 2022 compared to net cash used in investing activities of $6,024.2 million for the year ended December 31, 2021. Net cash used in investing activities for the year ended December 31, 2022 were primarily related to cash outflows of $142.2 million for capital expenditures made mainly relating to investment in facilities and IT infrastructure and $5.6 million in relation to investments in long-term equity.

In the year ended December 31, 2021, net cash used in investing activities of $6,024.2 million was largely attributable to the cash element of the Merger consideration of $5,914.5 million (net of cash acquired). During the year, capital expenditure of $93.8 million was made mainly related to the investment in facilities and IT infrastructure. Further cash outflow of $2.5 million was made in respect of the Company's investment in Oncacare, a loan of $10.0 million was provided to Oncacare and $4.1 million in relation to investments in long-term equity.

Net cash used in financing activities

Net cash used in financing activities amounted to $864.2 million for the year ended December 31, 2022 compared with net cash provided by financing activities of $5,114.7 million for the year ended December 31, 2021. In the year ended December 31, 2022, the Company repaid external financing of $800.0 million and repurchased shares to the value of $100.0 million. This was offset by $35.8 million that was received by the Company from the exercise of share options.

In the year ended December 31, 2021, the Company drew down external financing of $6,015.0 million to fund the completion of the Merger. This was offset by debt discount and certain debt issue costs of $109.9 million. As part of the external
61


financing, the Company paid financing professional fees of $30.3 million and made payments of principal on the external debt of $513.8 million. The Company also repaid the 2020 Senior Notes on July 1, 2021, including early repayment charges, totaling $364.0 million. During the year ended December 31, 2021, $118.6 million was received by the Company from the exercise of share options.

Net cash outflow
As a result of these cash flows, cash and cash equivalents decreased by $463.4 million for the year ended December 31, 2022 compared to a decrease of $88.1 million for the year ended December 31, 2021.

C.     Research and development, patents and licenses
    
ICON plays a critical role in new drug development by undertaking activities in each of the different stages of the drug development process. Clinical trials result in an advancement in the field of medical science as they establish the safety and efficacy of new drugs, thus resolving scientific uncertainty. As one of a number of world leaders in clinical research and commercialization, ICON is a trusted partner for pharmaceutical and medical device companies in helping them to accelerate the development of drugs and devices that save lives and improve the quality of life. ICON's role in ensuring that the trial design is scientifically valid is a crucial part of the design and involves scientists, medical doctors and biostatisticians. ICON works with the sponsors in designing the conduct of the clinical research trial. ICON's role of conducting clinical trials is an integral part of the research and development process leading ultimately to a decision as to whether or not each drug is safe for human consumption, has the desired effect on targeted diseases and the best means of delivering that drug to the patient.

D.     Trend information

Other than as disclosed elsewhere in this annual report, we are not aware of any trends, uncertainties, demands, or commitments or events since December 31, 2022 that are reasonably likely to have a material adverse effect on our revenues, income, profitability, liquidity or capital resources, or that would cause the reported financial information in this annual report to be not necessarily indicative of future operating results or financial conditions.

E.     Critical Accounting Estimates

Note 2 to the audited consolidated financial statements provided elsewhere in this Form 20-F describes the significant accounting policies used in the preparation of the consolidated financial statements. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the period. We base our estimates and judgments on historical experience and on the other factors that we believe are reasonable under current circumstances. Actual results may differ from these estimates if these assumptions prove to be incorrect or if conditions develop other than as assumed for the purposes of such estimates. The following is a discussion of the critical accounting estimates and judgments used by management. The application of these critical accounting estimates is discussed with the Audit Committee of the Board of Directors.

Revenue Recognition - Clinical Trial Services

Clinical trial services are a single performance obligation satisfied over time i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. We have concluded that ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research project. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. An assessment of the realizable contract value is judgmental in nature. The realizable value assessment is updated at each reporting period, having regard to (i) contract terms and (ii) customer experience.

Revenue is recognized on a percentage completion basis as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured therefore based on an input measure being total project costs (inclusive of third party costs) at each reporting period. Measurement of the progress towards completion involves judgment and estimation. Assessment of completion requires an evaluation of labor and related time cost incurred at the reporting date and third party costs incurred at the reporting date. The assessment of third party costs incurred (principally investigator costs) requires a review of activity performed and recorded by the third party services providers. The timing of payments to third parties in respect of cost incurred reflect invoicing by third parties. The timing difference between the activity performed and receipt of invoices from third parties may result in significant accrued amounts at reporting periods.

The assessment of progress towards completion also requires an up to date evaluation of the forecast costs to complete in respect of these projects. Given the long-term nature of the clinical trials, and the complex nature of those trials, the forecast costs to complete (being internal direct costs and costs that will be incurred by third parties (principally investigators)) is judgmental. Forecast time (and related costs) is determined by reference to (i) contract terms and (ii) past experience. Forecast third party costs to complete are determined by project by reference to (i) contract terms and (ii) past experience.
62


Business Combinations
We use the acquisition method to account for business combinations, and accordingly, the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree are recorded at their estimated fair values on the date of the acquisition. We use significant judgments, estimates and assumptions in determining the estimated fair value of assets acquired, liabilities assumed and non-controlling interest. Estimated fair values were based on various valuation methodologies, including an income approach using primarily discounted cash flow techniques for the customer relationships intangible assets. The aforementioned income methods utilize management's estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. We have recorded and allocated to our reporting units the excess of the purchase price over the fair value of the net assets acquired, known as goodwill.

Recoverability of Goodwill and Long-Lived Assets
Goodwill

The Company assesses its goodwill for impairment annually or when events or circumstances indicate a possible impairment. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment.
In performing a qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management’s annual and multi-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.

A quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required.

The income-based fair value methodology requires management's assumptions and judgments regarding economic conditions in the markets in which the Company operates and conditions in the capital markets, many of which are outside of management's control. At the reporting unit level, fair value estimation requires management's assumptions and judgments regarding the effects of overall economic conditions on the specific reporting unit, along with assessment of the reporting unit's strategies and forecasts of future cash flows, terminal growth rates and discount rates.

Under the market-based fair value methodology, judgment is required in evaluating market multiples and recent transactions.

The Company completed its most recent annual goodwill impairment testing as of September 30, 2022, a date which is consistent with the prior year. For the years ended December 31, 2022 and 2021, the Company determined that there was no impairment of goodwill.

Other long lived assets

The Company assesses long-lived assets (such as intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group might not be recoverable. If indicators of impairment are present, we evaluate the carrying value of long-lived asset in relation to estimates of future undiscounted cash flows. Any future impairment could have a material adverse effect on our financial condition or results of operations.


63


Taxation
Given the global nature of our business and the multiple taxing jurisdictions in which we operate, the determination of the Company’s provision for income taxes requires significant judgments and estimates, the ultimate tax outcome of which may not be certain. Although we believe our estimates are reasonable, the final outcome of these matters may be different than those reflected in our historical income tax provisions and accruals.

The provision for income taxes includes federal, state, local and foreign taxes. We apply the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. We account for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and therefore have not provided for deferred taxes in respect of this item. Recognition of deferred income tax assets is based on management’s belief that it is more likely than not that the income tax benefit associated with certain temporary differences, income tax operating loss, capital loss carryforwards, and income tax credits, would be realized. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. We recognize the effect of income tax positions only if those positions will more likely than not be sustained. We determined the amount of the valuation allowance based, in part, on our assessment of future taxable income and in light of our ongoing income tax strategies. If our estimate of future taxable income or tax strategies changes at any time in the future, we would record an adjustment to our valuation allowance. Recording such an adjustment could have a material effect on our financial condition or results of operations.












































64


Item 6. Directors, Senior Management and Employees.

A.Directors and Senior Management

The following table and accompanying biographies set forth certain information concerning each of ICON plc’s Directors, officers and other key employees as of February 24, 2023.
NameAgePosition
Ciaran Murray 60Chair and Director
Dr. Steve Cutler (1)(5)62Chief Executive Officer and Director
Brendan Brennan (1)(5)44Chief Financial Officer
Rónán Murphy (2)(3)(5)65Lead Independent Director
Dr. John Climax 70Director
Joan Garahy (2)(4) 60Director
Eugene McCague (3)(4)64Director
Julie O'Neill (3)(4)56Director
Dr. Linda Grais (2) 66Director
Diarmaid Cunningham 48Chief Administrative Officer, General Counsel & Company Secretary
 
(1)Named Executive Officer of the Company.
(2)Member of Compensation and Organization Committee.
(3)Member of Audit Committee.
(4)Member of Nominating, Sustainability and Governance Committee.
(5)Member of Execution Committee.

Ciaran Murray
Mr. Ciaran Murray graduated with a Bachelor of Commerce degree from University College Dublin in 1982. Mr. Murray subsequently qualified as a chartered accountant with PwC. Following qualification, Mr. Murray gained extensive global experience working as an executive in the fast moving consumer goods and technology sectors in Ireland, Italy, the UK and the US. Mr. Murray has been the Chair of ICON plc since March 2017 and an outside Director since May 2018. Mr. Murray served as Chief Executive Officer from October 2011 until March 2017 and was Chief Financial Officer from joining ICON plc in 2005 until his appointment as Chief Executive Officer in 2011. During his time with ICON plc, Mr. Murray was recognized for his leadership of ICON and the CRO industry.  Mr. Murray served as Chair of the Association of Clinical Research Organizations (ACRO) which represents the CRO industry globally. In addition, Mr. Murray was named as a leader in CRO Innovation by PharmaVOICE100, a listing of the most influential people in the bio pharma industry. University College Dublin awarded Mr. Murray an honorary degree of Doctor of Laws in 2013 for his support of third level research and innovation in Ireland. In 2018, the Royal Dublin Society awarded Mr. Murray the RDS Gold Medal for Enterprise for making an exceptional impact on Irish industry and commerce. Mr. Murray is also a member of the advisory Board of UCD Smurfit Business School.

Dr. Steve Cutler

Dr. Steve Cutler was appointed Chief Executive Officer of ICON plc in March 2017, having previously served as Chief Operating Officer from January 2014. Dr. Cutler served as Group President of Clinical Research Services since November 2011 until his appointment as Chief Operating Officer. Dr. Cutler was appointed to the Board of ICON plc in November 2015. Prior to joining the Company, Dr. Cutler held the position of Chief Executive Officer of Kendle, having previously served as Chief Operating Officer. Prior to Kendle, Dr. Cutler spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe, as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Dr. Cutler held positions with Sandoz (now Novartis) in Australia and Europe. Dr. Cutler holds a B.Sc. and a Ph.D. from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).
65


Brendan Brennan
Mr. Brendan Brennan has served as Chief Financial Officer since February 2012. Mr. Brennan has developed his career over the last 20+ years from experience in various industries. Mr. Brennan joined ICON in 2006 and he has served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. Prior to this he developed his broad financial experience in Cement Roadstone Holdings, a major Irish building materials organization. Mr. Brennan also spent a number of years in public accounting with PwC. Mr. Brennan is a Fellow of the Institute of Chartered Accountants in Ireland and holds a bachelor’s degree in Accounting and Finance from Dublin City University. Over his years in the CRO industry, Mr. Brennan has been involved in many industry organizations and developments including ACRO (Association of Clinical Research Organizations) where he was the founding Chairman of the industry CFO round table group, a group formed to aid CROs dealing with the various industry challenges. Mr. Brennan held the position of Chairman of the round table from its foundation in 2017 to December 31, 2019.
Rónán Murphy
Mr. Rónán Murphy has served as an outside Director of the Company since October 2016. He was appointed as Lead Independent Director in January 2019. Mr. Murphy is the former Senior Partner of PwC Ireland. He was elected Senior Partner in 2007 and was re-elected for a further four year term in 2011. Following completion of the maximum two terms, Mr. Murphy retired from the firm in 2015. Mr. Murphy was also a member of the PwC EMEA Leadership Board for a five year period from 2010 to 2015. Mr. Murphy joined PwC in 1980 and was admitted to the Partnership in 1992. Mr. Murphy is presently Chairman of Greencoat Renewables PLC and a non-executive Director of Davy Stockbrokers. Mr. Murphy currently serves as a council member of the ESRI and as Chair of Business in the Community Ireland. He is also a founding Board Member of the British Irish Chamber of Commerce. Mr. Murphy completed a Bachelor of Commerce and Masters in Business Studies at University College Dublin before qualifying as a chartered accountant in 1982.    
Dr. John Climax
Dr. John Climax, one of the Company’s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009 and as Chief Executive Officer from June 1990 to October 2002. Since January 2010 he has held a position as an outside Director of the Company. Dr. Climax has over 30 years of experience in the clinical research industry. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his Ph.D. in pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland and an honorary professorship at the National University of Singapore. He is currently Executive Chairman of DS Biopharma and CEO of Afimmune, both of which are private companies.
Joan Garahy    
Ms. Joan Garahy was appointed as an outside Director of ICON plc in November 2017. Ms. Garahy is a Non-Executive Director of UNICEF Ireland, Irish Residential Properties REIT plc, and IPB Insurance CLG. Ms. Garahy’s previous executive roles include founder and CEO of ClearView Investment & Pensions Limited, a financial advisory company, Managing Director of HBCL Investment & Pensions Ltd, Director of Investments at HC Financial Services Group, Head of Research at the Irish National Pension Reserve Fund, Head of Research at Hibernian Investment Managers and her equity analyst roles with Goodbody Stockbrokers and NCB Group. Ms. Garahy was also previously Senior Independent non-executive Director of Kerry Group plc and a non executive director at Galway University Foundation and she is currently a member of the board of The Irish Chamber Orchestra. Ms. Garahy is a Qualified Financial Advisor, she holds a Bachelor of Science degree from University College Galway, a Master of Science from University College Dublin and a Diploma in Accounting & Finance from ACCA.
Eugene McCague
Mr. Eugene McCague was appointed as an outside Director of the Company in October 2017. Mr. McCague was a corporate partner of Arthur Cox, one of Ireland’s premier law firms, from 1988 until June 2017. During his time with Arthur Cox, Mr. McCague served as both managing partner and chairman of Arthur Cox and also advised a wide range of public and private companies on mainstream corporate work, mergers and acquisitions, corporate restructurings and corporate governance. In addition to his distinguished legal career, Mr. McCague also has extensive board experience with commercial, government and educational organizations. Mr. McCague currently serves on the board of the Irish branch of AON Insurance and he also serves as chairman of Ibec, Ireland’s leading business representative association. Mr. McCague’s previous board roles include the Health Service Executive, the Irish state body which administers public health service in Ireland, chairman of the governing body of the Dublin Institute of Technology, chairman of the Dublin Institute of Technology Foundation and chairman of the governing authority of University College Dublin and director of Fly Leasing Limited. Mr. McCague was also president of the Dublin Chamber of Commerce in 2006. Mr. McCague holds a Bachelor of Civil Law degree and a diploma in European Law from University College Dublin. 

66


Julie O’Neill
Ms. Julie O’Neill has served as an outside Director of ICON plc since July 2019. Ms. O’Neill was formerly Executive Vice President, Global Operations of Alexion Pharmaceuticals, Inc., where she was responsible for global manufacturing operations and expanding and improving supply chain and quality operations in the US, Europe, and Asia. Before joining Alexion, Ms. O’Neill was Vice President of Operations and General Manager for Ireland at Gilead Sciences and earlier in her career, Ms. O'Neill held leadership positions in operations, manufacturing and quality functions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. Ms. O’Neill serves as a Board Member of DBV Technologies, Hookipa Pharma Inc.,ILC Dover, Achilles Therapeutics plc and Angus Chemical Company. She also chairs the board of Ireland’s National Institute for Bioprocessing Research and Training. Ms. O’Neill holds a Bachelor of Science in Pharmacy from Trinity College Dublin, a Masters of Business Administration from University College Dublin and is a Chartered Director of The Institute of Directors in Ireland. Ms. O'Neill is also a member of the Strategy Committee of the State Claims Agency.

Dr. Linda Grais

Dr. Linda Grais has served as an outside Director of ICON plc since July 2021 having previously served as a member of the PRA Health Sciences board from October 2015 to July 2021. Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc. from June 2012 to December 2017. Prior to her employment by Ocera, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals and Arca Biopharma, Inc. and sits on the compensation and audit committees of Arca Biopharma, Inc. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.

Diarmaid Cunningham

Mr. Diarmaid Cunningham is Chief Administrative Officer, General Counsel and Company Secretary. Mr. Cunningham joined the Company as General Counsel in November 2009. From 2009 until 2013, Mr. Cunningham was based in the Company’s global headquarters in Dublin. In 2013, Mr. Cunningham was seconded to the Company’s US headquarters in Pennsylvania and that secondment ended in 2018 when Mr. Cunningham returned to Dublin. In July 2016, Mr. Cunningham’s role expanded to include Chief Administrative Officer in addition to General Counsel. This expansion of his role means Mr. Cunningham has responsibility to the Company’s Quality Assurance, Client Contracts Services, Facilities and Procurement groups in addition to his responsibility for the Company’s Legal group. Mr. Cunningham graduated with a Bachelor of Business and Legal Studies from University College Dublin in 1997, qualified as a lawyer in 2001 and completed the Stanford Executive Program at Stanford University in California in 2015. Mr. Cunningham served as Secretary to the Board of the Association of Clinical Research Organizations (ACRO) in 2013, 2014, 2020 and 2021. ACRO represents the CRO industry globally to key stakeholders including pharmaceutical, biotech and medical device companies, regulators, legislators and patient groups. Prior to joining the Company, Mr. Cunningham spent 10 years with A&L Goodbody, one of Ireland's premier corporate law firms. In January 2021, Mr. Cunningham was appointed as a non-executive director of the Irish charity The Jack & Jill Foundation.


67


Board Diversity Matrix

Board Diversity Matrix (As of February 24, 2023)
Total Number of Directors8
Part I: Gender Identity
FemaleMale
Directors35
Part II: Demographic Background
Asian1
White34
LGBTQ+1
Did Not Disclose Demographic Background0

Board Diversity Matrix (As of July 27, 2022)
Total Number of Directors9
Part I: Gender Identity
FemaleMale
Directors36
Part II: Demographic Background
Asian1
White35
LGBTQ+1
Did Not Disclose Demographic Background0

B.Compensation

Compensation Discussion & Analysis

Remuneration policy

The Compensation and Organization Committee seeks to achieve the following goals with the Company’s executive compensation programs: to attract, motivate and retain key executives and to reward executives for value creation. The Committee seeks to foster a performance-oriented environment by ensuring that a significant portion of each executive’s cash and equity compensation is based on the achievement of performance targets that are important to the Company, its shareholders and other stakeholders.

The Company’s executive compensation program has three main elements: base salary, a bonus plan and equity incentives in the form of share related awards granted under the Company’s equity incentive plans. All elements of key executives’ compensation are determined by the Compensation and Organization Committee based on the achievement of the Group’s and individual performance objectives. Base salary, bonus awards and Directors’ fees were determined by the Compensation and Organization Committee in U.S. dollars or euro. 

Outside Directors’ remuneration

Outside Directors are remunerated by way of Directors’ fees and are also eligible for participation in the share equity incentive schemes. During 2022, each outside Director (excluding the Board Chairman) was paid an annual retainer of $90,000 and additional fees for Board Committee service.

Mr. Murray’s Executive Chairman term expired on May 12, 2018 and he transitioned to the outside Director role of Chair. The current arrangement with the Chair provides for payment of €330,000 (translated at average rate for the year: $346,891) annually.

Mr. Rónán Murphy was appointed as Lead Independent Director with effect from January 1, 2019 and receives an additional annual fee of $25,000 for this role.

Outside Directors are not eligible for performance related bonuses and no pension contributions are made on their behalf. The Compensation and Organization Committee sets outside Directors' remuneration.

68


Executive Directors’ and Key Executive Officers’ remuneration

Total cash compensation is divided into a base salary portion and a bonus incentive portion. The Committee targets total cash compensation with regard to healthcare/biopharmaceutical companies of similar market capitalization and peer CRO companies, adjusted upward or downward based on individual performance and experience and level of responsibility. The Compensation and Organization Committee believes that the higher the executive’s level of responsibility within the Company, the greater the percentage of the executive’s compensation that should be tied to the Company’s performance. Target bonus incentive for executive officers range between 60% and 125% with actual pay outs for 2022 ranging from 48% to 100%, of salary, based on Group and individual performance.

A total bonus of $1.5 million was awarded to the following individuals; Dr. Steve Cutler Chief Executive Officer ($1.2 million) and Mr. Brendan Brennan Chief Financial Officer ($0.3 million) to reflect their contribution to the performance of the Company during 2022. These amounts were approved by the Compensation and Organization Committee and will be paid during the year ended December 31, 2023.

The Company’s executives are eligible to receive equity incentives, including stock options, Restricted Share Units and Performance Share Units, granted under the Company’s equity incentive plans. If executives receive equity incentive grants, they are normally approved annually at the first scheduled meeting of the Committee in the fiscal year. The grant date and value is determined by the Committee and the number of units granted is determined based on the closing price of the Company's shares on the day of grant. Newly hired executives may receive sign-on grants. In addition, the Committee may, at its discretion, issue additional equity incentive awards to executives if the Committee determines such awards are necessary to ensure appropriate incentives are in place. The equity awards granted to each participant are determined by the Committee at the start of each year based on peer group data, advice from independent compensation consultants, and Committee judgment.

All executive officers are eligible to participate in applicable pension plans. The Company’s contributions are generally a fixed percentage of their annual compensation, supplementing contributions by the executive. The Company has the discretion to make additional contributions if deemed appropriate by the Committee. The Company’s contributions are determined at the peer group median of comparable Irish companies and peer CRO companies. Contributions to this plan are recorded as an expense in the Consolidated Statement of Operations.

Third party Agreements and Arrangements

ICON has not identified any arrangements or agreements relating to compensation or other payments provided by a third party to ICON’s directors or director nominees in connection with their candidacy or board service as required to be disclosed pursuant to NASDAQ Rule 5250(b)(3).

69


Executive Compensation

Summary compensation table - Year ended December 31, 2022
Name & principal
position
YearSalaryBonusPension
contribution
All other compensationSubtotalShare-based
compensation
Director’s FeesTotal
compensation
$’000$’000$’000$’000$’000$’000$’000$’000
Dr. Steve Cutler
Chief Executive Officer
20221,168 1,173 125 31 2,497 7,487 44 10,028 
Brendan Brennan,
Chief Financial Officer
2022556 342 70 30 998 1,645 — 2,643 
Total20221,724 1,515 195 61 3,495 9,132 44 12,671 

Summary compensation table - Year ended December 31, 2021
Name & principal
position
YearSalary *BonusPension
contribution
All other compensationSubtotalShare-based
compensation
Director’s FeesTotal
compensation
$’000$’000$’000$’000$’000$’000$’000$’000
Dr. Steve Cutler
Chief Executive Officer
20211,146 2,300 121 31 3,598 5,959 44 9,601 
Brendan Brennan,
Chief Financial Officer
2021607 914 76 35 1,632 1,341 — 2,973 
Total20211,753 3,214 197 66 5,230 7,300 44 12,574 

Director Compensation
Summary compensation table - Year ended December 31, 2022
NameYearSalaryCompany
pension  contribution
All other compensationSubtotalShare-based
compensation
Director’s feesTotal
Compensation
$’000$’000$’000$’000$’000$’000$’000
Ciaran Murray2022— — — — 267 363 630 
Steve Cutler20221,168 125 1,204 2,497 7,487 44 10,028 
Rónán Murphy2022— — — — 200 150 350 
Hugh Brady*2022— — — — 80 54 134 
John Climax2022— — — — 213 90 303 
Joan Garahy2022— — — — 200 123 323 
William Hall*2022— — — — 80 58 138 
Eugene McCague2022— — — — 200 125 325 
Julie O'Neill2022— — — — 200 110 310 
Mary Pendergast*2022— — — — 80 54 134 
Colin Shannon**2022— — — — — 85 85 
Linda Grais2022— — — — 133 98 231 
Total20221,168 125 1,204 2,497 9,140 1,354 12,991 

* Professor Hugh Brady, Professor William Hall and Ms. Mary Pendergast resigned from the Board on July 26, 2022.
** Mr. Colin Shannon resigned from the Board on December 9, 2022.


70


Summary compensation table - Year ended December 31, 2021
NameYearSalary *Company
pension  contribution
All other compensationSubtotalShare-based
compensation
Director’s feesTotal
Compensation
$’000$’000$’000$’000$’000$’000$’000
Ciaran Murray2021— — — — 200 372 572 
Steve Cutler20211,146 121 2,331 3,598 5,959 44 9,601 
Rónán Murphy2021— — — — 240 144 384 
Hugh Brady2021— — — — 253 90 343 
John Climax2021— — — — 253 78 331 
Joan Garahy2021— — — — 200 110 310 
William Hall2021— — — — 253 103 356 
Eugene McCague2021— — — — 200 119 319 
Julie O'Neill2021000— 200 86 286 
Mary Pendergast2021— — — — 253 90 343 
Colin Shannon*2021— — — — — 45 45 
Linda Grais*2021— — — — — 45 45 
Total20211,146 121 2,331 3,598 8,011 1,326 12,935 

* Mr. Colin Shannon and Dr. Linda Grais were appointed to the Board on July 1, 2021.

Disclosure of Compensation Agreements
 
Employment Contracts, Termination of Employment and Change in Control Arrangements

The Company does not have any termination or change of control agreements with its named executive officers other than as set out below and in the agreements relating to their equity incentives which provide for accelerated vesting on change of control.

Directors’ and Executive Officers’ service agreements and letters of engagement

The following information reflects the agreements in effect as of December 31, 2022.

Mr. Ciaran Murray

Mr. Ciaran Murray has served as Chair of the Board of Directors since May 2018 having served as Executive Chairman of the Board of Directors from March 2017 until May 2018. Mr. Murray served as Chief Executive Officer of the Company from October 2011 until March 2017. Mr. Murray has served as a Director of the Company since September 2011. He previously served as Chief Financial Officer of the Company from October 2005 until October 2011. Mr. Murray entered into an agreement with the Company in respect of his role as Executive Chairman which was effective from March 2017. Mr. Murray’s Executive Chairman term expired on May 12, 2018 and he transitioned to Chair. The current arrangement with Mr. Murray provides for the payment to him of fees of €330,000 (translated at average rate for the year: $346,891) per annum in respect of his position as Chairman. His previous service agreement as Executive Chairman included termination provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions which still apply. As Chief Financial Officer, Chief Executive and Executive Chairman, Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units. The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018 were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018. He was previously granted and held at February 24, 2023 58,646 ordinary share options at exercise prices ranging from $71.95 to $125.74 per share and 1,388 Restricted Share Units, which vest in May 2023.

71


Dr. Steve Cutler

Dr. Steve Cutler has served as Chief Executive Officer since March 2017 having served as Chief Operating Officer of the Company from January 2014 until March 2017. Prior to his appointment as Chief Operating Officer he served as Group President Clinical Research Services since November 2011. He has served as an Executive Director of the Company since November 2015. The Chief Executive Officer service agreement with Dr. Cutler is terminable on 12 months’ notice by either party. Under the terms of this agreement Dr. Cutler is entitled to receive an annual salary of $1,173,251 effective from April 1, 2022 and a bonus to be agreed by the Compensation and Organization Committee. He is also entitled to receive a pension contribution, a car allowance of $12,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February 24, 2023 208,885 ordinary share options at exercise prices ranging from $71.95 to $231.68 per share, 18,173 Restricted Share Units which vest on various dates between March 2023 and March 2025 and 32,121 (up to a maximum of 64,242) Performance Share Units which vest between March 2023 and March 2025 subject to the fulfillment of certain performance conditions. His Chief Executive Officer service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside director positions authorized by the Company. The agreement with Dr. Cutler includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions. Dr. Cutler has a separate agreement with the Company in respect to his role as a director of ICON plc. Under the terms of this agreement he is entitled to receive an annual fee of $44,000.

Mr. Brendan Brennan

Mr. Brendan Brennan has served as Chief Financial Officer since February 2012 having previously served as acting Chief Financial Officer since October 2011. Prior to this appointment, he served in a number of senior finance roles in the Company including the role of Senior Vice President of Corporate Finance. The service agreement with Mr. Brennan is terminable on 12 months’ notice by either party. Under the terms of this agreement Mr. Brennan is entitled to receive an annual salary of $621,467 (€532,032) effective from April 1, 2022 and a bonus to be agreed by the Compensation and Organization Committee. He is also entitled to receive a pension contribution, a car allowance of €20,000 and medical insurance coverage for himself and his dependents. He was previously granted and held at February 24, 2023 53,105 ordinary share options at exercise prices ranging from $83.47 to $231.68 per share, 3,958 Restricted Share Units, which vest on various dates between March 2023 and March 2025, and 7,048 (up to a maximum of 14,096) Performance Share Units which vest between March 2023 and March 2025 subject to the fulfillment of certain performance conditions. His service agreement requires him to devote his full time and attention to his duties for the Company excepting certain outside Director positions authorized by the Board. The agreement with Mr. Brennan includes termination and change of control provisions and also includes certain post-termination clauses including non-disclosure, non-competition and non-solicitation provisions.

Mr. Rónán Murphy

Mr. Rónán Murphy has served as Lead Independent Director from January 2019 having served as an outside Director of the Company since October 2016. The current arrangements with Mr. Murphy provide for the payment to him of Directors fees of $147,500 per annum. He was previously granted and held at February 24, 2023 9,622 ordinary share options at an exercise prices ranging from $90.03 to $125.74 and 925 Restricted Share Units, which vest in May 2023.

Dr. John Climax

Dr. John Climax, one of the Company’s co-founders, served as Chairman of the Board of the Company from November 2002 to December 2009. He also served as Chief Executive Officer of the Company from June 1990 to October 2002 and is currently an outside Director of the Company. The current arrangements with Dr. Climax provide for the payment to him of Directors fees of $90,000 per annum. He was previously granted and held at February 24, 2023 33,255 ordinary share options at exercise prices ranging from $65.60 to $125.74 per share and 925 Restricted Share Units, which vest in May 2023.

Ms. Joan Garahy

Ms. Joan Garahy has served as an outside Director of the Company since November 2017. The current arrangements with Ms. Garahy provide for the payment to her of Directors fees of $122,500 per annum. She was previously granted and held at February 24, 2023 5,005 ordinary share options at an exercise price of $125.74 and 925 Restricted Share Units, which vest in May 2023.

Mr. Eugene McCague

Mr. Eugene McCague has served as an outside Director of the Company since October 2017. The current arrangements with Mr. McCague provide for the payment to him of Directors fees of $122,500 per annum. He was previously granted and held at February 24, 2023 5,005 ordinary share options at an exercise price of $125.74 and 925 Restricted Share Units, which vest in May 2023.


72


Ms. Julie O'Neill

Ms. Julie O'Neill has served as an outside Director of the Company since July 2019. The current arrangements with Ms. O'Neill provide for the payment to her of Directors fees of $115,000 per annum. She was previously granted and held at February 24, 2023 925 Restricted Share Units, which vest in May 2023.

Dr. Linda Grais

Dr. Linda Grais has served as an outside Director of the Company since July 2021 having served as a member of the PRA Health Sciences, Inc. board since October 2015. The current arrangements with Dr. Grais provide for the payment to her of Director fees of $102,500 per annum. She was previously granted and held at February 24, 2023 925 Restricted Share Units, which vest in May 2023.

C.Board Practices

Board of Directors

The business of the Company is managed by the Directors who may exercise all the powers of the Company which are not required by the Companies Act 2014 of Ireland or by the Constitution of the Company to be exercised by the Company in general meeting. A meeting of Directors, at which a quorum is present, may exercise all powers exercisable by the Directors. The Directors may delegate (with power to sub-delegate) to any Director holding any executive office and to any Committee consisting of one or more Directors, together with such other persons as may be appointed to such Committee by the Directors, provided that a majority of the members of each Committee appointed by the Directors shall at all times consist of Directors and that no resolution of any such Committee shall be effective unless two of the members of the Committee present at the meeting at which it was passed are Directors.

The Board comprises one executive and seven outside Directors at the date of this report. The outside Directors bring independent judgment to bear on issues of strategy, performance, resources, key appointments and standards. The Company considers all of its outside Directors to be of complementary skills, experience and knowledge and each outside Director has specific skills, experience and knowledge that are valuable to the Company. The Board members between them have strong financial, pharmaceutical, CRO, scientific, medical and other skills and knowledge which are harnessed to address the challenges facing the Group. The Board meets regularly throughout the year and all Directors have full and timely access to the information necessary for them to discharge their duties. The Directors have access to the advice and services of the Company Secretary and may seek external independent professional advice where required. The Board considers its current size (8 Directors) to be adequate but continues to look for suitable qualified potential candidates to join the Board.

As set out below, certain other matters are delegated to Board Committees and all Board Committees report to the Board. The Company maintains what it considers an appropriate level of insurance cover in respect of legal action against its Directors. The Board, through the Nominating, Sustainability and Governance Committee, engages in succession planning for the Board and in so doing considers the strength and depth of the Board and the levels of knowledge, skills and experience of the Directors necessary for the Company to achieve its objectives. The Board meets at least four times each year. During the year ended December 31, 2022 the Board held five board meetings. All Directors allocated sufficient time to the Company during the year ended December 31, 2022 to effectively discharge their responsibilities to the Company.

Directors’ retirement and re-election

The Company’s Constitution provides that, unless otherwise determined by the Company at a general meeting, the number of Directors shall not be more than 15 nor less than 3. The Constitution also provides that one third of the Directors who are subject to retirement by rotation, rounded down to the next whole number if it is a fractional number, shall retire from office at each annual general meeting.

The Board of Directors adopted a Non-Executive Director Policy for Service on April 24, 2018. The Policy was amended on April 21, 2020 and provides that, subject to individual waiver by the Board, an outside Director of ICON plc shall serve on the Board of the Directors for an initial term which expires at the fourth annual general meeting after their appointment. Each outside director may serve a further term of 3 years, subject to the Board’s approval. After the second 3 year term the Board may request that the outside Director serve up to 3 further terms of 1 year each. After a third 1 year term the Board may request that the outside director serve for further 1 year terms in the event that the Board has particular requirement or desire for the outside director’s skill, knowledge or experience. For an outside Director who previously served as an executive of the Company, the initial 3 year term referred to in this policy is deemed to commence on the date that he/she is determined to be independent as per the NASDAQ Rules. This policy does not apply to Dr. John Climax as he is a founder of the Company.

However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at the Annual General Meeting (AGM). Accordingly, at the AGM of the Company to be held in 2023, all directors will retire and offer themselves for re-election.


73


Lead Independent Director

The Board of Directors adopted a Lead Independent Director Charter on February 14, 2017 which provides that in circumstances where the Chairman of the Board is not independent, the independent members of the Board of Directors shall appoint, from among their number, a Lead Independent Director. The Lead Independent Director shall generally assist in optimizing the effectiveness and independence of the Board of Directors by performing such duties as described in the charter, on behalf of the Board of Directors, including coordinating the meetings of the other non-employee and independent directors, and such other duties as determined from time to time by the Board of Directors and/or its independent members. Mr. Rónán Murphy was appointed as Lead Independent Director with effect from January 1, 2019.

Board Committees

The Board has delegated some of its responsibilities to Board Committees. There are currently four Committees. These are the Audit Committee, the Compensation and Organization Committee, the Nominating, Sustainability and Governance Committee and the Execution Committee. The Integration Committee was retired by the Board on April 26, 2022. Each Committee has been charged with specific responsibilities and each has written terms of reference that are reviewed periodically. Minutes of Committee meetings are available to all members of the Board. The Company Secretary is available to act as secretary to each of the Board Committees if required. Appropriate key executives are regularly invited to attend meetings of the Board Committees. The Audit Committee, Compensation and Organization Committee and Nominating, Sustainability and Governance Committee each completed a self-evaluation of the performance of the Committee in respect to the year ended December 31, 2021 and each Committee was satisfied with their performance. The evaluations in respect to the year ended December 31, 2022 will be completed in 2023.

Audit Committee

The Audit Committee meets a minimum of four times a year. It reviews the quarterly and annual financial statements, the effectiveness of the system of internal control and recommends the appointment and removal of the external auditors. It monitors the adequacy of internal accounting practices and addresses all issues raised and recommendations made by the external auditors. The Audit Committee pre-approves all audit and non-audit services provided to the Company by its external auditors on a quarterly basis. The Audit Committee, on a case by case basis, may approve additional services not covered by the quarterly pre-approval, as the need for such services arises. The Audit Committee reviews all services which are provided by the external auditor to review the independence and objectivity of the external auditor, taking into consideration relevant professional and regulatory requirements. The Chief Financial Officer, the Head of Internal Audit, the Chief Administrative Officer and General Counsel and the external auditors normally attend all meetings of the Audit Committee and have direct access to the Committee Chairperson at all times. The Audit Committee is currently comprised of three independent Directors: Rónán Murphy (Chairperson), Eugene McCague and Julie O'Neill. On April 26, 2022, Hugh Brady stepped down as a member of the Committee and Julie O'Neill joined the Committee.

Compensation and Organization Committee

The Compensation and Organization Committee is responsible for senior executive remuneration. The Committee aims to ensure that remuneration packages are competitive so that individuals are appropriately rewarded relative to their responsibility, experience and value to the Company. Annual bonuses for the executive Directors and senior executive management are determined by the Committee based on the achievement of the Company’s objectives. The Committee also oversees succession planning for the Company’s senior management. The Compensation and Organization Committee is currently comprised of the following independent Directors: Joan Garahy (Chairperson), Rónán Murphy and Linda Grais. On April 26, 2022, William Hall and Mary Pendergast stepped down as members of the Committee and Linda Grais joined the Committee.

Nominating, Sustainability and Governance Committee

The Nominating, Sustainability and Governance Committee is responsible for Board succession, oversight of the Board and committee composition and performance and oversight of the Company's corporate governance and business ethics initiatives and strategies and activities in respect to environmental, social and governance (ESG) matters. The Committee reviews the membership of the Board of the Company and Board Committees on an ongoing basis. As part of this, it regularly evaluates the balance of skills, knowledge and experience on the Board and then, based on this evaluation, identifies and, if appropriate, recommends individuals to join the Board of the Company. The Committee uses external search consultants as needed to assist it in identifying potential new outside Directors. Once potential suitable candidates are identified either by the external search consultants or by members of the Nominating, Sustainability and Governance Committee, the Committee then discusses and considers the skills, knowledge and experience of the potential candidate. The Committee will assess if the Board of the Company requires and would benefit from the potential candidate’s skills, knowledge and experience and, if it decides the potential candidate is suitable, the Committee would recommend to the Board of the Company that the potential candidate be appointed. The Board of the Company then decides whether or not to appoint the candidate. The Committee considers diversity of the Board members when making recommendations to the Board of the Company. The Committee Charter was updated in February 2022 to include specific responsibilities in respect to the oversight of the Company's strategic plans, objectives and risks relating to ESG matters. The Committee changed its name to Nominating, Sustainability and Governance Committee in
74


April 2022. The Nominating, Sustainability and Governance Committee currently comprises the following independent Directors: Eugene McCague (Chairperson), Joan Garahy and Julie O'Neill. On April 26, 2022, William Hall stepped down as a member of the Committee and Julie O'Neill joined the Committee.

Integration Committee

The Integration Committee was set up in April 2021 to assist the Board with its oversight responsibilities in relation to the integration of PRA Health Sciences into the ICON Group. The Integration Committee was retired by the Board on April 26, 2022. Matters that were in the remit of the Integration Committee are now delivered by Management to the full Board. During 2022, up to its retirement in April, the Integration Committee was comprised of the following independent Directors: Ciaran Murray (Chairperson), Rónán Murphy, Eugene McCague and Julie O'Neill.

Execution Committee
    
The primary function of the Execution Committee is to exercise the powers and authority of the Board in intervals between meetings of the Board within the limits set out in the Charter of the Execution Committee. The Execution Committee exercises business judgment to act in what the Committee members reasonably believe to be in the best interest of the Company and its shareholders. All powers exercised by the Execution Committee are ratified at board meetings. This Committee convenes as often as it determines to be necessary or appropriate. The Execution Committee is currently comprised of the following Directors and Officers: Steve Cutler (Chairperson), Rónán Murphy and Brendan Brennan.

Attendance at Board and Committee meetings

Attendance at Board and Committee meetings by the Directors who held office during 2022 are set out as follows:
Directors’ Attendance Table    
 BoardAuditCompensation
and
Organization
Nominating, Sustainability
and
Governance
Integration (3)
  
DirectorNumber of meetings attended / number of meetings eligible to attend as a Director
Ciaran Murray (1)5/52/2
Dr. Steve Cutler 5/5
Rónán Murphy (1)5/55/53/32/2
Prof. Hugh Brady (1) (4)3/32/2
Dr. John Climax (1)5/5
Joan Garahy (1)5/52/33/4
Prof. William Hall (1) 3/32/22/2
Eugene McCague (1)5/55/54/42/2
Julie O'Neill (1)5/53/32/22/2
Mary Pendergast (1) 3/32/2
Colin Shannon (5)5/5
Dr. Linda Grais (1)5/51/1
(1)Independent Director as defined under NASDAQ Rule 5605(a)(2).
(2)All decisions by the Execution Committee were made by written resolution and therefore no meetings were held.
(3)The Integration Committee was retired on April 26, 2022.
(4)Professor Hugh Brady, Professor William Hall and Ms. Mary Pendergast resigned from the Board on July 26, 2022.
(5)Mr. Colin Shannon resigned from the Board on December 9, 2022.

D.Employees

At December 31, 2022, December 31, 2021 and December 31, 2020 we employed approximately 41,100, 38,330 and 15,730 people respectively. Our employees are not unionized and we believe we have a satisfactory relationship with our employees.



75


E.Share Ownership
 
Shares

The following table sets forth certain information as of February 24, 2023 regarding beneficial ownership of our ordinary shares by all of our current Directors and executive officers. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law.
Name of Owner or
Identity of Group
No. of
Shares (1)
% of total
Shares
Mr. Ciaran Murray1,680 — %
Dr. Steve Cutler 42,377 0.05 %
Mr. Brendan Brennan 23,547 0.03 %
Mr. Rónán Murphy 1,680 — %
Dr. John Climax509,297 0.62 %
Ms. Joan Garahy 1,680 — %
Mr. Eugene McCague 1,680 — %
Ms. Julie O'Neill1,490 — %
Dr. Linda Grais 3,994 — %

(1)As used in these tables, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e. the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.

Restricted Share Units and Performance Share Units

The following table sets forth certain information as of February 24, 2023 regarding beneficial ownership of Restricted Share Units (“RSUs”) and Performance Share Units (“PSUs”) which have been issued to our current Directors and executive officers.
Name of Owner or
Identity of Group
No. of
RSUs
Vesting Date
 
No. of
PSUs (1)
Vesting Date
 
Mr. Ciaran Murray1,388May 21, 2023
Dr. Steve Cutler2,958 March 3, 202311,202 March 3, 2023
3,201 March 3, 202310,354 March 3, 2024
3,018 March 3, 202310,565 March 3, 2025
2,959 March 3, 2024
3,018 March 3, 2024
3,019 March 3, 2025
Mr. Brendan Brennan 694March 3, 20232,425 March 3, 2023
698March 3, 20232,444 March 3, 2024
622March 3, 20232,179 March 3, 2025
698March 3, 2024
622March 3, 2024
624March 3, 2025
Mr. Rónán Murphy 925May 21, 2023
Dr. John Climax925May 21, 2023
Ms. Joan Garahy925May 21, 2023
Mr. Eugene McCague925May 21, 2023
Ms. Julie O'Neill925May 21, 2023
Dr. Linda Grais 925May 21, 2023
 

76


(1)Of the issued PSUs, performance conditions will determine how many vest. If performance targets are exceeded, additional PSUs will be issued and will vest in accordance with the terms of the relevant PSU award. The PSUs vest based on service and specified EPS targets over the periods 2020 – 2022, 2021 – 2023 and 2022 - 2024. Depending on the actual amount of EPS from 2020 to 2024, up to a maximum of 39,169 additional PSUs may also be granted to Dr. Steve Cutler and Mr. Brendan Brennan.

Share Options

The following table sets forth certain information as of February 24, 2023 regarding options to acquire ordinary shares of the Company by all of our current Directors and executive officers.
Name of Owner or
Identity of Group
No. of
Options (1)
Exercise priceExpiration Date
Mr. Ciaran Murray45,948 $71.95 March 4, 2024
7,693 $90.03 May 19, 2025
5,005 $125.74 May 18, 2026
Dr. Steve Cutler 6,128 $71.95 March 4, 2024
25,156 $83.47 March 3, 2025
29,613 $115.11 March 3, 2026
32,272 $140.38 March 3, 2027
42,386 $159.33 March 3, 2028
37,461 $174.96 March 3, 2029
35,869 $231.68 March 3, 2030
Mr. Brendan Brennan9,306 $83.47 March 3, 2025
9,584 $115.11 March 3, 2026
8,796 $140.38 March 3, 2027
9,176 $159.33 March 3, 2028
8,842 $174.96 March 3, 2029
7,401 $231.68 March 3, 2030
Mr. Rónán Murphy 4,617 $90.03 May 19, 2025
5,005 $125.74 May 18, 2026
Dr. John Climax10,000 $68.39 March 18, 2023
10,557 $65.60 May 20, 2024
7,693 $90.03 May 19, 2025
5,005 $125.74 May 18, 2026
Ms. Joan Garahy5,005 $125.74 May 18, 2026
Mr. Eugene McCague5,005 $125.74 May 18, 2026
(1) The title of securities covered by all of the above options are non-qualified.

In February 2018, the Board approved the appointment of Mr. Murray as Chair of the Board of Directors with effect from May 12, 2018. Mr. Murray ceased to be an employee of the Company as of this date. Mr. Murray was granted and held ordinary share options, Restricted Share Units and Performance Share Units as Chief Financial Officer, Chief Executive Officer and Executive Chairman. The vesting of the ordinary share options and Restricted Share Units which were unvested on Mr. Murray ceasing to be an ICON plc employee (May 12, 2018) were accelerated and the outstanding ordinary share options and Restricted Share Units vested on that date. The unvested Performance Share Units with vesting dates between May 12, 2018 and March 31. 2019 were forfeited on Mr. Murray ceasing to be an ICON plc employee on May 12, 2018.

Equity Incentive Plans

On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or Non-Executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to Non-Executive Directors vest over twelve months.

77


On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the “2013 RSU Plan”) pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015, the 2013 RSU Plan was amended and restated in order to increase the number of ordinary shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.
  
On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the “2008 Employee Plan”) pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the “2008 Consultants Plan”), pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may grant options to any consultant, adviser or Non-Executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.

On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the “2008 Option Plans”) were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans. An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.
 
Each option granted under the 2008 Option Plans will be a nonqualified stock option, or NSO and not an incentive stock option as described in Section 422 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans will be evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price will be specified in each Stock Option Agreement, however, option prices will not be less than 100% of the fair market value of an ordinary share on the date the option is granted.
 
Share option awards are granted with an exercise price equal to the market price of the Company’s shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. Share options granted to Non-Executive Directors during 2018 vest over 12 months and expire eight years from the date of grant.

Legacy PRA Equity Incentive Plans

The following represent the legacy PRA equity incentive plans, which still have equity outstanding but have been terminated as of July 1, 2021 as to grants of future awards.

Pursuant to the Merger Agreement, effective on July 1, 2021, each outstanding stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.

PRA Health Sciences, Inc. 2020 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2020 Stock Incentive Plan (“the 2020 Plan”), was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.

The PRA Health Sciences, Inc. 2018 Stock Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021. The 2018 Stock Incentive Plan (the “2018 Plan”), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).

The PRA Health Sciences, Inc. 2014 Omnibus Incentive Plan was amended and restated and assumed by the Company effective as of July 1, 2021 (the “2014 Plan”). On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.
78



The 2013 Stock Incentive Plan for Key Employees of PRA Health Sciences and its Subsidiaries was amended and restated and assumed by the Registrant effective as of July 1, 2021 (the “2013 Plan”). On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.

Item 7. Major Shareholders and Related Party Transactions.
 
A.Major Shareholders

The following table sets forth certain information regarding beneficial ownership of ICON's ordinary shares as of February 24, 2023 (i) by each person that beneficially owns more than 5% of the outstanding ordinary shares, based upon information known to us and publicly available information; and (ii) by all of our current Directors, officers and other key employees as a group. Unless otherwise indicated below, to our knowledge, all persons listed below have sole voting and investment power with respect to their ordinary shares, except to the extent authority is shared by spouses under applicable law. None of the persons listed below have voting rights that differ from any other person listed below.
2022 (4)2021 (5)2020 (6)
Name of Owner or Identity of GroupNo. of Shares (1)Percent of ClassNo. of Shares (1)Percent of ClassNo. of Shares (1)Percent of Class
Massachusetts Financial Services Company (2)
8,119,214 9.9 %7,228,317 8.9 %2,268,437 3.9 %
WCM Investment Management (2)5,885,414 7.2 %7,179,979 8.8 %3,976,550 7.5 %
All Directors, officers and other key employees as a group (3)1,116,311 1.4 %1,129,726 1.4 %1,152,168 2.2 %
 
(1)As used in this table, each person has the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have "beneficial ownership" of any security if that such person has the right to acquire such security within 60 days after such date.
(2)Neither the Company nor any of its officers, Directors or affiliates holds any voting power in this entity.
(3)Includes 401,416 ordinary shares issuable upon the exercise of stock options granted by the Company, 31,940 RSUs awarded by the Company to Directors, officers and other key employees and 88,074 PSUs awarded by the Company to Directors, officers and other key employees. Of the PSUs, performance conditions determine how many of them will vest and, if performance targets are exceeded, additional PSUs will be issued and vest in accordance with the terms of the relevant PSU award, the figure included is the maximum amount of PSUs that may be issued.
(4)This information is based on the Schedule 13G, Amendment No. 2, filed with the SEC by Massachusetts Financial Services Company on February 8, 2023 for shares held on December 30, 2022; and the Schedule 13G/ Amendment No. 8 filed with the SEC by WCM Investment Management on February 10, 2023 for shares held on December 31, 2022, respectively.
(5)This information is based on the Schedule 13G, Amendment No. 1, filed with the SEC by Massachusetts Financial Services Co on February 2, 2022 for shares held on December 31, 2021; and the Schedule 13F filed with the SEC by WCM Investment Management on January 26, 2022 for shares held on December 31, 2021; respectively.
(6)This information is based on the Schedule 13F/ Amendment No. 1 filed with the SEC by Massachusetts Financial Services Company on May 12, 2021 for shares held on December 31, 2020; and the Schedule 13F, Amendment No. 1, filed with the SEC by WCM Investment Management on February 23, 2021 for shares held on December 31, 2020; respectively.

ICON plc, is not directly or indirectly, owned or controlled by another corporation or by any government.


79


B.Related Party Transactions

Subsidiaries of the Company earned revenue of $2,000 (December 31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year ended December 31, 2022. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December 31, 2022 (December 31, 2021: $12,000). 

Subsidiaries of the Company earned revenue of $235,000 (December 31, 2021: $551,000) from Afimmune Limited during the year ended December 31, 2022. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December 31, 2022 (December 31, 2021: $197,000). 

Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year ended December 31, 2022. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December 31, 2022.

On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December 31, 2022 (December 31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December 31, 2022 (December 31, 2021: $264,000). During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare to $9.2 million. At December 31, 2022 accrued interest of $183,000 remained outstanding.

The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.

C. Interests of experts and counsel

Not applicable

Item 8.   Financial Information.
 
A.Consolidated Statements and Other Financial Information

See Item 18.

Legal Proceedings

We do not expect any current litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

Dividend Policy

We have not paid cash dividends on our ordinary shares and do not currently intend to pay cash dividends on our ordinary shares in the foreseeable future.

B.Significant Changes

There have been no significant changes to our business that we believe could reasonably be expected to have a material adverse effect on our business, results of operations and financial condition.







80


Item 9.   The Offer and Listing.

A.Offer and listing details

ICON’s ordinary shares are traded on the NASDAQ Global Select Market under the symbol “ICLR”. ICON plc’s American Depositary Receipt ("ADR") program was terminated on January 31, 2013 and ICON plc’s ordinary shares began directly trading on NASDAQ on February 4, 2013. Prior to that date, ICON plc’s American Depositary Shares ("ADSs") were traded on NASDAQ and ICON plc’s Depository for the ADSs was The Bank of New York Mellon.

B.Plan of distribution

Not applicable.

C.Markets

NASDAQ.

D.Selling shareholders

Not applicable.

E.Dilution

Not applicable.

F.Expenses of the issue

Not applicable.

Item 10. Additional Information.

A.Share Capital

Not applicable.

B.Memorandum and articles of association

    Constitution

We hereby incorporate by reference our Constitution, as amended, located under the heading “Constitution of the Company” in Exhibit 3.1.

The following is a summary of certain provisions of the current Constitution of the Company. This summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Constitution of the Company, which are included as an exhibit to this annual report.

Objects

The Company is incorporated under the name ICON plc, and is registered in Ireland under registered number 145835. The Company's objects, which are detailed in the Constitution of the Company, are broad and include, but are not limited to the carrying on the business of an investment holding company.

Directors

Subject to certain exceptions, Directors may not vote on matters in which they have a material interest. Any Director who holds any executive office, serves on any Committee or otherwise performs services, which, in the opinion of the Directors, are outside the scope of the ordinary duties of a Director, may be paid such extra remuneration as the Directors may determine. The Directors may exercise all the powers of the Company to borrow money. These powers may be amended by special resolution of the shareholders. There is no requirement for Directors to hold shares set out in the Constitution. The Directors are not required to retire at any particular age. The Constitution provides that one-third of the Directors must retire and offer themselves for re-election at each Annual General Meeting ("AGM") of the Company and that the Directors to retire by rotation are those who have been longest in office since their last appointment or reappointment. However in July 2022, the Board of Directors unanimously agreed that all of the Directors will retire and stand for re-election annually at each AGM. All of the shareholders entitled to attend and vote at the AGM may vote on the re-election of Directors.

81


Rights, Preferences and Dividends Attaching to Shares

The Company has only one class of shares, Ordinary Shares with a par value of €0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.

Action Necessary to Change the Rights of Shareholders

The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.

Annual and General Meetings

The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15 months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (“EGM”) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21 clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days’ notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.

Limitations on the Right to Own Shares

There are no limitations on the right to own shares in the Constitution of the Company.

Disclosure of Share Ownership

Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.

Other Provisions of the Constitution

There are no provisions in the Constitution of the Company:

(i) delaying or prohibiting a change in the control of the Company, but which operate only with respect to a merger, acquisition or corporate restructuring;

(ii) discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares; or

(iii) governing changes in capital, in each case, where such provisions are more stringent than those required by law.

C.Material Contracts
The following is a summary of each contract (not being a contract entered into in the ordinary course of business) that has been entered into: (a) within the two years immediately preceding the date of this Form 20-F which are, or may be, material to us; or (b) at any time which contain obligations or entitlements which is, or may be, material to us as at the date of this Form 20-F:
Agreement and Plan of Merger
On February 24, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with PRA Health Sciences, Inc. (“PRA”), ICON US Holdings Inc., a Delaware corporation and subsidiary of ICON (“US HoldCo”), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (“Merger Subsidiary”). On July 1, 2021 (the
82


“Closing Date”), pursuant to the terms and subject to the conditions of the Merger Agreement, Merger Sub was merged with and into PRA, with PRA surviving as a subsidiary of ICON and US HoldCo.
As a result of the Merger, each share of PRA common stock issued and outstanding immediately prior to the completion of the Merger (other than shares held by any shareholder who properly demands and perfects his, her or its appraisal rights with respect to such shares and treasury shares held by PRA) was canceled and converted into the right to receive: (i) from ICON, 0.4125 of one ICON ordinary share and (ii) from US Holdco and the surviving corporation $80.00 in cash, without interest.
Equity awards of PRA that are outstanding prior to the effective time of the Merger were generally treated as follows (subject to the terms and conditions set forth in the Merger Agreement):
Each outstanding PRA stock option and restricted stock unit was assumed by ICON on the same terms and conditions (including vesting conditions) and converted to a stock option or restricted stock unit based on ICON ordinary shares with the number of ICON ordinary shares and exercise price in the case of stock options determined at a conversion ratio as set forth under the Merger Agreement; and
Each outstanding share of PRA restricted stock was vested at the Closing and was canceled and converted into the right to receive the per share merger consideration.
The foregoing description of the Merger and the Merger Agreement, and the related transactions contemplated thereby, does not purport to be complete and is subject to, and qualified in its entirety by reference to, the full text of the Merger Agreement which is attached as Exhibit 2.1 to ICON’s Current Report on Form 6-K filed with the Securities and Exchange Commission (the “SEC”) on February 24, 2021 and incorporated herein by reference herein.
Senior Secured Credit Facilities
In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay the outstanding amount of (i) PRA’s existing credit facilities and (ii) the Company's senior secured notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the revolving loan facility will mature in July 2026.
Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25% (with a step up of 0.25% if the first lien net leverage ratio exceeds 4.00 to 1.00). The senior secured term loan facility is subject to a floor of 0.50%. The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively.
The Borrowers’ (as defined in the Senior Secured Credit Facilities) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes (see below), subject to other permitted liens.
The Senior Secured Credit Facilities contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. In addition, the revolving credit loan facility contains a financial covenant that requires ICON to maintain a Total Net Leverage Ratio (as defined in the Senior Secured Credit Facilities) of 5.75:1.00 prior to June 30, 2023 and 4.50:1.00 on and after June 30, 2023, subject to a step-down of 0.50:1.00 following a Material Acquisition (as defined in the Senior Secured Credit Facilities), which will be tested at the end of any fiscal quarter only if amounts are drawn under the revolving credit loan facility (excluding cash collateralized and backstopped letters of credit) in excess of 30% of the revolving commitments.
The Senior Secured Credit Facilities provide that, upon the occurrence of certain events of default, the obligations thereunder may be accelerated. Such events of default will include payment defaults to the lenders thereunder, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness, voluntary and involuntary bankruptcy proceedings, material money judgments, material pension-plan events, change of control and other customary events of default.

83


Senior Secured Notes
In addition to the Senior Secured Credit Facilities, on July 1, 2021, Indigo Merger Sub, Inc. (which was merged with and into PRA Health Sciences, Inc.) (the “Issuer”), a wholly-owned subsidiary of the Company, issued $500.0 million in aggregate principal amount of 2.875% senior secured notes due July 2026 (the “Senior Secured Notes”) in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026. The Issuer will pay interest on the Senior Secured Notes on January 15 and July 15 of each year. Interest on the Senior Secured Notes will accrue at a rate of 2.875% per annum.
The proceeds from the Offering and borrowings made under the Senior Secured Credit Facilities, together with cash on hand, were used to (i) fund the cash consideration payable by ICON for the Merger, (ii) repay existing indebtedness of ICON and PRA and (iii) pay fees and expenses related to the Merger, the Offering and the Senior Secured Credit Facilities.
The Senior Secured Notes are guaranteed on a senior secured basis by ICON and its direct and indirect subsidiaries that guarantee the Senior Secured Credit Facilities. The Senior Secured Notes are secured by a lien on substantially all of ICON’s, the Issuer’s and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Notes have a first-priority lien on such assets, which rank pari passu with the liens securing the Senior Secured Credit Facilities, subject to other permitted liens.
At any time prior to July 15, 2023, the Issuer may redeem all or part of the Senior Secured Notes at a redemption price equal to 100% of the principal amount of the Notes plus an applicable make whole premium and accrued and unpaid interest to, but not including the redemption date. At any time prior to July 15, 2023, the Issuer may, with the proceeds of certain equity offerings, redeem up to 40% of the aggregate principal amount of the Senior Secured Notes at a redemption price of 102.875% of the principal amount plus accrued and unpaid interest to, but not including, the date of redemption. In addition, at any time and from time to time prior to July 15, 2023, the Issuer may redeem up to 10% per annum of the aggregate principal amount of the Senior Secured Notes at a redemption price of 103.000% of the aggregate principal amount thereof, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.
The Indenture contains contain customary negative covenants, including, but not limited to, restrictions on the ability of ICON and its subsidiaries to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, pay dividends or make other restricted payments, sell or otherwise transfer assets or enter into transactions with affiliates. The Indenture contains customary events of default and remedies.
D.Exchange Controls and Other Limitations Affecting Security Holders
Irish exchange control regulations ceased to apply from and after December 31, 1992. Except as indicated below, there are no restrictions on non-residents of Ireland dealing in domestic securities, which includes shares or depository receipts of Irish companies. Except as indicated below, dividends and redemption proceeds also continue to be freely transferable to non-resident holders of such securities.
The Financial Transfers Act, 1992 gives power to the Minister for Finance of Ireland to make provision for the restriction of financial transfers between Ireland and other countries and persons. Financial transfers are broadly defined, and include all transfers which would be movements of capital or payments within the meaning of the treaties governing the European Communities. The acquisition or disposal of shares issued by an Irish incorporated company and associated payments may fall within this definition. In addition, dividends or payments on redemption or purchase of shares and payments on a liquidation of an Irish incorporated company would fall within this definition.
The Financial Transfers Act, 1992 prohibits financial transfers involving a number of persons, entities and bodies, which is subject to amendment on an ongoing, regular basis and currently includes, but is not limited to: certain persons and activities in Belarus, Bosnia & Herzegovina, Burundi, Sudan, South Sudan, the Central African Republic, Libya, Lebanon, Mali, the Democratic People's Republic of Korea, Myanmar/Burma, Tunisia, Zimbabwe, Venezuela, certain persons, entities and bodies in the Syrian Arab Republic, the Republic of Guinea-Bissau, Nicaragua, Democratic Republic of Congo, Iran, Ukraine and Russia; persons associated with the Taliban in Afghanistan, associated with ISIL (Da’esh) and Al-Qaeda, associated with Turkey’s unauthorized drilling activities in the Eastern Mediterranean and certain known terrorists and terrorist groups and countries that harbor certain terrorist groups, without the prior permission of the Central Bank of Ireland.
There are no restrictions under the Company’s Constitution or under Irish Law that limit the right of non-residents or foreign owners to hold the Company’s ordinary shares or vote at general meetings of the Company.
84


E.Taxation
General
The following discussion is based on existing Irish tax law, Irish court decisions and the practice of the Revenue Commissioners of Ireland, and the convention between the United States and Ireland for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to taxes on income and capital gains (the "Treaty"). This discussion does not purport to deal with the tax consequences of owning the ordinary shares for all categories of investors, some of which may be subject to special rules. Prospective purchasers of ordinary shares are advised to consult their own tax advisors concerning the overall tax consequences arising in their own particular situations under Irish law. Each prospective investor should understand that future legislative, administrative and judicial changes could modify the tax consequences described below, possibly with retroactive effect.

As used herein, the term "U.S. Holder" means a beneficial owner of ordinary shares that (i) owns the ordinary shares as capital assets; (ii) is a U.S. citizen or resident, a U.S. corporation, an estate the income of which is subject to U.S. federal income taxation regardless of its source or a trust that meets the following two tests: (A) a U.S. court is able to exercise primary supervision over the administration of the trust, and (B) one or more U.S. persons have the authority to control all substantial decisions of the trust; and for the purpose of the discussion under Irish Taxation of U.S. Holders (A) is not a resident of, or ordinarily resident in, Ireland for the purposes of Irish tax; and (B) is not engaged in trade or business in Ireland through a permanent establishment.

AS USED HEREIN, REFERENCES TO THE ORDINARY SHARES SHALL INCLUDE SHARES HELD IN THE ACCOUNTS OF PARTICIPANTS THROUGH THE DEPOSITARY TRUST COMPANY (“THE DTC”).

Irish Taxation

Irish corporation tax on income

ICON is a public limited company incorporated and resident for tax purposes in Ireland by virtue of its place of central management and control being in Ireland.

Companies which are resident in the Republic of Ireland ("Ireland") are subject to Irish corporation tax on their total profits (wherever arising and, generally, whether or not remitted to Ireland). The question of residence, by virtue of management and control, is essentially one of fact. It is the present intention of the Company's management to continue to manage and control the Company from Ireland, so that the Company will continue to be resident in Ireland.

The standard rate of Irish corporation tax on trading income (with certain exceptions) is currently 12.5%.

A research and development tax credit is available in Ireland where an Irish resident company incurs qualifying expenditure on research and development activities. Qualifying expenditure incurred in a particular accounting period results in a tax credit of 25% of that expenditure.

Corporation tax is charged at the rate of 25% on a company's non-trading income and certain types of trading income not eligible for the lower rate of 12.5% referred to above.

Capital gains arising to an Irish resident company are liable to tax at 33%. However, a capital gains tax exemption is available in Ireland for qualifying Irish resident companies in respect of disposals of certain qualifying shareholdings.

The exemption from capital gains tax on the disposal of shares by an Irish resident company will apply where certain conditions are met. These conditions principally are:

The company claiming the exemption must hold (directly or indirectly) at least 5% of the ordinary share capital of the company in which the interest is being disposed of, throughout a continuous period of at least 12 months, in the two-year period prior to disposal;

The shares being disposed of must be in a company, which at the date of disposal, is resident in a Member State of the European Communities or in a country with which Ireland has signed or made specific arrangements to sign a double tax agreement (together a “Relevant Territory”);

The shares must be in a company which is primarily a trading company or the company making the disposal together with its “5% plus subsidiaries” should be primarily a trading group; and

The shares must not derive the greater part of their value from land or mineral rights in Ireland.




85


Irish withholding tax on dividends

Unless specifically exempted, all dividends paid by the Company, will be subject to Irish withholding tax. The current rate for dividend withholding tax is 25%.

An individual shareholder who is neither resident nor ordinarily resident for tax purposes in Ireland but is resident in a country with which Ireland has a double tax treaty (which includes the U.S.), or in a member state of the European Communities, other than Ireland (together, a Relevant Territory), will be exempt from withholding tax provided he or she makes the requisite declaration.

Irish resident corporate shareholders will be exempt from withholding tax. Where the shareholding held by the recipient company, in the company paying the dividend is not 51% or greater a declaration must be made to avail of the exemption.

Non-Irish resident corporate shareholders will be exempt from withholding tax on the production of the appropriate certificates and declarations where they:

are resident in a Relevant Territory and are not controlled (directly or indirectly) by Irish residents;

are ultimately controlled (directly or indirectly) by residents of a Relevant Territory;

have the principal class of their shares, or shares of a 75% parent, substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories; or

are wholly owned by two or more companies, each of whose principal class of shares is substantially and regularly traded on one or more recognized stock exchanges in a Relevant Territory (including Ireland) or Territories.

U.S. holders of ordinary shares should note, however, that detailed documentation requirements may need to be complied with. Special arrangements are available in the case of an interest in shares held in Irish companies through a depositary or in accounts of participants through the DTC. In certain cases, the depositary or the DTC can receive and pass on a dividend from an Irish company without deducting withholding tax, provided the depositary or the DTC is a qualifying intermediary, and provided the person beneficially entitled to the distribution would meet the same conditions outlined above for the withholding tax exemption to apply and has provided the qualifying intermediary with the appropriate declarations. The depositary or the DTC shall be regarded as a qualifying intermediary provided the following conditions are met:

the depositary or the DTC is resident in a Relevant Territory;

the depositary or the DTC have entered into a qualifying intermediary agreement with the Irish tax authorities (Irish Revenue Commissioners); and

the depositary or the DTC have been authorized by the Irish Revenue Commissioners as a qualifying intermediary and such authorization has not expired or been revoked.

Irish income tax on dividends

Irish resident or ordinarily resident shareholders will generally be liable to Irish income tax on dividend income at their marginal rate of income tax. This income may also be liable to Pay Related Social Insurance (“PRSI”) of up to 4% and the Universal Social Charge (“USC”) of up to 11% (up to 15% in total).

Under certain circumstances, non-Irish resident shareholders will be subject to Irish income tax on dividend income. Where withholding tax of 25% has been deducted, this will fully satisfy the non-Irish resident shareholder’s tax liability. No PRSI or USC should apply in these circumstances.

However, a non-Irish resident shareholder will not have an Irish income tax liability on dividends from the Company if the holder is neither resident nor ordinarily resident in Ireland and the holder is:

an individual resident in a Relevant Territory;

a corporation that is ultimately controlled by person(s) resident in a Relevant Territory;

a corporation whose principal class of shares (or its 75% or greater parent’s principal class of shares) is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory;

a corporation resident in another EU member state or in a Relevant Territory, which is not controlled directly or indirectly by Irish residents; or

a corporation that is wholly owned by two or more corporations each of whose principal class of shares is substantially and regularly traded on a recognized stock exchange in an EU country or in a Relevant Territory.

86


U.S. Holders who do not qualify for the above income tax exemption may be able to obtain treaty benefits under the Treaty.

Irish domicile levy

Certain non-Irish resident individuals that are domiciled in Ireland will be subject to an annual levy of €200,000 if the market value of their Irish-located property on 31 December exceeds €5,000,000, their worldwide annual income exceeds €1,000,000 and their liability to Irish income tax in that year is less than €200,000.

Irish capital gains tax on disposal of shares

Irish resident or ordinarily resident shareholders will be liable to capital gains tax at 33% on gains arising from the disposal or part disposal of their shareholding.

A person who is not resident or ordinarily resident in Ireland, who has not been an Irish resident within the past five years and who does not carry on a trade in Ireland through a branch or agency will not be subject to Irish capital gains tax on the disposal of ordinary shares or shares held in accounts of participants through the DTC, so long as the shares do not derive the greater part of their value from Irish land or mineral rights.

There are provisions to subject a person who disposes of an interest in a company while temporarily being non-Irish resident, to Irish capital gains tax. This treatment will apply to Irish domiciled individuals:

who cease to be Irish resident;

who beneficially own the relevant assets when they cease to be resident;

if there are not more than 5 years of assessment between the last year of Irish tax residence prior to becoming temporarily non-resident and the tax year that he/she resumes Irish tax residency;

who dispose of the relevant assets during this temporary non-residence; and

the interest disposed of represents 5% or greater of the issued share capital of the company or is worth at least €500,000.

In these circumstances the person will be deemed, for Irish capital gains tax purposes, to have sold and immediately reacquired the interest in the company on the date of his or her departure and will be subject to tax at 33% of the taxable gain.

Irish capital acquisitions tax

Irish capital acquisitions tax (referred to as CAT) applies to gifts and inheritances. Subject to certain tax-free thresholds, gifts and inheritances are liable to tax at 33%.

Where a gift or inheritance is taken under a disposition made after December 1, 1999 it will be within the charge to CAT:

to the extent that the property of which the gift or inheritance consists is situated in Ireland at the date of the gift or inheritance;

where the person making the gift or inheritance is or was resident or ordinarily resident in Ireland at the date of the disposition under which the gift or inheritance is taken;

in the case of a gift taken under a discretionary trust where the person from whom the gift is taken was resident or ordinarily resident in Ireland at the date he/she made the settlement, or at the date of the gift or, if he/she is dead at the date of the gift, at the date of his/her death; or

where the person receiving the gift or inheritance is resident or ordinarily resident in Ireland at the date of the gift or inheritance.

For these purposes a non-Irish domiciled individual will not be regarded as resident or ordinarily resident in the Republic of Ireland on a particular date unless they are resident or ordinarily resident in Ireland on that date and have been resident for the 5 consecutive tax years immediately preceding the year of assessment in which the date falls.

The person who receives the gift or inheritance (“the beneficiary”) is primarily liable for CAT. In the case of an inheritance, where a beneficiary and personal representative of the deceased are both non-residents, a solicitor must be appointed to be responsible for paying inheritance tax. Taxable gifts or inheritances received by an individual since December 5, 1991 from donors in the same threshold class are aggregated and only the excess over a specified tax-free threshold is taxed. The tax-free threshold is dependent on the relationship between the donor and the beneficiary and the aggregation since December 5, 1991 of all previous gifts and inheritances, within the same tax threshold.


87


The tax-free threshold amounts that apply are:
€16,250 in the case of persons who are not related to one another;

€32,500 in the case of gifts or inheritances received from inter alia a brother or sister or from a brother or sister of a parent or from a grandparent; and

€335,000 in the case of gifts and inheritances received from a parent (or from a grandparent by a minor child of a deceased child) and specified inheritances received by a parent from a child for gifts or inheritances taken on or after October 9, 2019.

Gifts and inheritances passing between spouses are exempt from CAT.

A gift or inheritance of the ordinary shares or American Depositary Shares (ADSs) in the Company will be within the charge to CAT, notwithstanding that the person from whom or by whom the gift or inheritance is received is domiciled or resident outside Ireland.

The Estate Tax Convention between Ireland and the United States generally provides for CAT paid on inheritances in Ireland to be credited against U.S. Federal Estate tax payable in the U.S. and for tax paid in the U.S. to be credited against tax payable in Ireland, based on priority rules set forth in the Estate Tax Convention. The Estate Tax Convention does not apply to CAT paid on gifts.

Irish stamp duty

Irish stamp duty, which is a tax on certain documents, is payable on all transfers of ordinary shares (other than between spouses) whenever a document of transfer is executed. Where the transfer is attributable to a sale of shares, stamp duty will be charged at a rate of 1%, rounded to the nearest euro. The stamp duty is calculated on the amount or value of the consideration (i.e. purchase price) or, if the transfer is by way of a gift (subject to certain exceptions) or for consideration less than the market value, on the market value of the shares. Where the consideration for the sale is expressed in a currency other than euro, the duty will be charged on the euro equivalent calculated at the rate of exchange prevailing on the date of the transfer.

Transfers through the DTC of book entry interests in shares are not subject to Irish stamp duty.

A transfer of ordinary shares by a shareholder to a depositary or custodian for deposit and a transfer of ordinary shares from the depositary or the custodian for the purposes of the withdrawal of the underlying ordinary shares in accordance with the terms of a deposit agreement will be subject to stamp duty at the 1% rate if the transfer relates to a sale, a contemplated sale, a gift or any other change in the beneficial ownership of such ordinary shares. However, transfers of ordinary shares into or out of the DTC are not subject to Irish stamp duty where no change in beneficial ownership of the shares has occurred and provided a contract for sale in respect of the transferring shares is not in place.

The person accountable for payment of stamp duty is normally the transferee or, in the case of a transfer by way of gift, or for a consideration less than the market value, all parties to the transfer.

Transfers of ordinary shares between associated companies (broadly, companies within a 90% group relationship and subject to the satisfaction of certain conditions) are exempt from stamp duty in Ireland. In the case of transfers of ordinary shares where no beneficial interest passes (e.g. a transfer of shares from a beneficial owner to his nominee), no stamp duty arises.

No stamp duty shall arise on the transfer of ordinary shares where the consideration for the transfer does not exceed €1,000, provided the instrument contains a statement certifying that the transaction does not form part of a larger transaction or a series of larger transactions, in respect of which the amount of the total consideration attributable to the shares would exceed €1,000.

F.Dividends and paying agents

Not applicable.

G.Statement by experts

Not applicable.

H.Documents on Display

We are subject to the informational requirements of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and file reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC at http://www.sec.gov.

We “incorporate by reference” information that we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this
88


report and more recent information automatically updates and supersedes more dated information contained or incorporated by reference in this report. Our SEC file number for Exchange Act reports is 333-08704.

As a foreign private issuer, we are exempt from certain rules under the Exchange Act, including prescribing the furnishing and content of proxy statements to shareholders.

We will provide without charge to each person, including any beneficial owner, on the written or oral request of such person, a copy of any or all documents referred to above which have been or may be incorporated by reference in this report (not including exhibits to such incorporated information that are not specifically incorporated by reference into such information). Requests for such copies should be directed to us at the following address: ICON plc, South County Business Park, Leopardstown, Dublin 18, Ireland, D18 X5R3 Attention: Corporate Governance, email: corporate.governance@iconplc.com.

I.Subsidiary Information

Not applicable.

Exemptions From Corporate Governance Listing Requirements Under the NASDAQ Marketplace Rules

NASDAQ may provide exemptions from certain NASDAQ corporate governance standards to a foreign private issuer if, among other reasons those standards are contrary to a law, rule or regulation of a public authority exercising jurisdiction over such issuer or contrary to generally accepted business practices in the issuer’s home country of domicile, provided, that, the foreign private issuer properly notifies NASDAQ and makes the required disclosure except to the extent that such exemptions would be contrary to United States federal securities laws.

The exemptions that the Company relies on, and the practices the Company adheres to, are as follows:

The Company is exempt from provisions set forth in NASDAQ Rule 5620(c), which requires each issuer (other than limited partnerships) to provide for a quorum in its by-laws for any meeting of the holders of common stock, which shall in no case be less than 33.33% of the outstanding shares of the issuer’s common voting stock. The Company’s Constitution requires that only 3 members be present, in person or by proxy, at a shareholder meeting to constitute a quorum. This quorum requirement is in accordance with Irish law and generally accepted business practices in Ireland.

The Company is exempt from provisions set forth in NASDAQ Rule 5635(c) which requires (other than for certain specified exceptions) shareholder approval prior to the establishment or material amendment of a stock option or purchase plan or other equity compensation arrangement made or materially amended, pursuant to which stock may be acquired by officers, Directors, employees or consultants. Irish law does not require shareholder approval with respect to equity compensation arrangements. Accordingly, the 2019 Consultants and Directors Restricted Share Unit Plan, the 2013 Employees Restricted Share Unit Plan and the amendments to the Employee Share Option Plan 2008 and Consultants Share Option Plan 2008 were adopted by the Board of Directors without shareholder approval.

The Company is exempt from provisions set forth in NASDAQ Rule 5605(b)(2), which requires independent Directors to hold regularly scheduled meetings at which only independent Directors are present. Irish law does not require independent Directors to hold regularly scheduled meetings at which only independent Directors are present. The Company holds regularly scheduled meetings which all of the Directors may attend and the Lead Independent Director may call meetings of the independent Directors and non-employee Directors of the Board, as appropriate, in accordance with the Lead Independent Director Charter.


Item 11. Quantitative and Qualitative Disclosures about Market Risk.

The principal market risks (i.e. risk of loss arising from adverse changes in market rates and prices) to which we are exposed include foreign currency risk and interest rate risk.

Foreign Currency Exchange Risk

We are subject to a number of foreign currency risks given the global nature of our operations. The principal foreign currency risks to which the business is subject to includes both foreign currency translation risk and foreign currency transaction risk.

Although domiciled in Ireland, we report our results in U.S. dollars. As a consequence, the results of our non-U.S. based operations, when translated into U.S. dollars, could be affected by fluctuations in exchange rates between the U.S. dollar and the currencies of those operations.

89


We are also subject to foreign currency transaction exposures as the currency in which our contracts are priced can be different from the currencies in which costs relating to those contracts are incurred. Our operations in the United States are not materially exposed to such currency differences as the majority of revenues and costs are in U.S. dollars. However, outside the United States the multinational nature of our activities means that contracts may be priced in a single currency, most often U.S. dollars, or euro, while costs arise in a number of currencies, depending, among other things, on which of our offices provide staff for the contract and the location of investigator sites. Although many such contracts benefit from some degree of natural hedging due to the matching of contract revenues and costs in the same currency, where costs are incurred in currencies other than those in which contracts are priced, fluctuations in the relative value of those currencies could have a material effect on our results of operations. We regularly review our foreign currency exposures and enter into forward currency contracts to manage our exposure. We had no open foreign currency contracts at December 31, 2022.

The following significant exchange rates applied during the year:

Average RateClosing Rate
2022202120222021
Euro:USD1.05121.1886 1.07051.1370 
Pound Sterling:USD1.23471.3788 1.20831.3532 
Interest Rate Risk

We are exposed to interest rate risk in respect of our cash and cash equivalents and available for sale investments. Our treasury function actively manages our available cash resources and invests surplus cash balances to ensure optimum returns for the Company. Financial instruments are classified either as cash and cash equivalents or available for sale investments depending upon the maturity of the related investment. Funds may be invested in the form of floating rate notes and medium term minimum “A-” rated corporate securities. We may be subject to interest rate risk in respect of interest rate changes on amounts invested. Interest rate risk is managed by monitoring the composition of the Company’s investment portfolio on an ongoing basis having regard to current market interest rates and future trends.

Because the Company has variable rate debt, fluctuations in interest rates affect our business. We attempt to minimize interest rate risk and lower our overall borrowing costs through the utilization of interest rate cap and interest rate swap derivative agreements. We have entered into certain interest rate cap and interest rate swap agreements with three financial institutions with respect to a portion of our outstanding debt. Accordingly, any change in market value associated with these agreements is offset by the opposite market impact on the portion of the debt covered by such agreements. As December 31, 2022, we have interest rate cap agreements with a notional value of $2.1 billion to minimize interest rate risk on approximately $4.7 billion of variable rate indebtedness. Because we do not attempt to hedge all of our variable rate debt, we may incur higher interest costs for the portions of our unhedged debt.

We regularly evaluate our debt arrangements, as well as market conditions, and we will explore the opportunity to modify our existing arrangements or pursue additional financing arrangements that may result in the issuance of new debt securities by us or our affiliates.

The sensitivity analysis below represents the hypothetical change in the net interest payable of a 1% movement in market interest rates. 

Interest for the year ended December 31, 2022 (in thousands)Interest
Change 1% increase in
market interest rate
(in thousands)
Interest
Change 1% decrease in
market interest rate
(in thousands)
Interest income$2,345 $8,322 $1 
Interest expense*($229,731)($277,546)($181,982)
 ($227,386)($269,224)($181,981)

*8% of the interest costs fixed due to high yield bond issuance. $20.5 million financing fees have been allocated to interest cost which are not impacted by a change in interest rate.

Item 12. Description of Securities Other than Equity Securities.

Not applicable.


90


Part II

Item 13. Defaults, Dividend Arrearages and Delinquencies.

None.

Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds.

None.

Item 15. Controls and Procedures.

A.Disclosure controls and procedures

An evaluation was carried out under the supervision and with the participation of the Company's management, including the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), of the effectiveness of our disclosure controls and procedures as at December 31, 2022. Based on that evaluation, the CEO and CFO have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

B.Management's Annual Report on Internal Accounting Control over Financial Reporting

Reference is made to page 95 of this Form 20-F.

C.Attestation Report of Independent Registered Public Accounting Firm

Reference is made to page 98 of this Form 20-F.

D.Changes in Internal Controls over Financial Reporting

There were no changes in our internal controls over financial reporting during the period covered by this Form 20-F that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

Item 16. Reserved.


Item 16A. Audit Committee Financial Expert

Mr. Rónán Murphy acts as the Audit Committee financial expert serving on our Audit Committee and Board of Directors. The Board has determined that Mr. Murphy is independent.

Item 16B. Code of Ethical Conduct

Our Global Code of Ethical Conduct applies to all officers, directors (including a non-executive director when carrying out their duties as a director of ICON plc), and employees of ICON plc, its subsidiaries and branches. There are no waivers from the provisions of the Code of Ethical Conduct that are required to be disclosed. This Code of Ethical Conduct is available on our website at: https://investor.iconplc.com/corporate-governance/governance-documents.














91


Item 16C. Principal Accountant Fees and Services

Our principal accountants for the years ended December 31, 2022 and December 31, 2021 were KPMG, Dublin, Ireland (Audit firm ID: 1116). The table below summarizes the fees for professional services rendered by KPMG for the audit of our annual financial statements for the years ended December 31, 2022 and December 31, 2021 and fees billed for other services rendered by KPMG.
Year ended
December 31, 2022
(in thousands)
Year ended
December 31, 2021
(in thousands)
Audit fees (1)$4,680 47.1 %$2,906 32.0 %
Audit related fees (2)34 0.4 %2,113 23.2 %
Tax fees (3)5,219 52.5 %4,066 44.8 %
All other fees (4)— — %— — %
 
Total
$9,933 100 %$9,085 100 %
    
(1) Audit fees include annual audit fees for the Company and its subsidiaries.

(2) Audit related fees principally consist of fees for financial due diligence services, fees for the audit of employee benefit plans and fees for pension reviews.

(3) Tax fees are fees for tax compliance and tax consultation services.

(4) All other fees include the aggregate fees billed for products and services other than the services reported in items (1) through (3) above. There were no other fees amounts billed to the company in the years ended December 31, 2022 and December 31, 2021.

The Audit Committee pre-approves all audit and non-audit services provided to the Company by its auditors.

Item 16D. Exemptions from the Listing Standards for Audit Committees

Not applicable.

92


Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

In the year ended December 31, 2022, 420,530 ordinary shares were redeemed by the Company for a total consideration of $100.0 million. All ordinary shares that are redeemed under the buyback program were canceled in accordance with the constitutional documents of the Company and the nominal value of these shares transferred to an undenominated capital fund as required under Irish Company law.

 Total Number
of Shares Purchased
Average Price Paid per ShareTotal Number
of Shares Purchased
Total Price
Paid for Shares Purchased (in thousands)
 
March 03/01/2022 - 03/31/2022420,530 $237.75 420,530 $99,983 
 420,530 $237.75 420,530 $99,983 

No ordinary shares were redeemed by the Company during the year ended December 31, 2021.

Under the repurchase programs, a broker purchased the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The programs are designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information, applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker were irrevocable and the trading decisions in respect of the repurchase programs were made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the programs. In addition, acquisitions under the programs may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the programs.


Item 16F. Changes in Registrant's Certifying Accountant

Not applicable.

Item 16G. Corporate Governance

See Item 10 "Exemptions from Corporate Governance Listing Requirements under the NASDAQ Marketplace Rules".

Item 16H. Mine Safety Disclosure

Not applicable.

Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

Part III

Item 17. Financial Statements.

See item 18.











93


Item 18. Financial Statements.

The following consolidated financial statements of ICON plc and its subsidiaries, and the independent registered public accounting firm's report thereon, are included in Part III, Item 18 of this Annual Report:

94


Management's Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.

The Company's internal control over financial reporting is a process designed by, or under the supervision of, the Company's executive and financial officers and effected by the Company's board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles.

A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorization of management and Directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of the inherent limitation due to, for example, the potential for human error or circumvention of control, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2022. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework 2013. Based upon the assessment performed, we determined that, as of December 31, 2022 the Company's internal control over financial reporting was effective. There have been no changes in the Company's internal control over financial reporting during 2022 that have materially affected, or are reasonably likely to affect materially, the Group's internal control over financial reporting.

KPMG, an independent registered public accounting firm, has audited the consolidated financial statements of ICON plc and subsidiaries as of and for the year ended December 31, 2022, included herein, and has issued an audit report on the effectiveness of our internal control over financial reporting, which is included below.

95


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors
ICON plc:
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of ICON plc and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operation, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three‑year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the three‑year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 24, 2023 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue recognition for clinical trial service contracts.

As discussed in Note 3 to the consolidated financial statements, the Company recognized revenue of US$7,741,386 thousand for the year ended 31 December 2022, a portion of which relates to clinical trial service revenue. As discussed in Note 2 to the consolidated financial statements, clinical trial service revenue is recognized over time, using an input measure, being total project costs (inclusive of third-party costs, principally pass-through/ reimbursable expenses) incurred at each reporting period as a percentage of forecasted total project costs, to measure progress towards satisfying the Company’s performance obligation. The transaction price is based on the contract or latest change order value, adjusted to reflect the estimated realizable contract value.

We identified the evaluation of revenue recognition for clinical trial service revenue as a critical audit matter. Complex and subjective auditor judgment was required to evaluate the Company’s estimate of total forecast project costs and the estimated realizable contract values.

The following are the primary procedures we performed to address this critical audit matter:

We evaluated the design and tested the operating effectiveness of certain internal controls related to the revenue process, including controls over total forecast project costs and estimated realizable contract values.

We tested the total forecast project costs and the realizable contract values for a selection of clinical trial service contracts, by evaluating:

96


direct costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the direct costs by comparing the amounts to source data
third-party costs incurred, both during the year and cumulative over the life of the contracts. We tested the accuracy and completeness of the third-party costs incurred by comparing the costs to invoices received
findings from interviews with operational personnel of the Company to assess progress to date, the estimate of remaining costs to be incurred and factors impacting the amount of time and costs to complete the selected contracts, including an understanding of the nature and complexity of the work to be performed
correspondence of amendments to the scope or contract value, if any, between the Company and the customer for the selected contracts as part of our evaluation of contract progress
quarterly movements in forecast project costs and project margins and investigating the reasons for those movements, and
the reasonableness of the Company’s adjustments from total contract value to arrive at realizable contract value. We confirmed total contract value with customers and compared the assumptions used to derive the adjustments from total contract value to realizable contract value to underlying records.

We also evaluated the Company’s methods, assumptions and data used to accurately estimate total forecast project costs and realizable contract values, by comparing historical estimates developed at contract inception to actual results for a selection of clinical trial service contracts.


(signed) KPMG

We have served as the Company’s auditor since 1990.

Dublin, Ireland

February 24, 2023






































97



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors

ICON plc:

Opinion on Internal Control Over Financial Reporting
We have audited ICON plc and subsidiaries’ (the Company) internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements), and our report dated February 24, 2023, expressed an unqualified opinion on those consolidated financial statements.


Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.



(signed) KPMG

Dublin, Ireland

February 24, 2023

98


ICON plc
CONSOLIDATED BALANCE SHEETS
 December 31, 2022December 31, 2021
ASSETS(in thousands)
Current Assets:  
Cash and cash equivalents$288,768 $752,213 
Available for sale investments (Note 8a)1,713 1,712 
Accounts receivable, net of allowance for credit losses (Note 4)1,731,388 1,342,770 
Unbilled revenue (Note 4)957,655 623,121 
Other receivables63,658 56,760 
Prepayments and other current assets137,094 114,323 
Income taxes receivable48,790 50,299 
Total current assets3,229,066 2,941,198 
Non-current Assets:
Property, plant and equipment, net (Note 9)350,320 336,444 
Goodwill (Note 10)8,971,670 9,037,931 
Intangible assets, net (Note 11)4,278,659 4,710,843 
Operating right-of-use assets (Note 15)153,832 198,123 
Other receivables70,790 70,557 
Income taxes receivable21,380 18,637 
Deferred tax asset (Note 20)76,930 48,392 
Equity method investments (Note 8c) 2,373 
Investments in equity-long term (Note 8b)32,631 22,592 
Total Assets$17,185,278 $17,387,090 
LIABILITIES AND SHAREHOLDERS’ EQUITY  
Current Liabilities:  
Accounts payable$81,194 $90,764 
Unearned revenue (Note 4)1,507,449 1,323,961 
Other liabilities (Note 12)1,005,025 949,629 
Income taxes payable41,783 59,433 
Current bank credit lines and loan facilities (Note 13)55,150 55,150 
Total current liabilities2,690,601 2,478,937 
Non-current Liabilities:  
Non-current bank credit lines and loan facilities (Note 13)4,599,037 5,381,162 
Lease liabilities (Note 15)131,644 159,483 
Non-current other liabilities (Note 16)38,260 42,596 
Non-current income taxes payable239,188 172,109 
Deferred tax liability (Note 20)988,585 1,085,976 
Commitments and contingencies (Note 17)  
Total Liabilities8,687,315 9,320,263 
Shareholders' Equity:  
Ordinary shares par value 6 euro cents per share;
100,000,000 shares authorized (Note 18)
  
81,723,555 shares issued and outstanding at December 31, 2022 and
81,554,683 shares issued and outstanding at December 31, 2021.
6,649 6,640 
Additional paid-in capital6,840,306 6,733,910 
Other undenominated capital (Note 18b)1,162 1,134 
Accumulated other comprehensive income (Note 25)(171,538)(90,937)
Retained earnings1,821,384 1,416,080 
Total Shareholders' Equity8,497,963 8,066,827 
Total Liabilities and Shareholders’ Equity$17,185,278 $17,387,090 
The accompanying notes are an integral part of these consolidated financial statements.
99


ICON plc
CONSOLIDATED STATEMENTS OF OPERATIONS
 Year Ended December 31,
 202220212020
 (in thousands, except share and per share data)
Revenue$7,741,386 $5,480,826 $2,797,288 
 
Costs and expenses:
   
Direct costs (excluding depreciation and amortization) 5,527,045 3,972,612 1,979,883 
Selling, general and administrative778,753 585,330 342,449 
Depreciation and amortization569,513 314,987 66,126 
Transaction and integration related (Note 6)39,695 198,263 (759)
Restructuring (Note 19)31,143 31,105 18,089 
Total costs and expenses6,946,149 5,102,297 2,405,788 
Income from operations795,237 378,529 391,500 
Interest income2,345 574 2,724 
Interest expense (Note 13)(229,731)(182,423)(13,019)
Income before income tax expense 567,851 196,680 381,205 
Income tax expense (Note 20)(59,411)(41,334)(47,875)
Income before share of earnings from equity method investments508,440 155,346 333,330 
Share of equity method investments(3,136)(2,161)(366)
Net Income505,304 153,185 332,964 
Net income attributable to noncontrolling interest  (633)
Net income attributable to the Group$505,304 $153,185 $332,331 
Net income per Ordinary Share attributable to the Group (Note 24):
Basic$6.20 $2.28 $6.20 
Diluted$6.13 $2.25 $6.15 
Weighted average number of ordinary shares outstanding:   
Basic (Note 2)81,532,320 67,110,186 52,859,911 
Diluted (Note 2)82,468,363 68,068,311 53,283,585 
The accompanying notes are an integral part of these consolidated financial statements.

100


ICON plc
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 Year Ended December 31,
 202220212020
 (in thousands)
Net income $505,304 $153,185 $332,964 
Other comprehensive income, net of tax
Currency translation adjustment(89,530)(60,617)46,526 
Unrealized capital loss - investments  (231)
Actuarial gain/(loss) on defined benefit pension plan12,657 4,266 (4,138)
Amortization of cash flow hedge 113 (910)
(Loss)/gain on cash flow hedge(3,728)778 (905)
Total comprehensive income424,703 97,725 373,306 
Less net income attributable to noncontrolling interest  (633)
Total comprehensive income attributable to the Group$424,703 $97,725 $372,673 
    The accompanying notes are an integral part of these consolidated financial statements.
101


ICON plc
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME
(in thousands, except share and per share data)
Group
SharesAmountAdditional
Paid-in
Capital
Other
Undenominated
Capital
Accumulated
Other
Comprehensive
Income
Retained
Earnings
TotalRedeemable Noncontrolling Interest
Balance at January 1, 202053,622,206 $4,635 $577,961 $1,052 $(75,819)$1,110,226 $1,618,055 $39,510 
Comprehensive Income (net of tax):       — 
Net income— — — — — 332,331 332,331 633 
Currency translation adjustment— — — — 46,526 — 46,526 — 
Unrealized capital loss - investments— — — — (231)— (231)— 
Actuarial loss on defined benefit pension plan— — — — (4,138)— (4,138)— 
Amortization of cash flow hedge— — — — (910)— (910)— 
Loss on cash flow hedge— — — — (905)— (905)— 
Total comprehensive income372,673 
Exercise of share options193,417 13 13,176 — — — 13,189 — 
Issue of restricted share units / performance share units207,688 14 — — — — 14 — 
Share based compensation expense— — 25,981 — — — 25,981 — 
Share issue costs— — (14)— — — (14)— 
Repurchase of ordinary shares(1,235,218)(82)— 82 — (175,000)(175,000)— 
Share repurchase costs— — — — — (140)(140)— 
Noncontrolling interest adjustment to redemption amount— — — — — (4,522)(4,522)4,522 
Exercise of call option on noncontrolling interest shares— — — — — — — (44,665)
Balance at December 31, 202052,788,093 $4,580 $617,104 $1,134 $(35,477)$1,262,895 $1,850,236  
The accompanying notes are an integral part of these consolidated financial statements.
102


ICON plc
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME
(in thousands, except share and per share data)
Group
SharesAmountAdditional
Paid-in
Capital
Other
Undenominated
Capital
Accumulated
Other
Comprehensive
Income
Retained
Earnings
Total
Balance at December 31, 202052,788,093 $4,580 $617,104 $1,134 $(35,477)$1,262,895 $1,850,236 
Comprehensive income (net of tax):
Net income— — — — — 153,185 153,185 
Currency translation adjustment— — — — (60,617)— (60,617)
Actuarial gain on defined benefit pension plan— — — — 4,266 — 4,266 
Amortization of cash flow hedge— — — — 113 — 113 
Settlement of cash flow hedge— — — — 778 — 778 
Total comprehensive income97,725 
Exercise of share options1,065,529 77 118,512 — — — 118,589 
Issue of restricted share units / performance share units328,634 23 — — — — 23 
Share based compensation expense— — 133,553 — — — 133,553 
Share issue costs— — (853)— — — (853)
Issue of shares associated with a business combination27,372,427 1,960 5,656,195 — — — 5,658,155 
Replacement share-based awards issued to acquiree employees— — 209,399 — — — 209,399 
Balance at December 31, 202181,554,683 $6,640 $6,733,910 $1,134 $(90,937)$1,416,080 $8,066,827 
                        
The accompanying notes are an integral part of these consolidated financial statements.









103


ICON plc
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME
(in thousands, except share and per share data)
Group
SharesAmountAdditional
Paid-in
Capital
Other
Undenominated
Capital
Accumulated
Other
Comprehensive
Income
Retained
Earnings
Total
Balance at December 31, 202181,554,683 $6,640 $6,733,910 $1,134 $(90,937)$1,416,080 $8,066,827 
Comprehensive income (net of tax):
Net income— — — — — 505,304 505,304 
Currency translation adjustment— — — — (89,530)— (89,530)
Actuarial gain on defined benefit pension plan— — — — 12,657 — 12,657 
Loss on cash flow hedge— — — — (3,728)— (3,728)
Total comprehensive income424,703 
Exercise of share options348,286 21 35,807 — — — 35,828 
Issue of restricted share units / performance share units241,116 16 — — — — 16 
Share based compensation expense— — 70,606 — — — 70,606 
Share issuance costs— — (17)— — — (17)
Repurchase of ordinary shares(420,530)(28)— 28 — (99,983)(99,983)
Share repurchase costs— — — — — (17)(17)
Balance at December 31, 202281,723,555 $6,649 $6,840,306 $1,162 $(171,538)$1,821,384 $8,497,963 
The accompanying notes are an integral part of these consolidated financial statements.
104


ICON plc
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended December 31,
202220212020
Cash flows from operating activities:(in thousands)
Net income$505,304 $153,185 $332,964 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense569,513 314,987 66,126 
Impairment of long lived assets28,767 20,037 5,411 
Reduction in carrying value of operating right-of-use assets45,215 45,339 28,480 
Loss on equity method investments3,136 2,161 366 
Amortization of financing costs and debt discount17,749 12,890 523 
Stock compensation expense70,523 133,844 26,271 
Loss on extinguishment of debt 14,434  
Loss on issuance of debt 59,460  
Deferred tax (benefit)/expense(124,985)(60,616)927 
Unrealized foreign exchange (gain)/loss(13,009)(6,054)5,979 
Other non-cash items11,324 4,480 (7,859)
Changes in operating assets and liabilities:
Accounts receivable(420,695)113,513 (175,040)
Unbilled revenue(332,592)(17,656)(5,748)
Unearned revenue192,944 (69,121)291,844 
Other net assets10,121 108,259 (2,209)
Net cash provided by operating activities563,315 829,142 568,035 
Cash flows from investing activities:
Purchase of property, plant and equipment(142,160)(93,750)(40,885)
Purchase of subsidiary undertakings (net of cash acquired) (5,914,475)(47,931)
Investment in equity method investments (2,450)(2,450)
Loan to equity method investment (10,000) 
Sale of available for sale investments481 497 47,902 
Purchase of available for sale investments(482)(480) 
Proceeds from investments in equity - long term1,906 500 87 
Purchase of investments in equity - long term(5,612)(4,077)(3,299)
Net cash used in investing activities(145,867)(6,024,235)(46,576)
Cash flows from financing activities:
Financing costs (30,328)(1,554)
Drawdown of credit lines and facilities75,000 5,905,100 350,000 
Repayment of credit lines and facilities(875,000)(877,780)(350,000)
Purchase of noncontrolling interest  (43,923)
Proceeds from the exercise of equity compensation35,844 118,589 13,203 
Share issue costs(17)(853)(14)
Repurchase of ordinary shares(99,983) (175,000)
Share repurchase costs(17) (140)
Settlement of cash flow hedge  (905)
Net cash (used in)/provided by financing activities(864,173)5,114,728 (208,333)
Effect of exchange rate movements on cash(16,720)(7,727)6,870 
Net (decrease)/increase in cash and cash equivalents(463,445)(88,092)319,996 
Cash and cash equivalents at beginning of year752,213 840,305 520,309 
Cash and cash equivalents at end of year288,768 752,213 840,305 
The accompanying notes are an integral part of these consolidated financial statements.
105


ICON plc
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

1. Description of Business

ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.

We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December 31, 2022 we had approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December 31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.

ICON’s ordinary shares are traded on the NASDAQ Global Select Market under the symbol “ICLR”.

We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.

2. Summary of Significant Accounting Policies

The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.

Basis of consolidation

The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.
 
Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.

Disclosure of fair value of financial instruments

Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.

Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
106


The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements – quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.

Business combinations

The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.

Foreign currencies and translation of subsidiaries

The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income.

Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:

Year ended
December 31,
 202220212020
(in thousands)
 
Amounts (credited)/charged
$(25,997)$(14,316)$5,979 
    
Revenue recognition

The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.


107


Clinical trial service revenue

A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

Laboratory services revenue

Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

Contracting services revenue

The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.

Consulting services revenue

Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

Data services revenue

The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above.
108


At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

Commissions

Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.

Reimbursable expenses

Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.

Direct costs

Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.

Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.

Cash and cash equivalents

Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.

Investments in debt, equity and other

Available for sale investments

The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification

Long term investments

The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2021 and December 31, 2022 qualify for the NAV practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.

Equity method investments

The Company’s investments that are not consolidated are accounted for under the equity method if the Company exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.


109


Accounts receivable, net and unbilled revenue    
    
Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.

Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.

Accounts receivable early payment discounting

Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 'Transfers and Servicing' (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.

Property, plant and equipment

Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: 
 Years
Building  40
Computer equipment and software
2-8
Office furniture and fixtures8
Laboratory equipment  5
Motor vehicles5
    
Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.

Leases

The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December 31, 2022 and December 31, 2021, the Company did not account for any leases as finance leases.
    Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.
The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.
Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.

In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.

110


ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, Property, Plant, and Equipment – Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.

Intangible assets

Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

Estimated Useful Life
Customer relationships23 years
Order backlog3 years
Trade names3 years
Patient database7 years
Technology assets5 years

The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.

Impairment of goodwill and long-lived assets

Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.

Debt issuance costs

Debt issuance costs relating to the Company’s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company’s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.

Derivative financial instruments

The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts.

Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income
111


and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.

The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.

Income taxes

The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.

Government grants

Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.

Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.

Research and development credits

Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.

Pension costs

The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.

The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 'Defined Benefit Plans – Pension'. These plans are presented in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.

Share-based compensation

The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 'Compensation – Stock Compensation'. Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.
Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on
112


the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.
Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.

Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled.

Replacement awards

In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.

Transaction and integration-related expenses

Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.

Restructuring

Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company’s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset’s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.

Redeemable noncontrolling interests and equity

The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 'Distinguishing Liabilities from Equity'. On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova.

Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.

Net income per ordinary share

Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.



113


Reclassifications
Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period’s presentation.
Impact of Recently Issued or Adopted Accounting Standards 
No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company’s consolidated financial statements.

3. Disaggregation of Revenue
Revenue disaggregated by customer profile is as follows:
Year ended
December 31, 2022December 31, 2021December 31, 2020
(in thousands)
Top client$683,546 $441,173 $337,904 
Clients 2-51,506,087 1,291,946 754,906 
Clients 6-101,112,636 752,325 350,865 
Clients 11-251,585,739 1,077,073 501,643 
Other2,853,378 1,918,309 851,970 
Total$7,741,386$5,480,826$2,797,288
Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.

4. Contract Balances

Accounts receivable and unbilled revenue are as follows:
December 31, 2022December 31, 2021
(in thousands)
Billed services (accounts receivable)$1,751,950 $1,349,851 
Allowance for credit losses (note 5)(20,562)(7,081)
Accounts receivable (net)1,731,388 1,342,770 
Unbilled services (unbilled revenue)$957,655 $623,121 
Accounts receivable and unbilled revenue, net$2,689,043 $1,965,891 

Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
(in thousands, except percentages)December 31, 2022December 31, 2021$ Change% Change
Unbilled services (unbilled revenue)$957,655 $623,121 $334,534 53.7 %
Unearned revenue (payments on account)(1,507,449)(1,323,961)(183,488)13.9 %
Net balance$(549,794)$(700,840)$151,046 21.6 %

114


Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.

The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December 31, 2022 and December 31, 2021 were $406.3 million and $323.6 million (see note 12 - Other liabilities).

Unbilled services as at December 31, 2022 increased by $334.5 million as compared to December 31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2021 and December 31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.

The credit loss expense recognized on the Group's receivables and unbilled services was $17.8 million and $0.9 million for the twelve months ended December 31, 2022 and 2021, respectively.

As of December 31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3 billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.

5. Allowance for Credit Losses
The Company does business with most major international pharmaceutical companies. Provision for credit losses at December 31, 2022 and December 31, 2021 comprises:
December 31, 2022December 31, 2021
 (in thousands)
Opening provision$7,081 $7,149 
Amounts used during the year(3,913)(116)
Amounts provided during the year17,800 705 
Amounts released during the year (544)
Foreign exchange(406)(113)
 
Closing provision
$20,562 $7,081 
 






115


6. Business Combinations

PRA Health Sciences, Inc. Acquisition

On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations.

The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers’ commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.

Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021.

In the years ended December 31, 2022 and 2021, the Company incurred Merger-related expenses of $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the “Transaction and integration related” line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December 31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $0.8 million and $57.1 million, respectively.

The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the “Interest expense” line item in the Consolidated Statement of Operations for the year ended December 31, 2021. During the year ended December 31, 2021, the Company deferred $76.2 million of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.

The Merger Date fair value of the consideration transferred consisted of the following:

 (in thousands)
Fair value of cash consideration5,308,646 
Fair value of ordinary shares issued to acquiree stockholders5,658,126 
Fair value of replacement share-based awards issued to acquiree employees209,399 
Repayment of term loan obligations and accrued interest *865,800 
12,041,971 
* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.


116


The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:

July 1,
2021
(in thousands)
Cash and cash equivalents$259,971 
Accounts receivable and unbilled revenue934,308 
Other current assets125,156 
Fixed assets156,851 
Operating lease right-of-use assets180,601 
Goodwill *8,084,314 
Intangible assets4,919,000 
Deferred tax assets25,190 
Other assets33,928 
Accounts payable(50,259)
Accrued expenses and other current liabilities(380,048)
Current portion of operating lease liabilities(36,506)
Unearned revenue(739,278)
Non-current portion of operating lease liabilities(147,204)
Deferred tax liabilities(1,119,762)
Other non-current liabilities(204,291)
Net assets acquired$12,041,971 

* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.

The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):
Estimated Fair ValueEstimated Useful Life
Customer relationships3,938,000 23 years
Order backlog500,000 3 years
Trade names202,000 3 years
Patient database168,000 7 years
Technology assets111,000 5 years
4,919,000 

117


At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:
Measurement period adjustments
(in thousands)
Cash and cash equivalents$ 
Accounts receivable and unbilled revenue 
Other current assets14,465 
Fixed assets(6,137)
Operating lease right-of-use assets(11,744)
Goodwill70,436 
Intangible assets *44,000 
Deferred tax assets(147,039)
Other assets(1,166)
Accounts payable 
Accrued expenses and other current liabilities(37,496)
Current portion of operating lease liabilities1,865 
Unearned revenue **19,623 
Non-current portion of operating lease liabilities10,454 
Non-current deferred tax liabilities193,837 
Other non-current liabilities(151,098)
* In the year ended December 31, 2022, the Company incurred $2.2 million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.

** The unearned revenue measurement period adjustment also includes $16.0 million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.

7. Fair Value

The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.

The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments.











118


As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
Assets:
Available for sale securities (short-term) (a)1,713    1,713 
Available for sale investments (long-term) (b)   32,663 32,663 
Derivative instruments (c) 12   12 
Total assets$1,713 $12 $ $32,663 $34,388 
Liabilities:
Derivative instruments (c) 3,670   3,670
Total Liabilities$ $3,670 $ $ 3,670

As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):

Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
Assets:
Available for sale securities (short-term) (a)1,712$ $  1,712
Available for sale investments (long-term) (b) $ $ 20,57920,579
Total assets$1,712 $ $ $20,579 $22,291 

(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

(c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.

Non-recurring Fair Value Measurements

Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December 31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,250.4 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,971.7 million and identifiable intangible assets, net of $4,278.7 million.

As of December 31, 2022 and 2021, the fair value of total debt approximated $4,650.3 million and $5,507.2 million, respectively, as determined under Level 2 measurement for these financial instruments.

119


8. Investments

(a)     Available for sale investments (short-term)
The Company held $1.7 million of available for sale investments at both December 31, 2022 and December 31, 2021. The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits.
Short term investments at December 31, 2022 have an average maturity of 2.8 years compared to 2.7 years at December 31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.

(b)    Available for sale investments (long-term)

The Company entered into subscription agreements with a number of funds. Capital totaling $20.6 million had been advanced under the terms of the subscription agreements at December 31, 2022 (December 31, 2021: $16.9 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 qualify for the NAV practical expedient in ASC 820 'Fair value measurements and disclosures'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $6.3 million (December 31, 2021: $3.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $32.6 million at December 31, 2022 (December 31, 2021: $22.6 million). At December 31, 2022, the Company had committed to future investments of $23.3 million in respect of these funds.

(c)     Equity method investments

The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company’s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations.

The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.

The following table represents our equity method investments at December 31, 2022:
Ownership PercentageCarrying ValueCarrying Value
December 31, 2022December 31, 2022December 31, 2021
(in thousands)
Oncacare Limited49 %$ $2,373 

During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025.

The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. The outstanding balance of the Company's loan receivable with Oncacare at December 31, 2022 is $9.2 million.

120


9. Property, Plant and Equipment, net

The carrying amount of Property, Plant and Equipment for the years ended December 31, 2022 and 2021 is as follows:
December 31, 2022December 31, 2021
 (in thousands)
Cost  
Land$3,724 $3,724 
Building70,880 82,017 
Computer equipment and software500,135 506,322 
Office furniture and fixtures50,600 107,507 
Laboratory equipment59,946 29,210 
Leasehold improvements65,167 70,123 
Motor vehicles41 65 
 750,493 798,968 
Less accumulated depreciation and asset write offs(400,173)(462,524)
Property, plant and equipment (net)$350,320 $336,444 

Property, Plant and Equipment depreciation expense is as follows:
December 31, 2022December 31, 2021
 (in thousands)
Depreciation expense$106,426 $75,484 

The Company regularly updates its register of property, plant and equipment and during the year ended December 31, 2022 and the year ended December 31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.


10. Goodwill

The change in the carrying amount of Goodwill for the years ended December 31, 2022 and 2021 is as follows:
December 31, 2022December 31, 2021
 (in thousands)
Opening goodwill$9,037,931 $936,257 
Current year acquisitions (note 6) 8,120,006 
Prior period acquisition (note 6)(35,692) 
Foreign exchange movement(30,569)(18,332)
Closing goodwill$8,971,670 $9,037,931 

There were no goodwill impairment losses for the years ended December 31, 2022 and 2021.

121


11. Intangible Assets

The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:
December 31, 2022December 31, 2021
Cost(in thousands)
Customer relationships$4,076,435 $4,056,642 
Order backlog536,934 528,022 
Trade names & brands204,621 204,685 
Patient database170,238 170,525 
Technology assets120,984 121,507 
Total cost5,109,212 5,081,381 
Accumulated amortization(830,553)(370,538)
 
Net book value
$4,278,659 $4,710,843 
On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0 million, Order backlog of $500.0 million, Trade names of $202.0 million, Patient database of $168.0 million and Technology assets of $111.0 million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets were finalized in June 30, 2022. In total, $677.1 million has been amortized in the period since the date of acquisition, $453.6 million has been amortized in the year ended December 31, 2022.

Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows:
 Year Ended
December 31, 2022
(in thousands)
2023$460,711 
2024339,940 
2025223,674 
2026209,681 
2027198,300 
 $1,432,306 

122


12. Other Liabilities

The carrying amount of Other Liabilities for the years ended December 31, 2022 and 2021 is as follows:
December 31, 2022December 31, 2021
 (in thousands)
General trade and overhead liabilities*$530,204 $459,814 
Personnel related liabilities395,862 413,185 
Operating lease liabilities43,657 49,949 
Facility related liabilities16,896 12,055 
Other liabilities12,852 7,204 
Restructuring liabilities5,512 7,377 
Short term government grants42 45 
 $1,005,025 $949,629 

*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December 31, 2022 and $323.6 million at December 31, 2021.



13. Non-current Bank Credit Lines and Loan Facilities

The Company had the following debt outstanding as of December 31, 2022 and 2021:

Principal amount
Interest rate as ofInterest rate as ofDecember 31,December 31,
(in thousands)December 31, 2022December 31, 202120222021Maturity Date
Credit Facilities:
Senior Secured Term Loan7.092 %2.750 %$4,201,213 $5,001,213 July 2028
Senior Secured Notes
2.875 %2.875 %500,000 500,000 July 2026
Total debt4,701,213 5,501,213 
Less current portion of long-term debt and debt issuance costs(55,150)(55,150)
Total long-term debt4,646,063 5,446,063 
Less long-term portion of debt issuance costs and debt discount
(47,026)(64,901)
Total long-term debt, net$4,599,037 $5,381,162 

The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.


123


The Company incurred interest costs from various financing arrangements during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December 31, 2022 and December 31, 2021, the Company expensed $17.7 million and $86.7 million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.

Year ended
December 31, 2022December 31, 2021December 31, 2020
(in thousands)
Interest expense on drawn facilities$209,189 $93,809 $13,406 
Amortization of financing costs17,749 12,890 523 
Transaction and one time financing costs 75,391  
Other financing costs/(credits)2,793 333 (910)
Total financing costs$229,731 $182,423 $13,019 

As of December 31, 2022, the contractual maturities of the Company's debt obligations were as follows:

Current maturities of long-term debt:(in thousands)
202355,150 
202455,150 
202555,150 
202655,150 
2027 and thereafter4,480,613 
Total$4,701,213 

The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").

Senior Secured Credit Facilities

In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA’s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin. On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement.

Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.

The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $300.0 million remained undrawn under the senior secured revolving loan facility.

124


The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.

On December 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $66.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.8 million.

On September 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $53.6 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.9 million.

On June 30, 2022, the Company repaid $100.0 million of the senior secured term loan facility and made a quarterly interest payment of $39.4 million. This repayment resulted in an additional charge associated with previously capitalized fees of $0.9 million.

On March 31, 2022, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $35.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $3.2 million.

On December 29, 2021, the Company repaid $500.0 million of the senior secured term loan facility and made a quarterly interest payment of $40.8 million. This repayment resulted in an additional charge associated with previously capitalized fees of $5.6 million.

On September 27, 2021, the Company repaid $13.8 million of the senior secured term loan facility and made a quarterly interest payment of $40.4 million.

Senior Secured Notes

In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026.

Fair Value of Debt
The estimated fair value of the Company’s debt was $4,650.3 million and $5,507.2 million at December 31, 2022 and December 31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.

14. Derivatives

The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.

On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%.

On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.

The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.

The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income.

125


The fair value of the Company’s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:

December 31, 2022
AssetLiabilityNotional
(in thousands)
Derivatives designated as hedging instruments:
Interest Rate CapsOther Assets and Liabilities$12$3,3632,100,606
Interest Rate SwapOther Assets and Liabilities$$3071,100,606
Total derivatives designated as hedging instruments$12$3,6703,201,213

During 2023, the Company estimates that an additional $3.3 million will be reflected as interest expense in the consolidated statements.

At December 31, 2021 the fair value of the Company's derivative financial instruments was $nil as the Company had no outstanding derivative financial instruments.

The Company recognized $0.1 million of gain within OCI and reclassified $0.1 million of gain from OCI to the income statement for the year end December 31, 2022.

15. Operating Leases
Lease costs recorded under operating leases as of December 31, 2022 and 2021 were as follows:
Year ended
December 31, 2022December 31, 2021
(in thousands)
Operating lease costs$53,880 $51,200 
Income from sub-leases(1,165)(1,338)
Net operating lease costs$52,715 $49,862 
Of the total cost of $52.7 million incurred in the year ended December 31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9 million incurred in the year ended December 31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.
Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December 31, 2022 and December 31, 2021 totaled $28.7 million and $10.2 million, respectively.
During the years ended December 31, 2022 and December 31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $24.8 million and $15.4 million, respectively, as part of an office consolidation program (see note 19 - Restructuring Charges).
The weighted average remaining lease term and weighted-average discount rate at December 31, 2022 were 6.90 years and 2.45%, respectively. The weighted average remaining lease term and weighted-average discount rate at December 31, 2021 were 6.91 years and 2.51%, respectively.
126


Future minimum lease payments under non-cancelable leases as of December 31, 2022 were as follows:
Minimum rental
payments
(in thousands)
2023$47,479 
202434,400 
202525,045 
202620,430 
202717,249 
Thereafter45,065 
Total future minimum lease payments 189,668 
Lease imputed interest(14,367)
Total$175,301 
Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $43.7 million and $49.9 million have been included in other liabilities as at December 31, 2022 and December 31, 2021, respectively.

16. Non-current other liabilities

The carrying amount of Non-current other liabilities for the years ended December 31, 2022 and 2021 is as follows:

December 31, 2022December 31, 2021
 (in thousands)
Defined benefit pension obligations, net (note 21)$13,033 $16,262 
Other non-current liabilities25,227 26,334 
 $38,260 $42,596 

17. Commitments and Contingencies

Litigation

We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

Operating Leases

The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See note 15 - Operating leases for rental expense pursuant to ASC 842 for the years ended December 31, 2022 and December 31, 2021 and future minimum rental commitments as of December 31, 2022.

18. Share Capital

Holders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote.


127


(a)Employee share based payments

During the year ended December 31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December 31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.

During the year ended December 31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December 31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.

On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company’s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.

    During the year ended December 31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December 31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.
 
(b)Share Repurchase Program

A resolution was passed at the Company’s Annual General Meeting (“AGM”) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022. On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1 million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0 million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6 million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3 million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0 million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.

All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.

Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.













128


19. Restructuring Charges

A restructuring charge of $31.1 million was recognized during the year ended December 31, 2022 under a restructuring plan adopted following a review of operations. The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $2.7 million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $24.5 million and fixed asset impairment of $4.0 million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.
 Year Ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Restructuring charges$31,143 $31,105 $18,089 
 
Net charge
$31,143 $31,105 $18,089 

At December 31, 2022, a total liability of $6.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $1.4 million of facilities related liabilities of which $0.9 million is included within other liabilities and $0.5 million is included within non-current other liabilities. The remaining provision of $4.6 million relates to workforce reduction and is included within other liabilities.

Year Ended
December 31, 2022December 31, 2021
(in thousands)
Opening provision$10,311 $4,675 
Additional provision in the year4,364 11,273 
Utilization(8,653)(5,637)
Ending provision$6,022 $10,311 


20. Income Taxes

The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.

The components of income before income tax expense are as follows:
 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Ireland$432,963 $231,893 $280,310 
United States(270,440)(278,413)41,950 
Other405,328 243,200 58,945 
 
Income before income tax expense
$567,851 $196,680 $381,205 

    

129


The components of income tax expense are as follows:
 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Income tax expense:   
Current tax expense:   
Ireland$53,248 $18,469 $28,963 
United States60,753 35,478 3,022 
Other70,395 48,003 14,963 
 
Total current tax expense
184,396 101,950 46,948 
Deferred tax (benefit)/expense:   
Ireland(6,166)553 1,654 
United States(118,475)(52,717)4,577 
Other(344)(8,452)(5,304)
 
Total deferred tax (benefit)/expense
(124,985)(60,616)927 
Income tax expense allocated to continuing operations59,411 41,334 47,875 
Income tax expense was allocated to the following components of other comprehensive income:   
Currency impact on long term funding7,211 1,776 68 
Total$66,622 $43,110 $47,943 

Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:

 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)$70,980 $24,586 $47,651 
Rate differential from amortization of intangible assets(59,330)(31,228)(2,298)
Foreign and other income taxed at higher rates52,464 51,273 10,241 
Research & development tax incentives(2,608)(3,120)(1,243)
Movement in valuation allowance(777)3,101 3,581 
Effects of change in tax rates(300)(128)108 
Change in unrecognized tax benefits8,392 5,246 (1,672)
Impact of stock compensation(8,756)(9,083)(5,150)
Other(654)687 (3,343)
 
Income tax expense
$59,411 $41,334 $47,875 

    

130


The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:
December 31, 2022December 31, 2021
 (in thousands)
Deferred tax liabilities:  
Property, plant and equipment$10,927 $19,606 
Operating right-of-use-assets23,260 33,449 
Goodwill37,150 33,354 
Intangible assets1,078,302 1,201,086 
Other9,054 1,761 
 
Total deferred tax liabilities recognized
1,158,693 1,289,256 
Deferred tax assets:  
Operating loss and tax credits carryforwards88,697 86,893 
Property, plant and equipment6,010 5,846 
Operating lease liabilities27,593 36,106 
Intangible assets3,602 4,596 
Accrued expenses and unbilled revenue64,016 69,198 
Stock compensation21,862 25,557 
Deferred compensation 2,917 3,445 
Unearned revenue66,565 64,924 
Other9,155 602 
Total deferred tax assets290,417 297,167 
Valuation allowance for deferred tax assets(43,379)(45,495)
Deferred tax assets recognized247,038 251,672 
 
Overall net deferred tax asset/(liability)
$(911,655)$(1,037,584)


At December 31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.6 million.

At December 31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $5.4 million and $401.9 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $5.4 million U.S. federal NOLs, approximately $3.5 million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $5.3 million are limited by Section 382 for the years 2023 - 2036. As of December 31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $93.0 million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years.


131


    The expected expiry dates of the US NOLs are as follows: 
Federal
NOL's
State
NOL's
 
(in thousands)   
2023-2036$5,268 $249,530 
2033-2041 145,632 
Indefinite95 6,736 
 $5,363 $401,898 
    
In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.

At December 31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $37.9 million. At December 31, 2022 those subsidiaries also had additional operating loss carryforwards of $14.8 million which are due to expire between 2023 and 2029 and operating loss carryforwards of $18.2 million which are due to expire between 2030 and 2039. In addition, at December 31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.7 million.

The valuation allowance at December 31, 2022 was approximately $43.4 million. The valuation allowance for deferred tax assets as of December 31, 2021 and December 31, 2020 was $45.5 million and $32.8 million respectively. The net change in the total valuation allowance was a decrease of $2.1 million during 2022 and an increase of $12.8 million during 2021. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expense and a decrease of $1.3 million was recognized in Other Comprehensive Income. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of an acquired entity, $4.4 million was recognized within income tax expenses, and $0.9 million was recognized in Other Comprehensive Income.

The valuation allowances at December 31, 2022 and December 31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.

The Company has recognized a deferred tax liability of $1.6 million (2021: $0.8 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland’s tax treaty network and the EU parent subsidiary directive.

132


A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Unrecognized tax benefits at start of year$202,065 $19,078 $20,156 
Increase related to acquired tax positions170,047  
Increase related to prior year tax positions16,098 204 401 
Decrease related to prior year tax positions(5,442)(1,695)(1,271)
Increase related to current year tax positions5,701 18,613 2,931 
Settlements (844)(369)
Lapse of statute of limitations(838)(3,338)(2,770)
 
Unrecognized tax benefits at end of year
$217,584 $202,065 $19,078 

The relevant statute of limitations for unrecognized tax benefits totaling $37.9 million could potentially expire during 2023.

Included in the balance of total unrecognized tax benefits at December 31, 2022 were potential benefits of $217.6 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December 31, 2021 and December 31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $202.1 million and $19.1 million respectively.

Interest and penalties recognized during the year ended December 31, 2022 amounted to a net charge of $7.1 million (2021: $1.9 million, 2020: ($0.6 million)) and are included within the income tax expense. Total accrued interest and penalties as of December 31, 2022 and December 31, 2021 were $22.6 million and $15.5 million respectively and are included in closing income taxes payable at those dates.

Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.
 
21. Employee Benefits

Defined Contribution Plans

Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation.

The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were $30.2 million, $23.7 million and $17.0 million respectively.

Pension and Postretirement Benefit Plans

The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:

December 31, 2022December 31, 2021
Other receivables$6,492 $ 
Non-current other liabilities (note 16)(13,033)(16,262)
133



In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $11.6 million and $8.0 million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively.

ICON Development Solutions Limited pension plan

One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022, December 31, 2021 and December 31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'. The plan has been closed to new entrants with effect from July 1, 2003.
Funded status
 
December 31, 2022December 31, 2021
 (in thousands)
Projected benefit obligation$(19,558)$(41,813)
Fair value of plan assets26,050 36,198 
 Funded status$6,492 $(5,615)

The funded status as at December 31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December 31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.
Change in benefit obligation
 
December 31, 2022December 31, 2021
 (in thousands)
Benefit obligation at beginning of year$41,813 $43,988 
Service cost117 134 
Interest cost672 665 
Plan participants' contributions19 23 
Benefits paid(514)(489)
Actuarial gain(18,636)(2,097)
Foreign currency exchange rate changes(3,913)(411)
 
Benefit obligation at end of year
$19,558 $41,813 

Change in plan assets
 
December 31, 2022December 31, 2021
 (in thousands)
Fair value of plan assets at beginning of year$36,198 $34,612 
Expected return on plan assets1,258 1,171 
Actual return on plan assets(7,305)1,176 
Employer contributions70 91 
Plan participants' contributions19 23 
Benefits paid(514)(489)
Foreign currency exchange rate changes(3,676)(386)
 Fair value of plan assets at end of year$26,050 $36,198 

The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.

134


The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Service cost$117 $134 $100 
Interest cost672 665 746 
Expected return on plan assets(1,258)(1,171)(1,214)
Amortization of net loss228 625 160 
Net periodic benefit cost$(241)$253 $(208)
    
The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

December 31, 2022December 31, 2021December 31, 2020
Discount rate1.8 %1.5 %2.1 %
Rate of compensation increase3.7 %3.4 %3.3 %
Expected rate of return on plan assets3.8 %3.4 %4.0 %

Other comprehensive income
 
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Actuarial (gain)/loss - benefit obligation$(18,636)$(2,097)$5,294 
Actuarial loss/(gain) – plan assets7,305 (1,176)(878)
Actuarial loss recognized in net periodic benefit cost(228)(625)(160)
 Total$(11,559)$(3,898)$4,256 

The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.3 million and $Nil respectively.

Benefit Obligation

The following assumptions were used in determining the benefit obligation at December 31, 2022 and December 31, 2021:
December 31, 2022December 31, 2021
Discount rate4.9 %1.8 %
Rate of compensation increase3.6 %3.7 %

A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.

Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in the discount rate.

135


Plan Assets

The Company's pension plan asset allocation is as follows:
Asset Category
 
December 31, 2022December 31, 2021
Government Bonds88 % %
Diversified Bonds12 % %
Equities %24 %
Corporate Bonds (including 50% high yield bonds) %37 %
Secured Loans and Multi Asset Credit %39 %
 100 %100 %

During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company’s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December 31, 2022 and December 31, 2021, respectively.


Plan Asset Fair Value Measurements
 December 31, 2022December 31, 2021
(in thousands)
Government Bonds$22,887 $ 
Diversified Bonds$3,163 $ 
Equities$ $8,782 
Corporate Bonds (including 50% high yield bonds)$ $13,434 
Secured Loans and Multi Asset Credit$ $13,982 
 $26,050 $36,198 

The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.

Cash Flows
    
The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2023.

The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.
(in thousands)
2023$302 
2024371 
2025402 
2026703 
2027643 
Years 2028 - 20323,614 

The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.

136


Aptiv Solutions pension plan

On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 and December 31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'.

Funded surplus/(deficit)
 
December 31, 2022December 31, 2021
 (in thousands)
Projected benefit obligation$(5,806)$(7,643)
Fair value of plan assets5,681 6,964 
 Funded deficit$(125)$(679)

The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 were 2.3% and 0.4%, respectively.

Change in benefit obligation
 
December 31, 2022December 31, 2021
 (in thousands)
Benefit obligation at beginning of year$7,643 $8,620 
Service cost146 150 
Interest cost30 12 
Plan participants' contributions82 95 
Settlement(218)(483)
Prior service cost(23)(82)
Benefits paid and transferred balances(182)76 
Actuarial gain(1,527)(484)
Foreign currency exchange rate changes(145)(261)
Benefit obligation at end of year$5,806 $7,643 

Change in plan assetsDecember 31,December 31,
20222021
(in thousands)
Fair value of plan assets at beginning of year$6,964 $7,601 
Expected return on plan assets29 15 
Actual return on plan assets(987)(238)
Scheme contributions114 128 
Plan participants' contributions82 95 
Benefits paid and transferred balances(182)76 
Settlement(218)(483)
Foreign currency exchange rate changes(121)(230)
Fair value of plan assets at end of year$5,681 $6,964 

The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.
137


PRA Switzerland AG pension plan

On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'.

Funded surplus/(deficit)
 
December 31, 2022December 31, 2021
 (in thousands)
Projected benefit obligation$(5,345)$(4,990)
Fair value of plan assets4,059 3,017 
 Funded deficit$(1,286)$(1,973)

The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 was 2.3% and 0.4%, respectively.

Change in benefit obligation
 
December 31, 2022December 31, 2021
 (in thousands)
Benefit obligation at beginning of period$4,990 $4,890 
Service cost404 207 
Interest cost20 19 
Plan participants’ contributions2,396 135 
Settlement(844) 
Benefits paid(946)(113)
Actuarial (gain)/loss(627)1 
Foreign currency exchange rate changes(48)(149)
Benefit obligation at end of year$5,345 $4,990 

Change in plan assets
 
December 31, 2022December 31, 2021
(in thousands)
Fair value of plan assets at beginning of period$3,017 $2,849 
Expected return on plan assets29 15 
Actual return on plan assets87  
Scheme contributions325 135 
Plan participants’ contributions2,396 135 
Benefits paid(946)(113)
Settlement(844) 
Foreign currency exchange rate changes(5)(4)
Fair value of plan assets at end of year$4,059 $3,017 

The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.
138


22. Equity Incentive Schemes and Stock Compensation Charges
Share Options

On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.
On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.
 
An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.
 
Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant.

PRA Equity Incentive Plans

The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.
Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.
PRA Health Sciences, Inc. 2020 Stock Incentive Plan (the "2020 Plan”), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021.
The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.
The 2018 Stock Incentive Plan (the “2018 Plan”), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).
On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.
On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.
139


The following table summarizes the transactions for the Company's share option plans for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

 Options Granted
Under Plans
Weighted Average Exercise Price
Outstanding at December 31, 2019656,107 $87.80 
Granted107,737 $159.83 
Exercised(193,417)$68.19 
Canceled(16,681)$92.21 
Outstanding at December 31, 2020553,746 $108.53 
Assumed through business combinations *2,177,130 $108.78 
Granted100,299 $177.76 
Exercised(1,065,529)$111.29 
Canceled/expired(70,186)$128.46 
Outstanding at December 31, 20211,695,460 $110.38 
Granted108,643 $229.94 
Exercised(348,286)$102.87 
Canceled/expired(77,698)$143.08 
Outstanding at December 31, 20221,378,119 $119.86 
Vested and exercisable at December 31, 20221,047,803 $102.29 
*Represents stock options issued as replacement awards in connection with the Merger.

The weighted average remaining contractual life of options outstanding and options exercisable at December 31, 2022, was 4.69 years and 4.25 years respectively (2021: 5.39 years and 4.55 years respectively).

Outstanding and exercisable share options:

The following table summarizes information concerning outstanding and exercisable share options as of December 31, 2022:

Options OutstandingOptions Exercisable
Range Exercise
Price
Number of
Shares
Weighted
Average
Remaining
Contractual Life
Weighted Average Exercise PriceNumber of
Shares
Weighted Average Exercise Price
14.88 - 96.15
494,565 2.70— 494,565 — 
103.81 - 124.00
226,489 5.58— 203,605 — 
125.74 - 147.26
386,518 5.65— 303,054 — 
159.33 - 231.68
270,547 6.24— 46,579 — 
14.88 - 231.68
1,378,119 4.69$119.86 1,047,803 $102.29 
 
Options outstanding include both vested and unvested options as at December 31, 2022. Options exercisable represent options which have vested at December 31, 2022. From the date of grant, substantially all options vest over a five year period.

140


Fair value of Stock Options Assumptions

The weighted average fair value of options granted during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:
 Year Ended
December 31, 2022December 31, 2021December 31, 2020
Weighted average fair value$68.42 $49.15 $42.43 
Assumptions:
Expected volatility31 %30 %30 %
Dividend yield % % %
Risk-free interest rate1.86 %0.78 %0.57 %
Expected life5.0 years5.0 years5.0 years

The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:

July 1, 2021
Weighted average grant date fair value$107.21 
Assumptions:
Expected volatility30 %
Dividend yield %
Risk-free interest rate0.56 %
Expected life3.5 years
    
Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.

Restricted Share Units and Performance Share Units

On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.

On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months.

141


The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December 31, 2022:
PSU Outstanding
Number of Shares
PSU
Weighted Average
Grant Date
Fair Value
RSU Outstanding
Number
of Shares
RSU
Weighted Average
Grant Date Fair Value
Outstanding at December 31, 2021154,190 $160.23 572,785 $191.20 
Granted64,682 $229.79 302,307 $216.85 
Shares vested(46,087)$140.48 (195,029)$174.35 
Forfeited(20,365)$185.90 (97,451)$205.25 
Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 

The fair value of RSUs vested for the year ended December 31, 2022 totaled $34.1 million (2021: $83.5 million). The share price range for the year was $137.47 - $265.96 (2021: $115.11 - $206.71).

The fair value of PSUs vested for the year ended December 31, 2022 totaled $6.5 million (2021: $5.1 million). The share price range for the year was $137.47 - $166.51 (2021: $115.11 - $125.74).

The PSUs vest based on service and specified EPS targets over the period 2021 – 2023 and 2022 – 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional 76,210 PSUs may also be granted.

Non-cash stock compensation expense

Income from operations for the year ended December 31, 2022 is stated after charging $70.5 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:

 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Direct costs$22,854 $18,551 $8,557 
Selling, general and administrative47,669 41,457 17,714 
Transaction and integration related * 73,836  
Total compensation costs$70,523 $133,844 $26,271 
* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger

The income tax expense for the year ended December 31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December 31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December 31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $2.5 million.

23. Business Segment and Geographical Information

The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.

The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 'Segment Reporting'. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.

142


The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.

Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.

ICON Ireland acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts.

ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.

The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland.

There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.

Reportable geographic information at December 31, 2022 and December 31, 2021 and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 is as follows:
 
a) The distribution of revenue by geographical area was as follows:

 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Ireland$1,984,567 $1,365,909 $1,181,292 
Rest of Europe1,618,350 1,175,515 416,884 
U.S.3,574,610 2,581,007 925,563 
Other563,859 358,395 273,549 
 
Total
$7,741,386 $5,480,826 $2,797,288 

b) The distribution of income from operations (including Restructuring) by geographical area was as follows:

 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Ireland *$218,088 $131,961 $276,478 
Rest of Europe253,799 177,863 35,765 
U.S.254,849 39,132 58,018 
Other68,501 29,573 21,239 
 
Total
$795,237 $378,529 $391,500 
* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.
143


c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:

December 31, 2022December 31, 2021
 (in thousands)
Ireland$143,025 $118,253 
Rest of Europe99,721 121,174 
U.S.213,311 239,828 
Other48,095 55,312 
 
Total
$504,152 $534,567 

 
24. Net Income Per Ordinary Share

Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
    
Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares.
    
There is no difference in net income used for basic and diluted net income per ordinary share.
    
Basic and diluted net income per ordinary share attributable to the Group for the year ended December 31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.
    
The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
December 31, 2022December 31, 2021December 31, 2020
Weighted average number of ordinary shares outstanding for basic net income per ordinary share81,532,320 67,110,186 52,859,911 
Effect of dilutive share options outstanding936,043 958,125 423,674 
Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,468,363 68,068,311 53,283,585 

144


The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:
December 31, 2022December 31, 2021December 31, 2020
(in thousands)
Net income attributable to the Group$505,304 153,185 $332,331 
Noncontrolling interest adjustment to redemption amount  (4,522)
Net income attributable to the Group (including NCI redemption adjustment)505,304 153,185 327,809 
December 31, 2022December 31, 2021December 31, 2020
Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):
Basic $6.20 $2.28 $6.20 
Diluted $6.13 $2.25 $6.15 

25. Accumulated Other Comprehensive Income
Year ended
December 31, 2022December 31, 2021
 (in thousands)
Currency translation adjustments$(175,369)$(85,840)
Actuarial gain/(loss) on defined benefit pension plan (note 21)7,559 (5,098)
Loss on cash flow hedge(3,728) 
Amortization of loss on cash flow hedge 1 
 Total$(171,538)$(90,937)


26. Supplemental Disclosure of Cash Flow Information
 Year ended
December 31, 2022December 31, 2021December 31, 2020
 (in thousands)
Cash paid for interest$210,918 $106,205 $13,062 
Cash paid for income taxes (net of refunds)$116,322 $55,105 $27,604 

27. Related Parties

Subsidiaries of the Company earned revenue of $2,000 (December 31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December 31, 2022 (December 31, 2021: $12,000). 

Subsidiaries of the Company earned revenue of $235,000 (December 31, 2021: $551,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December 31, 2022 (December 31, 2021: $197,000). 

Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December 31, 2022.

145


On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December 31, 2022 (December 31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December 31, 2022 (December 31, 2021: $264,000). During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December 31, 2022 accrued interest of $183,000 remained outstanding.

The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.


28. Subsequent Events

The Company has evaluated subsequent events from the Balance Sheet date through February 24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.

146


Item 19. Exhibits.

Exhibits of ICON plc and subsidiaries
Exhibit
Number
Title
Agreement and Plan of Merger, dated as of February 24, 2021, by and among ICON plc, ICON US Holdings Inc., Indigo Merger Sub, Inc and PRA Health Sciences, Inc. (incorporated by reference to exhibit 2.1 to the Form 6K (file No. 333-08704) filed on February 24, 2021.
Description of Securities Registered Under Section 12 of the Exchange Act.
Credit Agreement, dated as of July 1, 2021, by and among ICON Luxembourg, S.À R.L., ICON Clinical Investments, LLC, Indigo Merger Sub, Inc. (which, after giving effect to the Merger on the Closing Date was succeeded by PRA Health Sciences, Inc.), ICON Public Limited Company, the other borrowers party thereto from time to time, the subsidiary guarantors party thereto from time to time, lenders party thereto Citibank, N.A., as administrative agent, and Citibank, N.A., London Branch, as collateral agent (incorporated by reference to exhibit 99.1 to the Form 6K (File No. 333-08704) filed on July 1, 2021).
Indenture, dated as of July 1, 2021, by and among Indigo Merger Sub, Inc., PRA Health Sciences, Inc., the guarantors party thereto and Citibank, N.A., London Branch as trustee, notes collateral agent, paying agent, transfer agent and registrar (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 1, 2021).
Amendment No. 1 to the Credit Agreement referred to at Exhibit 2.3, dated as of November 29, 2022, by and among ICON Public Limited Company and Citibank, N.A., as administrative agent.
Description of the Constitution of the Company (incorporated by reference to exhibit 99.2 to the Form 6K (File No. 333-08704) filed on July 25, 2016).
Section 302 certifications.
Section 906 certifications.
List of Subsidiaries (incorporated by reference to Item 4 of Form 20-F filed herewith).
Consent of KPMG, Independent Registered Public Accounting Firm.
101.1*Interactive Data Files (Inline XBRL – Related Documents).
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)

*   Filed herewith

147


SIGNATURES

The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
 ICON plc 
   
   
   
 /s/ Brendan Brennan 
 Brendan Brennan 
 Chief Financial Officer 
Date: February 24, 2023
148
EX-2.2 2 exhibit22-2022.htm EX-2.2 Document

Exhibit 2.2

Description of Securities
Registered Under Section 12 of the Exchange Act

As of December 31, 2022 ICON plc (“we,” “us,” and “our”) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading symbolName of each exchange on which registered
Ordinary shares, nominal value €0.06 per share
ICLR
NASDAQ Global Select Market

Ordinary Shares

Item 10.General

Item 10.A.1. Limitations or qualifications
Not applicable.
Item 10.A.2. Other rights
Not applicable.
Item 10.A.3. Type and class of securities
    Each ICON plc share has nominal value of €0.06 per share. The respective number of shares that have been issued as of December 31, 2022 is given in the Consolidated Balance Sheet of the annual report on Form 20-F for the fiscal year ended December 31, 2022. All ICON shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities or profit-sharing certificates have been issued.
Item 10.A.4. Pre-emptive rights
Not applicable.

Item 10.B Memorandum and articles of association

10.B.1 Shareholder Rights, Preferences and Dividends Attaching to Shares
    The Company has only one class of shares, Ordinary Shares with a par value of €0.06 per share. All such Ordinary Shares rank equally with respect to voting, payment of dividends and on any winding-up of the Company. Any dividend, interest or other sum payable to a shareholder that remains unclaimed for one year after having been declared may be invested by the Directors for the benefit of the Company until claimed. If the Directors so resolve, any dividend which has remained unclaimed for 12 years from the date of its declaration shall be forfeited and cease to remain owing by the Company. In the event of the Company being wound up, if the assets available for distribution among the Members shall be more than sufficient to repay the whole of the share capital paid up or credited as paid up at the commencement of the winding up, the excess shall be distributed among the Members in proportion to the capital at the commencement of the winding up paid up or credited as paid up on the said Ordinary Shares held by them respectively. An Ordinary Share shall be deemed to be a redeemable share in certain circumstances. The liability of shareholders to invest additional capital is limited to the amounts remaining unpaid on the shares held by them.

10.B.2. Action Necessary to Change the Rights of Shareholders
    The rights attaching to shares in the Company may be varied by special resolutions passed at class meetings of that class of shareholders of the Company.

10.B.3 Annual and General Meetings
    The AGM shall be held in such place and at such time as shall be determined by the board, but no more than 15 months shall pass between the dates of consecutive AGMs. Directors may call an Extraordinary General Meeting (“EGM”) at any time. The members, in accordance with the Constitution of the Company and Irish Company law, may also requisition EGMs. Notice of the AGM or an EGM passing any special resolution must be given at least 21 clear days prior to the scheduled date and, in the case of any other general meeting, not less than 14 clear days’ notice. All holders of Ordinary Shares are entitled to attend, speak at and vote at general meetings of the Company.






10.B.4 Limitations on the Right to Own Shares
    There are no limitations on the right to own shares in the Constitution of the Company.

10.B.5 Disclosure of Share Ownership
    Under Irish law, the Company can require parties to disclose their interests in shares. The Constitution of the Company entitle the Directors to require parties to provide details regarding their identity and the nature and extent of any interest which such parties hold in Ordinary Shares. Under Irish law, if a party acquires or disposes of Ordinary Shares so as to bring their interest above or below 3% of the total issued share capital of the Company, they must notify the Company of that. The Company would also need to be notified of the acquisition by an existing substantial (i.e. 3% plus) shareholder, of every movement of one whole percentage integer (e.g. 3.9% to 4.1% but not 4.1% to 4.9%) or more.


EX-2.5 3 exhibit25-2022.htm EX-2.5 Document
Exhibit 2.5
FIRST AMENDMENT TO CREDIT AGREEMENT
This FIRST AMENDMENT to the Credit Agreement referred to below, dated as of November 29, 2022 (this “First Amendment”) by and among ICON PUBLIC LIMITED COMPANY, an Irish public limited company (“Holdings”), and CITIBANK, N.A., as Administrative Agent (the “Administrative Agent”). Capitalized terms not otherwise defined in this First Amendment have the same meanings as specified in the Credit Agreement, as amended by this First Amendment (the “Amended Credit Agreement”).
RECITALS
WHEREAS, ICON LUXEMBOURG, S.À R.L., a société à responsabilité limitée incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (R.C.S. Luxembourg) under number B66588 (the “Lux Borrower”), ICON Clinical Investments, LLC, a Delaware limited liability company (the “Lux U.S. Subsidiary Borrower”), PRA Health Sciences, Inc., a Delaware corporation (the “U.S. Borrower”, and together with the Lux Borrower and Lux U.S. Subsidiary Borrower, the “Borrowers”), Holdings, the other parties party thereto, and the several financial institutions parties from time to time, as lender (the “Lenders”) and the Administrative Agent, entered into that certain Credit Agreement, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”);
WHEREAS, Holdings has requested and the Administrative Agent hereby provides notice to each of the other parties to the Credit Agreement, that pursuant to clause (i)(a) of the defined term USD Early Opt-in Election of the Credit Agreement, at least five currently outstanding Dollar denominated syndicated credit facilities in the U.S. syndicated loan market on or about the date hereof contain (as a result of amendment or originally executed) a USD SOFR-based rate as a benchmark rate;
WHEREAS, the Administrative Agent and Holdings have jointly elected to declare that an USD Early Opt-in Election has occurred pursuant to clause (ii) of the defined term Early Opt-in Election of the Credit Agreement and have determined in accordance with the Credit Agreement that USD LIBOR should be replaced with USD Term SOFR as a benchmark rate for purposes of the Credit Agreement and the other Loan Documents; and
WHEREAS, in accordance with Section 2.14(a) of the Credit Agreement, Holdings and the Administrative Agent are willing to effect the amendments set forth herein and agree to the terms of the Amended Credit Agreement, in each case, on the terms and subject to the terms and conditions in this First Amendment.
NOW, THEREFORE, in consideration of the covenants and agreements contained herein, as well as other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:




1


Article I
AMENDMENTS TO CREDIT AGREEMENT
Section 1.1Early-Opt In Election. In accordance with clauses (i) and (ii) of the defined term Early Opt-in Election of the Credit Agreement, at the request of Holdings, the Administrative Agent has provided notice to the parties under the Credit Agreement, and the Administrative Agent and Holdings have jointly elected to declare that an USD Early Opt-in Election has occurred and have elected to replace, in accordance with clause (i)(A) of the definition of USD Benchmark Replacement, the USD LIBOR-based rate with a USD SOFR-based rate as set forth in the Amended Credit Agreement.
Section 1.2Amendment of Existing Credit Agreement; Existing Term Loans.
(a)Amendment. On the First Amendment Effective Date, the Borrower and the Administrative Agent hereto agree that the Credit Agreement shall hereby be amended in accordance with Section 2.14(a) and the definition of USD Benchmark Replacement Conforming Changes, to delete the stricken text (indicated textually in the same manner as the following example: stricken text) and to add the double-underlined text (indicated textually in the same manner as the following example: double-underlined text) as set forth in the Amended Credit Agreement attached hereto as Exhibit A, subject to the satisfaction of the conditions precedent set forth in Article II below.
(b)Exhibit I of the Existing Credit Agreement is hereby amended and restated in its entirety in the form set forth on Exhibit B hereto.
(c)Existing Loans. The Administrative Agent and Holdings confirm and agree that the Term Loans and Revolving Loans outstanding on the date hereof as Eurocurrency Rate Loans (as defined in the Credit Agreement prior to giving effect to this First Amendment) with an Interest Period ending after the First Amendment Effective Date, may remain outstanding as such until the conclusion of such applicable Interest Period, at which point such Term Loans and Revolving Loans, as applicable, shall be converted to USD Term SOFR Loans bearing interest at a rate determined by reference to the USD Adjusted Term SOFR in accordance with the terms of the Credit Agreement.
Article II

CONDITIONS TO EFFECTIVENESS
The effectiveness of this First Amendment will occur as set forth below.
Section 1.1First Amendment. The effectiveness of the Amendments contained in Article I are subject to the satisfaction (or written waiver) of the following conditions (the date of satisfaction of such conditions being referred to herein as the “First Amendment Effective Date”):
(a)The Administrative Agent shall have received this First Amendment, executed and delivered by Holdings and the Administrative Agent.
(b)The Administrative Agent shall have given notice to the Lenders of the Early Opt-in Election represented by this First Amendment on November 17, 2022, and shall have not received by 5:00 p.m. (New York City time) on November 28, 2022, written notice of objection to this First Amendment from Lenders comprising the Required Lenders.
2



Article III
REPRESENTATIONS AND WARRANTIES
To induce the other parties hereto to enter into this First Amendment, Holdings represents and warrants to each of the Lenders and the Administrative Agent that, as of the First Amendment Effective Date:
(a)this First Amendment has been duly authorized, executed and delivered by Holdings and constitutes, and the Amended Credit Agreement constitutes, the legal, valid and binding obligation of Holdings, enforceable against Holdings in accordance with its terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law); and
(b)no Default or Event of Default shall have occurred and be continuing on the First Amendment Effective Date both before and after giving effect to the transactions contemplated hereunder.
Article IV

EFFECTS ON LOAN DOCUMENTS
Except as specifically amended herein or contemplated hereby, all Loan Documents shall continue to be in full force and effect and are hereby in all respects ratified and confirmed. Except as specifically amended herein or contemplated hereby, the execution, delivery and effectiveness of this First Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents or in any way limit, impair or otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Loan Documents. Holdings acknowledges and agrees that, on and after the First Amendment Effective Date, this First Amendment shall constitute a Loan Document for all purposes of the Amended Credit Agreement. On and after the First Amendment Effective Date, each reference in the Amended Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to “Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Amended Credit Agreement, and this First Amendment and the Amended Credit Agreement shall be read together and construed as a single instrument. Nothing herein shall be deemed to entitle the Borrower to a further consent to, or a further waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Amended Credit Agreement or any other Loan Document in similar or different circumstances.




3



Article V
MISCELLANEOUS
Section 1.1Execution by the Administrative Agent. The Administrative Agent is entering into, and signing, this First Amendment in respect of the amendments set forth in Article I hereof, in accordance with the definition of Early Opt-in Election.
Section 1.2Indemnification. The Borrower hereby confirms that the indemnification provisions set forth in Section 9.03 of the Amended Credit Agreement shall apply to this First Amendment and the transactions contemplated hereby.
Section 1.3Reaffirmation. Holdings, on behalf of each of the Loan Parties, each as party to the Credit Agreement, the Collateral Documents and the other Loan Documents to which it is a party, in each case as amended, supplemented or otherwise modified from time to time, hereby (i) reaffirms (A) each Lien granted by it to the Administrative Agent for the benefit of the Secured Parties and (B) any guaranties made by it pursuant to the Credit Agreement, and (ii) acknowledges and agrees that the grants of security interests by the Loan Parties contained in the Collateral Documents shall remain in full force and effect after giving effect to the First Amendment. Nothing contained in this First Amendment shall be construed as substitution or novation of the obligations outstanding under the Credit Agreement or the other Loan Documents, which shall remain in full force and effect, except to any extent modified hereby.
Section 1.4Amendments; Execution in Counterparts; Severability.
(a)This First Amendment may not be amended nor may any provision hereof be waived except pursuant to a writing signed by Holdings and the Administrative Agent, in each case to the extent required by the Amended Credit Agreement; and
(b)Any provision of this First Amendment that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
Section 1.5Governing Law; Waiver of Jury Trial; Jurisdiction. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS FIRST AMENDMENT, THE AMENDED CREDIT AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN. The provisions of Section 9.09 of the Amended Credit Agreement are incorporated herein by reference, mutatis mutandis.
Section 1.6Headings. Section headings in this First Amendment are included herein for convenience of reference only, are not part of this First Amendment and are not to affect the construction of, or to be taken into consideration in interpreting, this First Amendment.
Section 1.7Counterparts. This First Amendment may be executed by one or more of the parties to this First Amendment on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed counterpart of a signature page of this First Amendment by facsimile transmission or electronic transmission (e.g., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this First Amendment. Without limitation of the foregoing, the words
4



“execution”, “executed”, “signed”, “signature” and words of like import shall be deemed to include electronic signatures, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transaction Act.
[Remainder of page intentionally left blank.]
5



IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to be duly executed and delivered by their respective proper and duly authorized officers as of the day and year first above written.
ICON PUBLIC LIMITED COMPANY, as Holdings

By: __ /s/ Brendan Brennan______________________
Name: Brendan Brennan
Title: Chief Financial Officer, ICON plc


    [Signature Page to First Amendment to Credit Agreement]



Administrative Agent:

CITIBANK N.A., as Administrative Agent

By:    _______/s/ Louise O’Mara_____________
Name: Louise O’Mara
Title: Managing Director

[Signature Page to First Amendment to Credit Agreement]


EXHIBIT A
Amended Credit Agreement
[See attached.]







EXHIBIT B
Exhibit I - Form of Borrowing Request
[See attached.]



Execution Version
CREDIT AGREEMENT

dated as of

July 1, 2021
(as amended by the First Amendment, dated as of November 29, 2022)

among

ICON LUXEMBOURG, S.À R.L.,
INDIGO MERGER SUB, INC.,
ICON CLINICAL RESEARCH LIMITED,
ICON GLOBAL TREASURY UNLIMITED COMPANY,
ICON US HOLDINGS INC.
and ICON CLINICAL INVESTMENTS, LLC,
as Borrowers

ICON PUBLIC LIMITED COMPANY,
as Holdings and a Guarantor,
THE SUBSIDIARY GUARANTORS PARTY HERETO,
as Subsidiary Guarantors

The Lenders Party Hereto,

CITIBANK, N.A.,
as Administrative Agent

and

CITIBANK, N.A., LONDON BRANCH,
as Collateral Agent
_______________________________

CITIGROUP GLOBAL MARKETS INC. and
J.P. MORGAN SECURITIES PLC,
as Joint Bookrunners,

CITIGROUP GLOBAL MARKETS INC.,
BANCO SANTANDER S.A.,
HSBC CONTINENTAL EUROPE SA,
J.P. MORGAN SECURITIES PLC and
MORGAN STANLEY BANK INTERNATIONAL LIMITED,
as Joint Lead Arrangers

|

TABLE OF CONTENTS
Page
ARTICLE I DEFINITIONS    1
Section 1.01    Defined Terms    1
Section 1.02    Classification of Loans and Borrowings    78
Section 1.03    Terms Generally    78
Section 1.04    Accounting Terms; GAAP    7879
Section 1.05    [Reserved]    7980
Section 1.06    Special Luxembourg Provisions    7980
Section 1.07    Certain Conditions, Calculations and Tests    80
Section 1.08    Divisions    83
ARTICLE II THE CREDITS    83
Section 2.01    Commitments and Loans    83
Section 2.02    Loans and Borrowings    84
Section 2.03    Requests for Borrowings    8485
Section 2.04    Determination of Dollar Amounts    8586
Section 2.05    Swingline Loans    86
Section 2.06    Letters of Credit    8788
Section 2.07    Funding of Borrowings    9293
Section 2.08    Interest Elections    9394
Section 2.09    Termination and Reduction of Commitments    95
Section 2.10    Repayment of Loans; Evidence of Debt    9596
Section 2.11    Prepayment of Loans    9697
Section 2.12    Fees    101
Section 2.13    Interest    102103
Section 2.14    Benchmark Replacement Setting    103104
Section 2.15    Increased Costs    106107
Section 2.16    Break Funding Payments.    107108
Section 2.17    Taxes.    108
Section 2.18    Payments Generally; Allocations of Proceeds; Pro Rata Treatment; Sharing of Set-offs.    112113
Section 2.19    Mitigation Obligations; Replacement of Lenders.    115
Section 2.20    Incremental Credit Extensions.    115116
Section 2.21    Judgment Currency.    119120
Section 2.22    Extensions of Loans and Commitments.    119120
Section 2.23    Loan Repurchases.    122123
Section 2.24    Refinancing Amendment.    124
Section 2.25    Illegality.    125
Section 2.26    Defaulting Lenders.    125126
ARTICLE III REPRESENTATIONS AND WARRANTIES    127128


Table of Contents
(continued)
Page
Section 3.01    Organization; Powers; Subsidiaries    127128
Section 3.02    Authorization; Enforceability    128129
Section 3.03    Governmental Approvals; No Conflicts    128129
Section 3.04    Financial Condition; No Material Adverse Change    128129
Section 3.05    Properties    129
Section 3.06    Litigation, Environmental and Labor Matters    129130
Section 3.07    Compliance with Laws and Agreements    130
Section 3.08    Investment Company Status    130131
Section 3.09    Taxes    130131
Section 3.10    ERISA    130131
Section 3.11    Disclosure    131
Section 3.12    Federal Reserve Regulations    131132
Section 3.13    Security Interest in Collateral    131132
Section 3.14    Solvency    132
Section 3.15    Compliance with Anti-Corruption Laws and Sanctions    132
Section 3.16    No Irish Financial Assistance    132133
Section 3.17    Luxembourg Matters    132133
Section 3.18    PATRIOT Act, etc    133
ARTICLE IV CONDITIONS    133134
Section 4.01    Conditions Precedent to the Closing Date    133134
Section 4.02    Each Credit Event after the Closing Date    137138
ARTICLE V AFFIRMATIVE COVENANTS    138
Section 5.01    Financial Statements and Other Information    138
Section 5.02    Notices of Material Events    140141
Section 5.03    Existence; Conduct of Business    140141
Section 5.04    Payment of Obligations    141
Section 5.05    Maintenance of Properties; Insurance    141142
Section 5.06    Books and Records; Inspection Rights    141142
Section 5.07    Compliance with Laws    142
Section 5.08    Use of Proceeds    142
Section 5.09    Subsidiary Guarantors; Pledges; Additional Collateral; Further Assurances; Guarantor Coverage Test    142143
Section 5.10    Designation of Subsidiaries    144145
Section 5.11    Maintenance of Ratings    144145
Section 5.12    Transactions with Affiliates    144145
Section 5.13    Fiscal Periods    147148
Section 5.14    Anti-Terrorism and Anti-Money Laundering    147148
Section 5.15    Post-Closing Schedule    147148
ii


Table of Contents
(continued)
Page
ARTICLE VI NEGATIVE COVENANTS    147148
Section 6.01    Indebtedness    147148
Section 6.02    Liens    153154
Section 6.03    Asset Sales    154
Section 6.04    Restricted Payments, Investments, Loans, Advances, Guarantees and Acquisitions    154155
Section 6.05    [Reserved]    159160
Section 6.06    [Reserved]    160
Section 6.07    Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries    160
Section 6.08    Amendments to Subordinated Indebtedness and Certain Other Documents, etc    162
Section 6.09    Sale and Leaseback Transactions    162
Section 6.10    [Reserved]    162163
Section 6.11    Merger, Consolidation or Sale of Assets    162163
Section 6.12    Financial Covenant    163164
ARTICLE VII EVENTS OF DEFAULT AND REMEDIES    164
Section 7.01    Events of Default    164
Section 7.02    Borrowers’ Right to Cure    167
ARTICLE VIII THE AGENTS    168169
Section 8.01    The Agents    168169
Section 8.02    Erroneous Payments    173
ARTICLE IX MISCELLANEOUS    175176
Section 9.01    Notices    175176
Section 9.02    Waivers; Enforcement; Amendments    177
Section 9.03    Expenses; Indemnity; Damage Waiver    180
Section 9.04    Successors and Assigns    182
Section 9.05    Survival    187188
Section 9.06    Counterparts; Integration; Effectiveness    187188
Section 9.07    Severability    188
Section 9.08    Right of Setoff    188
Section 9.09    Governing Law; Jurisdiction; Consent to Service of Process; Foreign Process Agent.    188189
Section 9.10    WAIVER OF JURY TRIAL    189190
Section 9.11    Headings    189190
Section 9.12    Confidentiality    189190
Section 9.13    Release of Liens and Guarantees.    190191
Section 9.14    USA PATRIOT Act    191192
Section 9.15    Appointment for Perfection    191192
iii


Table of Contents
(continued)
Page
Section 9.16    No Fiduciary Relationship    192
Section 9.17    Interest Rate Limitation    192193
Section 9.18    Acknowledgement and Consent to Bail-In of Affected Financial Institutions.    192193
Section 9.19    Certain ERISA Matters.    193194
Section 9.20    Acknowledgement Regarding Any Supported QFCs    194
ARTICLE X THE GUARANTY    195
Section 10.01    The Guarantee    195
Section 10.02    Obligations Unconditional    195196
Section 10.03    Reinstatement    197
Section 10.04    Certain Additional Waivers    197
Section 10.05    Remedies    197198
Section 10.06    Rights of Contribution    197198
Section 10.07    Guaranty of Payment; Continuing Guarantee    197198
Section 10.08    Guarantee Limitations    197198
Section 10.09    Keepwell    198199

iv


Table of Contents
(continued)
Page
SCHEDULES:

Schedule 1.01A     –     Agreed Guarantee and Security Principles
Schedule 1.01B     –     Existing Investments
Schedule 1.01C     –     Existing Liens
Schedule 1.01D        –     Excluded Subsidiaries
Schedule 1.01E         –     Foreign Security Documents
Schedule 1.01F        –     Subsidiary Guarantors
Schedule 2.01         –     Commitments
Schedule 3.01         –     Subsidiaries
Schedule 3.03         –     Certain Existing Indebtedness
Schedule 3.05         –     Material Intellectual Property Litigation
Schedule 3.06         –     Material Litigation
Schedule 3.07         –     Compliance with Laws
Schedule 3.10         –     Prohibited Transactions
Schedule 3.13         –     Existing Liens to be Released at Closing
Schedule 5.15         –     Post-Closing Schedule
Schedule 6.01         –     Existing Indebtedness
Schedule 6.07         –     Existing Restrictions

EXHIBITS:
Exhibit A     –     Form of Assignment and Assumption
Exhibit B    –     Auction Procedures
Exhibit C    –     Form of Solvency Certificate
Exhibit D     –     Form of Joinder Agreement
Exhibit E-1     –     Form of First Lien Intercreditor Agreement
Exhibit E-2     –     Form of First-Second Lien Intercreditor Agreement
Exhibit F     –     Form of U.S. Security Agreement
Exhibit G-1     –     Form of U.S. Tax Compliance Certificate
Exhibit G-2     –     Form of U.S. Tax Compliance Certificate
Exhibit G-3     –     Form of U.S. Tax Compliance Certificate
Exhibit G-4     –     Form of U.S. Tax Compliance Certificate
Exhibit H     –     Form of Irish Qualifying Lender Confirmation
Exhibit I    –    Form of Borrowing Request
Exhibit J    –    Form of Perfection Certificate Supplement

v



CREDIT AGREEMENT, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), among ICON LUXEMBOURG, S.À R.L., a société à responsabilité limitée incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (R.C.S. Luxembourg) under number B66588 (the “Lux Borrower”), ICON Clinical Investments, LLC, a Delaware limited liability company (the “Lux U.S. Subsidiary Borrower”), INDIGO MERGER SUB, INC., a Delaware corporation (“Merger Sub” and, prior to the consummation of the Acquisition, the “U.S. Borrower”) (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by PRA Health Sciences, Inc., a Delaware corporation (the “Target” and, following the consummation of the Acquisition, the “U.S. Borrower”), ICON PUBLIC LIMITED COMPANY, an Irish public limited company (“Holdings”), the Revolving Borrowers (as such term is defined in Article I), each Additional Borrower, the Subsidiary Guarantors (as such term is defined in Article I) party hereto, the LENDERS from time to time party hereto, CITIBANK, N.A., as Administrative Agent, and CITIBANK, N.A., LONDON BRANCH, as Collateral Agent.
NOW, THEREFORE, the parties hereto agree as follows:
Article I

Definitions
Section 1.01Defined Terms. As used in this Agreement, the following terms have the meanings specified below:
ABR”, when used in reference to any Loan or Borrowing, refers to a Loan, or the Loans comprising such Borrowing, bearing interest at a rate determined by reference to the Alternate Base Rate.
Accepting Term Lender” has the meaning assigned to such term in Section 2.11(e).
ACH Indebtedness” means Indebtedness incurred in the ordinary course of business arising in connection with any automated clearinghouse transfers of funds or other payment processing service.
Acquisition” means the merger of Merger Sub with and into the Target, with the Target as the surviving corporation, as provided for in the Acquisition Agreement and the related transactions.
Acquisition Agreement” means the Agreement and Plan of Merger dated as of February 24, 2021 among Holdings, U.S. Holdco, Merger Sub and the Target (including, without limitation, all exhibits, schedules and disclosure letters thereto), as the same may be altered, amended, changed, supplemented or with any provision or condition therein waived.
Acquisition Agreement Representations” means such representations and warranties made by or with respect to the Target and its subsidiaries in the Acquisition Agreement as are material to the interests of the Lenders, but only to the extent that Holdings (or its applicable subsidiaries) have the right (taking into account any applicable cure periods) to terminate its obligation to consummate the Acquisition under the Acquisition Agreement or the right not to consummate the Acquisition pursuant to the Acquisition Agreement as a result of a breach of such representations and warranties, in each case in accordance with the terms thereof.
Acquisition Documents” means the Acquisition Agreement and any other documents executed or issued, or to be executed or issued, by or on behalf of the Target and/or the U.S. Borrower in respect of the Acquisition (but excluding the Loan Documents).



Additional Borrower” means any one or more Restricted Subsidiaries that is or becomes a Subsidiary Guarantor designated by Holdings as a borrower of any Incremental Loans hereunder, Revolving Loans or Other Refinancing Loans; provided, however, that only Restricted Subsidiaries organized under the laws of Ireland, Luxembourg, England and Wales and/or a jurisdiction located in the United States may be designated by Holdings as Additional Borrowers; provided, further, that the Additional Borrower shall have satisfied the requirements set forth in Section 4.01(c), and for such purposes, any reference to the Closing Date in such Section 4.01(c) shall be deemed to be a reference to the date on which such Subsidiary Guarantor becomes an Additional Borrower. For the avoidance of doubt, any Restricted Subsidiary designated as an Additional Borrower shall cease to be an “Additional Borrower” upon the repayment of all Loans (or, in the case of an Additional Borrower that is a Revolving Borrower, the repayment of all Loans and termination of all Revolving Commitments) in respect of which such Restricted Subsidiary was designated as an “Additional Borrower” and shall be deemed to be a Guarantor.
Additional Lender” has the meaning assigned to such term in Section 2.20(a).
Adjusted EURIBOR Rate” means, with respect to any Eurocurrency Borrowing denominated in euros, for any Interest Period, an interest rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the sum of (a) the EURIBOR Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate; provided that, with respect to Revolving Loans, such rate shall not be less than zero.
Adjusted LIBO Rate” means, with respect to any Eurocurrency Borrowing denominated in any Agreed Currency other than euros, for any Interest Period, an interest rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the sum of (a) the LIBO Rate for such Interest Period multiplied by (b) the Statutory Reserve Rate; provided that (i) with respect to Revolving Loans, such rate shall not be less than zero and (ii) with respect to the Initial Term Loans, such rate shall not be less than 0.50%.
Administrative Agent” means Citibank, N.A., in its capacity as administrative agent for the Lenders hereunder.
Administrative Questionnaire” means an Administrative Questionnaire in a form supplied by the Administrative Agent.
Affected Financial Institution” means (a) any EEA Financial Institution or (b) any UK Financial Institution.
Affiliate” means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.
Agent Parties” has the meaning assigned to such term in Section 9.01(c).
Agents” has the meaning assigned to such term in Section 8.01.
Agreed Currencies” means (i) Dollars, (ii) euro (solely with respect to Revolving Loans and Letters of Credit), (iii) Pounds Sterling (solely with respect to Revolving Loans and Letters of Credit) and (iv) any other Foreign Currency agreed to by the Administrative Agent, each of the Lenders and each Issuing Bank of the applicable Class of Loans.
Agreed Guarantee and Security Principles” means the Agreed Guarantee and Security Principles set forth on Schedule 1.01A. For the avoidance of doubt, the Agreed Guarantee and Security Principles shall only apply to Guarantees proposed to be granted by, assets of, and Equity Interests in, Holdings and the Foreign Subsidiaries.
2


Agreement” has the meaning assigned to such term in the preamble hereto.
Alternate Base Rate” means, for any day, a rate per annum equal to the greatest of (a) the Eurocurrency RateUSD Adjusted Term SOFR for a one month Interest Period on such day (or if such day is not a Business Day, the immediately preceding Business Day) plus 1%, (b) the Prime Rate in effect on such day, (c) the Federal Funds Effective Rate in effect on such day plus ½ of 1% and (d) 1%; provided, that for the avoidance of doubt, the Eurocurrency Rate for any day shall be based on the rate appearing on the applicable Bloomberg screen page (or on any successor or substitute page of such page) at approximately 11:00 a.m. London time on such day. Any change in the Alternate Base Rate due to a change in the Prime Rate, the Federal Funds Effective Rate or the Eurocurrency RateUSD Adjusted Term SOFR shall be effective from and including the effective date of such change in the Prime Rate, the Federal Funds Effective Rate or the Eurocurrency RateUSD Adjusted Term SOFR, respectively.
Alternate Currencies” means all Agreed Currencies other than Dollars.
Alternate Currency Benchmark Replacement shall mean, with respect to any Eurocurrency Loan denominated in an Alternate Currency or any RFR Loan, the sum of: (a) the alternate benchmark rate (which may be an Alternate Currency SOFR-Based Rate) that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the applicable Eurocurrency Rate or Daily Simple RFR for syndicated credit facilities denominated in such Alternate Currency at such time and (b) the Alternate Currency Benchmark Replacement Adjustment.
With respect to Eurocurrency Loans denominated in an Alternate Currency and RFR Loans, if the Alternate Currency Benchmark Replacement would be less than the “floor”, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or removal of this Agreement or otherwise) with respect to Eurocurrency Loans denominated in such Alternate Currency or RFR Loans, the Alternate Currency Benchmark Replacement with respect to such Alternate Currency will be deemed to be the “floor” for the purposes of this Agreement and the other Loan Documents.
Alternate Currency Benchmark Replacement Adjustment” shall mean, with respect to any replacement of applicable Eurocurrency Rate or Daily Simple RFR with an Alternate Currency Unadjusted Benchmark Replacement for any applicable Interest Period, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the applicable Eurocurrency Rate or Daily Simple RFR with the applicable Alternate Currency Unadjusted Benchmark Replacement by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the applicable Eurocurrency Rate or Daily Simple RFR with the applicable Alternate Currency Unadjusted Benchmark Replacement for syndicated credit facilities at such time.
Alternate Currency Benchmark Replacement Conforming Changes” shall mean, with respect to any Alternate Currency Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Interest Period,” timing and frequency of determining rates and making payments of interest and other administrative matters) that the Administrative Agent, in consultation with Holdings, decides may be appropriate to reflect the adoption and implementation of such Alternate Currency Benchmark Replacement and
3


to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of the Alternate Currency Benchmark Replacement exists, in such other manner of administration as the Administrative Agent, in consultation with Holdings, decides is reasonably necessary in connection with the administration of this Agreement).
Alternate Currency Benchmark Replacement Date” shall mean the earlier to occur of the following events with respect to the applicable Eurocurrency Rate or Daily Simple RFR:
(1)    in the case of clause (1) or (2) of the definition of “Alternate Currency Benchmark Transition Event,” the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of the applicable Eurocurrency Rate or Daily Simple RFR permanently or indefinitely ceases to provide the applicable Eurocurrency Rate or Daily Simple RFR; or
(2)    in the case of clause (3) of the definition of “Alternate Currency Benchmark Transition Event,” the date of the public statement or publication of information referenced therein.
Alternate Currency Benchmark Transition Event” shall mean the occurrence of one or more of the following events with respect to the applicable Eurocurrency Rate or Daily Simple RFR:
(1)a public statement or publication of information by or on behalf of the administrator of the applicable Eurocurrency Rate or Daily Simple RFR announcing that such administrator has ceased or will cease to provide the applicable Eurocurrency Rate or Daily Simple RFR, permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the applicable Eurocurrency Rate or Daily Simple RFR;
(2)a public statement or publication of information by the regulatory supervisor for the administrator of the applicable Eurocurrency Rate or Daily Simple RFR, the U.S. Federal Reserve System, an insolvency official with jurisdiction over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR, a resolution authority with jurisdiction over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR or a court or an entity with similar insolvency or resolution authority over the administrator for the applicable Eurocurrency Rate or Daily Simple RFR, which states that the administrator of the applicable Eurocurrency Rate or Daily Simple RFR has ceased or will cease to provide the applicable Eurocurrency Rate or Daily Simple RFR permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the applicable Eurocurrency Rate or Daily Simple RFR; or
(3)a public statement or publication of information by the regulatory supervisor for the administrator of the applicable Eurocurrency Rate or Daily Simple RFR announcing that the applicable Eurocurrency Rate or Daily Simple RFR is no longer representative.
Alternate Currency Benchmark Transition Start Date” shall mean (a) in the case of an Alternate Currency Benchmark Transition Event, the earlier of (i) the applicable Alternate
4


Currency Benchmark Replacement Date and (ii) if such Alternate Currency Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90th day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or publication) and (b) in the case of an Alternate Currency Early Opt-in Election, the date specified by the Administrative Agent or the Required Lenders, as applicable, by notice to the Borrower, the Administrative Agent (in the case of such notice by the Required Lenders) and the Lenders.
Alternate Currency Benchmark Unavailability Period” shall mean, if an Alternate Currency Benchmark Transition Event and its related Alternate Currency Benchmark Replacement Date have occurred with respect to the applicable Eurocurrency Rate or Daily Simple RFR and solely to the extent that the applicable Eurocurrency Rate or Daily Simple RFR has not been replaced with an Alternate Currency Benchmark Replacement, the period (x) beginning at the time that such Alternate Currency Benchmark Replacement Date has occurred if, at such time, no Alternate Currency Benchmark Replacement has replaced the applicable Eurocurrency Rate or Daily Simple RFR for all purposes hereunder in accordance with Section 2.14 and (y) ending at the time that an Alternate Currency Benchmark Replacement has replaced the applicable Eurocurrency Rate or Daily Simple RFR for all purposes hereunder pursuant to Section 2.14.
Alternate Currency Compounded SOFR” shall mean the compounded average of Alternate Currency SOFR for the applicable Alternate Currency Corresponding Tenor, with the rate, or methodology for this rate, and conventions for this rate (which may include compounding in arrears with a lookback and/or suspension period as a mechanism to determine the interest amount payable prior to the end of each Interest Period) being established by the Administrative Agent in accordance with:
(1)     the rate, or methodology for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining compounded Alternate Currency SOFR; provided that:
(2)    if, and to the extent that, the Administrative Agent determines that Alternate Currency Compounded SOFR cannot be determined in accordance with clause (1) above, then the rate, or methodology for this rate, and conventions for this rate that the Administrative Agent determines are substantially consistent with prevailing market convention for determining Alternate Currency Compounded SOFR for syndicated credit facilities at such time (as a result of amendment or as originally executed);
provided, further, that if the Administrative Agent decides that any such rate, methodology or convention determined in accordance with clause (1) or clause (2) is not administratively feasible for the Administrative Agent, then Alternate Currency Compounded SOFR will be deemed unable to be determined for purposes of the definition of “Alternate Currency Benchmark Replacement.”
Alternate Currency Corresponding Tenor” with respect to an Alternate Currency Benchmark Replacement means a tenor (including overnight) having approximately the same length (disregarding business day adjustment) as the applicable tenor for the applicable Interest Period with respect to the applicable Eurocurrency Rate or Daily Simple RFR.
Alternate Currency Daily Simple SOFR” shall mean, for any day, Alternate Currency SOFR, with the conventions for this rate (which may include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or
5


recommended by the Relevant Governmental Body for determining “Alternate Currency Daily Simple SOFR” for syndicated business loans; provided that, if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.
Alternate Currency Early Opt-in Election” shall mean the occurrence of:
(1)(i) a determination by the Administrative Agent or (ii) a notification by the Required Lenders to the Administrative Agent (with a copy to the Borrower) that the Required Lenders have determined that syndicated credit facilities denominated in the applicable Alternate Currency being executed at such time, or that include language similar to that contained in Section 2.14, are being executed or amended, as applicable, to incorporate or adopt a new benchmark interest rate to replace the applicable Eurocurrency Rate or Daily Simple RFR, and
(2)(i) the election by the Administrative Agent or (ii) the election by the Required Lenders to declare that an Alternate Currency Early Opt-in Election has occurred and the provision, as applicable, by the Administrative Agent of written notice of such election to Holdings and the Lenders or by the Required Lenders of written notice of such election to the Administrative Agent and Holdings.
    “Alternate Currency Equivalent” shall mean, at any time, with respect to any amount denominated in Dollars, the Equivalent Amount thereof in the applicable Alternate Currency as determined by the Administrative Agent or the applicable Issuing Bank, as the case may be, at such time on the basis of the spot rate (determined in respect of the most recent Computation Date) for the purchase of such Alternate Currency with Dollars.
Alternate Currency SOFR” with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark, (or a successor administrator) on the Federal Reserve Bank of New York’s Website.
Alternate Currency SOFR-Based Rate” shall mean Alternate Currency SOFR, Alternate Currency Daily Simple SOFR, Alternate Currency Compounded SOFR or Alternate Currency Term SOFR.
Alternate Currency Term SOFR” shall mean the forward-looking term rate based on Alternate Currency SOFR that has been selected or recommended by the Relevant Governmental Body.
Alternate Currency Unadjusted Benchmark Replacement” shall mean the Alternate Currency Benchmark Replacement excluding the Alternate Currency Benchmark Replacement Adjustment.
Alternative Incremental Facility Indebtedness” means any Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of senior secured notes or loans or unsecured notes or loans that are issued or made in lieu of the Incremental Loans; provided that (i) if such Indebtedness is secured, such Indebtedness is secured by all or a portion of the Collateral on a pari passu or junior basis with the Obligations and is not secured by any property or assets of Holdings or any Restricted Subsidiary other than the Collateral, (ii) such Indebtedness does not mature prior to the Latest Maturity Date at the time such Indebtedness is incurred or have a Weighted Average Life to Maturity that is shorter than the remaining Weighted Average Life to Maturity of the Term Loans maturing on the Latest Maturity Date; provided that
6


this clause (ii) shall not apply to (x) Term A Facilities and (y) customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (ii)), (iii) such Indebtedness is not guaranteed by any of Holdings’ Restricted Subsidiaries other than the Loan Parties, (iv) if such Indebtedness is secured, a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable; provided that if no such intercreditor agreement is then in effect, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable, (v) such Indebtedness shall contain covenants and events of default that are either (x) no more restrictive (taken as a whole) to Holdings and its Restricted Subsidiaries than those included in this Agreement in all material respects as determined by Holdings in good faith or (y) are on market terms at the time of issuance, as determined by Holdings in good faith, which terms shall also be implemented for the benefit of the Initial Term Loans and the Revolving Loans; provided that such Indebtedness in the form of Term A Facilities or Revolving Commitments may contain one or more financial maintenance covenants (and related events of default) irrespective of whether or not such covenants (and related events of default) are included in this Agreement for the benefit of the Term Loans (but such covenants shall be included for the benefit of the other Revolving Commitments), (vi) to the extent such Alternative Incremental Facility Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured pari passu with the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Alternative Incremental Facility Indebtedness had been incurred as Incremental Term Loans under Section 2.20 and (vii) such Alternative Incremental Facility Indebtedness may participate on a pro rata basis or a less than pro rata basis (but not a greater than pro rata basis) than the Initial Term Loans in mandatory prepayments pursuant to Sections 2.11(c)(i) and (c)(iii) under this Agreement (or offers to purchase in circumstances similar to those described in Section 2.11(c)(i) and (c)(iii); provided that notwithstanding the foregoing, the terms and conditions applicable to such Indebtedness may provide for any additional or different covenants or events of default that are applicable only during periods after the Latest Maturity Date that is in effect on the date such Indebtedness is issued, incurred or obtained, include Permitted Conversion Provisions and require the repurchase or repayment upon a change of control, fundamental change, delisting or similar events. Alternative Incremental Facility Indebtedness will include any Registered Equivalent Notes issued in exchange therefor.
Anti-Corruption Laws” means all laws, rules, and regulations of any jurisdiction applicable to Holdings or its Subsidiaries from time to time concerning or relating to bribery or corruption.
Applicable Borrower” means, (a) with respect to the Lux Term Loans, the Lux Borrower and the Lux U.S. Subsidiary Borrower, (b) with respect to the U.S. Term Loans, the U.S. Borrower, (c) with respect to any Revolving Loan, the Revolving Borrower to which such Revolving Loan was made, (d) with respect to any Swingline Loan, the Revolving Borrower to which such Swingline Loan was made, and (e) with respect to any Incremental Loan or any Other Refinancing Loan, the Borrower or Borrowers to which such Loan is made.
Applicable Lender” has the meaning assigned to such term in Section 2.06(d).
Applicable Margin means, for any day,
(i) with respect to the Initial Term Loans, (x) from the Closing Date until the first Business Day following delivery of the Compliance Certificate for the first fiscal quarter ending after the Closing Date pursuant to Section 5.01(c), (a) for any EurocurrencyUSD Term SOFR Initial Term LoanLoans, 2.50% per annum and (b) for any ABR Initial Term Loan, 1.50% per
7


annum and (y) thereafter, the following percentages per annum, based upon the First Lien Net Leverage Ratio as specified in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 5.01(c):
First Lien Net Leverage Ratio
EurocurrencyUSD Term SOFR Initial Term Loans
ABR Initial Term Loans
> 4.00 to 1.002.50%1.50%
≤ 4.00 to 1.002.25%1.25%

(ii) with respect to (a) any Eurocurrency Initial Revolving Loan, USD Term SOFR Initial Revolving Loan or RFR Initial Revolving Loan and (b) any ABR Initial Revolving Loan, the following percentages per annum based on the current corporate family rating assigned by S&P to Holdings:
S&P Rating
Eurocurrency Initial Revolving Loans, USD Term SOFR Initial Revolving Loans and RFR Initial Revolving Loans
ABR Initial Revolving Loans
BB+ (or higher)1.25%0.25%
BB1.60%0.60%
BB- (or lower)2.00%1.00%

and
(iii) with respect to any other Loan, as specified in the applicable Extension Amendment (to the extent such Extension Amendment specifies a different rate from the rate then applicable to the Loans being so extended), Incremental Amendment or Refinancing Amendment.
Any increase or decrease in the Applicable Margin under clause (i) above resulting from a change in the First Lien Net Leverage Ratio shall become effective as of the first Business Day after the date on which a Compliance Certificate is delivered pursuant to Section 5.01(c). Any increase or decrease in the Applicable Margin under clause (ii) above resulting from a change in Holdings’ corporate family rating from S&P shall become effective as of the first Business Day following the date on which a notice of a change in rating has been delivered by Holdings pursuant to Section 5.01(g).
Applicable Percentage” means, (a) with respect to any Revolving Lender in respect of a Revolving Credit Event, its Revolving Percentage and (b) with respect to any Term Lender, a percentage equal to a fraction the numerator of which is the outstanding principal amount of such Lender’s Term Loans and the denominator of which is the aggregate outstanding amount of the Term Loans of all Term Lenders. When references herein to the “Applicable Percentage” refer to the aggregate outstandings hereunder, the Applicable Percentage of each Lender shall be determined in a manner consistent with the foregoing, but taking into account all of their relevant
8


Revolving Commitments (or related Revolving Credit Exposures) and outstanding Term Loans hereunder. In making the foregoing determinations, if any of the relevant amounts are denominated in a currency other than Dollars, the Dollar Amounts thereof (as determined by the Administrative Agent in good faith) shall be utilized. If the context indicates that the “Applicable Percentage” is to be determined for a relevant Class or Tranche, then only the respective Class or Tranche shall be included as otherwise provided above in determining the relevant Applicable Percentages.
Applicable Utilization Fee Rate” means on any date, with respect to the Revolving Commitments, the applicable rate per annum set forth below based upon the Average Revolving Utilization:
Level
Average Revolving Utilization
Applicable Utilization Fee Rate
I
< 33.34%
0.10%
II
≥ 33.34% but ≤ 66.66%
0.20%
III
> 66.66%
0.40%

Approved Fund” has the meaning assigned to such term in Section 9.04(b).
Asset Sale” means any Disposition (or series of related Dispositions) by Holdings or any Restricted Subsidiary of:
(1)any shares of Equity Interests of a Restricted Subsidiary (other than directors’ qualifying shares or shares required by applicable law to be held by a Person other than Holdings or a Restricted Subsidiary);
(2)all or substantially all the assets of any division or line of business of Holdings or any Restricted Subsidiary; or
(3)any other assets of Holdings or any Restricted Subsidiary outside of the ordinary course of business of Holdings or such Restricted Subsidiary,
other than, in the case of clauses (1), (2) and (3) above:
(i)a Disposition by a Restricted Subsidiary to Holdings or by Holdings or a Restricted Subsidiary to a Restricted Subsidiary;
(ii)for purposes of Section 6.03 only, a Disposition that constitutes a Restricted Payment (or would constitute a Restricted Payment but for the exclusions from the definition thereof) that is not prohibited by Section 6.04 or that constitutes a Permitted Investment;
(iii)a Disposition of all or substantially all the assets of Holdings and its Restricted Subsidiaries, taken as a whole, in accordance with Section 6.11 or any disposition that constitutes a Change of Control pursuant to this Agreement;
9


(iv)a Disposition of assets with a fair market value of less than or equal to $30,000,000 (as determined in good faith by Holdings or its Subsidiaries, as applicable) in any single transaction or series of related transactions;
(v)Dispositions of damaged, expired, short-dated, worn-out or obsolete equipment or assets in the ordinary course of business that, in Holdings’ reasonable judgment, are no longer either used or useful in the business of Holdings or its Subsidiaries;
(vi)the non-exclusive license or sublicense of intellectual property or other general intangibles and licenses, leases or subleases of other property, in each case, in the ordinary course of business;
(vii)[reserved];
(viii)to the extent allowable under Section 1031 of the Code, any exchange of like property (excluding any boot thereon) for use in a Permitted Business;
(ix)any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary;
(x)any issuance or sale by any Restricted Subsidiary of Equity Interests to Holdings or another Restricted Subsidiary;
(xi)foreclosures, condemnation, expropriation or any similar action on assets of Holdings or any of its Restricted Subsidiaries;
(xii)the sale or discount of inventory, accounts receivable or notes receivable in the ordinary course of business or the conversion of accounts receivable to notes receivable;
(xiii)any surrender or waiver of contract rights or the settlement, release or surrender of contract rights or other litigation claims in the ordinary course of business;
(xiv)the unwinding, settlement or termination of any obligations under or in respect of any Swap Agreements (including any Permitted Equity Derivatives, Permitted Hedging Obligations and Swap Obligations);
(xv)Dispositions of Investments in joint ventures made in the ordinary course of business or to the extent required by, or made pursuant to, buy/sell arrangements between the joint venture parties set forth in joint venture arrangements and similar binding arrangements;
(xvi)the lapse or abandonment of intellectual property rights in the ordinary course of business, or which are not, individually or in the aggregate, useful or material to the conduct of the business of Holdings and its Restricted Subsidiaries taken as a whole;
(xvii)Dispositions of cash or Cash Equivalents;
10


(xviii)a Disposition in connection with a co-development or collaboration agreement;
(xix)the creation of a Permitted Lien (but not the sale or other disposition of the property subject to such Lien);
(xx)Dispositions of Equity Interests in any Subsidiary prior to the time such Subsidiary becomes a wholly-owned Subsidiary, in each case pursuant to any stock appreciation rights plans, equity incentive or achievement plans or any similar plans or the exercise of warrants, options or other securities convertible into or exchangeable for the Equity Interests of such Subsidiary, so long as such rights, plans, warrants, options or other securities were not entered into or issued in connection with or in contemplation of such person becoming a Subsidiary;
(xxi)a sale, assignment or other transfer of Securitization Assets in connection with a Qualified Securitization Financing or a Qualified Receivables Factoring;
(xxii)Dispositions of Investments made in Drug Development Funds not exceeding, for any individual or series of related Dispositions, the greater of $120,000,000 and 10% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such Disposition(s);
(xxiii)any Sale and Leaseback Transaction provided that the Capital Lease Obligations arising in connection therewith would be permitted under Section 6.01;
(xxiv)discounting of customer invoices in the ordinary course of business;
(xxv)[reserved];
(xxvi)Disposition of any assets made to obtain the approval of any applicable antitrust authority in connection with any acquisition or other Investment not prohibited by this Agreement;
(xxvii)any Sale and Leaseback Transaction related to the Headquarters;
(xxviii)the issuance of directors’ qualifying shares and shares issued to foreign nationals as required by applicable law;
(xxix)Dispositions of property to the extent that (i) such property is exchanged for credit against the purchase price of similar replacement property that is promptly purchased or (ii) the proceeds of such Asset Sale are promptly applied to the purchase price of such replacement property (which replacement property is actually promptly purchased); and
(xxx)Dispositions that otherwise constitute a Permitted Investment or otherwise constitute a Restricted Payment permitted by Section 6.04 or a Permitted Lien.
11


Assignment and Assumption” means an assignment and assumption agreement entered into by a Lender and an assignee (with the consent of any party whose consent is required by Section 9.04), and accepted by the Administrative Agent, in the form of Exhibit A or any other form approved by the Administrative Agent.
Attributable Debt” in respect of a sale and leaseback transaction means, at the time of determination, the present value of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction including any period for which such lease has been extended or may, at the option of the lessor, be extended. Such present value shall be calculated using a discount rate equal to the rate of interest implicit in such transaction, determined in accordance with GAAP.
Auction Manager” has the meaning assigned to such term in Section 2.23(a).
Auction Procedures” means the auction procedures with respect to Purchase Offers set forth in Exhibit B hereto.
Auto Renewal Letter of Credit” has the meaning assigned to such term in Section 2.06(c).
Availability Period” means, with respect to any Tranche of Revolving Commitments, the period from and including the Closing Date to but excluding the earlier of the Maturity Date with respect to the Revolving Commitments of such Tranche and the date of termination of all of the Revolving Commitments of such Tranche.
Available Revolving Commitment” means, at any time with respect to any Lender, the Revolving Commitments of such Lender then in effect minus the Revolving Credit Exposure of such Lender at such time; it being understood and agreed that any Lender’s Swingline Exposure shall not be deemed to be a component of the Revolving Credit Exposure for purposes of calculating the commitment fee under Section 2.12(a).
Average Revolving Utilization” means, on the last day of each fiscal quarter, the percentage equal to a fraction the numerator of which is the average daily outstanding principal amount of all Revolving Loans and the total LC Exposure during such fiscal quarter and the denominator of which is the aggregate Revolving Commitments of all Revolving Lenders.
Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.
Bail-In Legislation” means (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).
Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy”, as now or hereafter in effect, and any successor thereto.
Benefit Plan” means any of (a) an “employee benefit plan” (as defined in ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for
12


purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”.
Benefit Plan Laws” means all laws, rules, regulations, codes, ordinances, or binding orders, decrees, judgments, injunctions, notices or agreements issued, promulgated or entered into by any Governmental Authority, relating to Plans, Multiemployer Plans, Non-U.S. Plans and Irish Pension Schemes, including without limitation, ERISA and any other comparable law, rule or regulation relating to Non-U.S. Plans and Irish Pension Schemes.
Board” means the Board of Governors of the Federal Reserve System of the United States of America.
Board of Directors” means:
(1)with respect to a corporation, the board of directors of the corporation or any committee thereof duly authorized to act on behalf of such board;
(2)with respect to a partnership, the Board of Directors of the general partner of the partnership;
(3)with respect to a limited liability company managed by the member or members, the managing member or members or any controlling committee of managing members thereof;
(4)with respect to a limited liability company managed by a manager or managers, the manager or managers and any controlling committee of managers; and
(5)with respect to any other Person, the board or committee of such Person serving a similar function.
Borrower Materials” has the meaning assigned to such term in the final paragraph of Section 5.01.
Borrowers” means, collectively, the Lux Borrower, the U.S. Borrower, each Revolving Borrower, the Lux U.S. Subsidiary Borrower and each Additional Borrower.
Borrowing” means (a) Revolving Loans of the same Class, Type and currency made, converted or continued on the same date and, in the case of Eurocurrency Loans, USD Term SOFR Loans or RFR Loans meeting the foregoing requirements under this clause (a), as to which a single Interest Period is in effect, (b) Term Loans of the same Class and Type made on the same date and, in the case of Eurocurrency Loans, USD Term SOFR Loans or RFR Loans meeting the foregoing requirements under this clause (b), as to which a single Interest Period is in effect or (c) a Swingline Loan.
Borrowing Request” means a request by the Applicable Borrower for a Borrowing, in substantially the form of Exhibit I hereto, in accordance with Section 2.03.
Business Day” means any day that is not a Saturday, Sunday or other day on which commercial banks in New York City or London, United Kingdom or, if such day relates to the payment of any obligation or the performance of any covenant, duty or obligation of (x) a Borrower organized in Luxembourg or (y) a Borrower incorporated in Ireland, are authorized or required by law to remain closed; provided that, when used in connection with a Eurocurrency Loan, USD Term SOFR Loan or RFR Loan, the term “Business Day” shall also exclude any day on which banks are not open for dealings in the relevant Agreed Currency in the London
13


interbank market or the principal financial center of the country of such Agreed Currency (and, if the Borrowings or LC Disbursements which are the subject of a borrowing, drawing, payment, reimbursement or rate selection are denominated in euros, the term “Business Day” shall also exclude any day on which the TARGET payment system is not open for the settlement of payments in euro).
Capital Lease Obligations” of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP; provided that all obligations of any person that are or would be characterized as operating lease obligations in accordance with GAAP on December 31, 2015 (whether or not such operating lease obligations were in effect on such date) shall continue to be accounted for as operating lease obligations (and not as Capital Lease Obligations) for purposes of this Agreement regardless of any change in GAAP following December 31, 2015 that would otherwise require such obligations to be recharacterized (on a prospective or retroactive basis or otherwise) as Capital Lease Obligations.
Capital Markets Indebtedness” means (i) any Indebtedness consisting of bonds, debentures, Notes or other similar debt securities issued in (a) a public offering registered under the Securities Act or (b) a private placement to institutional investors that is resold in accordance with Rule 144A or Regulation S of the Securities Act, whether or not it includes registration rights entitling the holders of such debt securities to registration thereof with the SEC and (ii) any Indebtedness consisting of term loan facilities.
Capitalized Software Expenditures” means, for any period, the aggregate of all expenditures (whether paid in cash or accrued as liabilities) by Holdings and the Restricted Subsidiaries during such period in respect of licensed or purchased software or internally developed software and software enhancements that, in conformity with GAAP, are or are required to be reflected as capitalized costs on the consolidated balance sheet of Holdings and the Restricted Subsidiaries.
Cash Collateralized” means, with respect to any Letter of Credit, as of any date, that the Applicable Borrower shall have deposited in the LC Collateral Account, in the name of the Administrative Agent and for the benefit of the Lenders, an amount in cash equal to 102% of the LC Exposure as of such date plus any accrued and unpaid interest thereon pursuant to such documentation and arrangements as are reasonably satisfactory to the Administrative Agent. “Cash Collateralize” shall have the correlative meaning.
Cash Equivalents” means:
(a)(i) United States dollars, Canadian dollars, euro, Pounds Sterling, Yen, Swiss Francs or any national currency of any member state of the European Union, (ii) with respect to Holdings or any Restricted Subsidiary, the national currency of the jurisdiction in which such Person is organized or domiciled, and (iii) any other foreign currency held by Holdings and the Restricted Subsidiaries in the ordinary course of business;
(b)direct obligations of, or obligations the principal of and interest on which are unconditionally guaranteed by, the United States of America or a member state of the European Union (or by any agency thereof to the extent such obligations are backed by the full faith and credit of the United States of America or such member state), in each case maturing within eighteen months from the date of acquisition thereof;
14


(c)investments in commercial paper maturing within 270 days from the date of acquisition thereof and having, at such date of acquisition, the highest credit rating obtainable from S&P or from Moody’s;
(d)certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from the date of acquisition, demand deposits, bankers’ acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any domestic or foreign commercial bank having capital and surplus of not less than $250,000,000 in the case of U.S. banks and $250,000,000 (or the foreign currency equivalent as of the date of determination) in the case of non-U.S. banks;
(e)fully collateralized repurchase agreements with a term of not more than thirty (30) days for securities described in clauses (b) and (d) above and entered into with a financial institution satisfying the criteria described in clause (d) above;
(f)marketable short-term money market and similar liquid funds having a rating of at least P-2 or A-2 from either Moody’s or S&P, respectively (or, if at any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from another nationally recognized statistical rating agency);
(g)Investments with average maturities of 24 months or less from the date of acquisition in money market funds and similar liquid funds rated AA- (or the equivalent thereof) or better by S&P or Aa3 (or the equivalent thereof) or better by Moody’s (or, if at any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from another nationally recognized statistical rating agency);
(h)securities issued or fully guaranteed by any state, commonwealth or territory of the United States of America or by any political subdivision (including any municipality) or taxing authority of any such state, commonwealth or territory, the securities of which state, commonwealth, territory, political subdivision or taxing authority (as the case may be) are rated at least “A” (or A-1, SP1 or other then equivalent grade) by S&P or at least “A1” (or “Prime-1” or MIG-1 or other then equivalent grade) by Moody’s as of the date of acquisition and, in each case, with a maturity of not more than two years from the date of acquisition thereof;
(i)investment funds investing substantially all of their assets in securities of the types described in clauses (a) through (h) above; and
(j)in the case of any Holdings or Foreign Subsidiary, other short-term investments that are analogous to the foregoing, are of comparable credit quality and are customarily used by companies in the jurisdiction of Holdings or such Foreign Subsidiary for cash management purposes.
Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in clause (a) above; provided that such amounts are converted into any currency listed in clause (a) above as promptly as practicable and in any event within ten business days following the receipt of such amounts.
Cash Management Agreement” means any agreement to provide cash management services, including treasury, depository, overdraft, netting, foreign exchange facilities, credit or debit card, electronic funds transfer and other cash management arrangements.
“Cash Management Bank” means any Person (A) that is a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger) and any Person who was a
15


Lender, an Agent or a Lead Arranger (or any Affiliate of a Lender, an Agent or a Lead Arranger) at the time it entered into a Cash Management Agreement, in each case, in its capacity as a party to such Cash Management Agreement; provided that if such Person is (or was, at the time it entered into a Cash Management Agreement) an Affiliate of a Lender, an Agent or a Lead Arranger (other than any such Person that is an Affiliate of Citibank, N.A.), such person shall deliver to the Administrative Agent a letter agreement pursuant to which such person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 and Section 10 of the U.S. Security Agreement as if it were a Lender or (B) that is designated in writing by Holdings to the Administrative Agent as a “Cash Management Bank”; provided that if such Person is not a Lender, Agent or Lead Arranger, such Person executes and delivers to the Administrative Agent and Holdings a letter agreement in form and substance reasonably acceptable to the Administrative agent and Holdings pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 hereof and Section 10 of the U.S. Security Agreement as if it were a Lender.
Central Bank Rate” means the Bank of England’s Bank Rate as published by the Bank of England from time to time.
Central Bank Rate Adjustment” means, in relation to the Central Bank Rate prevailing at close of business on any RFR Business Day, the 20% trimmed arithmetic mean (calculated by the Administrative Agent) of the Central Bank Rate Spreads for the 5 most immediately preceding RFR Business Days for which the RFR is available.
Central Bank Rate Spread” means, in relation to any RFR Business Day, the difference (expressed as a percentage rate per annum) calculated by the Administrative Agent of (x) the RFR for such RFR Business Day and (y) the Central Bank Rate prevailing at close of business on such RFR Business Day.
CFC” means a “controlled foreign corporation” within the meaning of Section 957 of the Code.
Change in Law” means the occurrence, after the Closing Date, of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rules, guideline, requirement or directive (whether or not having the force of law) by any Governmental Authority; provided, however, that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder, issued in connection therewith or in implementation thereof shall be deemed to be a “Change in Law” regardless of the date enacted, adopted, issued or implemented and (ii) all reports, notes, guidelines, rules, requests and directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, shall, in each case, be deemed to be a “Change in Law” regardless of the date enacted, adopted, issued or implemented.
Change of Control” means (a) the acquisition of beneficial ownership, directly or indirectly, by any Person or group (within the meaning of the Securities Exchange Act of 1934 and the rules of the SEC thereunder as in effect on the Closing Date), of Equity Interests representing more than 50% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of Holdings; (b) the occurrence of a change of control, or other similar provision, as defined in any agreement or instrument evidencing any Material Indebtedness triggering a default or mandatory prepayment, which default or mandatory
16


prepayment has not been waived in writing (other than Indebtedness subject to repayment on the Closing Date in connection with the Transactions); or (c) any Borrower ceasing to be either a direct or indirect wholly-owned subsidiary of Holdings. For the avoidance of doubt, none of the Transactions shall be deemed a Change of Control so long as, after giving effect thereto, clauses (a) through (c) above are complied with.
Notwithstanding the foregoing, a transaction will not be deemed to constitute a Change of Control if (x) Holdings becomes a direct or indirect wholly-owned Subsidiary of a holding company and (y)(i) the direct or indirect holders of the Voting Stock of such holding company immediately following that transaction are substantially the same as the holders of Holdings’ issued and outstanding Equity Interests immediately prior to that transaction or (ii) immediately following that transaction no Person (other than a holding company satisfying the requirements of this sentence) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.
Class”, when used in reference to (a) any Loan or Borrowing, refers to whether such Loan, or the Loans comprising such Borrowing, are Loans of a particular Tranche; provided that any Loans within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as separate Classes of Loans and Borrowings for purposes of this Agreement, (b) any Commitment, refers to whether such Commitment is a Commitment of a particular Tranche; provided that any Commitments within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as separate Classes of Commitments for purposes of this Agreement and (c) any Lender, refers to whether such Lender is a Lender of a particular Tranche; provided that any Lender holding Loans or Commitments within a Tranche having different Maturity Dates, Applicable Margins, currency of denomination (except pursuant to a Class of revolving commitments allowing extensions of credit thereunder in multiple currencies), repayments or other terms shall be regarded as a Lender with respect to separate Classes of Loans and/or Commitments (as applicable) for purposes of this Agreement.
Closing Date” means July 1, 2021.
Code” means the United States Internal Revenue Code of 1986, as amended from time to time (unless otherwise provided herein).
Collateral” means any and all property owned, leased or operated by a Loan Party on which Liens are purported to be granted pursuant to the Collateral Documents as security for the Secured Obligations; provided that Collateral shall exclude Excluded Assets.
Collateral Agent” means Citibank, N.A., London Branch in its capacity as collateral agent for the Secured Parties.
Collateral Documents” means, collectively, the U.S. Security Agreement, each Foreign Security Document and all other agreements, instruments and documents executed in connection with this Agreement that are intended to create or evidence Liens to secure the Secured Obligations, and shall also include, without limitation, all other security agreements, pledge agreements, deeds of trust, intercreditor agreements, collateral assignments and any agreements entered into for the purposes of perfection, now, or hereafter executed by Holdings or any of its Restricted Subsidiaries and delivered to the Collateral Agent.
17


Commitment” means, with respect to each Lender, such Lender’s Revolving Commitment, Term Loan Commitment, Extended Revolving Commitment, Other Refinancing Commitment and Incremental Commitment.
Commodity Exchange Act” means the Commodity Exchange Act (7 U.S.C. § 1 et seq.), as amended from time to time, and any successor statute.
Companies Act” means the Companies Act 2014 of Ireland.
Compliance Certificate” has the meaning assigned to such term in clause (c) of Section 5.01.
Computation Date” shall have the meaning assigned to such term in Section 2.04.
Consolidated Depreciation and Amortization Expense” means with respect to any period, the total amount of depreciation and amortization expense, including any amortization of deferred financing fees, accretion of royalty liabilities, amortization in relation to terminated Swap Obligations and amortization of intangibles, including, but not limited to, goodwill, of the Group for such period on a consolidated basis and otherwise determined in accordance with GAAP.
Consolidated EBITDA” means, for any Test Period, Consolidated Net Income plus, without duplication, and, other than clauses (vii) and (viii), solely to the extent deducted (and not otherwise excluded) in determining Consolidated Net Income,
(i)expense for Taxes paid or accrued, to the extent accounted for as Income Taxes under GAAP,
(ii)consolidated interest expense and charges and deferred financing fees, losses on hedging obligations or other derivative instruments entered into for the purpose of hedging interest rate risk, net of gains on such hedging obligations, and costs of surety bonds in connection with financing activities,
(iii)Consolidated Depreciation and Amortization Expense,
(iv)non-cash charges recorded in respect of purchase accounting and non-cash exchange, translation or performance losses relating to any foreign currency hedging transactions or currency fluctuations,
(v)any other non-cash charges, expenses or losses, including, without limitation, (x) any non-cash compensation expense, non-cash translation loss and non-cash expense relating to the vesting of warrants and (y) pursuant to any management equity plan or stock plan or pursuant to Statement of Financial Accounting Standards 158 (codified under Accounting Standards Codification 715); provided that accruals or reserves for potential cash items in any future period may or may not (at the election of Holdings) be added back in such period and, to the extent added back, the cash payment in respect of such accrual or reserve in a future period shall be subtracted from Consolidated EBITDA in such future period,
(vi)expenses with respect to casualty events,
(vii)the amount of Run-rate cost savings, synergies and operating expense reductions projected by Holdings to be realized as a result of any
18


Transactions, any Permitted Acquisition, any other Investment, dispositions, divestitures, restructurings, operating improvements, cost savings initiatives and other similar initiatives projected by Holdings in good faith to result from actions taken, committed to be taken or with respect to which substantial steps have been taken or are expected in good faith to be taken, other than in the case of the Transactions, within 24 months of such transaction, initiative or event, in each case, calculated as though such cost savings, synergies and operating expense reductions had been realized on the first day of the applicable Test Period and net of the amount of actual benefits received during such period from such transaction; provided, that (A) such cost savings and synergies are factually supportable in the good faith judgment of Holdings and (B) no cost savings or synergies shall be added pursuant to this clause (vii) to the extent duplicative of any expenses or charges otherwise added to Consolidated EBITDA or Consolidated Net Income, whether through a pro forma adjustment or otherwise, for such period (the “Pro Forma Synergies”); provided, further, that (1) the aggregate amount of any adjustments under this clause (vii) permitted to be made in respect of the Transactions when calculating Consolidated EBITDA for any Test Period ending after the second anniversary of the Closing Date shall not exceed the greater of (x) $150,000,000 and (y) the amount of such adjustments made in respect of the Transactions pursuant to this clause (vii) prior to such date and (2) the aggregate amount of any adjustments made pursuant to this clause (vii) for any period shall not exceed in the aggregate 25% of Consolidated EBITDA for such period (before giving effect to any such adjustments),
(viii)(i) to the extent covered by insurance and actually reimbursed within 365 days of the first date of determination by Holdings that there exists reasonable evidence that such amount will in fact be reimbursed by the insurer, expenses with respect to liability or casualty or business interruption and (ii) to the extent actually reimbursed, expenses incurred to the extent covered by indemnification provisions in any agreement in connection with any acquisition permitted under this Agreement,
(ix)cash charges and legal expenses in connection with litigation to the extent not constituting an extraordinary, non-recurring or unusual loss, charge or expense in an aggregate amount for any Test Period not to exceed $5 million,
(x)all reserves taken during such period on account of contingent cash payments that may be required in future periods,
(xi)[reserved],
(xii)the amount of any minority interest expense consisting of Subsidiary income attributable to minority equity interests of third parties in any non-wholly-owned Subsidiary deducted (and not added back) in such period in calculating Consolidated Net Income,
(xiii)the amount of loss or discount on sales of receivables, Securitization Assets and related assets to any Securitization Subsidiary in connection with a Qualified Securitization Financing or to any other Person in connection with a Qualified Receivables Factoring,
(xiv)restructuring costs (including in connection with any tax related restructuring), integration costs, retention, recruiting, relocation and signing or completion bonuses and expenses, stock option and other equity-based
19


compensation expenses and the amount of payments made to option holders in connection with, or as a result of, any distribution being made to shareholders, severance costs, systems establishment costs, costs relating to entry into a new market or to exiting a market, costs associated with office and facility openings, pre-openings, closings, expansions and consolidations (including but not limited to termination costs, moving costs and legal costs), new operation costs, unused warehouse space costs, new contract or corporate development costs, software and other intellectual property development costs, project start-up costs, costs relating to early termination of rights fee arrangements, consulting fees, curtailments or modifications to pension and post-retirement employee benefits and any costs attributable to the undertaking and/or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions, synergies and/or similar initiatives or programs (including, without limitation, in connection with the Transactions or any inventory optimization program, integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any facility opening and/or pre-opening, any implementation of operational and reporting systems and technology initiatives (including any expense relating to the implementation of enhanced accounting or IT functions or new system designs)), any employee ramp-up charges or any charges related to underutilized personnel (including duplicative personnel),
(xv)extraordinary, unusual, special, exceptional or non-recurring charges, expenses or losses (as determined by Holdings in good faith),
(xvi)any add backs and other adjustments consistent with Regulation S-X,
(xvii)fees, costs and expenses (including, without limitation, premium) incurred in connection with the Transactions and other transaction fees, costs, accruals and expenses (including rationalization, legal, tax and other costs and expenses) incurred in connection with any acquisition, investment, dividend, restricted payment, disposition, recapitalization, merger, consolidation or amalgamation, issuance, exchange or repayment of Indebtedness, option buyouts, refinancing, amendments or other modifications of debt instruments, early extinguishment of debt, hedging agreements or other derivative instruments (in each case whether or not such transaction was successfully completed),
(xviii)without limiting the generality of clause (v) above, any costs or expense incurred by Holdings or a Restricted Subsidiary pursuant to any management equity plan or stock option or phantom equity plan or any other management or employee benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash proceeds contributed to the capital of Holdings or net cash proceeds of an issuance of Equity Interests of Holdings (other than Disqualified Equity Interests) solely to the extent that such net cash proceeds are excluded from the calculation set forth in Section 6.04(a)(ii)(C),
(xix)without limiting the generality of clause (v) above, the amount of expenses relating to payments made to option, phantom equity or profits interest holders of Holdings or any of its direct or indirect Subsidiaries or parent companies in connection with, or as a result of, any distribution being made to equity holders of such Person or its direct or indirect parent companies, which
20


payments are being made to compensate such option, phantom equity or profits interest holders as though they were equity holders at the time of, and entitled to share in, such distribution, in each case to the extent permitted under this Agreement and expenses relating to distributions made to equity holders of such Person or its direct or indirect parent companies resulting from the application of Financial Accounting Standards Codification Topic 718— Compensation — Stock Compensation (formerly Financial Accounting Standards Board Statement No. 123 (Revised 2004)), and
(xx)any net pension or other post-employment benefit costs representing amortization of unrecognized prior service costs, actuarial losses, including amortization of such amounts arising in prior periods, amortization of the unrecognized net obligation (and loss or cost) existing at the date of initial application of FASB Accounting Standards Codification Topic 715—Compensation—Retirement Benefits and any other items of a similar nature to the extent deducted (and not added back) in calculating Consolidated Net Income,
minus, to the extent included in Consolidated Net Income and without duplication,
(1)any unusual, infrequent or extraordinary income or gains, and
(2)any other non-cash income (except to the extent representing an accrual for future cash income); provided that, to the extent non-cash gains are deducted pursuant to this clause (2) for any previous period and not otherwise added back to Consolidated EBITDA, Consolidated EBITDA shall be increased by the amount of any cash receipts (or any netting arrangements resulting in reduced cash expenses) in respect of such non-cash gains received in subsequent periods to the extent not already included therein,
all calculated for Holdings and its Restricted Subsidiaries in accordance with GAAP (to the extent applicable) on a consolidated basis; provided that, to the extent included in Consolidated Net Income, (A) currency translation gains and losses shall be excluded in determining Consolidated EBITDA (including the net loss or gain resulting from swap agreements for currency exchange risk) and (B) any adjustments resulting from the application of Statement of Financial Accounting Standards 133 (codified under Accounting Standards Codification 815) shall be excluded in determining Consolidated EBITDA.
For the avoidance of doubt, the foregoing additions to, and subtractions from, Consolidated EBITDA shall not give effect to any items attributable to the Unrestricted Subsidiaries, other than as set forth in the last sentence of Section 1.04(a). For the purposes of calculating Consolidated EBITDA for any Test Period, if during such Test Period or after such Test Period but prior to the applicable date of determination, Holdings or any Restricted Subsidiary shall have made any Specified Transaction, converted any Restricted Subsidiary into an Unrestricted Subsidiary, or converted any Unrestricted Subsidiary into a Restricted Subsidiary, Consolidated EBITDA shall be calculated for such Test Period after giving effect thereto on a Pro Forma Basis in accordance with Section 1.07, as if such Specified Transaction or conversion, and any related incurrence or repayment of Indebtedness, occurred on the first day of such Test Period. If since the beginning of such Test Period any Person (that subsequently became a Restricted Subsidiary or was merged with or into Holdings or any Restricted Subsidiary since the beginning of such period but prior to the end of such Test Period) shall have made any Specified Transaction or such conversions that would have required adjustment pursuant to this definition, then the Consolidated EBITDA shall be calculated on a Pro Forma Basis in accordance with Section 1.07 for such period as if such Specified Transaction or conversion had occurred on the first day of such Test Period.
21


Consolidated Interest Expense” means, with reference to any period, the sum, without duplication, of the interest expense paid in cash of the Group calculated on a consolidated basis for such period in accordance with GAAP, including, without limitation, interest expense under Capital Lease Obligations that is treated as interest in accordance with GAAP, imputed interest with respect to Attributable Debt and net payments, if any, pursuant to interest rate Permitted Hedging Obligations, but excluding any (i) non-cash interest expense attributable to the movement in mark-to-market valuation of Permitted Hedging Obligations or other derivative instruments pursuant to Statement of Financial Accounting Standards No. 133 (codified under Accounting Standards Codification 815), (ii) non-cash interest expense attributable to the amortization of gains or losses resulting from the termination of Permitted Hedging Obligations prior to or reasonably contemporaneously with the Closing Date, (iii) amortization of deferred financing fees, (iv) expensing of commitment, bridge or other financing fees and (v) interest expense arising out of the amortization of debt discount under Accounting Standards Codification 470-20; less interest income of the Group for such period (including income pursuant to any Permitted Hedging Obligations).
Consolidated Net Income” means, with reference to any period, the net income (or loss) of the Group calculated in accordance with GAAP on a consolidated basis (without duplication) for such period; provided that there shall be excluded:
(a)any income (or loss) of any Person other than Holdings or a Restricted Subsidiary, but any such income so excluded may be included in such period or any later period to the extent of any cash dividends or distributions actually paid in the relevant period to Holdings or any Restricted Subsidiary of Holdings,
(b)solely for the purpose of determining the amount available for Restricted Payments under Section 6.04(a)(ii)(A) and for the purpose of determining the amount of Excess Cash Flow, the income of, and any amounts referred to in clause (a) of this proviso paid to, any Subsidiary (other than a Guarantor) to the extent that, on the date of determination, the declaration or payment of cash dividends or other cash distributions by such Subsidiary of that income is not at the time permitted by applicable law or any agreement or instrument applicable to such Subsidiary, unless such restriction with respect to the payment of cash dividends or other cash distributions has been legally waived or otherwise released; provided that Consolidated Net Income of the referent Person will be increased by the amount of dividends or other distributions or other payments actually paid in cash (or to the extent converted into cash) or Cash Equivalents to such Person or a Restricted Subsidiary thereof in respect of such period, to the extent not already included therein,
(c)any fees, costs and expenses (including, without limitation, any premium) directly incurred or paid during such period, or any amortization thereof for such period, in connection with (x) the Transactions, (y) any other Permitted Acquisition or other acquisition not prohibited under this Agreement, and, to the extent permitted hereunder, any other Investments and any Dispositions, and (z) to the extent permitted hereunder, issuances or incurrence of Indebtedness, issuances of Equity Interests or refinancing transactions and modifications of instruments of Indebtedness (in each case, including any such transaction consummated prior to the Closing Date, and any such transaction undertaken but not completed) and any charges or non-recurring costs incurred during such period as a result of such transaction,
(d)at the option of Holdings, the effects of discontinued operations (but if such operations are classified as discontinued due to the fact that they are subject to an agreement to dispose of such operations or in contemplation of the same, or are otherwise classified as “held for sale” under GAAP, only when and to the extent such operations are
22


actually disposed of) and any net after-tax gains or losses from asset dispositions (other than in the ordinary course of business (as determined by Holdings in good faith)),
(e)any non-cash amounts included in Consolidated Interest Expense,
(f)non-cash compensation expense incurred with any issuance of equity interests to an employee of such Person or any Restricted Subsidiary,
(g)any income (loss) for such period attributable to the early extinguishment of Indebtedness, together with any related provision for Taxes on any such income,
(h)any gain or loss realized as a result of the cumulative effect of a change in accounting principles,
(i)any gains or losses resulting from any reappraisal, revaluation or write-up or write-down of assets or liabilities (including any gains and losses attributable to movement in the mark-to-market valuation of any convertible indebtedness, any related call options or warrant transactions and any other derivatives and Deferred Acquisition Consideration),
(j)any non-cash charges recorded in respect of intangible assets, including goodwill,
(k)the effect of any purchase allocation accounting adjustments in respect of any acquisition consummated prior to the Closing Date, the Transactions and any acquisition permitted under this Agreement, and the amortization or write-off of any amounts in respect thereof,
(l)any unusual, infrequent or extraordinary loss or charge and any restructuring charges or reserves, including write-downs and write-offs, any costs incurred in connection with the Transactions, Permitted Investments and Dispositions, costs related to the closure, consolidation and integration of facilities, information technology infrastructure and legal entities, and severance and retention bonuses, any charges to establish accruals and reserves or to make payments associated with the reassessment or realignment of the business and operations of Holdings and its Subsidiaries (including, without limitation, the sale or closing of facilities, severance, stay bonuses and curtailments or modifications to pension and post-retirement employee benefit plans, asset impairments or asset disposals (including leased facilities), charges for purchase and lease commitments, start-up costs for new facilities, reserves for excess, obsolete or unbalanced inventories, relocation costs which are not otherwise capitalized, and any related promotional costs of exiting products or product lines, start up, transition, integration and other restructuring and business optimization costs,
(m)any amortization of debt discount under Accounting Standards Codification 470-20,
(n)any non-cash foreign translation gains and losses including, without limitation, in respect of Swap Agreements,
(o)accruals and reserves (including contingent liabilities) that are established or adjusted within twelve months after the Closing Date that are so required to be established as a result of the Transactions or other Permitted Acquisitions in accordance with GAAP, or changes as a result of adoption of modification of accounting policies, and
23


(p)any deferred tax expense associated with tax deductions or net operating losses arising as a result of the Transactions, or the release of any valuation allowance related to such items.
Consolidated Total Indebtedness” means at any time the sum, without duplication, of the aggregate Indebtedness of Holdings and its Restricted Subsidiaries consisting of obligations for borrowed money, Capital Lease Obligations and purchase money debt obligations and obligations evidenced by bonds, debentures, notes or similar instruments (other than Indebtedness with respect to Cash Management Agreements, Swap Agreements and intercompany Indebtedness), in each case that is of a type that would be reflected on a consolidated balance sheet of Holdings prepared as of such time in accordance with GAAP. For the avoidance of doubt and notwithstanding anything to the contrary contained above, Consolidated Total Indebtedness excludes (x) all Indebtedness incurred under a Qualified Securitization Financing or a Qualified Receivables Factoring and (y) letters of credit other than to the extent drawn and not reimbursed after two (2) Business Days.
Consolidated Working Capital” means, as at any date of determination, the excess of Current Assets over Current Liabilities.
Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative thereto.
Controlled Affiliate” has the meaning assigned to such term in Section 3.15.
Convertible Debt Security” means debt securities or other Indebtedness, the terms of which provide for conversion into, or exchange for, Equity Interests (other than Disqualified Equity Interests) of Holdings, cash in lieu thereof or a combination of Equity Interests and cash in lieu thereof.
Covered Jurisdiction” mean each of the United States (including any state or subdivision thereof), Luxembourg, Ireland and any other jurisdiction designated by Holdings and approved by the Administrative Agent, acting reasonably and in good faith.
Credit Agreement Refinancing Indebtedness” means any (a) Permitted Pari Passu Secured Refinancing Debt, (b) Permitted Junior Secured Refinancing Debt, (c) Permitted Unsecured Refinancing Debt or (d) Indebtedness incurred pursuant to a Refinancing Amendment, in each case, issued, incurred or otherwise obtained (including by means of the extension or renewal of existing Indebtedness) in exchange for, or to extend, renew, replace or refinance, in whole or part, existing Loans and Commitments (including any successive Credit Agreement Refinancing Indebtedness) (“Refinanced Debt”); provided that (i) such exchanging, extending, renewing, replacing or refinancing Indebtedness (including, if such Indebtedness includes any Other Refinancing Revolving Commitments, the unused portion of such Other Refinancing Revolving Commitments) is in an original aggregate principal amount not greater than the aggregate principal amount of the Refinanced Debt (and, in the case of Refinanced Debt consisting, in whole or in part, of unused Revolving Commitments, Incremental Revolving Commitments, Extended Revolving Commitments or Other Refinancing Revolving Commitments, the amount thereof) plus unpaid accrued interest and premium (including tender premium) thereon, any committed and undrawn amounts associated with, upfront fees and original issue discount (“OID”) on, and underwriting discounts, fees, commissions and expenses incurred in connection with, such exchanging, extending, renewing, replacing or refinancing Indebtedness, (ii) such Indebtedness has a final maturity date equal to or later than, and, except in the case of Other Refinancing Revolving Commitments, a Weighted Average Life to Maturity
24


equal to or greater than, the Refinanced Debt; provided that this clause (ii) shall not apply to (x) Permitted Pari Passu Secured Refinancing Debt in the form of Term A Facilities and (y) customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (ii)), (iii) such Indebtedness shall contain covenants and events of default that are either (x) no more restrictive (taken as a whole) to Holdings and its Restricted Subsidiaries than those included in this Agreement in all material respects as determined by Holdings in good faith or (y) are on market terms at the time of issuance, as determined by Holdings in good faith, which terms shall also be implemented for the benefit of the Initial Term Loans and the Revolving Loans; provided that Credit Agreement Refinancing Indebtedness in the form of Term A Facilities or revolving facilities may contain one or more financial maintenance covenants (and related events of default) irrespective of whether or not such covenants (and related events of default) are included in this Agreement for the benefit of the Term Loans (but such covenants shall be included for the benefit of the other Revolving Commitments), (iv) such Credit Agreement Refinancing Indebtedness may participate on a pro rata basis or a less than pro rata basis (but not a greater than pro rata basis) than the Initial Term Loans in mandatory prepayments under this Agreement and (v) such Refinanced Debt shall be repaid, defeased or satisfied and discharged, and all accrued interest, fees and premiums (if any) in connection therewith shall be paid, on the date such Credit Agreement Refinancing Indebtedness is issued, incurred or obtained.
Credit Event” means a Borrowing, the issuance, extension or increase in amount of a Letter of Credit, an LC Disbursement or any of the foregoing.
Credit Exposure” means, as to any Lender at any time, the sum of (a) such Lender’s Revolving Credit Exposure at such time, plus (b) an amount equal to the aggregate principal amount of its Term Loans outstanding at such time.
Cure Amount” has the meaning assigned to such term in Section 7.02(a).
Cure Expiration Date” has the meaning assigned to such term in Section 7.02(a).
Current Assets” means, at any time, the consolidated current assets (other than cash and Cash Equivalents, the current portion of current and deferred Taxes, permitted loans made to third parties, assets held for sale, available for sale Investments, pension assets, deferred bank and financing fees and derivative financial instruments including any Swap Agreements) of Holdings and its Restricted Subsidiaries.
Current Liabilities” means, at any time, the consolidated current liabilities of Holdings and its Restricted Subsidiaries at such time, but excluding, without duplication, (a) the current portion of any long-term Indebtedness or any Swap Agreements, (b) outstanding revolving loans and undrawn letters of credit, (c) the current portion of interest expense, (d) the current portion of any Capital Lease Obligations, (e) the current portion of current and deferred Taxes, (f) liabilities in respect of unpaid earn-outs, (g) the current portion of any other long-term liabilities, (h) accruals relating to restructuring reserves, (i) liabilities in respect of funds of third parties on deposit with Holdings and its Restricted Subsidiaries, (j) deferred revenue arising from cash receipts and (k) advances and deposits from customers accounted for as unearned income.
Daily Simple RFR” means, for any day (an “RFR Interest Day”), an interest rate per annum equal to (x) SONIA for the day that is 5 RFR Business Days prior to (i) if such RFR Interest Day is an RFR Business Day, such RFR Interest Day or (ii) if such RFR Interest Day is not an RFR Business Day, the RFR Business Day immediately preceding such RFR Interest Day (such RFR Business Day determined pursuant to each of subclauses (i) and (ii), the “RFR Lookback Day”), (y) if SONIA is not available for the RFR Lookback Day determined pursuant to clause (x) above, the Daily Simple RFR for such RFR Lookback Day shall be the percentage
25


rate per annum which is the aggregate of (I) the Central Bank Rate for such RFR Lookback Day and (II) the applicable Central Bank Rate Adjustment or (z) if clause (y) applies but the Central Bank Rate for the applicable RFR Lookback Day is not available, the Daily Simple RFR for such RFR Lookback Day shall be the percentage rate per annum which is the aggregate of (I) the most recent Central Bank Rate for an RFR Business Day which is no more than five RFR Business Days before that RFR Lookback Day and (II) the applicable Central Bank Rate Adjustment; provided that, with respect to Revolving Loans, such rate shall not be less than zero.
Debtor Relief Law” means the Bankruptcy Code, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, examinership or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.
Declined Prepayment Amount” has the meaning assigned to such term in Section 2.11(e).
Declining Term Lender” has the meaning assigned to such term in Section 2.11(e).
Default” means any event or condition which constitutes an Event of Default or which upon notice, lapse of time or both would, unless cured or waived, become an Event of Default.
Defaulting Lender” means, subject to Section 2.26, any Lender that (a) has failed within two (2) Business Days of the date required to be funded or paid, to (i) fund all or any portion of its Loans, (ii) fund all or any portion of its participations in Letters of Credit or Swingline Loans or (iii) pay over to any Secured Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent and the Applicable Borrower in writing that such failure is the result of such Lender’s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) has notified the Applicable Borrower and the Administrative Agent in writing that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three (3) Business Days after written request by the Administrative Agent or the Applicable Borrower, to confirm in writing to the Administrative Agent and the Applicable Borrower that it will comply with its prospective funding obligations hereunder (provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Applicable Borrower), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity, or (iii) become the subject of a Bail-In Action; provided that a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting
26


Lender (subject to Section 2.26) upon delivery of written notice of such determination to the Applicable Borrower and each Lender.
Deferred Acquisition Consideration” means any purchase price adjustments, contingent or other deferred payment payments of a similar nature (including any non-compete payments and consulting payments) made in connection with any Permitted Acquisition or other acquisition permitted under this Agreement.
Designated Non-Cash Consideration” means the fair market value of non-cash consideration received by Holdings or a Restricted Subsidiary in connection with a Disposition pursuant to Section 6.03(a) that is designated as Designated Non-Cash Consideration pursuant to a certificate of Holdings, setting forth the basis of such valuation (which amount will be reduced by the fair market value of the portion of the non-cash consideration converted to cash or Cash Equivalents within one hundred eighty (180) days following the consummation of the applicable Disposition; provided that any such consideration once converted to cash and/or Cash Equivalents, shall be deemed to constitute Net Proceeds received on the date such applicable Designated Non-Cash Consideration was converted to cash and/or Cash Equivalents and shall be subject to Section 2.11(c)(i)).
Designated Representative” means, with respect to any series of Alternative Incremental Facility Indebtedness, Permitted Pari Passu Secured Refinancing Debt, Permitted Junior Secured Refinancing Debt or Ratio Debt, the trustee, administrative agent, collateral agent, security agent or similar agent hereunder or under the agreement pursuant to which such Indebtedness is issued, incurred or otherwise obtained, as the case may be, and each of their successors in such capacities.
Disposition” means a sale, transfer, lease, disposition or exclusive license, including any “Disposition” by means of a merger, consolidation or similar transaction. “Dispose” and “Disposed” as to any assets subject to a Disposition shall have a corollary meaning.
Disposition Consideration” means for any Disposition, the aggregate fair market value of any assets sold, transferred, leased, licensed or otherwise disposed of.
Disqualified Equity Interest” means, with respect to any Person, any Equity Interest in such Person that by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable, either mandatorily or at the option of the holder thereof), or upon the happening of any event or condition:
(1)matures or is mandatorily redeemable (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests), whether pursuant to a sinking fund obligation or otherwise;
(2)is convertible or exchangeable at the option of the holder thereof for Indebtedness or Equity Interests (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests); or
(3)is or may be redeemable (other than solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity Interests and cash in lieu of fractional shares of such Equity Interests) or is or may be required to be repurchased by such Person or any of its Affiliates (other than, at the option of such Person, solely for Equity Interests in such Person or of Holdings that do not constitute Disqualified Equity
27


Interests and cash in lieu of fractional shares of such Equity Interests), in whole or in part, at the option of the holder thereof;
in each case, on or prior to the date that occurs 91 days after the Latest Maturity Date; provided, however, that any Equity Interests that would not constitute Disqualified Equity Interest but for provisions thereof giving holders thereof the right to require such Person to purchase or redeem such Equity Interests upon the occurrence of an “asset sale,” “fundamental change” or “change of control” occurring prior to the date that is 91 days after the Latest Maturity Date shall not constitute Disqualified Equity Interest if the “asset sale,” “fundamental change” or “change of control” provisions applicable to such Equity Interests are not more favorable to the holders of such Equity Interests than Section 6.03 and the provisions relating to a Change of Control contained herein; provided, further, however, that if such Equity Interests is issued to any plan for the benefit of directors, managers, employees or consultants of Holdings or its Subsidiaries or by any such plan to such directors, managers, employees or consultants, such Equity Interests shall not constitute Disqualified Equity Interest solely because it may be required to be repurchased by Holdings or its Subsidiaries in order to satisfy applicable statutory or regulatory obligations or as a result of such employee’s, director’s, officer’s, management member’s or consultant’s termination, death or disability.
The amount of any Disqualified Equity Interest that does not have a fixed redemption, repayment or repurchase price will be calculated in accordance with the terms of such Disqualified Equity Interest as if such Disqualified Equity Interest were redeemed, repaid or repurchased by the issuer thereof on any date on which the amount of such Disqualified Equity Interest is to be determined hereunder; provided, however, that if such Disqualified Equity Interest could not be required to be repurchased by the issuer thereof at the time of such determination, the repurchase price will be the book value of such Disqualified Equity Interest as reflected in the most recent financial statements of such Person.
Disqualified Lender” means (a) certain banks, financial institutions and other institutional lenders that have been specified by Holdings in writing to Citi prior to March 18, 2021, (b) any of Holdings, the Target’s or their respective Subsidiaries’ competitors that have been specified to (i) the Lead Arrangers by Holdings in writing before the Closing Date or (ii) to the Administrative Agent by Holdings in writing after the Closing Date at any time and from time to time and (c) in the case of each of clauses (a) and (b), any of their respective affiliates (other than any bona fide debt funds) that are either (x) identified in writing to the Lead Arrangers or, after the Closing Date, the Administrative Agent by Holdings from time to time or (y) clearly identifiable as affiliates of such persons on the basis of such affiliate’s name; provided that the foregoing provisions shall not apply retroactively to disqualify any person if such person shall have become a Lender or participant prior to such person’s designation as a Disqualified Lender, but shall disqualify such person from taking any further assignment, transfer, allocation or participation after such designation.
Dollar Amount” of any currency at any date means (i) the amount of such currency if such currency is Dollars or (ii) the equivalent in such currency of Dollars if such currency is a Foreign Currency, calculated on the basis of the Exchange Rate for such currency, on or as of the most recent Computation Date provided for in Section 2.04.
Dollar Equivalent” shall mean, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in any Alternate Currency, the Equivalent Amount thereof in Dollars as determined by the Administrative Agent or relevant Issuing Bank, as applicable, at such time on the basis of the spot rate (determined in respect of the most recent Computation Date or other applicable date of determination) for the purchase of Dollars with such Alternate Currency.
Dollars” or “$” refers to lawful money of the United States of America.
28


Domestic Subsidiary” means a Subsidiary organized under the laws of the United States, any state thereof or the District of Columbia.
Drug Development Fund” means a fund, the primary business purpose of which is to invest in the development of pharmaceutical products or investigational medicinal products or devices, in which Holdings or any of its Restricted Subsidiaries owns a minority of the Equity Interests.
ECF Payment Amount” has the meaning assigned to such term in Section 2.11(c)(iii).
ECP” means an “eligible contract participant” as defined in the Commodity Exchange Act and the regulations thereunder.
EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.
EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein and Norway.
EEA Resolution Authority” means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.
Effective Yield” means, as to any Loans of any Class, the effective yield on such Loans as determined by Holdings in good faith, taking into account the applicable interest rate margins, any interest rate floors or similar devices, all recurring fees and other fees, including upfront or similar fees or original issue discount (amortized over the shorter of (x) the Weighted Average Life to Maturity of such Loans and (y) the four years following the date of incurrence thereof) payable generally to Lenders making such Loans, but excluding (i) any arrangement, structuring, commitment, ticking, underwriting or similar fees or other fees payable in connection therewith that are not generally shared with the Lenders thereunder and (ii) any customary consent fees paid generally to consenting Lenders.
Eligible Transferee” means an “accredited investor” (as defined in regulation D of the Securities Act) that (w) is not a natural person, (x) is not a Defaulting Lender, in each case at the time of the respective assignment or participation to such Person, (y) has provided any documentation required pursuant to the provisions of Section 2.17 and (z) is not a Disqualified Lender.
Enforcement Event” has the meaning assigned to such term in Schedule 1.01A.
Environmental Laws” means all applicable laws, rules, regulations, codes, ordinances, or binding orders, decrees, judgments, injunctions, notices or agreements issued, promulgated or entered into by any Governmental Authority, relating to pollution or protection of the environment, including management or reclamation of natural resources, and the management, Release or threatened Release of any Hazardous Material or to occupational health and safety matters, as such occupational health and safety matters relate to exposure or handling of Hazardous Materials.
Environmental Liability” means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), directly
29


or indirectly resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage or treatment of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release or threatened Release of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.
Equity Interests” means shares of capital stock, partnership interests, membership interests in a limited liability company, shares (parts sociales) in a Luxembourg private limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any of the foregoing; provided that “Equity Interests” shall not include Convertible Debt Securities.
Equivalent Amount” of any currency with respect to any amount of Dollars at any date shall mean the equivalent in such currency of such amount of Dollars, calculated on the basis of the Exchange Rate for such other currency at 11:00 a.m., London time, on the date on or as of which such amount is to be determined.
ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time.
ERISA Affiliate” means any trade or business (whether or not incorporated) that, together with Holdings, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of the Code.
ERISA Event” means (a) any “reportable event”, as defined in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30-day notice period is waived); (b) failure to satisfy the minimum funding standard under Section 412 of the Code or Section 302 of ERISA, whether or not waived; (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA of an application for a waiver of the minimum funding standard with respect to any Plan; (d) the incurrence by Holdings or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan other than any PBGC premiums due but not delinquent under Section 4007 of ERISA; (e) a determination that any Plan is, or is reasonably expected to be, considered an at-risk plan within the meaning of Section 430 of the Code or Section 303 of ERISA; (f) the receipt by Holdings or any ERISA Affiliate from the PBGC or a plan administrator of any written notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan; (g) the incurrence by Holdings or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal of Holdings or any of its ERISA Affiliates from any Multiemployer Plan; (h) the receipt by Holdings or any ERISA Affiliate of any notice that a Multiemployer Plan is, or is expected to be insolvent within the meaning of Title IV of ERISA; or (i) the receipt by Holdings or any ERISA Affiliate of any notice that a Multiemployer Plan is in endangered or critical status under Section 432 of the Code or Section 305 of ERISA; (j) the occurrence of any event which triggers the full or partial wind up of any occupational pension scheme (within the meaning of section 2 of the Irish Pensions Act 1990 (as amended) (the “Pensions Act”)) sponsored by Holdings or its Subsidiaries (an “Irish Pension Scheme”); (k) the failure by an Irish Pension Scheme to meet the funding standard prescribed by Part IV of the Pensions Act as at a date in relation to which the trustees of the Irish Pension Scheme are required to cause an actuarial funding certificate to be prepared in accordance with the Pensions Act; (l) where any funding proposal (within the meaning of section 49 of the Pensions Act) which has been put in place to address a deficit within an Irish Pension Scheme goes off track (within the meaning of the Irish Pensions Authority’s prescribed guidance under section 49 of the Pensions Act, “the Irish Pensions Authority” being the body established under Part II of the Pensions Act); (m) where a prosecution for an offence is brought under section 3 of the Pensions Act against the sponsoring employer or trustees concerning an Irish Pension Scheme or where the Irish Pensions
30


Authority brings proceedings before the Irish High Court concerning an Irish Pension Scheme under Part IX of the Pensions Act; (n) where the Irish Pensions Authority commences an investigation of or appoints an authorised officer over an Irish Pension Scheme in accordance with its powers under Part II of the Pensions Act, or where the Irish Pensions Authority issues to the trustees of an Irish Pension Scheme an advisory notice (within the meaning of section 26M of the Pensions Act) or a notice to trustees to provide an external report (within the meaning of section 26N of the Pensions Act); (o) where the Irish Financial Services and Pensions Ombudsman (being the person appointed as the “Ombudsman” under section 8(1)(a) of the Financial Services and Pensions Ombudsman Act 2017 (as amended)) either makes a determination against or brings enforcement proceedings against the sponsoring employer or the trustees concerning an Irish Pension Scheme; (p) where any arbitration proceedings or proceedings before the Irish High Court are initiated relating to a dispute between the sponsoring employer and/or the trustees and/or members (whether potential or actual) and/or beneficiaries (whether potential or actual) of an Irish Pension Scheme; or (q) the failure by Holdings or its Subsidiaries to remit contributions to an Irish Pension Scheme within the prescribed period set out in section 58A of the Pensions Act or failure by Holdings or its Subsidiaries to pay any other contributions to an Irish Pension Scheme which may be required under the terms of the Irish Pensions Scheme within a reasonable period after the due date for payment of such contributions.
Erroneous Payment” has the meaning assigned to it in Section 8.02(a).
Erroneous Payment Deficiency Assignment” has the meaning assigned to it in Section 8.02(d).
Erroneous Payment Impacted Class” has the meaning assigned to it in Section 8.02(d).
Erroneous Payment Return Deficiency” has the meaning assigned to it in Section 8.02(d).
Erroneous Payment Subrogation Rights” has the meaning assigned to it in Section 8.02(d).
EU” means the European Union.
EU Bail-In Legislation Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.
EURIBOR Rate” means, for any Interest Period when used in reference to any Loan or Borrowing denominated in euros, (a) the rate of interest (rounded upwards, if necessary, to the nearest 1/100th) appearing on the applicable Bloomberg screen (or on any successor or substitute page of such service, or any successor to such service as determined by Administrative Agent) (the “EURIBOR Screen Rate”) as the Euro interbank offered rate for deposits in Euros for a term comparable to such Interest Period, at approximately 11:00 a.m. (Brussels time) on the date which is two Business Days prior to the commencement of such Interest Period (but if more than one rate is specified on such page, the rate will be an arithmetic average of all such rates) and (b) if such rate is not available at such time for any reason, then the “EURIBOR Rate” for such Interest Period shall be the interest rate per annum reasonably determined by the Administrative Agent in good faith to be the rate per annum at which deposits in euros for delivery on the first day of such Interest Period in immediately available funds in the approximate amount of the Eurocurrency Rate Loan being made, continued or converted by the Administrative Agent and with a term equivalent to such Interest Period would be offered to the Administrative Agent by major banks in the London or other offshore interbank market for Euros at their request at approximately 11:00 a.m. (Brussels time) two Business Days prior to the commencement of such Interest Period; provided that, to the extent that an interest rate is not ascertainable pursuant to the foregoing
31


provisions of this definition, “EURIBOR Rate” shall be the interest rate per annum equal to the Interpolated Screen Rate.
EURIBOR Screen Rate” has the meaning assigned to such term in the definition of “EURIBOR Rate”.
euro” and/or “EUR” means the single currency of the Participating Member States.
Eurocurrency” when used in reference to a currency, means an Agreed Currency (other than Dollars), and when used in reference to any Loan or Borrowing, means that such Loan, or the Loans comprising such Borrowing, bears interest at a rate determined by reference to the Eurocurrency Rate (other than any ABR Loan or ABR Borrowing).
Eurocurrency Payment Office” of the Administrative Agent means, for each Foreign Currency, the office, branch, affiliate or correspondent bank of the Administrative Agent for such currency as specified from time to time by the Administrative Agent to Holdings and each Lender.
Eurocurrency Rate” means (a) in the case of Loans denominated in an Agreed Currency other than euros and Pounds Sterling, the Adjusted LIBO Rate or (b) in the case of Loans denominated in euros, the Adjusted EURIBOR Rate.
Event of Default” has the meaning assigned to such term in Section 7.01.
Excess Cash Flow” means, for any period, an amount equal to the excess of:
(a)the sum, without duplication, of:
(i)Consolidated Net Income of the Group for such period;
(ii)an amount equal to the amount of all non-cash charges (including depreciation and amortization) to the extent deducted in arriving at such Consolidated Net Income, but excluding any such non-cash charges representing an accrual or reserve for potential cash items in any future period and excluding amortization of a prepaid cash item that was paid in a prior period; and
(iii)decreases in Consolidated Working Capital for such period (measured as the decrease, if any, of Consolidated Working Capital at the beginning of such Excess Cash Flow Period compared to Consolidated Working Capital at the end of such Excess Cash Flow Period); provided that any such decreases arising from acquisitions or dispositions by Holdings and its Restricted Subsidiaries completed during such period and the effect of reclassification during such period of current assets to long-term assets and current liabilities to long-term liabilities shall be excluded; over
(b)the sum, without duplication, of:
(i)an amount equal to the amount of all non-cash credits included in arriving at such Consolidated Net Income (but excluding any non-cash credit to the extent representing the reversal of an accrual or reserve described in clause (a)(ii) above) and cash charges, expenses and losses excluded by virtue of clauses (a) through (p) of the definition of “Consolidated Net Income;”
(ii)without duplication of amounts deducted pursuant to this clause (ii) in prior fiscal years, the aggregate amount of all principal payments of Indebtedness of
32


Holdings and its Restricted Subsidiaries (including (A) the principal component of payments in respect of Capital Lease Obligations and (B) the amount of any scheduled repayment of Term Loans pursuant to Section 2.10 and mandatory prepayment of Term Loans pursuant to Section 2.11 to the extent required due to a Disposition or casualty event that resulted in an increase to such Consolidated Net Income and not in excess of the amount of such increase, but excluding (W) all other prepayments of Term Loans (other than prepayments referred to in clause (B) above)), (X) all prepayments of Revolving Loans and Swingline Loans, except to the extent there is an equivalent permanent reduction in commitments thereunder, (Y) all prepayments in respect of any other revolving credit facility, except to the extent there is an equivalent permanent reduction in commitments thereunder and (Z) payments of any Subordinated Indebtedness (except to the extent permitted to be paid pursuant to Section 6.04) made during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case of clauses (A) and (B) above, except to the extent financed with the proceeds of other long term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness));
(iii)an amount equal to the aggregate net non-cash gain on dispositions by Holdings and its Restricted Subsidiaries during such period (other than dispositions in the ordinary course of business) to the extent included in arriving at such Consolidated Net Income;
(iv)increases in Consolidated Working Capital for such period (measured as the increase, if any, of Consolidated Working Capital at the beginning of such Excess Cash Flow Period compared to Consolidated Working Capital at the end of such Excess Cash Flow Period); provided (x) any such increases arising from acquisitions or dispositions by Holdings and its Restricted Subsidiaries completed during such period and the effect of reclassification during such period of current assets to long-term assets and current liabilities to long-term liabilities shall be excluded;
(v)cash payments by Holdings and its Restricted Subsidiaries during such period in respect of long-term liabilities of Holdings and its Restricted Subsidiaries (other than Indebtedness) to the extent such payments are not expensed during such period or are not deducted in calculating Consolidated Net Income, except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness);
(vi)without duplication of amounts deducted under Sections 2.11(c)(iii)(b)(3), (4) and (5), the aggregate amount of expenditures actually made by Holdings and its Restricted Subsidiaries from internally generated cash flow of Holdings and its Restricted Subsidiaries in cash during such period (including expenditures for the payment of financing fees) to the extent that such expenditures are not expensed during such period or are not deducted (or were excluded) in calculating Consolidated Net Income;
(vii)the aggregate amount of any premium, make-whole or penalty payments actually paid in cash by Holdings and its Restricted Subsidiaries during such period that are made in connection with any prepayment of Indebtedness to the extent such payments are not expensed during such period or are not deducted in calculating Consolidated Net Income;
(viii)the amount of cash Taxes paid or payable in respect of the period which have been accrued at the end of the period under GAAP, together with any increase in reserves which have been set aside (without duplication) in such period, to the extent they
33


exceed the amount of tax expense deducted in determining Consolidated Net Income for such period;
(ix)cash expenditures in respect of Swap Agreements during such fiscal year to the extent not deducted in arriving at such Consolidated Net Income; and
(x)the amount of Restricted Payments pursuant to clauses (i), (iv), (v), (vi), (xiv), (xviii), (xxii) and (xxvii) of Section 6.04(b) paid in cash during such period, in each case, to the extent such Restricted Payments were financed with internally generated cash flow of Holdings and its Restricted Subsidiaries.
Notwithstanding anything to the contrary herein, for purposes of calculating “Excess Cash Flow”, Consolidated Net Income shall not be calculated on a Pro Forma Basis and for the avoidance of doubt, the Consolidated Net Income of a Person acquired in any Permitted Acquisition or other acquisition during an Excess Cash Flow Period shall be included in such calculation for such Excess Cash Flow Period only from and after the date of the consummation of such Permitted Acquisition or similar acquisition.
Excess Cash Flow Period” means each fiscal year of Holdings commencing with the fiscal year ended December 31, 2022.
Exchange Rate” means, on any day, with respect to any Foreign Currency, the rate at which such Foreign Currency may be exchanged into Dollars, as set forth at approximately 11:00 a.m., Local Time, on such date on the applicable Bloomberg screen page for such Foreign Currency. In the event that such rate does not appear on any Bloomberg screen page, the Exchange Rate with respect to such Foreign Currency shall be determined by reference to such other publicly available service for displaying exchange rates as may be reasonably selected by the Administrative Agent or, in the event no such service is selected, such Exchange Rate shall instead be calculated on the basis of the arithmetical mean of the buy and sell spot rates of exchange of the Administrative Agent for such Foreign Currency on the London market at 11:00 a.m., Local Time, on such date for the purchase of Dollars with such Foreign Currency, for delivery two (2) Business Days later; provided that if at the time of any such determination, for any reason, no such spot rate is being quoted, the Administrative Agent, after consultation with Holdings, may use any reasonable method it deems appropriate to determine such rate, and such determination shall be conclusive absent manifest error.
Excluded Accounts” means (i) accounts used exclusively for payroll, (ii) accounts used exclusively for payroll taxes and/or withheld income taxes, (iii) accounts used exclusively for employee wage and benefit payments, (iv) escrow accounts and trust accounts, in each case entered into in the ordinary course of business and consistent with prudent business practice conduct where the applicable Loan Party holds the funds exclusively for the benefit of one or more unaffiliated third parties, (v) accounts exclusively used to secure letters of credit, bank guarantees, obligations under Cash Management Agreements and obligations under Swap Agreements, in each case, to the extent constituting Permitted Liens and (vi) accounts exclusively used to hold deposits from customers that are required pursuant to agreements with such customers to be held in a segregated account that, pursuant to such agreements, is not permitted to be subject to a Lien securing the Obligations.
Excluded Assets” means (i) any fee-owned real property and any leasehold interests in real property (other than the Headquarters); (ii) motor vehicles and other assets subject to certificates of title; (iii) pledges and security interests prohibited by applicable law, rule or regulation (including any requirement to obtain the consent of any governmental authority or third party) after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or similar provisions under applicable law and other than proceeds and receivables thereof
34


the assignment of which is expressly deemed effective under the Uniform Commercial Code or other applicable law notwithstanding such prohibition (iv) Margin Stock and Equity Interests in any Person other than wholly-owned Subsidiaries, to the extent a pledge of such Equity Interests is prohibited by the Organizational Documents, or agreements with other equity holders, of such equity; (v) voting Equity Interests in any Restricted Subsidiary of any U.S. Corporate Subsidiary that is a CFC or FSHCO to the extent such Equity Interest exceeds 65% of the outstanding voting Equity Interests of such CFC or FSHCO; (vi) assets to the extent a security interest in such assets could reasonably result in a material adverse Tax consequence to Holdings or any of its Restricted Subsidiaries (including as a result of the operation of Section 956 of the Code or any similar law or regulation in any applicable jurisdiction) as reasonably determined by the Borrowers in consultation with the Administrative Agent; (vii) any lease, license or other agreement and any property subject to a permitted purchase money security interest or similar permitted arrangement or Lien permitted by clauses (4), (5), (7) (solely in respect of Liens referenced in clauses (4), (5) and (11) of the definition of “Permitted Liens”), (9) (with respect to cash collateral or deposits), (11), (16), (19), (22) (with respect to cash collateral or deposits with a value not in excess of $50,000,000), (27) and (34) of the definition of “Permitted Liens” to the extent that a grant of a security interest therein would violate or invalidate such lease, license, contract, property right or agreement or purchase money arrangement or the documents governing such Permitted Lien or create a right of termination in favor of any other party thereto (other than a Loan Party), in each case (other than with respect to property subject to such purchase money interests or similar arrangements or Lien permitted by clauses (4), (5), (7) (solely in respect of Liens referenced in clauses (4), (5) and (11) of the definition of “Permitted Liens”) or (11) of the definition of “Permitted Liens”), after giving effect to the applicable anti-assignment provisions of the Uniform Commercial Code or similar provisions under applicable law other than proceeds and receivables thereof and only so long as the applicable provision giving rise to such violation or invalidity or such right of termination was not incurred in anticipation of this Agreement; (viii) those assets as to which the Administrative Agent and the Borrowers reasonably agree that the cost (including, without limitation, costs of notarization, taxes, stamp duties, registration or other applicable fees), consequences or burden of obtaining such a security interest or perfection thereof are excessive in relation to the benefit to the Lenders of the security to be afforded thereby; (ix) any of the capital stock of Restricted Subsidiaries not owned directly by a Loan Party; (x) any governmental licenses or state or local franchises, charters and authorizations, to the extent security interests in such licenses, franchises, charters or authorizations are prohibited or restricted thereby after giving effect to the applicable anti-assignment provisions of the UCC or similar provisions under applicable law, and other than proceeds and receivables thereof, the assignment of which is expressly deemed effective under the Uniform Commercial Code or other applicable law notwithstanding such prohibition (xi) any assets to the extent expressly excluded pursuant to the Agreed Guarantee and Security Principles; (xii) any “intent-to-use” applications for trademarks or service marks filed in the United States Patent and Trademark Office (“PTO”), or any successor office thereto or any successor office thereto, prior to the filing and acceptance of a “Statement of Use” or “Amendment to Allege Use” with respect thereto, only to the extent, if any, that, and solely during the period, if any, in which, the grant of a security interest therein would impair the validity or enforceability of such intent-to-use application or any registration that issues from such intent-to-use application under applicable federal Law; (xiii) any Excluded Accounts; (xiv) letter-of-credit rights (except to the extent a security interest therein can be perfected by the filing of UCC financing statements or similar filings under applicable law) (it being understood that no actions shall be required to perfect a security interest in letter of credit rights, other than the filing of a Uniform Commercial Code financing statement or applicable filings under applicable law); (xv) any commercial tort claim with a value not in excess of $10,000,000; (xvi) [reserved]; (xvii) [reserved]; (xviii) Equity Interests in Unrestricted Subsidiaries; and (xiv) Equity Interests in Securitization Subsidiaries, to the extent a pledge of such Equity Interests is prohibited by the applicable Qualified Securitization Financing and Securitization Assets sold or pledged pursuant to a Qualified Securitization Financing or a Qualified Receivables Factoring. In addition notwithstanding anything to the contrary herein or in any Loan Documents, the following assets shall not be required to be subject to a fixed charge in Ireland: (a) all plant and equipment, in
35


each case, located in Ireland and (b) customer contracts or other agreements with third parties (including, without limitation, distribution agreements, license agreements or similar agreements); provided that, for the avoidance of doubt, the Headquarters shall be subject to a fixed charge in Ireland.
Excluded Subsidiary” means (a) any Foreign Subsidiary of any U.S. Corporate Subsidiary and, in the case of any such Foreign Subsidiary that is a CFC, any Subsidiary of such CFC; provided that this clause (a) shall not apply at any time after the Closing Date to any entity that is a Restricted Subsidiary of Holdings on the Closing Date unless this clause (a) applied to such entity on the Closing Date, (b) any Domestic Subsidiary of any U.S. Corporate Subsidiary that has no material assets other than equity interests and/or indebtedness of one or more (1) Foreign Subsidiaries of any U.S. Corporate Subsidiary that are excluded under clause (a) or (2) entities described in clause (b)(1) (a “FSHCO”), (c) any Subsidiary that is prohibited or restricted by applicable law, rule or regulation or by any contractual obligation existing on the Closing Date or at the time of acquisition thereof after the Closing Date and not in contemplation thereof, in each case, from guaranteeing the Loans or which would require governmental (including regulatory) consent, approval, license or authorization to provide a guarantee unless such consent, approval, license or authorization has been received or a Subsidiary a guarantee from which could reasonably result in a material adverse Tax consequence to Holdings or any of its Subsidiaries (including as a result of the operation of Section 956 of the Code or any similar law or regulation in any applicable jurisdiction) as reasonably determined by the Borrowers, in consultation with the Administrative Agent, (d) not-for-profit Subsidiaries, if any, (e) certain special purpose entities, (f) captive insurance companies, if any, (g) any Subsidiary where the Administrative Agent and the Borrowers agree the cost, consequences or burden of obtaining a guarantee by such Subsidiary would be excessive in light of the practical benefit to the Lenders afforded thereby, (h) each Subsidiary listed on Schedule 1.01D hereto, (i) any non-wholly-owned Subsidiaries, (j) at the option of Holdings, any Subsidiary that is not a Material Subsidiary and (k) any Securitization Subsidiary.
Excluded Swap Obligation” means, with respect to any Guarantor, (x) as it relates to all or a portion of the Guarantee of such Guarantor, any Swap Obligation if, and to the extent that, such Swap Obligation (or any Guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor’s failure for any reason to constitute an “eligible contract participant” as defined in the Commodity Exchange Act and the regulations thereunder at the time the Guarantee of such Guarantor becomes effective with respect to such Swap Obligation or (y) as it relates to all or a portion of the grant by such Guarantor of a security interest, any Swap Obligation if, and to the extent that, such Swap Obligation (or such security interest in respect thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor’s failure for any reason to constitute an “eligible contract participant” as defined in the Commodity Exchange Act and the regulations thereunder at the time the security interest of such Guarantor becomes effective with respect to such Swap Obligation. If a Swap Obligation arises under a master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to swaps for which such Guarantee or security interest is or becomes illegal.
Excluded Taxes” means, with respect to any payments made to the Administrative Agent, any Lender or any other recipient of any payment to be made by or on account of any obligation of any Loan Party under any Loan Document, (a) Taxes imposed on (or measured by) net income, franchise or similar Taxes, and branch profits Taxes (in each case, however denominated), in each case imposed by the jurisdiction under the laws of which such recipient is organized, or in which it carries on a trade or business or is deemed to be a resident for tax purposes, or in which its principal office is located or, in the case of any Lender, in which its
36


applicable lending office is located or as a result of any other present or former connection between such recipient and the jurisdiction (other than a connection arising solely as a result of it having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document), (b) in the case of a Lender, any U.S. federal withholding Tax that is imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan, Letter of Credit or Commitment pursuant to a Legal Requirement in effect on the date on which (i) such Lender acquires such interest in the Loan, Letter of Credit or Commitment (other than pursuant to an assignment request by Holdings under Section 2.19(b)) or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.17(a), amounts with respect to such Taxes were payable either to such Lender's assignor immediately before such Lender acquired such applicable interest in the applicable Loan, Letter of Credit or Commitment or to such Lender immediately before it changed its lending office, (c) any Taxes attributable to such Person's failure to comply with Section 2.17(e) or (h), (d) any Tax that is imposed pursuant to FATCA, (e) in the case of a Revolving Lender, solely with respect to any Revolving Loan, Extended Revolving Loan or Incremental Revolving Loan, in each case, extended to a Revolving Borrower that is tax resident in the Republic of Ireland, any Irish Tax that would not have been imposed (i) if the Revolving Lender had been an Irish Qualifying Lender but on that date the Revolving Lender is not or has ceased to be an Irish Qualifying Lender other than as a result of any change after the date it became a Revolving Lender under this Agreement in (or in the interpretation, administration or application of) any law or Treaty or any law or published practice or concession of any relevant tax authority or (ii) where the relevant Revolving Lender is an Irish Qualifying Lender solely on account of being an Irish Treaty Lender and that Lender has not complied with its obligations under Section 2.17(e), (f)(i) any Luxembourg withholding tax due under the so-called Luxembourg Relibi Law dated 23 December 2005 by the Grand-Duchy of Luxembourg and (ii) Luxembourg registration duties (droits d’enregistrement) payable due to a registration, submission or filing by the Administrative Agent, a Lender or an Issuing Bank of any Loan Document, except if such registration, submission or filing is required to maintain, establish, enforce or preserve the rights of the Administrative Agent, a Lender or an Issuing Bank under such Loan Document, and (g) any U.S. federal backup withholding tax imposed under Section 3406 of the Code (or any successor provision). For the avoidance of doubt, (1) for purposes of this definition of “Excluded Taxes,” the terms “Lender” and “Revolving Lender” shall include any Issuing Bank and any Swingline Lender and (2) for purposes of clause (e) of this definition of “Excluded Taxes,” the term “Revolving Loan” shall include any Letter of Credit and any Swingline Loan.
Executive Order No. 13224” shall mean the Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001, as the same as been, or shall hereafter be, renewed, extended, amended or replaced.
Existing Revolving Credit Agreement” means the Multicurrency Revolving Facility Agreement, dated as of March 12, 2018, by and among Icon Public Limited Company, Icon Investments Five Unlimited Company, Santander UK PLC, as agent, and the lenders party thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).
Extended Commitments” means the Extended Term Loan Commitments and the Extended Revolving Commitments.
Extended Loan” means the Extended Term Loans and the Extended Revolving Loans.
Extended Revolving Commitment” shall have the meaning given to such term in Section 2.22(a)(iii).
37


Extended Revolving Loans” means Revolving Loans made by one or more Lenders to the Borrowers pursuant to Section 2.22.
Extended Term Loan” shall have the meaning given to such term in Section 2.22(a)(ii).
Extended Term Loan Commitment” means the commitment of any Lender, established pursuant to Section 2.22, to make Extended Term Loans to the Applicable Borrower.
Extending Revolving Lender” shall have the meaning given to such term in Section 2.22(a)(iii).
Extension” shall have the meaning given to such term in Section 2.22(a).
Extension Amendment” means any amendment entered into pursuant to Section 2.22(c).
Extension Offer” shall have the meaning given to such term in Section 2.22(a).
Facility Office” means the office or offices through which the Lender will perform its obligations under this Agreement.
FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof, any agreements entered into pursuant to current Section 1471(b)(1) of the Code (or any amended or successor version described above) and any intergovernmental agreement, treaty, convention or similar agreement among Governmental Authorities (and related legislation, official regulations or other administrative guidance) implementing any of the foregoing.
Federal Funds Effective Rate” means, for any day, the weighted average (rounded upwards, if necessary, to the next 1/100 of 1%) of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average (rounded upwards, if necessary, to the next 1/100 of 1%) of the quotations for such day for such transactions received by the Administrative Agent from three Federal funds brokers of recognized standing selected by it.
Financial Covenant” means the covenant specified in Section 6.12(a).
Financial Covenant Cross Default” shall have the meaning given to such term in Section 7.01(d).
Financial Covenant Event of Default” shall have the meaning given to such term in Section 7.01(d).
Financial Covenant Material Acquisition” shall mean an acquisition (or series of related acquisitions (being acquisitions which form part of the same overall sale and purchase transaction)) within the six month period prior to the relevant Test Period by any member of the Group where the aggregate consideration of such acquisition or related acquisitions is greater than $50.0 million.
Financial Officer” means the chief financial officer, principal accounting officer, treasurer or controller of Holdings.
38


First Amendment” means the First Amendment to the Credit Agreement, dated as of November 29, 2022, by and among Holdings and the Administrative Agent.
“First Amendment Effective Date” shall have the meaning assigned to such term in the First Amendment.
First Lien Intercreditor Agreement” means a “pari passu” Intercreditor Agreement, among the Collateral Agent, the Administrative Agent and one or more Designated Representatives for holders of Indebtedness that is secured by Collateral on a basis pari passu with the Liens securing the Obligations, in the form of Exhibit E-1 or any other form approved by Holdings, the Administrative Agent and the Collateral Agent.
First Lien Net Leverage Ratio” means, with respect to any Test Period, the ratio of (i) Consolidated Total Indebtedness secured by a Lien on the Collateral that ranks pari passu with the Liens on the Collateral securing the Obligations, net of Unrestricted Cash, as of the last day of such Test Period, to (ii) Consolidated EBITDA for such Test Period.
First-Second Lien Intercreditor Agreement” means a “junior lien” Intercreditor Agreement, among the Collateral Agent, the Administrative Agent and one or more Designated Representatives for holders of Indebtedness that is secured by Liens on the Collateral that are junior to the Liens securing the Obligations, in the form of Exhibit E-2 or any other form approved by Holdings, the Administrative Agent and the Collateral Agent.
Fixed Amounts” shall have the meaning assigned to such term in Section 1.07(g).
Fixed Charge Coverage Ratio” means, for any Test Period, the ratio of Consolidated EBITDA of the Group to Fixed Charges of the Group.
Fixed Charges” means, with respect to any Person for any Test Period, the sum, without duplication, of: (a) Consolidated Interest Expense for such period; plus (b) the amount of all dividend payments on any series of Preferred Equity or Disqualified Equity Interests of Holdings or any Restricted Subsidiary (other than dividends paid or accrued in Equity Interests of Holdings (other than Disqualified Equity Interests) or dividends paid or accrued to Holdings or any Restricted Subsidiary) paid in cash during such period (without duplication).
Fixed Incremental Amount” shall have the meaning given to such term in Section 2.20(d).
Foreign Currencies” means Agreed Currencies other than Dollars.
Foreign Currency LC Exposure” means, at any time, the sum of (a) the Dollar Amount of the aggregate undrawn and unexpired amount of all outstanding Foreign Currency Letters of Credit at such time plus (b) the aggregate Dollar Amount of all LC Disbursements in respect of Foreign Currency Letters of Credit that have not yet been reimbursed at such time.
Foreign Currency Letter of Credit” means a Letter of Credit denominated in a Foreign Currency.
Foreign Lender” means any Lender that is not a United States person within the meaning of Section 7701(a)(30) of the Code.
Foreign Loan Parties” means Holdings, Lux Borrower and each Foreign Subsidiary that is a Borrower or a Subsidiary Guarantor.
39


Foreign Security Documents” means each security document set forth on Schedule 1.01E.
Foreign Subsidiary” means any Subsidiary which is not a Domestic Subsidiary.
Foreign Subsidiary Guarantor” means any Subsidiary Guarantor which is a Foreign Subsidiary.
FSHCO” has the meaning assigned to such term in the definition of “Excluded Subsidiary”.
GAAP” means generally accepted accounting principles in the United States of America.
Governmental Authority” means the government of the United States of America, any other nation or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).
Group” means Holdings and its Restricted Subsidiaries.
Guarantee” of or by any Person (the “guarantor”) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or obligation; provided that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business or customary and reasonable indemnity obligations in effect on the Closing Date or entered into in connection with any acquisition or Disposition of assets permitted under this Agreement (other than such obligations with respect to Indebtedness). The amount of any Guarantee shall be deemed to be an amount equal to the lesser of (a) the stated or determinable amount of the primary payment obligation in respect of which such Guarantee is made and (b) the maximum amount for which the guaranteeing Person may be liable pursuant to the terms of the instrument embodying such Guarantee (or as set forth in Section 10.08 hereto, as applicable), unless such primary payment obligation and the maximum amount for which such guaranteeing Person may be liable are not stated or determinable, in which case the amount of the Guarantee shall be such guaranteeing Person’s maximum reasonably possible liability in respect thereof as reasonably determined by Holdings in good faith.
Guarantor” means each Borrower (with respect to the primary obligations of each other Loan Party), Holdings and the other Subsidiary Guarantors.
Guarantor Coverage Test” means confirmation that (by reference to the latest annual audited financial statements delivered to the Administrative Agent pursuant to Section 5.01(a)): (1) the Consolidated EBITDA of the Borrowers and Guarantors equals or exceeds 80.0% of Consolidated EBITDA (in each case, calculated prior to making pro forma adjustments (including clause (vii) of the definition of “Consolidated EBITDA”), except that pro forma effect shall be
40


given to the Acquisition (other than any pro forma adjustments with respect thereto pursuant to clause (vii) of the definition of “Consolidated EBITDA”) of the Group or (2) if the test set out in clause (1) cannot be satisfied on the first Guarantor Coverage Test Date after the Closing Date, the aggregate assets of Borrowers and Guarantors equals or exceeds 80.0% of the Total Assets of the Group, provided that, solely for purposes of calculating the Guarantor Coverage test:
(a)to the extent any Borrower or Guarantor generates negative EBITDA, such Borrower or Guarantor shall be deemed to have zero (0) EBITDA, for the purpose of calculating the numerator of the Guarantor Coverage Test, and
(b)unless otherwise elected by Holdings, to the extent that any Subsidiary of Holdings (w) is an Unrestricted Subsidiary, (x) is incorporated or organized under the laws of Russia, Ukraine, China, India or France, (y) is otherwise not required to (or is unable to) become a Guarantor under clause (c), (d), (e), (f), (h) or (i) of “Excluded Subsidiaries” above or under the Agreed Guarantee and Security Principles or (z) the Consolidated EBITDA of such Subsidiary is less than 1.0% of Consolidated EBITDA of the Group, such Subsidiaries shall be deemed to have zero (0) EBITDA and zero (0) assets for the purpose of calculating the denominator of the Guarantor Coverage Test.
Guarantor Coverage Test Date” shall mean the date of delivery of each Compliance Certificate with respect to annual financial statements required to be delivered pursuant to Section 5.01(a) in respect of each fiscal year ending after the Closing Date.
Guaranty” means the Guarantee set forth in Article X.
Hazardous Materials” means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, infectious or medical wastes and all other substances or wastes of similar nature regulated pursuant to any, or which may give rise to liability under, Environmental Law.
Headquarters” means the corporate headquarters of Holdings as of the Closing Date, located in Dublin, Ireland.
Hedge Bank” means each counterparty to a Swap Agreement that is (A) a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger) and each other Person if, at the date of entering into such Swap Agreement, such Person was a Lender, an Agent or a Lead Arranger (or an Affiliate of a Lender, an Agent or a Lead Arranger); provided that if such Person is not a Lender, an Agent or a Lead Arranger (other than any such Person that is an Affiliate of Citibank, N.A.), such Person delivers to the Administrative Agent a letter agreement pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 and Section 10 of the U.S. Security Agreement as if it were a Lender or (B) that is designated in writing by Holdings to the Administrative Agent as a “Hedge Bank”; provided that if such Person is not a Lender, Agent or Lead Arranger, such Person executes and delivers to the Administrative Agent and Holdings a letter agreement in form and substance reasonably acceptable to the Administrative agent and Holdings pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of Article VIII, Sections 9.03 and 9.09 hereof and Section 10 of the U.S. Security Agreement as if it were a Lender.
Holdings” has the meaning assigned to such term in the preamble hereto.
IFRS” has the meaning assigned to such term in Section 1.04(a).
41


IGPHS” means ICON Government and Public Health Solutions, Inc.
Immediate Family Members” means with respect to any individual, such individual’s child, stepchild, grandchild or more remote descendant, parent, stepparent, grandparent, spouse, former spouse, qualified domestic partner, sibling, mother-in-law, father-in-law, son-in-law and daughter-in-law (including adoptive relationships) and any trust, partnership or other bona fide estate-planning vehicle the only beneficiaries of which are any of the foregoing individuals or any private foundation or fund that is controlled by any of the foregoing individuals or any donor-advised fund of which any such individual is the donor.
Incremental Amendment” means an Incremental Amendment among the Applicable Borrower, any Additional Borrower, the Administrative Agent and one or more Incremental Term Lenders, Incremental Term Lenders and/or Incremental Revolving Lenders, as applicable, entered into pursuant to Section 2.20.
Incremental Commitments” means the Incremental Term Loan Commitments and the Incremental Revolving Commitments, collectively.
Incremental Lender” means an Incremental Term Lender or an Incremental Revolving Lender.
Incremental Loans” means the Incremental Term Loans and the Incremental Revolving Loans.
Incremental Revolving Commitment” has the meaning assigned to such term in Section 2.20(a).
Incremental Revolving Lender” means a Lender with an Incremental Revolving Commitment or an outstanding Incremental Revolving Loan.
Incremental Revolving Loans” means revolving loans made by one or more lenders to one or more Borrowers pursuant to such lenders’ Incremental Revolving Commitments.
Incremental Term Lender” means a Lender with an Incremental Term Loan Commitment or an outstanding Incremental Term Loan.
Incremental Term Loan Commitment” has the meaning assigned to such term in Section 2.20(a).
Incremental Term Loans” means Term Loans made by one or more Term Lenders to any Borrower pursuant to such Term Lenders’ Incremental Term Loan Commitments.
Incurrence-Based Amounts” shall have the meaning given to such term in Section 1.07(g).
Incurrence-Based Incremental Amount” has the meaning assigned to such term in Section 2.20(d).
Indebtedness” of any Person means, without duplication, (a) the principal component of all obligations of such Person for borrowed money, (b) the principal component of all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person (excluding trade accounts payable and accrued expenses arising in the ordinary course of business and licenses entered into in the ordinary course of business), (d) the principal component of all obligations of such Person in respect of the deferred purchase price of property
42


or services if and to the extent such obligation would appear as a liability upon the balance sheet of the specified Person in accordance with GAAP (including payments or other arrangements representing acquisition consideration, in each case entered into in connection with an acquisition, but excluding (i) accounts payable, accrued interest or other liability to trade creditors incurred in the ordinary course of business, (ii) deferred revenue, deferred compensation and severance, pension, health and welfare retirement and equivalent benefits to current or former employees, directors or managers of such Person and its Subsidiaries, and (iii) any Deferred Acquisition Consideration), (e) all Capital Lease Obligations of such Person, (f) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (g) all obligations, contingent or otherwise, of such Person in respect of bankers’ acceptances, (h) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed; provided that, if such Person has not assumed or otherwise become liable in respect of such Indebtedness, such obligations shall be deemed to be in an amount equal to the lesser of (i) the amount of such Indebtedness and (ii) fair market value of such property at the time of determination (in the Borrowers’ good faith estimate), (i) all Guarantees by such Person of Indebtedness of others and (j) all Disqualified Equity Interests (excluding any accrued dividends), in each case of clause (a) through (g), to the extent such Indebtedness would appear as a liability upon the balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP. The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor. For the avoidance of doubt, deferred revenue and advances and deposits received from customers shall not constitute Indebtedness.
Indemnified Taxes” means Taxes imposed on or with respect to any payments made by or on account of any obligation of any Loan Party under any Loan Document other than (i) Excluded Taxes and (ii) Other Taxes.
Initial Lien” has the meaning assigned to such term in section 6.02.
Initial Revolving Commitment” means, with respect to each Revolving Lender, its Revolving Commitment as of the Closing Date, as may be increased or decreased from time to time in accordance with this Agreement. The amount of each Revolving Lender’s Initial Revolving Commitment as of the Closing Date is set forth on Schedule 2.01. The aggregate principal Dollar Amount of the Initial Revolving Commitments on the Closing Date is $300,000,000.
Initial Revolving Loans” means the Loans made by Revolving Lenders pursuant to Section 2.01(c). Each Initial Revolving Loan shall be a Eurocurrency Loan denominated in an Agreed Currency (other than Pounds Sterling), an or Dollars), a USD Term SOFR Loan, a RFR Loan denominated in Pounds Sterling or an ABR Loan denominated in Dollars.
Initial Term Loans” means, collectively, the Lux Term Loans and the U.S. Term Loans.
Insolvency or Liquidation Proceeding” means, with respect to any Person, (a) any voluntary or involuntary case or proceeding under any Debtor Relief Law with respect to any such Person, (b) any other voluntary or involuntary insolvency, reorganization or bankruptcy case or proceeding, or any receivership, liquidation, reorganization, examinership, administration or other similar event, case, process, action or proceeding or private or judicial foreclosure with respect to any such Person or with respect to all or any material portion of its assets, (c) any liquidation, dissolution, examinership, reorganization or winding up of any such Person whether voluntary or involuntary or otherwise and whether or not involving insolvency or bankruptcy or
43


(d) any assignment for the benefit of creditors or any other marshalling of all or any material part of the assets and liabilities of any such Person. In addition, in respect of any Luxembourg Loan Party, “Insolvency or Liquidation Proceeding” shall also mean a Luxembourg Insolvency Event.
Intercompany Subordination Agreement” means that certain intercompany subordination agreement entered into on the Closing Date by Holdings and certain of its Restricted Subsidiaries (as amended, restated, amended and restated, supplemented or otherwise modified from time to time; provided that any modification that is materially adverse to the Senior Creditors (as defined therein) shall only be permitted if such modification is reasonably acceptable to the Administrative Agent; provided further that it is understood and agreed that the joinder of Obligors (as defined therein) or Subordinated Creditors (as defined therein) to the Intercompany Subordination Agreement is not materially adverse to the Senior Creditors and shall not require the consent of the Administrative Agent).
Intercreditor Agreement” means a First Lien Intercreditor Agreement or a First-Second Lien Intercreditor Agreement, as applicable.
Interest Election Request” means a request by the applicable Borrower to convert or continue a Borrowing in accordance with Section 2.08.
Interest Payment Date” means (a) with respect to any ABR Loan (other than a Swingline Loan), the last Business Day of each March, June, September and December and the applicable Maturity Date, (b) with respect to any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan, the last day of the Interest Period applicable to the Borrowing of which such Loan is a part and, in the case of a Eurocurrency Borrowing or USD Term SOFR Borrowing with an Interest Period of more than three months’ duration, each day prior to the last day of such Interest Period that occurs at intervals of three months’ duration after the first day of such Interest Period and the applicable Maturity Date and (c) with respect to any Swingline Loan, the day that such Loan is required to be repaid and the latest Maturity Date with respect to any Revolving Commitments.
Interest Period” means (a) with respect to any Eurocurrency Borrowing or USD Term SOFR Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one, three or six months thereafter (or, if acceptable to each participating Lender therein, twelve months thereafter or less than one month thereafter), as the Applicable Borrower may elect and (b) with respect to any RFR Borrowing, the period commencing on the date of such Borrowing and ending on the numerically corresponding day in the calendar month that is one or three months thereafter, as the Applicable Borrower may elect; provided that (i) if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless, in the case of a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing only, such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day and (ii) any Interest Period pertaining to a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period. For purposes hereof, the date of a Borrowing initially shall be the date on which such Borrowing is made and thereafter shall be the effective date of the most recent conversion or continuation of such Borrowing.
Interpolated Screen Rate” means, with respect to any Eurocurrency Loan denominated in any currency for any Interest Period, a rate per annum which results from interpolating on a linear basis between (a) the applicableEURIBOR Screen Rate for the longest maturity for which a EURIBOR Screen Rate is available that is shorter than such Interest Period and (b) the applicableEURIBOR Screen Rate for the shortest maturity for which a EURIBOR Screen Rate is
44


available that is longer than such Interest Period, in each case as of approximately 11:00 a.m. (London time) on the Quotation Day.
Investments” means, with respect to any Person, all direct or indirect investments by such Person in other Persons (including Affiliates) in the forms of loans (including Guarantees or other obligations), advances or capital contributions (excluding accounts receivable, credit card and debit card receivables, trade credit, advances to customers, commission, travel and similar advances to officers and employees, in each case, created or made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities, together with all items that are or would be classified as investments on a balance sheet prepared in accordance with GAAP. If Holdings or any Restricted Subsidiary sells or otherwise disposes of any Equity Interests of any direct or indirect Restricted Subsidiary such that, after giving effect to any such sale or disposition, such Person is no longer a Restricted Subsidiary, Holdings will be deemed to have made an Investment on the date of any such sale or disposition equal to the fair market value of Holdings’ Investments in such Subsidiary that were not sold or disposed of in an amount determined as provided in the penultimate paragraph of Section 6.04. The acquisition by Holdings or any Restricted Subsidiary of a Person that holds an Investment in a third Person will be deemed to be an Investment by Holdings or such Restricted Subsidiary in such third Person in an amount equal to the fair market value of the Investments held by the acquired Person in such third Person in an amount determined as provided in the penultimate paragraph of Section 6.04. Except as otherwise provided in this Agreement, the amount of an Investment will be determined at the time the Investment is made and without giving effect to subsequent changes in value, less any amounts paid, repaid, refinanced, distributed or otherwise received in cash in respect of such Investment. For the avoidance of doubt, Permitted Equity Derivatives and acquisitions of or licenses for intellectual property or tangible assets used or useful in a Permitted Business do not constitute Investments.
Ireland” means the Republic of Ireland.
Irish Pension Scheme” has the meaning assigned to such term in the definition of “ERISA Event”.
Irish Qualifying Lender” means a Lender or Participant, as the case may be, that is beneficially entitled to interest in respect of a Loan advanced to a Borrower that is tax resident in Ireland under this Agreement and is:
(1)a bank within the meaning of Section 246 of the TCA whose Facility Office is located in Ireland and is carrying on a bona fide banking business in Ireland for the purposes of Section 246(3)(a) of the TCA; or
(2)(a)    a company (within the meaning of Section 246 of the TCA) that is resident for the purposes of tax (residence for these purposes to be determined in accordance with the laws of the territory of which the Lender or Participant, as the case may be, claims to be resident) in a member state of the European Communities (other than Ireland) or in a territory with which Ireland has concluded a Treaty where:
(A)    that member state or territory imposes a tax that generally applies to interest receivable in that member state or territory by companies from sources outside that member state or territory; or
(B)    where that member state or territory imposes a tax that generally applies to interest received in that member state or territory from sources outside
45


that member state or territory and the interest is payable into an account located in that member state or territory; or
(a)a company (within the meaning of Section 246 of the TCA) where interest payable in respect of an advance:
(A)    is exempted from the charge to income tax under a Treaty that is in effect by virtue of the procedures set out in Section 826(1) of the TCA; or
(B)    would be exempted from the charge to income tax under a Treaty if such Treaty was in effect by virtue of the procedures set out in Section 826(1) of the TCA but such Treaty is not in effect at the date the interest is paid;
(a)a corporation established in the United States of America and subject to U.S. federal income tax on its worldwide income; or
(b)a limited liability company (“LLC”) established in the United States of America, provided that the ultimate recipients of the interest for Irish tax purposes would, if they were themselves Lenders, be Irish Qualifying Lenders within the meaning of paragraph (2)(a) or (2)(b) or (2)(c) of this definition and the business conducted through the LLC is so structured for market reasons and not for tax avoidance purposes;
provided that in each case at (a), (b), (c) or (d) the Lender or Participant, as the case may be, is not carrying on a trade or business in Ireland through an agency or branch with which the interest payment is connected; or
(3)an Irish Treaty Lender; or
(4)a company (within the meaning of Section 4 of the TCA):
(a)which advances money in the ordinary course of a trade which includes the lending of money; and
(b)in whose hands any interest payable in respect of money so advanced is taken into account in computing the trading income of the company for Irish corporation tax purposes; and
(c)which has complied with all of the provisions of Section 246(5)(a) of the TCA including making the appropriate notifications thereunder to the Borrowers and the Revenue Commissioners; and
(d)whose Facility Office is located in Ireland; or
(5)a qualifying company within the meaning of Section 110 of the TCA and whose Facility Office is located in Ireland; or
(6)an investment undertaking within the meaning of Section 739B of the TCA and whose Facility Office is located in Ireland.
Irish Qualifying Lender Confirmation” has the meaning set forth in Section 2.17(h).
46


Irish Treaty Lender” means, a Lender or Participant, as the case may be, that is a resident of an Irish Treaty State for the purposes of a Treaty and that does not carry on a business in Ireland through a permanent establishment with which a Loan under this Agreement is effectively connected and subject to completion of any procedural formalities, is entitled under the Treaty to receive payments of interest in respect of this Agreement without deduction of Irish tax.
Irish Treaty State” means a jurisdiction that has a double taxation agreement with Ireland (a “Treaty”) that is in effect and makes provision for full exemption from withholding tax imposed by Ireland on interest.
Issuing Bank” means Citibank, N.A. and any other Lender designated by the Revolving Borrowers as an “Issuing Bank” hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent), each in its capacity as the issuer of one or more Letters of Credit hereunder, and its successors in such capacity as provided in Section 2.06(i), in each case so long as such Person shall remain an Issuing Bank hereunder. All references contained in this Agreement and the other Loan Documents to the “Issuing Bank” shall be deemed to apply equally to each of the institutions referred to in the foregoing sentence of this definition in their respective capacities as issuers of any and all Letters of Credit issued by each such institution. Each Issuing Bank may, in its discretion, arrange for one or more Letters of Credit to be issued by branches or Affiliates of such Issuing Bank, in which case the term “Issuing Bank” shall include any such branch or Affiliate with respect to Letters of Credit issued by such branch or Affiliate. Each Issuing Bank may cause Letters of Credit to be issued by unaffiliated financial institutions and such Letters of Credit shall be treated as issued by such Issuing Bank for all purposes under the Loan Documents. Notwithstanding anything to the contrary herein, Citibank, N.A. shall not be obligated to issue trade letters of credit.
Joinder Agreement” has the meaning assigned to such term in Section 5.09(f).
Latest Maturity Date” means, at any date of determination, the latest Maturity Date applicable to any Loan or Commitment hereunder at such time, including the latest maturity date of any Other Refinancing Loan, any Other Refinancing Commitment, any Other Term Loan, any Extended Loan, any Extended Loan Commitment, any Incremental Loan or any Incremental Commitment in each case as extended in accordance with this Agreement from time to time.
LC Collateral Account” has the meaning assigned to such term in Section 2.06(j).
LC Disbursement” means a payment made by an Issuing Bank pursuant to a Letter of Credit.
LC Exposure” means, at any time, the sum of (a) the aggregate undrawn Dollar Amount of all outstanding Letters of Credit at such time plus (b) the aggregate Dollar Amount of all LC Disbursements that have not yet been reimbursed at such time. The LC Exposure of any Revolving Lender at any time shall be its Revolving Percentage of the total LC Exposure at such time.
LC Sublimit” has the meaning assigned to such term in Section 2.06(b).
LCT Test Date” has the meaning assigned to such term in Section 1.07(f).
Lead Arrangers” means Citigroup Global Markets Inc., Banco Santander S.A., HSBC Continental Europe SA, J.P. Morgan Securities Plc and Morgan Stanley Bank International Limited.
47


Legal Requirements” means, as to any Person, the Organizational Documents of such person, and any treaty, law (including the common law), statute, ordinance, code, rule, regulation, guidelines, license, permit requirement, judgment, decree, verdict, order, consent order, consent decree, writ, declaration or injunction or determination of an arbitrator or a court or other Governmental Authority, and the interpretation or administration thereof, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject, in each case whether or not having the force of law.
Legal Reservations” means (a) the principle that equitable remedies are remedies which may be granted or refused at the discretion of the court, the limitation of enforcement by laws relating to bankruptcy, insolvency, court protection, liquidation, reorganization, court schemes, moratoria, examinership, administration and other laws generally affecting the rights of creditors, the time barring of claims, the possibility that an undertaking to assume liability for or to indemnify a person against non-payment of stamp duty may be void, defenses of set-off or counterclaim, (b) any payment made in compensation for a breach of the Loan Documents may be a penalty and may not be enforceable in whole or in part and (c) similar principles, rights and defenses under the laws of any relevant jurisdiction.
Lenders” means the Persons listed on Schedule 2.01 and any other Person that shall have become a Lender hereunder pursuant to Section 2.20, Section 2.24 or pursuant to an Assignment and Assumption, other than any such Person that ceases to be a party hereto pursuant to an Assignment and Assumption. Unless the context otherwise requires, the term “Lenders” includes the Swingline Lender.
Letter of Credit” means any standby or trade letter of credit issued under the Revolving Commitments pursuant to this Agreement.
LIBO Rate” means, for any Interest Period when used in reference to any Loan or Borrowing denominated in any Agreed Currency other than euros, the greater of (i) (x) in the case of Revolving Loans, 0% per annum and (y) in the case of Initial Term Loans, 0.50% per annum and (ii) rate per annum determined by the Administrative Agent at approximately 11:00 a.m. (London time) on the date that is two (2) Business Days prior to the commencement of such Interest Period by reference to the ICE Benchmark Administration Interest Settlement Rates (or by reference to the rates provided by any Person that takes over the administration of such rate if the ICE Benchmark Administration is no longer making a “LIBO Rate” rate available) for deposits in the relevant Agreed Currency (as set forth by the Bloomberg Information Service or any successor thereto or any other service selected by the Administrative Agent that has been nominated by the ICE Benchmark Administration (or any successor thereto) as an authorized information vendor for the purpose of displaying such rates) for a period equal to such Interest Period (the “LIBO Screen Rate”); provided that, to the extent that an interest rate is not ascertainable pursuant to the foregoing provisions of this definition, “LIBO Rate” shall be the interest rate per annum equal to the Interpolated Screen Rate.
LIBO Screen Rate” has the meaning assigned to such term in the definition of “LIBO Rate”.
Lien” means, with respect to any asset, (a) any mortgage, deed of trust, lien, license, pledge, hypothecation, encumbrance, assignment, charge or security interest in, on or of such asset, (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset and (c) in the case of securities, any purchase option, call or similar right of a third party with respect to such securities; provided that any
48


precautionary UCC financing statements or similar filings (including any filing of a UCC financing statement or other filing with a Governmental Authority in respect of an operating lease or a consignment) and any filings with any Governmental Authority in respect of any license shall not constitute Liens to the extent that such operating lease, consignment or license to which the filings relate are otherwise Permitted Liens hereunder; provided that in no event shall any operating lease or any non-exclusive license, sub-license or cross-license to intellectual property be deemed to constitute a Lien.
Limited Condition Transaction” means any (a) any Permitted Acquisition or Investment which Holdings or any of its Restricted Subsidiaries is contractually committed to consummate, which commitment is not conditioned on the availability of, or on obtaining, third party financing, or (b) redemption or repayment of Indebtedness requiring irrevocable advance notice or any irrevocable offer to purchase Indebtedness that is not subject to obtaining financing.
Limited Originator Recourse” means a letter of credit, cash collateral account or other such credit enhancement issued in connection with the incurrence of Indebtedness by a Securitization Subsidiary under a Qualified Securitization Financing.
Loan Documents” means this Agreement, any promissory notes issued pursuant to Section 2.10(e) of this Agreement, any Letter of Credit applications, the Collateral Documents, any Intercreditor Agreement, any Joinder Agreement, any Incremental Amendment, Extension Amendment or Refinancing Amendment, and any intercreditor agreements and subordination agreements. Any reference in the Agreement or any other Loan Document to a Loan Document shall include all appendices, exhibits or schedules thereto, and all amendments, restatements, supplements or other modifications thereto, and shall refer to the Agreement or such Loan Document as the same may be in effect at any and all times such reference becomes operative.
Loan Parties” means, collectively, Holdings, the Borrowers and the Subsidiary Guarantors.
Loans” means the loans made by the Lenders to the Borrowers pursuant to this Agreement.
Local Time” means (i) New York City time in the case of a Loan, Borrowing or LC Disbursement denominated in Dollars and (ii) local time in the case of a Loan, Borrowing or LC Disbursement denominated in a Foreign Currency (it being understood that such local time shall mean London, England time, unless otherwise notified by the Administrative Agent).
Lux Borrower” has the meaning assigned to such term in the preamble hereto or any Additional Borrower organized under the laws of Luxembourg.
Lux U.S. Subsidiary Borrower” has the meaning assigned to such term in the preamble hereto.
Luxembourg” means the Grand Duchy of Luxembourg.
Luxembourg Companies Register” means the Luxembourg Register of Commerce and Companies (R.C.S. Luxembourg).
Luxembourg Guarantor” has the meaning assigned to such term in Section 10.08.
Luxembourg Insolvency Event” means, in relation to any entity incorporated or existing under the laws of Luxembourg or any of their assets, any corporate action, legal proceedings or other procedure or step in relation to bankruptcy (faillite), insolvency, judicial or voluntary liquidation (liquidation judiciaire ou volontaire), composition with creditors (concordat préventif
49


de la faillite), moratorium or reprieve from payment (sursis de paiement), controlled management (gestion contrôlée), fraudulent conveyance (action paulienne), general settlement with creditors, the appointment of a juge délégué, a commissaire, a juge-commissaire, a mandataire ad hoc, an administrateur provisoire, a liquidateur or a curateur reorganization or similar laws affecting the rights of creditors generally.
Luxembourg Loan Party” means any Lux Borrower or any Luxembourg Guarantor.
Lux Term Loan Commitments” means with respect to each Term Lender, the commitment, if any, of such Term Lender to make Lux Term Loans hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09 and (b) reduced or increased from time to time pursuant to assignments by or to such Term Lender pursuant to Section 9.04. The amount of each Term Lender’s Lux Term Loan Commitment as of the Closing Date is set forth on Schedule 2.01, or in the Assignment and Assumption (or other documentation contemplated by this Agreement) pursuant to which such Term Lender shall have assumed its Lux Term Loan Commitment, as applicable, and any other Refinancing Commitments and any Incremental Term Loan Commitments of Lux Term Loan Commitments. The aggregate principal amount of the Lux Term Loan Commitments on the Closing Date is $4,415,000,000.
Lux Term Loan Repayment Date” has the meaning assigned to such term in Section 2.10(a)(i).
Lux Term Loans” means the term loans made by the Term Lenders to the Lux Borrower and the Lux U.S. Subsidiary Borrower on the Closing Date pursuant to Section 2.01. Each Lux Term Loan shall be a EurocurrencyUSD Term SOFR Loan denominated in Dollars or an ABR Loan denominated in Dollars.
Majority in Interest” means, at any time, (i) in the case of the Revolving Lenders, Lenders having Revolving Credit Exposures and unused aggregate Revolving Commitments representing more than 50% of the sum of the aggregate Revolving Credit Exposures and the unused Revolving Commitments at such time and (ii) in the case of the Term Lenders, Lenders holding outstanding Loans representing more than 50% of all Term Loans outstanding at such time. In making the above calculations, the Dollar Amounts (as determined in good faith by the Administrative Agent) of all amounts denominated in currencies other than Dollars shall be utilized. If the context indicates that the “Majority in Interest” is to be determined for a relevant Class or Tranche, then only the respective Class or Tranche shall be included as otherwise provided above in determining the applicable Majority in Interest.
Margin Stock” has the meaning assigned to such term in Regulation U of the Board.
Market Capitalization” means an amount equal to (i) the total number of issued and outstanding shares of common Equity Interests of Holdings or any one of the Borrowers’ other parent entities that are traded on a securities exchange on the date of the declaration of a Restricted Payment, multiplied by (ii) the arithmetic mean of the closing prices per share of such common Equity Interests on the principal securities exchange on which such common Equity Interests are traded for the 30 consecutive trading days immediately preceding the date of declaration of such Restricted Payment.
Material Acquisition” means any Permitted Acquisition that involves the payment of acquisition consideration by Holdings and its Restricted Subsidiaries in excess of $50,000,000.
Material Adverse Effect” means a material adverse effect on (a) the business, assets, property or financial condition of Holdings and its Restricted Subsidiaries taken as a whole or (b)
50


the rights or remedies of the Administrative Agent and the Lenders hereunder and under the other Loan Documents.
Material Disposition” means any Asset Sale that involves payment of Disposition Consideration to Holdings or any of its Restricted Subsidiaries in excess of $50,000,000.
Material Indebtedness” means Indebtedness (other than (i) the Loans and Letters of Credit or (ii) any intercompany Indebtedness between or among members of the Group) of any one or more of Holdings and its Restricted Subsidiaries in an aggregate principal amount exceeding the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination. For purposes of determining Material Indebtedness, the “principal amount” of the obligations of Holdings or any Restricted Subsidiary in respect of any Swap Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that Holdings or such Restricted Subsidiary would be required to pay if such Swap Agreement were terminated at such time.
Material Intellectual Property” shall mean intellectual property that is material to the business of Holdings and its Subsidiaries, taken as a whole, as determined by Holdings in good faith.
Material Subsidiary” means each Restricted Subsidiary (i) which, as of the most recent fiscal quarter of Holdings, for the period of four consecutive fiscal quarters then ended, for which financial statements have been delivered pursuant to Section 5.01, contributed greater than five percent (5%) of Consolidated EBITDA of the Group for such period or (ii) which contributed greater than five percent (5%) of Total Assets of the Group as of such date.
Maturity Date” means (i) with respect to the Term Loans that have not been extended pursuant to Section 2.22, the date occurring seven years after the Closing Date, (ii) with respect to the Initial Revolving Loans and Initial Revolving Commitments of the Revolving Lenders that have not been extended pursuant to Section 2.22, the date occurring five years after the Closing Date and (iii) with respect to any other tranche of Loans (including any Incremental Loans, Extended Loans, and Other Refinancing Loans), the maturity dates specified therefor in the applicable Incremental Amendment, Extension Amendment or Refinancing Amendment; provided that if any such day is not a Business Day, the Maturity Date shall be the Business Day immediately succeeding such day.
Merger Sub” has the meaning assigned to such term in the preamble hereto.
Minimum Extension Condition” shall have the meaning given to such term in Section 2.22(b).
Minimum Tranche Amount” shall have the meaning given to such term in Section 2.22(b).
Moody’s” means Moody’s Investors Service, Inc., and any successor to its rating agency business.
Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA.
Net Proceeds” means, with respect to any event, (a) the cash proceeds received in respect of such event including (i) any cash received in respect of any non-cash proceeds (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but excluding any interest and royalty payments), but only as and when received, (ii) in the case of a casualty,
51


insurance proceeds and (iii) in the case of a condemnation or similar event, condemnation awards and similar payments, net of (b) the sum of (i) all reasonable fees and out-of-pocket expenses paid to third parties (other than Affiliates) in connection with such event, (ii) in the case of a Disposition of an asset (including pursuant to a Sale and Leaseback Transaction or a casualty or a condemnation or similar proceeding), the amount of all payments required to be made as a result of such event to repay Indebtedness (other than Loans and limited to such Indebtedness’ proportionate share of such prepayment) secured by such asset or otherwise subject to mandatory prepayment as a result of such event and (iii) the amount of all taxes paid (or reasonably estimated to be payable) and the amount of any reserves established to fund contingent liabilities reasonably estimated to be payable, in each case that are directly attributable to such event (as determined reasonably and in good faith by a Financial Officer); provided that on the date on which such reserve is no longer required to be maintained, the remaining amount of such reserve shall then be deemed to be Net Proceeds.
New Loan Party” has the meaning assigned to such term in Section 5.09(a).
New Note Documents” means the New Notes Indenture and the New Notes, as each such document may be amended, restated, supplemented or otherwise modified from time to time.
New Notes” means the $500 million aggregate principal amount of 2.875% Senior Secured Notes due 2026 issued on July 1, 2021 by Merger Sub.
New Notes Indenture” means that certain indenture, dated as of July 1, 2021, between Merger Sub and Citibank, N.A., London Branch, as trustee and collateral agent, relating to the New Notes.
Non-U.S. Plan” means any plan, fund or other similar program established, contributed to (regardless of whether through direct contributions or through employee withholding) or maintained outside the United States of America by Holdings or any one or more of its Subsidiaries primarily for the benefit of employees of Holdings or such Subsidiaries residing outside the United States of America (other than an Irish Pension Scheme or any plans, funds or other similar programs that are maintained exclusively by a Governmental Authority), which plan, fund or other similar program provides, or results in, retirement income or a deferral of income in contemplation of retirement, and which plan is not subject to ERISA or the Code.
Obligations” means (a) all unpaid principal of and accrued and unpaid interest on the Loans (including any Loans (plus any accrued and unpaid interest) held by the Administrative Agent as a result of an Erroneous Payment Deficiency Assignment in accordance with Section 8.02(d) with respect to which it has Erroneous Payment Subrogation Rights), all LC Exposure, all accrued and unpaid fees and all expenses, reimbursements, indemnities and other obligations and indebtedness (including interest accruing during the pendency of any bankruptcy, insolvency, receivership, examinership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), obligations and liabilities of any of Holdings, the Borrowers and the other Loan Parties to any of the Lenders, the Administrative Agent, the Collateral Agent, any Issuing Bank or any indemnified party, individually or collectively, existing on the Closing Date or arising thereafter, direct or indirect, joint or several, absolute or contingent, matured or unmatured, liquidated or unliquidated, secured or unsecured, arising by contract, operation of law or otherwise, arising or incurred under this Agreement or any of the other Loan Documents or in respect of any of the Loans made or reimbursement or other obligations incurred or any of the Letters of Credit or other instruments at any time evidencing any thereof and (b) the payment of all obligations of Holdings and its Restricted Subsidiaries under each Cash Management Agreement and Swap Agreement entered into with any counterparty that is a Secured Party; provided that, notwithstanding anything to the contrary, the Obligations shall exclude any Excluded Swap Obligations.
52


OFAC” means Office of Foreign Assets Control of the United States Department of the Treasury.
OID” has the meaning assigned to such term in the definition of “Credit Agreement Refinancing Indebtedness”.
Organizational Documents” means, with respect to any Person, (i) in the case of any corporation, the certificate of incorporation, articles of incorporation, constitution or deed of incorporation and by-laws (or similar documents) of such Person, (ii) in the case of any limited liability company, the constitution, certificate or articles of formation or organization or deed of incorporation and operating agreement or memorandum and articles of association or constitution (or similar constituent documents) of such Person, (iii) in the case of any limited partnership, the certificate of formation and limited partnership agreement (or similar constituent documents) of such Person (and, where applicable, the equityholders or shareholders registry of such Person), (iv) in the case of any general partnership, the partnership agreement (or similar constituent document) of such Person, (v) in any other case, the functional equivalent of the foregoing, and (vi) any shareholder, voting trust or similar agreement between or among any holders of Equity Interests of such Person.
Other Refinancing Commitments” means the Other Refinancing Term Commitments and the Other Refinancing Revolving Commitments.
Other Refinancing Loans” means the Other Refinancing Term Loans and the Other Refinancing Revolving Loans.
Other Refinancing Revolving Commitments” means one or more Classes of Revolving Commitments hereunder that result from a Refinancing Amendment.
Other Refinancing Revolving Loans” means the revolving loans made pursuant to any Other Refinancing Revolving Commitment.
Other Refinancing Term Commitments” means one or more Classes of Term Loan Commitments hereunder that result from a Refinancing Amendment.
Other Refinancing Term Loans” means one or more Classes of Term Loans that result from a Refinancing Amendment.
Other Revolving Loan Commitments” has the meaning set forth in Section 2.20(a).
Other Revolving Loans” means Incremental Revolving Loans made pursuant to Other Revolving Loan Commitments.
Other Taxes” means all present or future stamp, court, filing, intangible, recording or documentary Taxes or any other similar Taxes arising from any payment made under any Loan Document or from the execution, delivery, performance, registration or enforcement of, from the receipt or perfection of a security interest under, or otherwise with respect to, this Agreement or any other Loan Document, other than (1) Luxembourg registration duties (droits d’enregistrement) payable due to a registration, submission or filing by the Administrative Agent, the Collateral Agent a Lender or an Issuing Bank of any Loan Document, except if such registration, submission or filing is required to maintain, establish, enforce or preserve the rights of the Administrative Agent, the Collateral Agent, a Lender or an Issuing Bank under such Loan Document or (2) such Taxes that are imposed with respect to an assignment or change in lending office (other than an assignment made pursuant to Section 2.19(b)) as a result of a present or former connection between the assignor, assignee or Lender and the jurisdiction imposing such Taxes (other than a connection arising solely as a result of it having executed, delivered, become
53


a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).
Other Term Loan Commitments” has the meaning set forth in Section 2.20(a).
Other Term Loans” means Incremental Term Loans made pursuant to Other Term Loan Commitments.
Overnight Foreign Currency Rate” means, for any amount payable in a Foreign Currency, the rate of interest per annum as determined by the Administrative Agent at which overnight or weekend deposits in the relevant currency (or if such amount due remains unpaid for more than three (3) Business Days, then for such other period of time as the Administrative Agent may elect) for delivery in immediately available and freely transferable funds would be offered by the Administrative Agent to major banks in the interbank market upon request of such major banks for the relevant currency as determined above and in an amount comparable to the unpaid principal amount of the related Credit Event, plus any taxes, levies, imposts, duties, deductions, charges or withholdings imposed upon, or charged to, the Administrative Agent by any relevant correspondent bank in respect of such amount in such relevant currency.
Participant” has the meaning set forth in Section 9.04(c)(i).
Participant Register” has the meaning set forth in Section 9.04(c)(ii).
Participating Member State” means any member state of the EU that has the euro as its lawful currency in accordance with the legislation of the EU and relating to the Economic and Monetary Union.
PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity performing similar functions.
Perfection Certificate Supplement” shall mean the Perfection Certificate with respect to Loan Parties in the form attached hereto as Exhibit J, or such other form as is reasonably satisfactory to Holdings and the Administrative Agent.
Perfection Requirements” means the making or procuring of appropriate registrations, filings, endorsements, notarizations, acknowledgement, stampings and/or notifications of any Loan Document (and/or any Liens created under it) customary or necessary for the enforceability, fixing of priority, or production in evidence of the relevant Loan Document and/or Lien.
Permitted Acquisition” means any Investment permitted under clause (4) of the definition of “Permitted Investments” and any other Investment permitted under this Agreement that constitutes the purchase or other acquisition, in one transaction or a series of transactions, by Holdings or any Restricted Subsidiary of all or substantially all the assets constituting a business unit, division, product line (including rights in respect of any drug or other pharmaceutical product) or line of business of, another Person, in a single transaction or a series of related transactions, such Person will be a Restricted Subsidiary and in any event, only to the extent that such assets or such Person will be owned and/or licensed by Holdings or a Restricted Subsidiary.
Permitted Business” means the business and any services, activities or businesses incidental, or reasonably related or complementary or similar to, any line of business engaged in by Holdings and its Subsidiaries as of the Closing Date or any business activity that is a reasonable extension, development or expansion thereof or ancillary thereto.
54


Permitted Conversion Provisions” means provisions permitting holders to convert or exchange Indebtedness into or for Equity Interests of Holdings (and cash in lieu of fractional shares) or at the option of Holdings or the issuer of such Indebtedness, Equity Interests of Holdings, cash or any combination of the foregoing (provided that any payment of any such cash shall be subject to compliance with the provisions set forth in this agreement, including those set forth in Article VI).
Permitted Debt” has the meaning set forth in Section 6.01(b).
Permitted Equity Derivatives” means any forward purchase, accelerated share purchase, call option, warrant transaction or other equity derivative transactions relating to the Equity Interests of Holdings entered into by Holdings or any Restricted Subsidiary provided that any Restricted Payment made in connection with such transaction is permitted pursuant to Section 6.04, including any Swap Agreements executed in connection therewith (or deemed executed therewith).
Permitted Hedging Obligations” means obligations of Holdings or any Restricted Subsidiary in respect of non-speculative Swap Agreements entered into (i) to hedge or mitigate risks to which Holdings or any Restricted Subsidiary has actual exposure (other than those in respect of Equity Interests of Holdings or any of its Restricted Subsidiaries but excluding Convertible Debt Securities) or (ii) in order to effectively cap, collar or exchange interest rates (from fixed to floating rates, from one floating rate to another floating rate or otherwise) with respect to any interest-bearing liability or investment of Holdings or any Restricted Subsidiary.
Permitted Investments” means:
(1)the Transactions;
(2)any Investment in Holdings by a Restricted Subsidiary or any Investment by Holdings or a Restricted Subsidiary in a Restricted Subsidiary (including, for the avoidance of doubt, the purchase of Equity Interests of non-wholly owned Restricted Subsidiaries);
(3)any Investment in cash and Cash Equivalents;
(4)any Investment by Holdings or any Restricted Subsidiary in a Person, if as a result of such Investment: (a) such Person becomes a Restricted Subsidiary; or (b) such Person is merged, consolidated or amalgamated with or into, or transfers or conveys substantially all of its assets to, or is liquidated into, Holdings or a Restricted Subsidiary;
(5)any Investment made as a result of the receipt of non-cash consideration from (i) an Asset Sale that was made pursuant to and in compliance with Section 6.03 or (ii) a Disposition of assets not constituting an Asset Sale;
(6)any Investments to the extent made in exchange for the issuance of Equity Interests (other than Disqualified Equity Interests) of Holdings or any of its direct or indirect parent companies;
(7)any Investments received in settlement, satisfaction, compromise or resolution of (A) obligations of trade creditors or customers or other debts that were incurred in the ordinary course of business of Holdings or any of its Restricted Subsidiaries, including pursuant to any plan of reorganization or similar arrangement upon the bankruptcy or insolvency
55


of any trade creditor or customer; or (B) judgments, litigation, arbitration or other disputes;
(8)Investments represented by Swap Obligations, Permitted Hedging Obligations and Permitted Equity Derivatives;
(9)(a) loans and advances to, or guarantees of Indebtedness of officers, directors, employees, consultants and members of management not in excess of $25,000,000 outstanding at any one time, in the aggregate and (b) other loans and advances to employees, directors, officers, members of management and consultants for business-related travel expenses, moving expenses and other similar expenses or payroll advances, in each case incurred in the ordinary course of business or consistent with past practices or to future, present and former employees, directors, officers, members of management and consultants (and their Controlled Affiliates and Immediate Family Members) to fund such Person’s purchase of Equity Interests of Holdings or any direct or indirect parent company thereof;
(10)[reserved];
(11)any guarantee of Indebtedness permitted to be incurred by Section 6.01 and performance guarantees provided in the ordinary course of business;
(12)any Investment existing on, or made pursuant to binding commitments existing on, the date hereof and any Investment consisting of an extension, modification or renewal of any Investment existing on, or made pursuant to a binding commitment existing on, the date hereof, which, in the case of Investments with a fair market value (as determined by Holdings in good faith) in excess of $5,000,000, is set forth on Schedule 1.01B; provided, that the amount of any such Investment may be increased (a) as required by the terms of such Investment as in existence on the date hereof or (b) as otherwise permitted under this Agreement;
(13)Investments of any Person in existence at the time such Person becomes a Restricted Subsidiary, or is merged, consolidated or amalgamated with or into, or transfers or conveys substantially all of its assets to, or is liquidated into, Holdings or a Restricted Subsidiary; provided such Investment was not made in connection with or in anticipation of such Person becoming a Restricted Subsidiary and, to the extent in an amount not greater than such Investment as existing on the date such Person became a Restricted Subsidiary, any modification, replacement, renewal or extension thereof;
(14)Investments in the ordinary course of business in prepaid expenses, negotiable instruments held for collection and lease, utility and worker’s compensation, performance and other similar deposits provided to third parties;
(15)receivables owing to Holdings or any Restricted Subsidiary if created or acquired in the ordinary course of business and payable or dischargeable in accordance with customary trade terms; provided, that such trade
56


terms may include such concessionary trade terms as Holdings or any such Restricted Subsidiary deems reasonable under the circumstances;
(16)advances, loans or extensions of trade or other credit (including to officers, directors, consultants and employees of Holdings, its Subsidiaries or its direct and indirect parent companies) in the ordinary course of business by Holdings or any of its Restricted Subsidiaries;
(17)lease, utility and similar deposits in the ordinary course of business and other deposits constituting Permitted Liens;
(18)Investments in the ordinary course of business consisting of endorsements for collection or deposit;
(19)Investments among Holdings and its Subsidiaries in the ordinary course of business for purposes of funding the working capital and maintenance capital expenditure requirements and research and development activities of Holdings and its Subsidiaries;
(20)Investments consisting of purchases and acquisitions of inventory, supplies, materials and equipment or purchases of contract rights or licenses or leases of intellectual property, in each case in the ordinary course of business;
(21)any customary upfront, milestone, marketing or other funding payment in the ordinary course of business to another Person in connection with obtaining a right to receive royalty or other payments in the future;
(22)Investments in any joint ventures in an amount outstanding at any one time not to exceed the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (with the fair market value as determined in good faith by Holdings of each Investment (other than any Investment consisting of a guarantee) being measured at the time made and without giving effect to subsequent changes in value); provided, however, that if any Investment pursuant to this clause (22) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant to this clause (22) for so long as such Person continues to be a Restricted Subsidiary;
(23)Investments in a Permitted Business in an aggregate amount, taken together with all other Investments made pursuant to this clause (23) that are at that time outstanding, not to exceed the greater of $290,000,000 and 25% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination; provided, however, that if any Investment pursuant to this clause (23) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant
57


to this clause (23) for so long as such Person continues to be a Restricted Subsidiary;
(24)Investments consisting of co-development agreements or consisting of the licensing or contribution of intellectual property, new drug applications or similar assets pursuant to development, marketing or manufacturing agreements, alliances or arrangements or similar agreements or arrangements with other Persons;
(25)other Investments in any Person having an aggregate fair market value (measured on the date each such Investment was made and without giving effect to subsequent changes in value), when taken together with all other Investments made pursuant to this clause (25) that are at the time outstanding, not to exceed the greater of $290,000,000 and 25% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination; provided, however, that if any Investment pursuant to this clause (25) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (2) above and shall cease to have been made pursuant to this clause (25) for so long as such Person continues to be a Restricted Subsidiary;
(26)Investments in or relating to a Securitization Subsidiary that, in the good faith determination of Holdings, are necessary or advisable to effect or maintain any Qualified Securitization Financing or any repurchase obligation in connection therewith;
(27)Investments in IGPHS to fund its cash management and working capital requirements;
(28)(x) Investments in Drug Development Funds, (y) Investments in Oncacare Limited to fund its cash management and working capital requirements and (z) loans made to Oncacare Limited pursuant to the shareholders agreement thereof, in an aggregate amount, taken together with all other Investments made pursuant to this clause (28) that are at that time outstanding, not to exceed the greater of $580,000,000 and 50% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination;
(29)Investments consisting of purchases and acquisitions of assets or services in the ordinary course of business;
(30)Investments made in the ordinary course of business in connection with obtaining, maintaining or renewing client contacts and loans or advances made to distributors in the ordinary course of business;
(31)Guarantees by Holdings or any of its Restricted Subsidiaries of leases (other than capitalized leases) or of other obligations that do not constitute Indebtedness, in each case entered into in the ordinary course of business and consistent with past practice;
58


(32)any Investment in any Subsidiary or any joint venture in connection with intercompany cash management arrangements or related activities arising in the ordinary course of business and consistent with past practice;
(33)[reserved]; and
(34)any Investment by Holdings or any of its Restricted Subsidiaries so long as the Total Net Leverage Ratio on a Pro Forma Basis is less than or equal to 4.25:1.00.
Permitted Junior Secured Refinancing Debt” means any secured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of second-lien secured notes or second-lien secured loans; provided that (i) such Indebtedness is secured by all or a portion of the Collateral on a junior-priority basis with the Obligations and is not secured by any property or assets of Holdings or any Subsidiary other than the Collateral, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Credit Agreement Refinancing Indebtedness at the time such Indebtedness is incurred; provided that this clause (iii) shall not apply to customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), (iv) such Indebtedness is not guaranteed by any of Holdings’ Subsidiaries other than the Loan Parties and (v) a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First-Second Lien Intercreditor Agreement; provided that if such Indebtedness is the initial Permitted Junior Secured Refinancing Debt incurred after the Closing Date, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First-Second Lien Intercreditor Agreement. Permitted Junior Secured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Permitted Liens” means:
(1)Liens to secure the Secured Obligations (including any Incremental Loans);
(2)Liens on assets of Foreign Subsidiaries or non-Guarantor Subsidiaries securing Indebtedness (and other related obligations) of such Foreign Subsidiary or non-Guarantor Subsidiary that was incurred pursuant to Section 6.01(b)(xi) and Liens securing Indebtedness (and other related obligations) incurred pursuant to Section 6.01(b)(xvi);
(3)Liens in favor of Holdings or any Restricted Subsidiary;
(4)Liens on property or Equity Interests of another Person existing at the time such other Person becomes a Subsidiary of Holdings or is merged with or into or consolidated with Holdings or any Subsidiary of Holdings; provided, that such Liens (a) are not incurred in contemplation thereof and (b) do not extend to any other property owned by Holdings or any of its Restricted Subsidiaries (other than after acquired property of such Person (to the extent required to become subject to such Liens under the terms of the applicable agreements as in effect at the time such Person becomes a Subsidiary of Holdings) and assets and property affixed or appurtenant thereto);
59


(5)Liens on property (including Equity Interests) existing at the time of acquisition of the property by Holdings or any Subsidiary of Holdings; provided, that such Liens were in existence prior to such acquisition and not incurred in contemplation of, such acquisition;
(6)any Lien on any property or asset of Holdings or any Restricted Subsidiary existing on the date hereof which, in the case of Liens securing Indebtedness with an outstanding principal amount in excess of $5,000,000, shall be set forth on Schedule 1.01C;
(7)Liens granted in replacement of or substitute for, or to secure any refinancing (or successive refinancings), as a whole or in part, of any Indebtedness or other obligation secured by, a Lien referred to in clause (4), (5), (6), (11), (33), (37) or (38) hereof; provided, that the new Lien is limited to all or part of the same property and assets that secured or, under the written agreements pursuant to which the original Lien arose, could secure the refinanced Indebtedness (plus improvements and accessions to, such property or proceeds or distributions thereof);
(8)Liens on the Equity Interests of Unrestricted Subsidiaries;
(9)Liens (a) to secure the performance of, or arising in connection with, public or statutory obligations (including worker’s compensation laws, unemployment insurance laws or similar legislation), insurance, surety or appeal bonds, performance bonds or other obligations of a like nature, good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases, deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business (including Liens to secure letters of credit issued to assure payment or performance of such obligations), (b) in respect of letters of credit, bank guarantees or similar instruments issued for the account of Holdings or any Subsidiary supporting obligations of the type set forth in clause (a) above and (c) Liens on cash and Cash Equivalents securing letters of credit issued in the ordinary course of business;
(10)Liens on securities that are the subject of repurchase agreements permitted hereunder;
(11)Liens to secure Indebtedness (and related obligations) permitted by Section 6.01(b)(x) covering only the assets acquired with, improved, constructed, leased or financed by such Indebtedness and the proceeds thereof;
(12)Liens for taxes, assessments or other governmental charges or claims that are (i) not yet delinquent or (ii) being contested in good faith by appropriate proceedings and with respect to which adequate reserves have been established in accordance with, and to the extent required by, applicable accounting standards;
(13)Liens imposed by law, such as carriers’, warehousemen’s, landlord’s and mechanics’ Liens, in each case, either (i) incurred in the ordinary course of business or (ii) for sums not yet due or being contested in good faith by appropriate proceedings;
(14)survey exceptions, encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens incidental to the conduct of the business of such Person or to the ownership of their properties which were not incurred in connection with Indebtedness and that do not in the
60


aggregate materially adversely affect the value of said properties or materially impair their use in the operation of the business of such Person;
(15)Liens to secure any Ratio Debt, Alternative Incremental Facility Indebtedness, Permitted Pari Passu Secured Refinancing Debt and any Permitted Junior Secured Refinancing Debt and any Permitted Refinancing Indebtedness in respect thereof, in each case contemplated to be secured thereunder; provided that this clause (15) shall be subject to the applicable Intercreditor Agreement;
(16)Liens on insurance policies, premiums and proceeds thereof, or other deposits, to secure insurance premium financings and other liabilities to insurance carriers;
(17)Liens securing or arising out of judgments, decrees, orders, awards or notices of lis pendens and associated rights related to litigation with respect to which Holdings or any Subsidiary shall then be proceeding with an appeal or other proceedings for review, or in respect of which the period within which such appeal or proceedings may be initiated shall not have expired;
(18)Liens arising by virtue of any statutory or common law provisions relating to banker’s liens and rights of set-off or similar rights and remedies as to deposit accounts or other funds maintained with a depository or financial institution or as to purchase orders and other agreements entered into with customers in the ordinary course of business;
(19)Liens on cash, Cash Equivalents or other property arising in connection with the defeasance, discharge or redemption of Indebtedness;
(20)Liens on specific items of inventory or other goods (and the proceeds thereof) of Holdings or any Restricted Subsidiary securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods;
(21)Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into in the ordinary course of business;
(22)Liens securing obligations in an aggregate amount not to exceed $50,000,000 in respect of obligations under or in respect of Swap Agreements (including Permitted Hedging Obligations);
(23)Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods in the ordinary course of business;
(24)Liens on equipment or inventory of Holdings or any Restricted Subsidiary granted in the ordinary course of business to Holdings’ or such Restricted Subsidiary’s supplier at which such equipment or inventory is located;
(25)usual and customary Liens incurred to secure ACH Indebtedness, business credit card programs, and netting services, overdrafts and related liabilities arising from treasury, depositary and cash management services and Liens in the nature of the right of setoff in favor of counterparties to contractual agreements with the Loan Parties in the ordinary course of business;
61


(26)any encumbrance or restriction (including put and call arrangements) with respect to Equity Interests of any joint venture, minority investment or similar arrangement pursuant to any joint venture, shareholders, investor rights or similar agreement;
(27)Liens (i) consisting of deposits or advances made by Holdings or any of its Restricted Subsidiaries in connection with any letter of intent or purchase agreement in respect of any Permitted Acquisition or Investment permitted under this Agreement or (ii) consisting of an option or agreement to Dispose of any property permitted to be sold pursuant to Section 6.03;
(28)leases, subleases, non-exclusive licenses or non-exclusive sublicenses granted to third parties (a) entered into in the ordinary course of business which do not materially interfere with the conduct of the business of Holdings and its Restricted Subsidiaries and which do not secure any Indebtedness, or (b) that are not otherwise prohibited by Section 6.03;
(29)Liens (i) of a collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection and (ii) attaching to commodity trading accounts or other commodities brokerage accounts incurred in the ordinary course of business, including Liens encumbering reasonable customary initial deposits and margin deposits;
(30)ground leases in respect of real property on which facilities owned or leased by Holdings or any of its Subsidiaries are located and other Liens affecting the interest of any landlord (and any underlying landlord) of any real property leased by Holdings or any Subsidiary;
(31)any interest or title of a lessor or licensor under any lease, sublease, license or sublicense entered into by Holdings or any Restricted Subsidiary (A) existing on the date hereof (but not created in contemplation hereof), (B) entered into in the ordinary course of its business or (C) entered into in connection with a Permitted Acquisition;
(32)Liens to secure contractual payments (contingent or otherwise) payable by Holdings or its Subsidiaries to a seller after the consummation of an acquisition of a product, business, license or other assets;
(33)other Liens securing Indebtedness to the extent such Indebtedness, when taken together with all other Indebtedness secured by Liens incurred pursuant to this clause (33) that are at that time outstanding and the Indebtedness secured by Liens pursuant to clause (7) above with respect to the refinancing indebtedness originally secured by Liens pursuant to this clause (33), does not exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination; provided that any such Liens on the Collateral incurred pursuant to this clause (33) securing Capital Markets Indebtedness shall be junior to the Liens securing the Obligations and subject to the First-Second Lien Intercreditor Agreement.
(34)Liens on any assets held by a trustee (i) under any indenture or other debt instrument where the proceeds thereof of the securities issued thereunder are held in escrow pursuant to customary escrow arrangements pending the release thereof, and (ii) under any indenture pursuant to customary discharge, redemption or defeasance provisions;
62


(35)Liens on Securitization Assets in connection with Qualified Securitization Financing or a Qualified Receivables Factoring or Liens existing by reason of other contractual requirements of a Securitization Subsidiary or any Qualified Securitization Financing or Qualified Receivables Factoring;
(36)Liens on deposits or other amounts held in escrow to secure payments (contingent or otherwise) payable by Holdings or any of its Restricted Subsidiaries with respect to the settlement, satisfaction, compromise or resolution or judgments, litigation, arbitration or other disputes;
(37)Liens securing the Obligations under the New Notes Indenture and Permitted Refinancing Indebtedness thereof, subject to a First Lien Intercreditor Agreement;
(38)purchase options, calls and similar rights of, and restrictions for the benefit of, a third party with respect to Equity Interests held by Holdings or any Restricted Subsidiary in joint ventures;
(39)Liens securing Indebtedness permitted under Section 6.01(b)(iv) and Permitted Refinancing Indebtedness thereof; provided that such Indebtedness shall be secured solely by Liens existing at the time such Restricted Subsidiary is acquired by Holdings or a Restricted Subsidiary of Holdings and shall not extend to any other property owned by Holdings or any of its other Restricted Subsidiaries (other than after acquired property of such Person (to the extent required to become subject to such Liens under the terms of the applicable agreements as in effect at the time such Person becomes a Subsidiary of Holdings)); and
    (40)    Liens securing the Headquarters arising as a result of a Sale and Leaseback Transaction thereof.
For purposes of determining compliance with this definition, (A) Permitted Liens need not be incurred solely by reference to one category of Permitted Liens described above but are permitted to be incurred in part under any combination thereof and (B) in the event that a Lien (or any portion thereof) meets the criteria of one or more of the categories of Permitted Liens described above, Holdings may, in its sole discretion, classify or reclassify such item of Permitted Liens (or any portion thereof) in any manner that complies with this definition and Holdings may divide and classify a Lien in more than one of the types of Permitted Liens in one of the above clauses.
Permitted Pari Passu Secured Refinancing Debt” means any secured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of senior secured notes or loans; provided that (i) such Indebtedness is secured by all or a portion of the Collateral on a pari passu basis with the Obligations and is not secured by any property or assets of Holdings or any Subsidiary other than the Collateral, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Refinanced Debt; provided that this clause (iii) shall not apply to (x) Term A Facilities and (y) customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), (iv) such Indebtedness is not guaranteed by any of Holdings’ Subsidiaries other than the Loan Parties and (v) a Designated Representative acting on behalf of the holders of such Indebtedness shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement; provided that if such Indebtedness is the initial Permitted
63


Pari Passu Secured Refinancing Debt incurred after the Closing Date, then Holdings, the Borrowers, the Subsidiary Guarantors, the Administrative Agent, the Collateral Agent and the Designated Representative for such Indebtedness shall have executed and delivered a First Lien Intercreditor Agreement. Permitted Pari Passu Secured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Permitted Refinancing Indebtedness” means any Indebtedness issued in exchange for, or the net proceeds of which are used to extend, refinance, renew, replace, defease or refund (collectively, to “refinance”), other Indebtedness; provided that (a) the principal amount (or accreted value, if applicable) of such Permitted Refinancing Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the Indebtedness so refinanced (plus unpaid accrued interest and premium (including tender premium) thereon, any committed or undrawn amounts associated with, OID or upfront fees on, and underwriting discounts, fees, commissions and expenses incurred in connection with, such Permitted Refinancing Indebtedness), (b) the final maturity date of such Permitted Refinancing Indebtedness is no earlier than the maturity date for the Indebtedness being refinanced (it being understood that, in each case, any mandatory prepayment provision or provision requiring an offer to purchase such Indebtedness as a result of a change of control, fundamental change, delisting, asset sale or similar provision or any Permitted Conversion Provisions shall not violate the foregoing restriction), (c) if the Indebtedness (including any Guarantee thereof) being refinanced is by its terms subordinated in right of payment to the Secured Obligations, such Permitted Refinancing Indebtedness (including any Guarantee thereof) shall be subordinated in right of payment to the Secured Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Indebtedness being refinanced, taken as a whole (as determined in good faith by the Board of Directors of Holdings), (d) such Permitted Refinancing Indebtedness contains mandatory prepayment or redemption (or similar provisions), if any, covenants, if any, and events of default, if any, and is benefited by guarantees, if any, which are customary for Indebtedness of such type (reasonably determined in good faith by the Board of Directors of Holdings), (e) no Permitted Refinancing Indebtedness shall have direct obligors or contingent obligors that were not the direct obligors or contingent obligors (or that would not have been required to become direct obligors or contingent obligors) in respect of the Indebtedness being refinanced, (f) if the Indebtedness being refinanced is secured, such Permitted Refinancing Indebtedness may be secured on terms no less favorable, taken as a whole, to the Secured Parties than those contained in the documentation (including any intercreditor agreement) governing the Indebtedness being refinanced (as determined in good faith by the Board of Directors of Holdings) and (g) if the Indebtedness being refinanced was subject to an Intercreditor Agreement, and if the respective Permitted Refinancing Indebtedness is to be secured by the Collateral, the Permitted Refinancing Indebtedness shall likewise be subject to an appropriate Intercreditor Agreement.
Permitted Unsecured Refinancing Debt” means any unsecured Indebtedness incurred after the Closing Date by any Loan Party (and may in any case be co-borrowed or co-issued by any other Loan Party on a joint and several basis) in the form of one or more series of unsecured notes or loans; provided that (i) such Indebtedness is not secured by any property or assets of Holdings or any Subsidiary, (ii) such Indebtedness constitutes Credit Agreement Refinancing Indebtedness, (iii) such Indebtedness does not mature or have scheduled amortization or scheduled payments of principal prior to the maturity date of the Refinanced Debt; provided that this clause (iii) shall not apply to customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)), and (iv) such Indebtedness is not guaranteed by any of Holdings’ Subsidiaries other than the Loan Parties. Permitted Unsecured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.
64


Plan” means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Sections 412 or 430 of the Code or Sections 302 or 303 of ERISA, and in respect of which Holdings or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA.
Platform” has the meaning assigned to such term in the final paragraph of Section 5.01.
Pounds Sterling” means the lawful currency of the United Kingdom.
Preferred Equity” means, with respect to the Equity Interests of any Person, Equity Interests of any class of classes (however designated) which is preferred as to the payment of dividends or distributions, or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Person, over shares of Equity Interests of any other class of such Person.
Prepayment Event” means:
(1) any Asset Sale (other than (x) Asset Sales resulting inthe Net Proceeds that,which together with the aggregate amount of Net Proceeds received from all such sales, transfers or other Asset Salesdispositions (x) occurring in the same fiscal year of Holdings, do not exceed $100,000,000 or (y) with respect to any individual Asset Sale resulting in Net Proceeds thattransaction, do not exceed $25,000,000) or;
(2) any casualty or other insured damage to, or any taking under power of eminent domain or by condemnation or similar proceeding of, any property or asset of Holdings or any Restricted Subsidiary with a fair market value immediately prior to such event greater than (x) $100,000,000 in any fiscal year of Holdings or (y) $25,000,000 with respect to any individual event; or
(3) the incurrence by Holdings or any Restricted Subsidiary of any Indebtedness, other than Indebtedness permitted under Section 6.01 or permitted by the Required Lenders pursuant to Section 9.02.
Prime Rate” means the rate of interest per annum publicly announced from time to time by Citibank, N.A. as its prime rate in effect at its principal office in New York City; each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective.
Pro Forma Basis” and “Pro Forma Effect” mean, with respect to compliance with any test or covenant or calculation of any ratio hereunder, the determination or calculation of such test, covenant or ratio (including in connection with Specified Transactions) in accordance with Section 1.07.
Pro Forma Synergies” has the meaning assigned to such term in the definition of “Consolidated EBITDA”.
Process Agent” has the meaning assigned to such term in Section 9.09(e).
PTE” means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.
Public Lender” has the meaning assigned to such term in the final paragraph of Section 5.01.
65


Purchase Offer” has the meaning assigned to such term in Section 2.23(a).
Purchasing Borrower Party” means any Borrower that desires to effect a Purchase Offer pursuant to Section 2.23.
QFC Credit Support” has the meaning assigned to such term in Section 9.20.
Qualified ECP Guarantor” means, in respect of any Swap Obligation, each Guarantor that has total assets exceeding $10,000,000 at the time the relevant Guarantee or grant of the relevant security interest becomes effective with respect to such Swap Obligation or such other person as constitutes an “eligible contract participant” under the Commodity Exchange Act or any regulations promulgated thereunder and can cause another person to qualify as an “eligible contract participant” at such time by entering into a keepwell under Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.
Qualified Equity Interests” means any Equity Interest that are not Disqualified Equity Interests.
Qualified Receivables Factoring” means any transaction or series of transactions that may be entered into by Holdings or any Restricted Subsidiary pursuant to which Holdings or such Subsidiary may sell, convey, assign or otherwise transfer Securitization Assets (which may include a backup or precautionary grant of security interest in such Securitization Assets so sold, conveyed, assigned or otherwise transferred or purported to be so sold, conveyed, assigned or otherwise transferred) to any Person other than a Securitization Subsidiary, which may include Standard Securitization Undertakings. The grant of a security interest in any accounts receivable of Holdings or any of its Restricted Subsidiaries to secure the Obligations shall not be deemed to be a Qualified Receivables Factoring.
Qualified Securitization Financing” means any Securitization Financing of a Securitization Subsidiary that meets the following conditions: (a) such Qualified Securitization Financing (including financing terms, covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to Holdings and the Securitization Subsidiary as determined by Holdings in good faith and (b) all sales and/or contributions of Securitization Assets and related assets to the Securitization Subsidiary are made at fair market value as determined by Holdings in good faith. The grant of a security interest in any Securitization Assets of Holdings or any of the Restricted Subsidiaries (other than a Securitization Subsidiary) to secure Indebtedness under this Agreement prior to engaging in any Securitization Financing shall not be deemed a Qualified Securitization Financing.
Quotation Day” means, with respect to any Eurocurrency Borrowing and any Interest Period, the Business Day on which it is market practice in the London interbank market for the Administrative Agent to give quotations for deposits in the Agreed Currency of such Eurocurrency Borrowing for delivery on the first day of such Interest Period.
Ratio Debt” means Indebtedness incurred pursuant to Section 6.01(a).
Receivables Repurchase Obligation” means any obligation of a seller of receivables in a Qualified Receivables Factoring or Qualified Securitization Financing to repurchase receivables arising as a result of a breach of a representation, warranty or covenant or otherwise, including as a result of a receivable or portion thereof becoming subject to any asserted defense, dispute, off-set or counterclaim of any kind as a result of any action taken by, any failure to take action by or any other event relating to the seller, in each case, that are customary (as determined in good faith by Holdings) for non-recourse receivables financings.
66


Refinanced Debt” has the meaning assigned to such term in the definition of “Credit Agreement Refinancing Indebtedness”.
Refinancing” means the repayment in full of, and the termination of any commitment to make extensions of credit, all indebtedness (other than contingent obligations not then due and that by their terms expressly survive the termination of the foregoing) outstanding under (v) the Existing Revolving Credit Agreement, (w) the Target Credit Agreement, (x) the Target Receivables Financing Agreement, (y) the Series A Notes and (z) the Series B Notes.
Refinancing Amendment” means an amendment to or an amendment and restatement of this Agreement in form and substance reasonably satisfactory to the Administrative Agent and the Borrowers executed by each of (a) Holdings, the Borrowers and the Subsidiary Guarantors, (b) the Administrative Agent, (c) the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans), and (d) each Refinancing Lender and Lender that agrees to provide any portion of the Credit Agreement Refinancing Indebtedness being incurred pursuant thereto, in accordance with Section 2.24.
Refinancing Lender” means, at any time, any bank, insurance company, financial institution or institutional lender or Approved Fund (with respect to the foregoing) that, in any case, is not an existing Lender (and that is not Holdings or any of its Subsidiaries or Affiliates) and that agrees to provide any portion of any Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment in accordance with Section 2.24; provided that each Refinancing Lender (other than any Person that is a Lender, an Affiliate of a Lender or an Approved Fund of a Lender at such time) shall be subject to the approval of the Administrative Agent and the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans) (such approval not to be unreasonably withheld or delayed), in each case to the extent any such consent would be required from the Administrative Agent and the Issuing Banks and the Swingline Lender (in the case of Other Refinancing Revolving Commitments or Other Refinancing Revolving Loans) under Section 9.04(b)(i) for an assignment of Loans or Commitments to such Refinancing Lender.
Register” has the meaning set forth in Section 9.04(b)(iv).
Registered Equivalent Notes” means, with respect to any notes originally issued in a Rule 144A or other private placement transaction under the Securities Act, substantially identical notes (having the same Guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered with the SEC.
Related Parties” means, with respect to any specified Person, such Person’s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person’s Affiliates.
Release” means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration of Hazardous Materials into or through the environment (including, without limitation, ambient air, surface water, groundwater and surface or subsurface strata).
Relevant Governmental Body” means (a) with respect to a USD Benchmark Replacement in respect of Dollars, the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto. and (b) with respect to an Alternate Currency Benchmark Replacement in respect of any Alternate Currency, (1) the central bank for the currency in which such amounts are denominated hereunder or any central bank or other supervisor which is responsible for supervising either (A) such USD Benchmark Replacement or Alternate Currency Benchmark
67


Replacement, as applicable or (B) the administrator of such USD Benchmark Replacement or Alternate Currency Benchmark Replacement, as applicable or (2) any working group or committee officially endorsed or convened by (A) the central bank for the currency in which such amounts are denominated, (B) any central bank or other supervisor that is responsible for supervising either (i) such USD Benchmark Replacement or Alternate Currency Benchmark Replacement, as applicable or (ii) the administrator of such USD Benchmark Replacement or Alternate Currency Benchmark Replacement, as applicable, (C) a group of those central banks or other supervisors or (D) the Financial Stability Board or any part thereof.
Repricing Event” means (a) the incurrence by any Loan Party of any new or replacement bank indebtedness comprised of term loans that are secured pari passu with the Initial Term Loans (including, without limitation, any new or additional term loans under this Agreement, whether incurred directly or by way of the conversion of Initial Term Loans into a new tranche of replacement term loans under this Agreement), (i) the primary purpose of which is to have an Effective Yield that is less than the applicable Effective Yield for Initial Term Loans and (ii) the proceeds of which are used to prepay (or, in the case of a conversion, deemed to prepay or replace), in whole or in part, the outstanding principal of the Initial Term Loans or (b) any amendment or waiver, the primary purpose of which is to reduce the Effective Yield of any Initial Term Loans; provided that in no event shall any prepayment or repayment of Initial Term Loans in connection with a Change of Control, Transformative Acquisition or Transformative Disposition constitute a Repricing Event.
Required Lenders” means, at any time, Lenders having Credit Exposures and unused Commitments representing more than 50% of the sum of the total Credit Exposures and unused Commitments at such time. The total Credit Exposure and Commitments of any Defaulting Lender shall be disregarded in determining Required Lenders at any time. For all purposes of determining the Required Lenders hereunder, if any relevant Credit Exposures or unused Commitments are denominated in currencies other than Dollars, the respective Dollar Amounts (as determined in good faith by the Administrative Agent) thereof shall be utilized.
Required Net Proceeds Percentage” means, as of any date of determination, (i) in the case of any Prepayment Event described in clause (1) or clause (2) of the definition thereof, (a) 100% if the First Lien Net Leverage Ratio is greater than 4.50:1.00, (b) 50% if the First Lien Net Leverage Ratio is less than or equal to 4.50:1.00 and greater than 4.00:1.00 and (c) 0% if the First Lien Net Leverage Ratio is less than or equal to 4.00:1.00 and (ii) in the case of any Prepayment Event described in clause (3) of the definition thereof, 100%.
Required Revolving Lenders” means, at any time, Lenders having Revolving Credit Exposures and unused Revolving Commitments representing more than 50% of the sum of the total Revolving Credit Exposures and unused Revolving Commitments at such time. The total Revolving Credit Exposure and Revolving Commitments of any Defaulting Lender shall be disregarded in determining Required Revolving Lenders at any time. For all purposes of determining the Required Revolving Lenders hereunder, if any relevant Revolving Credit Exposures or unused Revolving Commitments are denominated in currencies other than Dollars, the respective Dollar Amounts (as determined in good faith by the Administrative Agent) thereof shall be utilized.
Resolution Authority” means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.
Responsible Officer” means the chief executive officer, president, authorized signatory, an executive vice president or senior vice president or a Financial Officer of Holdings.
Restricted Investment” means an Investment that is not a Permitted Investment.
68


Restricted Payment” means (i) any dividend or any other payment or distribution on account of Holdings’ or any of its Restricted Subsidiaries’ Equity Interests (including, without limitation, any payment in connection with any merger or consolidation involving Holdings or any of its Restricted Subsidiaries, other than any such merger or consolidation constituting a Permitted Investment) or to the direct or indirect holders of Holdings’ or any of its Restricted Subsidiaries’ Equity Interests in their capacity as such (other than (A) dividends or distributions payable in Equity Interests (other than Disqualified Equity Interests) of Holdings, (B) dividends or other payments and distributions payable to Holdings or a Restricted Subsidiary, (C) dividends or distributions payable to other holders of Equity Interests of a Restricted Subsidiary on no more than a pro rata basis and (D) payments on account of the transfer or issuance of any Restricted Subsidiary’s Equity Interests to Holdings or any other Restricted Subsidiary), (ii) any purchase, redemption or other acquisition or retirement for value, directly or indirectly (including, without limitation, in connection with any merger or consolidation involving the Holdings), any Equity Interests of Holdings, (iii) any principal payment on or with respect to, or purchase, redemption, defeasance or other acquisition or retirement for value any Subordinated Indebtedness (excluding any intercompany Indebtedness between or among members of the Group) or any Indebtedness (excluding any intercompany Indebtedness between or among members of the Group) of Holdings or any Restricted Subsidiary that is secured by Liens that are junior to the Liens securing the Obligations, except a payment of principal at, or within 365 days of, the stated maturity thereof or (iv) any Restricted Investment. Notwithstanding the foregoing, a “Restricted Payment” shall not include any of the payments or other transactions contemplated by the Transactions.
Restricted Subsidiary” means any Subsidiary of Holdings other than an Unrestricted Subsidiary.
Revenue Commissioners” means the Revenue Commissioners of Ireland.
Revolving Borrowers” means the Lux Borrower, Merger Sub (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by Target), ICON CLINICAL RESEARCH LIMITED, a limited liability company incorporated under the laws of Ireland with registration number 201978 and with registered address at South County Business Park, Leopardstown, Dublin 18, Ireland, ICON GLOBAL TREASURY UNLIMITED COMPANY, an unlimited liability company incorporated under the laws of Ireland with registration number 649443 and with registered address at South Country Business Park, Leopardstown, Dublin 18, Ireland, and ICON US HOLDINGS INC., a Delaware corporation, and each Additional Borrower that becomes a Revolving Borrower.
Revolving Borrowing” means a Borrowing comprised of Revolving Loans of any Class.
Revolving Commitment” means, with respect to each Revolving Lender, the commitment, if any, of such Revolving Lender to make Revolving Loans and to acquire participations in Letters of Credit hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09, (b) increased from time to time pursuant to Section 2.20 and (c) reduced or increased from time to time pursuant to assignments by or to such Lender pursuant to Section 9.04. For the avoidance of doubt, “Revolving Commitments” includes the Initial Revolving Commitments, any Incremental Revolving Commitments, any Extended Revolving Commitments and any Other Refinancing Revolving Commitments.
Revolving Commitment Increases” has the meaning assigned to such term in Section 2.20(a).
Revolving Credit Event” means a Revolving Borrowing of any Class, the issuance, extension or increase in amount of a Letter of Credit, an LC Disbursement with respect to a Letter of Credit or any of the foregoing.
69


Revolving Credit Exposure” means, with respect to any Revolving Lender at any time, and without duplication, the sum of the outstanding principal amount of such Revolving Lender’s Revolving Loans and its LC Exposure and Swingline Exposure at such time.
Revolving Lender” means, as of any date of determination, each Lender that has a Revolving Commitment or, if the Revolving Commitments have terminated or expired, a Lender with Revolving Credit Exposure.
Revolving Loan” means any Initial Revolving Loan, any Extended Revolving Loan, any Other Refinancing Revolving Loan and any Incremental Revolving Loan.
Revolving Percentage” the percentage equal to a fraction the numerator of which is such Lender’s Revolving Commitment and the denominator of which is the aggregate Revolving Commitments of all Revolving Lenders (if the Revolving Commitments of any Class have terminated or expired, the Revolving Percentages shall be determined based upon the Revolving Commitments of such Class most recently in effect, giving effect to any assignments); provided that when a Defaulting Lender shall exist, the Revolving Commitments of such Defaulting Lender shall be excluded from the denominator in calculating the “Revolving Percentage.”
RFR” means, for any Obligations consisting of any interest, fees or other amounts denominated in Pounds Sterling, SONIA.
RFR Business Day” means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which banks are closed for general business in London.
RFR Interest Day” has the meaning assigned to such term in the definition of “Daily Simple RFR”.
RFR Loan” means a Loan that bears interest at a rate based on Daily Simple RFR.
RFR Lookback Day” has the meaning assigned to such term in the definition of “Daily Simple RFR”.
Run-rate” means the full recurring benefit for a period that is associated with any action taken, committed to be taken or with respect to which substantial steps have been taken or are expected to be taken (in the good faith determination of Holdings) (including any savings expected to result from the elimination of a public target’s compliance costs with public company requirements).
S&P” means S&P Global Ratings, and any successor to its rating agency business.
Sale and Leaseback Transaction” means any sale or other transfer of any property or asset by any Person with the intent to lease such property or asset as lessee.
Sanctioned Country” means, at any time, a country or territory that is itself the target of Sanctions (at the time of this Agreement, the Crimea region of Ukraine, Cuba, Iran, North Korea, and Syria).
Sanctioned Person” means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC, the U.S. Department of State, the United Nations Security Council, the European Union or any EU member state, Her Majesty’s Treasury of the United Kingdom, (b) any Person operating, organized or resident in a Sanctioned Country or (c) any Person controlled or owned 50.0% or more by one or more of such Persons.
70


Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State, or (b) the United Nations Security Council, the European Union or any EU member state, or Her Majesty’s Treasury of the United Kingdom.
Screen Rate” means the LIBO Screen Rate or the EURIBOR Screen Rate, as applicable.
SEC” means the United States Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.
Section 82” has the meaning assigned to such term in Section 3.16.
Secured Net Leverage Ratio” means, with respect to any Test Period, the ratio of (a) Consolidated Total Indebtedness secured by a Lien on Collateral, net of Unrestricted Cash, as of the last day of such Test Period to (b) Consolidated EBITDA for such Test Period.
Secured Obligations” means all Obligations; provided that, notwithstanding anything to the contrary, the Secured Obligations shall exclude (i) any Excluded Swap Obligations, (ii) each Cash Management Agreement and Swap Agreement entered into with any counterparty that is not a Secured Party and (iii) Obligations in respect of any Cash Management Agreement or Swap Agreement that has been designated by each of the parties to such Cash Management Agreement or Swap Agreement (including, for the avoidance of doubt, the applicable Secured Party) as not constituting “Secured Obligations.”
Secured Parties” means the holders of the Secured Obligations from time to time and shall include (i) each Lender and Issuing Bank in respect of its Loans and LC Exposure respectively, (ii) the Administrative Agent, the Collateral Agent, the Issuing Banks and the Lenders in respect of all other present and future obligations and liabilities of Holdings and each Restricted Subsidiary of every type and description arising under or in connection with this Agreement or any other Loan Document, (iii) each Hedge Bank, (iv) each indemnified party under Section 9.03 in respect of the obligations and liabilities of any Borrower to such Person hereunder and under the other Loan Documents, (v) each Cash Management Bank and (vi) their respective successors and (in the case of a Lender, permitted) transferees and assigns.
Securities Act” means the United States Securities Act of 1933, as amended from time to time and any successor statute.
Securitization Assets” means (a) the accounts receivable, royalty or other revenue streams and other rights to payment and other assets related thereto and the proceeds thereof and (b) contract rights, lockbox accounts and records with respect to such accounts receivable and any other assets customarily transferred together with accounts receivable in a securitization financing.
Securitization Fees” means distributions or payments made directly or by means of discounts with respect to any participation interest issued or sold in connection with, and other fees and expenses (including reasonable fees and expenses of legal counsel) paid to a Person that is not a Securitization Subsidiary in connection with any Qualified Securitization Financing.
Securitization Financing” means any transaction or series of transactions that may be entered into by Holdings or any of its Subsidiaries pursuant to which Holdings or any of its Subsidiaries may sell, convey or otherwise transfer to (a) a Securitization Subsidiary (in the case of a transfer by Holdings or any of its Subsidiaries) or (b) any other Person (in the case of a transfer by a Securitization Subsidiary), or may grant a security interest in (which in either case
71


may include a backup or precautionary grant) any Securitization Assets of Holdings or any of its Subsidiaries, and any assets related thereto, including all collateral securing such Securitization Assets, all contracts and all guarantees or other obligations in respect of such Securitization Assets, proceeds of such Securitization Assets and other assets that are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving Securitization Assets.
Securitization Subsidiary” means a wholly-owned Subsidiary of Holdings (or another Person formed for the purposes of engaging in a Qualified Securitization Financing in which Holdings or any Subsidiary of Holdings makes an investment and to which Holdings or any Subsidiary of Holdings transfers Securitization Assets and related assets) that engages in no activities other than in connection with the financing of Securitization Assets of Holdings or its Subsidiaries, all proceeds thereof and all rights (contingent and other), collateral and other assets relating thereto, and any business or activities incidental or related to such business, and which is designated by the Board of Directors or such other Person (as provided below) as a Securitization Subsidiary.
Series A Notes” means the 2.32% Series A Senior Notes due December 8, 2023 issued by Icon Investments Five Unlimited Company on December 8, 2020.
Series B Notes” means the 2.43% Series B Senior Notes due December 8, 2025 issued by Icon Investments Five Unlimited Company on December 8, 2020.
Solvent” means, with respect to Holdings and its Subsidiaries, on the Closing Date, after giving effect to the consummation of the Transactions, and after giving effect to the application of the proceeds of such indebtedness under such Transactions:
(a)    The amount of the fair saleable value of the assets of Holdings and its Subsidiaries on a consolidated basis exceeds:
(i)    the value of all liabilities of Holdings and its Subsidiaries (on a consolidated basis), including contingent and other liabilities, as generally determined in accordance with applicable United States federal laws governing determinations of the insolvency of debtors; and
(ii)    the amount that will be required to pay the probable liabilities of Holdings and its Subsidiaries on its existing debts (including contingent liabilities) as such debts become absolute and matured;
(b)    Holdings and its Subsidiaries (on a consolidated basis) do not have an unreasonably small amount of capital for the operation of the businesses in which it is engaged or proposed to be engaged; and
(c)    Holdings and its Subsidiaries (on a consolidated basis) will be able to pay its liabilities, including contingent and other liabilities, as they mature.
SONIA” means, with respect to any RFR Business Day, a rate per annum equal to the Sterling Overnight Index Average for such RFR Business Day published by the SONIA Administrator on the SONIA Administrator’s Website.
SONIA Administrator” means the Bank of England (or any successor administrator of the Sterling Overnight Index Average).
72


SONIA Administrator’s Website” means the Bank of England’s website, currently at http://www.bankofengland.co.uk, or any successor source for the Sterling Overnight Index Average identified as such by the SONIA Administrator from time to time.
Specified Representations” means the representations and warranties set forth in Sections 3.01 (as it relates to organizational existence of the Loan Parties), 3.02 (as it relates to the due authorization, execution and delivery of the Loan Documents), 3.03 (as it relates to no conflicts with or violations of Organizational Documents), 3.08, 3.12, 3.14 (limited to execution, delivery and performance of the Loan Documents), 3.15 and 3.16.
Specified Transaction” means (a) at the option of Holdings, any designation of operations or assets of Holdings or a Restricted Subsidiary as discontinued operations (as defined under GAAP), (b) at the option of Holdings, any Investment that results in a Person becoming a Restricted Subsidiary, (c) any designation of a Subsidiary as a Restricted Subsidiary or an Unrestricted Subsidiary, (d) any Material Acquisition, (e) any Material Disposition that results in a Restricted Subsidiary ceasing to be a Subsidiary of Holdings or any Disposition of a business unit, line of business or division or product line of Holdings, in each case whether by merger, consolidation, amalgamation or otherwise, (f) or any incurrence or repayment of Indebtedness (other than Indebtedness incurred or repaid under any revolving credit facility or line of credit in the ordinary course of business for working capital purposes) that by the terms of this Agreement requires such test to be calculated on a Pro Forma Basis or after giving Pro Forma Effect and (g) the Transactions.
Standard Securitization Undertakings” means representations, warranties, covenants and indemnities entered into by Holdings or any Subsidiary of Holdings that are customary (as determined by Holdings in good faith) in a Securitization Financing or a Qualified Receivables Factoring, including without limitation those relating to the servicing of the assets of a Securitization Subsidiary, it being understood that a Receivables Repurchase Obligations shall be deemed to be a Standard Securitization Undertaking.
Statutory Reserve Rate” means, with respect to any currency, a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve, liquid asset, fees or similar requirements (including any marginal, special, emergency or supplemental reserves or other requirements) established by any central bank, monetary authority, the Board, the Financial Conduct Authority or the Prudential Regulatory Authority of the United Kingdom, the European Central Bank or other Governmental Authority for any category of deposits or liabilities customarily used to fund loans in such currency, expressed in the case of each such requirement as a decimal. Such reserve, liquid asset, fees or similar requirements shall, in the case of Dollar denominated Loans, include those imposed pursuant to Regulation D of the Board. Eurocurrency Loans and RFR Loans shall be deemed to be subject to such reserve, liquid asset, fee or similar requirements without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Lender under any applicable law, rule or regulation, including Regulation D of the Board. The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve, liquid asset or similar requirement.
Subordinated Indebtedness” means any Indebtedness of Holdings or any Restricted Subsidiary the payment of which is contractually subordinated in right of payment of the obligations under the Loan Documents (excluding intercompany Indebtedness between or among members of the Group).
subsidiary” means, with respect to any Person (the “parent”) at any date, (i) any corporation, limited liability company, partnership, association or other entity the accounts of which would be consolidated with those of the parent in the parent’s consolidated financial statements if such financial statements were prepared in accordance with GAAP as of such date,
73


as well as any other corporation, limited liability company, partnership, association or other entity of which securities or other ownership interests representing more than 50% of the equity or more than 50% of the ordinary voting power or, in the case of a partnership, more than 50% of the general partnership interests are, as of such date, owned, Controlled or held; and (ii) in the case of any Person incorporated in Ireland, any subsidiary of that Person within the meaning of Section 7 of the Companies Act or Regulation 4 of the European Communities (Companies Group Accounts) Regulations 1992.
Subsidiary” means any subsidiary of Holdings (unless a contrary intention appears herein).
Subsidiary Guarantor” means each Subsidiary that is party to this Agreement from time to time. The Subsidiary Guarantors as of the Closing Date will be each Subsidiary of Holdings as set forth in Schedule 1.01F. Notwithstanding anything herein or in any other Loan Document to the contrary, no Excluded Subsidiary or Unrestricted Subsidiary shall be required to be a Subsidiary Guarantor; provided that Holdings shall be required to comply with the provisions set forth in Section 5.09(f). Notwithstanding the foregoing, Holdings may elect to cause any Restricted Subsidiary that is not otherwise required to be a Subsidiary Guarantor to provide a Guarantee by causing such Restricted Subsidiary to execute a Joinder Agreement (or, in the case of any Foreign Subsidiary, a guaranty of the Secured Obligations (which may be the Guarantee or, if reasonably required by the Administrative Agent in order to create a legally enforceable Guarantee, a guaranty governed by the laws of the applicable country in which such Foreign Subsidiary is incorporated or organized) and all documents, financing statements, agreements, instruments, certificates, notices and acknowledgements and filings which the Administrative Agent may reasonably request to ensure the creation, perfection and priority of the Liens on the assets of such Foreign Subsidiary, in each case (i) in a form reasonably acceptable to the Administrative Agent, (ii) governed by the laws of the applicable country in which such Foreign Subsidiary is incorporated or organized and (iii) subject to the Agreed Guarantee and Security Principles and customary exceptions for transactions of this type in such applicable country), and any such Restricted Subsidiary shall be a Loan Party and Subsidiary Guarantor for all purposes hereunder. In the event that Holdings elects to cause a Foreign Subsidiary to be a Subsidiary Guarantor in accordance with the foregoing, such Foreign Subsidiary shall cease to be an Excluded Subsidiary for purposes of the Loan Documents.
Supported QFC” has the meaning assigned to such term in Section 9.20.
Swap Agreement” means any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of Holdings or its Restricted Subsidiaries shall be a Swap Agreement.
Swap Obligations” means any and all obligations of Holdings or any Restricted Subsidiary, whether absolute or contingent and howsoever and whensoever created, arising, evidenced or acquired (including all renewals, extensions and modifications thereof and substitutions therefor), under (a) any and all Swap Agreements with a Hedge Bank, (b) any and all cancellations, buy backs, reversals, terminations or assignments of any such Swap Agreement transaction and (c) any obligation to pay or perform under any agreement, contract or transaction that constitutes a “swap” within the meaning of section 1a(47) of the Commodity Exchange Act. For the avoidance of doubt, Permitted Equity Derivatives shall not constitute Swap Obligations.
74


Swingline Exposure” means, at any time, the aggregate principal amount of all Swingline Loans outstanding at such time. The Swingline Exposure of any Lender at any time shall be its Revolving Percentage of the total Swingline Exposure at such time.
Swingline Lender” means Citibank, N.A. (acting through itself or one of its designated affiliates or branch offices), in its capacity as lender of Swingline Loans hereunder and any other Lender designated by the Applicable Borrower as a “Swingline Lender” hereunder that has agreed to such designation (and is reasonably acceptable to the Administrative Agent).
Swingline Loan” means a Loan made pursuant to Section 2.05.
Target” means PRA Health Sciences, Inc., a Delaware corporation, and its Subsidiaries (prior to consummation of the Acquisition). References to Target herein and in the other Loan Documents shall, from and after the Closing Date, mean PRA Health Sciences, Inc.
TARGET” means the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative, such other payment system (if any) reasonably determined by the Administrative Agent to be a suitable replacement) for the settlement of payments in euro.
Target Credit Agreement” means the Credit Agreement, dated October 28, 2019, by and among the Target, PNC Bank, National Association, as administrative agent, the lenders party thereto and the other parties thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).
Target Receivables Financing Agreement” means the Receivables Financing Agreement, dated as of March 22, 2016, by and among the Target, PNC Capital Markets LLC, as structuring agent, the lenders party thereto and the other parties thereto (as amended, restated, amended and restated, supplemented or otherwise modified from time to time).
Taxes” means all present or future taxes, levies, imposts, duties, assessments, withholdings or similar charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.
Tax Group” has the meaning assigned to such term in Section 6.04(b)(xxii).
TCA” means the Taxes Consolidation Act 1997 of Ireland.
Term A Facility” means Indebtedness with amortization in excess of 1% and less than or equal to 10% per year that is marketed principally to regulated commercial banks (as determined by Holdings) in an aggregate principal amount for all Term A Facilities outstanding at any time not to exceed the greater of $1,160,000,000 and 100% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination.
Term Lender” means, as of any date of determination, each Lender that holds Term Loan Commitments or Term Loans.
Term Loan Commitments” means, collectively, the Lux Term Loan Commitments, the U.S. Term Loan Commitments, the Extended Term Loan Commitments, the Incremental Term Loan Commitments and the Other Refinancing Term Commitments.
Term Loan Increases” means one or more new Incremental Term Loan Commitments which are in the same Tranche as any outstanding Term Loans.
75


Term Loans” means, collectively, the Lux Term Loans, the U.S. Term Loans, any Incremental Term Loan (including any Other Term Loan), any Other Refinancing Term Loans of the applicable Class or any Extended Term Loan.
Test Period” means, at any date of determination, the most recently completed four consecutive fiscal quarters ending on or prior to such date for which financial statements are available.
Total Assets” means the total assets of the Group, as shown on the most recent balance sheet of Holdings for which financial statements are available on which any calculation of Total Assets is being made, calculated on a Pro Forma Basis in accordance with Section 1.07 to give effect to any Material Acquisition or Material Disposition since the date of such balance sheet. For the avoidance of doubt, any Indebtedness or Lien incurred, Investment or Restricted Payment made in each case was permitted under this Agreement at the time of such incurrence, making or receipt, shall continue to be permitted hereunder, regardless of any subsequent decrease in Total Assets.
Total Net Leverage Ratio” means, with respect to any Test Period, the ratio of (a) Consolidated Total Indebtedness net of Unrestricted Cash as of the last day of such Test Period to (b) Consolidated EBITDA for such Test Period.
Tranche” means a category of Commitments and extensions of credit thereunder (e.g. Lux Term Loans, U.S. Term Loans and Incremental Term Loans).
Transactions” means (a) the execution, delivery and performance by the Loan Parties of this Agreement and the other Loan Documents, (b) the borrowing of Loans and other credit extensions and the use of the proceeds thereof, (c) the granting of Liens pursuant to the Collateral Documents, (d) the Acquisition (including the execution of the Acquisition Documents, the payment of the Deferred Acquisition Consideration and the other transactions contemplated by the Acquisition Documents), (e) the execution, delivery and performance of the New Note Documents and the issuance of the New Notes thereunder, (f) the Refinancing, (g) any other transactions related to or entered into in connection with any of the foregoing, including without limitation each of the transactions described in the memorandum prepared by KPMG and provided to the Administrative Agent prior to the Closing Date and (h) the payment of the fees and expenses incurred in connection with any of the foregoing.
Transformative Acquisition” shall mean any acquisition by Holdings, any Borrower or any other Restricted Subsidiary that (i) is not permitted by the terms of the Loan Documents immediately prior to the consummation of such acquisition or (ii) if permitted by the terms of the Loan Documents immediately prior to the consummation of such acquisition, would not provide Holdings, any Borrower and the other Restricted Subsidiaries with adequate flexibility under the Loan Documents for the continuation and/or expansion of their combined operations following such consummation, as determined by the Borrowers acting in good faith.
Transformative Disposition” shall mean any Disposition by Holdings, any Borrower or any other Restricted Subsidiary that (i) is not permitted by the terms of the Loan Documents immediately prior to the consummation of such disposition or (ii) if permitted by the terms of the Loan Documents immediately prior to the consummation of such disposition, would not provide Holdings, the Borrowers and the other Restricted Subsidiaries with adequate flexibility under the Loan Documents for the continuation and/or expansion of their combined operations following such consummation, as determined by the Borrowers acting in good faith.
Type”, when used in reference to any Loan or Borrowing, refers to Loans or Borrowings in a single currency and whether the rate of interest on such Loan, or on the Loans comprising
76


such Borrowing, is determined by reference to the Eurocurrency Rate, USD Term SOFR, Daily Simple RFR or the Alternate Base Rate.
UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York or any other state the laws of which are required to be applied in connection with the issue of perfection of security interests.
UK Financial Institution” means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.
UK Resolution Authority” means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.
Unliquidated Obligations” means, at any time, any Secured Obligations (or portion thereof) that are contingent in nature or unliquidated at such time, including any Secured Obligation that is: (i) an obligation to reimburse a bank for drawings not yet made under a letter of credit issued by it; (ii) any other obligation (including any guarantee) that is contingent in nature at such time; and (iii) an obligation to provide collateral to secure any of the foregoing types of obligations.
Unrestricted Cash” means at any time the sum of (i) unrestricted cash and Cash Equivalents whether or not held in a pledged account plus (ii) cash and Cash Equivalents restricted in favor of the Obligations (which may also include cash and Cash Equivalents securing other Indebtedness secured by a Lien on the Collateral along with the Obligations at such time), in each case, such unrestricted cash and restricted cash and Cash Equivalents to be determined in accordance with GAAP.
Unrestricted Subsidiary” means (1) IGPHS, (2) each Securitization Subsidiary, (3) any Subsidiary that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors of Holdings in accordance with Section 5.10 and (4) any Subsidiary of an Unrestricted Subsidiary.
“USD Adjusted Term SOFR” means, for purposes of any calculation, the rate per annum equal to (a) USD Term SOFR for such calculation plus (b) the USD Term SOFR Adjustment; provided that if USD Adjusted Term SOFR as so determined shall ever be less than the USD Floor, then USD Adjusted Term SOFR shall be deemed to be the USD Floor.
USD Available Tenor” means, as of any date of determination and with respect to any then-current Benchmark for any currency, as applicable, (x) if any then-current USD Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such USD Benchmark, as applicable, pursuant to this Agreement as of such date.
USD Benchmark” means, initially, the USD LIBORTerm SOFR Reference Rate; provided that if a replacement of an initial or subsequent USD Benchmark Transition Event has occurred pursuant to Section 2.14, then “USD Benchmark” means the applicable USD Benchmark Replacement to the extent that such USD Benchmark Replacement has replaced such prior benchmark rate. Any reference to “USD Benchmark” shall include, as applicable, the published component used in the calculation thereof.
77


USD Benchmark Replacement” means, for any USD Available Tenor:(i)    For, for purposes of Section 2.14(a), the first alternative set forth below that can be determined by the Administrative Agent:
(A)    the sum of: (i) USD Term SOFR and (ii) 0.11448% (11.448 basis points) for a USD Available Tenor of one-month’s duration, 0.26161% (26.161 basis points) for a USD Available Tenor of three-months’ duration and 0.42826% (42.826 basis points) for a USD Available Tenor of six-months’ duration, or
(B)    the sum of: (i) USD Daily Simple SOFR and (ii) the spread adjustment selected or recommended by the Relevant Governmental Body for the replacement of the tenor of USD LIBOR with a USD SOFR-based rate having approximately the same length as the interest payment period specified in Section 2.14(a); and(ii)    For purposes of 2.14(b), the sum of (a) the alternate benchmark rate that has been selected by the Administrative Agent and Holdings giving due consideration to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Administrative Agent and Holdings as the replacement for such USD Available Tenor of such USD Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by the Relevant Governmental Body, for Dollar-denominated syndicated credit facilities at such time in the U.S. syndicated loan market; provided that, if the USD Benchmark Replacement as determined pursuant to clause (i) or (ii) above would be less than the USD Floor, the USD Benchmark Replacement will be deemed to be the USD Floor for the purposes of this Agreement and the other Loan Documents.
USD Benchmark Replacement Conforming Changes” means, with respect to any USD Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “ABR,” the definition of “Business Day,” the definition of “U.S. Government Securities Business Day,” the definition of “Interest Period,” or any similar or analogous definition (or the addition of a concept of “interest period”), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions and other technical, administrative or operational matters) that the Administrative Agent, in consultation with Holdings, decides may be appropriate to reflect the adoption and implementation of such USD Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such USD Benchmark Replacement exists, in such other manner of administration as the Administrative Agent, in consultation with Holdings, decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).
USD Benchmark Transition Event” means, with respect to any then-current USD Benchmark other than USD LIBOR, the occurrence of one or more of the following events: a public statement or publication of information by or on behalf of the administrator of any then-current USD Benchmark, the regulatory supervisor for the administrator of such USD
78


Benchmark, the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such USD Benchmark, a resolution authority with jurisdiction over the administrator for such USD Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for such USD Benchmark, announcing or stating that (a) such administrator has ceased or will cease on a specified date to provide all USD Available Tenors of such USD Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any USD Available Tenor of such USD Benchmark or (b) all USD Available Tenors of such USD Benchmark are or will no longer be representative of the underlying market and economic reality that such USD Benchmark is intended to measure and that representativeness will not be restored.
USD Daily Simple SOFR” means, for any day, USD SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate recommended by the Relevant Governmental Body for determining “USD Daily Simple SOFR” for syndicated business loans; provided, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.
USD Early Opt-in Effective Date” means, with respect to any USD Early Opt-in Election, the sixth (6th) Business Day after the date notice of such USD Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such USD Early Opt-in Election is provided to the Lenders, written notice of objection to such USD Early Opt-in Election from Lenders comprising the Required Lenders.
USD Early Opt-in Election” means, in the case of Loans denominated in Dollars, if the then-current USD Benchmark is USD LIBOR, the occurrence of the following:
(i)    (a) a notification by the Administrative Agent to (or the request by Holdings to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollars denominated syndicated credit facilities in the U.S. syndicated loan market at such time contain (as a result of amendment or as originally executed) a USD SOFR-based rate (including USD SOFR, a term USD SOFR or any other rate based upon USD SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and
(ii)    the joint election by the Administrative Agent and Holdings to trigger a fallback from USD LIBOR and the provision by the Administrative Agent of written notice of such election to the Lenders.
USD Floor” means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to the initial USD Benchmark, which is 0% with respect to the Initial Revolving Loans and 0.50% with respect to the Initial Term Loans.
USD LIBOR” means the London interbank offered rate for Dollars.
USD SOFR” means a rate per annum equal to the secured overnight financing rate for such Business Day published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http://www.newyorkfed.org (or any successor source for the secured
79


overnight financing rate identified as such by the administrator of the secured overnight financing rate from time to time).
“USD SOFR” means a rate equal to the secured overnight financing rate as administered by the USD Term SOFR Administrator.
“USD Term SOFR” means,
(a)     for any calculation with respect to a USD SOFR Loan, the USD Term SOFR Reference Rate for a tenor comparable to the applicable Interest Period on the day (such day, the “USD Periodic Term SOFR Determination Day”) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Period, as such rate is published by the USD Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (New York City time) on any USD Periodic Term SOFR Determination Day the USD Term SOFR Reference Rate for the applicable tenor has not been published by the USD Term SOFR Administrator and a USD Benchmark Replacement Date with respect to the USD Term SOFR Reference Rate has not occurred, then USD Term SOFR will be the USD Term SOFR Reference Rate for such tenor as published by the USD Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such USD Term SOFR Reference Rate for such tenor was published by the USD Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such USD Periodic Term SOFR Determination Day, and
    (b)    for any calculation with respect to an ABR Loan on any day, the USD Term SOFR Reference Rate for a tenor of one month on the day (such day, the “ABR Term SOFR Determination Day”) that is two (2) U.S. Government Securities Business Days prior to such day, as such rate is published by the USD Term SOFR Administrator; provided, however, that if as of 5:00 p.m. (New York City time) on any ABR Term SOFR Determination Day the USD Term SOFR Reference Rate for the applicable tenor has not been published by the USD Term SOFR Administrator and a USD Benchmark Replacement Date with respect to the USD Term SOFR Reference Rate has not occurred, then USD Term SOFR will be the USD Term SOFR Reference Rate for such tenor as published by the USD Term SOFR Administrator on the first preceding U.S. Government Securities Business Day for which such USD Term SOFR Reference Rate for such tenor was published by the USD Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day is not more than three (3) U.S. Government Securities Business Days prior to such ABR SOFR Determination Day.
“USD Term SOFR Adjustment” means, for any calculation with respect to a USD Term SOFR Loan, a percentage per annum as set forth below for the applicable Interest Period therefor:
Interest Period
Percentage
One month
0.11448 %
Three months
0.26161%
Six months
0.42826%

“USD Term SOFR Administrator” means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the USD Term SOFR Reference Rate selected by the Administrative Agent in its reasonable discretion).
80


“USD Term SOFR Loan” means a Loan that bears interest at a rate based on Adjusted Term SOFR, other than pursuant to clause (c) of the definition of “Alternate Base Rate”.
USD Term SOFR Reference Rate” means, for the applicable corresponding tenor, the forward-looking term rate based on USD SOFR that has been selected or recommended by the Relevant Governmental Body.
U.S. Borrower” has the meaning assigned to such term in the preamble hereto or any Additional Borrower organized under the laws of the United States, any state thereof or the District of Columbia.
U.S. Corporate Subsidiary” means a Domestic Subsidiary of Holdings that is treated as a corporation for U.S. federal income tax purposes.
“U.S. Government Securities Business Day” means any day except for (a) a Saturday, (b) a Sunday or (c) a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.
U.S. Holdco” means ICON US Holdings, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Holdings.
U.S. Person” means any Person that is a “United States person” as defined in Section 7701(a)(30) of the Code.
U.S. Security Agreement” means that certain Pledge and Security Agreement (including any and all supplements thereto), substantially in the form attached as Exhibit F, dated as of the Closing Date (or such earlier date to the extent executed prior to the Closing Date by certain of the Foreign Grantors (as defined therein) party thereto), between the U.S. Borrower, each other Domestic Subsidiary that is a Subsidiary Guarantor and each Foreign Grantor (as defined therein) party thereto and the Collateral Agent, for the benefit of the Collateral Agent and the other Secured Parties, and any other pledge or security agreement entered into after the date hereof by any other Loan Party that is a Domestic Subsidiary (as required by this Agreement or any other Loan Document), or by any Foreign Loan Party with respect to Domestic Pledged Equity (each as defined in the U.S. Security Agreement), with the Collateral Agent.
U.S. Special Resolution Regime” has the meaning assigned to such term in Section 9.20.
U.S. Tax Compliance Certificate” has the meaning assigned to such term in Section 2.17(e)(i)(A)(iii).
U.S. Term Loan Commitments” means with respect to each Term Lender, the commitment, if any, of such Term Lender to make U.S. Term Loans hereunder, as such commitment may be (a) reduced or terminated from time to time pursuant to Section 2.09 and (b) reduced or increased from time to time pursuant to assignments by or to such Term Lender pursuant to Section 9.04. The amount of each Term Lender’s U.S. Term Loan Commitment as of the Closing Date is set forth on Schedule 2.01, or in the Assignment and Assumption (or other documentation contemplated by this Agreement) pursuant to which such Term Lender shall have assumed its U.S. Term Loan Commitment, as applicable, and any other Refinancing Commitments and any Incremental Term Loan Commitments. The aggregate principal amount of the U.S. Term Loan Commitments on the Closing Date is $1,100,000,000.
U.S. Term Loan Repayment Date” has the meaning assigned to such term in Section 2.10(a)(ii).
81


U.S. Term Loans” means the term loans made by the Term Lenders to the U.S. Borrower on the Closing Date pursuant to Section 2.01. Each U.S. Term Loan shall be a EurocurrencyUSD Term SOFR Loan denominated in Dollars or an ABR Loan denominated in Dollars.
USA Patriot Act” has the meaning assigned to such term in Section 9.14.
Voting Stock” of any specified Person means as of any date the Equity Interests of such Person of the class or classes that has the general voting power under ordinary circumstances to elect at least a majority of the Board of Directors of such Person (irrespective of whether or not at the time Equity Interests of any other class or classes shall have or might have voting power by reason of the happening of any contingency).
Weighted Average Life to Maturity” means, when applied to any Indebtedness at any date, the number of years obtained by dividing: (a) the sum of the products obtained by multiplying (i) the amount of each then remaining installment, sinking fund, serial maturity or other required payments of principal, including payment at final maturity, in respect thereof, by (ii) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment; by (b) the then outstanding principal amount of such Indebtedness.
Write-Down and Conversion Powers” means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or other financial institution or affiliate of a bank, investment firm or other financial institution, to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.
Section 1.02Classification of Loans and Borrowings. For purposes of this Agreement, Loans may be classified and referred to by Class (e.g., a “Term Loan”) or by Type (e.g., a “Eurocurrency Loan”) or by Class and Type (e.g., a “Eurocurrency Term Loan”). Borrowings also may be classified and referred to by Class (e.g., a “Term Loan Borrowing”) or by Type (e.g., a “Eurocurrency Borrowing”) or by Class and Type (e.g., a “Term Loan Eurocurrency Borrowing”).
Section 1.03Terms Generally. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”. The word “will” shall be construed to have the same meaning and effect as the word “shall”. The word “law” shall be construed as referring to all statutes, rules, regulations, codes and other laws (including official rulings and interpretations thereunder having the force of law or with which affected Persons customarily comply), and all judgments, orders and decrees, of all Governmental Authorities. Unless the context requires otherwise (a) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, restated, supplemented or otherwise modified (subject to any restrictions on such amendments,
82


restatements, supplements or modifications set forth herein), (b) any definition of or reference to any statute, rule or regulation shall be construed as referring thereto as from time to time amended, supplemented or otherwise modified (including by succession of comparable successor laws), (c) any reference herein to any Person shall be construed to include such Person’s successors and assigns (subject to any restrictions on assignment set forth herein) and, in the case of any Governmental Authority, any other Governmental Authority that shall have succeeded to any or all functions thereof, (d) the words “herein”, “hereof” and “hereunder”, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (e) all references herein to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, this Agreement and (f) the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights. Any references in this Agreement or any other Loan Document to “Permitted Liens” is not intended to subordinate or postpone, and shall not be interpreted as subordinating or postponing, or as any agreement to subordinate or postpone, any Lien created by any of the Loan Documents to any Permitted Lien.
Section 1.04Accounting Terms; GAAP. Except as otherwise expressly provided herein, all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time; provided that, if Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change occurring after the Closing Date in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith. At any time after the Closing Date, Holdings may elect (by written notice to the Administrative Agent) to change its financial reporting (both hereunder and for its audited financial statements generally) from GAAP to International Financial Reporting Standards (as issued by the International Accounting Standards Board and the International Financial Reporting Standards Interpretations Committee and/or adopted by the European Union (“IFRS”)), as in effect from time to time, in which case all references herein to GAAP (except for historical financial statements theretofore prepared in accordance with GAAP) shall instead be deemed references to the IFRS and the related accounting standards as shown in the first set of audited financial statements prepared in accordance therewith and delivered pursuant to this Agreement; provided that, if Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change occurring as a result of the adoption of IFRS or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Administrative Agent or the Required Lenders request an amendment to any provision hereof for such purpose), then such provision shall be interpreted on the basis of GAAP as otherwise required above (and without regard to this sentence) until such notice shall have been withdrawn or such provision amended in accordance herewith; provided further that, if, after the adoption of IFRS by Holdings, Holdings notifies the Administrative Agent that Holdings requests an amendment to any provision hereof to eliminate the effect of any change in IFRS occurring after such adoption of IFRS or in the application thereof on the operation of such provision (or if the Administrative Agent notifies Holdings that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in IFRS or in the application thereof, then such provision shall be interpreted on the basis of IFRS as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith. Notwithstanding any other provision contained herein, all terms of an accounting or financial nature used herein shall be construed, and all computations of amounts and ratios referred to herein shall be made (i)
83


without giving effect to any election under Accounting Standards Codification 825-10-25 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of Holdings or any Subsidiary at “fair value”, as defined therein, (ii) without giving effect to any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof and (iii) for the avoidance of doubt, except as provided in the definition of “Consolidated Net Income”, without giving effect to the financial condition, results and performance of the Unrestricted Subsidiaries. For purposes of calculating Consolidated Net Income, Total Assets and Consolidated EBITDA under this Agreement and any other Loan Document, IGPHS shall be treated as a Restricted Subsidiary of Holdings, notwithstanding the fact that IGPHS is an Unrestricted Subsidiary for all other purposes of the Loan Documents.
Section 1.05[Reserved].
Section 1.06Special Luxembourg Provisions. Words in the English language used in this Agreement to describe Luxembourg law concepts only intend to describe such concepts and the consequences of the use of those words in English law or any other foreign law are to be disregarded.
Without prejudice to the generality of any provision of this Agreement, to the extent this Agreement relates to any Luxembourg Loan Party or any entity incorporated or existing under the laws of Luxembourg, a reference to: (a) a winding-up, administration or dissolution includes, without limitation, bankruptcy (faillite), insolvency, liquidation, composition with creditors (concordat préventif de la faillite), moratorium or reprieve from payment (sursis de paiement), controlled management (gestion contrôlée), fraudulent conveyance (actio pauliana), general settlement with creditors, reorganization or similar laws affecting the rights of creditors generally; (b) a receiver, administrative receiver, administrator, trustee, custodian, sequestrator, conservator or similar officer appointed for the reorganization or liquidation of the business of a Person includes, without limitation, a juge délégué, commissaire, juge-commissaire, mandataire ad hoc, administrateur provisoire, liquidateur or curateur; (c) a lien or security interest includes any hypothèque, nantissement, gage, privilège, sûreté réelle, droit de rétention and any type of security in rem (sûreté réelle) or agreement or arrangement having a similar effect and any transfer of title by way of security; (d) a person being unable to pay its debts includes that person being in a state of cessation de paiements; (e) creditors process means an executory attachment (saisie exécutoire) or conservatory attachment (saisie conservatoire); (f) by-laws or constitutional documents includes its up-to-date (restated) articles of association (statuts coordonnés) and (g) a director, a manager or authorized officer includes an administrateur or a gérant.
Section 1.07Certain Conditions, Calculations and Tests.
(a)Notwithstanding anything to the contrary herein, financial ratios and tests, including the First Lien Net Leverage Ratio, the Secured Net Leverage Ratio, the Total Net Leverage Ratio, the Fixed Charge Coverage Ratio and the determination of any basket or covenant based on Consolidated EBITDA or Total Assets shall be calculated in the manner prescribed by this Section 1.07; provided, that notwithstanding anything to the contrary in clause (b) of this Section 1.07, when calculating the Secured Net Leverage Ratio, the First Lien Net Leverage Ratio and the Total Net Leverage Ratio, each as applicable, for purposes of (i) the definition of “Applicable Margin”, (ii) the definition of “ECF Payment Amount” and (iii) Section 6.12 (other than for the purpose of determining pro forma compliance with Section 6.12), the events described in this Section 1.07 that occurred subsequent to the end of the applicable Test Period shall not be given Pro Forma Effect. In addition, whenever a financial ratio or test or
84


determination of Consolidated EBITDA or Total Assets is to be calculated on a Pro Forma Basis, the reference to “Test Period” for purposes of calculating such financial ratio or test or determination of Consolidated EBITDA or Total Assets shall be deemed to be a reference to, and shall be based on, the most recently ended Test Period for which internal financial statements of Holdings are available (as determined in good faith by Holdings). For the avoidance of doubt, the provisions of the foregoing sentence shall not apply for purposes of calculating the Secured Net Leverage Ratio, the First Lien Net Leverage Ratio or the Total Net Leverage Ratio, each as applicable, for purposes of (i) the definition of “ECF Payment Amount” and (ii) Section 6.12 (other than for the purpose of determining pro forma compliance with Section 6.12), each of which shall be based on the financial statements delivered pursuant to Section 5.01(a) or (b), as applicable, for the relevant Test Period.
(b)For purposes of calculating any financial ratio or test (or Consolidated EBITDA or Total Assets), Specified Transactions (with any incurrence or repayment of any Indebtedness in connection therewith to be subject to clause (d) of this Section 1.07) that have been made (i) during the applicable Test Period or (ii) if applicable as described in clause (a) above, subsequent to such Test Period and prior to or simultaneously with the event for which the calculation of any such ratio or test (or Consolidated EBITDA or Total Assets) is made shall be calculated on a Pro Forma Basis assuming that all such Specified Transactions (and any increase or decrease in Consolidated EBITDA and the component financial definitions used therein attributable to any Specified Transaction) had occurred on the first day of the applicable Test Period (or, in the case of Consolidated EBITDA or Total Assets, on the last day of the applicable Test Period). If since the beginning of any applicable Test Period any Person that subsequently became a Restricted Subsidiary or was merged, amalgamated or consolidated with or into Holdings or any of its Restricted Subsidiaries since the beginning of such Test Period shall have made any Specified Transaction that would have required adjustment pursuant to this Section 1.07, then such financial ratio or test (or Consolidated EBITDA or Total Assets) shall be calculated to give Pro Forma Effect thereto in accordance with this Section 1.07.
(c)Whenever Pro Forma Effect is to be given to a Specified Transaction, the pro forma calculations shall be made in good faith by a responsible financial or accounting officer of Holdings and may include, for the avoidance of doubt, the amount of Run-rate cost savings, synergies and operating expense reductions projected by Holdings to be realized as a result of any Specified Transaction (including the Transactions) which is being given Pro Forma Effect that have been realized or are expected to be realized and for which the actions necessary to realize such cost savings, operating expense reductions and synergies are taken, committed to be taken or with respect to which substantial steps have been taken or are expected in good faith to be taken (calculated on a Pro Forma Basis as though such cost savings, operating expense reductions and synergies had been realized on the first day of such period and as if such cost savings, operating expense reductions and synergies were realized during the entirety of such period and net of the amount of actual benefits realized during such period from such actions, and any such adjustments shall be included in the initial pro forma calculations of such financial ratios or tests and during any subsequent Test Period in which the effects thereof are expected to be realized) relating to such Specified Transaction; provided that (A) such amounts are reasonably identifiable and factually supportable in the good faith judgment of Holdings, (B) the aggregate amount of cost savings, synergies and operating expense reductions, when aggregated with the addbacks being made for such Test Period pursuant to clause (vii) of the definition of Consolidated EBITDA, shall not exceed the cap set forth therein, (C) any cost savings, synergies and operating expense reductions included pursuant to this Section 1.08(c) shall be subject to the other limitations set forth in clause (vii) of the definition of Consolidated EBITDA and (D) no amounts shall be added to the extent duplicative of any amounts that are otherwise added back in computing Consolidated EBITDA (or any other components thereof), whether through a pro forma adjustment or otherwise, with respect to such period.
85


(d)In the event that (w) Holdings or any Restricted Subsidiary incurs (including by assumption or guarantees) or repays (including by redemption, repayment, retirement or extinguishment) any Indebtedness (other than Indebtedness incurred or repaid under any revolving credit facility (including, without limitation, the Revolving Loans) in the ordinary course of business for working capital purposes), (x) Holdings or any Restricted Subsidiary issues, repurchases or redeems Disqualified Equity Interests or (y) any Restricted Subsidiary issues, repurchases or redeems Preferred Equity, (i) during the applicable Test Period or (ii) if applicable as described in clause (a) above, subsequent to the end of the applicable Test Period and prior to or simultaneously with the event for which the calculation of any such ratio is made, then such financial ratio or test shall be calculated giving Pro Forma Effect to such incurrence or repayment of Indebtedness, or such issuance or redemption of Disqualified Equity Interests or Preferred Equity, in each case to the extent required, as if the same had occurred on the last day of the applicable Test Period (except in the case of the Fixed Charge Coverage Ratio (or similar ratio), in which case such incurrence, assumption, guarantee, redemption, repayment, retirement or extinguishment of Indebtedness or such issuance, repurchase or redemption of Disqualified Equity Interests or Preferred Equity will be given effect, as if the same had occurred on the first day of the applicable Test Period).
(e)If any Indebtedness bears a floating rate of interest and is being given Pro Forma Effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the date of the event for which the calculation of the Fixed Charge Coverage Ratio is made had been the applicable margin for the entire period (taking into account any interest hedging arrangements applicable to such Indebtedness). Interest on a Capital Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a Responsible Officer of Holdings to be the rate of interest implicit in such Capital Lease Obligation in accordance with GAAP. For purposes of the computation above, interest on any Indebtedness under a revolving credit facility computed on a Pro Forma Basis shall be computed on the average daily balances of such Indebtedness during the applicable period. Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rate, shall be determined to have been based upon the rate actually chosen, or if none, then based upon such optional rate chosen as Holdings or Restricted Subsidiary may designate.
(f)Solely for purposes of determining (i) compliance on a Pro Forma Basis with any provision of this Agreement that requires the calculation of the First Lien Net Leverage Ratio, Secured Net Leverage Ratio, Total Net Leverage Ratio, Fixed Charge Coverage Ratio, Total Assets or Consolidated EBITDA or (ii) whether a Default or an Event of Default has occurred and is continuing, in each case in connection with any determination as to whether a Limited Condition Transaction or any Indebtedness and Liens to be incurred in connection with such Limited Condition Transaction is permitted to be consummated, the date of determination of whether such Limited Condition Transaction or any Indebtedness and Liens to be incurred in connection with such Limited Condition Transaction is permitted hereunder shall, at the option of Holdings, be the date on which the definitive agreements for such Limited Condition Transaction are entered into or the date such irrevocable notice or offer for such Limited Condition Transaction is delivered, as applicable (the “LCT Test Date”) (provided that Holdings exercise such option by delivering to the Administrative Agent a certificate of a Responsible Officer on or prior to the LCT Test Date), with such determination to give Pro Forma Effect to such Limited Condition Transaction and the other transactions to be entered into in connection therewith (including any incurrence of Indebtedness or Liens and the use of proceeds thereof) as if they had occurred at the beginning of the most recent Test Period ending prior to the LCT Test Date. For the avoidance of doubt, (x) if Holdings has exercised such option and any of the tests, ratios, baskets or amounts for which compliance was determined or tested as of the LCT Test Date are exceeded as a result of fluctuations in any such test, ratio, basket or amount, including due to fluctuations in Total Assets or Consolidated EBITDA or total assets of Holdings or the Person subject to such Limited Condition Transaction, at or prior to the consummation of the Limited
86


Condition Transaction, such test, ratios, baskets and amounts will not be deemed to have been exceeded as a result of such fluctuations solely for purposes of determining whether the Limited Condition Transaction is permitted to be consummated and (y) if any Default or Event of Default occurs following the LCT Test Date and prior to the consummation of such Limited Condition Transaction, any such Default or Event of Default shall be deemed not to have occurred or be continuing for purposes of determining whether any action being taken in connection with such Limited Condition Transaction is permitted. If Holdings has exercised such option for any Limited Condition Transaction, then, in connection with any subsequent calculation of such test, ratios, baskets or amounts on or following the relevant LCT Test Date and prior to the earlier of (i) the date on which such Limited Condition Transaction is consummated and (ii) the date that the definitive agreements for such Limited Condition Transaction are terminated or expire without consummation of such Limited Condition Transaction, any such test, ratio basket or basket shall be calculated on a Pro Forma Basis assuming such Limited Condition Transaction and the other transactions in connection therewith (including any incurrence of Indebtedness or Liens and the use of proceeds thereof) have been consummated; provided that if Holdings elects to have such determinations occur at the time of entry into such definitive agreement or the date such irrevocable notice or offer for such Limited Condition Transaction is delivered, as applicable, any indebtedness to be incurred (and any associated lien) shall be deemed incurred at the time of such election (until such time as the indebtedness is actually incurred or the applicable acquisition agreement is terminated without actually consummating the applicable acquisition) and outstanding thereafter for purposes of pro forma compliance with any applicable financial test.
(g)Notwithstanding anything to the contrary herein, with respect to any amounts incurred or transactions (or series of transactions) entered into (or consummated) in reliance on a provision within the same covenant of this Agreement that does not require compliance with a financial ratio or test (any such amounts, the “Fixed Amounts”) substantially concurrently or in a series of related transactions with any amounts incurred or transactions entered into (or consummated) in reliance on a provision within the same covenant of this Agreement that requires compliance with any such financial ratio or test (including any First Lien Net Leverage Ratio test, any Secured Net Leverage Ratio, any Total Net Leverage Ratio, any Fixed Charge Coverage Ratio or the amount of Consolidated EBITDA) (any such amounts, the “Incurrence-Based Amounts”), it is understood and agreed that (a) the Fixed Amounts under such covenant shall be disregarded in the calculation of the financial ratio or test applicable to any substantially concurrent utilization of the Incurrence-Based Amounts and (b) the entire transaction (or series of related transactions) shall be calculated on a Pro Forma Basis (including the use of proceeds of all Indebtedness to be incurred and any repayments, repurchases and redemptions of Indebtedness; provided that, for purposes of such calculations, Unrestricted Cash shall not include the cash proceeds of any Indebtedness the incurrence of which is the specified transaction or that is incurred to finance the specified transaction). Notwithstanding anything herein to the contrary, if at any time any applicable ratio or financial test for any category based on an Incurrence-Based Amount permits Indebtedness, Liens, Restricted Payments, Asset Sales, and Investments, as applicable, previously incurred under a category based on a Fixed Amount, such Indebtedness, Liens, Restricted Payments, Asset Sales, and Investments, as applicable, shall be deemed to have been automatically reclassified as incurred under such category based on an Incurrence-Based Amount.
Section 1.08Divisions. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction’s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time.
87


Article II

The Credits
Section 2.01Commitments and Loans.
(a)Subject to the terms and conditions set forth herein, each Term Lender agrees, severally and not jointly, to make a Lux Term Loan to the Lux Borrower and the Lux U.S. Subsidiary Borrower on the Closing Date in a principal amount not to exceed its Lux Term Loan Commitment. The full amount of the Lux Term Loan Commitments must be drawn in a single drawing on the Closing Date and amounts repaid or prepaid in respect of Lux Term Loans may not be reborrowed.
(b)Subject to the terms and conditions set forth herein, each Term Lender agrees, severally and not jointly, to make a U.S. Term Loan to the U.S. Borrower on the Closing Date in a principal amount not to exceed its U.S. Term Loan Commitment. The full amount of the U.S. Term Loan Commitments must be drawn in a single drawing on the Closing Date and amounts repaid or prepaid in respect of U.S. Term Loans may not be reborrowed.
(c)Subject to the term and conditions set forth herein, each Revolving Lender agrees to make Revolving Loans to any Revolving Borrower in Agreed Currencies from time to time during the Availability Period in an aggregate principal amount that will not result in (i) subject to Sections 2.04 and 2.11(c), the Dollar Amount of such Lender’s Revolving Credit Exposure exceeding such Lender’s Revolving Commitment and (ii) subject to Sections 2.04 and 2.11(c), the sum of the Dollar Amount of the total Revolving Credit Exposures exceeding the aggregate Revolving Commitments. Within the foregoing limits and subject to the terms and conditions set forth herein, each Revolving Borrower may borrow, prepay and reborrow Revolving Loans.
(d)Each Borrower hereunder shall only be liable as a primary obligor for the Loans made to such Borrower and shall not be jointly and severally liable for Loans made to any other Borrower; provided that, notwithstanding the foregoing, the Lux Borrower and the Lux U.S. Subsidiary Borrower shall be jointly and severally liable for the Lux Term Loans made pursuant to Section 2.01(a).
(e)For the avoidance of doubt, at the Closing Date, each Term Lender shall fund an equal percentage of the principal amount of the total U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of the total U.S. Term Loans funded by each Term Lender shall equal the percentage of the principal amount of the Lux Term Loans funded by such Term Lender). As provided in Section 9.04(b)(ii)(G), at all times after the Closing Date, the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such assignor’s U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of an assignor’s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor’s Lux Term Loans that are assigned).
Section 2.02Loans and Borrowings.
(a)Each Loan (other than a Swingline Loan) shall be made as part of a Borrowing consisting of Loans of the same Class and Type made under a single Tranche and shall be made by the Lenders of such Class under such Tranche ratably in accordance with their respective Commitments in respect of the applicable Class and in respect of the applicable Tranche. The failure of any Lender to make any Loan required to be made by it shall not relieve any other Lender of its obligations hereunder; provided that the Commitments of the Lenders are
88


several and no Lender shall be responsible for any other Lender’s failure to make Loans as required. Any Swingline Loan shall be made in accordance with the procedures set forth in Section 2.05.
(b)Subject to Section 2.14, (i) each Revolving Borrowing shall be comprised entirely of ABR Loans, Eurocurrency Loans, USD Term SOFR Loans or RFR Loans and (ii) each Lux Term Loan Borrowing and each U.S. Term Loan Borrowing shall be comprised entirely of ABR Loans or EurocurrencyUSD Term SOFR Loans, in each case, as the Applicable Borrower may request in accordance herewith; provided that each ABR Loan shall only be made in Dollars. Each Swingline Loan shall be an ABR Loan. Subject to Section 2.19, each Lender at its option may make any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan by causing any domestic or foreign branch or Affiliate of such Lender to make such Loan (and in the case of a branch or Affiliate, the provisions of Sections 2.14, 2.15, 2.16 and 2.17 (including, for the avoidance of doubt, the requirements and limitations of such sections) shall apply to such branch or Affiliate to the same extent as if it were a Lender); provided that (x) any exercise of such option shall not affect the obligation of the Applicable Borrower to repay such Loan in accordance with the terms of this Agreement, (y) if the respective branch or Affiliate is a Foreign Lender, the same shall comply with the requirements of Section 2.17 and (z) with respect to any Loans incurred by a Borrower that is organized or tax resident in Ireland, the branch or Affiliate, whether or not a Foreign Lender, shall comply with the requirements of Section 2.17.
(c)At the commencement of each Interest Period for any Borrowing of Eurocurrency Revolving Loans, USD Term SOFR Revolving Loans or RFR Revolving Loans, such Borrowing shall be in an aggregate amount that is an integral multiple of $500,000 (or, if such Borrowing is denominated in a Foreign Currency, 500,000 units of such currency) and not less than $2,000,000 (or, if such Borrowing is denominated in a Foreign Currency, 2,000,000 units of such currency). At the time that each ABR Revolving Borrowing is made, such Borrowing shall be in an aggregate amount that is an integral multiple of $500,000 and not less than $1,000,000; provided that an ABR Revolving Borrowing may be in an aggregate amount that is equal to the entire unused balance of the aggregate Revolving Commitments of the relevant Class, or that is required to finance the reimbursement of an LC Disbursement as contemplated by Section 2.06(e). Each Swingline Loan shall be in an amount that is an integral multiple of $500,000 and not less than $1,000,000. Borrowings of more than one Type and Class and under more than one Tranche may be outstanding at the same time; provided that there shall not at any time be more than a total of eight (8) Eurocurrency Revolving Borrowings, USD Term SOFR Revolving Borrowings and RFR Revolving Borrowings outstanding.
(d)Notwithstanding any other provision of this Agreement, the Applicable Borrower shall not be entitled to request, or to elect to convert or continue, any Borrowing of any Class if the Interest Period requested with respect thereto would end after the Maturity Date of such Class.
Section 2.03Requests for Borrowings. To request a Borrowing, the Applicable Borrower shall notify the Administrative Agent of such request (a) in the case of a EurocurrencyUSD Term SOFR Borrowing denominated in Dollars, by telephonic notice not later than 11:00 a.m., New York City time, three (3) Business Days before the date of the proposed Borrowing, (b) in the case of a Eurocurrency Borrowing denominated in an Agreed Currency other than Dollars or an RFR Borrowing, by telephonic notice not later than 11:00 a.m., New York City time, four (4) Business Days before the date of the proposed Borrowing or (c) in the case of an ABR Borrowing, by telephonic notice not later than 11:00 a.m., New York City time, one (1) Business Day before the date of the proposed Borrowing; provided that (x) any such notice of an ABR Revolving Borrowing to finance the reimbursement of an LC Disbursement as contemplated by Section 2.06(e) may be given not later than 10:00 a.m., New York City time, on the date of the proposed Borrowing and (y) any notice with respect to Borrowings to be made on
89


the Closing Date may be given with such shorter time than the deadline described in clause (a), (b) or (c), as applicable, as the Administrative Agent may agree in its sole discretion. Each such telephonic Borrowing Request shall be irrevocable and shall be confirmed promptly by email to the Administrative Agent of a written Borrowing Request in a form approved by the Administrative Agent and signed by the Applicable Borrower; provided that in respect of the Loans to be borrowed on the Closing Date, any written Borrowing Request may be provided by the Applicable Borrower on a conditional basis (provided that (1) to the extent the Applicable Borrower does not borrow any Eurocurrency Loans, USD Term SOFR Loans or RFR Loans set forth in such conditional Borrowing Request, the Applicable Borrower shall be required to compensate the Lenders under Section 2.16 for the losses, costs or expenses related thereto and (2) any such Borrowing Request shall be irrevocable once funding of the Borrowings has been initiated by the Administrative Agent), and such Borrowing Request may be provided no later than 2:00 pm, New York City Time, on the Business Day prior to such Borrowing. Each telephonic and written Borrowing Request shall specify the following information in compliance with Section 2.02:
(a)the aggregate amount of the requested Borrowing;
(b)the date of such Borrowing, which shall be a Business Day;
(c)the Class of such Borrowing and whether such Borrowing is to be an ABR Borrowing, a Eurocurrency Borrowing, USD Term SOFR Borrowing or an RFR Borrowing;
(d)(i) in the case of a Eurocurrency Borrowing or an RFR Borrowing, the Agreed Currency and the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term “Interest Period” and (ii) in the case of a USD Term SOFR Borrowing, the initial Interest Period to be applicable thereto, which shall be a period contemplated by the definition of the term “Interest Period”; and
(e)the Applicable Borrower and the location and number of the Applicable Borrower’s account to which funds are to be disbursed, which shall comply with the requirements of Section 2.07.
If no election as to the Type of Borrowing is specified, then, in the case of a Borrowing denominated in Dollars, the requested Borrowing shall be an ABR Borrowing. If no Interest Period is specified with respect to any requested Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month’s duration. Promptly following receipt of a Borrowing Request in accordance with this Section 2.03, the Administrative Agent shall advise each applicable Lender of the details thereof and of the amount of such Lender’s Loan to be made as part of the requested Borrowing.
Section 2.04Determination of Dollar Amounts. The Administrative Agent will determine the Dollar Amount of:
(a)each Revolving Borrowing utilizing Revolving Commitments as of the date two (2) Business Days prior to the date of such Borrowing or, if applicable, the date of conversion/continuation of any such Borrowing as a Revolving Borrowing,
(b)the LC Exposure as of the date of each request for the issuance, amendment, renewal or extension of any Letter of Credit, and
90


(c)all outstanding Revolving Credit Exposure on and as of the last Business Day of each calendar month and, during the continuation of an Event of Default, on any other Business Day elected by the Administrative Agent in its discretion or upon instruction by the Required Lenders.
Each day upon or as of which the Administrative Agent determines Dollar Amounts as described in the preceding clauses (a), (b) and (c) is herein described as a “Computation Date” with respect to each Credit Event for which a Dollar Amount is determined on or as of such day.
Section 2.05Swingline Loans.
(a)Subject to the terms and conditions set forth herein, the Swingline Lender agrees to make Swingline Loans in Dollars to the Applicable Borrower from time to time during the Availability Period, in an aggregate principal amount at any time outstanding that will not result in (i) the aggregate principal amount of outstanding Swingline Loans exceeding $25,000,000 or (ii) the Dollar Amount of the total Revolving Credit Exposures exceeding the aggregate Revolving Commitments; provided that the Swingline Lender shall not be required to make a Swingline Loan to refinance an outstanding Swingline Loan. Within the foregoing limits and subject to the terms and conditions set forth herein, the Applicable Borrower may borrow, prepay and reborrow Swingline Loans.
(b)To request a Swingline Loan, the Applicable Borrower shall notify the Administrative Agent of such request by telephone (confirmed by telecopy), not later than 2:00 p.m., New York City time, on the day of a proposed Swingline Loan. Each such notice shall be irrevocable and shall specify the requested date (which shall be a Business Day) and amount of the requested Swingline Loan. The Administrative Agent will promptly advise the Swingline Lender of any such notice received from the Applicable Borrower. The Swingline Lender shall make each Swingline Loan available to the Applicable Borrower by means of a credit to the general deposit account of such Applicable Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an LC Disbursement as provided in Section 2.06(e), by remittance to the applicable Issuing Banks) by 2:00 p.m., New York City time, on the requested date of such Swingline Loan.
(c)The Swingline Lender may by written notice given to the Administrative Agent not later than 10:00 a.m., New York City time, on any Business Day require the Revolving Lenders to acquire participations on such Business Day in all or a portion of the Swingline Loans outstanding. Such notice shall specify the aggregate amount of Swingline Loans in which Revolving Lenders will participate. Promptly upon receipt of such notice, the Administrative Agent will give notice thereof to each Revolving Lender, specifying in such notice such Lender’s Revolving Percentage of such Swingline Loan or Loans. Each Revolving Lender hereby absolutely and unconditionally agrees, upon receipt of notice as provided above, to pay to the Administrative Agent, for the account of the Swingline Lender, such Revolving Lender’s Revolving Percentage (after giving effect to the reallocation provisions of paragraph (d) below) of such Swingline Loan or Loans. Each Revolving Lender acknowledges and agrees that its obligation to acquire participations in Swingline Loans pursuant to this paragraph in an amount equal to its Revolving Percentage thereof is absolute and unconditional and shall not be affected by any circumstance whatsoever, including the occurrence and continuance of a Default or reduction or termination of the Revolving Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever. Each Revolving Lender shall comply with its obligation under this paragraph by wire transfer of immediately available funds, in the same manner as provided in Section 2.07 with respect to Loans made by such Lender (and Section 2.07 shall apply, mutatis mutandis, to the payment obligations of the Revolving Lenders), and the Administrative Agent shall promptly pay to the Swingline Lender the amounts so received by it from the Revolving Lenders. The Administrative Agent shall notify
91


the Applicable Borrower of any participations in any Swingline Loan acquired pursuant to this paragraph, and thereafter payments in respect of such Swingline Loan shall be made to the Administrative Agent and not to the Swingline Lender. Any amounts received by the Swingline Lender from an Applicable Borrower (or other party on behalf of such Applicable Borrower) in respect of a Swingline Loan after receipt by the Swingline Lender of the proceeds of a sale of participations therein shall be promptly remitted to the Administrative Agent; any such amounts received by the Administrative Agent shall be promptly remitted by the Administrative Agent to the applicable Revolving Lenders that shall have made their payments pursuant to this paragraph and to the Swingline Lender, as their interests may appear; provided that any such payment so remitted shall be repaid to the Swingline Lender or to the Administrative Agent, as applicable, if and to the extent such payment is required to be refunded to the Applicable Borrower for any reason. The purchase of participations in a Swingline Loan pursuant to this paragraph shall not relieve the Applicable Borrower of any default in the payment thereof.
(d)Reallocations and Extensions. If the Maturity Date shall have occurred in respect of any Class of Revolving Commitments at a time when another Tranche or Tranches of any other Class of Revolving Commitments is or are in effect with a longer Maturity Date, then on the earliest occurring Maturity Date all then-outstanding Swingline Loans shall be repaid in full (and there shall be no adjustment to the participations in such Swingline Loans as a result of the occurrence of such earliest Maturity Date); provided, however, that if on the occurrence of such earliest Maturity Date (after giving effect to any repayments of Revolving Loans and any reallocation of Letter of Credit participations as contemplated in Section 2.06(k)), there shall remain obligations to fund Swingline Loans hereunder and there shall exist sufficient unutilized Revolving Commitments of any other Class or Classes or Extended Revolving Commitments so that the respective outstanding Swingline Loans could be incurred pursuant to such Revolving Commitments of such other Class or Classes or Extended Revolving Commitments which will remain in effect after the occurrence of such earliest Maturity Date, then there shall be an automatic adjustment on such date of the risk participations of each Revolving Lender holding Revolving Commitments of such other Class or Classes or that is an Extending Revolving Lender and such outstanding Swingline Loans shall be deemed to have been incurred solely pursuant to the relevant Revolving Commitments of such other Class or Classes or Extended Revolving Commitments and such Swingline Loans shall not be so required to be repaid in full on such earliest Maturity Date.
Section 2.06Letters of Credit.
(a)General. Subject to the terms and conditions set forth herein, the Applicable Borrower may request the issuance of Letters of Credit denominated in Agreed Currencies, in each case for its own account (or for the account of any Restricted Subsidiary), in a form reasonably acceptable to the Administrative Agent and the applicable Issuing Bank, at any time and from time to time during the Availability Period. In the event of any inconsistency between the terms and conditions of this Agreement and the terms and conditions of any form of letter of credit application or other agreement submitted by the Applicable Borrower to, or entered into by the Applicable Borrower with, the applicable Issuing Bank relating to any Letter of Credit, the terms and conditions of this Agreement shall control.
(b)Notice of Issuance, Amendment, Renewal, Extension; Certain Conditions. To request the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit from an Issuing Bank), the Applicable Borrower shall email or telecopy (or transmit by any other electronic communication, if arrangements for doing so have been approved by such Issuing Bank) to such Issuing Bank and the Administrative Agent (reasonably in advance of, but not less than three (3) Business Days prior to, the requested date of issuance (or such shorter period as such Issuing Bank may agree), amendment, renewal or extension and which, in the case of a Letter of Credit to be issued on the Closing Date, may be
92


conditioned on the occurrence of the Closing Date) a notice in the applicable Issuing Bank’s customary form requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date on which such Letter of Credit is to expire (which shall comply with paragraph (c) of this Section 2.06), the amount of such Letter of Credit, the Agreed Currency applicable thereto), the name and address of the beneficiary thereof and such other information as shall be necessary to prepare, amend, renew or extend such Letter of Credit. The Applicable Borrower also shall submit a letter of credit application on such Issuing Bank’s standard form and related documents in connection with any request for a Letter of Credit and in connection with any request for a Letter of Credit to be amended, renewed, modified or extended. A Letter of Credit shall be issued, amended, renewed or extended only (A) if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Applicable Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension (i) subject to Section 2.04, the Dollar Amount of the LC Exposure shall not exceed $15,000,000 (the “LC Sublimit”) and (ii) subject to Section 2.04, the sum of the Dollar Amount of the total Revolving Credit Exposures shall not exceed the aggregate Revolving Commitments; provided that the LC Sublimit may be increased from time to time upon agreement between the Administrative Agent and Borrowers, so long as any increase has been appropriately committed by a Lender (that is or shall be an Issuing Bank), on terms and conditions satisfactory to the Administrative Agent and (B) in accordance with such Issuing Bank’s usual and customary policies and practices from time to time; provided, further, that the Dollar Amount of the LC Exposure in respect of each Issuing Bank may not be increased or decreased without the applicable Issuing Bank’s consent.
(c)Expiration Date. Each Letter of Credit shall expire at or prior to the close of business on the earlier of (i) the date one year after the date of the issuance of such Letter of Credit (or, in the case of any renewal or extension thereof, one year after such renewal or extension) and (ii) the date that is five (5) Business Days prior to the Maturity Date with respect to the Revolving Commitments pursuant to which issued (or if any Extended Revolving Commitments, Incremental Revolving Commitments or Other Refinancing Revolving Commitments are outstanding, the last Maturity Date applicable thereto (so long as the aggregate amount of such Letters of Credit are not in excess of such commitments)); provided that any Letter of Credit may contain customary automatic renewal provisions agreed upon by the Applicable Borrower and the Issuing Bank pursuant to which the expiration date of such Letter of Credit (an “Auto Renewal Letter of Credit”) shall automatically be extended for consecutive periods of up to twelve (12) months (but not to a date later than the date set forth in clause (ii) above); provided that any such Auto Renewal Letter of Credit must permit the applicable Issuing Bank to prevent any such renewal at least once in each twelve month period (commencing with the date of issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof not later than a day in each such twelve month period to be agreed upon at the time such Letter of Credit is issued. Unless otherwise directed by such Issuing Bank, the Applicable Borrower shall not be required to make a specific request to such Issuing Bank for any such renewal. Once an Auto Renewal Letter of Credit has been issued, the Lenders shall be deemed to have authorized (but may not require) such Issuing Bank to permit the renewal of such Letter of Credit at any time to an expiry date not later than such Maturity Date.
(d)Participations. By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and without any further action on the part of any Issuing Bank or any Revolving Lender in respect of the Tranche under which such Letter of Credit is issued (each such Revolving Lender, an “Applicable Lender”), the Issuing Banks hereby grant to each Applicable Lender, and each Applicable Lender hereby acquires from the Issuing Bank, a participation in such Letter of Credit equal to such Applicable Lender’s Applicable Percentage of the aggregate Dollar Amount available to be drawn under such Letter of Credit. In consideration and in furtherance of the foregoing, each Applicable Lender hereby absolutely and
93


unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Banks, such Applicable Lender’s Applicable Percentage (after giving effect to the reallocation provisions of paragraph (k) below) of each LC Disbursement made by the Issuing Banks and not reimbursed by the Applicable Borrower on the date due as provided in paragraph (e) of this Section 2.06, or of any reimbursement payment required to be refunded to the Applicable Borrower for any reason. Each Revolving Lender acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit or the occurrence and continuance of a Default or reduction or termination of the Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.
(e)Reimbursement. If an Issuing Bank shall make any LC Disbursement in respect of a Letter of Credit, the Applicable Borrower shall reimburse such LC Disbursement by paying to such Issuing Bank in Dollars the Dollar Amount equal to such LC Disbursement, calculated as of the date such Issuing Bank made such LC Disbursement (or if the Issuing Bank shall so elect in its sole discretion by notice to the Applicable Borrower, in such other Agreed Currency which was paid by such Issuing Bank pursuant to such LC Disbursement in an amount equal to such LC Disbursement) not later than 12:00 noon, Local Time, on the first Business Day immediately following the date that such LC Disbursement is made, if the Applicable Borrower shall have received notice of such LC Disbursement on the date of such LC Disbursement; provided that, if such LC Disbursement is not less than the Dollar Amount of $1,000,000, the Applicable Borrower may, subject to the conditions to borrowing set forth herein, request in accordance with Section 2.03 or 2.05 that such payment be financed with an ABR Revolving Borrowing or Swingline Loan in an equivalent Dollar Amount of such LC Disbursement and, to the extent so financed, the Applicable Borrower’s obligation to make such payment shall be discharged and replaced by the resulting ABR Revolving Borrowing or Swingline Loan. If the Applicable Borrower fails to make such payment when due, the Administrative Agent shall notify each Applicable Lender of the applicable LC Disbursement, the payment then due from the Applicable Borrower in respect thereof and such Lender’s Applicable Percentage thereof. Promptly following receipt of such notice, each Applicable Lender shall pay to the Administrative Agent its Applicable Percentage (after giving effect to the reallocation provisions of paragraph (k) below) of the payment then due from the Applicable Borrower, in the same manner as provided in Section 2.07 with respect to Loans made by such Lender (and Section 2.07 shall apply, mutatis mutandis, to the payment obligations of the Applicable Lenders), and the Administrative Agent shall promptly pay to the Issuing Bank the amounts so received by it from the Applicable Lenders. Promptly following receipt by the Administrative Agent of any payment from the Applicable Borrower pursuant to this paragraph, the Administrative Agent shall distribute such payment to the applicable Issuing Bank or, to the extent that Applicable Lenders have made payments pursuant to this paragraph to reimburse the applicable Issuing Bank, then to such Lenders and the applicable Issuing Bank as their interests may appear. Any payment made by an Applicable Lender pursuant to this paragraph to reimburse an Issuing Bank for any LC Disbursement (other than the funding of ABR Revolving Loans or a Swingline Loan as contemplated above) shall not constitute a Loan and shall not relieve the Applicable Borrower of its obligations to reimburse such LC Disbursement. If the Applicable Borrower’s reimbursement of, or obligation to reimburse, any amounts in any Foreign Currency would subject the Administrative Agent, any Issuing Bank or any Revolving Lender to any stamp duty, ad valorem charge or similar tax that would not be payable if such reimbursement were made or required to be made in Dollars, the Applicable Borrower shall, at its option, either (x) pay the amount of any such tax requested by the Administrative Agent, such Issuing Bank or the relevant Revolving Lender or (y) reimburse each LC Disbursement made in such Foreign Currency in Dollars, in an amount equal to the Equivalent Amount, calculated using the applicable Exchange Rates, on the date such LC Disbursement is made, of such LC Disbursement.
94


(f)Obligations Absolute. The Applicable Borrower’s obligations to reimburse LC Disbursements as provided in paragraph (e) of this Section 2.06 shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever and irrespective of (i) any lack of validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, (iii) payment by an Issuing Bank under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit, or (iv) any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section 2.06, constitute a legal or equitable discharge of, or provide a right of setoff against, the Applicable Borrower’s obligations hereunder. Neither the Administrative Agent, the Revolving Lenders nor the Issuing Banks, nor any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of the applicable Issuing Bank; provided that the foregoing shall not be construed to excuse such Issuing Bank from liability to the Applicable Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by the Applicable Borrower to the extent permitted by applicable law) suffered by the Applicable Borrower that are caused by such Issuing Bank’s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof. The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of the applicable Issuing Bank (as finally determined by a court of competent jurisdiction), such Issuing Bank shall be deemed to have exercised care in each such determination. In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, such Issuing Bank may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.
(g)Disbursement Procedures. Each Issuing Bank shall, promptly following its receipt thereof, examine all documents purporting to represent a demand for payment under a Letter of Credit. Each Issuing Bank shall promptly notify the Administrative Agent and the Applicable Borrower by telephone (confirmed by telecopy) of such demand for payment and whether such Issuing Bank has made or will make an LC Disbursement thereunder; provided that any failure to give or delay in giving such notice shall not relieve the Applicable Borrower of its obligations to reimburse such Issuing Bank and the Applicable Lenders with respect to any such LC Disbursement.
(h)Interim Interest. If an Issuing Bank shall make any LC Disbursement, then, unless the Applicable Borrower shall reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to but excluding the date that the Applicable Borrower reimburses such LC Disbursement, at the rate per annum then applicable to ABR Revolving Loans (or in the case such LC Disbursement is denominated in a Foreign Currency, at the Overnight Foreign Currency Rate for such Agreed Currency plus the then effective Applicable Margin with respect to Eurocurrency Revolving Loans or USD Term SOFR Revolving Loans, as applicable); provided that, if the Applicable Borrower fails to reimburse such
95


LC Disbursement when due pursuant to paragraph (e) of this Section 2.06, then Section 2.13(d) shall apply. Interest accrued pursuant to this paragraph shall be for the account of the Issuing Banks, except that interest accrued on and after the date of payment by any Applicable Lender pursuant to paragraph (e) of this Section 2.06 to reimburse the Issuing Banks shall be for the account of such Applicable Lender to the extent of such payment.
(i)Replacement or Resignation of Issuing Bank. Each Issuing Bank may be replaced at any time by written agreement among the Applicable Borrower, the Administrative Agent, the replaced Issuing Bank and the successor Issuing Bank. Any Issuing Bank may resign at any time by giving 60 days’ prior notice to the Administrative Agent and the Applicable Borrowers. The Administrative Agent shall notify the Revolving Lenders of any such replacement or resignation of the Issuing Bank. At the time any such replacement or resignation shall become effective, the Applicable Borrower shall pay all unpaid fees accrued for the account of the replaced or resigning Issuing Bank pursuant to Section 2.12. From and after the effective date of any such replacement, (i) the successor Issuing Bank shall have all the rights and obligations of the Issuing Bank under this Agreement with respect to Letters of Credit to be issued thereafter and (ii) references herein to the term “Issuing Bank” shall be deemed to refer to such successor or to any previous Issuing Bank, or to such successor and all previous Issuing Banks, as the context shall require. After the replacement or resignation of an Issuing Bank hereunder, the replaced Issuing Bank or resigning bank shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Bank under this Agreement with respect to Letters of Credit then outstanding and issued by it prior to such replacement or resignation, but shall not be required to issue additional Letters of Credit.
(j)Cash Collateralization. If any Event of Default shall occur and be continuing, on the Business Day that the Applicable Borrower receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, a Majority in Interest of the Revolving Lenders) demanding the deposit of cash collateral pursuant to this paragraph, the Applicable Borrower shall deposit in an account with the Administrative Agent, in the name of the Administrative Agent and for the benefit of the Revolving Lenders (the “LC Collateral Account”), an amount in cash equal to 102% of the Dollar Amount of the LC Exposure as of such date plus any accrued and unpaid interest thereon; provided that (i) the portions of such amount attributable to undrawn Foreign Currency Letters of Credit or LC Disbursements in a Foreign Currency that the Applicable Borrower is not late in reimbursing shall be deposited in the applicable Foreign Currencies in the actual amounts of such undrawn Letters of Credit and LC Disbursements and (ii) the obligation to deposit such cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of Default with respect to the Applicable Borrower described in clause (h) or (i) of Section 7.01. For the purposes of this paragraph, the Foreign Currency LC Exposure shall be calculated using the applicable Exchange Rate on the date notice demanding cash collateralization is delivered to the Applicable Borrower. The Applicable Borrower also shall deposit cash collateral pursuant to this paragraph as and to the extent required by Section 2.11(c). Such deposit shall be held by the Administrative Agent as collateral for the payment and performance of the Secured Obligations. The Administrative Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account and the Applicable Borrower hereby grants the Administrative Agent, for the ratable benefit of the Secured Parties, a security interest in the LC Collateral Account. Other than any interest earned on the investment of such deposits in Cash Equivalents, which investments shall be made at the option and sole discretion of the Administrative Agent and at the Applicable Borrower’s risk and expense, such deposits shall not bear interest. Interest or profits, if any, on such investments shall accumulate in such account. Moneys in such account shall be applied by the Administrative Agent to reimburse the Issuing Banks for LC Disbursements for which they have not been reimbursed and, to the extent not so applied, shall be held for the satisfaction of the reimbursement obligations of the Applicable
96


Borrower for the LC Exposure at such time or, if the maturity of the Loans has been accelerated (but subject to the consent of a Majority in Interest of the Revolving Lenders), be applied to satisfy other Secured Obligations. If the Applicable Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Applicable Borrower within three (3) Business Days after all Events of Default have been cured or waived. If the Applicable Borrower is required to provide an amount of cash collateral hereunder pursuant to Section 2.11(c), such amount (to the extent not applied as aforesaid) shall be returned to the Applicable Borrower as and to the extent that, after giving effect to such return, the aggregate Revolving Credit Exposures would not exceed the aggregate Revolving Commitments and no Default shall have occurred and be continuing.
(k)Reallocations and Extensions. If the Maturity Date in respect of any Class of Revolving Commitments occurs prior to the expiration of any Letter of Credit, then (i) if Extended Revolving Commitments or one or more other Tranches of Revolving Commitments of any other Class or Classes in respect of which the Maturity Date shall not have occurred are then in effect and the obligations to issue Letters of Credit hereunder remain at such time, such Letters of Credit shall automatically be deemed to have been issued (including for purposes of the obligations of the Revolving Lenders to purchase participations therein and to make Revolving Loans and payments in respect thereof pursuant to Section 2.06(e)) under (and ratably participated in by Revolving Lenders pursuant to) Extended Revolving Commitments or the Revolving Commitments of such other Class or Classes in respect of such non-terminating Extended Revolving Commitments or Tranches up to an aggregate amount not to exceed the aggregate principal amount of the unutilized Extended Revolving Commitments or Revolving Commitments of such other Class or Classes thereunder at such time (it being understood that no partial face amount of any Letter of Credit may be so reallocated) and (ii) to the extent not reallocated pursuant to the immediately preceding clause (i), the Applicable Borrower shall Cash Collateralize any such Letter of Credit in accordance with Section 2.06(j). Except to the extent of reallocations of participations pursuant to clause (i) of the immediately preceding sentence, the occurrence of a Maturity Date with respect to a given Class of Revolving Commitments shall have no effect upon (and shall not diminish) the percentage participations of the Revolving Lenders in any Letter of Credit issued before such Maturity Date.
(l)Issuing Bank Agreements. Each Issuing Bank (other than the Administrative Agent or its affiliates) agrees that, unless otherwise requested by the Administrative Agent, each Issuing Bank shall report in writing to the Administrative Agent (i) on the first Business Day of each month, the daily activity (set forth by day) in respect of Letters of Credit during the immediately preceding month, including all issuances, extensions, amendments and renewals, all expirations and cancellations and all disbursements and reimbursements, (ii) on or prior to each Business Day on which such Issuing Bank expects to issue, amend, renew or extend any Letter of Credit, the date of such issuance, amendment, renewal or extension, and the currency and aggregate face amount of the Letters of Credit to be issued, amended, renewed or extended by it and outstanding after giving effect to such issuance, amendment, renewal or extension occurred (and whether the amount thereof changed), it being understood that such Issuing Bank shall not permit any issuance, renewal, extension or amendment resulting in an increase in the amount of any Letter of Credit to occur without first obtaining written confirmation from the Administrative Agent that it is then permitted under this Agreement, (iii) on each Business Day on which such Issuing Bank makes any LC Disbursement, the date of such LC Disbursement and the amount of such LC Disbursement, (iv) on any Business Day on which the Applicable Borrower fails to reimburse an LC Disbursement required to be reimbursed to such Issuing Bank on such day, the date of such failure and the amount and currency of such LC Disbursement and (v) on any other Business Day, such other information as the Administrative Agent shall reasonably request, as to the Letters of Credit issued by such Issuing Bank.
97


(m)Letters of Credit Issued for Restricted Subsidiaries. Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Restricted Subsidiary, the Applicable Borrower shall be obligated to reimburse the Issuing Banks hereunder for any and all drawings under such Letter of Credit. The Applicable Borrower hereby acknowledges that the issuance of Letters of Credit for the account of Restricted Subsidiaries inures to the benefit of the Applicable Borrower, and that the Applicable Borrower’s business derives substantial benefits from the businesses of such Restricted Subsidiaries.
Section 2.07Funding of Borrowings.
(a)Each Lender shall make each Loan to be made by it hereunder on the proposed date thereof by wire transfer of immediately available funds (i) in the case of Loans denominated in Dollars, by 12:00 noon, New York City time, to the account of the Administrative Agent most recently designated by it for such purpose by notice to the Lenders and (ii) in the case of each Loan denominated in a Foreign Currency, by 12:00 noon, Local Time, in the city of the Administrative Agent’s Eurocurrency Payment Office for such currency and at such Eurocurrency Payment Office for such currency; provided that Swingline Loans shall be made as provided in Section 2.05. The Administrative Agent will make such Loans available to the Applicable Borrower by promptly crediting the amounts so received, in like funds, to (x) an account of the Applicable Borrower designated by the Applicable Borrower in the applicable Borrowing Request in the case of Loans denominated in Dollars and (y) an account of the Applicable Borrower in the relevant jurisdiction and designated by the Applicable Borrower in the applicable Borrowing Request, in the case of Loans denominated in a Foreign Currency; provided that ABR Revolving Loans made to finance the reimbursement of an LC Disbursement as provided in Section 2.06(e) shall be remitted by the Administrative Agent to the applicable Issuing Bank.
(b)Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing that such Lender will not make available to the Administrative Agent such Lender’s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with paragraph (a) of this Section 2.07 and may, in reliance upon such assumption, make available to the Applicable Borrower a corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Applicable Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount with interest thereon, for each day from and including the date such amount is made available to the Applicable Borrower to but excluding the date of payment to the Administrative Agent, at (i) in the case of such Lender, the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation (including without limitation the Overnight Foreign Currency Rate in the case of Loans denominated in a Foreign Currency) or (ii) in the case of an Applicable Borrower, the interest rate applicable to the relevant Class of ABR Loans. If such Lender pays such amount to the Administrative Agent, then such amount shall constitute such Lender’s Loan included in such Borrowing.
Section 2.08Interest Elections.
(a)Each Borrowing initially shall be of the Type, and under the applicable Tranche, specified in the applicable Borrowing Request and, in the case of a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, shall have an initial Interest Period as specified in such Borrowing Request. Thereafter, subject to clause (f) below, the Applicable Borrower may elect to convert such Borrowing to a different Type or to continue such Borrowing and, in the case of a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, may elect Interest Periods therefor, all as provided in this Section 2.08. The Applicable Borrower may elect different options with respect to different portions of the affected Borrowing, in which
98


case each such portion shall be allocated ratably among the Lenders holding the Loans comprising such Borrowing, and the Loans comprising each such portion shall be considered a separate Borrowing. This Section 2.08 shall not apply to Swingline Loans, which may not be converted or continued. Notwithstanding any other provision of this Section 2.08, the Applicable Borrower shall not be permitted to change the Tranche of any Borrowing, except as otherwise expressly contemplated by Section 2.22.
(b)To make an election pursuant to this Section 2.08, the Applicable Borrower shall notify the Administrative Agent of such election (which may be made (x) telephonically and followed by irrevocable written notice via an Interest Election Request in a form approved by the Administrative Agent and signed by the Applicable Borrower in the case of a borrowing denominated in Dollars or (y) by irrevocable written notice via an Interest Election Request in a form approved by the Administrative Agent and signed by the Applicable Borrower in the case of a borrowing denominated in a Foreign Currency) by the time that a Borrowing Request would be required under Section 2.03 if the Applicable Borrower were requesting a Borrowing of the Type and Class resulting from such election to be made on the effective date of such election. Notwithstanding any contrary provision herein, this Section 2.08 shall not be construed to permit the Applicable Borrower to (i) change the currency of any Borrowing, (ii) elect an Interest Period for Eurocurrency Loans, USD Term SOFR Loans or RFR Loans that does not comply with Section 2.02(c) or (iii) convert any Borrowing to a Borrowing of a Type not available under the Class of Commitments or the Tranche pursuant to which such Borrowing was made.
(c)Each telephonic and written Interest Election Request shall specify the following information in compliance with Section 2.02:
(i)the Borrowing to which such Interest Election Request applies and, if different options are being elected with respect to different portions thereof, the portions thereof to be allocated to each resulting Borrowing (in which case the information to be specified pursuant to clauses (iii) and (iv) below shall be specified for each resulting Borrowing);
(ii)the effective date of the election made pursuant to such Interest Election Request, which shall be a Business Day;
(iii)whether the resulting Borrowing is to be an ABR Borrowing, a Eurocurrency Borrowing, a USD Term SOFR Borrowing or an RFR Borrowing; and
(iv)if the resulting Borrowing is a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, the Interest Period and Agreed Currency to be applicable thereto after giving effect to such election, which Interest Period shall be a period contemplated by the definition of the term “Interest Period”.
If any such Interest Election Request requests a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing but does not specify an Interest Period, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month’s duration.
(d)Promptly following receipt of an Interest Election Request, the Administrative Agent shall advise each applicable Lender of the details thereof and of such Lender’s portion of each resulting Borrowing.
(e)If the Applicable Borrower fails to deliver a timely Interest Election Request with respect to a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing prior to the end of the Interest Period applicable thereto, then, unless such Borrowing
99


is repaid as provided herein, at the end of such Interest Period, (i) in the case of a Borrowing of Initial Term Loans, such Borrowing shall continue as a Eurocurrency Borrowing or USD Term SOFR Borrowing, as applicable, with a three month Interest Period, (ii) in the case of any other Borrowing denominated in Dollars, such Borrowing shall be converted to an ABR Borrowing and (iii) in the case of a Borrowing denominated in a Foreign Currency in respect of which such Borrower shall have failed to deliver an Interest Election Request prior to the third (3rd) Business Day preceding the end of such Interest Period, such Borrowing shall automatically continue as a Eurocurrency Borrowing or RFR Borrowing, as applicable, in the same Agreed Currency with a one month Interest Period. Notwithstanding any contrary provision hereof, if an Event of Default has occurred and is continuing and the Administrative Agent, at the request of the Required Lenders, so notifies the Applicable Borrower, then, so long as an Event of Default is continuing (i) no outstanding Borrowing may be converted to or continued as a Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing and (ii) unless repaid, each Eurocurrency Borrowing, USD Term SOFR Borrowing and RFR Borrowing shall be converted to an ABR Borrowing (and any such Eurocurrency Borrowing denominated in a Foreign Currency and any such RFR Borrowing shall be redenominated in Dollars, based on the Dollar Amounts thereof, at the time of such conversion) at the end of the Interest Period applicable thereto.
Section 2.09Termination and Reduction of Commitments.
(a)Unless previously terminated, the Lux Term Loan Commitment of each Term Lender shall automatically and permanently terminate at 5:00 PM, New York City time, on the Closing Date (after giving effect to the incurrence of Lux Term Loans on such date).
(b)Unless previously terminated, the U.S. Term Loan Commitment of each Term Lender shall automatically and permanently terminate at 5:00 PM, New York City time, on the Closing Date (after giving effect to the incurrence of U.S. Term Loans on such date).
(c)Unless previously terminated, the Revolving Commitment of each Revolving Lender shall automatically and permanently termination on the relevant Maturity Date.
(d)Any Revolving Borrower (on behalf of all of the Revolving Borrowers) may at any time terminate, or from time to time reduce, the Revolving Commitments of any Class; provided that (i) each reduction of such Revolving Commitments shall be in an amount that is an integral multiple of $5,000,000 and not less than $10,000,000 and (ii) the Revolving Borrowers shall not terminate or reduce any Revolving Commitments if, after giving effect to any concurrent prepayment of the Revolving Loans of such Class in accordance with Section 2.11, the Dollar Amount of the sum of the total Revolving Credit Exposures in respect of such Class would exceed the aggregate Revolving Commitments of such Class.
(e)Any applicable Revolving Borrower shall notify the Administrative Agent of any election to terminate or reduce the Revolving Commitments of any Class under Section 2.09(d) at least three (3) Business Days prior to the effective date of such termination or reduction, specifying such election and the effective date thereof. Promptly following receipt of any notice, the Administrative Agent shall advise the Lenders of the contents thereof. Each notice delivered by any Revolving Borrower pursuant to this Section 2.09 shall be irrevocable; provided that a notice of termination of the Revolving Commitments of any Class delivered by any Revolving Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities or one or more other events specified therein, in which case such notice may be revoked by such Revolving Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. Any termination or reduction of the Revolving Commitments of any Class shall be permanent. Each reduction of the Revolving Commitments of any Class shall be made ratably among the applicable Lenders in accordance with their respective Revolving Commitments of such Class.
100


Section 2.10Repayment of Loans; Evidence of Debt.
(a)(i) The Lux Borrower and the Lux U.S. Subsidiary Borrower shall pay to the Administrative Agent, for the account of the Term Lenders, on each March 31, June 30, September 30 and December 31, beginning with December 31, 2021 or if any such date is not a Business Day, on the immediately following Business Day (each such date, a “Lux Term Loan Repayment Date”), a principal amount of the Lux Term Loans equal to 0.25% of the initial aggregate principal amount of such Lux Term Loans (as adjusted from time to time pursuant to Section 2.11), together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment; provided that, to the extent specified in the applicable Extension Offer, amortization payments required with respect to Extended Term Loans that are Lux Term Loans for periods solely after the applicable Maturity Date for Lux Term Loans shall be as specified in the applicable Extension Offer. All unpaid Lux Term Loans shall be paid in full in Dollars by the Lux Borrower and the Lux U.S. Subsidiary Borrower on the applicable Maturity Date.
        (ii) The U.S. Borrower shall pay to the Administrative Agent, for the account of the Term Lenders, on each March 31, June 30, September 30 and December 31, beginning with December 31, 2021 or if any such date is not a Business Day, on the immediately following Business Day (each such date, a “U.S. Term Loan Repayment Date”), a principal amount of the U.S. Term Loans equal to 0.25% of the initial aggregate principal amount of such U.S. Term Loans (as adjusted from time to time pursuant to Section 2.11), together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment; provided that, to the extent specified in the applicable Extension Offer, amortization payments required with respect to Extended Term Loans that are U.S. Term Loans for periods solely after the applicable Maturity Date for U.S. Term Loans shall be as specified in the applicable Extension Offer. All unpaid U.S. Term Loans shall be paid in full in Dollars by the U.S. Borrower on the applicable Maturity Date.
        (iii) The Applicable Borrower shall pay (A) to the Administrative Agent for the account of each Revolving Lender the then unpaid principal amount of each Revolving Loan on the Maturity Date in the currency of such Loan and (B) to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the Latest Maturity Date with respect to any Revolving Commitments and the first date after such Swingline Loan is made that is the 15th or last day of a calendar month and is at least two (2) Business Days after such Swingline Loan is made; provided that on each date that a Revolving Borrowing is made, the Applicable Borrower shall repay all Swingline Loans then outstanding.
(b)Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Applicable Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder.
(c)The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, the Tranche under which it was made, the Class, Agreed Currency and Type thereof and the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Applicable Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender’s share thereof.
(d)The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section 2.10 shall be prima facie evidence of the existence and amounts of the obligations recorded therein; provided that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the
101


Applicable Borrower to repay the Loans in accordance with the terms of this Agreement; provided further that in the case of any conflict between the accounts maintained pursuant to paragraph (b) and the Register, the Register shall control.
(e)Any Lender may request that Loans made by it be evidenced by a promissory note. In such event, the Applicable Borrower shall prepare, execute and deliver to such Lender promissory notes payable to such Lender or its registered assigns and in a form approved by the Administrative Agent. Thereafter, the Loans evidenced by such promissory notes and interest thereon shall at all times (including after assignment pursuant to Section 9.04) be represented by one or more promissory notes in such form payable to the payee named therein or its registered assigns.
Section 2.11Prepayment of Loans.
(a)The Applicable Borrower shall have the right at any time and from time to time to prepay any Borrowing of any Class or Tranche in whole or in part, subject to (i) the premium set forth in Section 2.12(b), (ii) the break funding payments required by Section 2.16 and (iii) prior notice in accordance with the provisions of this Section 2.11(a); provided any voluntary prepayments of the Initial Term Loans shall be made on a pro rata basis between the two Tranches of Initial Term Loans. The Applicable Borrower shall notify the Administrative Agent (and, in the case of prepayment of a Swingline Loan, the Swingline Lender) by telephone (confirmed by telecopy) of any prepayment hereunder (i) in the case of prepayment of a EurocurrencyUSD Term SOFR Borrowing denominated in Dollars, not later than 11:00 a.m., New York City time, three (3) Business Days before the date of prepayment (or such later time as approved by the Administrative Agent), (ii) in the case of prepayment of a Eurocurrency Borrowing denominated in an Agreed Currency other than Dollars or an RFR Borrowing, not later than 11:00 a.m., New York City time, four (4) Business Days before the date of prepayment (or such later time as approved by the Administrative Agent), (iii) in the case of prepayment of an ABR Borrowing, not later than 11:00 a.m., New York City time, one (1) Business Day before the date of prepayment (or such later time as approved by the Administrative Agent) or (iv) in the case of prepayment of a Swingline Loan, not later than 12:00 noon, New York City time, on the date of prepayment (or such later time as approved by the Administrative Agent). Each such notice shall be irrevocable and shall specify the prepayment date and the principal amount and Class and Tranche of each Borrowing or portion thereof to be prepaid; provided that a notice of prepayment may state that such notice is conditioned upon the effectiveness of other credit facilities or one or more other events specified therein, in which case such notice may be revoked by the Applicable Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied. Promptly following receipt of any such notice relating to a Borrowing, the Administrative Agent shall advise the Lenders of the contents thereof. Each partial prepayment of any Borrowing shall be in an amount that would be permitted in the case of an advance of a Borrowing of the same Type as provided in Section 2.02. Each prepayment of a Revolving Borrowing shall be applied ratably to the Revolving Loans included in the prepaid Revolving Borrowing, each voluntary prepayment of a Term Loan Borrowing shall be applied as directed by the Applicable Borrower and each mandatory prepayment of a Term Loan Borrowing shall be applied in accordance with Section 2.11(e). Prepayments shall be accompanied by (i) accrued interest to the extent required by Section 2.13 and (ii) break funding payments pursuant to Section 2.16.
(b)If at any time, (i) solely as a result of fluctuations in currency Exchange Rates, the sum of the aggregate principal Dollar Amount of all of the Revolving Credit Exposures (calculated, with respect to those Credit Events denominated in Foreign Currencies, as of the most recent Computation Date with respect to each such Credit Event) exceeds 105% of the aggregate Revolving Commitments or (ii) for any other reason, the sum of the aggregate principal Dollar Amount of all of the Revolving Credit Exposures of any Class (so calculated) exceeds the
102


aggregate Commitments of such Class, the Applicable Borrower shall in each case immediately repay the applicable Borrowings or Cash Collateralize LC Exposure in an account with the Administrative Agent pursuant to Section 2.06(j), as applicable, in an aggregate principal amount sufficient to cause the aggregate Dollar Amount of all Revolving Credit Exposures (so calculated) of each Class to be less than or equal to the aggregate Commitments of such Class.
(c)In the event and on each occasion that (i) any Net Proceeds are received by or on behalf of Holdings or any of its Restricted Subsidiaries in respect of any Prepayment Event, the Applicable Borrower shall, within ten (10) Business Days after such Net Proceeds are received, prepay the Obligations as set forth in Section 2.11(d)(i) below (and subject to Section 2.11(e)) in an aggregate amount equal to the Required Net Proceeds Percentage of such Net Proceeds; provided that:
(1)any Loan Party may use a portion of such Net Proceeds to prepay or repurchase Permitted Pari Passu Secured Refinancing Debt and, to the extent such debt is (x) secured on a pari passu basis with the Obligations and (y) pari passu in right of payment with the Obligations hereunder, any Alternative Incremental Facility Indebtedness and/or Ratio Debt to the extent any applicable credit agreement, indenture or other agreement governing such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt so requires, in each case in an amount not to exceed the product of (x) the amount of such Net Proceeds and (y) a fraction, the numerator of which is the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt, as applicable, and the denominator of which is the sum of the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt, as applicable, and the outstanding principal amount of Term Loans; and
(2)in the case of any event described in clause (1) or (2) of the definition of the term “Prepayment Event”, if Holdings or its Restricted Subsidiaries elect to apply all or a portion of the Net Proceeds from such event (or a portion thereof), within 18 months after receipt of such Net Proceeds, to acquire, maintain, develop, construct, improve, upgrade or repair assets useful in the business of Holdings or its Restricted Subsidiaries or to make capital expenditures, Permitted Acquisitions, Permitted Investments or Investments permitted by Section 6.04, then no prepayment shall be required pursuant to this paragraph in respect of such Net Proceeds; provided, that to the extent of any such Net Proceeds therefrom that have not been so applied by the end of such 18 month period (or committed to be applied by the end of the 18 month period and applied within 6 months after the end of such 18 month period), a prepayment shall be required at the end of such period in an amount equal to such Net Proceeds that have not been so applied (subject to clause (f) below); or
(i)any Loan Party incurs, issues or obtains any Credit Agreement Refinancing Indebtedness (other than solely by means of extending or renewing then existing Credit Agreement Refinancing Indebtedness without resulting in any Net Proceeds), the Applicable Borrower shall, on the date on which such Credit Agreement Refinancing Indebtedness is incurred, issued or obtained, prepay any Loans constituting
103


the applicable Refinanced Debt as set forth in Section 2.11(e) below in an aggregate amount equal to 100% of the Net Proceeds of such Credit Agreement Refinancing Indebtedness; and
(ii)no later than ten (10) business days after the date on which the financial statements with respect to such fiscal year in which such Excess Cash Flow Period occurs are delivered pursuant to Section 5.01(a), the Applicable Borrower shall make prepayments of the Term Loans (unless otherwise provided in any Incremental Amendment or Refinancing Amendment) in accordance with Section 2.11(d) in an aggregate principal amount (the “ECF Payment Amount”) equal to (a) (x) if the First Lien Net Leverage Ratio at the end of such period is greater than or equal to 4.50:1.00, 50% of Excess Cash Flow for the Excess Cash Flow Period then ended, (y) if the First Lien Net Leverage Ratio at the end of such period is less than 4.50:1.00 but greater than 4.00:1.00, 25% of Excess Cash Flow for the Excess Cash Flow Period then ended and (z) if the First Lien Net Leverage Ratio at the end of such period is less than or equal to 4.00:1.00 (but excluding, for purposes of such calculation, the proceeds of any Incremental Loans or any other Indebtedness incurred on such date in the calculation of the Unrestricted Cash), 0% of Excess Cash Flow for the Excess Cash Flow Period then ended minus (b) in the case of (a)(x) and (y) above, the sum of (1) all voluntary prepayments or permitted purchases of Term Loans, Alternative Incremental Facility Indebtedness, New Notes and other Indebtedness secured by the Collateral on a pari passu basis with the Obligations and Permitted Refinancing Indebtedness (in each case that is secured by the Collateral on a pari passu basis with the Obligations) during such Excess Cash Flow Period (and in the case of the first Excess Cash Flow Period after the Closing Date, during the fiscal year ended December 31, 2021) or, without duplication across Excess Cash Flow Periods, after the end of such Excess Cash Flow Period and prior to when such Excess Cash Flow prepayment is due (limited in the case of any voluntary prepayments made pursuant to Section 2.11(a)(ii) and purchases made pursuant to Section 2.23 to the discounted amount actually paid in respect of the principal amount of such Term Loans (as opposed to the face amount so prepaid)), (2) all voluntary prepayments of Revolving Loans during such Excess Cash Flow Period (and in the case of the first Excess Cash Flow Period after the Closing Date, during the fiscal year ended December 31, 2021) or, without duplication across Excess Cash Flow Periods, after the end of such Excess Cash Flow Period and prior to when such Excess Cash Flow prepayment is due, to the extent the Revolving Commitments are permanently reduced by the amount of such payments, in each case except to the extent financed with the proceeds of long-term Indebtedness (other than revolving Indebtedness), (3) without duplication of amounts deducted in prior periods and, at the option of Holdings, the aggregate consideration required to be paid in cash by Holdings or any of the Restricted Subsidiaries pursuant to binding contracts (the “Contract Consideration”) entered into prior to or during such period or prior to the payment date of the ECF Payment Amount relating to Permitted Acquisitions or other Investments, capital expenditures, Capitalized Software Expenditures, acquisitions of intellectual property or non-ordinary course acquisitions of other assets to be consummated or made during the fiscal year following such period; provided that Holdings may make a good faith estimate of such amount to the extent such amount is unable to be definitively determined at the date of determination of Excess Cash Flow for the applicable period; provided, further, that, to the extent the aggregate amount of cash flow (except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness)) actually utilized to finance such Permitted Acquisitions, other Investments, capital expenditures, Capitalized Software Expenditures, acquisitions of intellectual property or non-ordinary course acquisitions of other assets during such period of four consecutive fiscal quarters is less than the Contract Consideration, the amount of such shortfall shall be added to the calculation of Excess Cash Flow at the end of such period of four consecutive fiscal
104


quarters, (4) without duplication of amounts deducted pursuant to this clause (4) or clause (3) above in prior fiscal years, the amount of Investments made pursuant to the definition of “Permitted Investments” and Section 6.04 (other than Investments in (x) cash and Cash Equivalents and (y) Holdings or any of its Restricted Subsidiaries other than any Investments in the Equity Interests of Oncacare Limited) made during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness), (5) [reserved] and (6) without duplication of amounts deducted pursuant to this clause (6) or clause (3) above in prior fiscal years, the amount of capital expenditures, Capitalized Software Expenditures or acquisitions of intellectual property accrued or made in cash during such period and, at the election of Holdings, made after such period but prior to the date of the applicable Excess Cash Flow payment, in each case except to the extent financed with the proceeds of long-term Indebtedness of Holdings or its Restricted Subsidiaries (other than revolving Indebtedness); provided that a prepayment of Term Loans pursuant to this Section 2.11(c)(iii) shall only be required in the amount (if any) by which the ECF Payment Amount for such fiscal year exceeds an amount equal to the greater of $60,000,000 and 5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination; provided, further, that the Applicable Borrower may use a portion of such ECF Payment Amount to prepay or repurchase Permitted Pari Passu Secured Refinancing Debt and, to the extent such debt is (x) secured on a pari passu basis with the Obligations and (y) pari passu in right of payment with the Obligations hereunder, any Alternative Incremental Facility Indebtedness and/or Ratio Debt to the extent any applicable credit agreement, indenture or other agreement governing such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt so requires, in each case in an amount not to exceed the product of (x) the amount of such ECF Payment Amount and (y) a fraction, the numerator of which is the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt, as applicable, and the denominator of which is the sum of the outstanding principal amount of such Permitted Pari Passu Secured Refinancing Debt, such Alternative Incremental Facility Indebtedness and/or such Ratio Debt, as applicable, and the outstanding principal amount of Term Loans.
(d)Subject to Section 2.11(e) below and except as specified in any Extension Amendment, Incremental Amendment or Refinancing Amendment (with respect to the applicable Extended Term Loans or Incremental Loans or the Loans incurred pursuant to such Refinancing Amendment), (i) all such amounts pursuant to Sections 2.11(c)(i) and (iii) shall be applied pro rata among the Classes and Tranches of Term Loans and, in a manner determined by Holdings, applied to amortization payments; provided that Holdings shall notify the Administrative Agent of such determination and (ii) all such amounts pursuant to Section 2.11(c)(ii) shall be applied to prepay an aggregate principal amount of the applicable Loans constituting Refinanced Debt equal to the Net Proceeds of the applicable Credit Agreement Refinancing Indebtedness.
(e)The Borrowers shall notify the Administrative Agent in writing of any mandatory prepayment of Term Loans required to be made pursuant to Section 2.11(c)(i) and (iii) at least three (3) Business Days prior to the date of such prepayment. Each such notice shall specify the date of such prepayment and provide a reasonably detailed calculation of the amount of such prepayment. The Administrative Agent will promptly notify each Term Lender of the contents of any such prepayment notice and of such Term Lender’s ratable portion of such prepayment (based on such Term Lender’s Applicable Percentage of each relevant Tranche of the Term Loans). Any Term Lender (a “Declining Term Lender,” and any Term Lender which is not a Declining Term Lender, an “Accepting Term Lender”) may elect, by delivering written notice to the Administrative Agent and the Borrowers no later than 5:00 p.m. one (1) Business Day after
105


the date of such Term Lender’s receipt of notice from the Administrative Agent regarding such prepayment, that the full amount of any mandatory prepayment otherwise required to be made with respect to the Term Loans held by such Term Lender pursuant to Section 2.11(c)(i) and (iii) not be made (the aggregate amount of such prepayments declined by the Declining Term Lenders, the “Declined Prepayment Amount”); provided however that (x) no Term Lender may decline a mandatory prepayment solely with respect to one Tranche of Initial Term Loans and not the other Tranche of Initial Term Loans and (y) a Term Lender may not decline a prepayment made by the Applicable Borrower pursuant to any event described in clause (3) of the term “Prepayment Event”. If a Term Lender fails to deliver notice setting forth such rejection of a prepayment to the Administrative Agent within the time frame specified above or such notice fails to specify the principal amount of the Term Loans to be rejected, any such failure will be deemed an acceptance of the total amount of such mandatory prepayment of Term Loans. For the avoidance of doubt, the Applicable Borrower may, at its option, apply any Declined Prepayment Amount to prepay loans in accordance with Section 2.11(a) above.
(f)Notwithstanding any other provisions of this Section 2.11, to the extent (i) any Net Proceeds exist as a result of an Asset Sale or casualty event from Holdings and/or a Foreign Subsidiary (or with respect to any Lux Term Loan, a non-Luxembourg Subsidiary) that give rise to a prepayment event pursuant to Section 2.11(c)(i) or (ii) any Excess Cash Flow attributable to Holdings and/or a Foreign Subsidiary (or with respect to any Lux Term Loan, a non-Luxembourg Subsidiary) exists that gives rise to a prepayment event pursuant to Section 2.11(c)(iii), and, in either case, the repatriation of cash to which such prepayment obligation is attributable would result in a material adverse tax consequence and/or is prohibited, restricted or delayed by applicable local law from being repatriated or contributed to the Applicable Borrower, an amount equal to the portion of such Net Proceeds or Excess Cash Flow so affected will not be required to be applied to repay the Term Loans at the times provided in this Section 2.11 so long, but only so long, as the material adverse tax consequence would result from, and/or applicable local law will not permit repatriation or contribution to the Applicable Borrower; provided however that Holdings shall use commercially reasonable efforts to promptly take all actions, and cause the applicable Foreign Subsidiary (or with respect to any Lux Term Loan, the non-Luxembourg Subsidiary) to promptly take all actions, in each case reasonably required by the applicable local law to eliminate such material adverse tax consequence and/or permit such repatriation or contribution under applicable local law.
Section 2.12Fees.
(a)The Applicable Borrower agrees to pay to the Administrative Agent, for the account of each Revolving Lender, a commitment fee, which shall accrue at the rate of 35% of the Applicable Margin then in effect for Eurocurrency Revolving Loans or USD Term SOFR Revolving Loans, as applicable, per annum on the daily amount of the Available Revolving Commitment of such Revolving Lender during the period from and including the Closing Date to but excluding the date on which the last of the Revolving Commitments (or Extended Revolving Commitments) of such Revolving Lender terminates. Accrued commitment fees shall be payable in arrears on the last Business Day of March, June, September and December of each year and on the date on which the last of the Revolving Commitments terminate, commencing on the first such date to occur after the Closing Date; provided that any commitment fees accruing after the date on which such Revolving Commitments terminate shall be payable on demand. All commitment fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).
(b)The Applicable Borrower agrees to pay (i) to the Administrative Agent, for the account of each Revolving Lender, a participation fee with respect to its participations in Letters of Credit, which shall accrue at the same Applicable Margin used to determine the interest rate applicable to Eurocurrency Revolving Loans or USD Term SOFR Revolving Loans, as
106


applicable, on the average daily Dollar Amount of such Revolving Lender’s LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) during the period from and including the Closing Date to but excluding the later of the date on which the last of such Revolving Lender’s Revolving Commitment terminates and the date on which such Revolving Lender ceases to have any LC Exposure and (ii) to each Issuing Bank for its own account a fronting fee, which shall accrue at the rate of 0.125% per annum on the average daily Dollar Amount of the LC Exposure (excluding any portion thereof attributable to unreimbursed LC Disbursements) attributable to Letters of Credit issued by such Issuing Bank during the period from and including the Closing Date to but excluding the later of the date of termination of the last of the Revolving Commitments and the date on which there ceases to be any LC Exposure, as well as such Issuing Bank’s standard fees and commissions with respect to the issuance, amendment, cancellation, negotiation, transfer, presentment, renewal or extension of any Letter of Credit or processing of drawings thereunder. Unless otherwise specified above, participation fees and fronting fees accrued through and including the last day of March, June, September and December of each year shall be payable on the third (3rd) Business Day following such last day, commencing on the first such date to occur after the Closing Date; provided that all such fees shall be payable on the date on which the last of the Revolving Commitments terminate and any such fees accruing after the date on which the such Revolving Commitments terminate shall be payable on demand. Any other fees payable to the Issuing Bank pursuant to this paragraph shall be payable within ten (10) days after demand. All participation fees and fronting fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).
(c)The Applicable Borrower agrees to pay to the Administrative Agent, for the account of each Revolving Lender, a utilization fee (the “Utilization Fee”) which shall accrue at the Applicable Utilization Fee Rate on the daily Dollar Amount of the Revolving Loans and LC Exposure of such Revolving Lender during the period from and including the Closing Date to but excluding the date on which the last of the Revolving Commitments (or Extended Revolving Commitments) of such Revolving Lender terminates. Accrued Utilization Fees shall be payable in arrears on the last Business Day of March, June, September and December of each year and on the date on which the last of the Revolving Commitments terminate, commencing on the first such date to occur after the Closing Date. All Utilization Fees shall be computed on the basis of a year of 360 days and shall be payable for the actual number of days elapsed (including the first day but excluding the last day).
(d)The Borrowers agree to pay to the Administrative Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrowers and the Administrative Agent.
(e)The Borrowers agree to pay to the Collateral Agent, for its own account, fees payable in the amounts and at the times separately agreed upon between the Borrowers and the Collateral Agent.
(f)If a Repricing Event with respect to the Initial Term Loans occurs prior to the six-month anniversary of the Closing Date, the Applicable Borrower agrees to pay a premium equal to 1.00% of the principal amount of the Initial Term Loans subject to such Repricing Event; provided that, it is understood and agreed that any prepayment premium with respect to a Repricing Event payable pursuant to this clause (f) shall also apply to any required assignment pursuant to Section 9.02(d) by a Non-Consenting Lender in connection with any amendment described in Section 2.24 that occurs prior to the six-month anniversary of the Closing Date.
(g)All fees payable hereunder shall be paid on the dates due, in Dollars and immediately available funds, to the Administrative Agent (or to the Issuing Banks or the
107


Collateral Agent, in the case of fees payable to them) for distribution, in the case of commitment fees and participation fees, to the applicable Revolving Lenders. Fees paid shall not be refundable under any circumstances.
Section 2.13Interest.
(a)The Loans comprising each ABR Borrowing (including each Swingline Loan) shall bear interest at the Alternate Base Rate plus the Applicable Margin.
(b)(i) The Loans comprising each Eurocurrency Borrowing shall bear interest at the Eurocurrency Rate for the Interest Period in effect for such Borrowing plus the Applicable Margin and (ii) the Loans comprising each USD Term SOFR Borrowing shall bear interest at the USD Adjusted Term SOFR for the Interest Period in effect for such Borrowing plus the Applicable Margin.
(c) The Loans comprising each RFR Borrowing shall bear interest at the Daily Simple RFR for the Interest Period in effect for such Borrowing plus the Applicable Margin.
(d)Notwithstanding the foregoing, if any principal of or interest on any Loan or any fee or other amount payable by the Applicable Borrower hereunder is not paid when due, whether at stated maturity, upon acceleration or otherwise, such overdue amount shall bear interest, after as well as before judgment, at a rate per annum equal to (i) in the case of overdue principal of any Loan, 2% plus the rate otherwise applicable to such Loan as provided in the preceding paragraphs of this Section 2.13 or (ii) in the case of any other amount, 2% plus the rate applicable to ABR Loans as provided in paragraph (a) of this Section 2.13.
(e)Accrued interest on each Loan shall be payable in arrears on each Interest Payment Date for such Loan and in the case of Revolving Loans, upon termination of the applicable Revolving Commitments; provided that (i) interest accrued pursuant to paragraph (d) of this Section 2.13 shall be payable on demand, (ii) in the event of any repayment or prepayment of any Loan of any Class (other than a prepayment of an ABR Revolving Loan prior to the end of the Availability Period), accrued interest on the principal amount repaid or prepaid shall be payable on the date of such repayment or prepayment and (iii) in the event of any conversion of any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan prior to the end of the current Interest Period therefor, accrued interest on such Loan shall be payable on the effective date of such conversion.
(f)All interest hereunder shall be computed on the basis of a year of 360 days, except that (i) interest computed by reference to the Alternate Base Rate at times when the Alternate Base Rate is based on the Prime Rate shall be computed on the basis of a year of 365 days (or 366 days in a leap year), and (ii) for Borrowings denominated in Pounds Sterling, interest shall be computed on the basis of a year of 365 days, and in each case shall be payable for the actual number of days elapsed (including the first day but excluding the last day). The applicable Alternate Base Rate, USD Adjusted LIBO Rate, LIBO RateTerm SOFR, USD Term SOFR, Adjusted EURIBOR Rate, EURIBOR Rate or Daily Simple RFR shall be determined by the Administrative Agent, and such determination shall be conclusive absent manifest error.
Section 2.14Benchmark Replacement Setting.
On March 5, 2021 the Financial Conduct Authority (“FCA”), the regulatory supervisor of USD LIBOR’s administrator (“IBA”), announced in a public statement the future cessation or loss of representativeness of overnight/Spot Next, 1-month, 3-month, 6-month and 12- month USD LIBOR tenor settings. Notwithstanding anything to the contrary herein or in
108


any other Loan Document (and any Swap Agreement shall be deemed not to be a “Loan Document” for purposes of this Section 2.14):
(a)[Reserved].
(b)(a) Replacing USD LIBOR. On the earlier of (i) the date that all USD Available Tenors of USD LIBOR have either permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative and (ii) the USD Early Opt-in Effective Date, if the then-current USD Benchmark is USD LIBOR, the USD Benchmark Replacement will replace such USD Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such USD Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document. If the USD Benchmark Replacement is USD Daily Simple SOFR, all interest payments will be payable on a quarterly basis.(b)    Replacing Future USD Benchmarks. Upon the occurrence of a USD Benchmark Transition Event, the USD Benchmark Replacement will replace the then-current USD Benchmark for all purposes hereunder and under any Loan Document in respect of any such USD Benchmark setting at or after 5:00 p.m. on the fifth (5th) Business Day after the date notice of such USD Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such USD Benchmark Replacement from Lenders comprising the Required Lenders. At any time that the administrator of any then-current USD Benchmark has permanently or indefinitely ceased to provide such USD Benchmark or such USD Benchmark has been announced by the regulatory supervisor for the administrator of such USD Benchmark pursuant to public statement or publication of information to be no longer representative and will not be restored, the Applicable Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such USD Benchmark until the Applicable Borrower’s receipt of notice from the Administrative Agent that a USD Benchmark Replacement has replaced such USD Benchmark, and, failing that, the Applicable Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to ABR Loans. During the period referenced in the foregoing sentence, if a component of ABR is based upon the USD Benchmark, such component will not be used in any determination of ABR.
(c)USD Benchmark Replacement Conforming Changes. In connection with the implementation and administration of any USD Benchmark Replacement, the Administrative Agent, with the consent of Holdings (not be unreasonably withheld), will have the right to make USD Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such USD Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.
(d)Notices; Standards for Decisions and Determinations. The Administrative Agent will promptly notify Holdings and the Lenders of (i) the implementation of any USD Benchmark Replacement and (ii) the effectiveness of any USD Benchmark Replacement Conforming Changes. For the avoidance of doubt, any notice required to be delivered by the Administrative Agent as set forth in this Section 2.14 may be provided, at the option of the Administrative Agent with the consent of Holdings (not to be unreasonably withheld), in one or more notices and may be delivered together with, or as part of any amendment which implements any USD Benchmark Replacement or USD Benchmark Replacement Conforming Changes. Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of
109


an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 2.14.
(e)Unavailability of Tenor of USD Benchmark. At any time (including in connection with the implementation of any USD Benchmark Replacement), (i) if any then-current USD Benchmark is a term rate (including USD Term SOFR or USD LIBORReference Rate), then the Administrative Agent may remove any tenor of such USD Benchmark that is unavailable or non-representative for USD Benchmark (including USD Benchmark Replacement) settings and (ii) the Administrative Agent may reinstate any such previously removed tenor for USD Benchmark (including USD Benchmark Replacement) settings.
(f)Disclaimer. The Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to (i) the administration, submission or calculation on any other matter related to the London interbank offered rate or otherUSD Term SOFR Reference Rate, USD Adjusted Term SOFR or USD Term SOFR or any component definition thereof or rates in the definition of “Eurocurrency” or with respect tothereof, or any alternative or, successor rate thereto, or replacement rate thereof (including, without limitation any USD Benchmark Replacement implemented hereunder), (ii) the composition or characteristics of any such USD Benchmark Replacement, including whether it is similar to, or produces the same value or economic equivalence to USD LIBOR or any other USD Benchmark or have the same volume or liquidity as didthe USD Term SOFR Reference Rate, USD Adjusted Term SOFR or USD LIBORTerm SOFR or any other USD Benchmark, (iii) any actions or use of its discretion or other decisions or determinations made with respect to any matters covered by this Section 2.14 including, without limitation, whether or not a USD Benchmark Transition Event has occurred, the removal or lack thereof of unavailable or non-representative tenors, the implementation or lack thereof of any USD Benchmark Replacement Conforming Changes, the delivery or non-delivery of any notices required by clause (d) above or otherwise in accordance herewith, and (iv) the effect of any of the foregoing provisions of this Section 2.14.
(g)Alternate Currency Benchmark Replacement. Notwithstanding anything to the contrary herein or in any other Loan Document, upon the occurrence of an Alternate Currency Benchmark Transition Event or an Alternate Currency Early Opt-in Election, as applicable, the Administrative Agent and Holdings may amend this Agreement to replace the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR with an Alternate Currency Benchmark Replacement. Any such amendment with respect to an Alternate Currency Benchmark Transition Event will become effective at 5:00 p.m. on the fifth (5th) Business Day after the Administrative Agent has posted such proposed amendment to all Lenders so long as the Administrative Agent has not received, by such time, written notice of objection to such amendment from Lenders comprising the Required Lenders; provided that, to the extent the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR is replaced with an Alternate Currency SOFR-Based Rate, Lenders shall only be entitled to object to the Alternate Currency Benchmark Replacement Adjustments with respect thereto. Any such amendment with respect to an Alternate Currency Early Opt-in Election will become effective on the date that Lenders comprising the Required Lenders of each Class have delivered to the Administrative Agent written notice that such Required Lenders accept such amendment. No replacement of the Eurocurrency Rate applicable to an Alternate Currency or Daily Simple RFR with an Alternate Currency Benchmark Replacement pursuant to this Section 2.14 will occur prior to the applicable Alternate Currency Benchmark Transition Start Date.
(h)Alternate Currency Benchmark Replacement Conforming Changes. In connection with the implementation of an Alternate Currency Benchmark Replacement, the
110


Administrative Agent, with the consent of Holdings (not be unreasonably withheld), will have the right to make Alternate Currency Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Alternate Currency Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.
(i)Notices; Standards for Decisions and Determinations. The Administrative Agent will promptly notify Holdings and the Lenders of (i) any occurrence of an Alternate Currency Benchmark Transition Event or an Alternate Currency Early Opt-in Election, as applicable, and its related Alternate Currency Benchmark Replacement Date and Alternate Currency Benchmark Transition Start Date, (ii) the implementation of any Alternate Currency Benchmark Replacement, (iii) the effectiveness of any Alternate Currency Benchmark Replacement Conforming Changes and (iv) the commencement or conclusion of any Alternate Currency Benchmark Unavailability Period. Any determination, decision or election that may be made by the Administrative Agent or Lenders pursuant to this Section 2.14, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 2.14.
(j)Upon Holdings receipt of notice of the commencement of (i) an Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to an Alternate Currency, any Borrower may revoke a request made by such Borrower for a Eurocurrency Borrowing denominated in such Alternate Currency of, conversion to or continuation of Eurocurrency Loans denominated in such Alternate Currency to be made, converted or continued during any Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to such Alternate Currency and, failing that, any Eurocurrency Borrowing denominated in such Alternate Currency shall be ineffective and (ii) an Alternate Currency Benchmark Unavailability Period with respect to Daily Simple RFR, any Borrower may revoke a request made by such Borrower for an RFR Borrowing of, conversion to or continuation of RFR Loans to be made, converted or continued during any Alternate Currency Benchmark Unavailability Period with respect to the Daily Simple RFR and, failing that, any RFR Borrowing shall be ineffective. Furthermore, if any Eurocurrency Loan in any Alternate Currency or RFR Loan is outstanding on the date of Holdings’ receipt of notice of the commencement of an Alternate Currency Benchmark Unavailability Period with respect to the Eurocurrency Rate applicable to such Eurocurrency Loan or Daily Simple RFR, as applicable, then such Loan shall, on the last day of the Interest Period applicable to such Loan (or the next succeeding Business Day if such day is not a Business Day), at the Borrower’s election prior to such day: (A) be prepaid by the Applicable Borrower on such day or (B) be converted by the Administrative Agent to, and (subject to the remainder of this subclause (B)) shall constitute, an ABR Loan denominated in Dollars (in an amount equal to the Dollar Equivalent of such Alternate Currency) on such day (it being understood and agreed that if the Applicable Borrower does not so prepay such Loan on such day by 12:00 p.m. (New York City time) the Administrative Agent is authorized to effect such conversion of such Eurocurrency Loan or RFR Loan, as applicable, into an ABR Loan denominated in Dollars), and, in the case of such subclause (B), upon any subsequent implementation of an Alternate Currency Benchmark Replacement in respect of such Alternate Currency pursuant to this Section 2.10, such ABR Loan denominated in Dollars shall then be converted by the Administrative Agent to, and shall constitute, a Eurocurrency Loan denominated in such original Alternate Currency or RFR Loan denominated in such original Alternate Currency, as applicable (in an amount equal to the Alternate Currency Equivalent of such Alternate Currency) on the day of such implementation, giving effect to such Alternate Currency Benchmark Replacement in respect of such Alternate Currency.
111


(k)Tax Matters. At the Borrower’s request, the Administrative Agent and the Borrower shall use commercially reasonable efforts to satisfy any applicable guidance of the Internal Revenue Service, in a manner that is not adverse to the Lenders that is intended to prevent any Benchmark Transition Event from resulting in a deemed exchange of any Loan under this Agreement for purposes of Treasury Regulation Section 1.1001-3.
Section 2.15Increased Costs.
(a)If any Change in Law shall:
(i)impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender (except any such reserve requirement reflected in the Eurocurrency Rate) or any Issuing Bank;
(ii)impose on any Lender or any Issuing Bank or the London interbank market any other condition, cost or expense (other than Taxes) affecting this Agreement or Loans made by such Lender or any Letter of Credit or participation therein; or
(iii)subject the Administrative Agent, any Lender or any Issuing Bank to any Taxes (other than (A) Indemnified Taxes, (B) Other Taxes and (C) Excluded Taxes (including any change in the rate of Excluded Taxes)) with respect to this Agreement, any Loan made by it or any Letter of Credit or participation therein, or its deposits, reserves, other liabilities or capital attributable thereto;
and the result of any of the foregoing shall be to increase the cost to the Administrative Agent or such Lender of making or maintaining any Loan or of maintaining its obligation to make any such Loan (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency) or to increase the cost to the Administrative Agent, such Lender or such Issuing Bank of participating in, issuing or maintaining any Letter of Credit (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency) or to reduce the amount of any sum received or receivable by the Administrative Agent, such Lender or such Issuing Bank hereunder, whether of principal, interest or otherwise (including, without limitation, pursuant to any conversion of any Borrowing denominated in an Agreed Currency into a Borrowing denominated in any other Agreed Currency), then the Applicable Borrower will pay to the Administrative Agent, such Lender or such Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or such Issuing Bank, as the case may be, for such additional costs incurred or reduction suffered.
(b)If any Lender or Issuing Bank determines that any Change in Law regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender’s or Issuing Banks’s capital or on the capital of such Lender’s or Issuing Bank’s holding company, if any, as a consequence of this Agreement or the Loans made by, or participations in Letters of Credit held by such Lender, or Letters of Credit issued by such Issuing Bank, to a level below that which such Lender or Issuing Bank or such Lender’s or Issuing Bank’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s or Issuing Bank’s policies and the policies of such Lender’s or Issuing Bank’s holding company with respect to capital adequacy and liquidity), then from time to time the Applicable Borrower will pay to such Lender or Issuing Bank, as the case may be, such additional amount or amounts as will compensate such Lender or Issuing Bank or such Lender’s or Issuing Bank’s holding company for any such reduction suffered.
112


(c)A certificate of a Lender or Issuing Bank setting forth, in reasonable detail, the basis and calculation of the amount or amounts necessary to compensate such Lender or Issuing Bank or its holding company, as the case may be, as specified in paragraph (a) or (b) of this Section 2.15 shall be delivered to the Applicable Borrower and shall be conclusive absent manifest error. The Applicable Borrower shall pay such Lender or Issuing Bank, as the case may be, the amount shown as due on any such certificate within ten (10) days after receipt thereof.
(d)Failure or delay on the part of any Lender or any Issuing Bank to demand compensation pursuant to this Section 2.15 shall not constitute a waiver of such Lender’s or such Issuing Bank’s right to demand such compensation; provided that the Applicable Borrower shall not be required to compensate a Lender or Issuing Bank pursuant to this Section 2.15 for any increased costs or reductions incurred more than 180 days prior to the date that such Lender or Issuing Bank, as the case may be, notifies the Applicable Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender’s or Issuing Bank’s intention to claim compensation therefor; provided, further, that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof.
Section 2.16Break Funding Payments.
In the event of (a) the payment of any principal of any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan other than on the last day of an Interest Period applicable thereto (including as a result of an Event of Default or as a result of any prepayment pursuant to Section 2.11), (b) the conversion of any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan other than on the last day of the Interest Period applicable thereto, (c) the failure to borrow, convert, continue or prepay any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan on the date specified in any notice delivered pursuant hereto (regardless of whether such notice may be revoked under Section 2.11(a) and is revoked in accordance therewith) or (d) the assignment of any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Applicable Borrower pursuant to Section 2.20, then, in any such event the Applicable Borrower shall compensate each Lender for the loss, cost and expense attributable to such event. Such loss, cost or expense to any Lender shall be deemed to include an amount determined by such Lender to be the excess, if any, of (i) the amount of interest which would have accrued or has been payable on the principal amount of such Loan had such event not occurred, at the Eurocurrency Rate, USD Adjusted Term SOFR or Daily Simple RFR, as applicable, that would have been applicable to such Loan (but not the Applicable Margin applicable thereto), for the period from the date of such event to the last day of the then current Interest Period therefor (or, in the case of a failure to borrow, convert or continue, for the period that would have been the Interest Period for such Loan), over (ii) the amount of interest which would accrue on such principal amount for such period at the interest rate which such Lender would bid were it to bid, at the commencement of such period, for deposits in the relevant currency of a comparable amount and period from other banks in the eurocurrency market or other applicable market. A certificate of any Lender setting forth any amount or amounts that such Lender is entitled to receive pursuant to this Section 2.16, and setting forth in reasonable detail the calculations used by such Lender to determine such amount or amounts, shall be delivered to the Applicable Borrower and shall be conclusive absent manifest error. The Applicable Borrower shall pay such Lender the amount shown as due on any such certificate within ten (10) days after receipt thereof; provided that Applicable Borrower shall not be required to compensate a Lender pursuant to this Section 2.16 for any amounts under this Section 2.16 incurred more than 180 days prior to the date that such Lender notifies the Applicable Borrower of such amount and of such Lender’s intention to claim compensation therefor.
113


Section 2.17Taxes.
(a)All payments by or on account of any obligation of any Loan Party under any Loan Document shall to the extent permitted by applicable Legal Requirements be made free and clear of and without deduction or withholding for any Taxes. If an applicable withholding agent shall be required to deduct or withhold any Taxes from such payments, then (i) if such Taxes are Indemnified Taxes or Other Taxes, the sum payable by the applicable Loan Party shall be increased by the amount necessary so that after all required deductions or withholdings (including deductions and withholdings applicable to additional sums payable under this Section 2.17) each Agent and Lender receives an amount equal to the sum it would have received had no such deductions or withholdings of Indemnified Taxes or Other Taxes been made, (ii) the withholding agent shall be entitled to make such deductions or withholdings and (iii) the withholding agent shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable Legal Requirements.
(b)In addition, the Loan Parties shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable Legal Requirements or, at the option of the Administrative Agent, timely reimburse it for the payment of any Other Taxes.
(c)Each Borrower and each Loan Party with respect to any Loans made to such Borrower shall jointly and severally indemnify each Agent and each Lender, within ten (10) days after written demand therefor, for the full amount of any Indemnified Taxes and Other Taxes paid by such Agent or such Lender with respect to any Loans made to such Borrower (including Indemnified Taxes and Other Taxes imposed or asserted on or attributable to amounts payable under this Section 2.17) and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority; provided, however, that the Loan Parties shall not be required to indemnify any Agent or Lender pursuant to this Section 2.17(c) for any interest, penalties or expenses to the extent resulting from such Agent’s or such Lender’s failure to notify the Loan Parties of such possible indemnification claim within 120 days after such Agent or such Lender, as applicable, receives written notice from the applicable Governmental Authority of the specific Tax assessment or deficiency claim giving rise to such indemnification claim. A certificate setting forth in reasonable detail the basis for and calculation of such payment or liability delivered to the Applicable Borrower by a Lender or Agent or by the Administrative Agent on its own behalf or on behalf of a Lender or Agent, shall be conclusive absent manifest error.
(d)As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority pursuant to this Section 2.17, such Loan Party shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment (if the applicable Governmental Authority makes such receipts readily available to the applicable Loan Party), a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.
(e)Any Lender that is entitled to an exemption from or reduction of withholding tax with respect to any payments under this Agreement or any other Loan Document shall deliver to the Borrowers (with a copy to the Administrative Agent), at the time(s) and in the manner(s) reasonably requested by such Borrower or the Administrative Agent, such properly completed and executed documentation as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by a Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable Legal Requirements or reasonably requested by such Borrower or the Administrative Agent as will enable such Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting. Each Lender and
114


Administrative Agent agrees that if any documentation it previously delivered pursuant to this Section 2.17(e) (including any of the specific forms described below) has expired or become obsolete or inaccurate in any respect, it shall promptly update such documentation or notify the Applicable Borrower and the Administrative Agent in writing of its legal ineligibility to do so. Notwithstanding anything to the contrary in the preceding three sentences, the completion, execution and submission of such documentation with respect to any Tax imposed by any jurisdiction other than the United States, Ireland or Luxembourg, or, in each case, any political subdivision thereof, shall not be required if in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.
(i)Without limiting the generality of the foregoing,
(A)any Foreign Lender shall, to the extent it is legally eligible to do so, deliver to such U.S. Borrower and the Administrative Agent on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower or the Administrative Agent), two duly executed copies of whichever of the following is applicable:
(xix)in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United States is a party, IRS Form W-8BEN or W-8BEN-E;
(xx)IRS Form W-8ECI;
(xxi)in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of Exhibit G-1 to the effect that such Foreign Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the Code, a “10-percent shareholder” of such U.S. Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” related to such U.S. Borrower as described in Section 881(c)(3)(C) of the Code and that no payment under any Loan Document is effectively connected with such Foreign Lender’s conduct of a U.S. trade or business (a “U.S. Tax Compliance Certificate”) and (y) executed copies of IRS Form W-8BEN or W-8BEN-E; or
(xxii)to the extent a Foreign Lender is not the beneficial owner of payments made to it under the Loan Documents, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN or W-8BEN-E, a U.S. Tax Compliance Certificate substantially in the form of Exhibit G-2 or Exhibit G-3, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Foreign Lender is a partnership (and not a participating Lender) and one or more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of Exhibit G-4 on behalf of each such direct and indirect partner(s);
(B)any Foreign Lender shall, to the extent it is legally eligible to do so, deliver to such U.S. Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower
115


or the Administrative Agent), executed copies of any other form prescribed by applicable Legal Requirements as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable Legal Requirements to permit such U.S. Borrower or the Administrative Agent to determine the withholding or deduction required to be made (if any); and
(C)if a payment made to the Administrative Agent or a Lender under any Loan Document would be subject to United States federal withholding Tax imposed by FATCA if the Administrative Agent or such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), the Administrative Agent or such Lender shall deliver to Borrower and the Administrative Agent at the time or times prescribed by Legal Requirements and at such time or times reasonably requested by the Borrowers or the Administrative Agent such documentation prescribed by applicable Legal Requirements (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrowers or the Administrative Agent as may be necessary for the Borrowers and the Administrative Agent to comply with their obligations under FATCA and to determine that the Administrative Agent or such Lender has complied with the Administrative Agent or such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this Section 2.17(e)(i)(C), “FATCA” shall include any amendments made to FATCA after the date of this Agreement.
(ii)Without limiting the generality of the foregoing, each Lender that is a U.S. Person shall deliver to such U.S. Borrower and the Administrative Agent, on or prior to the date on which such Person becomes a party to this Agreement (and from time to time thereafter upon the reasonable request of such U.S. Borrower or the Administrative Agent), two properly completed and duly executed copies of IRS Form W-9 or any successor form, certifying that such Person is exempt from United States federal backup withholding Tax.
(iii)On or prior to the date on which it becomes a party to this Agreement, the Administrative Agent shall deliver to the U.S. Borrower either (1) two properly completed and duly signed copies of IRS Form W-9 certifying that the Administrative Agent is a U.S. Person that is exempt from U.S. federal backup withholding or (2) (x) with respect to payments received for the account of a Lender, two properly completed and duly signed copies of IRS Form W-8IMY evidencing the Administrative Agent’s agreement to be treated as a U.S. Person for U.S. federal withholding tax purposes and assuming primary responsibility for U.S. federal income tax withholding and (y) with respect to payments received for the Administrative Agent’s own account, two properly completed and duly signed copies of IRS Form W-8ECI. The Administrative Agent shall, whenever a lapse in time or change in circumstances renders any such documentation expired, obsolete or inaccurate in any respect, deliver promptly to the U.S. Borrower updated versions of the documentation described in the preceding sentence (or any new documentation reasonably requested by the U.S. Borrower); provided that the Administrative Agent shall not be required to furnish updated documentation to the extent it is not legally eligible to do so as a result of a Change in Law after the date hereof, in which event the Administrative Agent will promptly notify the U.S. Borrower of such ineligibility.
116


(iv)Without limiting the generality of the foregoing, any Lender that is an Irish Qualifying Lender solely on account of being an Irish Treaty Lender shall provide a self-certification form (a “Form 8-3-6. Interest”) to any Borrower that is tax resident in Ireland, which is to make a payment of interest under this Agreement to which that Irish Treaty Lender is entitled (with a copy to the Administrative Agent).
(v)Notwithstanding anything to the contrary in this Section 2.17(e), no Lender shall be required to provide any documentation pursuant to this Section 2.17(e) that such Lender is not legally eligible to provide.
(f)If the Administrative Agent or a Lender determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified by any Borrower or any Guarantor, as the case may be, or with respect to which any Borrower or any Guarantor, as the case may be, has paid additional amounts pursuant to this Section 2.17, it shall pay over such refund to such Borrower or such Guarantor (but only to the extent of indemnity payments made, or additional amounts paid, by such Borrower or such Guarantor under this Section 2.17 with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund); provided that such Borrower or Guarantor, as the case may be, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to such Borrower or Guarantor (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (f), in no event will the Administrative Agent or a Lender be required to pay any amount to any Borrower or any Guarantor pursuant to this paragraph (f) the payment of which would place the Administrative Agent or such Lender in a less favorable net after-Tax position than the Administrative Agent or such Lender would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This Section 2.17 shall not be construed to require the Administrative Agent or any Lender to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to any Borrower, any Guarantor or any other Person.
(g)Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes and Other Taxes attributable to such Lender (but only to the extent that any Loan Party has not already indemnified the Administrative Agent for such Indemnified Taxes and Other Taxes and without limiting or expanding the obligation of the Loan Parties to do so), (ii) any Taxes attributable to such Lender's failure to comply with the provisions of Section 9.04(c)(ii) relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are paid or payable by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this Section 2.17(g).
(h)(i)    Every Revolving Lender under any Revolving Loans, Extended Revolving Loans or Incremental Revolving Loans, as applicable, advanced to a Borrower that is tax resident in Ireland shall on or prior to the day on which such Revolving Lender becomes a
117


Revolving Lender under this Agreement, provide a confirmation in the form attached at Exhibit H (an “Irish Qualifying Lender Confirmation”). Each such Revolving Lender that becomes a Revolving Lender after the date of this Agreement shall provide, in any Assignment and Assumption which it executes on becoming a Revolving Lender, and each party that becomes a Participant with respect to the Revolving Loans, Extended Revolving Loans or Incremental Revolving Loans, as applicable, advanced to a Borrower that is tax resident in Ireland after the date of this Agreement shall provide, upon becoming a Participant, for the benefit of each Foreign Loan Party and Administrative Agent an Irish Qualifying Lender Confirmation.
(i)If a Revolving Lender or Participant, as the case may be, fails to provide an Irish Qualifying Lender Confirmation in accordance with this Section 2.17(h), then such Revolving Lender or Participant, as the case may be, shall be treated for the purposes of this Agreement (including by each Foreign Loan Party) as if it is not an Irish Qualifying Lender until such time as it provides an Irish Qualifying Lender Confirmation to the Administrative Agent (and the Administrative Agent, upon receipt of such Irish Qualifying Lender Confirmation, shall inform each Foreign Loan Party). For the avoidance of doubt, an Assignment and Assumption or participation, as the case may be, shall not be invalidated by any failure of a Revolving Lender or Participant, as the case may be, to comply with this Section 2.17(h).
(ii)Each Revolving Lender or Participant required to provide an Irish Qualifying Lender Confirmation in accordance with this Section 2.17(h), as the case may be, shall promptly notify the Administrative Agent if there has been a change in any of the details provided in the Irish Qualifying Lender Confirmation (excluding, for the avoidance of doubt, any Change in Law) and provide an updated Irish Qualifying Lender Confirmation at that time and shall, for as long as it is Revolving Lender or Participant, as the case may be, at the reasonable written request by or on behalf of a Borrower that is tax resident in Ireland, provide an updated Irish Qualifying Lender Confirmation.
(iii)Each Lender and Participant shall, upon written request from a Borrower that is tax resident in Ireland, provide such details as are necessary to enable such Borrower to comply with its reporting obligations under Section 891A, 891E, 891F and 891G of the TCA and any other applicable automatic exchange of information obligations.
For the avoidance of doubt, for purposes of this Section 2.17(h), (1) the term “Revolving Lender” shall include any Issuing Bank and any Swingline Lender and (2) the term “Revolving Loan” shall include any Letter of Credit and any Swingline Loan.
(i)For purposes of this Section 2.17, the term “Lender” shall include any Swingline Lender and any Issuing Bank.
Section 2.18Payments Generally; Allocations of Proceeds; Pro Rata Treatment; Sharing of Set-offs.
(a)Each Applicable Borrower shall make each payment required to be made by it hereunder (whether of principal, interest, fees, or reimbursement of LC Disbursements or of amounts payable under Section 2.15, 2.16 or 2.17, or otherwise) prior to (i) in the case of payments denominated in Dollars, 1:00 p.m., New York City time and (ii) in the case of payments denominated in a Foreign Currency, 1:00 p.m., Local Time, in the city of the Administrative Agent’s Eurocurrency Payment Office for such currency, in each case, on the date when due, in immediately available funds, without set-off or counterclaim. Any amounts received after such time on any date may, in the discretion of the Administrative Agent, be deemed to have been received on the next succeeding Business Day for purposes of calculating interest thereon. All
118


such payments shall be made (i) in the same currency in which the applicable Credit Event was made and (ii) to the Administrative Agent at the address specified in Section 9.01(a)(ii) or such other office as the Administrative Agent may hereafter designate in writing as such to the other parties hereto, or, in the case of a Credit Event denominated in a Foreign Currency, the Administrative Agent’s Eurocurrency Payment Office for such currency, except payments to be made directly to the applicable Issuing Bank or Swingline Lender as expressly provided herein and except that payments pursuant to Sections 2.15, 2.16, 2.17 and 9.03 shall be made directly to the Persons entitled thereto. The Administrative Agent shall distribute any such payments denominated in the same currency received by it for the account of any other Person to the appropriate recipient promptly following receipt thereof. If any payment hereunder shall be due on a day that is not a Business Day, the date for payment shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest, interest thereon shall be payable for the period of such extension. Notwithstanding the foregoing provisions of this Section 2.18, if, after the making of any Credit Event in any Foreign Currency, currency control or exchange regulations are imposed in the country which issues such currency with the result that the type of currency in which the Credit Event was made (the “Original Currency”) no longer exists or the Applicable Borrower is not able to make payment to the Administrative Agent for the account of the applicable Lenders in such Original Currency, then all payments to be made by the Applicable Borrower hereunder in such currency shall instead be made when due in Dollars in an amount equal to the Dollar Amount (as of the date of repayment) of such payment due, it being the intention of the parties hereto that the Applicable Borrower takes all risks of the imposition of any such currency control or exchange regulations.
(b)Any proceeds of Collateral received by the Administrative Agent or the Collateral Agent (whether as a result of any realization on the Collateral, any setoff rights, any distribution in connection with any proceedings or other action of any Loan Party in respect of Debtor Relief Laws or otherwise and whether received in cash or otherwise) (i) not constituting (A) a specific payment of principal, interest, fees or other sum payable under the Loan Documents (which shall be applied on a pro rata basis among the relevant Lenders under the Class of Loans being prepaid as specified by the Applicable Borrower) or (B) a mandatory prepayment (which shall be applied in accordance with Section 2.11) or (ii) after an Event of Default has occurred and is continuing and the Administrative Agent so elects or the Required Lenders so direct, such funds shall be applied, subject to the provisions of any Intercreditor Agreement, ratably first, to pay any fees, indemnities, or expense reimbursements including amounts then due to the Administrative Agent, the Collateral Agent and any Issuing Bank from the Borrowers, second, to pay any fees or expense reimbursements then due to the Lenders (in their capacities as such) from the Borrowers, third, to pay interest (including post-petition interest, whether or not an allowed claim in any Insolvency or Liquidation Proceeding) then due and payable on the Loans ratably, fourth, to repay principal on the Loans and unreimbursed LC Disbursements, to pay an amount to the Administrative Agent equal to one hundred two percent (102%) of the aggregate undrawn face amount of all outstanding Letters of Credit, to be held as cash collateral for such Obligations, and any other amounts owing with respect to any Secured Obligations constituting Swap Obligations and/or Cash Management Agreements ratably; provided that amounts which would otherwise be applied to cash collateralize outstanding Letters of Credit shall, unless all Revolving Loans and Swingline Loans have been paid in full, instead be utilized to repay such outstandings, and fifth, to the payment of any other Secured Obligation due to any Secured Party by the Borrowers. Notwithstanding anything to the contrary contained in this Agreement, unless so directed by the Applicable Borrower, or unless a Default is in existence, none of the Administrative Agent or any Lender shall apply any payment which it receives to any Eurocurrency Loan, USD Term SOFR Loan or RFR Loan, except (a) on the expiration date of the Interest Period or maturity date (as applicable) applicable to any such Eurocurrency Loan, USD Term SOFR Loan or RFR Loan or (b) in the event, and only to the extent, that there are no outstanding ABR Loans of the same Class and, in any event, the Applicable Borrower shall pay the break funding payment required in accordance with Section 2.16. The Administrative Agent,
119


the Collateral Agent and the Lenders shall have the continuing and exclusive right to apply and reverse and reapply any and all such received proceeds and payments to any portion of the Secured Obligations.
(c)If any Lender shall, by exercising any right of set-off or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of its Loans or participations in LC Disbursements or Swingline Loans resulting in such Lender receiving payment of a greater proportion of the aggregate amount of its Loans and participations in LC Disbursements and Swingline Loans and accrued interest thereon than the proportion received by any other Lender, then the Lender receiving such greater proportion shall purchase (for cash at face value) participations in the Loans and participations in LC Disbursements and Swingline Loans of other Lenders to the extent necessary so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Loans and participations in LC Disbursements and Swingline Loans; provided that (i) if any such participations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations shall be rescinded and the purchase price restored to the extent of such recovery, without interest, (ii) the provisions of this paragraph shall not be construed to apply to any payment made by the Borrowers pursuant to and in accordance with the express terms of this Agreement or any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or participations in LC Disbursements and Swingline Loans to any assignee or participant, other than, except as provided in Section 2.26, to Holdings or any Subsidiary thereof (as to which the provisions of this paragraph shall apply) and (iii) nothing in this Section 2.18(c) shall be construed to limit the applicability of Section 2.18(b) in the circumstances where Section 2.18(b) is applicable in accordance with its terms. The Borrowers consent to the foregoing and agree, to the extent they may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrowers rights of set-off and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrowers in the amount of such participation.
(d)Unless the Administrative Agent shall have received notice from the Applicable Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the relevant Lenders or Issuing Banks hereunder that the Applicable Borrower will not make such payment, the Administrative Agent may assume that the Applicable Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the relevant Lenders or Issuing Bank, as the case may be, the amount due. In such event, if the Applicable Borrower has not in fact made such payment, then each of the relevant Lenders or Issuing Bank, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation (including without limitation the Overnight Foreign Currency Rate in the case of Loans denominated in a Foreign Currency).
(e)Subject to Section 2.26, if any Lender shall fail to make any payment required to be made by it pursuant to Section 2.05(c), 2.06(d) or (e), 2.07(b), 2.18(d) or 9.03(c), then the Administrative Agent may, in its discretion (notwithstanding any contrary provision hereof), (i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender and for the benefit of the Administrative Agent, the Swingline Lender or any Issuing Bank to satisfy such Lender’s obligations to it under this Section 2.18 until all such unsatisfied obligations are fully paid and/or (ii) hold any such amounts in a segregated account as cash collateral for, and application to, any future funding obligations of such Lender under any this
120


Section 2.18; in the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its discretion.
Section 2.19Mitigation Obligations; Replacement of Lenders.
(a)If any Lender requests compensation under Section 2.15, if any Applicable Borrower is required to pay any additional amount or indemnification payment to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17 or if any Lender delivers a notice pursuant to Section 2.25, then such Lender shall use reasonable efforts to designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such Lender, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to Section 2.15 or 2.17, as the case may be, in the future or avoid such illegality under Section 2.25 and (ii) would not subject such Lender to any material unreimbursed cost or expense and would not otherwise be materially disadvantageous to such Lender. The Applicable Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or assignment.
(b)If (i) any Lender requests compensation under Section 2.15, (ii) the Applicable Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 2.17 or if any Lender delivers a notice pursuant to Section 2.25, or (iii) any Lender becomes a Defaulting Lender, then the Applicable Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in Section 9.04), all its interests, rights and obligations under the Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that (i) the Applicable Borrower shall have received the prior written consent of the Administrative Agent (and if a Revolving Commitment is being assigned, the Issuing Banks and the Swingline Lender), which consent shall not unreasonably be withheld, (ii) such Lender shall have received payment of an amount equal to the outstanding principal of its Loans and participations in LC Disbursements and Swingline Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder (including any amounts under Sections 2.12 and 2.16 but subject to Section 2.26(a)), from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Applicable Borrower (in the case of all other amounts including the fees set forth in Section 2.12, which shall be payable and calculated as if the Applicable Borrower were making a prepayment to such assigning Lender), (iii) in the case of any such assignment resulting from a claim for compensation under Section 2.15 or payments required to be made pursuant to Section 2.17, such assignment will result in a reduction in such compensation or payments and (iv) such assignment does not conflict with applicable law. A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrowers to require such assignment and delegation cease to apply.
Section 2.20Incremental Credit Extensions.
(a)Any Borrower may, by written notice to the Administrative Agent from time to time after the Closing Date, request (i) commitments to provide Term Loans of the same Tranche as any outstanding Term Loans (a “Term Loan Increase”), (ii) commitments to provide term Loans of a new Tranche denominated in an Agreed Currency (“Other Term Loan Commitments” and collectively with any Term Loan Increase, “Incremental Term Loan Commitments”), (iii) increases in the amount of Initial Revolving Commitments or then outstanding Other Revolving Loan Commitments (a “Revolving Commitment Increase”) or (iv) commitments to provide revolving Loans of a new Tranche available in one or more Agreed
121


Currencies (“Other Revolving Loan Commitments” and collectively with any Revolving Commitment Increase, “Incremental Revolving Commitments”), in each case from one or more Incremental Term Lenders and/or Incremental Revolving Lenders (which, in each case, may include any existing Lender or any other bank or other financial institution (any such other bank or other financial institution, an “Additional Lender”), but shall be required to be Persons which would qualify as assignees of a Lender in accordance with Section 9.04) willing to provide such Incremental Term Loans and/or Incremental Revolving Commitments, as the case may be, in their own discretion. For the avoidance of doubt, with respect to any Incremental Loans incurred by a Borrower that is organized in Ireland, each Incremental Lender shall comply with the requirements of Section 2.17, including the provision of an Irish Qualifying Lender Confirmation substantially in the form of Exhibit H (pursuant to which such Incremental Lender shall acknowledge that if it is not an Irish Qualifying Lender it will not be grossed up for any Irish withholding Tax applicable under relevant law as of the date such Incremental Lender becomes a party with respect to the Incremental Loans). Each notice provided pursuant to this Section 2.20 shall set forth (i) the type and amount of the Incremental Term Loan Commitments and/or Incremental Revolving Commitments being requested (which shall be in minimum increments of $1,000,000 and a minimum amount of $10,000,000), (ii) the date on which such Incremental Term Loan Commitments and/or Incremental Revolving Commitments are requested to become effective, (iii) in the case of Other Term Loan Commitments or Other Revolving Loan Commitments, the Agreed Currency or Agreed Currencies and (iv) whether such Incremental Commitments constitute a Term Loan Increase, Other Term Loan Commitments, a Revolving Commitment Increase or Other Revolving Loan Commitments.
(b)(A) The Applicable Borrower and each Incremental Lender shall execute and deliver to the Administrative Agent an Incremental Amendment and such other documentation as the Administrative Agent shall reasonably specify to evidence the Incremental Commitment of such Incremental Lender. Each Incremental Amendment providing for Incremental Term Loans shall specify the terms of the applicable Incremental Term Loans; provided that (i) the final maturity date of any Other Term Loans (excluding (x) Term A Facilities and (y) customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (i)) shall be no earlier than the Latest Maturity Date of any Class of Term Loans, (ii) such Class of Other Term Loans shall be denominated in an Agreed Currency, (iii) the Weighted Average Life to Maturity of any Other Term Loans (excluding (x) Term A Facilities and (y) customary “bridge loan” facilities with a tenor of no longer than one year (provided that such facilities automatically convert or exchange into long-term debt otherwise meeting the requirements of this clause (iii)) shall be no shorter than the remaining Weighted Average Life to Maturity of the Class of Term Loans with the Latest Maturity Date, (iv) with respect to any Other Term Loans made on or after the Closing Date, the Effective Yield of any Other Term Loans may be less than or exceed the Effective Yield then applicable to the Initial Term Loans; provided that in the case of Other Term Loans that are secured by Liens on Collateral that rank pari passu to the Liens securing the Initial Term Loans made prior to the date that is 24 months after the Closing Date (other than Term A Facilities) the Effective Yield of which exceeds the Effective Yield then applicable to the Initial Term Loans, the Applicable Margin for the Initial Term Loans is increased (to the extent necessary) such that the Effective Yield thereof is not less than the Effective Yield of such Other Term Loans minus 0.50%, (v) the covenants and events of default of any Other Term Loans shall be reasonably acceptable to the Administrative Agent or shall not, when taken as a whole, be materially more favorable to the lenders or holders thereof than the relevant terms applicable to the Initial Term Loans then outstanding unless such terms are added for the benefit of the Lenders of the Term Loans then outstanding; provided that the Other Term Loans shall have mandatory prepayment requirements in amounts that are less than or equal to those required under Section 2.11(c); provided, further, that Term A Facilities may be subject to (x) the Financial Covenant set forth in Section 6.12(a) or (y) one or more financial maintenance covenants (and related events of default) (provided that
122


such covenants shall be included for the benefit of the Revolving Commitments) and (vi) the terms of Incremental Term Loans under a Term Loan Increase shall be the same as the terms of the Term Loans of the Tranche that the Term Loan Increase is increasing (other than upfront fees and/or original issue discount). The Incremental Term Loans shall rank pari passu or junior in right of payment with the Initial Term Loans, shall be unsecured or secured on a pari passu or junior basis to the Initial Term Loans and shall not be (x) secured by any property or assets of Holdings or any Subsidiary other than the Collateral or (y) guaranteed by Holdings or any of its Subsidiaries other than any Guarantor; provided that, if such Incremental Term Loans are unsecured or secured on a junior basis to the Initial Term Loans, such Incremental Term Loans will be established as a separate Tranche from the Term Loans. In the case of any junior lien Incremental Term Loans, such Indebtedness shall be subject to the terms of a First-Second Lien Intercreditor Agreement.
(B) Each Incremental Amendment providing for Incremental Revolving Commitments shall specify the terms of the applicable Incremental Revolving Commitments; provided that (i) the final maturity date of any Other Revolving Loans shall be no earlier than the Latest Maturity Date of any Class of Revolving Loans, (ii) such Class of Other Revolving Loans shall be denominated in one or more Agreed Currencies, (iii) such Other Revolving Loans may have mandatory commitment reduction terms that are not identical to the Initial Revolving Loans, (iv) the covenants and events of default of any Other Revolving Loans shall be reasonably acceptable to the Administrative Agent or shall not, when taken as a whole, be materially more favorable to the lenders or holders thereof than the relevant terms applicable to the Initial Revolving Loans unless such terms are added for the benefit of the Lenders of the Initial Revolving Loans then outstanding; provided that the Other Revolving Loans may benefit from one or more financial maintenance covenants (and related events of default) (provided that such covenants shall be included for the benefit of the Initial Revolving Loans) and (iv) the terms of Incremental Revolving Loans under a Revolving Commitment Increase shall be the same as the terms of the Revolving Loans of the Tranche that the Revolving Commitment Increase is increasing (other than upfront fees and/or original issue discount). The Incremental Revolving Loans shall rank pari passu in right of payment with the Initial Revolving Loans, shall be secured on a pari passu with the Initial Revolving Loans and shall not be (x) secured by any property or assets of Holdings or any Subsidiary other than the Collateral or (y) guaranteed by Holdings or any of its Subsidiaries other than any Guarantor. The Incremental Revolving Loans shall be subject to the provisions of Section 2.05(d) and 2.06(k) to the extent dealing with Swingline Loans and Letters of Credit which mature or expire after a Maturity Date when there exists Incremental Revolving Commitments with a longer Maturity Date. Upon the effectiveness of any Incremental Amendment with respect to Incremental Revolving Commitments, all Swingline Loans and Letters of Credit shall be participated on a pro rata basis by all Revolving Lenders in accordance with their Revolving Credit Exposure existing on such date.
(c)Subject to Section 2.19, each Lender may, at its option, make any Loan available to the Applicable Borrower or an Additional Borrower by causing any foreign or domestic branch or Affiliate of such Lender to make such Loan (in which case such branch or Affiliate shall be treated as the “Lender” with respect to such Loan for all purposes of this Agreement); provided that (x) any exercise of such option shall not affect the obligation of the Applicable Borrower or such Additional Borrower to repay such Loan in accordance with the terms of this Agreement, (y) if the respective branch or Affiliate is a Foreign Lender, the same shall comply with the requirements of Section 2.17, and (z) with respect to any Revolving Loans advanced to an Additional Borrower that is tax resident in Ireland, the Affiliate, whether or not a Foreign Lender, shall comply with the requirements of Section 2.17.
(d)Notwithstanding the foregoing, no Incremental Commitment shall become effective under this Section 2.20 unless (i) at the time that any such Incremental Commitment is made (and after giving effect thereto), (A) no Event of Default shall exist;
123


provided that, in the event that any tranche of Incremental Term Loans is used to finance a Limited Condition Transaction and to the extent the Incremental Term Lenders participating in such tranche of Incremental Term Loans agree, the foregoing clause (A) shall be tested solely as of the LCT Test Date, and (B) the representations and warranties of the Applicable Borrower set forth in this Agreement shall be true and correct in all material respects (other than to the extent qualified by materiality or “Material Adverse Effect”, in which case, such representations and warranties shall be true and correct); provided that, in the event that the tranche of Incremental Term Loans is used to finance a Limited Condition Transaction, the foregoing clause (B) shall be limited to the Specified Representations at the discretion of the applicable Incremental Lenders, (ii) the aggregate principal amount of all Incremental Term Loan Commitments and Incremental Revolving Commitments established under this Agreement, together with any Alternative Incremental Facility Indebtedness incurred and any Permitted Refinancing Indebtedness in respect thereof, shall not exceed, as of any date of determination, the sum of (A) the greater of $1,160,000,000 and 100% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (the “Fixed Incremental Amount”), plus (B) an amount equal to the sum of all voluntary prepayments of Term Loans, Revolving Loans and Alternative Incremental Facility Indebtedness that is secured by a Lien on the Collateral that is pari passu with any Lien on the Collateral securing the Obligations; provided that, with respect to Revolving Loans and Alternative Incremental Facility Indebtedness in the form of revolving loans, such prepayment is accompanied by a permanent reduction in the revolving commitments therefore (the “Prepayment Incremental Amount”), plus (C) an unlimited amount so long as (1) in the case of any Indebtedness secured by a Lien on the Collateral that is pari passu with any Lien on the Collateral securing the Obligations, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.00:1.00, (2) in the case of any Indebtedness secured by the Collateral on a junior lien basis relative to the Liens on such Collateral securing the Obligations, the Secured Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25:1.00, and (3) in the case of unsecured Indebtedness, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25:1.00 or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than 2.00:1.00 (the amount pursuant to this clause (C), the “Incurrence-Based Incremental Amount”); provided that, (i) for the avoidance of doubt, if, as part of the same transaction or series of related transactions, the Applicable Borrower incurs Indebtedness pursuant to the Incurrence-Based Incremental Amount and substantially concurrently also incurs Indebtedness (x) pursuant to the Fixed Incremental Amount and/or the Prepayment Incremental Amount or (y) otherwise constituting a Fixed Amount, then the First Lien Net Leverage Ratio, Secured Net Leverage Ratio and/or Total Net Leverage Ratio, as applicable, will be calculated with respect to such incurrence pursuant to the Incurrence-Based Incremental Amount without regard to any such substantially concurrent incurrence of Indebtedness under the Fixed Incremental Amount, Prepayment Incremental Amount or any other Fixed Amount, (ii) the Applicable Borrower may elect to use the Incurrence-Based Incremental Amount regardless of whether there is capacity under the Fixed Incremental Amount and/or the Prepayment Incremental Amount, and if any Incremental Loans may be incurred under the Incurrence-Based Incremental Amount, the Fixed Incremental Amount or the Prepayment Incremental Amount and the Applicable Borrower does not make an election, the Applicable Borrower shall be deemed to have incurred such Incremental Loans under the Incurrence-Based Incremental Amount and (iii) if at any time after any Borrower has incurred Incremental Loans under the Fixed Incremental Amount and/or the Prepayment Incremental Amount, any portion of such Incremental Loans could then be incurred under the Incurrence-Based Incremental Amount, such amounts shall automatically be reclassified to the Incurrence-Based Incremental Amount (the sum of the Fixed Incremental Amount, the Prepayment Incremental Amount and the Incurrence-Based Incremental Amount, after giving effect to any reclassification, the “Maximum Incremental Amount”). The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Incremental Amendment. Each of the parties hereto hereby agrees that, upon the effectiveness of
124


any Incremental Amendment, this Agreement shall be amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Incremental Commitments (including any mechanical or other amendments necessary to reflect the establishment of the Incremental Revolving Commitments) evidenced thereby. Any such deemed amendment may be memorialized in writing by the Administrative Agent with the Applicable Borrower’s consent (not to be unreasonably withheld, delayed or conditioned) and furnished to the other parties hereto.
(e)The Incremental Amendment may, without the consent of any Agents (unless it directly adversely amends or modifies the rights or duties of any Agent) or Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Applicable Borrower, to effect the provisions of this Section 2.20 (including without limitation, (i) the addition of customary letter of credit, swingline and Defaulting Lender provisions with respect to any Incremental Revolving Lenders, (ii) the addition of a class vote of the Incremental Revolving Lenders for acceleration, waiver and amendment with respect to any particular Class of Incremental Revolving Loans), (iii) in the case of a Term Loan Increase, modifications to the amortization payment amount and/or the Applicable Margin of the applicable Tranche of Term Loans to provide that the then outstanding Term Loans and the Incremental Term Loans are fungible, (iv) to reset the terms of a Repricing Event to give effect to Incremental Term Loan Commitments and (iv) to implement any additional covenants applicable to the Incremental Loans and Incremental Commitments that, pursuant to this Section 2.20, may be applied to the then existing Loans and Commitments. The Applicable Borrower will use the proceeds of the Incremental Loans for general corporate purposes (including loans and other Investments in Holdings and its Subsidiaries as permitted herein, Permitted Acquisitions and Investments). Incremental Loans may be made by any existing Lender (but no existing Lender will have any obligation to make or provide any portion of any Incremental Loan) or by any other bank or other financial institution. No Lender shall be obligated to provide any Incremental Loans unless it so agrees.
(f)This Section 2.20 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.
Section 2.21Judgment Currency.
If for the purposes of obtaining judgment in any court it is necessary to convert a sum due from an Applicable Borrower hereunder in the currency expressed to be payable herein (the “specified currency”) into another currency, the parties hereto agree, to the fullest extent that they may effectively do so, that the rate of exchange used shall be that at which in accordance with normal banking procedures the Administrative Agent could purchase the specified currency with such other currency at the Administrative Agent’s main New York City office on the Business Day preceding that on which final, non-appealable judgment is given. The obligations of the Applicable Borrower and any Additional Borrower in respect of any sum due to any Lender or the Administrative Agent hereunder shall, notwithstanding any judgment in a currency other than the specified currency, be discharged only to the extent that on the Business Day following receipt by such Lender or the Administrative Agent (as the case may be) of any sum adjudged to be so due in such other currency such Lender or the Administrative Agent (as the case may be) may in accordance with normal, reasonable banking procedures purchase the specified currency with such other currency. If the amount of the specified currency so purchased is less than the sum originally due to such Lender or the Administrative Agent, as the case may be, in the specified currency, the Applicable Borrower agrees, to the fullest extent that it may effectively do so, as a separate obligation and notwithstanding any such judgment, to indemnify such Lender or the Administrative Agent, as the case may be, against such loss, and if the amount of the specified currency so purchased exceeds (a) the sum originally due to any Lender or the Administrative
125


Agent, as the case may be, in the specified currency and (b) any amounts shared with other Lenders as a result of allocations of such excess as a disproportionate payment to such Lender under Section 2.18, such Lender or the Administrative Agent, as the case may be, agrees to remit such excess to the Borrowers.
Section 2.22Extensions of Loans and Commitments.
(a)Notwithstanding anything to the contrary in this Agreement, pursuant to one or more offers (each, an “Extension Offer”) made from time to time by the Applicable Borrower to (i) all Term Lenders of Term Loans of any Tranche with a like Maturity Date, and/or (ii) all Incremental Revolving Lenders with a like Maturity Date, in each case on a pro rata basis (based on the aggregate outstanding principal amount of the respective Loans or the aggregate amount of the Commitments with the same Maturity Date, as the case may be, and using Dollar Amounts in the case of any amounts denominated in an Agreed Currency other than Dollars) and on the same terms to each such Lender, the Applicable Borrower may from time to time offer to extend the Maturity Date for any such Loans and otherwise modify the terms of such Loans and/or Commitments pursuant to the terms of the relevant Extension Offer (including by increasing the interest rate or fees payable in respect of such Loans and/or Commitments (and related outstandings) (each, an “Extension”), and each group of Loans or Commitments, as applicable, in each case of a given Tranche as so extended, as well as the original Loans and Commitments of the original respective Tranche (in each case not so extended), shall (for the avoidance of doubt) be part of a single Tranche; and any Extended Loans shall constitute a separate Class of Loans from the Class of Loans from which they were converted, so long as the following terms are satisfied:
(i)[reserved];
(ii)except as to interest rates, fees, amortization, final maturity date, premium, required prepayment dates and participation in prepayments (which shall, subject to the succeeding clauses (iii), (iv), (v), and (vi), be determined by the Applicable Borrower and set forth in the relevant Extension Offer), the Loans of any Term Lender extended pursuant to any Extension (“Extended Term Loans”) shall have the same terms as the Tranche of Loans subject to such Extension Offer;
(iii)except as to interest rates, fees and final maturity (which shall, subject to the requirements of this Section 2.22, be determined by the Applicable Borrower and set forth in the relevant Extension Offer), the Revolving Commitment, the Incremental Revolving Commitment or Other Refinancing Revolving Commitment of any Revolving Lender (an “Extending Revolving Lender”) extended pursuant to an Extension (an “Extended Revolving Commitment”), and the related outstanding, shall be a Revolving Commitment, Incremental Revolving Commitment or Other Refinancing Revolving Commitment (or related outstandings, as the case may be) with the same terms as the original Revolving Commitments of the same Class, the Incremental Revolving Commitments or Other Refinancing Revolving Commitments (and related outstandings); provided that (x) subject to the provisions of Sections 2.05(d) and 2.06(k) to the extent dealing with Letters of Credit and Swingline Loans which mature or expire after a Maturity Date when there exist Extended Revolving Commitments with a longer Maturity Date, all Letters of Credit and Swingline Loans shall be participated in on a pro rata basis by all Lenders with Revolving Commitments and Incremental Revolving Commitments in accordance with their pro rata share of the aggregate Revolving Commitments and Incremental Revolving Commitments (and except as provided in Sections 2.05(d) and 2.06(k), without giving effect to changes thereto on an earlier Maturity Date with respect to Swingline Loans and Letters of Credit theretofore incurred or issued; provided that the commitment of the Issuing Banks to issue Letters of Credit can only be extended with the
126


appropriate Issuing Banks’s consent) and all borrowings under Revolving Commitments of such Class and any related Incremental Revolving Commitments or Extended Revolving Commitments and repayments thereunder shall be made on a pro rata basis (except for (A) payments of interest and fees at different rates on Extended Revolving Commitments (and related outstandings) and (B) repayments required upon the Maturity Date for the non-extending Revolving Commitments of the same Class, or any related Incremental Revolving Commitments or Extended Revolving Commitments) and (y) at no time shall there be Revolving Commitments, Extended Revolving Commitments, Incremental Revolving Commitments and/or Other Refinancing Revolving Commitments hereunder (including Extended Revolving Commitments and any original Revolving Commitments) which have more than three different Maturity Dates;
(iv)the final maturity date for any Extended Term Loans shall be no earlier than the then Maturity Date for the Tranche of Loans so extended;
(v)the Weighted Average Life to Maturity of any Extended Term Loans shall be no shorter than the remaining Weighted Average Life to Maturity of the Tranche of Term Loans extended thereby;
(vi)any Extended Term Loans may participate on a pro rata basis or a less than pro rata basis (but not greater than a pro rata basis) with the existing Tranches of Term Loans mandatory repayments or prepayments hereunder, in each case as specified in the respective Extension Offer;
(vii)if the aggregate principal amount of applicable Term Loans (calculated on the face amount thereof) or Revolving Commitments, as the case may be, in respect of which applicable Term Lenders or Revolving Lenders, as the case may be, shall have accepted the relevant Extension Offer shall exceed the maximum aggregate principal amount of applicable Term Loans or Revolving Commitments, as the case may be, offered to be extended by the Applicable Borrower pursuant to such Extension Offer, then the applicable Term Loans or Revolving Loans, as the case may be, of the applicable Term Lenders or Revolving Lenders, as the case may be, shall be extended rateably up to such maximum amount based on the respective principal amounts (but not to exceed actual holdings of record) with respect to which such Term Lenders or Revolving Lenders, as the case may be, have accepted such Extension Offer;
(viii)all documentation in respect of such Extension shall be consistent with the foregoing,
(ix)the Extension shall not become effective unless, on the proposed effective date of the Extension, (x) the Applicable Borrower shall deliver to the Administrative Agent one or more legal opinions reasonably satisfactory to the Administrative Agent and a certificate of an authorized officer of each Loan Party dated the applicable date of the Extension and executed by an authorized officer of such Loan Party certifying and attaching the resolutions adopted by such Loan Party approving or consenting to such Extension and (y) the conditions set forth in Section 4.02 shall be satisfied (with all references therein to any Credit Event being deemed to be references to the Extension on the applicable date of the Extension) and the Administrative Agent shall have received a certificate to that effect dated the applicable date of the Extension and executed by a Financial Officer of Holdings;
(x)any applicable Minimum Extension Condition shall be satisfied unless waived by the Applicable Borrower; and
127


(xi)the Minimum Tranche Amount shall be satisfied unless waived by the Administrative Agent.
(b)With respect to all Extensions consummated by an Applicable Borrower pursuant to this Section 2.22, (i) such Extensions shall not constitute voluntary or mandatory payments or prepayments for purposes of Section 2.11 and (ii) no Extension Offer is required to be in any minimum amount or any minimum increment; provided that (A) the Applicable Borrower may at its election specify as a condition (a “Minimum Extension Condition”) to consummating any such Extension that a minimum amount (to be determined and specified in the relevant Extension Offer in Borrowers’ sole discretion and may be waived by Applicable Borrower) of Loans or Commitments of any or all applicable Tranches and Classes be tendered and (B) no Tranche of Extended Loans or Extended Commitments shall be in an amount (taking the Dollar Amount of any amounts denominated in Agreed Currencies other than Dollars) of less than $2,500,000 (the “Minimum Tranche Amount”), unless such Minimum Tranche Amount is waived by the Administrative Agent. Subject to compliance with the terms of this Section 2.22, the Administrative Agent, the Issuing Banks and the Lenders hereby consent to the Extensions and the other transactions contemplated by this Section 2.22 (including, for the avoidance of doubt, payment of any interest, fees or premium in respect of any Extended Term Loans and/or Extended Revolving Commitments on such terms as may be set forth in the relevant Extension Offer) and hereby waive the requirements of any provision of this Agreement (including, without limitation, Sections 2.11 and 2.18) or any other Loan Document that may otherwise prohibit any such Extension or any other transaction contemplated by this Section 2.22.
(c)No consent of any Lender, Issuing Bank or the Administrative Agent, the Collateral Agent shall be required to effectuate any Extension, other than the consent of each Lender agreeing to such Extension with respect to one or more of its Loans of any Class, Revolving Commitments or any Class and/or Other Refinancing Loans (or a portion thereof); provided that the consent of the Issuing Banks and the Swingline Lender shall be required to effect an Extension of Revolving Commitments. All Extended Loans and all obligations in respect thereof shall be Secured Obligations under this Agreement and the other Loan Documents that are secured by all or a portion of the Collateral on a pari passu or junior lien basis with all other applicable Obligations under this Agreement and the other Loan Documents; provided that, if such Extended Loans rank junior in right of security with any other Obligations, such Extended Loans will be subject to the terms of a First-Second Lien Intercreditor Agreement. The Lenders hereby irrevocably authorize the Administrative Agent to enter into amendments to this Agreement and the other Loan Documents with the Borrowers as may be necessary in order to establish new Tranches or sub-tranches in respect of Term Loans or Revolving Commitments so extended and such other amendments as may be necessary or appropriate in the reasonable opinion of the Administrative Agent and the Applicable Borrower in connection with the establishment of such new Tranches or subtranches, in each case on terms consistent with this Section 2.22 (each an “Extension Amendment”).
(d)In connection with any Extension, the Applicable Borrower shall provide the Administrative Agent at least five (5) Business Days (or such shorter period as may be agreed by the Administrative Agent) prior written notice thereof, and shall agree to such procedures, if any, as may be established by, or acceptable to, the Administrative Agent, in each case acting reasonably to accomplish the purposes of this Section 2.22.
(e)Notwithstanding anything to the contrary contained herein, no Lender shall be required to accept an Extension Offer.
128


Section 2.23Loan Repurchases.
(a)Subject to the terms and conditions set forth or referred to below, a Purchasing Borrower Party may from time to time, at its discretion, conduct modified Dutch auctions in order to purchase its Term Loans of one or more Classes (as determined by the Purchasing Borrower Party) (each, a “Purchase Offer”), each such Purchase Offer to be managed exclusively by the Administrative Agent (or such other financial institution chosen by the Purchasing Borrower Party) (in such capacity, the “Auction Manager”), so long as the following conditions are satisfied:
(i)each Purchase Offer shall be conducted in accordance with the procedures, terms and conditions set forth in this Section 2.23 and the Auction Procedures;
(ii)no Event of Default shall have occurred and be continuing on the date of the delivery of each notice of an auction and at the time of (and immediately after giving effect to) the purchase of any Term Loans in connection with any Purchase Offer);
(iii)the principal amount (calculated on the face amount thereof) of each and all Classes of Term Loans that the Purchasing Borrower Party offers to purchase in any such Purchase Offer shall be no less than U.S. $10,000,000 (unless another amount is agreed to by the Administrative Agent) (across all such Classes);
(iv)[reserved];
(v)the aggregate principal amount (calculated on the face amount thereof) of all Term Loans of the applicable Class or Classes so purchased by the Purchasing Borrower Party shall automatically be cancelled and retired by the Purchasing Borrower Party on the settlement date of the relevant purchase (and may not be resold), and in no event shall the Purchasing Borrower Party be entitled to any vote hereunder in connection with such Term Loans;
(vi)no more than one Purchase Offer with respect to any Class may be ongoing at any one time;
(vii)any Purchase Offer with respect to any Class shall be offered to all Term Lenders holding Term Loans of such Class on a pro rata basis; and
(viii)no purchase of any Term Loans shall be made from the proceeds of any Revolving Loan or Swingline Loan.
(b)The Purchasing Borrower Party must terminate any Purchase Offer if it fails to satisfy one or more of the conditions set forth above which are required to be met at the time which otherwise would have been the time of purchase of Term Loans pursuant to such Purchase Offer. If the Purchasing Borrower Party commences any Purchase Offer (and all relevant requirements set forth above which are required to be satisfied at the time of the commencement of such Purchase Offer have in fact been satisfied), and if at such time of commencement the Purchasing Borrower Party reasonably believes that all required conditions set forth above which are required to be satisfied at the time of the consummation of such Purchase Offer shall be satisfied, then the Purchasing Borrower Party shall have no liability to any Term Lender for any termination of such Purchase Offer as a result of its failure to satisfy one or more of the conditions set forth above which are required to be met at the time which otherwise would have been the time of consummation of such Purchase Offer, and any such failure shall not result in any Default or Event of Default hereunder. With respect to all purchases of Term Loans
129


of any Class or Classes made by the Purchasing Borrower Party pursuant to this Section 2.23, (x) the Purchasing Borrower Party shall pay on the settlement date of each such purchase all accrued and unpaid interest (except to the extent otherwise set forth in the relevant offering documents), if any, on the purchased Term Loans of the applicable Class or Classes up to the settlement date of such purchase, (y) such purchases (and the payments made by the Purchasing Borrower Party and the cancellation of the purchased Loans, in each case in connection therewith) shall not constitute voluntary or mandatory payments or prepayments for purposes of Section 2.11 hereof and (z) such purchases of Initial Term Loans shall be made on a pro rata basis between the two Tranches of Initial Term Loans.
(c)The Administrative Agent and the Lenders hereby consent to the Purchase Offers and the other transactions effected pursuant to and in accordance with the terms of this Section 2.23; provided that, notwithstanding anything to the contrary contained herein, no Lender shall have an obligation to participate in any such Purchase Offer. For the avoidance of doubt, it is understood and agreed that the provisions of Sections 2.11, 2.12, 2.16, 2.18 and 9.04 will not apply to the purchases of Term Loans pursuant to Purchase Offers made pursuant to and in accordance with the provisions of this Section 2.23. The Auction Manager acting in its capacity as such hereunder shall be entitled to the benefits of the provisions of Article VIII and Section 9.03 to the same extent as if each reference therein to the “Agents” were a reference to the Auction Manager, and the Administrative Agent shall cooperate with the Auction Manager as reasonably requested by the Auction Manager in order to enable it to perform its responsibilities and duties in connection with each Purchase Offer.
(d)This Section 2.23 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.
Section 2.24Refinancing Amendment.
At any time after the Closing Date, the Applicable Borrower may obtain, from any Lender or any Refinancing Lender, Credit Agreement Refinancing Indebtedness in respect of all or any portion of the Loans or Commitments of the Applicable Borrower then outstanding under this Agreement, in the form of Other Refinancing Loans or Other Refinancing Commitments in each case pursuant to a Refinancing Amendment; provided that such Credit Agreement Refinancing Indebtedness (i) will rank pari passu or, other than in the case of Other Refinancing Revolving Commitments and Other Refinancing Revolving Loans, junior in right of payment and of security with the other Loans and Commitments hereunder; provided that, if such Credit Agreement Refinancing Indebtedness ranks junior in right of security with any other Loans or Commitments hereunder, such Credit Agreement Refinancing Indebtedness will be subject to the terms of a First-Second Lien Intercreditor Agreement, (ii) will have such maturity dates, pricing, interest rate margins, rate floors, discounts, premiums and optional prepayment or redemption terms as may be agreed by the Applicable Borrower and the Lenders thereof; and (iii) will otherwise comply with the proviso to the definition of “Credit Agreement Refinancing Indebtedness”; provided further that any Person that provides any Credit Agreement Refinancing Indebtedness in the form of Other Refinancing Revolving Loans or Other Refinancing Revolving Commitments to an Additional Borrower that is organized in Ireland shall comply with the requirements of Section 2.17, including the provision of an Irish Qualifying Lender Confirmation substantially in the form of Exhibit H (pursuant to which such Person shall acknowledge that if it is not an Irish Qualifying Lender it will not be grossed up for any Irish withholding Tax applicable under relevant law as of the date such Person provides such Credit Agreement Refinancing Indebtedness). Any Other Refinancing Loans or Other Refinancing Commitments, as applicable, may participate on a pro rata basis or on a less than pro rata basis (but not on a greater than pro rata basis) in any mandatory prepayments hereunder, as specified in the applicable Refinancing Amendment. The effectiveness of any Refinancing Amendment shall be subject to the satisfaction on the date thereof of each of the conditions set forth in Section 4.02 and, if
130


reasonably requested by the Administrative Agent at its option, receipt by the Administrative Agent of legal opinions, board resolutions, officers’ certificates and/or reaffirmation agreements generally consistent with those delivered on the Closing Date pursuant to Sections 4.01(b), (e) and (g) (other than changes to such legal opinions resulting from a change in law, change in fact or change to counsel’s form of opinion reasonably satisfactory to the Administrative Agent). Each Tranche of Credit Agreement Refinancing Indebtedness pursuant to this Section 2.24 shall be in an aggregate principal amount that is not less than $5,000,000 (unless such Credit Agreement Refinancing Indebtedness is incurred to refinance all outstanding Loans with respect to a Tranche). The Administrative Agent shall promptly notify each Lender and the Collateral Agent as to the effectiveness of each Refinancing Amendment. Each of the parties hereto hereby agrees that, upon the effectiveness of any Refinancing Amendment, this Agreement shall be deemed amended and restated or amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Credit Agreement Refinancing Indebtedness incurred pursuant thereto (including any amendments necessary to treat the Loans and Commitments subject thereto as Other Refinancing Term Loans and/or Other Refinancing Term Commitments). Any Refinancing Amendment may, without the consent of any other Lenders or any Agents (unless it directly adversely amends or modifies the rights or duties of any Agent), effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Applicable Borrower, to effect the provisions of this Section 2.24 (including without limitation, the addition of customary Defaulting Lender provisions with respect to any Lenders providing Other Refinancing Revolving Loans and Other Refinancing Revolving Commitments). This Section 2.24 shall supersede any provisions in Section 2.18 or 9.02 to the contrary.
Section 2.25Illegality.
If any Lender determines that any law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable lending office to make, maintain or fund Loans whose interest is determined by reference to the Eurocurrency Rate, USD Term SOFR, USD Adjusted Term SOFR, USD Term SOFR Reference Rate or Daily Simple RFR with respect to any Agreed Currency, or to determine or charge interest rates based upon the Eurocurrency Rate, USD Term SOFR, USD Adjusted Term SOFR, USD Term SOFR Reference Rate or Daily Simple RFR with respect to any Agreed Currency, or any Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, any Agreed Currency in the London interbank market, then, on notice thereof by such Lender to the Applicable Borrower through the Administrative Agent, (i) any obligation of such Lender to make or continue Eurocurrency Loans, USD Term SOFR Loans or RFR Loans in such Agreed Currency or to convert ABR Loans to Eurocurrency Loans, USD Term SOFR Loans or RFR Loans in such Agreed Currency shall be suspended and (ii) if such notice asserts the illegality of such Lender making or maintaining ABR Loans the interest rate on which is determined by reference to the Eurocurrency RateUSD Adjusted Term SOFR component of the Alternate Base Rate, the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Eurocurrency RateUSD Adjusted Term SOFR component of the Alternate Base Rate. Upon receipt of such notice, (x) the Applicable Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all Eurocurrency Loans, USD Term SOFR Loans or RFR Loans in such Agreed Currency of such Lender to ABR Loans (the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Eurocurrency RateUSD Adjusted Term SOFR component of the Alternate Base Rate), either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurocurrency Loans, USD Term SOFR Loans or RFR Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurocurrency Loans, USD Term SOFR Loans or RFR Loans and (y) if such notice asserts the illegality of such Lender determining or charging interest rates based upon
131


the Eurocurrency Rate, USD Term SOFR, USD Adjusted Term SOFR or USD Term SOFR Reference Rate , the Administrative Agent shall during the period of such suspension compute the Alternate Base Rate applicable to such Lender without reference to the Eurocurrency RateUSD Adjusted Term SOFR component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon the Eurocurrency Rate, USD Term SOFR, USD Adjusted Term SOFR or USD Term SOFR Reference Rate. Upon any such prepayment or conversion, the Applicable Borrower shall also pay accrued interest on the amount so prepaid or converted.
Section 2.26Defaulting Lenders.
(a)Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law:
(i)such Defaulting Lender’s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in the definition of “Required Lenders”.
(b)Notwithstanding any provision of this Agreement to the contrary, if any Revolving Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Revolving Lender is a Defaulting Lender:
(i)fees shall cease to accrue on the unfunded portion of the Revolving Commitment of such Defaulting Lender pursuant to Section 2.12(a);
(ii)the unused Commitment and Revolving Credit Exposure of such Defaulting Lender shall not be included in determining whether the Required Lenders or Required Revolving Lenders or Majority in Interest of Revolving Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to Section 9.02); provided that this clause (ii) shall not apply to the vote of a Defaulting Lender in the case of an amendment, waiver or other modification requiring the consent of such Lender or each Lender affected thereby under Section 9.02;
(iii)if any Swingline Exposure or LC Exposure exists at the time such Revolving Lender becomes a Defaulting Lender then:
(A)so long as no Default has occurred and is continuing: all or any part of the Swingline Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Revolving Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k)) but only to the extent (A) the sum of all non-Defaulting Lenders’ Revolving Credit Exposures plus such Defaulting Lender’s Swingline Exposure does not exceed the total of all non-Defaulting Lenders’ Revolving Commitments and (B) each non-Defaulting Lender’s Revolving Credit Exposure in respect of any Class does not exceed such non-Defaulting Lender’s Revolving Commitment in respect of such Class; and all or any part of the LC Exposure of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Revolving Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k)) but only to the extent (C) the sum of all non-Defaulting Lenders’ Revolving Credit Exposures plus such Defaulting Lender’s LC Exposure does not exceed the total of all non-Defaulting Lenders’ Revolving Commitments;
132


(B)if the reallocations described in clause (A) above cannot, or can only partially, be effected, the Applicable Borrower shall within one (1) Business Day following notice by the Administrative Agent (x) first, prepay such Swingline Exposure and (y) second, Cash Collateralize for the benefit of the applicable Issuing Bank only the Applicable Borrower’s obligations corresponding to such Defaulting Lender’s LC Exposure (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in Section 2.06(j) for so long as such LC Exposure is outstanding;
(C)if the Applicable Borrower Cash Collateralizes any portion of such Defaulting Lender’s LC Exposure pursuant to clause (B) above, the Applicable Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to Section 2.12(b) with respect to such Defaulting Lender’s LC Exposure during the period (and to the extent) such Defaulting Lender’s LC Exposure is Cash Collateralized;
(D)if the LC Exposure of the non-Defaulting Lenders is reallocated pursuant to clause (A) above, then the fees payable to the Lenders pursuant to Section 2.12(a) and Section 2.12(b) shall be adjusted in accordance with such non-Defaulting Lenders’ Applicable Percentages (after giving effect to the reallocation provisions of Sections 2.05(d) and 2.06(k)); and
(E)if all or any portion of such Defaulting Lender’s LC Exposure is neither reallocated nor Cash Collateralized pursuant to clause (A) or (B) above, then, without prejudice to any rights or remedies of the applicable Issuing Bank or any other Lender hereunder, all letter of credit fees payable under Section 2.12(b) with respect to such Defaulting Lender’s LC Exposure shall be payable to the Issuing Bank until and to the extent that such LC Exposure is reallocated and/or Cash Collateralized; and
(iv)so long as such Lender is a Defaulting Lender, the Swingline Lender shall not be required to fund any Swingline Loan and no Issuing Bank shall be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure and the Defaulting Lender’s then outstanding LC Exposure will be 100% covered by the Revolving Commitments of the non-Defaulting Lenders and/or cash collateral will be provided by the Borrowers in accordance with Section 2.26(b)(iii), and participating interests in any such newly made Swingline Loan or any newly issued or increased Letter of Credit shall be allocated among non-Defaulting Lenders in a manner consistent with Section 2.26(b)(iii)(A) (and such Defaulting Lender shall not participate therein).
(c)Defaulting Lender Cure. If a Lender ceases to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any cash collateral), that Lender will, to the extent applicable, take such actions as the Administrative Agent may determine to be necessary to cause the applicable Loans to be held pro rata by the applicable Lenders in accordance with the applicable Commitments, whereupon such Lender will cease to be a Defaulting Lender, the Swingline Exposure and LC Exposure of the Lenders shall be readjusted to reflect the inclusion of such Lender’s Commitment and on such date such Lender shall purchase at par such of the Revolving Loans of any Class (other than Swingline Loans) of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Applicable Percentage; provided that no adjustments will be made
133


retroactively with respect to fees accrued or payments made by or on behalf of the Borrowers while that Lender was a Defaulting Lender; and provided, further, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender.
Article III

Representations and Warranties
In order to induce the Administrative Agent, the Collateral Agent and the Lenders to enter into this Agreement on the Closing Date and to make each Loan or other extension of credit to be made hereunder on the Closing Date and on the date of each other Credit Event, each of the Loan Parties represents and warrants to the Administrative Agent, the Collateral Agent and Lenders that, (i) on the Closing Date (after giving effect to the Transactions), solely with respect to the Specified Representations, and (ii) on the date of each other Borrowing (other than as provided in Section 2.20), that each of the following statements are true and correct in all material respects:
Section 3.01Organization; Powers; Subsidiaries. Each of Holdings and its Material Subsidiaries is duly organized or incorporated, as the case may be, and validly existing and (to the extent the concept is applicable in such jurisdiction) in good standing under the laws of the jurisdiction of its organization, has all requisite power and authority to carry on its business as now conducted and, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, is qualified to do business in, and (to the extent the concept is applicable in such jurisdiction) is in good standing in, every jurisdiction where such qualification is required. Schedule 3.01 hereto identifies each Subsidiary (other than Subsidiaries in respect of which Holdings and its Subsidiaries own less than 50% of the Equity Interests thereof) as of the Closing Date, noting whether such Subsidiary is a Material Subsidiary, whether such Subsidiary is an Unrestricted Subsidiary, the jurisdiction of its incorporation or organization, as the case may be, the percentage of issued and outstanding shares of each class of its capital stock or other equity interests owned by Holdings and the other Subsidiaries and, if such percentage is not 100% (excluding directors’ qualifying shares as required by law), a description of each class issued and outstanding. All of the outstanding shares of capital stock and other equity interests of each Material Subsidiary are validly issued and outstanding and fully paid and non-assessable (as such term is determined under applicable law) and all such shares and other equity interests owned by Holdings or another Material Subsidiary are owned, beneficially and of record, by Holdings or such Material Subsidiary free and clear of all Liens, other than Liens created under the Loan Documents and Liens permitted by Section 6.02. As of the Closing Date (and except pursuant to the Acquisition Agreement), there are no outstanding commitments or other obligations of any Material Subsidiary to issue, and no options, warrants or other rights of any Person to acquire, any shares of any class of capital stock or other equity interests of any Material Subsidiary.
Section 3.02Authorization; Enforceability. The Transactions are, subject to the Legal Reservations, within each Loan Party’s corporate or other organizational powers and have been (or, except with respect to the Loan Documents executed by one or more Loan Parties on the Closing Date, will on or prior to the Closing Date be) duly authorized by all necessary corporate or other organizational actions and, if required, actions by shareholders, members or equity holders. The Loan Documents to which each Loan Party is a party have been duly executed and delivered by such Loan Party and, subject to the Legal Reservations, constitute a legal, valid and binding obligation of such Loan Party and, subject to the Legal Reservations and the Perfection Requirements, enforceable in accordance with its terms, subject to (i) applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and
134


subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law, and (ii) the effect of foreign laws, rules and regulations as they relate to pledges of Equity Interests in or Indebtedness owed by Foreign Subsidiaries (other than with respect to those pledges and security interests made under the laws of the jurisdiction of formation of the applicable Foreign Subsidiary).
Section 3.03Governmental Approvals; No Conflicts. The Transactions (a) do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority, except such as have been obtained or made and are in full force and effect and except for (x) filings, notifications or registrations necessary to perfect Liens created pursuant to the Loan Documents and (y) consents, approvals, registrations, filings or other actions that will be obtained or made in connection with the Acquisition on or prior to the Closing Date, (b) will not violate any applicable law or regulation (except such non-compliance that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect) or the charter, by-laws or other Organizational Documents of Holdings or any of its Material Subsidiaries or any order of any Governmental Authority, (c) will not violate in any material respect or result in a default under any indenture, any material agreement or other material instrument (except such non-compliance that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect) binding upon Holdings or any of its Material Subsidiaries or its assets, or give rise to a right thereunder to require any payment to be made by Holdings or any of its Material Subsidiaries (other than the Indebtedness set forth on Schedule 3.03), and (d) will not result in the creation or imposition of any Lien on any asset of Holdings or any of its Material Subsidiaries, other than Liens created under the Loan Documents.
Section 3.04Financial Condition; No Material Adverse Change.
(a)Holdings has heretofore furnished to the Lenders (i) the audited condensed consolidated balance sheet and statements of operations, changes in stockholders’ equity (deficit) and cash flows as of and for the fiscal years ended December 31, 2018, December 31, 2019 and December 31, 2020 for Target and its subsidiaries, and (ii) the audited consolidated balance sheet and statements of comprehensive loss, stockholders’ equity (loss) and cash flows as of and for the fiscal years ended December 31, 2018, December 31, 2019 and December 31, 2020 for the Group. Such financial statements present fairly, in all material respects, the financial position and results of operations and cash flows of Target and its subsidiaries and the financial position and results of operations and cash flows of the Group, as the case may be, as of such dates and for such periods in accordance with GAAP.
(b)Since December 31, 2020, there has been no material adverse change in the business, operations or condition, financial or otherwise, of the Group, taken as a whole.
Section 3.05Properties.
(a)Each of Holdings and its Material Subsidiaries has good title to, or (to the knowledge of Holdings) valid leasehold interests in, all its real and personal property (excluding intellectual property, which is considered in Section 3.05(b)) material to its business, except for minor defects in title that do not interfere with its ability to conduct its business as currently conducted or to utilize such properties for their intended purposes.
(b)Each of Holdings and its Subsidiaries owns without restriction, free and clear of all Liens other than Permitted Liens, or is licensed to use, all trademarks, trade names, copyrights, patents and other intellectual property used in or necessary to the business of Holdings and its Subsidiaries, except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. All such intellectual property is, to the knowledge of Holdings, valid and enforceable and all registrations and applications for such intellectual property are, to
135


the knowledge of Holdings (to the extent such intellectual property is licensed from third parties), subsisting and have not expired or been abandoned except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as set forth in Schedule 3.05 attached hereto, Holdings’ Annual Report on Form 20-F for the year ended December 31, 2020 and the Target’s Annual Report on Form 10-K for the year ended December 31, 2020, no claim has been asserted or is pending by any Person challenging or questioning the use, scope, validity, effectiveness or ownership of any such intellectual property or alleging infringement, misappropriation, dilution or other violation by Holdings or any of its Subsidiaries of any intellectual property owned by any other Person, nor does Holdings know of any valid basis for any such claim, except for such claims that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, to the knowledge of Holdings, neither Holdings, its Subsidiaries, nor the operations of their businesses infringes upon, misappropriates, dilutes or otherwise violates any intellectual property of any Person.
Section 3.06Litigation, Environmental and Labor Matters.
(a)Except as set forth on Schedule 3.06 hereto, Holdings’ Annual Report on Form 20-F for the year ended December 31, 2020 and the Target’s Annual Report on Form 10-K for the year ended December 31, 2020, there are no actions, suits, proceedings or investigations by or before any arbitrator or Governmental Authority pending against or, to the knowledge of Holdings, threatened against or affecting Holdings or any of its Subsidiaries that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.
(b)Except with respect to matters that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect, neither Holdings nor any of its Subsidiaries (i) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii) has received written notice of any pending or threatened claim with respect to any Environmental Liability or (iii) has knowledge of any existing facts or circumstances that would reasonably be expected to result in Holdings or any of its Subsidiaries becoming subject to any Environmental Liability.
(c)As of the Closing Date, there are no strikes, lockouts or slowdowns against Holdings or any of its Subsidiaries pending or, to the knowledge of Holdings, threatened that have resulted in, or could reasonably be expected to result in, a Material Adverse Effect. The hours worked by and payments made to employees of Holdings and its Subsidiaries have not been in violation of the Fair Labor Standards Act or any other applicable Federal, state, local or foreign law relating to such matters that has resulted in, or could reasonably be expected to result in, a Material Adverse Effect.
Section 3.07Compliance with Laws and Agreements. Except as set forth in Schedule 3.07 hereto, each of Holdings and its Subsidiaries is in compliance with all laws, regulations and orders of any Governmental Authority applicable to it or its property, operations or assets and all indentures, agreements and other instruments binding upon it or its property, except where such non-compliance would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect.
Section 3.08Investment Company Status. None of the Loan Parties is required to be registered as an “investment company” as defined in the Investment Company Act of 1940.
Section 3.09Taxes. Except as would not reasonably be expected to result in a Material Adverse Effect, each of Holdings and its Subsidiaries has timely filed or caused to be filed all Tax returns and reports required to have been filed by it and has paid or caused to be paid
136


all Taxes required to have been paid by it, except Taxes that are being contested in good faith by appropriate proceedings diligently conducted and for which Holdings or such Subsidiary, as applicable, has set aside on its books adequate reserves in accordance with, and to the extent required by, applicable accounting principles.
Section 3.10ERISA.
(a)Except as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, (i) each Plan is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations thereunder, and (ii) all contributions required to be made under the terms of any Plan as of the date of this Agreement have been timely made, or if not yet due, have been properly reflected on the most recent consolidated balance sheet filed or incorporated by reference in the Companies’ financial statements.
(b)(i) No ERISA Event has occurred or is reasonably expected to occur and (ii) none of the Loan Parties or any of their respective ERISA Affiliates has engaged in a transaction that is subject to Sections 4069 or 4212(c) of ERISA, except, with respect to each of the foregoing clauses of this Section 3.10(b), as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.
(c)To the knowledge of Holdings and the Borrowers, there has been no prohibited transaction (within the meaning of Section 406 of ERISA or Section 4975 of the Code) with respect to any Plan, other than a transaction that is exempt under a statutory or administrative exemption, except as would not, either individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.
(d)Except where noncompliance or the incurrence of an obligation, in each case, would not reasonably be expected to result in a Material Adverse Effect, (i) each Non-U.S. Plan and each Irish Pension Scheme has been maintained in compliance with its terms and with the requirements of any and all applicable laws, statutes, rules, regulations and orders, and (ii) neither Holdings nor any Subsidiary has incurred any obligation in connection with the termination of or withdrawal from any Non-U.S. Plan or Irish Pension Scheme.
Section 3.11Disclosure. None of the factual information and data contemporaneously furnished in writing by or on behalf of any Loan Party (other than projected financial information, pro forma financial information, budgets, estimates, information based on third-party reports and information of a general economic or industry nature) to the Administrative Agent, Collateral Agent or any Lender in connection with the transactions contemplated hereby and the negotiation of this Agreement as of the Closing Date when taken as a whole contains, as of the date of such statement, certificate or other information was furnished, any material misstatement of fact or omits to state any material fact necessary to make the statements therein (when taken as a whole), in the light of the circumstances under which they were made, not materially misleading. With respect to projected financial information and pro forma financial information furnished in writing by or on behalf of any Loan Party to the Administrative Agent on or prior to the Closing Date, the Collateral Agent or any Lender, Holdings represents that such information was prepared in good faith based upon assumptions believed to be reasonable at the time such information was furnished, it being understood that such projected financial information and pro forma financial information are subject to significant uncertainties and contingencies, many of which are beyond Holdings’ control, are not to be viewed as facts, that actual results during the period or periods covered by any such information may differ from the projected results and such differences may be material, and that no assurance can be given that any projection will be realized.
137


Section 3.12Federal Reserve Regulations. No part of the proceeds of any Loan have been used or will be used, whether directly or indirectly, for any purpose that entails a violation of any of the Regulations of the Board, including Regulation T, U or X.
Section 3.13Security Interest in Collateral. To the extent the U.S. Security Agreement has been executed and delivered by the parties thereto and is then in effect, the U.S. Security Agreement will create in favor of the Collateral Agent, for the benefit of the Secured Parties, a valid and enforceable security interest in the Collateral covered thereby and (i) when the Collateral constituting certificated securities (as defined in the UCC) is delivered to the Collateral Agent, together with instruments of transfer duly endorsed in blank, the Liens under the U.S. Security Agreement will constitute a fully perfected security interest in all right, title and interest of the pledgors thereunder in such Collateral, prior and superior in right to any other Person, (ii) when a copyright security agreement is executed and delivered to the Collateral Agent and recorded with the U.S. Copyright Office, (iii) when a trademark security agreement or a patent security agreement is executed and delivered to the Collateral Agent and recorded with the U.S. Patent and Trademark Office, and (iv) (x) when financing statements in appropriate form are filed in the applicable filing offices and (y) to the extent applicable, when the registration of particulars of the U.S. Security Agreement at the Companies Registration Office of Ireland under section 409 of the Companies Act and payment of associated fees have been made and paid, the security interest created under the U.S. Security Agreement will constitute a fully perfected or recorded security interest in all right, title and interest of the Loan Parties in the remaining Collateral covered by the U.S. Security Agreement to the extent perfection can be obtained by filing UCC financing statements or filings with the U.S. Copyright Office or the U.S. Patent and Trademark Office, prior and superior to the rights of any other Person, except for (x) Permitted Liens and (y) certain items of Collateral located in or otherwise subject to foreign law where the grant of a Lien or priority and perfection thereof in accordance with the UCC may not be recognized or enforceable. For the avoidance of doubt, no Loan Party shall be required to take any action other than pursuant to the UCC or recordation with the U.S. Patent and Trademark Office or U.S. Copyright Office, as applicable, to perfect or record any security interest in Collateral constituting intellectual property (including the execution of any agreement, document or other instrument governed by the law of any jurisdiction other than the United States, any State thereof or the District of Columbia). As to any Collateral, the representations and the warranties with respect thereto contained in the relevant Collateral Documents shall be true and correct in all material respects.
Section 3.14Solvency. On the Closing Date immediately after the consummation of the Transactions, Holdings and its Subsidiaries, on a consolidated basis, are Solvent.
Section 3.15Compliance with Anti-Corruption Laws and Sanctions. Neither Holdings nor any of its Restricted Subsidiaries or, to the knowledge of Holdings and the Borrowers, any of their respective Affiliates over which any of the foregoing exercises management control (each, a “Controlled Affiliate”): (i) is the target of Sanctions; (ii) is owned or controlled by, or acts on behalf of, any Person that is the target of Sanctions; (iii) is a Sanctioned Person; (iv) is operating from, organized or resident in a Sanctioned Country; or (v) to their knowledge, has violated Anti-Corruption Laws or Sanctions in the past five years. Holdings, its Restricted Subsidiaries and their respective Controlled Affiliates will maintain in effect and enforce policies and procedures reasonably designed to promote and ensure compliance by Holding, its Restricted Subsidiaries, their respective Controlled Affiliates, and each of their respective directors, officers, employees and agents with Anti-Corruption Laws and Sanctions. Holdings will not, directly or knowingly, indirectly, use the proceeds of the Loans or Letters of Credit, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, (i) to fund any activities or business of or with a Sanctioned Person or in a Sanctioned Country or (ii) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the Loans or Letters of Credit, whether as Administrative Agent, arranger, Issuing
138


Bank, Lender, underwriter, advisor, investor, or otherwise). No part of the proceeds of the Loans or Letters of Credit will be used, directly or, knowingly, indirectly, for any payments to any person, including any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of Anti-Corruption Laws, including the United States Foreign Corrupt Practices Act of 1977, as amended.
Section 3.16No Irish Financial Assistance. None of the proceeds of the Term Loans made on the Closing Date and the financing which is the subject matter of the Loan Documents has been used, is being used or will be used at any time in any way which would constitute unlawful “financial assistance” within the meaning of, and as prohibited by, Section 82 of the Companies Act (as from time to time amended, replaced or re-enacted, “Section 82”) or which would result in the Loan Documents or the transactions thereby recorded (including without limitation any guarantees and indemnities thereby created) contravening Section 82.
Section 3.17Luxembourg Matters. Each Luxembourg Loan Party is in compliance with all requirements of the Luxembourg legislation and regulations on the domiciliation of companies, and in particular with the Luxembourg Act dated May 31, 1999 on the domiciliation of companies, as amended from time to time, except where failure to comply with any such requirement could not reasonably be expected to result in a Material Adverse Effect. No Luxembourg Loan Party is subject to bankruptcy (faillite), general settlement or composition with creditors (concordat préventif de faillite) controlled management (gestion contrôlée), reprieve from payment (sursis de paiement), judicial or voluntary liquidation (liquidation judiciaire ou volontaire), such other proceedings listed at Articles 13, items 2 to 12, and 14 of the Luxembourg Act dated December 19, 2002 on the Register of Commerce and Companies, on Accounting and on Annual Accounts of the Companies (as amended from time to time) (and which include foreign court decisions as to faillite, concordat or analogous procedures according to Council Regulation (EC) N° 2015/848 of May 20, 2015 on insolvency proceedings as amended (the “Insolvency Regulation”)). No Luxembourg Loan Party is in a state of cessation of payments (cessation de paiements) and no Luxembourg Loan Party has lost its creditworthiness. No application has been made by any Luxembourg Loan Party or, as far as it is aware, by any other person for the appointment of a commissaire, juge commissaire, liquidateur, curateur or similar officer pursuant to any insolvency or similar proceedings. No application has been made by any Luxembourg Loan Party for a voluntary or judicial winding up or liquidation. The head office (administration centrale), the place of effective management (siège de direction effective) and (for the purposes of the Insolvency Regulation) the center of main interests (centre des intérets principaux) of each Luxembourg Loan Party in Luxembourg is located at the place of its registered office (siège statutaire) in Luxembourg and it has no “establishment” (as that term is used in Article 2(10) of the Insolvency Regulation) in any other jurisdiction. In addition, each Luxembourg Loan Party is in compliance with any reporting requirements applicable to it pursuant to the Central Bank of Luxembourg regulation 2011/8 (as amended by regulation 2014/17) or the Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties (CCPs) and trade repositories (TRs), as amended, except where the failure to do so, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect.
Section 3.18PATRIOT Act, etc.     To the extent applicable, each Loan Party is in compliance, in all material respects, with (i) The Trading with the Enemy Act, 50 U.S.C. §§ 1701 et seq., as amended, and each of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended) and any other enabling legislation or executive order relating thereto, and (ii) the PATRIOT Act.
139


Article IV

Conditions
Section 3.01Conditions Precedent to the Closing Date. The obligations of the Lenders to extend Loans in respect of the Commitments on the date of the first Borrowing hereunder are subject to the satisfaction of the following conditions precedent, subject to the next to last paragraph of this Section 4.01:
(a)Execution. The Administrative Agent (or its counsel) shall have received (i) this Agreement, executed and delivered by a duly authorized officer of Holdings, each Borrower and each Guarantor, (ii) the U.S. Security Agreement, executed and delivered by a duly authorized officer of the U.S. Borrower and each Guarantor organized in the United States and (iii) each of the Foreign Security Documents, executed and delivered by a duly authorized officer of the Borrowers or Holdings (as appropriate).
(b)Organizational Documents and Necessary Consents. The Administrative Agent shall have received (i) a copy of the certificate of incorporation, memorandum of association or articles of incorporation and all applicable, if any, certificates of incorporation on a change of name or certificates of re-registration or other formation documents, including all amendments thereto, of each Loan Party as of the Closing Date, certified as of a recent date by the Secretary of State of the state of its organization in the case of a corporation incorporated in the United States, and (a certificate as to or of compliance evidencing the good standing of each such Loan Party as of a recent date, from such Secretary of State in the case of a corporation incorporated in the United States; (ii) a certificate of the secretary or assistant secretary or director of each Loan Party as of the Closing Date dated the Closing Date and certifying (A) that attached thereto is a true and complete copy of the by-laws (or similar governing documentation) of such Loan Party as in effect on the Closing Date and at all times since a date prior to the date of the resolutions described in clause (B) below, (B) that attached thereto is a true and complete copy of resolutions duly adopted by the board of directors or similar governing body of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such Person is a party, (in the case of each Borrower) the borrowings hereunder, (in the case of each such Loan Party) the granting of the Liens contemplated to be granted by it under the Collateral Documents and (in the case of each Guarantor) the Guaranteeing of the Secured Obligations as contemplated by this Agreement, the Collateral Documents and other Loan Documents, and that such resolutions have not been modified, rescinded or amended and are in full force and effect, (C) if applicable, that the certificate or articles of incorporation or other formation documents of such Loan Party have not been amended since the date of the last amendment thereto shown on the certificate of good standing furnished pursuant to clause (i) above or where a certificate of good standing is not applicable in its jurisdiction of incorporation that attach a true, up to date and correct copy of the certificate or articles of incorporation or other formation documents of each Loan Party duly certified as being true, up to date and correct and (D) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document delivered in connection herewith on behalf of such Loan Party; and (iii) a certificate of another officer as to the incumbency and specimen signature of the secretary or assistant secretary (or manager or director, if applicable) executing the certificate pursuant to clause (ii) above.
(c)KYC. To the extent requested at least 10 business days prior to the Closing Date, the Lenders shall have received all documentation and other information required by bank regulatory authorities under applicable “know-your-customer” and anti-money laundering rules and regulations, including the Patriot Act and, if applicable, the requirements of 31 C.F.R. § 1010.230, at least three business days prior to the Closing Date.
(d)Additional Requirements for Foreign Subsidiary Guarantors.
140


(i)The Administrative Agent shall have received, in respect of each Luxembourg Loan Party, a manager’s certificate in a form satisfactory to the Administrative Agent, dated as of the Closing Date and signed by a manager of each such Luxembourg Loan Party, certifying, inter alia, the following items:
(A)a true, correct, complete and up-to-date copy of its articles of association;
(B)a true, correct, complete and up-to-date copy of the resolutions of the board of managers of each Luxembourg Loan Party approving, inter alia, its entry into the Loan Documents to which it is a party;
(C)a true, correct, complete and up-to-date copy of an excerpt of the Luxembourg Companies Register dated on the Closing Date or at the earliest one (1) Business Day before the Closing Date;
(D)a true, correct, complete and up-to-date copy of a certified true certificate of non-registration of judgments (certificat de non-inscription d’une décision judiciaire) dated on the Closing Date or at the earliest one (1) Business Day before the Closing Date, issued by the Luxembourg Companies Register;
(E)a true, correct, complete and up-to-date copy of the specimen signatures of all authorized signatories;
(F)each Luxembourg Loan Party complies with, and adheres to, the provisions applicable to it of the Luxembourg Law dated May 31, 1999 concerning the domiciliation of companies, as amended and the relevant regulations;
(G)the entry by such Luxembourg Loan Party into the Loan Documents to which it is a party would not cause any borrowing, guaranteeing, security or similar limit binding on such Luxembourg Loan Party to be exceeded; and
(H)each copy document relating to it specified in the manager’s certificate is correct, complete and in full force and effect and has not been amended or superseded as at a date no earlier than the Closing Date.
(ii)The Administrative Agent shall have received, in respect of each Guarantor organized under the laws of Ireland, a director’s certificate in a form satisfactory to the Administrative Agent, dated as of the Closing Date and signed by a director or secretary of such Guarantor, certifying, inter alia, the following items
(A)that the entry by such Guarantor into the Loan Documents would:
(1)not cause any borrowing, guaranteeing, security or similar limit binding on such Guarantor to be exceeded;
(2)not constitute unlawful financial assistance for the purposes of Section 82; and
141


(3)not be prohibited by Section 239 of the Companies Act;
(B)a true, correct and up-to-date list of the present directors and secretary of such Guarantor;
(C)that neither the Guarantor nor any of its directors or secretaries, is a company or a person to whom either Chapter 3 (Restriction on directors of insolvent companies) or Chapter 4 (Disqualification generally) or Chapter 5 (Disqualification and restriction undertakings) of Part 14 of the Companies Act 2014 applies; and
(D)each copy document relating to it specified in the director’s certificate is correct, complete and in full force and effect and has not been amended or superseded as at a date no earlier than the date of this Agreement.
(e)Opinions of Counsel. The Administrative Agent shall have received, on behalf of itself, the Collateral Agent, the Lead Arrangers and the Lenders, (i) a written opinion of Cahill Gordon & Reindel LLP, New York counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (ii) a capacity and authority opinion of A&L Goodbody LLP, Irish counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (iii) an enforceability opinion of Matheson, Irish counsel for the Lead Arrangers, the Administrative Agent and the Lenders, in form and substance reasonably acceptable to the Administrative Agent, (iv) a capacity and authority opinion of Loyens & Loeff Luxembourg S.à r.l., Luxembourg counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, (v) an enforceability opinion of NautaDutilh Avocats Luxembourg S.à r.l., Luxembourg counsel for the Lead Arrangers, the Administrative Agent and the Lenders, in form and substance reasonably acceptable to the Administrative Agent, and (vi) a written opinion of McGuire Woods LLP, Virginia counsel for the Loan Parties, in form and substance reasonably acceptable to the Administrative Agent, in each case (A) dated the Closing Date, (B) addressed to the Administrative Agent, the Collateral Agent, the Lead Arrangers, the Lenders and the Issuing Banks, and, in each case, each of their permitted assigns, and (C) each Borrower and each other Loan Party and the Administrative Agent hereby request such counsel to deliver such opinions.
(f)Specified Representations. The Specified Representations shall be true and correct in all material respects on the Closing Date.
(g)Acquisition Agreement Representations. The Acquisition Agreement Representations shall be true and correct in all material respects on the Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case representations and warranties shall be true and correct in all material respects as of such earlier date), but only to the extent that Holdings (or its applicable subsidiaries) have the right (taking into account any applicable cure periods) to terminate its obligation to consummate the Acquisition under the Acquisition Agreement or the right not to consummate the Acquisition pursuant to the Acquisition Agreement as a result of a breach of such representations and warranties, in each case, in accordance with the terms thereof.
(h)Acquisition. The Acquisition shall have been consummated, or substantially simultaneously with the Borrowing of the Loans hereunder shall be consummated, in accordance with the Acquisition Agreement in all material respects.
142


(i)No Company Material Adverse Effect. Except (a) as disclosed in the Company SEC Documents (as defined in the Acquisition Agreement as in effect on February 24, 2021) prior to the date of the Acquisition Agreement (other than any disclosures contained or referenced therein under the captions “Risk Factors,” “Forward-Looking Statements,” “Quantitative and Qualitative Disclosures About Market Risk,” and any other disclosures contained or referenced therein of information, factors or risks to the extent they are predictive, cautionary, or forward-looking in nature) or (b) as set forth in the Company Disclosure Letter (as defined in the Acquisition Agreement as in effect on February 24, 2021), since the date of the Company Balance Sheet (as defined in the Acquisition Agreement as in effect on the February 24, 2021) there has not been or occurred any Company Material Adverse Effect (as defined in the Acquisition Agreement as in effect February 24, 2021).
(j)Solvency Certificate. The Administrative Agent shall have received a certificate of Holdings, signed by a director or senior financial officer of Holdings, in substantially the form attached hereto as Exhibit C, attesting to the solvency of Holdings and its Subsidiaries (including the Borrowers and their respective Subsidiaries), taken as a whole, after giving effect to the proposed Transactions on the Closing Date.
(k)Fees. To the extent invoiced at least three (3) Business Days prior to the Closing Date (except as otherwise agreed by the Borrowers), all costs, fees, expenses (including, without limitation, legal fees and expenses) and other compensation payable to each Lead Arranger, each Agent and the Lenders pursuant to any written agreement among any such parties and Holdings, shall have been paid to the extent due.
(l)Refinancing. The Refinancing shall have been consummated, or substantially simultaneously with the Borrowing of the Loans hereunder shall be consummated.
(m)Financial Statements. The Administrative Agent shall have received unaudited consolidated financial statements of the Target and its subsidiaries for the fiscal quarter ended March 31, 2021; provided that the filing of the required financial statements on form 10-Q by the Target will satisfy the foregoing requirements.
(n)Notice of Borrowing. A Borrowing Request shall have been delivered in accordance with the terms of Section 2.03.
(o)Collateral. The Administrative Agent (or its counsel) shall have received (i) certificates evidencing Equity Interests of wholly-owned Domestic Subsidiaries that are Material Subsidiaries of Holdings (to the extent available to Holdings) and the Target and its Domestic Subsidiaries (in the case of the Target and its Domestic Subsidiaries, to the extent delivered to Holdings by the Target prior to the Closing Date), to the extent certificated and required to be pledged as set out in the Loan Documents, and (ii) copies of UCC financing statements for entities organized in the United States.
Notwithstanding anything in this Agreement to the contrary, it is understood that only Holdings, the Borrowers and the other Loan Parties organized under the laws of the United States shall be required to provide guarantees and Collateral (subject to the terms set forth in this paragraph) on the Closing Date and the other Loan Parties may instead provide guarantees and Collateral within forty-five (45) Business Days after the Closing Date (subject to extensions to be reasonably agreed upon by the Administrative Agent), and to the extent any Collateral (including the grant or perfection of any security interest, other than (x) the delivery of certificates evidencing Equity Interests of wholly-owned Domestic Subsidiaries that are Material Subsidiaries of Holdings (to the extent available to Holdings) and the Target and its Domestic Subsidiaries (in the case of the Target and its Domestic Subsidiaries, to the extent delivered to Holdings by the Target prior to the Closing Date), to the extent certificated and required to be pledged as set out in
143


the Loan Documents, and (y) any Collateral the security interest in which may be perfected by the filing of a UCC financing statement for entities organized in the United States) is not or cannot reasonably be provided on the Closing Date after Holdings’ use of commercially reasonable efforts to do so or without undue burden or expense, then the provision of such collateral and perfection therein shall not constitute a condition precedent to the availability of the Loans on the Closing Date, but may instead be provided or perfected within ninety (90) days after the Closing Date (in each case, subject to extensions to be reasonably agreed upon by the Administrative Agent).
Without limiting the generality of the provisions of Section 9.03(b), for purposes of determining compliance with the conditions specified in this Section 4.01, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or the be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Closing Date specifying its objection thereto.
Section 3.02Each Credit Event after the Closing Date. Subject to Section 1.07(f), the obligation of each Lender to make a Loan on the occasion of any Borrowing, and of any Issuing Bank to issue, amend, renew or extend any Letter of Credit, after the Closing Date is subject to the satisfaction of the following conditions:
(a)Except as set forth in Section 2.20(d) with respect to Incremental Loans used to finance a Limited Condition Transaction, the representations and warranties of Holdings, each Borrower and their respective Restricted Subsidiaries set forth in this Agreement shall be true and correct in all material respects (or, if qualified as to “materiality” or “Material Adverse Effect”, in all respects) on and as of the date of such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable, except in the case of any such representation and warranty that expressly relates to an earlier date, in which case such representation and warranty shall be true and correct in all material respects (or, if qualified by materiality or “Material Adverse Effect”, in all respects) as of such earlier date.
(b)Except as set forth in Section 2.20(d) with respect to Incremental Loans used to finance a Limited Condition Transaction, at the time of and immediately after giving effect to such Borrowing or the date of issuance, amendment, renewal or extension of such Letter of Credit, as applicable, no Default or Event of Default shall have occurred and be continuing.
(c)A Borrowing Request shall have been delivered in accordance with the terms of Section 2.03 or a Letter of Credit application in accordance with the terms of Section 2.06(b).
Each Borrowing and each issuance, amendment, renewal or extension of a Letter of Credit shall be deemed to constitute a representation and warranty by the Applicable Borrower on the date thereof as to the matters specified in paragraphs (a) and (b) of this Section 4.02.
Article V

Affirmative Covenants
From the Closing Date until the Commitments have expired or been terminated and the principal of and interest on each Loan and all fees payable hereunder shall have been paid in full, and all Letters of Credit shall have expired, terminated or been Cash Collateralized and all LC Disbursements shall have been reimbursed, the Loan Parties covenant and agree with the Lenders that:
144


Section 3.01Financial Statements and Other Information. Holdings will furnish to the Administrative Agent, on behalf of each Lender:
(a)within one hundred twenty (120) days after the end of each fiscal year of Holdings, an audited consolidated balance sheet and related statements of operations, shareholders’ equity and cash flows for Holdings and its consolidated Subsidiaries as of the end of and for such year, setting forth in each case in comparative form the figures for the previous fiscal year (if any), with such audited balance sheet and related consolidated financial statements audited by KPMG LLP or other independent public accountants of recognized national standing (without a “going concern” or like qualification or exception and without any qualification or exception as to the scope of such audit, except to the extent solely due to the scheduled occurrence of a Maturity Date within one year from the date of such audit or failure to comply with Section 6.12) to the effect that such consolidated financial statements present fairly in all material respects the financial condition and results of operations of Holdings and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied;
(b)within sixty (60) days after the end of each of the first three fiscal quarters of each fiscal year of Holdings, a consolidated balance sheet and related statements of operations and cash flows for Holdings and its consolidated Subsidiaries as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of the end of) the previous fiscal year, all certified by one of its Financial Officers as presenting fairly in all material respects the financial condition and results of operations of Holdings and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes;
(c)within five (5) Business Days after any delivery of financial statements under clause (a) or (b) above, a certificate (a “Compliance Certificate”) of a Financial Officer of Holdings (1) certifying as to whether a Default has occurred and, if a Default has occurred, specifying the details thereof and any action taken or proposed to be taken with respect thereto, (2) commencing with the certificate delivered pursuant to clause (b) above for the first full fiscal quarter ending after the Closing Date setting forth (i) a calculation of the Total Net Leverage Ratio as of the last day of the most recent Test Period (ii) a calculation of the First Lien Net Leverage Ratio as of the last day of the most recent Test Period and (iii) a calculation of the Secured Net Leverage Ratio as of the last day of the most recent Test Period and (3) solely in the case of Compliance Certificates accompanying financial statements referred to in clause (a) above, (i) confirming whether the Guarantor Coverage Test is satisfied and setting forth computations thereof in reasonable detail and (ii) setting forth a calculation of Excess Cash Flow with respect to such fiscal year;
(d)for any period for which the Unrestricted Subsidiaries, taken together, are reasonably anticipated to have had revenues or total assets in an amount that is equal to or greater than 10% of the consolidated revenues or total assets, as applicable, of Holdings and its Restricted Subsidiaries, concurrently with the delivery of each set of consolidated financial statements referred to in Sections 5.01(a) and 5.01(b) above, if applicable, the related consolidating financial statements reflecting the adjustments necessary to eliminate the accounts of such Unrestricted Subsidiaries from such consolidated financial statements;
(e)promptly after any request therefor, such other information regarding the operations, business affairs and financial condition of Holdings or any Restricted Subsidiary, or compliance with the terms of any Loan Document, as may be reasonably requested by the Administrative Agent or by any Lender through the Administrative Agent;
145


(f)concurrently with the delivery of the certificate of a Financial Officer of Holdings under clause (c) above with respect to financial statements delivered pursuant to clause (a) above, a Perfection Certificate Supplement reflecting all changes since the Closing Date or the date of the information most recently received pursuant to this Section 5.01(f), as applicable (or, if there have been no changes to any such schedules since the Closing Date or the previous update required hereby, as applicable, a certification of a Financial Officer of Holdings (which may, at the option of Holdings, be included in the Compliance Certificate) as to the absence of any changes);
(g)concurrently with the delivery of each set of consolidated financial statements referred to in Sections 5.01(a) and 5.01(b) above, the related customary management discussion and analysis; and
(h)within five (5) Business Days of receipt of notice thereof by Holdings, written notice of any announcement by S&P of a change in Holdings’ corporate credit rating.
In no event shall the requirements set forth in this Section 5.01 require Holdings, the Borrowers or any of their Restricted Subsidiaries to provide any such information (i) which constitutes non-financial trade secrets or non-financial proprietary information, (ii) in respect of which disclosure to the Administrative Agent or any Lender (or their respective representatives or contractors) is prohibited by Law or (iii) which is subject to attorney-client or similar privilege or constitutes attorney work-product; provided that Holdings or a Restricted Subsidiary shall provide notice to the Administrative Agent that information has not been provided pursuant to this paragraph to the extent permitted by Law and not in contravention of such privilege.
Information required to be delivered pursuant to Sections 5.01(a), 5.01(b) and 5.01(f) shall be deemed to have been delivered if such information, or one or more annual, quarterly or other periodic reports containing such information, shall have been posted by the Administrative Agent on an IntraLinks or similar site to which the Lenders have been granted access or be available on the website of the SEC at http://www.sec.gov; provided that, for the avoidance of doubt, Holdings shall be required to provide copies of the Compliance Certificate. Information required to be delivered pursuant to this Section 5.01 may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent. In the event any financial statements delivered under clause (a) or (b) above shall be restated, the Borrowers shall deliver, promptly after such restated financial statements become available, revised Compliance Certificates with respect to the periods covered thereby that give effect to such restatement, signed by a Financial Officer of Holdings.
Holdings and each Borrower hereby acknowledges that (a) the Administrative Agent and the Lead Arrangers will make available to the Lenders materials and/or information provided by or on behalf of Holdings and the Borrowers hereunder (collectively, “Borrower Materials”) by posting the Borrower Materials on IntraLinks or another similar electronic system (the “Platform”) and (b) certain of the Lenders (each, a “Public Lender”) may have personnel who do not wish to receive material non-public information with respect to Holdings, the Borrowers or their respective Subsidiaries, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with respect to such Persons’ securities. Holdings and each Borrower hereby agrees that (w) all Borrower Materials that are to be made available to Public Lenders (other than materials made available on the website of the SEC) shall be clearly and conspicuously marked “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof; (x) by marking Borrower Materials “PUBLIC,” Holdings and each Borrower shall be deemed to have authorized the Administrative Agent, the Lead Arrangers and the Lenders to treat the Borrower Materials as not containing any material non-public information with respect to Holdings, each Borrower or their respective securities for purposes of United States Federal and state securities laws (provided, however, that
146


to the extent the Borrower Materials constitute Information, they shall be treated as set forth in Section 9.12); (y) all Borrower Materials marked “PUBLIC” are permitted to be made available through a portion of the Platform designated “Public Side Information”; and (z) the Administrative Agent and the Lead Arrangers shall be entitled to treat any Borrower Materials that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not designated “Public Side Information”.
Section 3.02Notices of Material Events. Holdings and each Restricted Subsidiary will, upon knowledge thereof by a Responsible Officer, furnish to the Administrative Agent prompt written notice of the following:
(a)the occurrence of any Default;
(b)the filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or affecting Holdings, Borrower or any Subsidiary or Affiliate thereof that could reasonably be expected to result in a Material Adverse Effect;
(c)the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect; or
(d)(i) any contribution required to be made with respect to a Non-U.S. Plan has not been timely made or (ii) Holdings or any Subsidiary has incurred any obligation in connection with the termination of, or withdrawal from, any Non-U.S. Plan, in each case, to the extent that such event could reasonably be expected to result in a Material Adverse Effect.
Each notice delivered under this Section 5.02 shall be accompanied by a statement of a Responsible Officer of Holdings setting forth the details of the event or development requiring such notice and any action taken or proposed to be taken with respect thereto. Information required to be delivered pursuant to clause (b) of this Section 5.02 shall be deemed to have been delivered if such information, or one or more annual or quarterly or other periodic reports containing such information, shall have been posted by the Administrative Agent on an IntraLinks or similar site to which the Lenders have been granted access or shall be available on the website of the SEC at http://www.sec.gov. Information required to be delivered pursuant to this Section 5.02 may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.
Section 3.03Existence; Conduct of Business. Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence and the rights, qualifications, licenses, permits, privileges, franchises, governmental authorizations and intellectual property rights material to the conduct of its business, and maintain all requisite authority to conduct its business in each jurisdiction in which its business is conducted; provided that (i) the foregoing shall not prohibit any Disposition, merger, amalgamation, consolidation, liquidation or dissolution permitted under Section 6.03 or Section 6.11 and (ii) neither Holdings nor any of its Material Subsidiaries shall be required to preserve any right, license, permit, privilege, franchise, patent, copyright, trademark, trade name or other intellectual property rights which in the reasonable good faith determination of Holdings are not useful or material to the conduct of the business of Holdings or its Material Subsidiaries, taken as a whole.
Section 3.04Payment of Obligations. Holdings and the Borrowers will, and will cause each of their Restricted Subsidiaries to, pay, discharge or otherwise satisfy, as the same shall become due and payable, all of their obligations and liabilities, including Tax liabilities,
147


except where (a) the validity or amount thereof is being contested in good faith by appropriate proceedings diligently conducted and Holdings, the Borrowers or such Restricted Subsidiary has set aside on its books adequate reserves with respect thereto in accordance with, and to the extent required by, applicable accounting principles or (b) the failure to do so could not reasonably be expected to result in a Material Adverse Effect.
Section 3.05Maintenance of Properties; Insurance. Holdings will, and will cause each of the Material Subsidiaries to, (a) keep and maintain all tangible property material to the conduct of its business in good working order and condition, ordinary wear and tear excepted, and (b) maintain with financially sound and reputable carriers (i) insurance in such amounts (with no greater risk retention) and against such risks and such other hazards, as is customarily maintained by companies of established repute engaged in the same or similar businesses operating in the same or similar locations and (ii) all insurance required pursuant to the Collateral Documents. Holdings and the Borrowers will furnish to the Lenders, upon request of the Administrative Agent, information in reasonable detail as to the insurance so maintained. Holdings and the Borrowers shall, within 90 days following the Closing Date (or such later date to which the Administrative Agent consents, such consent not to be unreasonably withheld or delayed) deliver to the Administrative Agent and the Collateral Agent endorsements (x) to all “All Risk” physical damage insurance policies on all of the Loan Parties’ tangible personal property and assets located in the United States of America naming the Collateral Agent as lender loss payee, and (y) to all general liability policies naming the Administrative Agent and the Collateral Agent an additional insured. In the event Holdings, the Borrowers or any of their respective Material Subsidiaries at any time or times hereafter shall fail to obtain or maintain any of the policies or insurance required herein or to pay any premium in whole or in part relating thereto, then the Administrative Agent, without waiving or releasing any obligations or resulting Default hereunder, may at any time or times thereafter (but shall be under no obligation to do so) obtain and maintain such policies of insurance and pay such premiums and take any other action with respect thereto which the Administrative Agent deems advisable. All sums so disbursed by the Administrative Agent shall constitute part of the Obligations, payable as provided in this Agreement.
Section 3.06Books and Records; Inspection Rights. Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, keep proper books of record and account in which full, true and correct entries in conformity with GAAP and applicable law are made of all material financial dealings and transactions in relation to its business and activities. Holdings and the Borrowers will, and will cause each of their respective Material Subsidiaries to, permit any representatives designated by the Administrative Agent (pursuant to a request made through the Administrative Agent), at reasonable times upon reasonable prior notice (but not more than once annually if no Event of Default shall exist), to visit and inspect its properties, to examine and make extracts from its books and records, including examination of its existing assessment reports and Phase I or Phase II studies, and to discuss its affairs, finances and condition with its officers and independent accountants, all at such reasonable times and as often as reasonably requested. Holdings and the Borrowers acknowledge that the Administrative Agent, after exercising its rights of inspection, may prepare and distribute to the Lenders certain reports pertaining to Holdings and its Material Subsidiaries’ assets for internal use by the Administrative Agent and the Lenders.
Section 3.07Compliance with Laws . Holdings and the Borrowers will, and will cause each of their respective Subsidiaries to, (i) comply with all laws, rules, regulations and orders of any Governmental Authority applicable to it or its property (including without limitation, Benefit Plan Laws and Environmental Laws); (ii) complete any investigation, study, sampling and testing and undertake any clean up, removal, remediation or other response necessary to remove and clean up any Release of Hazardous Materials, to the extent required under Environmental Laws; and (iii) respond to any action, suit or proceeding asserting any
148


Environmental Liability against Holdings, the Borrowers and each of their respective Subsidiaries, except, in each case of clause (i)-(iii), where the failure to do so, either individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.
Section 3.08Use of Proceeds. The Borrowers shall use the proceeds of (i) the Term Loans, together with the proceeds of the New Notes and available cash, to finance the Transactions and the Refinancing and to pay any related fees and expenses and (ii) the Revolving Loans and the Letters of Credit for any purpose not otherwise prohibited under this Agreement, including for general corporate purposes, working capital needs, the repayment of Indebtedness, the making of Restricted Payments and the making of Investments.
Section 3.09Subsidiary Guarantors; Pledges; Additional Collateral; Further Assurances; Guarantor Coverage Test.
(a)Within the time periods specified in Section 5.09(e) below, as applicable, after any Person becomes a Restricted Subsidiary that is not an Excluded Subsidiary or any Excluded Subsidiary that is not an Unrestricted Subsidiary ceases to be an Excluded Subsidiary (in each case, solely if such Person or Subsidiary is organized in any Covered Jurisdiction) (including by qualifying independently as, or being designated by the Borrowers as, a Material Subsidiary, which in the case of a qualification shall be the date on which financial statements have been delivered pursuant to Section 5.01 that demonstrate such qualification) or is required to become a Guarantor pursuant to Section 5.09(f) (in each case, a “New Loan Party”), Holdings and the Borrowers shall (subject to the Agreed Guarantee and Security Principles, in the case of any Foreign Subsidiary) cause each such New Loan Party to deliver to the Administrative Agent and the Collateral Agent a Joinder Agreement and a supplement to (i) in the case of a Domestic Subsidiary, the U.S. Security Agreement and (ii) each other applicable Collateral Document (in each case in the form contemplated thereby and modified as required in order to comply with local laws in accordance with the Agreed Guarantee and Security Principles, if applicable) pursuant to which such Subsidiary agrees to be bound by the terms and provisions of this Agreement, the U.S. Security Agreement (if applicable) and other applicable Collateral Document, to be accompanied by appropriate corporate resolutions, other corporate documentation and legal opinions as may be reasonably requested by, and in form and substance reasonably satisfactory to, the Administrative Agent, the Collateral Agent and their counsel.
(b)(i) Subject to the Agreed Guarantee and Security Principles (where applicable) and Section 5.09(e), Holdings will cause, and will cause each other Loan Party to cause, all of its owned property (whether personal, tangible, intangible, or mixed but excluding Excluded Assets) to be subject at all times to perfected Liens in favor of the Collateral Agent for the benefit of the Secured Parties to secure the Secured Obligations in accordance with the terms and conditions of the Collateral Documents on a first priority basis, subject to no other Liens other than Permitted Liens and (ii) without limiting the generality of the foregoing, and subject to the Agreed Guarantee and Security Principles (where applicable) and Section 5.09(e), Holdings will cause the issued and outstanding Equity Interests of each Subsidiary directly owned by Holdings or any other Loan Party (other than Excluded Assets) to be subject at all times to a first priority (subject to Permitted Liens), perfected Lien in favor of the Collateral Agent to secure the Secured Obligations in accordance with the terms and conditions of the Collateral Documents or such other pledge and security documents as the Administrative Agent or Collateral Agent shall reasonably request.
(c)Without limiting the foregoing, but subject to the Agreed Guarantee and Security Principles and Section 5.09(e), Holdings will, and will cause each other Loan Party to, execute and deliver, or cause to be executed and delivered, to the Collateral Agent such documents, agreements and instruments, and will take or cause to be taken such further actions (including the filing and recording of financing statements, fixture filings, deeds of trust and other
149


documents and such other actions or deliveries of the type required by Section 4.01, as applicable), which may be required by law or which the Administrative Agent or the Collateral Agent may, from time to time, reasonably request to carry out the terms and conditions of this Agreement and the other Loan Documents and to ensure perfection and priority of the Liens created or intended to be created by the Collateral Documents, all at the expense of Holdings.
(d)Subject to the Agreed Guarantee and Security Principles and Section 5.09(e), if any assets are acquired by a Loan Party (other than Excluded Assets and assets constituting Collateral that become subject to the Lien in favor of the Collateral Agent upon acquisition thereof), Holdings will notify the Administrative Agent thereof, and, if requested by the Administrative Agent, Holdings will cause such assets to be subjected to a Lien securing the Secured Obligations and will take, and cause the other Loan Parties to take, such actions as shall be necessary or reasonably requested by the Administrative Agent to grant and perfect such Liens, including actions described in paragraph (b) of this Section 5.09, all at the expense of Holdings.
(e)Notwithstanding anything to the contrary herein or in any other Loan Document but subject to clause (f) of this Section 5.09, (i) any deliverables delivered pursuant to this Section 5.09 as of the Closing Date shall be subject to the penultimate paragraph of Section 4.01, (ii) with respect to any property or assets acquired after the Closing Date or with respect to any New Loan Party, the Loan Parties shall have sixty (60) days, or ninety (90) days in the case of the Equity Interests, property or assets of, or actions required to be taken by, any Foreign Subsidiary, after the acquisition thereof or such Person becoming a New Loan Party (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto) to take the actions required by this Section; provided that, in the case of any Equity Interests, property or assets of any Foreign Subsidiary acquired or any Foreign Subsidiary becoming a New Loan Party within ninety (90) days after the Closing Date, the Loan Parties shall have the longer of (A) ninety (90) days after the Closing Date and (B) ninety (90) days after such acquisition or such Person becoming a New Loan Party to take any such actions (or, in each case such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), and (iii) no Loan Party shall have any obligation to (A) enter into control agreements with respect to any security interest or lien in any Deposit Account or Securities Account (in each case, as defined in the UCC) included in the Collateral or provide fixed security over bank accounts, (B) perfect any security interest or lien in any intellectual property included in the Collateral in any jurisdiction other than in the United States, and solely with respect to Material Intellectual Property, Ireland or Luxembourg, (C) to obtain any landlord waivers, estoppels or collateral access letters, (D) perfect a security interest in any letter of credit rights, other than the filing of a UCC financing statement, (E) pledge Equity Interests of any partnership, joint venture or non-wholly-owned Subsidiary which are not permitted to be pledged pursuant to the terms of such partnership’s, joint venture’s or non-wholly-owned Subsidiary’s organizational, joint venture or equivalent documents (after giving effect to the applicable anti-assignment provisions of the UCC or other applicable law) and (F) no Loan Party shall be required to enter into any Collateral Documents or take any perfection steps outside of the jurisdiction of organization of such Loan Party (other than in Covered Jurisdictions, including the recordation of patent, trademark and copyright security agreements in the United States Patent and Trademark Office and the United States Copyright Office).
(f)Subject to the proceeding sentence, Holdings shall ensure that the Guarantor Coverage Test is satisfied as of each Guarantor Coverage Test Date. If the Guarantor Coverage Test is not satisfied on any Guarantor Coverage Test Date: (i) Holdings shall ensure that within ninety (90) days after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), such other Restricted Subsidiaries (as Holdings may elect in its sole discretion) shall, subject to and on terms consistent with the Agreed Guarantee and Security Principles, accede as Subsidiary Guarantors to ensure that the Guarantor Coverage Test is satisfied
150


(calculated as if such Subsidiary Guarantors had been Subsidiary Guarantors at such Guarantor Coverage Test Date) by executing and delivering to the Collateral Agent (x) a Joinder Agreement substantially in the form of Exhibit D (each a “Joinder Agreement”) and (y) each applicable Collateral Document (or a supplement thereto) (in each case in the form contemplated thereby and modified as required in order to comply with local laws in accordance with the Agreed Guarantee and Security Principles, if applicable) and (ii) if Holdings has satisfied its obligations under clause (i) above within such ninety (90) days after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto), no Default, Event of Default or other breach of the Loan Documents shall arise from failure to satisfy the Guarantor Coverage Test as of such Guarantor Coverage Test Date (and for avoidance of doubt, no Default or Event of Default shall arise prior to such 90th day after such Guarantor Coverage Test Date (or such later date as may be agreed upon by the Administrative Agent in the exercise of its reasonable discretion with respect thereto)).
Section 3.10Designation of Subsidiaries. Holdings may, at any time from and after the Closing Date, designate any Restricted Subsidiary as an Unrestricted Subsidiary or any Unrestricted Subsidiary as a Restricted Subsidiary; provided that (i) immediately before and after such designation, no Event of Default shall have occurred and be continuing, (ii) no Restricted Subsidiary may be designated as an Unrestricted Subsidiary unless such Subsidiary is also an “unrestricted subsidiary” (or similar concept) for purposes of the New Notes, (iii) no Restricted Subsidiary that owns any Material Intellectual Property may be designated as an Unrestricted Subsidiary and (iv) no Restricted Subsidiary may be designated as an Unrestricted Subsidiary if it was previously designated as an Unrestricted Subsidiary pursuant to this Section 5.10. The designation of any Restricted Subsidiary as an Unrestricted Subsidiary after the Closing Date shall constitute an Investment by the applicable Loan Party therein at the date of designation in an amount equal to the fair market value (as determined in good faith by Holdings) of the applicable Loan Party’s (or any of its Restricted Subsidiaries’) investment therein. The designation of any Unrestricted Subsidiary as a Restricted Subsidiary after the Closing Date shall constitute (i) the incurrence at the time of designation of any Indebtedness or Liens of such Subsidiary existing at such time and (ii) a return on any Investment by the applicable Loan Party in Unrestricted Subsidiaries pursuant to the preceding sentence in an amount equal to the fair market value at the date of such designation of such Loan Party’s Investment in such Subsidiary. Notwithstanding the foregoing, no Borrower shall be permitted to be an Unrestricted Subsidiary.
Section 3.11Maintenance of Ratings. Use commercially reasonable efforts to cause the Term Loans and Holdings’ corporate credit and corporate family credit rating to continue to be rated by S&P and Moody’s (but not to maintain a specific rating).
Section 3.12Transactions with Affiliates.
(a)Holdings will not, and will not permit any of its Restricted Subsidiaries to, make any payment to or sell, lease, transfer or otherwise dispose of any of its properties or assets to, or purchase any property or assets from, or enter into or make or amend any transaction, contract, agreement, understanding, loan, or advance with or guarantee for the benefit of, any Affiliate of Holdings (each, an “Affiliate Transaction”) involving aggregate payments or consideration in excess of the greater of $95,000,000 and 8% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination, unless:
(i)such Affiliate Transaction is on terms that are not materially less favorable to Holdings or the relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by Holdings or such Restricted Subsidiary with an unrelated Person (as determined by Holdings in good faith); and
151


(ii)with respect to any Affiliate Transaction or series of related Affiliate Transactions involving aggregate consideration in excess of the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination, Holdings delivers to the Administrative Agent a resolution adopted in good faith by the majority of the Board of Directors of Holdings approving such Affiliate Transaction, together with a certificate signed by a Responsible Officer of Holdings certifying that the Board of Directors of Holdings determined or resolved that such Affiliate Transaction complies with Section 5.12(a)(i).
(b)The following items will not be deemed to be Affiliate Transactions and, therefore, will not be subject to Section 5.12(a):
(i)any employment or consulting agreement, incentive agreement, employee benefit plan, severance agreement, officer or director indemnification agreement or any similar arrangement entered into by Holdings or any of its Restricted Subsidiaries in the ordinary course of business or approved by the Board of Directors of Holdings and payments pursuant thereto;
(ii)transactions between or among (A) Holdings and its Restricted Subsidiaries or (B) one or more Restricted Subsidiaries;
(iii)transactions with any Person that is an Affiliate of Holdings solely because Holdings owns, directly or through a Restricted Subsidiary, an Equity Interest in, or controls, such Person;
(iv)payment of reasonable fees or other reasonable compensation (including bonuses) to, provision of customary benefits or indemnification agreements to, and the reimbursements of expenses (pursuant to indemnity arrangements or otherwise) of officers, directors, employees or consultants of Holdings, any of its Restricted Subsidiaries or any of Holdings’ direct or indirect parent companies;
(v)any capital contribution in, or issuance of Equity Interests (other than Disqualified Equity Interests), of Holdings;
(vi)Restricted Payments (or transfers or issuances that would constitute Restricted Payments but for the exclusions from the definition thereof) that do not violate Section 6.04 hereof and Permitted Investments;
(vii)loans or advances to employees of Holdings, any of its Restricted Subsidiaries or any of Holdings’ direct or indirect parent companies in the ordinary course of business of Holdings or its Restricted Subsidiaries;
(viii)transactions in which Holdings or any Restricted Subsidiary, as the case may be, delivers to the Administrative Agent a letter from an accounting, appraisal or investment banking firm of national standing stating that such transaction meets the requirements of Section 5.12(a);
(ix)transactions with customers, clients, suppliers, or purchasers or sellers of goods or services, in each case in the ordinary course of business and otherwise in compliance with the terms hereof which are fair to Holdings and its Restricted Subsidiaries, in the reasonable determination of the Board of Directors of Holdings or the senior management thereof, or are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party (as determined by the Board of Directors of Holdings or the senior management thereof in good faith);
152


(x)transactions in the ordinary course with (i) Unrestricted Subsidiaries or (ii) joint ventures in which Holdings or a Restricted Subsidiary of Holdings make a loan or other Investments to such joint venture (to the extent any such joint venture is only an Affiliate as a result of Investments by Holdings and its Restricted Subsidiaries in such joint venture) to the extent otherwise permitted under the definition of “Permitted Investments”;
(xi)the granting of registration and other customary rights in connection with the issuance of Equity Interests by Holdings;
(xii)the provision of services to directors or officers of Holdings, any of its Restricted Subsidiaries or any of Holdings’ direct or indirect parent companies of the nature provided by Holdings or any of its Restricted Subsidiaries to customers in the ordinary course of business;
(xiii)any agreement as in effect on the Closing Date or any renewals, events or extensions of any such agreement (so long as such renewals or extensions are not less favorable in any material respect to Holdings or the Restricted Subsidiaries as determined by Holdings in good faith) and the transactions evidenced thereby;
(xiv)the existence of, or the performance by Holdings or any of the Restricted Subsidiaries of its obligations under the terms of, any limited liability company agreement, limited partnership or other organizational documents or stockholders agreement (including any purchase agreement, put option agreements or call option agreements related thereto) to which it is a party as of the Closing Date and any similar agreements which it may enter into thereafter; provided, however, that the existence of, or the performance by Holdings or any Restricted Subsidiary of obligations under any future amendment to any such existing agreement or under any similar agreement entered into after such date shall only be permitted by this clause (xiv) to the extent that the terms of any such amendment or new agreement, taken as a whole, is no less favorable to Holdings and the Restricted Subsidiaries than the agreement in effect on the Closing Date (as determined by the Board of Directors of Holdings or the senior management thereof in good faith);
(xv)[reserved];
(xvi)transactions undertaken in connection with the Transactions;
(xvii)any customary transactions with a Securitization Subsidiary effected as part of a Qualified Securitization Financing;
(xviii)the payment of reasonable out-of-pocket costs and expenses relating to registration rights and indemnities provided to shareholders of Holdings or any direct or indirect parent thereof pursuant to the stockholders agreement or the registration rights agreement entered into on or after the Closing Date in connection therewith;
(xix)transactions (including, for the avoidance of doubt, the entering into of a tax sharing agreement) undertaken in good faith (as certified by a Responsible Officer of a Borrower in an officer’s certificate) for the purposes of improving the consolidated tax efficiency of Holdings and its Subsidiaries and not for the purpose of circumventing any provision of this Agreement;
(xx)repurchases by Holdings of the Term Loans or New Notes to the extent permitted hereunder; and
153


(xxi)Indebtedness permitted under Section 6.01, Liens permitted under Section 6.02, Asset Sales permitted under Section 6.03, Permitted Investments and Restricted Payments permitted under Section 6.04.
Section 3.13Fiscal Periods. With respect to Holdings and its Restricted Subsidiaries, change its fiscal year-end to dates other than December 31.
Section 3.14Anti-Terrorism and Anti-Money Laundering. With respect to Holdings and its Restricted Subsidiaries, directly or indirectly, (i) conduct any business or engage in making or receiving any contribution of funds, goods or services to or for the benefit of any person described in Section 3.18, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order or any other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law (and the Loan Parties shall deliver to the Lenders any certification or other evidence requested from time to time by any Lender in its reasonable discretion, confirming Holdings’ and its Restricted Subsidiaries’ compliance with this Section 5.14).
Section 3.15Post-Closing Schedule. Within the time periods specified on Schedule 5.15 hereto (as each may be extended by the Administrative Agent in its reasonable discretion), provide such Collateral Documents and complete such undertakings as are set forth on Schedule 5.15 hereto.
Article VI

Negative Covenants
From the Closing Date until the Commitments have expired or terminated and the principal of and interest on each Loan and all fees payable hereunder have been paid in full and all Letters of Credit have expired, terminated or been Cash Collateralized and all LC Disbursements shall have been reimbursed, the Loan Parties covenant and agree with the Lenders that:
Section 3.01Indebtedness.
(a)Holdings will not, and will not permit any Restricted Subsidiary to, incur, directly or indirectly, any Indebtedness, and Holdings will not issue any Disqualified Equity Interests and will not permit any of its Restricted Subsidiaries to issue any shares of Preferred Equity (other than the issuance of Preferred Equity by any Restricted Subsidiary to Holdings or another Restricted Subsidiary); provided, however, Holdings will be entitled to incur Indebtedness or issue Disqualified Equity Interests and any Restricted Subsidiary will be entitled to incur Indebtedness or issue Preferred Equity, so long as (i) both before and after giving effect to such incurrence or issuance, no Event of Default shall have occurred and be continuing and (ii) after giving effect to such incurrence or issuance on a Pro Forma Basis (and any Permitted Acquisition or Investment incurred in connection therewith) for the most recently ended Test Period prior to such incurrence or issuance (or, in the event the proceeds thereof are to be used to finance a Limited Condition Transaction (after giving effect to the incurrence of such Indebtedness and any Permitted Acquisition or Investment incurred in connection therewith), on the LCT Test Date), such Indebtedness shall not exceed an unlimited amount so long as (1) in the case of any Indebtedness secured by a Lien on the Collateral that is pari passu with any Lien on the Collateral securing the Obligations, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.00:1.00, (2) in the case of any Indebtedness secured by the Collateral on a junior lien basis relative to the Liens on such Collateral securing the Obligations, the Secured Net Leverage Ratio,
154


determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25:1.00, and (3) in the case of unsecured Indebtedness or Indebtedness that is secured by assets that do not constitute Collateral, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed 5.25:1.00 or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than 2.00:1.00; provided, further, that any such Indebtedness of non-Guarantor Subsidiaries, when combined with all outstanding Indebtedness incurred by non-Guarantor Subsidiaries pursuant to Section 6.01(b)(xi) hereof, shall not exceed, in the aggregate, the greater of (x) $175,000,000 and (y) 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination at any time outstanding; provided, further, that, to the extent such Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured by a Lien on the Collateral that is pari passu with Lien on the Collateral securing the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Indebtedness had been incurred as Incremental Term Loans under Section 2.20.
(b)Notwithstanding Section 6.01(a), Holdings and its Restricted Subsidiaries will be entitled to incur any or all of the following Indebtedness (collectively “Permitted Debt”):
(i)The Secured Obligations (including any Incremental Loans) and any Credit Agreement Refinancing Indebtedness;
(ii)Indebtedness owed to and held by Holdings or a Restricted Subsidiary as permitted under Section 6.04 or as a Permitted Investment; provided, that (x) any subsequent issuance or transfer of any Equity Interest that results in any such Indebtedness being held by a Person other than Holdings or a Restricted Subsidiary and (y) any subsequent transfer of such Indebtedness (other than to Holdings or a Restricted Subsidiary) shall be deemed, in each case, to constitute the incurrence of such Indebtedness by the obligor thereon that was not permitted by this clause (ii);
(iii)Indebtedness of Holdings to any Restricted Subsidiary and of any Restricted Subsidiary to Holdings or any other Restricted Subsidiary (including, without limitation, to consummate the Transactions (including, without limitation, the Acquisition)); provided that any Indebtedness owing by any Loan Party to a Restricted Subsidiary which is not a Loan Party shall be subordinated in right of payment to the Secured Obligations pursuant to the Intercompany Subordination Agreement or any other agreement reasonably satisfactory to the Administrative Agent and Holdings;
(iv)Indebtedness of a Restricted Subsidiary incurred prior to the date on which such Subsidiary was acquired by Holdings or a Restricted Subsidiary of Holdings (other than Indebtedness incurred in contemplation of such acquisition) and outstanding on such date; provided that (I) if secured, such Indebtedness shall be secured solely by Liens existing at the time such Restricted Subsidiary is acquired by Holdings or a Restricted Subsidiary of Holdings and shall not extend to any other property owned by Holdings or any of its other Restricted Subsidiaries and (II) (x) if such Indebtedness is secured by a Lien on the Collateral that is pari passu with the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis, the First Lien Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed the First Lien Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period, (y) if such Indebtedness is secured by a Lien on the Collateral that is junior to the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis, the Secured Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such
155


date, would not exceed the Secured Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma basis as of the most recently ended Test Period or (z) if such Indebtedness is unsecured or is secured by assets that do not constitute Collateral, either (a) the Total Net Leverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not exceed the Total Net Leverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period or (b) the Fixed Charge Coverage Ratio, determined on a Pro Forma Basis for the most recently ended Test Period prior to such date, would not be less than the Fixed Charge Coverage Ratio in effect immediately prior to the consummation of such acquisition calculated on a Pro Forma Basis as of the most recently ended Test Period;
(v)Permitted Refinancing Indebtedness in respect of Indebtedness incurred pursuant to Section 6.01(a), Sections 6.01(b)(iv), (xvii), (xxii) or (xxvii) or this clause (v);
(vi)Obligations under and in respect of non-speculative Swap Agreements (including Permitted Hedging Obligations);
(vii)(A) obligations in respect of worker’s compensation and self-insurance and performance, bid, stay, customs, appeal, replevin and surety bonds and performance and completion guarantees provided by Holdings or any Restricted Subsidiary in the ordinary course of business, and (B) reimbursement and indemnification obligations in respect of letters of credit, banker’s acceptances and other similar instruments issued in respect of obligations specified in clause (A) or to landlords or vendors in the ordinary course of business;
(viii)ACH Indebtedness and Indebtedness owed in respect of business credit card programs and any netting services, overdrafts and related liabilities arising from treasury, depository and cash management services;
(ix)Indebtedness consisting of any Guarantee by Holdings or any Restricted Subsidiary of Indebtedness or other obligations of Holdings or any of its Subsidiaries; provided that if the Indebtedness being guaranteed is subordinated to or pari passu with the Loans, then the Guarantee must be subordinated or pari passu, as applicable, to the same extent as the Indebtedness guaranteed;
(x)Capital Lease Obligations and Indebtedness incurred after the Closing Date in respect of purchase money indebtedness or Sale and Leaseback Transactions and Permitted Refinancing Indebtedness in respect thereof and in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and incurred pursuant to this clause (x), does not exceed the greater of $235,000,000 and 20% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination; provided that this clause (x) shall not apply to any Capital Lease Obligations or Indebtedness in respect of Sale and Leaseback Transactions, the proceeds of which are used to prepay, on a pro rata basis, Indebtedness hereunder and, to the extent required under the terms of such Indebtedness, Indebtedness that is secured by a Lien on the Collateral that is pari passu with the Lien on the Collateral securing the Secured Obligations that are secured on a first lien basis;
(xi)other Indebtedness of non-Guarantor Subsidiaries and Foreign Subsidiaries in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and
156


incurred pursuant to this clause (xi) and the principal amount of all Indebtedness of non-Guarantor Subsidiaries then outstanding and incurred pursuant to Section 6.01(a) hereof, does not exceed the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination;
(xii)Indebtedness of Holdings or any of its Restricted Subsidiaries consisting of (i) the financing of insurance premiums with the providers of such insurance or their affiliates or (ii) take-or-pay obligations contained in supply agreements, in each case, in the ordinary course of business;
(xiii)Indebtedness incurred in connection with judgments, decrees, attachments or awards that do not constitute an Event of Default;
(xiv)Indebtedness in the form of (i) guarantees of loans and advances to officers, directors, consultants and employees that constitute Permitted Investments pursuant to and in accordance with clause (9) of the definition thereof, and (ii) reimbursements owed to officers, directors, consultants and employees of Holdings or any of its Subsidiaries or Holdings’ direct or indirect parent companies;
(xv)Indebtedness consisting of obligations to make payments to current or former officers, directors and employees of Holdings, any of its Subsidiaries or Holdings’ direct or indirect parent companies, their respective estates, spouses or former spouses with respect to the cancellation, purchase or redemption of Equity Interests of Holdings, any of its Subsidiaries, or any of Holdings’ direct or indirect parent companies to the extent permitted under Section 6.04;
(xvi)Indebtedness (A) incurred in connection with a Qualified Securitization Financing that is not recourse (except for Standard Securitization Undertakings and Limited Originator Recourse) to Holdings or any Restricted Subsidiary, (B) incurred in connection with a Qualified Receivables Factoring or (C) incurred for working capital purposes, in an aggregate principal amount on the date of incurrence that, when taken together with the principal amount of all other Indebtedness then outstanding and incurred pursuant to this clause (xvi)(C), does not exceed the greater of $120,000,000 or 10% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination;
(xvii)(A) the New Notes (and any Guarantees thereof by the Guarantors), (B) any other Indebtedness that is outstanding on the Closing Date, which, in the case of Indebtedness with an outstanding principal amount in excess of $5,000,000, shall be listed on Schedule 6.01, and (C) any refinancing, extensions, renewals or replacements of any such Indebtedness described in (A) or (B) that does not increase the outstanding principal amount thereof (other than with respect to unpaid accrued interest and premium thereon, any committed or undrawn amounts and underwriting discounts, fees, commissions and expenses, associated with such Indebtedness);
(xviii)Indebtedness arising from agreements providing for indemnification, adjustment of purchase price or similar obligations, or from guaranties, surety bonds or performance bonds securing the performance of Holdings or any of its Restricted Subsidiaries pursuant to such agreements, in connection with Permitted Acquisitions, the Acquisition or permitted Dispositions;
(xix)Alternative Incremental Facility Indebtedness and Permitted Refinancing Indebtedness in respect thereof provided that as of the end of the most recently ended Test Period prior to the effectiveness of such Alternative Incremental
157


Facility Indebtedness (or in the case the proceeds thereof are used to finance a Limited Condition Transaction, as of the LCT Test Date) on a Pro Forma Basis (after giving effect to the use of proceeds of such Alternative Incremental Facility Indebtedness and any Permitted Acquisition or other acquisition or Investment to be consummated in connection therewith) in an aggregate principal amount, together with the principal amount of Incremental Loans incurred, shall not exceed the Maximum Incremental Amount; provided that, to the extent such Indebtedness is incurred prior to the date that is 24 months after the Closing Date and is comprised of term loans funded in Dollars that are secured pari passu with the Obligations, the provisions set forth in Section 2.20(b)(A)(iv) shall apply as if such Indebtedness had been incurred as Incremental Term Loans under Section 2.20;
(xx)Indebtedness in the form of an intercompany note issued in connection with a Permitted Acquisition involving a tender offer followed by a short form merger (i.e. a statutory short form merger that requires no further approvals to consummate); provided that (i) such short form merger is consummated within five (5) Business Days of the incurrence of such Indebtedness and (ii) not later than three (3) Business Days after consummation of the related short form merger, such Indebtedness (x) is extinguished or retired or (y) otherwise constitutes a Permitted Investment;
(xxi)Indebtedness, Disqualified Equity Interests or Preferred Equity of Holdings or of any of the Restricted Subsidiaries in an aggregate principal amount on the date of incurrence that, when taken together with all other Indebtedness of Holdings and the Restricted Subsidiaries then outstanding and incurred pursuant to this clause (xxi), does not exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination;
(xxii)Indebtedness under guarantees of the obligations of other members of the Group once such guarantees are entered into the in the normal course of trading;
(xxiii)Indebtedness incurred in respect of trade credit in the normal course of trading activities (including within the Group);
(xxiv)intra-day facility arrangements in the ordinary course of business and consistent with past practice;
(xxv)Indebtedness of, incurred on behalf of, or representing guarantees of Indebtedness of, joint ventures, in each case, that are Permitted Investments or are permitted under Section 6.04;
(xxvi)Indebtedness in respect of derivative transactions entered into by Group members to hedge currency or interest rate exposures and for other non-speculative purposes;
(xxvii)Indebtedness incurred in connection with any Sale and Leaseback Transaction related to the Headquarters;
(xxviii)Preferred Equity of a Restricted Subsidiary issued to Holdings or another Restricted Subsidiary; provided that any subsequent issuance or transfer of any capital stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of preferred stock (except to Holdings or another Restricted Subsidiary) shall be deemed in
158


each case to be an issuance of such shares of preferred stock not permitted by this clause (xxviii);
(xxix)(i) obligations in respect of self-insurance, performance, bid, appeal and surety bonds and completion guarantees and similar obligations provided by Holdings or any Restricted Subsidiary or (ii) obligations in respect of letters of credit, bank guarantees or similar instruments related thereto, in each case, in the ordinary course of business or consistent with past practice;
(xxx)[reserved];
(xxxi)(i) Indebtedness of Holdings or any Restricted Subsidiary supported by a letter of credit, in a principal amount not in excess of the stated amount of such letter of credit, so long as such letter of credit is otherwise permitted to be incurred pursuant to this Section 6.01 or (ii) obligations in respect of letters of support, guarantees or similar obligations issued, made or incurred for the benefit of any Restricted Subsidiary of Holdings to the extent required by law or in connection with any statutory filing or the delivery of audit opinions performed in jurisdictions other than within the United States;
(xxxii)[reserved];
(xxxiii)(i) Indebtedness of Holdings or any of the Restricted Subsidiaries undertaken in connection with cash management and related activities with respect to any Subsidiary or joint venture in the ordinary course of business, including with respect to financial accommodations of the type described in the definition of “Cash Management Agreement” and (ii) Indebtedness owed on a short term basis of no longer than 30 days to banks and other financial institutions incurred in the ordinary course of business of the Borrowers and their Restricted Subsidiaries with such banks or financial institutions that arises in connection with ordinary banking arrangements to manage cash balances of the Borrowers and their Restricted Subsidiaries;
(xxxiv)[reserved];
(xxxv)Indebtedness arising in the ordinary course of business from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business, provided that such Indebtedness (x) is extinguished within two Business Days of its incurrence or (y) arises in respect of one or more accounts of any Subsidiary that is a Foreign Subsidiary with any bank or other financial institution subject to a pooling or similar arrangement with one or more accounts of any other Subsidiaries that are Foreign Subsidiaries with such bank or other financial institution to the extent the net aggregate amount of funds in all such accounts subject to such pooling or similar arrangement with such bank or other financial institution is positive;
(xxxvi)[reserved]; and
(xxxvii) Indebtedness or Disqualified Equity Interests of Holdings and Indebtedness, Disqualified Equity Interests or Preferred Equity of Holdings or any Restricted Subsidiary in an aggregate principal amount or liquidation preference up to 100.0% of the net cash proceeds received by Holdings after the Closing Date from the issue or sale of Equity Interests of Holdings or cash contributed to the capital of Holdings (in each case, other than proceeds of Disqualified Equity Interests, sales of Equity Interests to Holdings or any of its Subsidiaries or proceeds which have been designated as
159


a Cure Amount) as determined in accordance with Section 6.04(a)(ii)(B) and (a)(ii)(D) to the extent such net cash proceeds or cash have not been applied pursuant to such clauses to make Restricted Payments pursuant to Section 6.04(b) or to make Permitted Investments (other than Permitted Investments specified in clauses (2), (3) or (4) of the definition thereof).
For purposes of determining compliance with this Section 6.01, in the event that an item of Indebtedness, Disqualified Equity Interests or Preferred Equity (or any portion thereof) at any time, whether at the time of incurrence or issuance or upon the application of all or a portion of the proceeds thereof or subsequently, meets the criteria of more than one of the categories of permitted Indebtedness, Disqualified Equity Interests or Preferred Equity described in Section 6.01(i) through (xxxvii) above, Holdings, in its sole discretion, will classify and may subsequently reclassify such item of Indebtedness, Disqualified Equity Interests or Preferred Equity (or any portion thereof) in any one or more of the types of Indebtedness, Disqualified Equity Interests or Preferred Equity described in Section 6.01(i) through (xxxvii) and will only be required to include the amount and type of such Indebtedness, Disqualified Equity Interests or Preferred Equity in such of the above clauses as determined by Holdings at such time. Holdings will be entitled to divide, classify and reclassify an item of Indebtedness in more than one of the types of Indebtedness described in clauses (i) through (xxxvii).
(c)For purposes of determining compliance with any Dollar-denominated restriction on the incurrence of Indebtedness, the Dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed, in the case of revolving credit debt; provided, that if such Indebtedness is incurred to extend, replace, refund, refinance, renew or defease other Indebtedness denominated in a foreign currency, and such extension, replacement, refunding, refinancing, renewal or defeasance would cause the applicable Dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such extension, replacement, refunding, refinancing, renewal or defeasance, such Dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing Indebtedness does not exceed the principal amount of such Indebtedness being extended, replaced, refunded, refinanced, renewed or defeased, plus the aggregate amount of fees, underwriting discounts, premiums and other costs and expenses incurred in connection with such refinancing. The principal amount of any Indebtedness incurred to refinance other Indebtedness, if incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective Indebtedness is denominated that is in effect on the date of such refinancing;
(d)The accrual of interest, the accretion of accreted value and the payment of interest in the form of additional Indebtedness shall not be deemed to be an incurrence of Indebtedness for purposes of this Section 6.01. The principal amount of any non-interest bearing Indebtedness or other discount security constituting Indebtedness at any date shall be the principal amount thereof that would be shown on a balance sheet of Holdings dated such date prepared in accordance with GAAP.
Section 3.02Liens. Holdings will not, and will not permit any Restricted Subsidiary to, directly or indirectly, incur or permit to exist any Lien (the “Initial Lien”) of any nature whatsoever on any of its properties (including Equity Interests of a Restricted Subsidiary to secure Indebtedness), whether owned at the Closing Date or thereafter acquired, securing any Indebtedness, other than Permitted Liens.
160


Section 3.03Asset Sales.
(a)Holdings will not, and will not permit any of its Restricted Subsidiaries to, consummate an Asset Sale unless:
(i)Holdings (or its Restricted Subsidiary, as the case may be) receives consideration at least equal to the fair market value (measured as of the date of the definitive agreement with respect to such Asset Sale) of the assets or shares of Equity Interests of a Restricted Subsidiary issued or sold or otherwise disposed of; and
(ii)if the property or assets sold or otherwise disposed in a single transaction or series of related transactions of have a fair market value in excess of $75,000,000 at the time of such disposition, at least 75% of the consideration received in the Asset Sale by Holdings or such Restricted Subsidiary is in the form of cash or Cash Equivalents. For purposes of this clause (ii), the following consideration shall be deemed to be cash consideration: (A) any securities, notes or other obligations received by Holdings or any Restricted Subsidiary that are converted within 180 days into cash or Cash Equivalents shall be deemed to be cash or Cash Equivalents, (B) any consideration arising from the assumption of liabilities, (C) any liabilities (as reflected on Holdings’ most recent consolidated balance sheet or in the footnotes thereto, or if incurred or accrued subsequent to the date of such balance sheet, such liabilities that would have been reflected on Holdings’ consolidated balance sheet or in the footnotes thereto if such incurrence or accrual had taken place on or prior to the date of such consolidated balance sheet, as determined in good faith by Holdings) of Holdings, other than liabilities that are by their terms subordinated to the Loans, that are assumed by the transferee of any such assets (or are otherwise extinguished in connection with the transactions relating to such Asset Sale) and for which Holdings and all Restricted Subsidiaries have been validly released by all applicable creditors in writing; (D) any contingent or deferred consideration payable in cash or Cash Equivalents) and (E) any Designated Non-Cash Consideration received in respect of such Asset Sale having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this clause (E) that is at that time outstanding, not in excess of the greater of $205,000,000 and 17.5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the time of the receipt of such Designated Non-Cash Consideration, with the fair market value of each item of Designated Non-Cash Consideration being measured at the time received and without giving effect to subsequent changes in value.
(b)Pending the final application of any Net Proceeds, Holdings (or the applicable Restricted Subsidiary) may invest the Net Proceeds in any manner that is not prohibited by this Agreement.
(c)Notwithstanding anything to the contrary herein, Holdings will not, and will not permit any of its Restricted Subsidiaries to, transfer any Material Intellectual Property to any Unrestricted Subsidiary.
Section 3.04Restricted Payments, Investments, Loans, Advances, Guarantees and Acquisitions.
(a)Holdings will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly make any Restricted Payment, unless:
(i)(x) in the case of a Restricted Payment utilizing clause (a)(ii)(B) below, no Event of Default shall have occurred and be continuing or would occur as a consequence thereof and (y) in the case of a Restricted Payment (other than an
161


Investment) utilizing clause (a)(ii)(B) below, after giving effect to such Restricted Payment on a Pro Forma Basis, Holdings would have had a Fixed Charge Coverage Ratio of at least 2.00 to 1.00;
(ii)such Restricted Payment, together with the aggregate amount of all other Restricted Payments made by Holdings and its Restricted Subsidiaries since the Closing Date (including Restricted Payments permitted by Section 6.04(b)(i), but excluding all other Restricted Payments permitted by Section 6.04(b)), is less than the sum, without duplication, of:
(A)the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such transactions, plus
(B)50% of the Consolidated Net Income of Holdings for the period (taken as one accounting period) from the first day of the fiscal quarter in which the Closing Date occurs to the end of Holdings’ most recently ended fiscal quarter for which internal financial statements are available at the time of such Restricted Payment (or, if such Consolidated Net Income for such period is a deficit, less 100% of such deficit); plus
(C)other than to the extent Restricted Payments have been made with respect to such Net Proceeds pursuant to Sections 6.04(b)(ii) or 6.04(b)(iv), 100% of the aggregate Net Proceeds and the fair market value of property received by Holdings since the Closing Date as a contribution to its common equity capital or from the issue or sale of Equity Interests (other than Disqualified Equity Interests) of Holdings or from the issue or sale of convertible or exchangeable Disqualified Equity Interests of Holdings or Convertible Debt Securities of Holdings, in each case that have been converted into or exchanged for Equity Interests of Holdings (other than Disqualified Equity Interests and Equity Interests and convertible or exchangeable Disqualified Equity Interests or debt securities sold to a Subsidiary of Holdings); plus
(D)100% of the aggregate amount received in cash and the fair market value of property (other than cash) and marketable securities received by Holdings or a Restricted Subsidiary after the Closing Date by means of (i) the sale or other disposition (other than to Holdings or a Restricted Subsidiary) of Restricted Investments made by Holdings or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from Holdings or its Restricted Subsidiaries and repayments of loans or advances which constitute Restricted Investments of Holdings or its Restricted Subsidiaries, (ii) the sale (other than to Holdings or a Restricted Subsidiary) of the Equity Interests of an Unrestricted Subsidiary, (iii) payments of interest, distributions or dividends in respect of Restricted Investments, in each case to the extent that such amounts were not otherwise included in the Consolidated Net Income of Holdings for such period and (iv) a distribution or dividend from an Unrestricted Subsidiary (other than in each case such Investment constituted a Permitted Investment); plus
(E)to the extent that any Restricted Investment that was made after the Closing Date is made in an entity that is not a Restricted Subsidiary that subsequently becomes a Restricted Subsidiary, the initial amount of such Restricted Investment (or, if less, the amount of cash received upon repayment or sale); plus
162


(F)to the extent that any Unrestricted Subsidiary designated as such after the Closing Date is redesignated as a Restricted Subsidiary after the Closing Date, the lesser of (i) the fair market value of the Restricted Investment in such Subsidiary as of the date of such redesignation or (ii) the aggregate amount of the Restricted Investments in such Subsidiary to the extent such Restricted Investments reduced the amount available under this clause (ii) and were not previously repaid or otherwise reduced; plus
(G)the aggregate amount of Subordinated Indebtedness repaid, defeased or satisfied and/or discharged; plus
(H)the Declined Prepayment Amount to the extent not applied to prepay the Term Loans of the Accepting Term Lenders.
(b)Section 6.04(a) will not prohibit:
(i)(x) the payment of any dividend or distribution or the consummation of any irrevocable purchase, redemption, acquisition or retirement for value of any Equity Interests of Holdings within 60 days after the date of declaration thereof or giving of the irrevocable advance notice thereof, as the case may be, if at the date of declaration or notice, the applicable dividend, distribution or payment would have complied with the provisions of this Agreement and (y) the repurchase of Equity Interests of Holdings pursuant to a plan under Rule 10b5-1 under the Securities Exchange Act of 1934 if at the date Holdings establishes such plan, such repurchase would have complied with the provisions of this Agreement;
(ii)the making of any Restricted Payment in exchange for, or out of or with the Net Proceeds of the substantially concurrent sale (other than to a Subsidiary of Holdings) of, Equity Interests of Holdings (other than Disqualified Equity Interests) or from the substantially concurrent contribution of common equity capital to Holdings; provided, that the amount of any such Net Proceeds that are utilized for any such Restricted Payment will not be considered to be Net Proceeds of Equity Interests for purposes of Section 6.04(a)(ii)(B) or Section 6.04(b)(iv);
(iii)the repurchase, redemption, defeasance or other acquisition or retirement for value of Subordinated Indebtedness with the Net Proceeds from a substantially concurrent incurrence of Permitted Refinancing Indebtedness;
(iv)the repurchase, redemption or other acquisition or retirement for value of any Equity Interests of Holdings, any Restricted Subsidiary or Holdings’ direct or indirect parent companies held by any current or former officer, director, manager, employee or consultant of Holdings or any of its Restricted Subsidiaries pursuant to any equity subscription agreement, stock option agreement, shareholders’ agreement or other similar agreement; provided, that the aggregate price paid for all such repurchased, redeemed, acquired or retired Equity Interests may not exceed in any calendar year the greater of $90,000,000 and 7.5% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (with any unused amount in any calendar year being carried forward and available in any succeeding calendar years); provided, further, that such amount in any twelve-month period may be increased by an amount not to exceed:
(A)the Net Proceeds from the sale of Equity Interests (other than Disqualified Equity Interests) of Holdings and, to the extent contributed to Holdings as common equity capital, the Net Proceeds from the sale of Equity
163


Interests (other than Disqualified Equity Interests) of any of Holdings’ direct or indirect parent companies, in each case to any current or former officer, director, manager, employee or consultant of Holdings, any of its Restricted Subsidiaries or any of its direct or indirect parent companies that occurs after the Closing Date; provided that the amount of any such Net Proceeds that are utilized for any such Restricted Payment will not be considered to be Net Proceeds of Equity Interests for purposes of Section 6.04(a)(ii)(B) or Section 6.04(b)(ii); plus
(B)the cash proceeds of key man life insurance policies received by Holdings or its Restricted Subsidiaries after the Closing Date; and
in addition, cancellation of Indebtedness owing to Holdings from any current or former officer, director, manager, employee or consultant (or any permitted transferees thereof) of Holdings or any of its Restricted Subsidiaries (or any direct or indirect parent company thereof), in connection with a repurchase of Equity Interests of Holdings or Holdings’ direct or indirect parent companies from such Persons will not be deemed to constitute a Restricted Payment for purposes of this Section 6.04 or any other provisions of this Agreement;
(v)the repurchase of Equity Interests of Holdings or Holdings’ direct or indirect parent companies (i) deemed to occur upon the exercise of options, warrants or other convertible securities upon the net exercise thereof or otherwise to the extent such Equity Interests represent a portion of the exercise price of those options, warrants or other convertible securities, (ii) upon the exercise of stock options, warrants or convertible securities in an equal or lesser amount to the amount exercised in order to reduce the dilutive effects of such exercise and (iii) deemed to occur upon the withholding of a portion of Equity Interests granted or awarded to any current or former officer, director, manager, employee or consultant to pay for taxes payable by such Person in connection with such grant or award (or the vesting thereof) (or, in each case, a Restricted Payment to any of Holdings’ direct or indirect parent companies in an amount sufficient to enable such company to repurchase any such Equity Interests);
(vi)payments of cash, dividends, distributions, advances or other Restricted Payments by Holdings or any of its Restricted Subsidiaries to allow the payment of cash in lieu of the issuance of fractional shares upon (i) the exercise of options or warrants or other securities convertible into or exercisable for Equity Interests of any such Person or (ii) the conversion or exchange of Equity Interests of any such Person (or a Restricted Payment to Holdings’ direct or indirect parent company in an amount sufficient to enable such company to make any such payments);
(vii)for the avoidance of doubt, payments of intercompany subordinated Indebtedness, the incurrence of which was permitted under Section 6.01;
(viii)the repurchase, redemption or other acquisition or retirement for value of any Subordinated Indebtedness pursuant to provisions similar to Section 6.03; provided, that, prior to consummating, or concurrently with, any such repurchase, Holdings or the Applicable Borrower has made a Prepayment Event required by this Agreement and has prepaid all Obligations required to be repaid in connection with such offers;
(ix)payments or distributions made in Equity Interests (other than Disqualified Equity Interests) of Holdings or any of its direct or indirect parent companies;
164


(x)other Restricted Payments of the type described in clause (i), (ii) or (iv) of the definition thereof in an aggregate amount not to exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination since the Closing Date, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing;
(xi)other Restricted Payments of the type described in clause (iii) of the definition thereof in an aggregate amount not to exceed the greater of $405,000,000 and 35% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination since the Closing Date, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing;
(xii)payments or distributions to dissenting stockholders pursuant to applicable law in connection with any merger or consolidation with, or other acquisition of, another Person;
(xiii)the purchase by Holdings or any Restricted Subsidiary of any remaining outstanding Equity Interests of any Subsidiary acquired in connection with a Permitted Investment structured as a tender offer pursuant to which not less than a majority of such Subsidiary’s Equity Interests was acquired;
(xiv)Restricted Payments in connection with the Transactions and any compensation payable to, and indemnification of, any current or former officer, director, manager, employee or stockholders of Holdings, any of its Subsidiaries and any of Holdings’ direct or indirect parent companies in respect of taxes owed by such Persons as a result of the Transactions;
(xv)[reserved];
(xvi)payments to holders of Equity Interests (or to the holders of Indebtedness that is convertible into or exchangeable for Equity Interests upon such conversion or exchange) in lieu of the issuance of fractional shares (or a Restricted Payment to Holdings’ direct or indirect parent company in an amount sufficient to enable such company to make any such payments);
(xvii)the distribution, as a dividend or otherwise, of Equity Interests of Unrestricted Subsidiaries;
(xviii)[reserved];
(xix)the purchase of any Permitted Equity Derivatives in connection with the issuance of any Convertible Debt Securities permitted under Section 6.01 (and the replacement of any such Permitted Equity Derivatives) provided that the purchase price for such Permitted Equity Derivatives, net of any proceeds relating to any concurrent sale or termination of any Permitted Equity Derivatives, in respect of any Convertible Debt Securities does not exceed the net cash proceeds from such issuance of Convertible Debt Securities;
(xx)the settlement or termination of any Permitted Equity Derivatives; provided that the entry into such Permitted Equity Derivative was permitted under this covenant;
165


(xxi)any Restricted Payments, excluding Restricted Investments, so long as (x) at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing and (y) on a Pro Forma Basis, as of the last day of the most recently ended Test Period, the Total Net Leverage Ratio does not exceed 4.00:1.00;
(xxii)for any taxable period for which Holdings and/or any of its Subsidiaries are members of a consolidated, combined, unitary or similar income Tax group for applicable income Tax purposes of which a direct or indirect parent company of Holdings is the common parent (a “Tax Group”), dividends or distributions by Holdings to such direct or indirect parent company of Holdings in an amount not to exceed the portion of any income Taxes of such Tax Group for such taxable period that is attributable to the taxable income of Holdings and/or the applicable Subsidiaries; provided that for each taxable period, the total amount of such payments made in respect of such taxable period will not exceed the amount that Holdings and/or such Subsidiaries, as applicable, would have been required to pay in respect of such taxable income as stand-alone taxpayers or a stand-alone Tax Group, reduced by any such income Taxes directly paid by Holdings or such Subsidiaries; provided that distributions pursuant to this clause (xxii) in respect of an Unrestricted Subsidiary shall be permitted only to the extent that cash distributions were made by such Unrestricted Subsidiary to Holdings or any of its Restricted Subsidiaries for such purpose;
(xxiii)[reserved];
(xxiv)[reserved];
(xxv)[reserved];
(xxvi)[reserved]
(xxvii)the declaration and payment of additional dividends and repurchases of Equity Interests of Holdings in an aggregate amount per annum not to exceed 6.0% of Market Capitalization, so long as at the time of and after giving effect to such Restricted Payment, no Event of Default has occurred and is continuing;
(xxviii)[reserved]; and
(xxix)distributions or payments of Securitization Fees, purchases of receivables pursuant to a Receivables Repurchase Obligation in connection with a Qualified Receivables Factoring or Qualified Securitization Financing and the payment or distribution of Securitization Fees.
For purposes of determining compliance with this covenant, in the event that a proposed Restricted Payment (or a portion thereof) meets the criteria of clauses (i) through (xxx) above or is entitled to be made pursuant to Section 6.04(a) and/or one or more of the exceptions contained in the definition of “Permitted Investments,” Holdings will be entitled to classify and reclassify (based on circumstances existing on the date of such classification or reclassification) such Restricted Payment (or portion thereof) among such clauses (i) through (xxvii), Section 6.04(a) and/or one or more of the exceptions contained in the definition of “Permitted Investments,” in a manner that otherwise complies with this covenant.
The amount of all Restricted Payments (or transfer or issuance that would constitute Restricted Payments but for the exclusions from the definition thereof) and Permitted Investments (other than cash) will be the fair market value on the date of the making the Restricted Payment
166


(or such transfer or issuance) or Permitted Investment of the asset(s) or securities proposed to be transferred or issued by Holdings or such Restricted Subsidiary, as the case may be, pursuant to the Restricted Payment (or transfer or issuance that would constitute a Restricted Payment but for the exclusions from the definition thereof) or Permitted Investment.
For purposes of covenant compliance with this Section 6.04, the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment, less any amount paid, repaid, returned, distributed or otherwise received in cash in respect of such Investment.
Section 3.05[Reserved].
Section 3.06[Reserved].
Section 3.07Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries.
(a)Holdings will not, and will not permit any of its Restricted Subsidiaries, to create or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to:
(i)pay dividends or make any other distributions on its Equity Interests to Holdings or any of its Restricted Subsidiaries or pay any indebtedness owed to Holdings or any of its Restricted Subsidiaries;
(ii)make loans or advances to Holdings or any of its Restricted Subsidiaries;
(iii)sell, lease or transfer any of its properties or assets to Holdings or any of its Restricted Subsidiaries; or
(iv)create, incur or permit to exist any Lien upon any of its property or assets.
(b)The restrictions in Section 6.07(a) will not apply to encumbrances or restrictions existing under or by reason of:
(i)agreements in effect at or entered into on the Closing Date set forth on Schedule 6.07 and any amendments or modifications thereof that do not materially expand the scope of any such restriction or condition;
(ii)this Agreement, the Loans, the Guarantees and the New Notes;
(iii)agreements governing Indebtedness, Disqualified Equity Interests or Preferred Equity permitted to be incurred under Section 6.01;
(iv)applicable law, rule, regulation or order;
(v)customary non-assignment provisions in contracts, leases and licenses otherwise permitted under this Agreement;
(vi)Capital Lease Obligations, any agreement governing purchase money indebtedness, security agreements or mortgages securing Indebtedness of a
167


Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such Capital Lease Obligations, purchase money indebtedness, security agreements or mortgages;
(vii)any agreement in connection with the sale or disposition of all or substantially all the Equity Interests or assets of a Restricted Subsidiary that imposes such encumbrance or restriction pending the closing of such sale or disposition;
(viii)customary restrictions and conditions contained in any agreement relating to any Disposition permitted by Section 6.03 pending the consummation of such Disposition;
(ix)Permitted Refinancing Indebtedness;
(x)Liens permitted to be incurred under Section 6.02 that limit the right of the debtor to dispose of the assets subject to such Liens;
(xi)provisions limiting the disposition or distribution of assets or property in joint venture agreements, partnership agreements, asset sale agreements, sale-leaseback agreements, stock sale agreements and other similar agreements (including agreements entered into in connection with a Restricted Investment), which limitation is applicable only to the assets that are the subject of such agreements;
(xii)[reserved];
(xiii)any agreement or instrument of, or affecting, any Restricted Subsidiary or its Equity Interests existing on or prior to the date on which such Restricted Subsidiary was acquired by Holdings or other Restricted Subsidiary (other than any such agreement or instrument entered into in contemplation of such Restricted Subsidiary acquired by Holdings or other Restricted Subsidiary);
(xiv)customary provisions contained in leases, sub-leases, licenses, sub-licenses or similar agreements, including with respect to intellectual property, and other agreements, in each case, entered into in the ordinary course of business;
(xv)customary non-assignment provisions in leases or licenses governing leasehold or license interests to the extent such provisions restrict the transfer of the lease or the property leased or licensed thereunder;
(xvi)any amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing of an agreement or arrangement referred to in clauses (i) through (xv) above of this Section 6.07(b); provided, that such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing is not materially more restrictive, as determined in good faith by Holdings, with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing
(xvii)restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business;
168


(xviii)customary provisions in joint venture agreements or arrangements and other similar agreements or arrangements relating solely to such joint venture and the Equity Interests issued thereby;
(xix)customary restrictions created in connection with any Qualified Securitization Financing or Qualified Receivables Factoring that, in the good faith determination of the board of directors of Holdings, are necessary or advisable to effect such Qualified Securitization Financing or such Qualified Receivables Factoring;
(xx)customary provisions restricting assignment of any agreement entered into in the ordinary course of business;
(xxi)restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business; and
(xxii)customary change of control provisions in client contracts.
Section 3.08Amendments to Subordinated Indebtedness and Certain Other Documents, etc. Holdings will not, nor will it permit any Restricted Subsidiary to amend, modify or waive any of its rights under any agreement or instrument governing or evidencing any Subordinated Indebtedness that constitutes Material Indebtedness to the extent such amendment, modification or waiver could reasonably be expected to be adverse in any material respect to the Lenders as determined by Holdings in good faith (it being understood and agreed that any increase or decrease in the interest rates or extension of the maturity dates or repayment under any Indebtedness among Holdings and its Subsidiaries or among one or more Subsidiaries shall not be deemed to be adverse in any material respect to the Lenders).
Section 3.09Sale and Leaseback Transactions. Holdings will not, nor will it permit any Restricted Subsidiary to, enter into any Sale and Leaseback Transaction unless (a) the sale or transfer of the property thereunder is permitted by Section 6.03 or is not an Asset Sale, (b) any Capital Lease Obligations arising in connection therewith are permitted by Section 6.01 and (c) any Liens arising in connection therewith (including Liens deemed to arise in connection with any such Capital Lease Obligations) are permitted by Section 6.02.
Section 3.10[Reserved].
Section 3.11Merger, Consolidation or Sale of Assets.
(a)Neither Holdings or any Borrower shall: (1) consolidate with or merge with or into another Person; or (2) directly or indirectly, sell, assign, transfer, convey, lease or otherwise dispose of (including by virtue of a merger, consolidation, amalgamation, liquidation or otherwise), all or substantially all of the assets of Holdings and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another Person, in each case, unless:
(i)either:
(A)Holdings or such Borrower is the surviving or transferee Person; or
(B)the Person formed by or surviving any such consolidation or merger or to which such sale, assignment, transfer, conveyance, lease or other disposition has been made is an entity organized or existing under the laws of the same jurisdiction as Holdings or such Borrower, as applicable;
169


provided that, for purposes of this Section 6.11(a)(i)(B), the United States, all states thereof and the District of Columbia shall be considered a single jurisdiction;
(ii)the Person formed by or surviving any such consolidation or merger (if other than Holdings or a Borrower) or the Person to which such sale, assignment, transfer, conveyance, lease or other disposition has been made (if other than Holdings or a Borrower) assumes all the obligations of Holdings or such Borrower, as applicable, under this Agreement pursuant to agreements reasonably satisfactory to the Administrative Agent; and
(iii)other than in the case of a Restricted Subsidiary merging into Holdings or a Borrower, immediately after such transaction (or, in the case of a Limited Condition Transaction, as of the LCT Test Date), no Event of Default exists.
(b)No Subsidiary Guarantor shall: (1) consolidate with or merge with or into another Person; or (2) directly or indirectly, sell, assign, transfer, convey, lease or otherwise dispose of (including by virtue of a merger, consolidation, amalgamation, liquidation or otherwise), all or substantially all of its assets taken as a whole, in one or more related transactions, to another Person, in each case, unless:
(i)the other Person is Holdings or a Borrower or any Restricted Subsidiary; or
(ii)either:
(A)such Subsidiary Guarantor is the surviving or transferee Person; or
(B)the Person formed by or surviving any such consolidation or merger (if other than such Subsidiary Guarantor) or the Person to which such sale, assignment, transfer, conveyance, lease or other disposition has been made (if other than such Subsidiary Guarantor) is organized in a Covered Jurisdiction and assumes all the obligations of such Subsidiary Guarantor under this Agreement; or
(iii)the transaction constitutes a Disposition (including by way of merger or consolidation) (A) that is not an Asset Sale or is an Asset Sale that is in compliance with Section 6.03 or (B) of such Subsidiary Guarantor or the Disposition of all or substantially all of the assets of such Subsidiary Guarantor that is not an Asset Sale or is an Asset Sale that is in compliance with Section 6.03.
Notwithstanding the foregoing in this Section 6.11, (i) Holdings and the Borrowers and the Restricted Subsidiaries may consummate the Transactions, (ii) Holdings and the Borrowers and the Restricted Subsidiaries may consummate a consolidation or merger the purpose of which is to effect a Permitted Investment or an Investment permitted by 6.04, (iii) any Subsidiary Guarantor may merge or consolidate with or into an Affiliate solely for the purpose of reorganizing in another jurisdiction and (iv) any Subsidiary Guarantor may liquidate, dissolver or wind up if Holdings determines in good faith that such liquidation, dissolution or conveyance is in the best interest of Holdings and the Restricted Subsidiaries taken as whole.
Section 3.12Financial Covenant. Holdings and each of the Restricted Subsidiaries covenant and agree that:
170


(a)If on the last day of any Test Period (commencing with the first Test Period ending on the last day of the first full fiscal quarter ending after the Closing Date) there are outstanding Revolving Loans, Swingline Loans and Letters of Credit (excluding Letters of Credit to the extent Cash Collateralized or backstopped (whether drawn or undrawn)) in an aggregate principal amount exceeding 30% of the aggregate principal amount of all Revolving Commitments (including any Incremental Revolving Commitments), no Loan Party shall permit the Total Net Leverage Ratio as of the last day of such Test Period to be greater than (x) 5.75 to 1.00 prior to June 30, 2023 and (y) 4.50 to 1.00 on and after June 30, 2023 (in each case, such compliance to be determined on the basis of the financial information most recently delivered to the Administrative Agent pursuant to the Compliance Certificate for such Test Period) (the “Financial Covenant”); provided that on one occasion prior to the Maturity Date of the Revolving Loans and Revolving Commitments where Holdings or any of its Subsidiaries consummates a Financial Covenant Material Acquisition after the Closing Date, the maximum Total Net Leverage Ratio for each of the next four Test Periods following such Material Acquisition shall be 0.50 to 1.00 higher than the maximum Total Net Leverage Ratio otherwise indicated above for such Test Period.
(b)The provisions of this Section 6.12 are for the benefit of the Revolving Lenders only and the Required Revolving Lenders may amend, waive or otherwise modify this Section 6.12 or the defined terms used in this Section 6.12 (solely in respect of the use of such defined terms in this Section 6.12) or waive any Default or Event of Default resulting from a breach of this Section 6.12 without the consent of any Lenders other than the Required Revolving Lenders.
Article VII

Events of Default and Remedies
Section 3.01Events of Default.
If any of the following events (each, an “Event of Default”) shall occur on or after the Closing Date:
(a)any Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any LC Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise;
(b)any Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in clause (a) of this Section 7.01) payable under this Agreement or any other Loan Document, when and as the same shall become due and payable, and such failure shall continue unremedied for a period of five (5) Business Days;
(c)any representation or warranty made or deemed made by or on behalf of Holdings, any Borrower or any other Loan Party in or in connection with this Agreement or any other Loan Document or any amendment or modification hereof or thereof or waiver hereunder or thereunder, or in any certificate, financial statement or other instrument furnished pursuant to or in connection with this Agreement or any other Loan Document or any amendment or modification thereof or waiver thereunder, shall prove to have been incorrect in any material respect (or if such representation, warranty or statement is already qualified by materiality, in any respect) when made or deemed made); provided that (x) the failure of any representation or warranty made or deemed made by any Loan Party (other than the representations and warranties referred to in Section 4.01(f)) to be true and correct in any material respect on the Closing Date will not constitute an Event of Default and (y) in the case of any representation and/or warranty
171


that is capable of being cured, there shall be a grace period of 15 days following Holdings’ receipt of a written notice of the inaccuracy of the relevant representation, warranty or certification;
(d)Any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in Section 5.02, Section 5.03 (with respect to the legal existence of Holdings) or in Article VI; provided that Holdings’ or any Restricted Subsidiary’s failure to comply with the Financial Covenant (a “Financial Covenant Event of Default”) shall not constitute an Event of Default with respect to any Term Loans or Term Loan Commitments unless and until the Required Revolving Lenders have actually terminated the Revolving Commitments and declared all Obligations with respect to their Revolving Commitments to be immediately due and payable pursuant to this Section 7.01 as a result of such failure to comply (and such declaration has not been rescinded as of the applicable date) (the occurrence of such termination and declaration by the Required Revolving Lenders, a “Financial Covenant Cross Default”);
(e)Any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in this Agreement (other than those specified in clause (a), (b) or (d) of this Section 7.01) or any other Loan Document, and such failure shall continue unremedied for a period of thirty (30) days after notice thereof from the Administrative Agent to Holdings;
(f)Holdings or any Restricted Subsidiary shall fail to make any payment (whether of principal or interest and regardless of amount), in respect to any Material Indebtedness, when and as the same shall become due and payable after giving effect to any cure or grace period;
(g)any event or condition occurs that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits, after the expiration of any applicable grace period provided in the applicable agreement or instrument under which such Indebtedness was created, the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity; provided that this clause (g) shall not apply to (i) secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness, (ii) any redemption, repurchase, conversion, exchange or settlement with respect to any Convertible Debt Security pursuant to its terms unless such redemption, repurchase, conversion, exchange or settlement results from a default thereunder or an event of the type that constitutes an Event of Default, (iii) any early payment requirement or unwinding or termination with respect to any Swap Agreement (other than any such payment requirement or termination resulting from a default by Holdings or any Restricted Subsidiary), (iv) Indebtedness of any Person whose Equity Interests are being acquired in a Permitted Acquisition and which Indebtedness becomes due because of such Permitted Acquisition or (v) any breach or default that is (x) remedied by Holdings or the applicable Restricted Subsidiary or (y) waived (including in the form of an amendment) by the required holders of the applicable Indebtedness, in either case, prior to the acceleration of Loans pursuant to this Section 7.01;
(h)an involuntary case or application or proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization, winding-up, dissolution, examinership, compromise, arrangement or other relief in respect of Holdings or any Material Subsidiary or its debts, or of a substantial part of its assets, under any Federal, state or foreign bankruptcy, insolvency, receivership, examinership or similar law now or hereafter in effect or (ii) the appointment of a receiver, receiver and manager, trustee, custodian, sequestrator, conservator, examiner, liquidator or similar official for Holdings or any Material Subsidiary or for a substantial part of its assets, and, in any such case, such case or application or proceeding or
172


petition shall continue undismissed for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered;
(i)Holdings or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization, winding-up, dissolution, examinership, compromise, arrangement or other relief under any Federal, state or foreign bankruptcy, insolvency, examinership, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in clause (h) of this Section 7.01, (iii) apply for or consent to the appointment of a receiver, receiver and manager, trustee, custodian, sequestrator, conservator or similar official for, Holdings or any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing; provided, however, that the liquidation of any Restricted Subsidiary into another Restricted Subsidiary (so long as any such Restricted Subsidiary that is a Loan Party is liquidated into another Loan Party), other than as part of a credit reorganization, shall not constitute an Event of Default under this clause (i);
(j)one or more judgments for the payment of money in an aggregate amount in excess of the greater of $175,000,000 and 15% of Consolidated EBITDA for the Test Period most recently ended on or prior to the date of such determination (or the equivalent amount in any other currency) shall be rendered against Holdings or any Restricted Subsidiary or any combination thereof and the same shall remain undischarged for a period of sixty (60) consecutive days during which execution shall not be effectively stayed, vacated, discharged or bonded pending appeal; provided that any such amount shall be calculated after deducting from the sum so payable any amount of such judgment or order that is covered by a valid and binding policy of insurance in favor of Holdings or such Restricted Subsidiary (but only if the applicable insurer shall have been advised of such judgment and of the intent of Holdings or such Restricted Subsidiary to make a claim in respect of any amount payable by it in connection therewith and such insurer shall not have disputed coverage);
(k)an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect;
(l)(i) a contribution required to be made with respect to a Non-U.S. Plan has not been timely made; or Holdings or any Restricted Subsidiary has incurred any obligation in connection with the termination of, or withdrawal from, any Non-U.S. Plan; (ii) there shall result from any such event or events the imposition of a lien, the granting of a security interest or a liability; and (iii) such lien, security interest or liability, individually, and/or in the aggregate, has had, or could reasonably be expected to have a Material Adverse Effect;
(m)any material provision of any Loan Document for any reason ceases to be valid, binding and enforceable in accordance with its terms (or Holdings or any other Loan Party shall challenge the enforceability of any Loan Document or shall assert in writing that any provision of any of the Loan Documents has ceased to be or otherwise is not valid, binding and enforceable in accordance with its terms);
(n)any Collateral Document shall for any reason fail to create a valid and perfected first priority (subject to Permitted Liens) security interest in any material portion of the Collateral purported to be covered thereby, except as permitted by the terms of any Loan Document or the Agreed Guarantee and Security Principles, or as a result of any act or omission of the Administrative Agent so long as not resulting from the breach or non-compliance with any Loan Document by any Loan Party; or
173


(o)A Change of Control shall occur;
then, and in every such event (other than an event with respect to Holdings or any Borrower described in clause (h) or (i) of this Section 7.01), and at any time thereafter during the continuance of such event, the Administrative Agent may, and, at the request of the Required Lenders, shall, by notice to the Borrowers, (I) declare the Revolving Commitments of each Revolving Lender and any obligation of the Issuing Banks to issue, amend, renew or extend any Letter of Credit and the Swingline Lender to make Swingline Loans to be terminated, whereupon such Revolving Commitments and obligation will be terminated, (II) declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other Secured Obligations accrued hereunder and under the other Loan Documents, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and each Guarantor and (III) require the Revolving Borrowers to Cash Collateralize the then outstanding Letters of Credit (in an amount in cash equal to 102% of the Dollar Amount of the LC Exposure as of such date plus any accrued and unpaid interest thereon); and in case of any event with respect to Holdings or any Borrower described in clause (h) or (i) of this Section 7.01, (I) the Revolving Commitments of each Revolving Lender and any obligation of the Issuing Banks to issue Letters of Credit and any obligation of the Swingline Lender to make Swingline Loans will automatically terminate, (II) the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other Secured Obligations accrued hereunder and under the other Loan Documents, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Borrower and each Guarantor and (III) the obligation of the Revolving Borrowers to Cash Collateralize the Letters of Credit as aforesaid will automatically become effective; provided that, notwithstanding anything to the contrary, if the only Events of Default then having occurred and continuing are pursuant to a Financial Covenant Event of Default, then, unless a Financial Covenant Cross Default has occurred and is continuing, the Administrative Agent shall only take the actions set forth in this Section 7.01 at the request (or with the consent) of the Required Revolving Lenders (as opposed to the Required Lenders) and only with respect to the Revolving Commitments, Revolving Loans, Letters of Credit, Swingline Loans and obligations of the Revolving Lenders. Upon the occurrence and during the continuance of an Event of Default, the Administrative Agent may, and at the request of the Required Lenders shall, exercise any rights and remedies provided to the Administrative Agent under the Loan Documents or at law or equity, including all remedies provided under the UCC.
Section 3.02Borrowers’ Right to Cure. Notwithstanding anything to the contrary contained in Section 7.01:
(a)For the purpose of determining whether an Event of Default under the Financial Covenant has occurred, Holdings may on one or more occasions designate any portion of the net cash proceeds from a sale or issuance of Qualified Equity Interests of Holdings or any contribution to the common capital of Holdings (or from any other contribution to capital or sale or issuance of any other Equity Interests) (the “Cure Amount”), as an increase to Consolidated EBITDA for the applicable fiscal quarter; provided that (i) such amounts to be designated are actually received by Holdings on or after the first day of such applicable fiscal quarter and on or prior to the twentieth (20th) Business Day after the date on which financial statements are required to be delivered with respect to such applicable fiscal quarter (the “Cure Expiration Date”), (ii) such amounts do not exceed the aggregate amount necessary to cure any Event of Default under the Financial Covenant as of such date and (iii) the Revolving Borrowers shall have provided notice to the Administrative Agent on the date such amounts are designated as a “Cure Amount” (it being understood that to the extent any such notice is provided in advance of delivery
174


of a Compliance Certificate for the applicable period, the amount of such net cash proceeds that is designated as the Cure Amount may be different than the amount necessary to cure any Event of Default under the Financial Covenant and may be modified, as necessary, in a subsequent corrected notice delivered on or before the Cure Expiration Date (it being understood that in any event the final designation of the Cure Amount shall continue to be subject to the requirements set forth in clauses (i) and (ii) above)). The Cure Amount used to calculate Consolidated EBITDA for one fiscal quarter shall be used and included when calculating Consolidated EBITDA for each Test Period that includes such fiscal quarter.
(b)The parties hereby acknowledge that this Section 7.02 may not be relied on for purposes of calculating any financial ratios other than for determining actual compliance with Section 6.12 (and not Pro Forma Basis with Section 6.12 that is required by any other provision of this Agreement) and shall not result in any adjustment to any amounts (including the amount of Indebtedness) or increase in cash (and shall not be included for purposes of determining pricing, mandatory prepayments and the availability or amount permitted pursuant to any covenant under Article VI) with respect to the fiscal quarter with respect to which such Cure Amount was made other than the amount of the Consolidated EBITDA referred to in Section 7.02(a).
(c)In furtherance of clause (a) above, (A) upon actual receipt and designation of the Cure Amount by one or more Borrowers, the Financial Covenant shall be deemed satisfied and complied with as of the end of the relevant fiscal quarter with the same effect as though there had been no failure to comply with the Financial Covenant and any Event of Default under the Financial Covenant shall be deemed not to have occurred for purposes of the Loan Documents, and (B) upon delivery to the Administrative Agent prior to the Cure Expiration Date of a notice from Holdings stating its good faith intention to exercise its right set forth in this Section 7.02, neither the Administrative Agent nor any Lender may exercise any rights or remedies under Section 7.01 (or under any other Loan Document) on the basis of any actual or purported Event of Default under the Financial Covenant until and unless the Cure Expiration Date has occurred without the Cure Amount having been received and designated. Notwithstanding the foregoing, after the occurrence of an Event of Default under the Financial Covenant, the Revolving Borrowers shall not be able to request the making of any Revolving Loan or the issuance of any Letter of Credit under the Revolving Commitments during the period from the date on which the financial statements in respect of the applicable fiscal quarter or fiscal year are required to be delivered pursuant to Section 5.01(a) or (b) until receipt by one or more Borrowers of the Cure Amount or waiver of the Event of Default.
(d)(i) In each period of four (4) consecutive fiscal quarters, there shall be at least two consecutive (2) fiscal quarters in which no cure right set forth in this Section 7.02 is exercised and (ii) there shall be no pro forma reduction in Indebtedness with the Cure Amount for determining compliance with the Financial Covenant for the fiscal quarter with respect to which such Cure Amount was made.
(e)There can be no more than five (5) fiscal quarters in which the cure rights set forth in this Section 7.02 are exercised during the term of the Revolving Commitments and any Extended Revolving Commitments in respect thereof.
Article VIII

The Agents
Section 3.01The Agents.
Each of the Lenders and the Issuing Banks hereby irrevocably appoints Citibank, N.A. as its administrative agent and authorizes Citibank, N.A. to take such actions on its behalf,
175


including execution of the other Loan Documents, and to exercise such powers as are delegated to the Administrative Agent by the terms of the Loan Documents, together with such actions and powers as are reasonably incidental thereto, and Citibank, N.A. hereby accepts such appointment.
Citibank, N.A., London Branch or an Affiliate or designee thereof shall act as the Collateral Agent under the Loan Documents (for purposes of this Section 8.01 and Sections 9.03 and 2.17, the Administrative Agent and the Collateral Agent shall be collectively referred to as the “Agents”), and each of the Lenders and the Issuing Banks hereby irrevocably appoints and authorizes Citibank, N.A. (and Citibank, N.A., London Branch hereby accepts such appointment) and each such Affiliate and designee to act as the agent of such Lender and Issuing Bank for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the Secured Obligations, together with such powers and discretion as are reasonably incidental thereto. In this connection, any co-agents, sub-agents and attorneys-in-fact appointed by the Collateral Agent pursuant to this Section 8.01 for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the Collateral Documents, or for exercising any rights and remedies thereunder at the direction of the Administrative Agent, shall be entitled to the benefits of all provisions of this Section 8.01 and Article IX (including Section 9.03), as though such co-agents, sub-agents and attorneys-in-fact were the Collateral Agent under the Loan Documents as if set forth in full herein with respect thereto.
Except as otherwise provided in this Section 8.01, the provisions of this Article are solely for the benefit of the Agents and the Lenders, and the Borrowers shall not have rights as third-party beneficiaries of any of such provisions.
The banks serving as the Agents hereunder shall have the same rights and powers in their capacity as Lenders as any other Lender and may exercise the same as though they were not an Agent, and such banks and their Affiliates may accept deposits from, lend money to and generally engage in any kind of business with Holdings or any Subsidiary or other Affiliate thereof as if they were not an Agent hereunder.
The Agents shall not have any duties or obligations except those expressly set forth in the Loan Documents to which such Agent is a party. Without limiting the generality of the foregoing, (a) the Agents shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing, (b) the Agents shall not have any duty to take any discretionary action or exercise any discretionary powers including, without limitation, the timing and methods of realization of the Collateral, except discretionary rights and powers expressly contemplated by the Loan Documents that the respective Agent is required to exercise in writing as directed (i) in the case of the Collateral Agent, by the Administrative Agent (acting at the direction of the Required Lenders) or (ii) in the case of the Administrative Agent, by the Required Lenders (or such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02), and no Agent shall be required to take any action or omit to take any action (including disclosing information) that in its reasonable opinion or the opinion of its counsel, may expose it to liability, be contrary to any Loan Document or constitute a breach of any Law (including, but not limited to, any Law of England and Wales and the United States), and (c) except as expressly set forth in the Loan Documents, the Agents shall not have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Holdings or any of its Subsidiaries that is communicated to or obtained by any bank serving as an Agent or any of its Affiliates in any capacity. The Agents shall not be liable for any action taken or not taken by them with the consent or at the request of (i) in the case of the Collateral Agent, the Administrative Agent (acting at the direction of the Required Lenders) or (ii) in the case of the Administrative Agent, the Required Lenders (or in each case, such other number or percentage of the Lenders as shall be necessary under the circumstances as provided in Section 9.02 or elsewhere in the Loan Documents) or in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and non-appealable
176


judgment. The Agents shall be deemed not to have knowledge of any Default unless and until written notice thereof is given to the respective Agent by Holdings, a Borrower or a Lender, and no Agent shall be responsible for or have any duty to ascertain or inquire into (i) any recital, statement, warranty or representation made in or in connection with any Loan Document, (ii) the contents or accuracy of any certificate, report or other document delivered hereunder or in connection with any Loan Document, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth in any Loan Document, (iv) the legality, validity, enforceability, effectiveness, genuineness or sufficiency of any Loan Document, the Collateral or any other agreement, instrument or document, (v) the creation, validity, perfection, priority or enforceability of Liens on the Collateral or the existence, genuineness, sufficiency or value of the Collateral, (vi) the satisfaction of any condition set forth in Article IV or elsewhere in any Loan Document, other than to confirm receipt of items expressly required to be delivered to such Agent or (vii) the properties, books or records of the Borrowers.

The Agents shall not be required to expend or risk any of its own funds or otherwise incur any liability, financial or otherwise, in the performance of any of its duties hereunder or under any Loan Document to which it is a party, or be required to take any action that is contrary to this Agreement or applicable Law.
The Agents shall not be responsible for insuring the Collateral or for the payment of Taxes, charges, assessments or Liens upon the Collateral or otherwise as to the maintenance of the Collateral; nor shall any Agent have any duty to see to the payment or discharge of any tax, assessment or other governmental charge relating to the Collateral or any lien or encumbrance of any kind with respect to the Collateral.
The Agents shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing believed by them to be genuine and to have been signed or sent by the proper Person. The Agents also may rely upon any statement made to them orally or by telephone and believed by them to be made by the proper Person, and shall not incur any liability for relying thereon. The Agents may consult with legal counsel (who may be counsel for Holdings, the Subsidiary Guarantors or the Borrowers), independent accountants and other experts selected by them, and shall not be liable for any action taken or not taken by them in accordance with the advice of any such counsel, accountants or experts. Notwithstanding anything else to the contrary herein, each Agent may refrain from acting in accordance with any instructions or requests given by the Lenders (or, in the case of the Collateral Agent, given by the Administrative Agent at the direction of the Lenders) unless it shall first be indemnified to its satisfaction by the Lenders against any and all liability, cost and expense that may be incurred by it by reason of taking or continuing to take any such action in compliance with the instruction or request. Each Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or, as applicable in the case of the Collateral Agent, given by the Administrative Agent at the direction of the Lenders), and such request and any action taken or failure to act pursuant thereto shall be binding upon the Lenders and all future Lenders.
The Agents may perform any and all their duties and exercise their rights and powers by or through any one or more sub-agents appointed by the respective Agent. The Agents and any such sub-agent may perform any and all their duties and exercise its rights and powers through their respective Related Parties. The exculpatory provisions of the preceding paragraphs shall apply to any such sub-agent and to the Related Parties of the Agents and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as an Agent. The Agents shall not be responsible for the negligence or misconduct of any sub-agent that it selects in the absence of gross negligence or willful misconduct by the Agents, as determined in a final and non-appealable judgment by a court of competent jurisdiction.
177


The Agents shall not incur any liability for not performing any act or fulfilling any duty, obligation or responsibility hereunder by reason of any occurrence beyond the control of the Agents (including but not limited to any act or provision of any present or future Law, any act of God or war, civil unrest, local or national disturbance or disaster, any act of terrorism, or the unavailability of the Federal Reserve Bank wire or facsimile or other wire or communication facility).
The Agents shall not be obligated to carry out any particular “know your customer” or other checks on behalf of any Secured Party or otherwise.
The Agents may refrain without liability from doing anything that they determine, in reliance upon advice of legal counsel, would or might be contrary to any applicable Law (including but not limited to the Laws of the United States of America or any jurisdiction forming a part of it and of England and Wales) or any directive or regulation of any agency of any such state or jurisdiction and may without liability do anything which is, in its opinion in reliance upon the advice of legal counsel, necessary to comply with any such Law.
Subject to the appointment and acceptance of a successor Administrative Agent as provided in this paragraph, the Administrative Agent may resign at any time by notifying the Lenders, the Issuing Banks and the Borrowers. Any such resignation by the Administrative Agent hereunder shall also constitute its resignation as an Issuing Bank and the Swingline Lender, as applicable, in which case the resigning Administrative Agent (x) shall not be required to issue any further Letters of Credit or make any additional Swingline Loans hereunder and (y) shall maintain all of its rights as Issuing Bank or Swingline Lender, as the case may be, with respect to any Letters of Credit issued by it, or Swingline Loans made by it, prior to the date of such resignation. Upon any such resignation, the Required Lenders shall have the right (with the consent of the Borrowers (such consent not to be unreasonably withheld or delayed), provided that no consent of the Borrowers shall be required if an Event of Default under clause (a), (b), (h), (i) or (j) of Section 7.01 has occurred and is continuing) to appoint a successor. If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may, on behalf of the Lenders and the Issuing Banks, appoint a successor Administrative Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank (or another financial institution acceptable to Holdings). Upon the acceptance of its appointment as Administrative Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Administrative Agent, and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder. The fees payable by the Borrowers to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor. After the Administrative Agent’s resignation hereunder, the provisions of this Section 8.01 and Section 9.03 shall continue in effect for the benefit of such retiring Administrative Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while it was acting as Administrative Agent.
Subject to the appointment and acceptance of a successor Collateral Agent as provided in this paragraph, the Collateral Agent may resign at any time by notifying the Lenders and the Borrowers. Upon any such resignation, the Required Lenders shall have the right (with the consent of the Borrowers (such consent not to be unreasonably withheld or delayed); provided that no consent of the Borrowers shall be required if an Event of Default under clause (a), (b), (h), (i) or (j) of Section 7.01 has occurred and is continuing) to appoint a successor. If no successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Collateral Agent gives notice of its resignation, then the retiring Collateral Agent may, on behalf of the Lenders, appoint a successor Collateral Agent which shall be a bank with an office in New York, New York, or an Affiliate of any such bank.
178


Upon the acceptance of its appointment as Collateral Agent hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Collateral Agent, and the retiring Collateral Agent shall be discharged from its duties and obligations hereunder. The fees payable by the Borrowers to a successor Collateral Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor. After the Collateral Agent’s resignation hereunder, the provisions of this Section 8.01 and Section 9.03 shall continue in effect for the benefit of such retiring Collateral Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while it was acting as Collateral Agent.
Each Lender acknowledges that it has, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Agents or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.
None of the Lenders, if any, identified in this Agreement as a Lead Arranger shall have any right, power, obligation, liability, responsibility or duty under this Agreement other than those applicable to all Lenders as such. Without limiting the foregoing, none of such Lenders shall have or be deemed to have a fiduciary relationship with any Lender. Each Lender hereby makes the same acknowledgments with respect to the relevant Lenders in their respective capacities as a Lead Arranger as it makes with respect to the Agents in the preceding paragraph.
The Lenders are not partners or co-venturers, and no Lender shall be liable for the acts or omissions of, or (except as otherwise set forth herein in case of the Agents) authorized to act for, any other Lender. The Agents shall have the exclusive right on behalf of the Lenders to enforce the payment of the principal of and interest on any Loan after the date such principal or interest has become due and payable pursuant to the terms of this Agreement.
In their respective capacities, the Agents are “representatives” of the Secured Parties within the meaning of the term “secured party” as defined in the UCC. Each Lender authorizes the Agents to enter into each of the Collateral Documents to which it is a party and related documents in connection therewith and to take all action contemplated by such documents. Each Lender agrees that no Secured Party (other than the Agents) shall have the right individually to seek to realize upon the security granted by any Collateral Document, it being understood and agreed that such rights and remedies may be exercised solely by the Agents for the benefit of the Secured Parties upon the terms of the Collateral Documents. In the event that any Collateral is hereafter pledged by any Person as collateral security for the Secured Obligations, the Agents are hereby authorized, and hereby granted a power of attorney, to execute and deliver on behalf of the Secured Parties any Loan Documents necessary or appropriate to grant and perfect a Lien on such Collateral in favor of the Collateral Agent on behalf of the Secured Parties. The Lenders hereby authorize the Collateral Agent to release or, as applicable, subordinate any Lien granted to or held by the Collateral Agent upon any Collateral and to enter into non-disturbance or similar agreements, in each case, to the extent and in the circumstances described in Section 9.13. Upon request by the Collateral Agent at any time, the Lenders will confirm in writing the Collateral Agent’s authority to release or subordinate particular types or items of Collateral and enter into non-disturbance or similar agreements pursuant hereto.
The Administrative Agent and the Collateral Agent are authorized to (and at the request of the Borrowers will) enter into any Intercreditor Agreement (and any amendments, amendments and restatements, restatements or waivers of or supplements to or other modifications to, and extensions, restructuring, renewals, replacements of, such agreements) in
179


connection with the incurrence by any Loan Party of any Permitted Junior Secured Refinancing Debt, Permitted Pari Passu Secured Refinancing Debt, Alternative Incremental Facility Indebtedness, Permitted Refinancing Indebtedness or Indebtedness incurred pursuant to clauses (1) and (2) of the proviso set forth in Section 6.01(a) with respect thereto, or any other Indebtedness permitted by the terms of this Agreement to be secured by the Collateral on a pari passu or junior priority secured basis, in each case in order to permit such Indebtedness to be secured by a valid, perfected Lien (with such priority as may be designated by Holdings or relevant Restricted Subsidiary, to the extent such priority is permitted by the Loan Documents), and the parties hereto acknowledge that each Intercreditor Agreement is (if entered into) binding upon them. Each Lender (a) understands, acknowledges and agrees that Liens may be created on the Collateral pursuant to the documentation relating to any Indebtedness incurred as permitted by this Agreement which is (in accordance with the terms hereof) to be secured thereby, on a pari passu, or junior, secured basis to the Liens securing the Secured Obligations, which Liens securing any such other Indebtedness shall be subject to the terms and conditions of the relevant Intercreditor Agreement executed and delivered as required hereby, (b) hereby agrees that it will be bound by and will take no actions contrary to the provisions of the respective Intercreditor Agreement (if entered into) and (c) hereby authorizes and instructs the Administrative Agent and Collateral Agent to enter into any Intercreditor Agreement (and any amendments, amendments and restatements, restatements or waivers of or supplements to or other modifications to, such agreements) in connection with the incurrence by any Loan Party of any secured Indebtedness as contemplated above, in order to permit such Indebtedness to be secured by a valid, perfected Lien (with such priority as may be designated by the Applicable Borrower or relevant Restricted Subsidiary, to the extent such priority is permitted by the Loan Documents), and to subject the Liens on the Collateral securing the Secured Obligations to the provisions thereof.
Section 3.02Erroneous Payments.
(a)If the Administrative Agent notifies a Lender, Issuing Bank or Secured Party, or any Person who has received funds on behalf of a Lender, Issuing Bank or Secured Party such Lender or Issuing Bank (any such Lender, Issuing Bank, Secured Party or other recipient, a “Payment Recipient”) that the Administrative Agent has determined in its sole discretion (whether or not after receipt of any notice under immediately succeeding clause (b)) that any funds received by such Payment Recipient from the Administrative Agent or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender, Issuing Bank, Secured Party or other Payment Recipient on its behalf) (any such funds, whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise, individually and collectively, an “Erroneous Payment”) and demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property of the Administrative Agent and shall be segregated by the Payment Recipient and held in trust for the benefit of the Administrative Agent, and such Lender, Issuing Bank or Secured Party shall (or, with respect to any Payment Recipient who received such funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two Business Days thereafter, return to the Administrative Agent the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to the Administrative Agent in same day funds at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation from time to time in effect. A notice of the Administrative Agent to any Payment Recipient under this clause (a) shall be conclusive, absent manifest error.
(b)Without limiting immediately preceding clause (a), each Lender, Issuing Bank or Secured Party, or any Person who has received funds on behalf of a Lender, Issuing Bank
180


or Secured Party such Lender or Issuing Bank, hereby further agrees that if it receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise) from the Administrative Agent (or any of its Affiliates) (x) that is in a different amount than, or on a different date from, that specified in a notice of payment, prepayment or repayment sent by the Administrative Agent (or any of its Affiliates) with respect to such payment, prepayment or repayment, (y) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent by the Administrative Agent (or any of its Affiliates), or (z) that such Lender, Issuing Bank or Secured Party, or other such recipient, otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part) in each case:
(i)(A) in the case of immediately preceding clauses (x) or (y), an error shall be presumed to have been made (absent written confirmation from the Administrative Agent to the contrary) or (B) an error has been made (in the case of immediately preceding clause (z)), in each case, with respect to such payment, prepayment or repayment; and
(ii)such Lender, Issuing Bank or Secured Party shall (and shall cause any other recipient that receives funds on its respective behalf to) promptly (and, in all events, within one Business Day of its knowledge of such error) notify the Administrative Agent of its receipt of such payment, prepayment or repayment, the details thereof (in reasonable detail) and that it is so notifying the Administrative Agent pursuant to this Section 8.02(b).
(c)Each Lender, Issuing Bank or Secured Party hereby authorizes the Administrative Agent to set off, net and apply any and all amounts at any time owing to such Lender, Issuing Bank or Secured Party under any Loan Document, or otherwise payable or distributable by the Administrative Agent to such Lender, Issuing Bank or Secured Party from any source, against any amount due to the Administrative Agent under immediately preceding clause (a) or under the indemnification provisions of this Agreement.
(d)In the event that an Erroneous Payment (or portion thereof) is not recovered by the Administrative Agent for any reason, after demand therefor by the Administrative Agent in accordance with immediately preceding clause (a), from any Lender or Issuing Bank that has received such Erroneous Payment (or portion thereof) (and/or from any Payment Recipient who received such Erroneous Payment (or portion thereof) on its respective behalf) (such unrecovered amount, an “Erroneous Payment Return Deficiency”), upon the Administrative Agent’s notice to such Lender or Issuing Bank at any time, (i) such Lender or Issuing Bank shall be deemed to have assigned its Loans (but not its Commitments) of the relevant Class with respect to which such Erroneous Payment was made (the “Erroneous Payment Impacted Class”) in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount as the Administrative Agent may specify) (such assignment of the Loans (but not Commitments) of the Erroneous Payment Impacted Class, the “Erroneous Payment Deficiency Assignment”) at par plus any accrued and unpaid interest (with the assignment fee to be waived by the Administrative Agent in such instance), and is hereby (together with the Borrower) deemed to execute and deliver an Assignment and Assumption (or, to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to the Platform as to which the Administrative Agent and such parties are participants) with respect to such Erroneous Payment Deficiency Assignment, and such Lender or Issuing Bank shall deliver any Notes evidencing such Loans to Holdings or the Administrative Agent, (ii) the Administrative Agent as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, the Administrative Agent as the assignee Lender shall become a Lender or Issuing Bank, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning Lender or assigning Issuing Bank shall cease to be a
181


Lender or Issuing Bank, as applicable, hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Commitments which shall survive as to such assigning Lender or assigning Issuing Bank and (iv) the Administrative Agent may reflect in the Register its ownership interest in the Loans subject to the Erroneous Payment Deficiency Assignment. The Administrative Agent may, in its discretion, sell any Loans acquired pursuant to an Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing by the applicable Lender or Issuing Bank shall be reduced by the net proceeds of the sale of such Loan (or portion thereof), and the Administrative Agent shall retain all other rights, remedies and claims against such Lender or Issuing Bank (and/or against any recipient that receives funds on its respective behalf). For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Commitments of any Lender or Issuing Bank and such Commitments shall remain available in accordance with the terms of this Agreement. In addition, each party hereto agrees that, except to the extent that the Administrative Agent has sold a Loan (or portion thereof) acquired pursuant to an Erroneous Payment Deficiency Assignment, and irrespective of whether the Administrative Agent may be equitably subrogated, the Administrative Agent shall be contractually subrogated to all the rights and interests of the applicable Lender, Issuing Bank or Secured Party under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the “Erroneous Payment Subrogation Rights”).
(e)The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower or any other Loan Party, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of such Erroneous Payment that is, comprised of funds received by the Administrative Agent from any Borrower or any other Loan Party for the purpose of making such Erroneous Payment.
(f)To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to an Erroneous Payment, and hereby waives, and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by the Administrative Agent for the return of any Erroneous Payment received, including without limitation waiver of any defense based on “discharge for value” or any similar doctrine
(g)Each party’s obligations, agreements and waivers under this Section 8.02 shall survive the resignation or replacement of the Administrative Agent, any transfer of rights or obligations by, or the replacement of, a Lender or Issuing Bank, the termination of the Commitments and/or the repayment, satisfaction or discharge of all Obligations (or any portion thereof) under any Loan Document.
    (h)    Notwithstanding anything to the contrary herein or in any other Loan Document, no Loan Party or any of their respective Affiliates shall have any obligations or liabilities directly or indirectly arising out of this Section 8.02 in respect of any Erroneous Payment (other than having consented to the assignment referenced in Section 8.02(d) above).
Article IX

Miscellaneous
Section 3.01Notices.
(a)Except in the case of notices and other communications expressly permitted to be given by telephone (and subject to paragraph (b) below), all notices and other
182


communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by email, as follows:
(i)if to the Borrowers or any Loan Party, to the Borrowers at:
Attention: Chief Financial Officer with a copy to General Counsel
ICON plc
South County Business Park
Leopardstown
Dublin 18
Ireland
Email: Libhin.NicGabhann@iconplc.com with a copy to ICON General Counsel: Diarmaid.Cunningham@iconplc.com
Phone: +353 1 2912000

Attention: Board of Directors
ICON Luxembourg S.à r.l.
61 rue de Rollingerfrund
L- 2440
Luxembourg
Email: Michael.Gleeson@iconplc.com with a copy to ICON General Counsel: Diarmaid.Cunningham@iconplc.com
        Phone: +353 1 2912000

(ii)if to the Administrative Agent, to it at Citibank Delaware, One Penns Way, OPS 2/2, New Castle, DE 19720; Attn: Agency Operations; Phone: (302) 894-6010; Fax: (646) 274-5080; Borrower inquiries only: AgencyABTFSupport@citi.com; Borrower notifications: AgencyABTFSupport@citi.com; Disclosure Team Mail (Financial Reporting): Oploanswebadmin@citi.com; Investor Relations Team (investor inquiries only): global.loans.support@citi.com, or such other office or person as the Administrative Agent may hereafter designate in writing as such to the other parties hereto;
(iii)if to the Collateral Agent, to it at Citibank, N.A., London Branch, 6th Floor CGC1, Citigroup Centre, Canada Square, London, E14 5LB, United Kingdom, Attention: PFLA Team, Agency and Trust (Email issuerpfla@citi.com); and
(iv)if to any Lender or Issuing Bank, to it at its address (or telecopy number) set forth in its Administrative Questionnaire.
(b)Notices and other communications to the Administrative Agent or the Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices pursuant to Article II unless otherwise agreed by the Administrative Agent and the applicable Lender. The Administrative Agent or the Borrowers may, in their discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications.
(c)The Platform. THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE”. THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR
183


ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Administrative Agent or any of its Related Parties or any Lead Arranger (collectively, the “Agent Parties”) have any liability to any Loan Party, any Lender, or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of any Loan Party’s or the Administrative Agent’s transmission of Borrower Materials through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Agent Party; provided, however, that in no event shall any Agent Party have any liability to any Loan Party, any Lender or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).
(d)Any party hereto may change its address, email address or telephone number for notices and other communications hereunder by notice to the other parties hereto. All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt. Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable Law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the “Public Side Information” portion of the Platform and that may contain material non-public information with respect to Holdings, the Borrowers or their respective subsidiaries and its or their securities for purposes of United States Federal or state securities laws.
Section 3.02Waivers; Enforcement; Amendments.
(a)(i)    No failure or delay by the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender in exercising any right or power hereunder or under any other Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the Administrative Agent, the Collateral Agent, the Issuing Banks and the Lenders hereunder and under the other Loan Documents are cumulative and are not exclusive of any rights or remedies that they would otherwise have. No waiver of any provision of any Loan Document or consent to any departure by any Applicable Borrower therefrom shall in any event be effective unless the same shall be permitted by paragraph (b) of this Section 9.02, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. Without limiting the generality of the foregoing, the making of a Loan or issuance, extension or amendment of a Letter of Credit shall not be construed as a waiver of any Default, regardless of whether the Administrative Agent, the Collateral Agent, any Lender or any Issuing Bank may have had notice or knowledge of such Default at the time.
        (ii)    Notwithstanding anything to the contrary contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent or the Collateral Agent in accordance with Article VII for the benefit of all the Lenders and the Issuing Banks.
184


(b)Except as provided in Section 2.14, Section 2.20 with respect to an Incremental Amendment, Section 2.22 with respect to an Extension Amendment and Section 2.24 with respect to a Refinancing Amendment, neither this Agreement, any other Loan Document nor any provision hereof or thereof may be waived, amended or modified except pursuant to an agreement or agreements in writing entered into by (A) the Applicable Borrower and the Required Lenders or (B) by the Applicable Borrower and the Administrative Agent with the consent of the Required Lenders (in each case other than, with respect to any amendment or waiver contemplated in clauses (viii), (ix) and (xi) below, which shall only require the consent of the Required Revolving Lenders under the applicable Class of Revolving Commitments, as applicable (and not the Required Lenders)); provided that no such agreement shall (i) increase the Commitment of any Lender without the written consent of such Lender, (ii) reduce the principal amount of any Loan or LC Disbursement or reduce the rate of interest thereon or reduce any fees payable hereunder, without the written consent of each Lender directly affected thereby; provided that only the consent of the Required Lenders shall be necessary to reduce or waive any obligation of any Borrower to pay interest or fees at the applicable default rate set forth in Section 2.13(d), (iii) postpone the scheduled date of payment of the principal amount of any Loan (other than any reduction of the amount of, or any extension of the payment date for, the mandatory prepayments required under Section 2.11, in each case which shall only require the approval of the Required Lenders), or any interest thereon (other than interest payable at the applicable default rate of interest set forth in Section 2.13(d)), or any fees payable hereunder, or reduce the amount of, waive or excuse any such payment, or postpone the scheduled date of expiration of any Commitment, without the written consent of each Lender directly affected thereby, (iv) change Section 2.18(b) or (c) in a manner that would alter the pro rata sharing of payments required thereby, without the written consent of each Lender directly and adversely affected thereby, (v) change any of the provisions of this Section 9.02 or the definitions of “Required Lenders” or “Majority in Interest” or any other provision hereof specifying the number or percentage of Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Lender (it being understood that, solely with the consent of the parties prescribed by Section 2.20 or Section 2.24 to be parties to an Incremental Amendment or a Refinancing Amendment, as applicable, Incremental Loans and Other Refinancing Loans may be included in the determination of Required Lenders on substantially the same basis as the Term Loans are included on the Closing Date), (vi) except as provided in Section 9.13, release all or substantially all of the Guarantors from their obligations under the Guaranty without the written consent of each Lender, (vii) except as provided in Section 9.13 or in any Collateral Document, release all or substantially all of the Collateral, without the written consent of each Lender, (viii) amend, waive or otherwise modify any term or provision (including the waiver of any conditions set forth in Section 4.02 as to any credit extension under one or more Revolving Commitments) which directly affects Lenders under one or more Revolving Commitments and does not directly affect Lenders under any Term Loan Commitments, in each case, without the written consent of the Required Revolving Lenders under such applicable Class of Revolving Commitments (and in the case of multiple Revolving Commitments which are affected, such Required Revolving Lenders shall consent together as one Revolving Commitment); provided, however, that the waivers described in this clause (viii) shall not require the consent of any Lenders other than the Required Revolving Lenders under the applicable Class of Revolving Commitments; (ix) amend, waive or otherwise modify the Financial Covenant or any definition related thereto (solely in respect of the use of such defined terms in the Financial Covenant) or waive any Default or Event of Default resulting from a failure to perform or observe the Financial Covenant without the written consent of the Required Revolving Lenders (and in the case of multiple Revolving Commitments which are affected, such Required Revolving Lenders shall consent together as one Revolving Commitment); provided, however, that the amendments, waivers and other modifications described in this clause (ix) shall not require the consent of any Lenders other than the Required Revolving Lenders under the applicable Class of Revolving Commitments, (x) change any provisions of any Loan Document in a manner that by its terms adversely affects the rights in respect of payments due (including, for the avoidance of doubt, scheduled date of payment of the principal amount of any Loan (or any
185


interest thereon), mandatory prepayments or postpone the scheduled date of expiration of any Commitment) to Lenders holding Loans of any Class differently than those holding Loans of any other Class without the written consent of Lenders representing a Majority in Interest of each adversely affected Class, (xi) change the definition of “Required Revolving Lenders” or any other provision hereof specifying the number or percentage of Revolving Lenders required to waive, amend or modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Revolving Lender; provided, however, that the amendments, waivers and other modifications described in this clause (xi) shall not require the consent of any Lenders other than the Revolving Lenders under the applicable Class of Revolving Commitments or (xii) subordinate the Liens on the Collateral securing the Obligations to the Liens securing any other Indebtedness or subordinate the Obligations in right of payment to any other Indebtedness, other than indebtedness or liens in respect of which such subordination is permitted under Section 9.13 of this Agreement (as in effect on the Closing Date), in each case, without the written consent of each Lender; provided, further, that no such agreement shall amend, modify or otherwise affect the rights or duties of the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender hereunder without the prior written consent of the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender, as the case may be; provided, further, this Agreement and any other Loan Document may be amended with the consent of the Administrative Agent and the Borrowers (and without the consent of any other party) to add parallel debt or other foreign law provisions that the Administrative Agent and the Borrowers determine are necessary or advisable with respect to the jurisdiction of organization or incorporation of any Loan Party.
(c)Notwithstanding the foregoing, this Agreement and any other Loan Document may be amended (or amended and restated) with the written consent of the Required Lenders, the Administrative Agent and the Borrowers (x) to add one or more credit facilities (in addition to the Incremental Term Loans pursuant to an Incremental Amendment and any Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment) to this Agreement and to permit extensions of credit from time to time outstanding thereunder and the accrued interest and fees in respect thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Revolving Loans, the Term Loans, Incremental Term Loans and the accrued interest and fees in respect thereof and (y) to include appropriately the Lenders holding such credit facilities in any determination of the Required Lenders and Lenders, and for purposes of the relevant provisions of Section 2.18(b).
(d)If, in connection with any proposed amendment, waiver or consent requiring the consent of “each Lender” or “each Lender directly affected thereby,” the consent of the Required Lenders is obtained, but the consent of other necessary Lenders is not obtained (any such Lender whose consent is necessary but not obtained being referred to herein as a “Non-Consenting Lender”), then the Applicable Borrower may elect to (i) if no Event of Default exists, permanently prepay all of the Loans of any Class owing by it to, and terminating any Commitments of, each such Non-Consenting Lender or (ii) replace a Non-Consenting Lender as a Lender party to this Agreement; provided that, concurrently with such replacement, (i) another bank or other entity (which is reasonably satisfactory to the Applicable Borrower and the Administrative Agent) shall agree, as of such date, to purchase for cash the Loans and other Obligations due to the Non-Consenting Lender pursuant to an Assignment and Assumption and to become a Lender for all purposes under this Agreement and to assume all obligations of the Non-Consenting Lender to be terminated as of such date and to comply with the requirements of clause (b) of Section 9.04, and (ii) the Applicable Borrower shall pay to such Non-Consenting Lender in same day funds on the day of such replacement (1) all interest, fees and other amounts then accrued but unpaid to such Non-Consenting Lender by each Borrower hereunder to and including the date of termination, including without limitation payments due to such Non-Consenting Lender under Sections 2.15 and 2.17, (2) an amount, if any, equal to the payment which would have been due to such Lender on the day of such replacement under Section 2.19 had the Loans of
186


such Non-Consenting Lender been prepaid on such date rather than sold to the replacement Lender and (3) any amounts owing to such Lender pursuant to Section 2.12. A Lender shall not be required to make any such assignment and delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Applicable Borrower to require such assignment and delegation cease to apply. Each party hereto agrees that an assignment required pursuant to this clause (d) may be effected pursuant to an Assignment and Assumption executed by the Applicable Borrower, the Administrative Agent and the assignee and that the Non-Consenting Lender required to make such assignment need not be a party thereto, and each Lender hereby authorizes and directs the Administrative Agent to execute and deliver such documentation as may be required to give effect to an assignment in accordance with Section 9.04 on behalf of a Non-Consenting Lender and any such documentation so executed by the Administrative Agent shall be effective for purposes of documenting an assignment pursuant to Section 9.04.
(e)Notwithstanding anything to the contrary herein, (i) if following the date hereof, the Administrative Agent and any Loan Party shall have jointly identified an ambiguity, inconsistency, obvious error or any error or omission of a technical or immaterial nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrowers shall be permitted to amend such provision and such amendment shall become effective without any further action or consent of any other party to any Loan Documents if the same is not objected to in writing by the Required Lenders within five (5) Business Days following receipt of notice thereof (which notice shall be given at least five (5) Business Days prior to any such amendment) and (ii) guarantees, collateral security agreements, pledge agreements and related documents (if any) executed by the Loan Parties in connection with this Agreement may be in a form reasonably determined by the Administrative Agent and may be amended, supplemented and/or waived with the consent of the Administrative Agent at the request of any Borrower without the input or need to obtain the consent of any other Lenders if such amendment or waiver is delivered in order (x) to comply with local law or advice of local counsel, (y) to cure ambiguities, omissions or defects or (z) to cause such guarantees, collateral security agreements, pledge agreement or other documents to be consistent with this Agreement and the other Loan Documents.
(f)Notwithstanding anything in this Agreement or the other Loan Documents to the contrary, the Revolving Commitments, Term Loans and Revolving Credit Exposure of any Lender that is at the time a Defaulting Lender or Disqualified Lender shall not have any voting or approval rights under the Loan Documents and shall be excluded in determining whether all Lenders (or all Lenders of a Class), all affected Lenders (or all affected Lenders of a Class), a Majority in Interest of Lenders of any Class or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to this Section 9.02); provided that (x) the Commitment of any Defaulting Lender or Disqualified Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that affects any Defaulting Lender or Disqualified Lender more adversely than other affected Lenders shall require the consent of such Defaulting Lender or Disqualified Lender.
Section 3.03Expenses; Indemnity; Damage Waiver.
(a)Holdings and the Borrowers shall pay (i) all reasonable and documented out-of-pocket expenses incurred by the Agents, the Lead Arrangers and their respective Affiliates, including the reasonable fees, charges and disbursements of counsel for the Agents, in connection with the syndication and distribution (including, without limitation, via the internet or through a service such as IntraLinks) of the credit facilities provided for herein, the preparation and administration of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions
187


contemplated hereby or thereby shall be consummated), (ii) all reasonable and documented out-of-pocket expenses incurred by the Issuing Banks in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all documented out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender, including the reasonable fees, charges and disbursements of any counsel (other than in-house counsel) for the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender, in connection with the enforcement or protection of its rights in connection with this Agreement and any other Loan Document, including its rights under this Section 9.03, or in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit. Notwithstanding the foregoing, in no event shall Holdings or the Borrowers be required to reimburse the Lenders for more than one counsel to the Agents and the Lenders taken as a whole (and up to one local counsel in each applicable jurisdiction and regulatory counsel, and solely in the event of any actual or potential conflict of interest, one additional counsel in each relevant jurisdiction to each group of similarly situated affected persons taken as a whole); provided, that same shall be limited to (A) one counsel to the Administrative Agent, the Collateral Agent and for the Lenders (taken together as a single group or client), (B) if necessary, one local counsel required in any relevant local jurisdiction and applicable special regulatory counsel and (C) if representation of the Administrative Agent, the Collateral Agent and/or all Lenders in such matter by a single counsel would be inappropriate as determined by the Administrative Agent, the Collateral Agent and/or all Lenders due to the existence of an actual or potential conflict of interest, one additional counsel for the Administrative Agent, the Collateral Agent and for each Lender subject to such conflict.
(b)Holdings and the Borrowers shall, and jointly and severally agree to, indemnify the Administrative Agent, the Collateral Agent, the Lead Arrangers and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including the reasonable fees, charges and disbursements of any counsel for any Indemnitee, incurred by or asserted against any Indemnitee arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties hereto of their respective obligations thereunder or the consummation of the Transactions or any other transactions contemplated hereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by the Issuing Bank to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or release of Hazardous Materials on or from any property owned or operated by Holdings or any of its Subsidiaries, or any Environmental Liability related to Holdings or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory and regardless of whether (x) any Indemnitee is a party thereto or (y) such matter is initiated by a third party or by Holdings, any of its affiliates, equity holders, security holders or creditors; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (w) other than with respect to the Administrative Agent or the Collateral Agent, resulted from a material breach of the Loan Documents by such Indemnitee (as determined by a court of competent jurisdiction in a final and non-appealable judgment), (x) are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or any of its Related Parties, (y) other than with respect to the Administrative Agent or the Collateral Agent, result from a claim brought by any Loan Party against any Indemnitee for a material breach of such Indemnitee’s obligations hereunder or under any other Loan Document (as determined by a court of competent jurisdiction in a final and non-appealable judgment) (it being understood and agreed that the failure by any
188


Lender to fund any portion of its Term Loan Commitment hereunder when the conditions set forth in Section 4.01 have been satisfied and/or waived in accordance with this Agreement shall be deemed a material breach, and (z) result from disputes solely among Indemnitees not involving any act or omission of any Loan Party or any of their respective Related Parties (other than a dispute against the Agents or the Lead Arrangers in their capacities as such). Without limiting or expanding the provisions of Section 2.17(c), this Section 9.03(b) shall not apply with respect to Taxes other than any Taxes that represent losses, claims, damages, etc. from a non-Tax claim.
(c)To the extent that Holdings or the Borrowers fail to pay any amount required to be paid by it to the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender under paragraph (a) or (b) of this Section 9.03, each Lender severally agrees to pay to the Administrative Agent or the Collateral Agent, as the case may be, and each Revolving Lender severally agrees to pay to the Issuing Banks or the Swingline Lender, as the case may be, such Lender’s Applicable Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount (it being understood that the Borrowers’ failure to pay any such amount shall not relieve the Borrowers of any default in the payment thereof); provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent, the Collateral Agent, the Issuing Banks or the Swingline Lender in its capacity as such.
(d)To the extent permitted by applicable law, neither Holdings nor any Borrower shall assert, and hereby waive, any claim against any Indemnitee (i) for any damages arising from the use by others of information or other materials obtained through telecommunications, electronic or other information transmission systems (including the Internet) other than damages that are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Indemnitee or any of its Related Parties, or (ii) on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof.
(e)All amounts due under this Section 9.03 shall be payable not later than fifteen (15) days after written demand therefor.
Section 3.04Successors and Assigns.
(a)The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any branch or Affiliate of any Issuing Bank that issues any Letter of Credit), except that (i) neither Holdings nor any Borrower may assign or otherwise transfer any of their rights or obligations hereunder (and any attempted assignment or transfer by Holdings or any Borrower shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except to an Eligible Transferee. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby (including any branch or Affiliate of any Issuing Bank that issues any Letter of Credit), Participants (to the extent provided in paragraph (c) of this Section 9.04) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Banks and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.
(b)(i)    Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (other than (x) Holdings and its Affiliates, except to
189


the extent permitted in Section 2.23 and (y) any Person that is not an Eligible Transferee) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it) with the prior written consent of:
(A)Holdings (such consent not to be unreasonably withheld, delayed or conditioned); provided that Holdings shall be deemed to have consented to any assignment unless it shall object thereto by written notice to the Administrative Agent within ten (10) Business Days after having received written notice thereof; provided, further, that no consent of Holdings shall be required for (x) any assignment by any Agent or Lead Arranger (or any affiliate thereof) of Term Loans or related commitments pursuant to the primary syndication of such Term Loans and related commitments or (y) an assignment to a Lender, an Affiliate of a Lender, an Approved Fund or, if an Event of Default has occurred and is continuing, any other assignee;
(B)the Administrative Agent (such consent not to be unreasonably withheld or delayed); provided that no consent of the Administrative Agent shall be required for an assignment of all or any portion of a Term Loan to a Lender, an Affiliate of a Lender or an Approved Fund; and
(C)the Issuing Banks and the Swingline Lender (such consent not to be unreasonably withheld); provided that no consent of any Issuing Bank or the Swingline Lender shall be required for an assignment of all or any portion of a Term Loan or any related commitment.
(i)Assignments shall be subject to the following additional conditions:
(A)except in the case of an assignment to a Lender or an Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender’s Commitment or Loans of any Class, the amount of the applicable Commitment or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 (in the case of Revolving Commitments and Revolving Loans) or $1,000,000 (in the case of a Term Loan) unless each of the Applicable Borrower and the Administrative Agent otherwise consent; provided that no such consent of the Applicable Borrower shall be required if an Event of Default has occurred and is continuing and this clause shall not be construed to prohibit the assignment of all the assigning Lender’s rights and obligations in respect of one Class of Commitments or Loans;
(B)each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement; provided that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning Lender’s rights and obligations in respect of one Class of Commitments or Loans;
(C)the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500, such fee to be paid by either the assigning Lender or the assignee Lender or shared between such Lenders, and which fee may be waived at the discretion of the Administrative Agent;
190


(D)the assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire in which the assignee designates one or more credit contacts to whom all syndicate-level information (which may contain material non-public information about Holdings and its affiliates and their Related Parties or their respective securities) will be made available and who may receive such information in accordance with the assignee’s compliance procedures and applicable laws, including Federal and state securities laws;
(E)without the prior written consent of the Administrative Agent, no assignment shall be made to a prospective assignee that bears a relationship to the Applicable Borrower as described in Section 108(e)(4) of the Code;
(F)if, at the time of any assignment, the respective assignee would be entitled to greater increased cost payments pursuant to Section 2.15 than those that apply to the respective assignor, then the respective assignee shall not be entitled to charge the Borrowers for any such increased costs which would otherwise be owed to it pursuant to Section 2.15, but in each case only to the extent in excess of those that would have applied to the respective assignor at the time of such assignment; and
(G)the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such Assignor’s U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of an assignor’s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor’s Lux Term Loans that are assigned).
For the purposes of this Section 9.04(b), the term “Approved Fund” has the following meaning:
Approved Fund” means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or investing in commercial loans and similar extensions of credit in the ordinary course of its business and that is administered, advised or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.
(ii)Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) of this Section 9.04, from and after the effective date specified in each Assignment and Assumption the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.15, 2.16, 2.17 and 9.03). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 9.04 shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section 9.04.
191


(iii)The Administrative Agent, acting for this purpose as a non-fiduciary agent of the Borrowers, shall maintain at one of its offices located in the United States a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount of and interest on the Loans and LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive (absent manifest error), and the Borrowers, the Administrative Agent, the Issuing Banks and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrowers and, with respect to its interest, any Issuing Banks and any Lender, at any reasonable time and from time to time upon reasonable prior notice.
(iv)Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an assignee, the assignee’s completed Administrative Questionnaire (unless the assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section 9.04 and any written consent to such assignment required by paragraph (b) of this Section 9.04, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register; provided that if either the assigning Lender or the assignee shall have failed to make any payment required to be made by it pursuant to Section 2.07(b), 2.18(d) or 9.03(c), the Administrative Agent shall have no obligation to accept such Assignment and Assumption and record the information therein in the Register unless and until such payment shall have been made in full, together with all accrued interest thereon. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.
(c)(i)    Any Lender may, without the consent of the Applicable Borrower, the Administrative Agent, the Issuing Banks or the Swingline Lender, sell participations to one or more banks or other entities (excluding (x) Holdings, the Borrowers and their respective Affiliates and (y) any Person that is not an Eligible Transferee) (a “Participant”) in all or a portion of such Lender’s rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans owing to it); provided that (A) such Lender’s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (C) Holdings, the Borrowers and any Additional Borrower, the Administrative Agent, the Issuing Banks and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement and (D) without the prior written consent of the Administrative Agent, no participation shall be sold to a prospective participant that bears a relationship to the Applicable Borrower described in Section 108(e)(4) of the Code. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver described in the first proviso to Section 9.02(b) that affects such Participant. Subject to paragraph (c)(ii) of this Section 9.04, the Borrowers agree that each Participant shall be entitled to the benefits of Sections 2.15, 2.16 and 2.17 (subject to the requirements and limitations therein including the requirements under Section 2.17(e) and (h), it being understood that the documentation required under Section 2.17(e) shall be delivered to the participating Lender (except in the case of an Irish Treaty Lender, where the documentation shall be delivered to the Administrative Agent and the Applicable Borrower or Additional Borrower) and the documentation required under Section 2.17(h) and the documentation required for the purposes of satisfying the procedural formalities referred to in paragraph (4) of the definition of “Irish Qualifying Lender” (if required) shall be delivered to the Administrative Agent and the
192


applicable Borrower or Additional Borrower)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section 9.04. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 9.08 as though it were a Lender; provided such Participant agrees to be subject to Section 2.18(c) as though it were a Lender.
(i)A Participant shall not be entitled to receive any greater payment under Section 2.15 or 2.17 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrowers’ prior written consent (not to be unreasonably withheld or delayed). Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the applicable Borrower and Additional Borrowers, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under the Loan Documents (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant's interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) or Proposed Section 1.163-5(b) of the United States Treasury Regulations (or, in each case, any amended or successor version) and/or Irish law to the extent necessary to claim exemption from applicable Irish tax. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.
(d)Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including without limitation any pledge or assignment to secure obligations to a Federal Reserve Bank or any other central bank, and this Section 9.04 shall not apply to any such pledge or assignment of a security interest; provided that no such pledge or assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.
(e)In the case of any assignment or transfer by a Lender to a new Lender, or any participation by such Lender in favor of a Participant, of all or any part of such Lender’s rights and obligations under this Agreement or any of the other Loan Documents, such Lender and the new Lender or Participant (as applicable) hereby agree that, for the purposes of Article 1278 and/or Article 1281 of the Luxembourg Civil Code (to the extent applicable), any assignment, amendment and/or transfer of any kind permitted under, and made in accordance with the provisions of, this Agreement or any agreement referred to herein to which a Luxembourg Loan Party is a party (including any Collateral Document), any security created or guarantee given under or in connection with this Agreement or any other Loan Document shall be preserved and shall continue in full force and effect for the benefit of such new Lender or Participant (as applicable).
(f)Notwithstanding the foregoing, no assignment may be made or participation sold to a Disqualified Lender without the prior written consent of Holdings; provided that upon inquiry by any Lender to the Administrative Agent as to whether a specified potential assignee or prospective participant is on the list of Disqualified Lenders, the
193


Administrative Agent shall be permitted to disclose to such Lender whether such specified potential assignee or prospective participant is on the list of Disqualified Lenders; provided, further, that inclusion on the list of Disqualified Lenders shall not apply retroactively to disqualify any persons that have previously acquired an assignment or participation in the Loan if such person was not included on the list of Disqualified Lenders at the time of such assignment or participation. Notwithstanding anything contained in this Agreement or any other Loan Document to the contrary, if any Lender was a Disqualified Lender at the time of the assignment of any Loans or Commitments to such Lender, following written notice from the Applicable Borrower to such Lender and the Administrative Agent and otherwise in accordance with Section 2.19(b), as applicable: (1) such Lender shall promptly assign all Loans and Commitments held by such Lender to an Approved Fund; provided that (A) the Administrative Agent shall not have any obligation to the Borrowers, such Lender or any other Person to find such a replacement Lender, (B) the Borrowers shall not have any obligation to such Disqualified Lender or any other Person to find such a replacement Lender or accept or consent to any such assignment to itself or any other Person subject to the Borrowers’ consent in accordance with Section 9.04(b) and (C) the assignment of such Loans and/or Commitments, as the case may be, shall be at par plus accrued and unpaid interest and fees; (2) such Lender shall not have any voting or approval rights under the Loan Documents and shall be excluded in determining whether all Lenders (or all Lenders of any Class), all affected Lenders (or all affected Lenders of any Class), a Majority in Interest of Lenders of any Class or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to Section 9.02); provided that (x) the Commitment of any Disqualified Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that affects any Disqualified Lender adversely and in a manner that is disproportionate to other affected Lenders shall require the consent of such Disqualified Lender; and (3) no Disqualified Lender is entitled to receive information provided solely to Lenders by the Administrative Agent or any Lender or will be permitted to attend or participate in meetings attended solely by the Lenders and the Administrative Agent, other than the right to receive notices of Borrowings, notices of prepayments and other administrative notices in respect of its Loans or Commitments required to be delivered to Lenders pursuant to Article II.
(g)Notwithstanding anything in this Agreement to the contrary, any Lender may assign all or a portion of its rights and obligations with respect to the Term Loans or the Term Loan Commitments, under this Agreement to Holdings, a Borrower or any Subsidiaries through open market purchases on a pro-rata or non-pro rata basis, in each case subject to the following limitations:
(i)(x) if the assignee is Holdings or a Subsidiary, upon such assignment, the applicable assignee will automatically be deemed to have contributed or transferred the principal amount of such Term Loans, plus all accrued and unpaid interest thereon, to a Borrower or (y) if the assignee is a Borrower, (including through the contribution or other transfers set forth in clause (x)), the principal amount of such Term Loans, along with all accrued and unpaid interest thereon, so contributed, assigned or transferred to such Borrower (with the consent of such Borrower) in exchange for debt or equity securities will be deemed automatically cancelled and extinguished upon such assignment, contribution or transfer;
(ii)no Event of Default shall be continuing or shall result therefrom immediately prior to or after such assignment; and
(iii)the U.S. Term Loans and the Lux Term Loans shall trade as a strip, and each assignment of Initial Term Loans from any Term Lender to an assignee shall consist of an equal percentage of the respective principal amounts of such
194


Assignor’s U.S. Term Loans and Lux Term Loans (i.e., the percentage of the principal amount of an assignor’s U.S. Term Loans that are assigned shall equal the percentage of the principal amount of such assignor’s Lux Term Loans that are assigned); and
(iv)no assignment of any Term Loans or Term Loan Commitments shall be made from the proceeds of any Revolving Loan or Swingline Loan.
Section 3.05Survival. All covenants, agreements, representations and warranties made by the Loan Parties in the Loan Documents and in the certificates or other instruments delivered in connection with or pursuant to this Agreement or any other Loan Document shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of the Loan Documents and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement or any other Loan Document is outstanding and unpaid (except for Unliquidated Obligations) or any Letter of Credit is outstanding (unless such Letter of Credit has been Cash Collateralized) and so long as the Commitments have not expired or terminated. The provisions of Sections 2.15, 2.16, 2.17 and 9.03 and Article VIII shall survive and remain in full force and effect regardless of the resignation or replacement of the Administrative Agent or the Collateral Agent or any assignment of rights by, or the replacement of, a Lender, the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any other Loan Document or any provision hereof or thereof.
Section 3.06Counterparts; Integration; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents and any separate letter agreements with respect to fees payable to the Agents constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. This Agreement shall become effective upon the delivery by the Agents, the Lenders, Holdings, the Borrowers and each Subsidiary Guarantor of executed counterparts of the signature page to this Agreement. For the avoidance of doubt, upon the effectiveness of this Agreement, the Commitments shall become enforceable by the Borrowers. Delivery of an executed counterpart of a signature page of this Agreement by facsimile or by email as a “.pdf” or “.tif” attachment shall be effective as delivery of a manually executed counterpart of this Agreement. The words “execution,” “signed”, “signature” and words of like import herein shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on the electronic platform DocuSign, digital copies of a signatory’s manual signature and deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature to the extent and as provided in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.
Section 3.07Severability. Any provision of any Loan Document held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions thereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.
195


Section 3.08Right of Setoff. If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final and in whatever currency denominated) at any time held and other obligations at any time owing by such Lender or Affiliate to or for the credit or the account of any Borrower or any Guarantor against any of and all of the Secured Obligations held by such Lender, irrespective of whether or not such Lender shall have made any demand under the Loan Documents and although such obligations may be unmatured; provided that any recovery by any Lender or any Affiliate pursuant to its setoff rights under this Section 9.08 is subject to the provisions of Section 2.18(c). The rights of each Lender under this Section 9.08 are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.
Section 3.09Governing Law; Jurisdiction; Consent to Service of Process; Foreign Process Agent.
(a)This Agreement and each other Loan Document (except, as to any other Loan Document, as expressly set forth therein) shall be construed in accordance with and governed by the law of the State of New York; provided, however, that (i) the interpretation of the definition of “Company Material Adverse Effect” and whether there shall have occurred a “Company Material Adverse Effect”, (ii) whether the Acquisition has been consummated in accordance with the terms and conditions of the Acquisition Agreement, and (iii) whether the representations and warranties made by Target and its Subsidiaries in the Acquisition Agreement are true and correct and whether as a result of any failure thereof Holdings (or its applicable Subsidiaries) has the right to terminate its obligations under the Acquisition Agreement (or the right not to consummate the Acquisition pursuant to the Acquisition Agreement) shall be determined in accordance with the laws of the State of Delaware without regards to conflicts of laws principles that would result in the application of the laws of another jurisdiction.
(b)Each of Holdings, each Borrower and each Subsidiary Guarantor hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to any Loan Document, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in this Agreement or any other Loan Document shall affect any right that the Administrative Agent, any Issuing Bank or any Lender may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document against any Loan Party or its properties in the courts of any competent jurisdiction.
(c)Each of Holdings, each Borrower and each Subsidiary Guarantor hereby irrevocably and unconditionally waives, to the fullest extent they may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or any other Loan Document in any court referred to in paragraph (b) of this Section 9.09. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
(d)Each party to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 9.01. Nothing in this Agreement or any other Loan
196


Document will affect the right of any party to this Agreement to serve process in any other manner permitted by law.
(e)Holdings and each Subsidiary Guarantor hereby irrevocably and unconditionally appoints the U.S. Borrower and its successors hereunder (the “Process Agent”), as its agent to receive on behalf of Holdings and each Subsidiary Guarantor and their respective property all writs, claims, process and summonses in any action or proceeding brought against it in the State of New York. Such service may be made by mailing or delivering a copy of such process to Holdings and each Subsidiary Guarantor in care of the Process Agent at the address specified above for the Process Agent, and Holdings and each Subsidiary Guarantor irrevocably authorizes and directs the Process Agent to accept such service on its behalf. Failure by the Process Agent to give notice to Holdings and each Subsidiary Guarantor or failure of Holdings and each Subsidiary Guarantor to receive notice of such service of process shall not impair or affect the validity of such service on the Process Agent, Holdings and each Subsidiary Guarantor, or of any judgment based thereon. Holdings and each Subsidiary Guarantor covenants and agrees that it shall take any and all reasonable action, including the execution and filing of any and all documents that may be necessary to continue the delegation of the Process Agent above in full force and effect, and to cause the Process Agent to act as such. Holdings and each Subsidiary Guarantor hereto further covenants and agrees to maintain at all times an agent with offices in New York City to act as its Process Agent. Nothing herein shall in any way be deemed to limit the ability to serve any such writs, process or summonses in any other manner permitted by applicable law.
Section 3.10WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 9.10.
Section 3.11Headings. Article and Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.
Section 3.12Confidentiality. Each of the Administrative Agent, the Collateral Agent, the Swingline Lender, the Issuing Banks and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and its and their respective directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies under this Agreement or any other Loan Document or any suit, action or proceeding relating to this
197


Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section 9.12, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its Related Parties) to any swap, derivative or other transaction relating to Holdings or its Restricted Subsidiaries and their obligations, (g) on a confidential basis to (i) any rating agency in connection with rating Holdings or its Subsidiaries or the facilities evidenced by this Agreement or (ii) the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers with respect to the facilities evidenced by this Agreement, (h) with the prior written consent of Holdings, (i) to the extent such Information (i) becomes publicly available other than as a result of a breach of this Section 9.12 by the disclosing party or its Affiliates, (ii) is independently developed by the Agents or (iii) becomes available to the Administrative Agent, any Issuing Bank or any Lender on a nonconfidential basis from a source other than Holdings or any Borrower, (j) in consultation with the Lead Arrangers, to any prospective additional Agent and to such additional Agent’s respective officers, directors, employees, attorneys, accountants and advisors, in each case on a confidential basis or (k) for purposes of establishing a “due diligence” defense. For the purposes of this Section 9.12, “Information” means all information received from Holdings or any Borrower relating to Holdings or any Borrower or their respective businesses, other than any such information that is available to the Administrative Agent, the Collateral Agent, any Issuing Bank or any Lender on a nonconfidential basis prior to disclosure by Holdings or any Borrower. Any Person required to maintain the confidentiality of Information as provided in this Section 9.12 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.
Section 3.13Release of Liens and Guarantees.
(a)A Subsidiary Guarantor (that is not a Borrower) shall automatically be released from its obligations under the Loan Documents upon the consummation of any transaction permitted by this Agreement as a result of which such Subsidiary Guarantor ceases to be a Restricted Subsidiary or ceases to be organized in a Covered Jurisdiction. In addition, a Subsidiary Guarantor (that is not a Borrower) shall be released from its obligations under the Loan Documents upon the request of Holdings in connection with a transaction not prohibited under this Agreement, as a result of which such Subsidiary Guarantor becomes an Excluded Subsidiary. Notwithstanding the foregoing, no Subsidiary Guarantor (nor the security interest granted by such Subsidiary Guarantor) will be released solely as a result of such Subsidiary Guarantor ceasing to be a wholly-owned Subsidiary unless such Subsidiary ceased to be a wholly-owned Subsidiary as a result of a transaction that was entered into for a bona fide business purpose (as determined in good faith by Holdings) and, for the avoidance of doubt, not for the primary purpose of causing such release.
(b)Upon the termination of all the Commitments and payment and satisfaction in full in cash of all Secured Obligations (other than Unliquidated Obligations for which no claim has been made and Secured Obligations with respect to Cash Management Agreements and Swap Agreements), the security interests in the Collateral created by the Collateral Documents shall be automatically released.
(c)Upon (i) any Disposition (other than any lease or license) by any Loan Party (other than to another Loan Party, except where, in any jurisdiction outside of the United States, in order to effect such Disposition the Lien on such assets is required to be released (provided that in the case of such Disposition to another Loan Party outside of the United States, such other Loan Party shall concurrently (or on such later date as may be agreed by the Administrative Agent) grant a security interest on the released Collateral)) of any Collateral in a
198


transaction permitted under this Agreement, (ii) any Disposition in connection with any exercise of remedies of the Administrative Agent, the Collateral Agent and the Lenders pursuant to Article VII, (iii) any Disposition by any Loan Party of any Securitization Assets in connection with a Qualified Securitization Financing or a Qualified Receivables Factoring, (iv) the effectiveness of any written consent to the release of the security interest created under any Collateral Document in any Collateral pursuant to Section 9.02, (v) a Guarantor ceasing to be a Guarantor in accordance with the terms of this Agreement, with respect to the Collateral held by such Guarantor or (vi) any Collateral becoming Excluded Assets, the security interests in such Collateral created by the Collateral Documents shall be automatically released.
(d)In addition, upon the request of any holder (or prospective holder) of obligations secured by such Lien or, in the case of a license or sub-license, the applicable licensee or sub-licensee (or prospective licensee or sub-licensee), the Collateral Agent shall, at the reasonable request of any Borrower, (A) subordinate any Lien on any Collateral to the holder of any Liens on such Collateral permitted under clauses (4), (5), (7) (insofar as such Liens are replacements or substitutes for Liens permitted by clause (4) or (5)), (9), (10), (11), (21), (22) and (25) of the definition of “Permitted Liens,” and (B) enter into subordination, non-disturbance and similar agreements in connection with the licensing of intellectual property and other general intangibles permitted under this Agreement to the extent reasonably requested by a licensee or sub-licensee thereof.
(e)In connection with any termination, release or subordination, or in connection with any Indebtedness incurred pursuant to Section 6.01(b)(xvi)(ii) or in connection with any licensing or sub-licensing transactions permitted pursuant to Sections 6.02 and 6.03, the entry into non-disturbance or similar agreement, in each case, pursuant to this Section 9.13, the Collateral Agent shall execute and deliver to any Loan Party, at such Loan Party’s expense, all documents that such Loan Party shall reasonably request to evidence such termination, release or subordination, or reasonably required in order to reflect such non-disturbance or similar agreement; provided, however, that (i) the Collateral Agent shall have received a certificate of a Responsible Officer of Holdings certifying that any such transaction has been consummated in compliance with this Agreement and the other Loan Documents and that such termination, release or subordination is permitted hereby, and (ii) any such release shall not in any manner discharge, affect or impair the Secured Obligations or any Liens upon (or obligations of Holdings or any Subsidiary in respect of) all interests retained by Holdings or any Subsidiary, including (without limitation) the proceeds of the sale, all of which shall continue to constitute part of the Collateral. Any execution and delivery of documents pursuant to this Section 9.13 shall be without representation, recourse to or warranty by the Collateral Agent.
Section 3.14USA PATRIOT Act. Each Lender that is subject to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “USA Patriot Act”) hereby notifies each Loan Party that pursuant to the requirements of the USA Patriot Act, it is required to obtain, verify and record information that identifies such Loan Party, which information includes the name and address of such Loan Party and other information that will allow such Lender to identify such Loan Party in accordance with the USA Patriot Act.
Section 3.15Appointment for Perfection. Each Lender hereby appoints the Collateral Agent and each other Lender as its agent for the purpose of perfecting Liens, for the benefit of the Administrative Agent, the Collateral Agent and the Secured Parties, in assets which, in accordance with Article 9 of the UCC or any other applicable law can be perfected by possession. Should any Lender (other than the Collateral Agent) obtain possession of any such Collateral, such Lender shall notify the Collateral Agent thereof, and, promptly upon the Administrative Agent’s request therefor shall deliver such Collateral to the Collateral Agent or otherwise deal with such Collateral in accordance with the Collateral Agent’s instructions.
199


Section 3.16No Fiduciary Relationship. Each of Holdings and Borrower, on behalf of itself and its Subsidiaries, agrees that, in connection with all aspects of the transactions contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document) and any communications in connection therewith: (i) (A) the arranging and other services regarding this Agreement provided by the Lenders are arm’s-length commercial transactions between Holdings and its Affiliates, on the one hand, and the Lenders and their Affiliates, on the other hand, (B) it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) it is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents; (ii) (A) each of the Lenders and their Affiliates is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not, and will not be acting as an advisor, agent or fiduciary for Holdings, any Borrower or any of their respective Affiliates, or any other Person and (B) no Lender or any of its Affiliates has any obligation to Holdings, any Borrower or any of their respective Affiliates with respect to the transactions contemplated hereby except, in the case of a Lender, those obligations expressly set forth herein and in the other Loan Documents; and (iii) each of the Lenders and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of Holdings and its Affiliates, and no Lender or any of its Affiliates has any obligation to disclose any of such interests to Holdings, the Borrowers or their respective Affiliates. To the fullest extent permitted by law, Holdings and the Borrowers hereby waive and release any claims that they may have against each of the Lenders and their Affiliates with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.
Section 3.17Interest Rate Limitation. Notwithstanding anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable law (the “Maximum Rate”). If the Administrative Agent or any Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrowers. In determining whether the interest contracted for, charged, or received by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder.
Section 3.18Acknowledgement and Consent to Bail-In of Affected Financial Institutions.
(a)Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:
(i)the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution; and
(ii)the effects of any Bail-In Action on any such liability, including, if applicable:
200


(A)a reduction in full or in part or cancellation of any such liability;
(B)a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or
(C)the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of the applicable Resolution Authority.
Section 3.19Certain ERISA Matters.
(a)Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Lead Arranger and their respective Affiliates and not, for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that at least one of the following is and will be true:
(i)such Lender is not using “plan assets” (within the meaning of Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments or this Agreement,
(ii)the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement,
(iii)(A) such Lender is an investment fund managed by a “Qualified Professional Asset Manager” (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement, or
(iv)such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.
201


(b)In addition, unless either (1) clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and each Lead Arranger or any of their respective Affiliates and not, for the avoidance of doubt, to or for the benefit of any Borrower or any other Loan Party, that none of the Administrative Agent, any Lead Arranger or any of their respective Affiliates is a fiduciary with respect to the assets of such Lender involved in such Lender’s entrance into, participation in, administration of and performance of the Loans, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).
Section 3.20Acknowledgement Regarding Any Supported QFCs. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Permitted Hedging Obligations or any other agreement or instrument that is a QFC (such support, “QFC Credit Support”, and each such QFC, a “Supported QFC”), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the “U.S. Special Resolution Regimes”) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the United States):
(a)In the event a Covered Entity that is party to a Supported QFC (each, a “Covered Party”) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.
(b)As used in this Section 9.20, the following terms have the following meanings:
        “BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.

        “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b);
202


or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).

    “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.

    “QFC has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).

Article X

The Guaranty
Section 3.01The Guarantee.
(a)The Guarantors hereby, jointly and severally, guarantee to each Secured Party as hereinafter provided, as primary obligor and not merely as surety, the payment and performance of the Secured Obligations in full in cash when due (whether at stated maturity, as a mandatory prepayment, by acceleration, as a mandatory cash collateralization or otherwise) strictly in accordance with the terms hereof and thereof. Each Guarantor hereby further jointly and severally agrees that if any of the Secured Obligations are not paid in full in cash when due (whether at stated maturity, as a mandatory prepayment, by acceleration, as a mandatory cash collateralization or otherwise), each Guarantor will promptly pay the same, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Secured Obligations, the same will be promptly paid in full in cash when due (whether at extended maturity, as a mandatory prepayment, by acceleration, as a mandatory cash collateralization or otherwise) in accordance with the terms of such extension or renewal.
(b)Each Guarantor, and by its acceptance of this Guaranty, the Administrative Agent and each other Secured Party, hereby confirms that it is the intention of all such Persons that this Guaranty and the Obligations of each Guarantor hereunder not constitute a fraudulent transfer or conveyance for purposes of any Debtor Relief Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar foreign, federal or state law to the extent applicable to this Guaranty and the Obligations of each Guarantor hereunder. To effectuate the foregoing intention, the Administrative Agent, the other Secured Parties and the Guarantors hereby irrevocably agree that the Obligations of each Guarantor under this Guaranty at any time shall be limited to the maximum amount as will result in the Obligations of such Guarantor under this Guaranty not constituting a fraudulent transfer or conveyance under applicable law after giving full effect to such Guarantor’s contribution rights but before taking into account any liabilities of such Guarantor under any other guarantee of such Guarantor.
Section 3.02Obligations Unconditional. The obligations of the Guarantors under Section 10.01 are absolute and unconditional, irrespective of the value, genuineness, validity, regularity or enforceability of any of the Loan Documents or other documents relating to the Secured Obligations, or any substitution, release, impairment or exchange of any other guarantee of or security for any of the Secured Obligations, and, to the fullest extent permitted by applicable law, irrespective of any other circumstance whatsoever which might otherwise constitute a legal or equitable discharge or defense of a surety or guarantor (other than payment in full in cash of the Secured Obligations, other than Unliquidated Obligations for which no claim has been made), it being the intent of this Section 10.02 that the obligations of the Guarantors hereunder shall be absolute and unconditional under any and all circumstances. Each Guarantor agrees that it shall have no right of subrogation, indemnity, reimbursement or contribution against any other Guarantor for amounts paid under this Article X until such time as the Secured Obligations (other than Unliquidated Obligations for which no claim has been made) have been indefeasibly paid in
203


full in cash and the Commitments have expired or terminated. Without limiting the generality of the foregoing, it is agreed that, to the fullest extent permitted by law, the occurrence of any one or more of the following shall not alter or impair the liability of any Guarantor hereunder, which shall remain absolute and unconditional as described above:
(a)at any time or from time to time, without notice to any Guarantor, the time for any performance of or compliance with any of the Secured Obligations shall be extended, or such performance or compliance shall be waived;
(b)the maturity of any of the Secured Obligations shall be accelerated, or any of the Secured Obligations shall be modified, supplemented or amended in any respect, or any right under any of the Loan Documents or other documents relating to the Secured Obligations shall be waived or any other guarantee of any of the Secured Obligations or any security therefor shall be released, impaired or exchanged in whole or in part or otherwise dealt with;
(c)any Lien granted to, or in favor of, the Administrative Agent, the Collateral Agent or any other holder of the Secured Obligations as security for any of the Secured Obligations shall fail to attach or be perfected;
(d)any of the Secured Obligations shall be determined to be void or voidable (including, without limitation, for the benefit of any creditor of any Guarantor) or shall be subordinated to the claims of any Person (including, without limitation, any creditor of Guarantor);
(e)any failure or omission to assert or enforce or agreement or election not to assert or enforce, delay in enforcement, or the stay or enjoining, by order of court, by operation of law or otherwise, of the exercise or enforcement of, any claim or demand or any right, power or remedy (whether arising under any Loan Document, any Swap Agreement or any Cash Management Agreement, at law, in equity or otherwise) with respect to the Secured Obligations or any agreement relating thereto, or with respect to any other guaranty of or security for the payment of the Secured Obligations;
(f)any exercise of remedies with respect to any security for the Secured Obligations (including, without limitation, any collateral, including the Collateral, securing or purporting to secure any of the Secured Obligations) at such time and in such order and in such manner as the Collateral Agent and the Secured Parties may decide and whether or not every aspect thereof is commercially reasonable and whether or not such action constitutes an election of remedies and even if such action operates to impair or extinguish any right of reimbursement or subrogation or other right or remedy that any Guarantor would otherwise have, and without limiting the generality of the foregoing or any other provisions hereof, each Guarantor hereby expressly waives any and all benefits which might otherwise be available to such Guarantor under applicable law, including without limitation, California Civil Code Sections 2809, 2810, 2819, 2939, 2845, 2848, 2849, 2850, 2855, 2899 and 3433;
(g)any other circumstance whatsoever which may or might in any manner or to any extent vary the risk of any Guarantor as an obligor in respect of the Secured Obligations or which constitutes, or might be construed to constitute, an equitable or legal discharge of any Borrower or any other Guarantor for the Secured Obligations, or of such Guarantor under the guarantee contained in this Article X or of any security interest granted by any Guarantor, whether in an Insolvency or Liquidation Proceeding or in any other instance; or
(h)with respect to its obligations hereunder, each Guarantor hereby expressly waives diligence, presentment, demand of payment, protest and all notices whatsoever,
204


and any requirement that the Administrative Agent, the Collateral Agent or any other holder of the Secured Obligations exhaust any right, power or remedy or proceed against any Person under any of the Loan Documents or other documents relating to the Secured Obligations, or against any other Person under any other guarantee of, or security for, any of the Secured Obligations.
Section 3.03Reinstatement. The obligations of each Guarantor under this Article X shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of any Person in respect of the Secured Obligations is rescinded or must be otherwise restored by any holder of any of the Secured Obligations, whether as a result of any proceedings under any Debtor Relief Law, and each Guarantor agrees that it will jointly and severally indemnify the Administrative Agent and each holder of the Secured Obligations on demand for all reasonable costs and expenses (including, without limitation, the fees, charges and disbursements of counsel) incurred by the Administrative Agent or such holder of the Secured Obligations in connection with such rescission or restoration, including any such costs and expenses incurred in defending against any claim alleging that such payment constituted a preference, fraudulent transfer or similar payment under any proceedings under any debtor relief law.
Section 3.04Certain Additional Waivers. Each Guarantor further agrees that it shall have no right of recourse to security for the Secured Obligations, except through the exercise of rights of subrogation pursuant to Section 10.02 and through the exercise of rights of contribution pursuant to Section 10.06.
Section 3.05Remedies. Each Guarantor agrees that, to the fullest extent permitted by law, as between the Guarantors, on the one hand, and the Administrative Agent, the Collateral Agent and the other holders of the Secured Obligations, on the other hand, the Secured Obligations may be declared to be forthwith due and payable as provided in Article VII (and shall be deemed to have become automatically due and payable in the circumstances provided in said Article VII) for purposes of Section 10.01 notwithstanding any stay, injunction or other prohibition preventing such declaration (or preventing the Secured Obligations from becoming automatically due and payable) as against any other Person and that, in the event of such declaration (or the Secured Obligations being deemed to have become automatically due and payable), the Secured Obligations (whether or not due and payable by any other Person) shall forthwith become due and payable by each Guarantor for purposes of Section 10.01. Each Guarantor acknowledges and agrees that its respective obligations hereunder are secured in accordance with the terms of the Collateral Documents and that the holders of the Secured Obligations may exercise their remedies thereunder in accordance with the terms thereof.
Section 3.06Rights of Contribution. Each Guarantor agrees that, in connection with payments made hereunder, each Guarantor shall have contribution rights against the other Guarantors as permitted under applicable law. Such contribution rights shall be subordinate and subject in right of payment to the obligations of such Guarantors under the Loan Documents and no Guarantor shall exercise such rights of contribution until all Secured Obligations (other than Unliquidated Obligations for which no claim has been made) have been indefeasibly paid in full in cash and the Commitments have terminated.
Section 3.07Guaranty of Payment; Continuing Guarantee. The guarantee given by each Guarantor in this Article X is a guaranty of payment and not of collection, is a continuing guarantee, and shall apply to all Secured Obligations whenever arising.
Section 3.08Guarantee Limitations. The guarantee given by each Guarantor incorporated in Ireland does not apply to any liability to the extent that it would result in this guarantee constituting unlawful financial assistance within the meaning of Section 82. Notwithstanding anything to the contrary contained in this Agreement or in any other Loan
205


Documents, the guarantee obligations of each Guarantor established in Luxembourg or having its “centre of main interests” (as this term is used in Article 3(1) of the Insolvency Regulation) in Luxembourg (a “Luxembourg Guarantor”) in respect of the obligations of Holdings or any of its Subsidiaries which is not a direct or indirect subsidiary of such relevant Luxembourg Guarantor shall be limited at any time to an aggregate amount not exceeding 95% of the greater of:
(a)the Luxembourg Guarantor's own funds (capitaux propres), as referred to in Annex I to the grand-ducal regulation dated 18 December 2015 defining the form and content of the presentation of the balance sheet and profit and loss account, and enforcing the Luxembourg Law dated 19 December 2002 concerning the trade and companies register and the accounting and annual accounts of undertakings (the “Regulation”), as increased by the amount of any debts owed to the Luxembourg Guarantor by a company of the same group of the Luxembourg Guarantor, as shown in (x) the latest interim financial statements available (if any), at the date of demand of payment under this Agreement or, if not available, (y) the latest annual financial statements (comptes annuels) available at the date of demand of payment under this Agreement; and
(b)the Luxembourg Guarantor’s own funds (capitaux propres), as referred to in the Regulation, as increased by the amount of any debts owed to the Luxembourg Guarantor by a company of the same group of the Luxembourg Guarantor, at the date of entry into this Agreement.
The limitation set forth under items (a) and (b) above shall not apply to any amounts borrowed under this Agreement and made available, in any form whatsoever, to the Luxembourg Guarantor or any of its direct or indirect subsidiaries.
Should the financial information referred to in clause (a) and (b) above not be available on the date of this Agreement or on the date the guarantee is called, as the case may be, such financial information will be determined by Administrative Agent or any other person designated by Administrative Agent, acting reasonably, in accordance with the Luxembourg accounting principles applicable to the Luxembourg Guarantor and at the cost of the Luxembourg Guarantor.
Section 3.09Keepwell. Each Qualified ECP Guarantor hereby jointly and severally absolutely, unconditionally and irrevocably undertakes to provide such funds or other support as may be needed from time to time by each other Loan Party to honor all of its obligations under the Guarantees in respect of Swap Obligations (provided, however, that each Qualified ECP Guarantor shall only be liable under this Section 10.09 for the maximum amount of such liability that can be hereby incurred without rendering its obligations under this Section 10.09, or otherwise under the Guarantees, as it relates to such Loan Party, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations of each Qualified ECP Guarantor under this Section 10.09 shall remain in full force and effect until a discharge of Secured Obligations. Each Qualified ECP Guarantor intends that this Section 10.09 constitute, and this Section 10.09 shall be deemed to constitute, a “keepwell, support, or other agreement” for the benefit of each other Loan Party for all purposes of Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.
****
206


EXHIBIT I
[Form of]
BORROWING REQUEST
[ ], 20[ ]1
To:    Citibank, N.A. as Administrative Agent
    One Penns Way
    OPS 2/2
    New Castle, DE 19720
    Attn: Agency Operations
    Phone: (302) 894-6010
    Fax: (646) 274-5080
    AgencyABTFSupport@citi.com
Ladies and Gentlemen:
Reference is hereby made to the Credit Agreement, dated as of July 1, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), among ICON LUXEMBOURG, S.À R.L., a société à responsabilité limitée incorporated and existing under Luxembourg law, having its registered office at 61, rue de Rollingergrund, L-2440, Luxembourg and registered with the Luxembourg register of commerce and companies (R.C.S. Luxembourg) under number B66588 (the “Lux Borrower”), ICON CLINICAL INVESTMENTS, LLC, a Delaware limited liability company (the “Lux U.S. Subsidiary Borrower”), INDIGO MERGER SUB, INC., a Delaware corporation (“Merger Sub” and, prior to the consummation of the Acquisition, the “U.S. Borrower”) (which, after giving effect to the Acquisition on the Closing Date, shall be succeeded by PRA Health Sciences, Inc., a Delaware corporation (the “Target” and, following the consummation of the Acquisition, the “U.S. Borrower”), ICON PUBLIC LIMITED COMPANY, an Irish public limited company (“Holdings”), the Revolving Borrowers, each Additional Borrower, the Subsidiary Guarantors party thereto, the LENDERS from time to time party thereto, CITIBANK, N.A., as Administrative Agent and CITIBANK, N.A., LONDON BRANCH, as Collateral Agent. Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.
The Applicable Borrower hereby requests:
[A Borrowing of Loans][A conversion of Loans][A
continuation of Loans]

to be made on the terms set forth below:
(A) Aggregate amount of the requested Borrowing: _____________________________
1     To be delivered to the Administrative Agent (a) in the case of a USD Term SOFR Borrowing, by telephonic notice not later than 11:00 a.m., New York City time, three (3) Business Days before the date of the proposed Borrowing, (b) in the case of a Eurocurrency Borrowing or an RFR Borrowing, by telephonic notice not later than 11:00 a.m., New York City time, four (4) Business Days before the date of the proposed Borrowing or (c) in the case of an ABR Borrowing, by telephonic notice not later than 11:00 a.m., New York City time, one (1) Business Day before the date of the proposed Borrowing, except as expressly permitted by Section 2.03 of the Credit Agreement.
I-1


|US-DOCS\137541226.2||



(B) Date of such Borrowing:2

_________________________________
(C) Class of such Borrowing3
_________________________________
(D) Type of such Borrowing
[ABR Borrowing][Eurocurrency Borrowing][USD Term SOFR Borrowing][RFR Borrowing]
(E) Agreed Currency4
_________________________________
(F) Interest Period5
_________________________________
(G) Applicable Borrower
_________________________________
(H) Wire instructions for the Applicable Borrower account(s) and amount of requested Borrowing to be allocated to each Applicable Borrower:
_________________________________
[Remainder of Page Intentionally Blank]
2     Shall be a Business Day.
3     If no election as to the Type of Borrowing is specified, then, in the case of a Borrowing denominated in Dollars, the requested Borrowing shall be an ABR Borrowing.
4     In the case of a Eurocurrency Borrowing or an RFR Borrowing.
5     In the case of a Eurocurrency Borrowing, USD Term SOFR Borrowing or an RFR Borrowing. If no Interest Period is specified with respect to any requested Eurocurrency Borrowing, USD Term SOFR Borrowing or RFR Borrowing, then the Applicable Borrower shall be deemed to have selected an Interest Period of one month’s duration.
I-2

|US-DOCS\137541226.2||


[APPLICABLE BORROWER]
By:            
    Name:     
    Title:


I-3


|US-DOCS\137541226.2||
EX-12.1 4 exhibit121-2022.htm EX-12.1 Document

Exhibit 12.1

Certification of Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Brendan Brennan, certify that:

1. I have reviewed this annual report on Form 20-F of ICON plc ("the registrant").

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 24, 2023


/s/ Brendan Brennan Brendan Brennan Chief Financial Officer



Certification of Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Steve Cutler, certify that:

1. I have reviewed this annual report on Form 20-F of ICON plc ("the registrant").

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: February 24, 2023


/s/ Steve Cutler
Steve Cutler
Chief Executive Officer

EX-12.2 5 exhibit122-2022.htm EX-12.2 Document

Exhibit 12.2

Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the Annual Report of ICON plc (the "Company") on Form 20-F for the year ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Brendan Brennan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: February 24, 2023


/s/ Brendan Brennan Brendan Brennan Chief Financial Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.



Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the Annual Report of ICON plc (the "Company") on Form 20-F for the year ending December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steve Cutler, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: February 24, 2023


/s/ Steve Cutler
Steve Cutler
Chief Executive Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the report or as a separate disclosure document. A signed original of this written statement required by section 906 has been provided to ICON plc and will be retained by ICON plc and furnished to the Securities and Exchange Commission or its staff upon request.

EX-23.1 6 exhibit231-2022.htm EX-23.1 Document

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
The Board of Directors
ICON plc
We consent to the incorporation by reference in the registration statements (No. 333-231527, 333-204153, 333-190068, 333-152802, 333-257578 and 333-254891) each on Form S-8 of ICON plc of our reports dated February 24, 2023, with respect to the consolidated balance sheets of ICON plc as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, shareholders’ equity and comprehensive income, and cash flows for each of the years in the three-year period ended December 31, 2022, and the related notes and the effectiveness of internal control over financial reporting as of December 31, 2022, which reports appear in the December 31, 2022 Annual Report on Form 20‑F ICON plc.

/s/ KPMG
Dublin, Ireland
February 24, 2023


EX-101.SCH 7 iclr-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Description of business link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Summary of Significant accounting policies link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Disaggregation of Revenue link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Contract Balances link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Allowances for Credit Losses link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Investments link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Property, Plant and Equipment, net link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Derivatives link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Operating Leases link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Non-current other liabilities link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Share Capital link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Restructuring Charges link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Employee Benefits link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Business Segment and Geographical Information link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Net Income Per Ordinary Share link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Summary of Significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Summary of Significant accounting policies (Tables) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Disaggregation of Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Contract Balances (Tables) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Allowances for Credit Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Property, Plant and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Operating Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Non-current other liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Restructuring charges (Tables) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Employee Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Business Segment and Geographical Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Net Income Per Ordinary Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000061 - Disclosure - Description of business (Details) link:presentationLink link:calculationLink link:definitionLink 0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) link:presentationLink link:calculationLink link:definitionLink 0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000066 - Disclosure - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000067 - Disclosure - Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Contract Balances - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000068 - Disclosure - Contract Balances - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000069 - Disclosure - Allowances for Credit Losses (Details) link:presentationLink link:calculationLink link:definitionLink 0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 0000075 - Disclosure - Fair value - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) link:presentationLink link:calculationLink link:definitionLink 0000077 - Disclosure - Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000078 - Disclosure - Investments - Equity Method Investments (Details) link:presentationLink link:calculationLink link:definitionLink 0000079 - Disclosure - Property, Plant and Equipment, net (Details) link:presentationLink link:calculationLink link:definitionLink 0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 0000081 - Disclosure - Goodwill - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000083 - Disclosure - Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000085 - Disclosure - Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000090 - Disclosure - Derivatives - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) link:presentationLink link:calculationLink link:definitionLink 0000092 - Disclosure - Operating Leases - Lease Costs (Details) link:presentationLink link:calculationLink link:definitionLink 0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 0000095 - Disclosure - Non-current other liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000096 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000097 - Disclosure - Share Capital (Details) link:presentationLink link:calculationLink link:definitionLink 0000098 - Disclosure - Restructuring charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details) link:presentationLink link:calculationLink link:definitionLink 0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) link:presentationLink link:calculationLink link:definitionLink 0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000105 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details) link:presentationLink link:calculationLink link:definitionLink 0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 0000108 - Disclosure - Employee Benefits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000110 - Disclosure - Employee Benefits - Funded Status (Details) link:presentationLink link:calculationLink link:definitionLink 0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) link:presentationLink link:calculationLink link:definitionLink 0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details) link:presentationLink link:calculationLink link:definitionLink 0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) link:presentationLink link:calculationLink link:definitionLink 0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) link:presentationLink link:calculationLink link:definitionLink 0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) link:presentationLink link:calculationLink link:definitionLink 0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000131 - Disclosure - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000133 - Disclosure - Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 iclr-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 iclr-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 iclr-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Geographic Concentration Risk Geographic Concentration Risk [Member] Business Acquisition [Axis] Business Acquisition [Axis] Foreign Currencies and Translation of Subsidiaries Foreign Currency Transactions and Translations Policy [Policy Text Block] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Accrued expenses and other current liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities Deferred tax asset (Note 20) Deferred Income Tax Assets, Net Income taxes receivable Income Taxes Receivable, Noncurrent Total debt Long-Term Debt, Gross Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Deferred tax (benefit)/expense: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Payments of debt restructuring costs Payments of Debt Restructuring Costs Senior Secured Notes Senior Subordinated Notes [Member] Debt Instrument [Axis] Debt Instrument [Axis] Property, plant and equipment, gross Property, Plant and Equipment, Gross Disclosure of Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Tax Year 2029 to 2038 Tax Year 2029 to 2038 [Member] Tax Year 2027 to 2036 [Member] Unearned revenue Deferred Tax Asset, Contract With Customer, Liability Deferred Tax Asset, Contract With Customer, Liability Basis spread on variable rate (in percent) Debt Instrument, Basis Spread on Variable Rate Depreciation expense Depreciation Other non-current liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Exercise of share options (in shares) Options exercised by employees (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Weighted average discount rate (in percent) Operating Lease, Weighted Average Discount Rate, Percent Debt instrument, interest rate (in percent) Debt Instrument, Interest Rate, Stated Percentage Reimbursable expenses and Direct costs Compensation Related Costs, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital, Common Stock Intangible assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Issue of shares associated with a business combination (in shares) Stock Issued During Period, Shares, Acquisitions Other non-cash items Other Noncash Income (Expense) Settlement Defined Benefit Plan, Plan Assets, Payment for Settlement Document Information [Line Items] Document Information [Line Items] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] Equities Defined Benefit Plan, Equity Securities [Member] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Summary of Information Concerning Outstanding and Exercisable Share Options Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Equity Component [Domain] Equity Component [Domain] Fair value, nonrecurring Fair Value, Nonrecurring [Member] Net income per Ordinary Share attributable to the Group (Note 24): Earnings Per Share Reconciliation [Abstract] Credit Facilities: Secured Debt [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Number of Shares (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Increase related to current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Related party, loan interest rate Related Party Transaction, Rate Investment, Name [Domain] Investment, Name [Domain] Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits Summary of Income Tax Contingencies [Table Text Block] Financing costs Payments of Financing Costs Related Party [Domain] Related Party [Domain] Currency translation adjustments Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Non-current deferred tax liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities Actuarial gain/(loss) on defined benefit pension plan (note 21) Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Hedging Designation [Domain] Hedging Designation [Domain] Fair value of plan assets Fair value of plan assets at beginning of year  Fair value of plan assets at end of year Defined Benefit Plan, Plan Assets, Amount Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Plan Name [Domain] Plan Name [Domain] Deferred tax liabilities, undistributed foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Adjustments resulting from foreign currency translations Foreign Currency Disclosure [Table Text Block] Foreign Currency Disclosure Other comprehensive income, net of tax Other comprehensive income   Other Comprehensive Income (Loss), Net of Tax [Abstract] Weighted average contractual term of options outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type Award Type [Axis] Actuarial gain Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Five Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Operating lease liabilities Operating lease liabilities Operating Lease, Liability, Current Restructuring (Note 19) Restructuring charges Restructuring Costs Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount   Costs and expenses: Costs and Expenses [Abstract] Accounts receivable and unbilled revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Fixed assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Total long-term debt, net Long-Term Debt, Excluding Current Maturities Liabilities, Total Liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Prior period acquisition (note 6) Goodwill, Purchase Accounting Adjustments Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Schedule of Annual Benefit Payments which Reflect Expected Future Service Schedule of Expected Benefit Payments [Table Text Block] Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity common stock, shares outstanding (in shares) Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Revolving loan facility Revolving Credit Facility [Member] Revenue recognition Revenue from Contract with Customer [Policy Text Block] Current tax expense: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Document Type Document Type Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Estimated useful lives Property, Plant and Equipment, Useful Life Non-current Bank Credit Lines and Loan Facilities Long-Term Debt [Text Block] Compensation Related Costs Share Based Payments Disclosure [Table] Compensation Related Costs Share Based Payments Disclosure [Table] Compensation Related Costs Share Based Payments Disclosure [Table] Equity method investment, decrease in loan receivable Equity Method Investment, Decrease In Loan Receivable Equity Method Investment, Decrease In Loan Receivable Amounts provided during the year Accounts Receivable, Credit Loss Expense Accounts Receivable, Credit Loss Expense Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Severance costs Severance Costs Outstanding at beginning of period (USD per share) Outstanding at end of period (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Deferred tax (benefit)/expense Deferred Income Tax Expense (Benefit) Other receivables Assets for Plan Benefits, Defined Benefit Plan Exercise Price Range [Axis] Exercise Price Range [Axis] Other Liabilities Other Liabilities Disclosure [Text Block] Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Share repurchase costs Payments for Share Repurchase Costs Payments for Share Repurchase Costs Schedule of Contracts with Customers, Asset and Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Office furniture and fixtures Furniture and Fixtures, Gross Share issue costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amounts used during the year Accounts Receivable, Allowance for Credit Loss, Writeoff Debt Disclosure [Abstract] Debt Disclosure [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Restructuring reserve, noncurrent Restructuring Reserve, Noncurrent Net cash (used in)/provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Interest expense on drawn facilities Interest Expense, Debt Accounts receivable and unbilled revenue, net Contracts Receivable, Net Contracts Receivable, Net Line of credit Line of Credit [Member] Shareholders' Equity: Stockholders' Equity Attributable to Parent [Abstract] Prepayments and other current assets Prepaid Expense and Other Assets, Current Unbilled revenue (Note 4) Unbilled services (unbilled revenue) Contract with Customer, Asset, before Allowance for Credit Loss, Current Schedule of Components of Income Before Income Tax Expense (Benefit) [Table] Schedule of Components of Income Before Income Tax Expense (Benefit) [Table] Schedule of Components of Income Before Income Tax Expense (Benefit) [Table] Actuarial loss recognized in net periodic benefit cost Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax Other Undenominated Capital Other Undenominated Capital [Member] Other undenominated capital. Non-current portion of operating lease liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability Customer [Axis] Customer [Axis] Interest cost Defined Benefit Plan, Interest Cost Summary of Weighted Average Fair Values and Assumptions Used Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Summary of Components of Provision for Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Building Buildings and Improvements, Gross Restructuring Plan [Domain] Restructuring Plan [Domain] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Assumed through business combination (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination Purchase of subsidiary undertakings (net of cash acquired) Fair value of cash consideration Payments to Acquire Businesses, Gross Derivative Contract [Domain] Derivative Contract [Domain] Loss on cash flow hedge Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax Entity Registrant Name Entity Registrant Name 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Subsequent Events Subsequent Events [Text Block] Non-current bank credit lines and loan facilities (Note 13) Long-Term Line of Credit, Noncurrent Dividend yield (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Maximum Range Exercise Price (USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Other current assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Employee Stock Plan, 2008 Plan Employee Stock Plan, 2008 Plan [Member] Employee Stock Plan, 2008 Plan [Member] Employee Benefits Retirement Benefits [Text Block] Leases [Abstract] Leases [Abstract] Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Restructuring Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block] Net operating loss carryforwards Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Basis of Consolidation Consolidation, Policy [Policy Text Block] Redeemable non-controlling interests and equity Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block] Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy Minimum Minimum [Member] Accounts payable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable Entity Emerging Growth Company Entity Emerging Growth Company Allowances for Credit Losses Allowance For Doubtful Accounts [Text Block] Allowance For Doubtful Accounts [Text Block] Ordinary shares, par value (in EUR per share) Common Stock, Par or Stated Value Per Share (Loss)/gain on cash flow hedge Loss on cash flow hedge Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Impact of stock compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Investment, Name [Axis] Investment, Name [Axis] Fair Value Fair Value Disclosures [Text Block] Range 4 Range 4 [Member] Range 4 [Member] Benefits paid and transferred balances Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers Trading Symbol Trading Symbol Entity File Number Entity File Number Current portion of operating lease liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities Intangible Assets Intangible Assets Disclosure [Text Block] Debt securities, available for sale, cumulative amount advanced under subscription agreements Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Weighted Average Remaining Contractual Life Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Other Comprehensive Income Other Comprehensive Income (Loss) [Member] Currency impact on long term funding OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax Less net income attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Title of Individual [Axis] Title of Individual [Axis] Other Deferred Tax Assets, Tax Deferred Expense, Other Derivative Financial Instruments Derivatives, Policy [Policy Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Expected Expiry Dates of NOL's Summary of Operating Loss Carryforwards [Table Text Block] Rate differential from amortization of intangible assets Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount Drawdown of credit lines and facilities Proceeds from Lines of Credit Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Contribution to pension fund in the year ending December 31, 2021 Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Use of Estimates Use of Estimates, Policy [Policy Text Block] Lease Liability Lease Liability [Member] Lease Liability Business Combinations Business Combination Disclosure [Text Block] Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Net balance Advance Payments Netted Against Unbilled Contracts Receivable Advance Payments Netted Against Unbilled Contracts Receivable Percentage of company revenue (in percent) Concentration Risk, Percentage Ireland subsidiaries additional tax credit carryforward for income tax Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration Repayment of term loan obligations and accrued interest Business Combination, Consideration Transferred, Liabilities Incurred Settlement Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement Income Taxes Income Tax Disclosure [Text Block] Revenue earned from related parties Revenue from Related Parties 2021 Restructuring Plan 2021 Restructuring Plan [Member] 2021 Restructuring Plan Credit Facility [Domain] Credit Facility [Domain] Basic (USD per share) Earnings Per Share, Basic Fair value of stock units vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Period majority voting share capital can be sold to the company Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Purchase of noncontrolling interest Payments to Noncontrolling Interests Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income Loss [Text Block] Disclosure of the components of accumulated other comprehensive income (loss). Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block] Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Computer equipment and software Computer Equipment and Capitalized Software [Member] Computer Equipment and Capitalized Software [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Business Contact Business Contact [Member] Alternative minimum tax credit carry forwards Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax Motor vehicles Vehicles, Gross Vehicles, Gross Issue of restricted share units / performance share units Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Number of votes Number Of Votes Number Of Votes Repurchase of ordinary shares Payments for Repurchase of Common Stock Income Taxes Income Tax, Policy [Policy Text Block] Aptiv Solutions pension plan Aptiv Solutions Pension Plan [Member] Aptiv Solutions Pension Plan Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Retirement Plan Sponsor Location [Axis] Retirement Plan Sponsor Location [Axis] Pension plan period Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period The 2018 Legacy PRA Plan The 2018 Legacy PRA Plan [Member] The 2018 Plan Current Assets: Assets, Current [Abstract] Interest and penalties recognized as an expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Short term investments average maturity period Short Term Available For Sale Investments Average Remaining Maturity Period Short Term Available For Sale Investments Average Remaining Maturity Period Schedule of Distribution of Net Revenue by Geographical Area Revenue from External Customers by Geographic Areas [Table Text Block] Retained earnings Retained Earnings (Accumulated Deficit) Derivative, variable interest rate, reference rate in excess of Derivative, Variable Interest Rate, Reference Rate In Excess Of Derivative, Variable Interest Rate, Reference Rate In Excess Of Related Parties Related Party Transactions Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Foreign Plan [member] Foreign Plan [Member] Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Total Income Tax Effects Allocated Directly to Equity Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Current tax expense Current Income Tax Expense (Benefit) Accounts receivable and unbilled revenue Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Product Information [Line Items] Product Information [Line Items] Reconciliation of Provision of Income Taxes [Table] Reconciliation of Provision of Income Taxes [Table] Reconciliation of Provision of Income Taxes [Table] Deferred tax assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets Derivative, Fair Value, Net Derivative, Fair Value, Net Noncontrolling interest adjustment to redemption amount Noncontrolling interest adjustment to redemption amount Redeemable Noncontrolling Interest, Increase From Business Combination Redeemable Noncontrolling Interest, Increase From Business Combination Other non-current liabilities Other Sundry Liabilities, Noncurrent Document Information [Table] Document Information [Table] Ordinary shares, shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill (Note 10) Goodwill Opening goodwill Closing goodwill Goodwill Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Income tax expense (Note 20) Income tax expense allocated to continuing operations Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance for deferred tax assets Valuation allowance for deferred tax assets Deferred Tax Assets, Valuation Allowance Deferred tax liability (Note 20) Deferred Income Tax Liabilities, Net Corvus Pharmaceuticals Corvus Pharmaceuticals [Member] Corvus Pharmaceuticals Non-current portion of operating lease liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities Direct costs (excluding depreciation and amortization) Cost of Goods and Services Sold Oncacare Oncacare [Member] Oncacare Less accumulated depreciation and asset write offs Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Derivative instruments (c) Derivative Liability Derivative Liability Billed services (accounts receivable) Billed Contracts Receivable Maximum number of shares per employee (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee Clients 11-25 Clients 11-25 [Member] Clients 11-25 [Member] 2023 Defined Benefit Plan, Expected Future Benefit Payment, Year One Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts Receivable, Allowance for Credit Loss [Roll Forward] Accounts receivable (net) Contracts Receivable, Gross Contracts Receivable Number of countries in which company operates Number of Countries in which Entity Operates Government Bonds Government Bonds [Member] Government Bonds Current portion of operating lease liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021. Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Transaction and integration related (Note 6) Business Combination, Integration Related Costs Amounts due to third parties for reimbursable expenses Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses Afimmune Limited Afimmune Limited [Member] Afimmune Limited Bad debt expense Contract with Customer, Asset, Credit Loss Expense (Reversal) Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Current Liabilities: Liabilities, Current [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Proceeds from the exercise of equity compensation Total proceeds from exercise of stock options by employees Proceeds from Stock Options Exercised Award date, prior to 2018 Award Date, All Years Excluding 2018 [Member] Award Date, Prior to 2018 [Member] Unearned revenue (Note 4) Unearned revenue (payments on account) Contract with Customer, Liability, Current Retirement Plan Type [Domain] Retirement Plan Type [Domain] Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Amortization period Finite-Lived Intangible Asset, Useful Life Operating lease costs Operating Lease, Cost Senior secured revolving loan facility Senior Secured Revolving Loan Facility [Member] Senior Secured Revolving Loan Facility Fair Value, Liabilities Measured on Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Current year acquisitions (note 6) Goodwill, Acquired During Period Restructuring reserve, current Restructuring Reserve, Current Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Other receivables Other Assets, Noncurrent Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items] Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items] Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items] Depreciation and amortization expense Depreciation, Depletion and Amortization Percentage of option price for fair value of ordinary share (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Non-cancelable operating leases for facilities expiration period Lessee, Operating Lease, Term of Contract Amounts released during the year Accounts Receivable, Credit Loss Reversal Accounts Receivable, Credit Loss Reversal Less long-term portion of debt issuance costs and debt discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Schedule of Financing Cost Disclosure Of Detailed Information About Financing Cost [Table Text Block] Disclosure Of Detailed Information About Financing Cost Intangible assets Estimated Fair Value Value of intangible assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Derivative, number of instruments held Derivative, Number of Instruments Held Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Supplemental Disclosure of Cash Flow Information Cash Flow, Supplemental Disclosures [Text Block] Document Registration Statement Document Registration Statement Employee Stock Option Share-Based Payment Arrangement, Option [Member] Business acquisition, number of shares issued (in shares) Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders Expected volatility (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Summary of Components of Income Before Provision for Income Taxes Income Before Income Tax [Table Text Block] Income Before Income Tax, Table Exercise of share options Stock Issued During Period, Value, Stock Options Exercised U.S. Federal net operating loss carry forwards currently available for offset Operating Loss Carryforwards, US Federal Operating Loss Carryforwards, US Federal Ordinary shares, shares authorized (in shares) Common Stock, Shares Authorized Goodwill Deferred Tax Liabilities, Goodwill Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Income taxes payable Accrued Income Taxes, Current Maximum Maximum [Member] Business combination acquisition percentage (in percent) Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Repurchase of ordinary shares Ordinary shares redeemed, value Stock Repurchased and Retired During Period, Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Unearned revenue Increase (Decrease) in Contract with Customer, Liability Total derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Measurement Frequency [Domain] Measurement Frequency [Domain] Share Capital Stockholders' Equity Note Disclosure [Text Block] Schedule of Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Purchase of available for sale investments Payments to Acquire Debt Securities, Available-for-Sale Investments in equity-long term (Note 8b) Other Long-Term Investments Schedule of Supplemental Disclosure of Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Actual plan asset allocations Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage Income tax benefit related to stock compensation Share-Based Payment Arrangement, Expense, Tax Benefit Income from sub-leases Sublease Income PRA Switzerland AG pension plan PRA Switzerland AG Pension Plan [Member] PRA Switzerland AG Pension Plan Repurchase of ordinary shares (in shares) Ordinary shares redeemed (in shares) Stock Repurchased and Retired During Period, Shares Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Repayment of credit lines and facilities Repayments of Lines of Credit Summary of Assumptions Used in Calculating Pension Benefit Obligations Defined Benefit Plan, Assumptions [Table Text Block] Business Segment and Geographical Information Segment Reporting Disclosure [Text Block] Selling, general and administrative Selling, General and Administrative Expenses [Member] Entity Address, Country Entity Address, Country Non-current other liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block] Consultants Restricted Stock Units 2019 Consultants Restricted Stock Units Twenty Nineteen [Member] Consultants Restricted Stock Units Twenty Nineteen [Member]   Overall net deferred tax asset/(liability) Deferred Tax Liabilities, Net LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Performance Share Unit (PSUs) Performance Share Unit [Member] Performance Share Unit [Member] Weighted average number of ordinary shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Debt discount paid Debt Instrument, Unamortized Discount Number of employees Entity Number of Employees Schedule of Product Information [Table] Schedule of Product Information [Table] Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill Basic (in shares) Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares) Weighted Average Number of Shares Outstanding, Basic Ownership Percentage Equity Method Investment, Ownership Percentage Schedule of Non-cash Stock Compensation Expense Schedule of Non Cash Stock Compensation Expense [Table Text Block] Schedule of Non Cash Stock Compensation Expense. Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Derivative, notional Amount Derivative, Notional Amount Beginning balance Ending balance Redeemable Noncontrolling Interest, Equity, Carrying Amount Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Document Accounting Standard Document Accounting Standard Entity Well Known Seasoned Issuer Entity Well-known Seasoned Issuer Rest of Europe Rest Of Europe [Member] Rest Of Europe [Member] Other financing costs/(credits) Interest Expense (Credit), Other Interest Expense (Credit), Other Restructuring liabilities Restructuring Reserve and Other Liabilities, Current Restructuring Reserve and Other Liabilities, Current Senior secured credit facility and senior secured notes Senior Secured Credit Facility And Senior Secured Notes [Member] Senior Secured Credit Facility And Senior Secured Notes Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] Number of Shares (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable   Income before income tax expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Available for sale investments (long-term) (b) Debt Securities, Available-for-Sale, Noncurrent Equity Incentive Schemes and Stock Compensation Charges Share-Based Payment Arrangement [Text Block] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Allowance for credit losses (note 5) Opening provision   Closing provision Accounts Receivable, Allowance for Credit Loss Order backlog Order or Production Backlog [Member] Foreign currency exchange rate changes Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Business Combinations [Abstract] Business Combinations [Abstract] Other assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Actuarial loss/(gain) – plan assets Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Award Date [Axis] Award Date [Axis] Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Unrealized foreign exchange (gain)/loss Foreign Currency Transaction Gain (Loss), Unrealized Related Party [Axis] Related Party [Axis] Goodwill [Roll Forward] Goodwill [Roll Forward] Net income attributable to noncontrolling interest Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Goodwill, expected tax deductible amount Business Acquisition, Goodwill, Expected Tax Deductible Amount Debt Issuance Costs Debt, Policy [Policy Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Share based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Plan participants' contributions Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Non-current income taxes payable Accrued Income Taxes, Noncurrent General trade and overhead liabilities Other Sundry Liabilities, Current Income tax expense: Income Tax Expense (Benefit), Continuing Operations [Abstract] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Additional operating loss carryforward Net operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Compensation Related Costs Share Based Payments Disclosure [Line Items] Compensation Related Costs Share Based Payments Disclosure [Line Items] Compensation Related Costs Share Based Payments Disclosure [Line Items] Total unrecognized tax benefits net of potential benefits Unrecognized Tax Benefits that Would Impact Effective Tax Rate Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Shares expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Change in unearned revenue (payments on account) Change in unearned revenue (payments on account) Increase (Decrease) In Contracts With Customers, Liability, Current Increase (Decrease) In Contracts With Customers, Liability, Current Minimum Range Exercise Price (USD per share) Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Other retirement plans Other Retirement Plans [Member] Other Retirement Plans Effects of change in tax rates Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Income Tax Authority [Domain] Income Tax Authority [Domain] Schedule of Provision for Credit Losses Allowance for Doubtful Accounts [Table Text Block] Allowance for Doubtful Accounts, Table Europe Europe [Member] Net change in the total valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Business acquisition, share price (in USD per share) Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held Fair Value Disclosures [Abstract] Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Derivative Instruments and Hedging Activities Disclosure [Abstract] The 2020 Legacy PRA Plan The 2020 Legacy PRA Plan [Member] The 2020 Legacy PRA Plan Reconciliation of Provision of Income Taxes [Line Items] Reconciliation of Provision of Income Taxes [Line Items] Reconciliation of Provision of Income Taxes [Line Items] Credit Facility [Axis] Credit Facility [Axis] Unrealized capital loss - investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Equity [Abstract] Equity [Abstract] Shares vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Consultants Stock Plan, 2008 Plan Consultants Stock Plan, 2008 Plan [Member] Consultants Stock Plan, 2008 Plan [Member] Ordinary shares which have been reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Schedule of Distribution of Long-lived Assets, Net, by Geographical Area Long-Lived Assets by Geographic Areas [Table Text Block] Derivative, fixed interest rate Derivative, Fixed Interest Rate Diversified Bonds Diversified Bonds [Member] Diversified Bonds Deferred compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits DS Biopharma Limited DS Biopharma Limited [Member] DS Biopharma Limited [Member] Aptiv Solutions Aptiv Solutions [Member] Aptiv Solutions [Member] Settlement of cash flow hedge Payments for Hedge, Financing Activities Net income Temporary Equity, Net Income Noncontrolling interest adjustment to redemption amount Temporary Equity, Accretion to Redemption Value, Adjustment Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Unearned revenue Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue Net (decrease)/increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Schedule of Restructuring Charges Restructuring and Related Costs [Table Text Block] Property, plant and equipment Deferred Tax Assets, Property, Plant and Equipment Entity Central Index Key Entity Central Index Key Interest income Investment Income, Interest Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Increase related to acquired tax positions Unrecognized Tax Benefits, Increase Resulting from Acquisition Consideration transferred Business Combination, Consideration Transferred Transaction and integration related Transaction And Integration Expense [Member] Transaction And Integration Expense City Area Code City Area Code ASSETS Assets [Abstract] Pension Costs Pension and Other Postretirement Plans, Policy [Policy Text Block] Foreign exchange Allowance For Doubtful Accounts Foreign Currency Translation Adjustments Allowance For Doubtful Accounts Foreign Currency Translation Adjustments Current bank credit lines and loan facilities (Note 13) Line of Credit, Current Non-executive director Non-executive Director [Member] Non-executive Director [Member] Net Income per Ordinary Share Earnings Per Share, Policy [Policy Text Block] 2023 Long-Term Debt, Maturity, Year One Stock compensation expense Total compensation costs Share-Based Payment Arrangement, Noncash Expense Investment in equity method investments Payments to Acquire Equity Method Investments Weighted average fair value (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Repayments of senior debt Repayments of Senior Debt Variable Rate [Axis] Variable Rate [Axis] Non-current other liabilities (Note 16) Other Liabilities, Noncurrent Other Liabilities, Noncurrent Share of equity method investments Loss on equity method investments Income (Loss) from Equity Method Investments Purchase of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Laboratory equipment Machinery and Equipment, Gross Replacement share-based awards issued to acquiree employees APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Non-current other liabilities (note 16) Benefit obligation at beginning of year   Benefit obligation at end of year Defined Benefit Plan, Benefit Obligation Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating loss and tax credits carryforwards Deferred Tax Assets Operating Loss And Tax Credits Carryforwards Deferred Tax Assets Operating Loss And Tax Credits Carryforwards Customer [Domain] Customer [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Change in unbilled receivables (in percent) Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent Net Income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest PSUs Based on Service and EPS Targets Performance Based Grants [Member] Performance Based Grants [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Range 2 Range 2 [Member] Range 2 [Member] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] 2024 Long-Term Debt, Maturity, Year Two Business Combinations Transaction and Integration-related Expenses Business Combinations Policy [Policy Text Block] Increase (decrease) in equity method investments Increase (Decrease) In Equity Method Investments Increase (Decrease) In Equity Method Investments Expenses incurred from related party transactions Related Party Transaction, Expenses from Transactions with Related Party Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Restructuring reserve Opening provision Ending provision Restructuring Reserve Share repurchase costs Adjustment to Retained Earning Share Repurchase costs Adjustment to Retained Earning Share Repurchase costs Statistical Measurement [Domain] Statistical Measurement [Domain] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Long-lived assets Long-Lived Assets Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Scheme contributions Defined Benefit Plan, Scheme Contributions Defined Benefit Plan, Scheme Contributions Other net assets Increase (Decrease) in Other Current Liabilities Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Net income attributable to the Group Net income Net income attributable to the Group Net Income (Loss) Attributable to Parent Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Stock compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Tax Period [Domain] Tax Period [Domain] Movement in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Total assets Assets, Fair Value Disclosure Restructuring Plan [Axis] Restructuring Plan [Axis] Senior Secured Term Loan Term Loan Facility [Member] Term Loan Facility Operating Leases Lessee, Operating Leases [Text Block] Number of interest rate derivatives held Number of Interest Rate Derivatives Held Plan Name [Axis] Plan Name [Axis] Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Elements [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Number of reporting segments Number of Operating Segments Less current portion of long-term debt and debt issuance costs Long-term Debt, Current Maturities, Gross Long-term Debt, Current Maturities, Gross Schedule of Distribution of Income from Operations by Geographical Area Operating Income by Geography [Table Text Block] Operating Income by Geography. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Income from operations, excluding restructuring and other items Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses Level 1 Fair Value, Inputs, Level 1 [Member] Unearned revenue Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current  Total Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax Senior Secured Notes Senior Secured Notes [Member] Senior Secured Notes 2023-2036 Tax Year 2023 to 2036 [Member] Tax Year 2023 to 2036 New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Derivative instruments (c) Derivative Asset Derivative Asset Schedule of Other Liabilities Other Liabilities [Table Text Block] Related Party Transaction [Domain] Related Party Transaction [Domain] Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net Participant's contributions percentage of annual compensation (in percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Accounts Receivable, after Allowance for Credit Loss [Abstract] Accounts Receivable, after Allowance for Credit Loss [Abstract] Canceled/expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Computer equipment and software Capitalized Computer Software, Gross Document Annual Report Document Annual Report MeDiNova MeDiNova Research [Member] MeDiNova Research [Member] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Geographical Geographical [Axis] Non-current other liabilities (note 16) Liability, Defined Benefit Plan, Noncurrent Percentage of share capital acquired (in percent) Business Acquisition, Percentage of Voting Interests Acquired Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Technology assets Technology-Based Intangible Assets [Member] Schedule of Property Plant and Equipment, Net Property, Plant and Equipment [Table Text Block] Available for sale investments (Note 8a) Available for sale investments Debt Securities, Available-for-Sale, Current Change in advance payments netted against unbilled contracts receivable (in percent) Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent Outstanding number of shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Country Region Country Region Restructuring Type [Axis] Restructuring Type [Axis] Entity Shell Company Entity Shell Company Decrease related to prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Other restructuring costs Other Restructuring Costs Schedule of Plan Asset Fair Value Measurements Schedule of Allocation of Plan Assets [Table Text Block] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Long-Term Debt, Maturity, Year Three Motor vehicles Vehicles [Member] Income tax expense was allocated to the following components of other comprehensive income: Other Comprehensive Income (Loss), Tax [Abstract] Net Revenue Revenue Benchmark [Member] Document Period End Date Document Period End Date Audit Information [Abstract] Audit Information Schedule of Accumulated Other Comprehensive Income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Total Assets Assets Majority investor, ownership percentage Equity Method Investment, Majority Ownership Percentage Equity Method Investment, Majority Ownership Percentage Net income per Ordinary Share attributable to the Group (Note 24): Earnings Per Share [Abstract] Assumptions: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Number of locations in which company operates Number of Locations Number of Locations Carrying value of long-term investments in equity Equity Securities, FV-NI, Current Interest Rate Swap Interest Rate Swap [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Average exercise price of option per share (USD per share) Exercised (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Long-term debt at fair value Long-Term Debt, Fair Value Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Personnel related liabilities Employee-related Liabilities, Current Clients 6-10 Clients 6-10 [Member] Clients 6-10 [Member] Deferred tax (benefit)/expense Deferred Income Taxes and Tax Credits Net Income Per Ordinary Share Earnings Per Share [Text Block] Other Deferred Tax Liabilities, Other Interest Rate Caps Interest Rate Cap [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Total comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Award Type [Domain] Award Type [Domain] Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Accounts Receivable, Net and Unbilled Revenue Receivable [Policy Text Block] Income taxes receivable Income Taxes Receivable, Current Loss on issuance of debt Gain (Loss) On Issuance Of Debt Gain (Loss) On Issuance Of Debt Government grants Government Grants [Policy Text Block] Government Grants, Policy Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign exchange movement Goodwill, Foreign Currency Translation Gain (Loss) Customer relationships Customer Relationships [Member] Entity Address, City or Town Entity Address, City or Town Facility related liabilities Accrued Utilities, Current Income before share of earnings from equity method investments Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest Change in unrecognized tax benefits Unrecognized Tax Benefits, Period Increase (Decrease) Foreign currency exchange rate changes Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Years 2028 - 2032 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Auditor name Auditor Name Pension Plan Pension Plan [Member] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] U.S. federal net operating loss carry forwards Operating Loss Carryforwards Leasehold improvements Leasehold Improvements, Gross Increase related to prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Exercisable - weighted average remaining contractual life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Fair Value Measured at Net Asset Value Per Share Fair Value Measured at Net Asset Value Per Share [Member] Laboratory equipment   Equipment [Member] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Switzerland SWITZERLAND Research & development tax incentives Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Subsequent Events [Abstract] Subsequent Events [Abstract] Additional number of ordinary shares which have been reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Stock repurchase program, authorized percentage (in percent) Stock Repurchase Program Authorized Percentage Stock Repurchase Program Authorized Percentage Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Tax Year 2022 to 2028 Tax Year 2022 to 2028 [Member] Tax Year 2020 to 2026 [Member] Amortization of intangible assets Amortization of Intangible Assets Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Schedule of Goodwill Schedule of Goodwill [Table Text Block] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Benefits paid and transferred balances Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers Total long-term debt Long-term Debt, Excluding Current Maturities, Gross Long-term Debt, Excluding Current Maturities, Gross Commitment to acquire future long-term investments Commitment To Acquire Long-Term Investments Commitment To Acquire Long-Term Investments Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total Shareholders' Equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Restricted Stock Units 2013 Restricted Stock Units Twenty Thirteen [Member] Restricted Stock Units Twenty Thirteen [Member] Tax credit carry forward Tax Credit Carryforward, Amount Forfeited (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Ireland IRELAND Operating lease liabilities Deferred Tax Assets, Operating Lease, Liability Deferred Tax Assets, Operating Lease, Liability Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Fixed assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Award Date [Domain] Award Date [Domain] Sale of available for sale investments Proceeds from Sale of Debt Securities, Available-for-Sale Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Net operating lease costs Net operating lease costs Lease, Cost Ordinary Shares Common Stock [Member] Lease Cost Lease, Cost [Table Text Block] Stock units to be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Range 3 Range 3 [Member] Range 3 [Member] Shares vested (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Issue of shares associated with a business combination Stock Issued During Period, Value, Acquisitions Loans and Leases Receivable, Related Parties Loans and Leases Receivable, Related Parties Office furniture and fixtures Furniture and Fixtures [Member] Variable rate component two Variable Rate Component Two [Member] Variable Rate Component Two Lease liabilities (Note 15) Operating Lease, Liability, Noncurrent Document Shell Company Report Document Shell Company Report Defined contribution plan, cost Defined Contribution Plan, Cost Statistical Measurement [Axis] Statistical Measurement [Axis] Proceeds from investments in equity - long term Proceeds from Sale of Long-Term Investments Other receivables Nontrade Receivables, Current Subsidiaries Subsidiary of Common Parent [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Intangible assets Deferred Tax Liabilities, Other Finite-Lived Assets Clients 2-5 Clients 2-5 [Member] Clients 2-5 [Member] Loan granted tp related party Loans and Leases Receivable, Related Parties, Additions Estimated useful lives of assets Schedule Of Useful Lives For Property Plant Equipment [Table Text Block] Schedule Of Useful Lives For Property Plant Equipment Other undenominated capital (Note 18b) Other Undenominated Capital Other undenominated capital. Accounts receivable, net of allowance for credit losses (Note 4) Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Schedule of Amounts Recognized in Balance Sheet Schedule of Amounts Recognized in Balance Sheet [Table Text Block] Fair value of replacement share-based awards issued to acquiree employees Business Combination, Consideration Transferred, Other Canceled/expired (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Change in unbilled receivables Increase (Decrease) In Contract with Customer, Asset, Gross, Current Increase (Decrease) In Contract with Customer, Asset, Gross, Current United Kingdom UNITED KINGDOM Statement [Line Items] Statement [Line Items] ICON Development Solutions Limited pension plan ICON Development Solutions Limited Pension Plan [Member] ICON Development Solutions Limited Pension Plan Other Rest Of Europe And Other Countries [Member] Rest Of Europe And Other Countries [Member] Amortization adjustment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period Outstanding at beginning of period (in shares) Outstanding at ending of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Schedule of Underlying Asset Split of Fund Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Variable Rate [Domain] Variable Rate [Domain] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Total cost Finite-Lived Intangible Assets, Gross Selling, general and administrative Selling, General and Administrative Expense Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Goodwill Goodwill Disclosure [Text Block] Operating right-of-use assets (Note 15) Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Auditor firm ID Auditor Firm ID Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report 2024 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Foreign Country Foreign Tax Authority [Member] Local Phone Number Local Phone Number Schedule of Transactions for Company's Share Option Plans Share-Based Payment Arrangement, Option, Activity [Table Text Block] Income from operations Operating Income (Loss) Range 1 Range 1 [Member] Range 1 [Member] Impact of Recently Issued or Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] State NOL's State and Local Jurisdiction [Member] Accrued expenses and unbilled revenue Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Share price of equity instruments other than options, vested in period (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share Total Liabilities Liabilities, Fair Value Disclosure Cash and cash equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents Foreign and other income taxed at higher rates Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Transaction and integration related (Note 6) Business Combination, Integration Related Costs (Credits) Business Combination, Integration Related Costs (Credits) Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Address Type [Domain] Address Type [Domain] Impairment of long lived assets Impairment, Long-Lived Asset, Held-for-Use Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Derivative [Line Items] Derivative [Line Items] Diluted (in shares) Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares) Weighted Average Number of Shares Outstanding, Diluted Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Interest rate cap and interest rate swap Interest Rate Cap And Interest Rate Swap [Member] Interest Rate Cap And Interest Rate Swap Redeemable Noncontrolling Interest Redeemable Noncontrolling Interest [Member] Redeemable Noncontrolling Interest [Member] Expected life Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Base rate Base Rate [Member] Gross debt issuance costs Debt Issuance Costs, Gross Percentage of outstanding shares authorized Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized Net prior service cost for defined benefit pension plan that will be amortized Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year Granted (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Utilization Restructuring Reserve Utilizations Restructuring Reserve Utilizations Deferred tax assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Increase (decrease) in equity securities, FV-NI Increase (Decrease) in Equity Securities, FV-NI Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Net income attributable to the Group (including NCI redemption adjustment) Net Income (Loss) Available to Common Stockholders, Basic Equity Method Investments Equity Method Investments [Table Text Block] Ordinary shares, shares issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Equity method investments Equity Method Investments   Amounts (credited)/charged Foreign Currency Transaction Gain (Loss), before Tax Acquisition related costs Business Combination, Acquisition Related Costs Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities PRA Health Sciences, Inc PRA Health Sciences, Inc [Member] PRA Health Sciences, Inc Schedule of measurement period adjustments Schedule Of Measurement Period Adjustments [Table Text Block] Schedule Of Measurement Period Adjustments Debt instrument, face amount Debt Instrument, Face Amount Federal NOL's Internal Revenue Service (IRS) [Member] Investment in Debt, Equity and Other Investment, Policy [Policy Text Block] Total comprehensive income attributable to the Group Total comprehensive income attributable to the Group Comprehensive Income (Loss), Net of Tax, Attributable to Parent Entity Current Reporting Status Entity Current Reporting Status Other liabilities (Note 12) Other liabilities Other Liabilities, Current Other non-U.S subsidiaries operating loss carryforwards for income tax Net operating loss carryforwards, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Fixed asset impairment Tangible Asset Impairment Charges Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Workforce reductions Employee Severance [Member] Impairment of long lived assets Operating Lease, Impairment Loss Other Other Countries [Member] Other Countries [Member] Income before income tax expense Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Derivative [Table] Derivative [Table] Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Actuarial gain/(loss) on defined benefit pension plan Actuarial gain (loss) on defined benefit pension plan Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Effect of exchange rate movements on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, plant and equipment, net (Note 9) Property, plant and equipment (net) Property, Plant and Equipment, Net Variable rate component one Variable Rate Component One [Member] Variable Rate Component One Schedule of Future Intangible Asset Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Change in advance payments netted against unbilled contracts receivable Increase in advance payments netted against unbilled contracts receivable Change in Advance Payments Netted Against Unbilled Contracts Receivable Change in Advance Payments Netted Against Unbilled Contracts Receivable Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset Title of Individual [Domain] Title of Individual [Domain] Patient database Database Rights [Member] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total long-term debt, net Long-Term Debt Payments to settle debt obligations that existed prior to acquisition date Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date Restructuring Charges Restructuring and Related Activities Disclosure [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] 2027 and thereafter Long-Term Debt, Maturity, Year Five And Thereafter Long-Term Debt, Maturity, Year Five And Thereafter Non-current Assets: Assets, Noncurrent [Abstract] Accumulated other comprehensive income (Note 25)  Total Accumulated Other Comprehensive Income (Loss), Net of Tax Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Expected rate of return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Total current assets Assets, Current Cash paid for income taxes (net of refunds) Income Taxes Paid, Net Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block] Assumed through business combination (USD per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price Reduction in carrying value of operating right-of-use assets Operating Lease, Right-of-Use Asset, Amortization Expense Revenue: Revenues [Abstract] Intangible assets, net (Note 11)   Net book value Finite-Lived Intangible Assets, Net Net loss that will be amortized Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year Accrued expenses and other current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Fair Value, Assets Measured on Recurring Basis Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summary of Significant accounting policies Significant Accounting Policies [Text Block] Cash tax benefit related to stock options exercised Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Notional Derivative Asset, Notional Amount Options Granted Under Plans Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property, Plant and Equipment, net Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Stock Option and Award Plans Stock Option And Award Plans [Member] Stock Option And Award Plans [Member] Non-current other liabilities Other Noncurrent Liabilities [Table Text Block] Exercise of call option on noncontrolling interest shares Temporary Equity, Accretion to Redemption Value Interest receivable, related party loans Interest Receivable, Related Party Loans Interest Receivable, Related Party Loans Retirement period used as a basis to estimate expected cash flows Expected Retirement period Expected Retirement period Retirement Plan Sponsor Location [Domain] Retirement Plan Sponsor Location [Domain] Total costs and expenses Costs and Expenses Payables and Accruals [Abstract] Payables and Accruals [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Issue of restricted share units / performance share units (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Total Operating Lease, Liability Land Land Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] 2033-2041 Tax Year 2033-2041 [Member] Tax Year 2033-2041 Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Provision for income taxes Income Tax Benefit [Member] Income Tax Benefit [Member] Granted (USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Operating lease right-of-use assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets Deferred tax assets: Deferred Tax Assets, Net [Abstract] Additional provision in the year Restructuring Charges 2026 Long-Term Debt, Maturity, Year Four Hedging Designation [Axis] Hedging Designation [Axis] Auditor location Auditor Location Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Description of business Nature of Operations [Text Block] Defined benefit pension obligations, net (note 21) Liability, Defined Benefit Pension Plan, Noncurrent Entity Filler Category Entity Filer Category United States U.S. UNITED STATES Vested and exercisable at end of period (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Accounting Standards Update 2021-08 Accounting Standards Update 2021-08 [Member] Commitments and contingencies (Note 17) Commitments and Contingencies Security Exchange Name Security Exchange Name Beginning balance (USD per share) Ending balance (USD per share) Weighted average exercise price (USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Estimated Useful Life Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Amortization of cash flow hedge Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Other non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Other Other Customers [Member] Other Customers [Member] Actuarial (gain)/loss - benefit obligation Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost Revenue Revenue from Contract with Customer, Excluding Assessed Tax Fair value of ordinary shares issued to acquiree stockholders Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Service cost Defined Benefit Plan, Service Cost Goodwill Goodwill, Fair Value Disclosure Secured Loans and Multi Asset Credit Asset-Backed Securities, Securitized Loans and Receivables [Member] Non-current Liabilities: Liabilities, Noncurrent [Abstract] Cover [Abstract] Cover [Abstract] Entity Voluntary Filers Entity Voluntary Filers Amortization of loss on cash flow hedge Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax Goodwill impairment charge Goodwill, Impairment Loss Purchase of investments in equity - long term Payments to Acquire Long-Term Investments Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Acquired entity Acquired Entity [Member] Acquired Entity Senior Secured Revolving Credit Facility Senior Secured Revolving Credit Facility [Member] Senior Secured Revolving Credit Facility Disaggregation of Revenue Contract Balances Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Unbilled revenue Increase (Decrease) in Contract with Customer, Asset Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Short term government grants Capital Government Grants Current Capital Government Grants Current Summary of RSU and PSU Activity Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block] Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block] Risk free interest rate (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Amortization of net loss Defined Benefit Plan, Amortization of Gain (Loss) Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Retirement Plan Name [Axis] Retirement Plan Name [Axis] Total Liabilities and Shareholders’ Equity Liabilities and Equity Amortization of financing costs and debt discount Amortization of Debt Issuance Costs Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Total deferred tax assets Deferred Tax Assets, Gross Top client Top Client [Member] Top Client [Member] Total accrued interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Lease imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Diluted (USD per share) Earnings Per Share, Diluted Shares vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share issue costs Payments of Stock Issuance Costs Contact Personnel Name Contact Personnel Name Identifiable intangible assets, net Finite-Lived Intangible Assets, Fair Value Disclosure Exercise Price Range [Domain] Exercise Price Range [Domain] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Schedule of Available-for-sale Securities [Table] Schedule of Available-for-Sale Securities [Table] Unrecognized tax benefits at start of year   Unrecognized tax benefits at end of year Unrecognized Tax Benefits Deferred tax assets recognized Deferred Tax Assets, Net of Valuation Allowance Share Repurchase Program [Axis] Share Repurchase Program [Axis] Amounts due from related parties Due from Related Parties Corporate Bonds (including 50% high yield bonds) Corporate Debt Securities [Member] Vested and exercisable at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Schedule of Operating Lease Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Unrecognized tax benefit, potentially expire in 2021 Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit Entity Address, Address Line One Entity Address, Address Line One Foreign Currency [Abstract] Foreign Currency [Abstract] Expected return on plan assets Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Buyback program Buyback Program [Member] Buyback Program [Member] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Loan to equity method investment Payments to Fund Long-Term Loans to Related Parties Interest expense (Note 13) Total financing costs Total financing costs Interest Expense Trade names & brands Trade names Trade Names [Member] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Schedule of Long-term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Operating right-of-use-assets Deferred Tax Liabilities, Leasing Arrangements Building   Building [Member] Contact Personnel Email Address Contact Personnel Email Address  Funded status Defined Benefit Plan, Funded (Unfunded) Status of Plan Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Limit of shares issued or to be issued pursuant to options granted (in shares) Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted Limit of Shares Issued or To Be Issued Pursuant to Options Granted Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block]   Total deferred tax liabilities recognized Deferred Tax Liabilities, Gross Rest of World Other Geographic Locations [Member] Other Geographic Locations [Member] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Plan participants' contributions Defined Benefit Plan, Plan Assets, Contributions by Plan Participant Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Effect of dilutive share options outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Impairment of goodwill and long-lived assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Projected benefit obligation Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Measurement Frequency [Axis] Measurement Frequency [Axis] Weighted Average Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Change in unearned revenue (payments on account) (in percent) Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent 2013 Legacy PRA Plan 2013 Legacy PRA Plan [Member] 2013 Legacy PRA Plan Tax Period [Axis] Tax Period [Axis] Other liabilities Other Accrued Liabilities, Current Number of shares authorized to be repurchased (in shares) Stock Repurchase Program, Number of Shares Authorized to be Repurchased Type of Adoption [Domain] Accounting Standards Update [Domain] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Research and development credits Research and Development Credits [Policy Text Block] Research and Development Credits [Policy Text Block] Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%) Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Revenue, remaining performance obligation (in percent) Revenue, Remaining Performance Obligation, Percentage Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Finite lived intangible assets, amortization expense, net, total Finite Lived Intangible Assets, Amortization Expense, Net Finite Lived Intangible Assets, Amortization Expense, Net Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Cost of Sales Direct costs Cost of Sales [Member] Option Plans 2008 Option Plans 2008 [Member] Option Plans 2008 [Member] Transaction and one time financing costs Transaction And One Time Financing Costs Transaction And One Time Financing Costs EX-101.PRE 11 iclr-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 iclr-20221231_g1.jpg begin 644 iclr-20221231_g1.jpg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end GRAPHIC 13 iclr-20221231_g10.jpg begin 644 iclr-20221231_g10.jpg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end GRAPHIC 14 iclr-20221231_g11.jpg begin 644 iclr-20221231_g11.jpg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iclr-20221231_g2.jpg begin 644 iclr-20221231_g2.jpg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end
GRAPHIC 16 iclr-20221231_g3.jpg begin 644 iclr-20221231_g3.jpg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ɓ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iclr-20221231_g4.jpg begin 644 iclr-20221231_g4.jpg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
  •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�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

  •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iclr-20221231_g5.jpg begin 644 iclr-20221231_g5.jpg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end
    GRAPHIC 19 iclr-20221231_g6.jpg begin 644 iclr-20221231_g6.jpg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end GRAPHIC 20 iclr-20221231_g7.jpg begin 644 iclr-20221231_g7.jpg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end GRAPHIC 21 iclr-20221231_g8.jpg begin 644 iclr-20221231_g8.jpg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end GRAPHIC 22 iclr-20221231_g9.jpg begin 644 iclr-20221231_g9.jpg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htm IDEA: XBRL DOCUMENT v3.22.4
    Cover
    12 Months Ended
    Dec. 31, 2022
    shares
    Document Information [Line Items]  
    Document Type 20-F
    Document Registration Statement false
    Document Annual Report true
    Document Period End Date Dec. 31, 2022
    Current Fiscal Year End Date --12-31
    Document Transition Report false
    Document Shell Company Report false
    Entity File Number 333-08704
    Entity Registrant Name ICON PLC
    Entity Incorporation, State or Country Code L2
    Entity Address, Address Line One South County Business Park,
    Entity Address, Address Line Two Leopardstown,
    Entity Address, City or Town Dublin 18, D18 X5R3
    Entity Address, Postal Zip Code D18 X5R3
    Entity Address, Country IE
    Title of 12(b) Security ORDINARY SHARES, PAR VALUE €0.06 EACH
    Trading Symbol ICLR
    Security Exchange Name NASDAQ
    Entity common stock, shares outstanding (in shares) 81,723,555
    Entity Well Known Seasoned Issuer Yes
    Entity Voluntary Filers No
    Entity Current Reporting Status Yes
    Entity Interactive Data Current Yes
    Entity Filler Category Large Accelerated Filer
    Entity Emerging Growth Company false
    ICFR Auditor Attestation Flag true
    Document Accounting Standard U.S. GAAP
    Entity Shell Company false
    Amendment Flag false
    Document Fiscal Year Focus 2022
    Document Fiscal Period Focus FY
    Entity Central Index Key 0001060955
    Business Contact  
    Document Information [Line Items]  
    Entity Address, Address Line One South County Business Park
    Entity Address, Address Line Two Leopardstown
    Entity Address, City or Town Dublin 18
    Entity Address, Postal Zip Code D18 X5R3
    Entity Address, Country IE
    Contact Personnel Name Brendan Brennan
    Contact Personnel Email Address Brendan.Brennan@iconplc.com
    Country Region 353
    City Area Code 1
    Local Phone Number 291-2000
    XML 24 R2.htm IDEA: XBRL DOCUMENT v3.22.4
    Audit Information
    12 Months Ended
    Dec. 31, 2022
    Audit Information [Abstract]  
    Auditor firm ID 1116
    Auditor name KPMG
    Auditor location Dublin, Ireland
    XML 25 R3.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED BALANCE SHEETS - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Current Assets:    
    Cash and cash equivalents $ 288,768 $ 752,213
    Available for sale investments (Note 8a) 1,713 1,712
    Accounts receivable, net of allowance for credit losses (Note 4) 1,731,388 1,342,770
    Unbilled revenue (Note 4) 957,655 623,121
    Other receivables 63,658 56,760
    Prepayments and other current assets 137,094 114,323
    Income taxes receivable 48,790 50,299
    Total current assets 3,229,066 2,941,198
    Non-current Assets:    
    Property, plant and equipment, net (Note 9) 350,320 336,444
    Goodwill (Note 10) 8,971,670 9,037,931
    Intangible assets, net (Note 11) 4,278,659 4,710,843
    Operating right-of-use assets (Note 15) 153,832 198,123
    Other receivables 70,790 70,557
    Income taxes receivable 21,380 18,637
    Deferred tax asset (Note 20) 76,930 48,392
    Equity method investments 0 2,373
    Investments in equity-long term (Note 8b) 32,631 22,592
    Total Assets 17,185,278 17,387,090
    Current Liabilities:    
    Accounts payable 81,194 90,764
    Unearned revenue (Note 4) 1,507,449 1,323,961
    Other liabilities (Note 12) 1,005,025 949,629
    Income taxes payable 41,783 59,433
    Current bank credit lines and loan facilities (Note 13) 55,150 55,150
    Total current liabilities 2,690,601 2,478,937
    Non-current Liabilities:    
    Non-current bank credit lines and loan facilities (Note 13) 4,599,037 5,381,162
    Lease liabilities (Note 15) 131,644 159,483
    Non-current other liabilities (Note 16) 38,260 42,596
    Non-current income taxes payable 239,188 172,109
    Deferred tax liability (Note 20) 988,585 1,085,976
    Commitments and contingencies (Note 17) 0 0
    Liabilities, Total 8,687,315 9,320,263
    Shareholders' Equity:    
    Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021. 6,649 6,640
    Additional paid-in capital 6,840,306 6,733,910
    Other undenominated capital (Note 18b) 1,162 1,134
    Accumulated other comprehensive income (Note 25) (171,538) (90,937)
    Retained earnings 1,821,384 1,416,080
    Total Shareholders' Equity 8,497,963 8,066,827
    Total Liabilities and Shareholders’ Equity $ 17,185,278 $ 17,387,090
    XML 26 R4.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED BALANCE SHEETS (Parenthetical) - € / shares
    Dec. 31, 2022
    Dec. 31, 2021
    Statement of Financial Position [Abstract]    
    Ordinary shares, par value (in EUR per share) € 6 € 6
    Ordinary shares, shares authorized (in shares) 100,000,000 100,000,000
    Ordinary shares, shares issued (in shares) 81,723,555 81,554,683
    Ordinary shares, shares outstanding (in shares) 81,723,555 81,554,683
    XML 27 R5.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Revenue:      
    Revenue $ 7,741,386 $ 5,480,826 $ 2,797,288
      Costs and expenses:      
    Direct costs (excluding depreciation and amortization) 5,527,045 3,972,612 1,979,883
    Selling, general and administrative 778,753 585,330 342,449
    Depreciation and amortization 569,513 314,987 66,126
    Transaction and integration related (Note 6) 39,695 198,263 (759)
    Restructuring (Note 19) 31,143 31,105 18,089
    Total costs and expenses 6,946,149 5,102,297 2,405,788
    Income from operations 795,237 378,529 391,500
    Interest income 2,345 574 2,724
    Interest expense (Note 13) (229,731) (182,423) (13,019)
    Income before income tax expense 567,851 196,680 381,205
    Income tax expense (Note 20) (59,411) (41,334) (47,875)
    Income before share of earnings from equity method investments 508,440 155,346 333,330
    Share of equity method investments (3,136) (2,161) (366)
    Net Income 505,304 153,185 332,964
    Net income attributable to noncontrolling interest 0 0 (633)
    Net income attributable to the Group $ 505,304 $ 153,185 $ 332,331
    Net income per Ordinary Share attributable to the Group (Note 24):      
    Basic (USD per share) $ 6.20 $ 2.28 $ 6.20
    Diluted (USD per share) $ 6.13 $ 2.25 $ 6.15
    Weighted average number of ordinary shares outstanding:      
    Basic (in shares) 81,532,320 67,110,186 52,859,911
    Diluted (in shares) 82,468,363 68,068,311 53,283,585
    XML 28 R6.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Statement of Comprehensive Income [Abstract]      
    Net income $ 505,304 $ 153,185 $ 332,964
    Other comprehensive income, net of tax      
    Currency translation adjustment (89,530) (60,617) 46,526
    Unrealized capital loss - investments 0 0 (231)
    Actuarial gain/(loss) on defined benefit pension plan 12,657 4,266 (4,138)
    Amortization of cash flow hedge 0 113 (910)
    (Loss)/gain on cash flow hedge (3,728) 778 (905)
    Total comprehensive income 424,703 97,725 373,306
    Less net income attributable to noncontrolling interest 0 0 (633)
    Total comprehensive income attributable to the Group $ 424,703 $ 97,725 $ 372,673
    XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)
    $ in Thousands
    Total
    Ordinary Shares
    Additional Paid-in Capital
    Other Undenominated Capital
    Accumulated Other Comprehensive Income
    Retained Earnings
    Redeemable Noncontrolling Interest
    Beginning balance (in shares) at Dec. 31, 2019   53,622,206          
    Beginning balance at Dec. 31, 2019 $ 1,618,055 $ 4,635 $ 577,961 $ 1,052 $ (75,819) $ 1,110,226  
    Increase (Decrease) in Stockholders' Equity [Roll Forward]              
    Net income 332,331         332,331  
    Currency translation adjustment 46,526       46,526    
    Unrealized capital loss - investments (231)       (231)    
    Actuarial gain (loss) on defined benefit pension plan (4,138)       (4,138)    
    Amortization of cash flow hedge (910)       (910)    
    Loss on cash flow hedge (905)       (905)    
    Total comprehensive income attributable to the Group 372,673            
    Exercise of share options (in shares)   193,417          
    Exercise of share options 13,189 $ 13 13,176        
    Issue of restricted share units / performance share units (in shares)   207,688          
    Issue of restricted share units / performance share units 14 $ 14          
    Share based compensation expense 25,981   25,981        
    Share issue costs (14)   (14)        
    Repurchase of ordinary shares (in shares)   (1,235,218)          
    Repurchase of ordinary shares (175,000) $ (82)   82   (175,000)  
    Share repurchase costs (140)         (140)  
    Noncontrolling interest adjustment to redemption amount (4,522)         (4,522) $ 4,522
    Ending balance (in shares) at Dec. 31, 2020   52,788,093          
    Ending balance at Dec. 31, 2020 1,850,236 $ 4,580 617,104 1,134 (35,477) 1,262,895  
    Beginning balance at Dec. 31, 2019             39,510
    Increase (Decrease) in Temporary Equity [Roll Forward]              
    Net income             633
    Noncontrolling interest adjustment to redemption amount (4,522)         (4,522) 4,522
    Exercise of call option on noncontrolling interest shares             (44,665)
    Ending balance at Dec. 31, 2020             $ 0
    Increase (Decrease) in Stockholders' Equity [Roll Forward]              
    Net income 153,185         153,185  
    Currency translation adjustment (60,617)       (60,617)    
    Unrealized capital loss - investments 0            
    Actuarial gain (loss) on defined benefit pension plan 4,266       4,266    
    Amortization of cash flow hedge 113       113    
    Loss on cash flow hedge 778       778    
    Total comprehensive income attributable to the Group 97,725            
    Exercise of share options (in shares)   1,065,529          
    Exercise of share options 118,589 $ 77 118,512        
    Issue of restricted share units / performance share units (in shares)   328,634          
    Issue of restricted share units / performance share units 23 $ 23          
    Share based compensation expense 133,553   133,553        
    Share issue costs (853)   (853)        
    Issue of shares associated with a business combination (in shares)   27,372,427          
    Issue of shares associated with a business combination 5,658,155 $ 1,960 5,656,195        
    Replacement share-based awards issued to acquiree employees $ 209,399   209,399        
    Ending balance (in shares) at Dec. 31, 2021 81,554,683 81,554,683          
    Ending balance at Dec. 31, 2021 $ 8,066,827 $ 6,640 6,733,910 1,134 (90,937) 1,416,080  
    Increase (Decrease) in Stockholders' Equity [Roll Forward]              
    Net income 505,304         505,304  
    Currency translation adjustment (89,530)       (89,530)    
    Unrealized capital loss - investments 0            
    Actuarial gain (loss) on defined benefit pension plan 12,657       12,657    
    Amortization of cash flow hedge 0            
    Loss on cash flow hedge (3,728)       (3,728)    
    Total comprehensive income attributable to the Group 424,703            
    Exercise of share options (in shares)   348,286          
    Exercise of share options 35,828 $ 21 35,807        
    Issue of restricted share units / performance share units (in shares)   241,116          
    Issue of restricted share units / performance share units 16 $ 16          
    Share based compensation expense 70,606   70,606        
    Share issue costs (17)   (17)        
    Repurchase of ordinary shares (in shares)   (420,530)          
    Repurchase of ordinary shares (99,983) $ (28)   28   (99,983)  
    Share repurchase costs $ (17)         (17)  
    Ending balance (in shares) at Dec. 31, 2022 81,723,555 81,723,555          
    Ending balance at Dec. 31, 2022 $ 8,497,963 $ 6,649 $ 6,840,306 $ 1,162 $ (171,538) $ 1,821,384  
    XML 30 R8.htm IDEA: XBRL DOCUMENT v3.22.4
    CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Cash flows from operating activities:      
    Net income $ 505,304 $ 153,185 $ 332,964
    Adjustments to reconcile net income to net cash provided by operating activities:      
    Depreciation and amortization expense 569,513 314,987 66,126
    Impairment of long lived assets 28,767 20,037 5,411
    Reduction in carrying value of operating right-of-use assets 45,215 45,339 28,480
    Loss on equity method investments 3,136 2,161 366
    Amortization of financing costs and debt discount 17,749 12,890 523
    Stock compensation expense 70,523 133,844 26,271
    Loss on extinguishment of debt 0 14,434 0
    Loss on issuance of debt 0 59,460 0
    Deferred tax (benefit)/expense (124,985) (60,616) 927
    Unrealized foreign exchange (gain)/loss (13,009) (6,054) 5,979
    Other non-cash items 11,324 4,480 (7,859)
    Changes in operating assets and liabilities:      
    Accounts receivable (420,695) 113,513 (175,040)
    Unbilled revenue (332,592) (17,656) (5,748)
    Unearned revenue 192,944 (69,121) 291,844
    Other net assets 10,121 108,259 (2,209)
    Net cash provided by operating activities 563,315 829,142 568,035
    Cash flows from investing activities:      
    Purchase of property, plant and equipment (142,160) (93,750) (40,885)
    Purchase of subsidiary undertakings (net of cash acquired) 0 (5,914,475) (47,931)
    Investment in equity method investments 0 (2,450) (2,450)
    Loan to equity method investment 0 (10,000) 0
    Sale of available for sale investments 481 497 47,902
    Purchase of available for sale investments (482) (480) 0
    Proceeds from investments in equity - long term 1,906 500 87
    Purchase of investments in equity - long term (5,612) (4,077) (3,299)
    Net cash used in investing activities (145,867) (6,024,235) (46,576)
    Cash flows from financing activities:      
    Financing costs 0 (30,328) (1,554)
    Drawdown of credit lines and facilities 75,000 5,905,100 350,000
    Repayment of credit lines and facilities (875,000) (877,780) (350,000)
    Purchase of noncontrolling interest 0 0 (43,923)
    Proceeds from the exercise of equity compensation 35,844 118,589 13,203
    Share issue costs (17) (853) (14)
    Repurchase of ordinary shares (99,983) 0 (175,000)
    Share repurchase costs (17) 0 (140)
    Settlement of cash flow hedge 0 0 (905)
    Net cash (used in)/provided by financing activities (864,173) 5,114,728 (208,333)
    Effect of exchange rate movements on cash (16,720) (7,727) 6,870
    Net (decrease)/increase in cash and cash equivalents (463,445) (88,092) 319,996
    Cash and cash equivalents at beginning of year 752,213 840,305 520,309
    Cash and cash equivalents at end of year $ 288,768 $ 752,213 $ 840,305
    XML 31 R9.htm IDEA: XBRL DOCUMENT v3.22.4
    Description of business
    12 Months Ended
    Dec. 31, 2022
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Description of business Description of Business
    ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.

    We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December 31, 2022 we had approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December 31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.

    ICON’s ordinary shares are traded on the NASDAQ Global Select Market under the symbol “ICLR”.

    We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.
    XML 32 R10.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    Summary of Significant accounting policies Summary of Significant Accounting Policies
    The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.

    Basis of consolidation

    The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.
     
    Use of estimates

    The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.

    Disclosure of fair value of financial instruments

    Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.

    Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

    Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

    Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

    Level 3: Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
    The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements – quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.

    Business combinations

    The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

    The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

    The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.

    Foreign currencies and translation of subsidiaries

    The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income.

    Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:

    Year ended
    December 31,
     202220212020
    (in thousands)
     
    Amounts (credited)/charged
    $(25,997)$(14,316)$5,979 
        
    Revenue recognition

    The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

    ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.
    Clinical trial service revenue

    A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

    Laboratory services revenue

    Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

    Contracting services revenue

    The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.

    Consulting services revenue

    Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

    Data services revenue

    The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

    When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

    Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

    The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above.
    At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

    Commissions

    Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.

    Reimbursable expenses

    Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.

    Direct costs

    Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.

    Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.

    Cash and cash equivalents

    Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.

    Investments in debt, equity and other

    Available for sale investments

    The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification

    Long term investments

    The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2021 and December 31, 2022 qualify for the NAV practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.

    Equity method investments

    The Company’s investments that are not consolidated are accounted for under the equity method if the Company exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.
    Accounts receivable, net and unbilled revenue    
        
    Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.

    Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.

    Accounts receivable early payment discounting

    Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 'Transfers and Servicing' (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.

    Property, plant and equipment

    Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: 
     Years
    Building  40
    Computer equipment and software
    2-8
    Office furniture and fixtures8
    Laboratory equipment  5
    Motor vehicles5
        
    Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.

    Leases

    The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December 31, 2022 and December 31, 2021, the Company did not account for any leases as finance leases.
        Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.
    The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.
    Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.

    In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.
    ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, Property, Plant, and Equipment – Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.

    Intangible assets

    Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

    Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

    Estimated Useful Life
    Customer relationships23 years
    Order backlog3 years
    Trade names3 years
    Patient database7 years
    Technology assets5 years

    The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.

    Impairment of goodwill and long-lived assets

    Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.

    Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.

    Debt issuance costs

    Debt issuance costs relating to the Company’s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company’s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.

    Derivative financial instruments

    The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts.

    Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income
    and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.

    The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.

    Income taxes

    The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.

    Government grants

    Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.

    Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.

    Research and development credits

    Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.

    Pension costs

    The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.

    The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 'Defined Benefit Plans – Pension'. These plans are presented in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.

    Share-based compensation

    The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 'Compensation – Stock Compensation'. Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.
    Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on
    the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.
    Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.

    Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled.

    Replacement awards

    In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.

    Transaction and integration-related expenses

    Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.

    Restructuring

    Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company’s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset’s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.

    Redeemable noncontrolling interests and equity

    The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 'Distinguishing Liabilities from Equity'. On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova.

    Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.

    Net income per ordinary share

    Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.
    Reclassifications
    Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period’s presentation.
    Impact of Recently Issued or Adopted Accounting Standards 
    No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company’s consolidated financial statements.
    XML 33 R11.htm IDEA: XBRL DOCUMENT v3.22.4
    Disaggregation of Revenue
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    Disaggregation of Revenue Disaggregation of Revenue
    Revenue disaggregated by customer profile is as follows:
    Year ended
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Top client$683,546 $441,173 $337,904 
    Clients 2-51,506,087 1,291,946 754,906 
    Clients 6-101,112,636 752,325 350,865 
    Clients 11-251,585,739 1,077,073 501,643 
    Other2,853,378 1,918,309 851,970 
    Total$7,741,386$5,480,826$2,797,288
    Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances
    Accounts receivable and unbilled revenue are as follows:
    December 31, 2022December 31, 2021
    (in thousands)
    Billed services (accounts receivable)$1,751,950 $1,349,851 
    Allowance for credit losses (note 5)(20,562)(7,081)
    Accounts receivable (net)1,731,388 1,342,770 
    Unbilled services (unbilled revenue)$957,655 $623,121 
    Accounts receivable and unbilled revenue, net$2,689,043 $1,965,891 

    Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
    (in thousands, except percentages)December 31, 2022December 31, 2021$ Change% Change
    Unbilled services (unbilled revenue)$957,655 $623,121 $334,534 53.7 %
    Unearned revenue (payments on account)(1,507,449)(1,323,961)(183,488)13.9 %
    Net balance$(549,794)$(700,840)$151,046 21.6 %
    Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

    Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.

    The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December 31, 2022 and December 31, 2021 were $406.3 million and $323.6 million (see note 12 - Other liabilities).

    Unbilled services as at December 31, 2022 increased by $334.5 million as compared to December 31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2021 and December 31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.

    The credit loss expense recognized on the Group's receivables and unbilled services was $17.8 million and $0.9 million for the twelve months ended December 31, 2022 and 2021, respectively.
    As of December 31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3 billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.
    XML 34 R12.htm IDEA: XBRL DOCUMENT v3.22.4
    Contract Balances
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    Contract Balances Disaggregation of Revenue
    Revenue disaggregated by customer profile is as follows:
    Year ended
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Top client$683,546 $441,173 $337,904 
    Clients 2-51,506,087 1,291,946 754,906 
    Clients 6-101,112,636 752,325 350,865 
    Clients 11-251,585,739 1,077,073 501,643 
    Other2,853,378 1,918,309 851,970 
    Total$7,741,386$5,480,826$2,797,288
    Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances
    Accounts receivable and unbilled revenue are as follows:
    December 31, 2022December 31, 2021
    (in thousands)
    Billed services (accounts receivable)$1,751,950 $1,349,851 
    Allowance for credit losses (note 5)(20,562)(7,081)
    Accounts receivable (net)1,731,388 1,342,770 
    Unbilled services (unbilled revenue)$957,655 $623,121 
    Accounts receivable and unbilled revenue, net$2,689,043 $1,965,891 

    Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
    (in thousands, except percentages)December 31, 2022December 31, 2021$ Change% Change
    Unbilled services (unbilled revenue)$957,655 $623,121 $334,534 53.7 %
    Unearned revenue (payments on account)(1,507,449)(1,323,961)(183,488)13.9 %
    Net balance$(549,794)$(700,840)$151,046 21.6 %
    Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned.

    Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet.

    The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December 31, 2022 and December 31, 2021 were $406.3 million and $323.6 million (see note 12 - Other liabilities).

    Unbilled services as at December 31, 2022 increased by $334.5 million as compared to December 31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2021 and December 31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer.

    The credit loss expense recognized on the Group's receivables and unbilled services was $17.8 million and $0.9 million for the twelve months ended December 31, 2022 and 2021, respectively.
    As of December 31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3 billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts.
    XML 35 R13.htm IDEA: XBRL DOCUMENT v3.22.4
    Allowances for Credit Losses
    12 Months Ended
    Dec. 31, 2022
    Accounts Receivable, after Allowance for Credit Loss [Abstract]  
    Allowances for Credit Losses Allowance for Credit Losses
    The Company does business with most major international pharmaceutical companies. Provision for credit losses at December 31, 2022 and December 31, 2021 comprises:
    December 31, 2022December 31, 2021
     (in thousands)
    Opening provision$7,081 $7,149 
    Amounts used during the year(3,913)(116)
    Amounts provided during the year17,800 705 
    Amounts released during the year— (544)
    Foreign exchange(406)(113)
     
    Closing provision
    $20,562 $7,081 
    XML 36 R14.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations
    12 Months Ended
    Dec. 31, 2022
    Business Combinations [Abstract]  
    Business Combinations Business Combinations
    PRA Health Sciences, Inc. Acquisition

    On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations.

    The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers’ commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.

    Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021.

    In the years ended December 31, 2022 and 2021, the Company incurred Merger-related expenses of $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the “Transaction and integration related” line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December 31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $0.8 million and $57.1 million, respectively.

    The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the “Interest expense” line item in the Consolidated Statement of Operations for the year ended December 31, 2021. During the year ended December 31, 2021, the Company deferred $76.2 million of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.

    The Merger Date fair value of the consideration transferred consisted of the following:

     (in thousands)
    Fair value of cash consideration5,308,646 
    Fair value of ordinary shares issued to acquiree stockholders5,658,126 
    Fair value of replacement share-based awards issued to acquiree employees209,399 
    Repayment of term loan obligations and accrued interest *865,800 
    12,041,971 
    * This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.
    The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:

    July 1,
    2021
    (in thousands)
    Cash and cash equivalents$259,971 
    Accounts receivable and unbilled revenue934,308 
    Other current assets125,156 
    Fixed assets156,851 
    Operating lease right-of-use assets180,601 
    Goodwill *8,084,314 
    Intangible assets4,919,000 
    Deferred tax assets25,190 
    Other assets33,928 
    Accounts payable(50,259)
    Accrued expenses and other current liabilities(380,048)
    Current portion of operating lease liabilities(36,506)
    Unearned revenue(739,278)
    Non-current portion of operating lease liabilities(147,204)
    Deferred tax liabilities(1,119,762)
    Other non-current liabilities(204,291)
    Net assets acquired$12,041,971 

    * The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.

    The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):
    Estimated Fair ValueEstimated Useful Life
    Customer relationships3,938,000 23 years
    Order backlog500,000 3 years
    Trade names202,000 3 years
    Patient database168,000 7 years
    Technology assets111,000 5 years
    4,919,000 
    At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:
    Measurement period adjustments
    (in thousands)
    Cash and cash equivalents$— 
    Accounts receivable and unbilled revenue— 
    Other current assets14,465 
    Fixed assets(6,137)
    Operating lease right-of-use assets(11,744)
    Goodwill70,436 
    Intangible assets *44,000 
    Deferred tax assets(147,039)
    Other assets(1,166)
    Accounts payable— 
    Accrued expenses and other current liabilities(37,496)
    Current portion of operating lease liabilities1,865 
    Unearned revenue **19,623 
    Non-current portion of operating lease liabilities10,454 
    Non-current deferred tax liabilities193,837 
    Other non-current liabilities(151,098)
    * In the year ended December 31, 2022, the Company incurred $2.2 million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.

    ** The unearned revenue measurement period adjustment also includes $16.0 million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.
    XML 37 R15.htm IDEA: XBRL DOCUMENT v3.22.4
    Fair Value
    12 Months Ended
    Dec. 31, 2022
    Fair Value Disclosures [Abstract]  
    Fair Value Fair Value
    The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

    Level 1 — Quoted prices in active markets for identical assets or liabilities.
    Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
    Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.

    The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments.
    As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,713 — — — 1,713 
    Available for sale investments (long-term) (b)— — — 32,663 32,663 
    Derivative instruments (c)— 12 — — 12 
    Total assets$1,713 $12 $— $32,663 $34,388 
    Liabilities:
    Derivative instruments (c)— 3,670 — — 3,670
    Total Liabilities$— $3,670 $— $— 3,670

    As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,712$— $— — 1,712
    Available for sale investments (long-term) (b)— $— $— 20,57920,579
    Total assets$1,712 $— $— $20,579 $22,291 

    (a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

    (b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

    (c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.

    Non-recurring Fair Value Measurements

    Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December 31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,250.4 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,971.7 million and identifiable intangible assets, net of $4,278.7 million.

    As of December 31, 2022 and 2021, the fair value of total debt approximated $4,650.3 million and $5,507.2 million, respectively, as determined under Level 2 measurement for these financial instruments.
    XML 38 R16.htm IDEA: XBRL DOCUMENT v3.22.4
    Investments
    12 Months Ended
    Dec. 31, 2022
    Investments, Debt and Equity Securities [Abstract]  
    Investments Investments
    (a)     Available for sale investments (short-term)
    The Company held $1.7 million of available for sale investments at both December 31, 2022 and December 31, 2021. The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits.
    Short term investments at December 31, 2022 have an average maturity of 2.8 years compared to 2.7 years at December 31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.

    (b)    Available for sale investments (long-term)
    The Company entered into subscription agreements with a number of funds. Capital totaling $20.6 million had been advanced under the terms of the subscription agreements at December 31, 2022 (December 31, 2021: $16.9 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 qualify for the NAV practical expedient in ASC 820 'Fair value measurements and disclosures'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $6.3 million (December 31, 2021: $3.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $32.6 million at December 31, 2022 (December 31, 2021: $22.6 million). At December 31, 2022, the Company had committed to future investments of $23.3 million in respect of these funds.
    (c)     Equity method investments

    The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company’s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations.

    The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.

    The following table represents our equity method investments at December 31, 2022:
    Ownership PercentageCarrying ValueCarrying Value
    December 31, 2022December 31, 2022December 31, 2021
    (in thousands)
    Oncacare Limited49 %$— $2,373 

    During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025.

    The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. The outstanding balance of the Company's loan receivable with Oncacare at December 31, 2022 is $9.2 million.
    XML 39 R17.htm IDEA: XBRL DOCUMENT v3.22.4
    Property, Plant and Equipment, net
    12 Months Ended
    Dec. 31, 2022
    Property, Plant and Equipment [Abstract]  
    Property, Plant and Equipment, net Property, Plant and Equipment, net
    The carrying amount of Property, Plant and Equipment for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Cost  
    Land$3,724 $3,724 
    Building70,880 82,017 
    Computer equipment and software500,135 506,322 
    Office furniture and fixtures50,600 107,507 
    Laboratory equipment59,946 29,210 
    Leasehold improvements65,167 70,123 
    Motor vehicles41 65 
     750,493 798,968 
    Less accumulated depreciation and asset write offs(400,173)(462,524)
    Property, plant and equipment (net)$350,320 $336,444 

    Property, Plant and Equipment depreciation expense is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Depreciation expense$106,426 $75,484 

    The Company regularly updates its register of property, plant and equipment and during the year ended December 31, 2022 and the year ended December 31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.
    XML 40 R18.htm IDEA: XBRL DOCUMENT v3.22.4
    Goodwill
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Goodwill Goodwill
    The change in the carrying amount of Goodwill for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Opening goodwill$9,037,931 $936,257 
    Current year acquisitions (note 6)— 8,120,006 
    Prior period acquisition (note 6)(35,692)— 
    Foreign exchange movement(30,569)(18,332)
    Closing goodwill$8,971,670 $9,037,931 

    There were no goodwill impairment losses for the years ended December 31, 2022 and 2021.
    XML 41 R19.htm IDEA: XBRL DOCUMENT v3.22.4
    Intangible Assets
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Intangible Assets Intangible Assets
    The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
    Cost(in thousands)
    Customer relationships$4,076,435 $4,056,642 
    Order backlog536,934 528,022 
    Trade names & brands204,621 204,685 
    Patient database170,238 170,525 
    Technology assets120,984 121,507 
    Total cost5,109,212 5,081,381 
    Accumulated amortization(830,553)(370,538)
     
    Net book value
    $4,278,659 $4,710,843 
    On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0 million, Order backlog of $500.0 million, Trade names of $202.0 million, Patient database of $168.0 million and Technology assets of $111.0 million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets were finalized in June 30, 2022. In total, $677.1 million has been amortized in the period since the date of acquisition, $453.6 million has been amortized in the year ended December 31, 2022.

    Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows:
     Year Ended
    December 31, 2022
    (in thousands)
    2023$460,711 
    2024339,940 
    2025223,674 
    2026209,681 
    2027198,300 
     $1,432,306 
    XML 42 R20.htm IDEA: XBRL DOCUMENT v3.22.4
    Other Liabilities
    12 Months Ended
    Dec. 31, 2022
    Other Liabilities Disclosure [Abstract]  
    Other Liabilities Other Liabilities
    The carrying amount of Other Liabilities for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    General trade and overhead liabilities*$530,204 $459,814 
    Personnel related liabilities395,862 413,185 
    Operating lease liabilities43,657 49,949 
    Facility related liabilities16,896 12,055 
    Other liabilities12,852 7,204 
    Restructuring liabilities5,512 7,377 
    Short term government grants42 45 
     $1,005,025 $949,629 

    *includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December 31, 2022 and $323.6 million at December 31, 2021.
    XML 43 R21.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities
    12 Months Ended
    Dec. 31, 2022
    Debt Disclosure [Abstract]  
    Non-current Bank Credit Lines and Loan Facilities Non-current Bank Credit Lines and Loan Facilities
    The Company had the following debt outstanding as of December 31, 2022 and 2021:

    Principal amount
    Interest rate as ofInterest rate as ofDecember 31,December 31,
    (in thousands)December 31, 2022December 31, 202120222021Maturity Date
    Credit Facilities:
    Senior Secured Term Loan7.092 %2.750 %$4,201,213 $5,001,213 July 2028
    Senior Secured Notes
    2.875 %2.875 %500,000 500,000 July 2026
    Total debt4,701,213 5,501,213 
    Less current portion of long-term debt and debt issuance costs(55,150)(55,150)
    Total long-term debt4,646,063 5,446,063 
    Less long-term portion of debt issuance costs and debt discount
    (47,026)(64,901)
    Total long-term debt, net$4,599,037 $5,381,162 

    The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.
    The Company incurred interest costs from various financing arrangements during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December 31, 2022 and December 31, 2021, the Company expensed $17.7 million and $86.7 million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.

    Year ended
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Interest expense on drawn facilities$209,189 $93,809 $13,406 
    Amortization of financing costs17,749 12,890 523 
    Transaction and one time financing costs— 75,391 — 
    Other financing costs/(credits)2,793 333 (910)
    Total financing costs$229,731 $182,423 $13,019 

    As of December 31, 2022, the contractual maturities of the Company's debt obligations were as follows:

    Current maturities of long-term debt:(in thousands)
    202355,150 
    202455,150 
    202555,150 
    202655,150 
    2027 and thereafter4,480,613 
    Total$4,701,213 

    The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").

    Senior Secured Credit Facilities

    In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA’s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin. On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement.

    Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.

    The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $300.0 million remained undrawn under the senior secured revolving loan facility.
    The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty.

    On December 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $66.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.8 million.

    On September 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $53.6 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.9 million.

    On June 30, 2022, the Company repaid $100.0 million of the senior secured term loan facility and made a quarterly interest payment of $39.4 million. This repayment resulted in an additional charge associated with previously capitalized fees of $0.9 million.

    On March 31, 2022, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $35.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $3.2 million.

    On December 29, 2021, the Company repaid $500.0 million of the senior secured term loan facility and made a quarterly interest payment of $40.8 million. This repayment resulted in an additional charge associated with previously capitalized fees of $5.6 million.

    On September 27, 2021, the Company repaid $13.8 million of the senior secured term loan facility and made a quarterly interest payment of $40.4 million.

    Senior Secured Notes

    In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026.

    Fair Value of Debt
    The estimated fair value of the Company’s debt was $4,650.3 million and $5,507.2 million at December 31, 2022 and December 31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.
    XML 44 R22.htm IDEA: XBRL DOCUMENT v3.22.4
    Derivatives
    12 Months Ended
    Dec. 31, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Derivatives Derivatives
    The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.

    On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%.

    On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.

    The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.

    The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income.
    The fair value of the Company’s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:

    December 31, 2022
    AssetLiabilityNotional
    (in thousands)
    Derivatives designated as hedging instruments:
    Interest Rate CapsOther Assets and Liabilities$12$3,3632,100,606
    Interest Rate SwapOther Assets and Liabilities$—$3071,100,606
    Total derivatives designated as hedging instruments$12$3,6703,201,213

    During 2023, the Company estimates that an additional $3.3 million will be reflected as interest expense in the consolidated statements.

    At December 31, 2021 the fair value of the Company's derivative financial instruments was $nil as the Company had no outstanding derivative financial instruments.

    The Company recognized $0.1 million of gain within OCI and reclassified $0.1 million of gain from OCI to the income statement for the year end December 31, 2022.
    XML 45 R23.htm IDEA: XBRL DOCUMENT v3.22.4
    Operating Leases
    12 Months Ended
    Dec. 31, 2022
    Leases [Abstract]  
    Operating Leases Operating Leases
    Lease costs recorded under operating leases as of December 31, 2022 and 2021 were as follows:
    Year ended
    December 31, 2022December 31, 2021
    (in thousands)
    Operating lease costs$53,880 $51,200 
    Income from sub-leases(1,165)(1,338)
    Net operating lease costs$52,715 $49,862 
    Of the total cost of $52.7 million incurred in the year ended December 31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9 million incurred in the year ended December 31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.
    Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December 31, 2022 and December 31, 2021 totaled $28.7 million and $10.2 million, respectively.
    During the years ended December 31, 2022 and December 31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $24.8 million and $15.4 million, respectively, as part of an office consolidation program (see note 19 - Restructuring Charges).
    The weighted average remaining lease term and weighted-average discount rate at December 31, 2022 were 6.90 years and 2.45%, respectively. The weighted average remaining lease term and weighted-average discount rate at December 31, 2021 were 6.91 years and 2.51%, respectively.
    Future minimum lease payments under non-cancelable leases as of December 31, 2022 were as follows:
    Minimum rental
    payments
    (in thousands)
    2023$47,479 
    202434,400 
    202525,045 
    202620,430 
    202717,249 
    Thereafter45,065 
    Total future minimum lease payments 189,668 
    Lease imputed interest(14,367)
    Total$175,301 
    Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $43.7 million and $49.9 million have been included in other liabilities as at December 31, 2022 and December 31, 2021, respectively.
    XML 46 R24.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current other liabilities
    12 Months Ended
    Dec. 31, 2022
    Payables and Accruals [Abstract]  
    Non-current other liabilities Non-current other liabilities
    The carrying amount of Non-current other liabilities for the years ended December 31, 2022 and 2021 is as follows:

    December 31, 2022December 31, 2021
     (in thousands)
    Defined benefit pension obligations, net (note 21)$13,033 $16,262 
    Other non-current liabilities25,227 26,334 
     $38,260 $42,596 
    XML 47 R25.htm IDEA: XBRL DOCUMENT v3.22.4
    Commitments and Contingencies
    12 Months Ended
    Dec. 31, 2022
    Commitments and Contingencies Disclosure [Abstract]  
    Commitments and Contingencies Commitments and Contingencies
    Litigation

    We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

    Operating Leases

    The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See note 15 - Operating leases for rental expense pursuant to ASC 842 for the years ended December 31, 2022 and December 31, 2021 and future minimum rental commitments as of December 31, 2022.
    XML 48 R26.htm IDEA: XBRL DOCUMENT v3.22.4
    Share Capital
    12 Months Ended
    Dec. 31, 2022
    Equity [Abstract]  
    Share Capital Share CapitalHolders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote.
    (a)Employee share based payments

    During the year ended December 31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December 31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.

    During the year ended December 31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December 31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.

    On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company’s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.

        During the year ended December 31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December 31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.
     
    (b)Share Repurchase Program

    A resolution was passed at the Company’s Annual General Meeting (“AGM”) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022. On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1 million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0 million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6 million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3 million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0 million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.

    All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.

    Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.
    XML 49 R27.htm IDEA: XBRL DOCUMENT v3.22.4
    Restructuring Charges
    12 Months Ended
    Dec. 31, 2022
    Restructuring and Related Activities [Abstract]  
    Restructuring Charges Restructuring Charges
    A restructuring charge of $31.1 million was recognized during the year ended December 31, 2022 under a restructuring plan adopted following a review of operations. The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $2.7 million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $24.5 million and fixed asset impairment of $4.0 million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.
     Year Ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Restructuring charges$31,143 $31,105 $18,089 
     
    Net charge
    $31,143 $31,105 $18,089 

    At December 31, 2022, a total liability of $6.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $1.4 million of facilities related liabilities of which $0.9 million is included within other liabilities and $0.5 million is included within non-current other liabilities. The remaining provision of $4.6 million relates to workforce reduction and is included within other liabilities.

    Year Ended
    December 31, 2022December 31, 2021
    (in thousands)
    Opening provision$10,311 $4,675 
    Additional provision in the year4,364 11,273 
    Utilization(8,653)(5,637)
    Ending provision$6,022 $10,311 
    XML 50 R28.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes
    12 Months Ended
    Dec. 31, 2022
    Income Tax Disclosure [Abstract]  
    Income Taxes Income Taxes
    The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.

    The components of income before income tax expense are as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland$432,963 $231,893 $280,310 
    United States(270,440)(278,413)41,950 
    Other405,328 243,200 58,945 
     
    Income before income tax expense
    $567,851 $196,680 $381,205 

        
    The components of income tax expense are as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Income tax expense:   
    Current tax expense:   
    Ireland$53,248 $18,469 $28,963 
    United States60,753 35,478 3,022 
    Other70,395 48,003 14,963 
     
    Total current tax expense
    184,396 101,950 46,948 
    Deferred tax (benefit)/expense:   
    Ireland(6,166)553 1,654 
    United States(118,475)(52,717)4,577 
    Other(344)(8,452)(5,304)
     
    Total deferred tax (benefit)/expense
    (124,985)(60,616)927 
    Income tax expense allocated to continuing operations59,411 41,334 47,875 
    Income tax expense was allocated to the following components of other comprehensive income:   
    Currency impact on long term funding7,211 1,776 68 
    Total$66,622 $43,110 $47,943 

    Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:

     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)$70,980 $24,586 $47,651 
    Rate differential from amortization of intangible assets(59,330)(31,228)(2,298)
    Foreign and other income taxed at higher rates52,464 51,273 10,241 
    Research & development tax incentives(2,608)(3,120)(1,243)
    Movement in valuation allowance(777)3,101 3,581 
    Effects of change in tax rates(300)(128)108 
    Change in unrecognized tax benefits8,392 5,246 (1,672)
    Impact of stock compensation(8,756)(9,083)(5,150)
    Other(654)687 (3,343)
     
    Income tax expense
    $59,411 $41,334 $47,875 

        
    The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:
    December 31, 2022December 31, 2021
     (in thousands)
    Deferred tax liabilities:  
    Property, plant and equipment$10,927 $19,606 
    Operating right-of-use-assets23,260 33,449 
    Goodwill37,150 33,354 
    Intangible assets1,078,302 1,201,086 
    Other9,054 1,761 
     
    Total deferred tax liabilities recognized
    1,158,693 1,289,256 
    Deferred tax assets:  
    Operating loss and tax credits carryforwards88,697 86,893 
    Property, plant and equipment6,010 5,846 
    Operating lease liabilities27,593 36,106 
    Intangible assets3,602 4,596 
    Accrued expenses and unbilled revenue64,016 69,198 
    Stock compensation21,862 25,557 
    Deferred compensation 2,917 3,445 
    Unearned revenue66,565 64,924 
    Other9,155 602 
    Total deferred tax assets290,417 297,167 
    Valuation allowance for deferred tax assets(43,379)(45,495)
    Deferred tax assets recognized247,038 251,672 
     
    Overall net deferred tax asset/(liability)
    $(911,655)$(1,037,584)


    At December 31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.6 million.

    At December 31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $5.4 million and $401.9 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $5.4 million U.S. federal NOLs, approximately $3.5 million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $5.3 million are limited by Section 382 for the years 2023 - 2036. As of December 31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $93.0 million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years.
        The expected expiry dates of the US NOLs are as follows: 
    Federal
    NOL's
    State
    NOL's
     
    (in thousands)   
    2023-2036$5,268 $249,530 
    2033-2041— 145,632 
    Indefinite95 6,736 
     $5,363 $401,898 
        
    In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.

    At December 31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $37.9 million. At December 31, 2022 those subsidiaries also had additional operating loss carryforwards of $14.8 million which are due to expire between 2023 and 2029 and operating loss carryforwards of $18.2 million which are due to expire between 2030 and 2039. In addition, at December 31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.7 million.

    The valuation allowance at December 31, 2022 was approximately $43.4 million. The valuation allowance for deferred tax assets as of December 31, 2021 and December 31, 2020 was $45.5 million and $32.8 million respectively. The net change in the total valuation allowance was a decrease of $2.1 million during 2022 and an increase of $12.8 million during 2021. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expense and a decrease of $1.3 million was recognized in Other Comprehensive Income. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of an acquired entity, $4.4 million was recognized within income tax expenses, and $0.9 million was recognized in Other Comprehensive Income.

    The valuation allowances at December 31, 2022 and December 31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.

    The Company has recognized a deferred tax liability of $1.6 million (2021: $0.8 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland’s tax treaty network and the EU parent subsidiary directive.
    A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Unrecognized tax benefits at start of year$202,065 $19,078 $20,156 
    Increase related to acquired tax positions170,047 — 
    Increase related to prior year tax positions16,098 204 401 
    Decrease related to prior year tax positions(5,442)(1,695)(1,271)
    Increase related to current year tax positions5,701 18,613 2,931 
    Settlements— (844)(369)
    Lapse of statute of limitations(838)(3,338)(2,770)
     
    Unrecognized tax benefits at end of year
    $217,584 $202,065 $19,078 

    The relevant statute of limitations for unrecognized tax benefits totaling $37.9 million could potentially expire during 2023.

    Included in the balance of total unrecognized tax benefits at December 31, 2022 were potential benefits of $217.6 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December 31, 2021 and December 31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $202.1 million and $19.1 million respectively.

    Interest and penalties recognized during the year ended December 31, 2022 amounted to a net charge of $7.1 million (2021: $1.9 million, 2020: ($0.6 million)) and are included within the income tax expense. Total accrued interest and penalties as of December 31, 2022 and December 31, 2021 were $22.6 million and $15.5 million respectively and are included in closing income taxes payable at those dates.

    Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.
    XML 51 R29.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits
    12 Months Ended
    Dec. 31, 2022
    Retirement Benefits [Abstract]  
    Employee Benefits Employee Benefits
    Defined Contribution Plans

    Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation.

    The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were $30.2 million, $23.7 million and $17.0 million respectively.

    Pension and Postretirement Benefit Plans

    The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:

    December 31, 2022December 31, 2021
    Other receivables$6,492 $— 
    Non-current other liabilities (note 16)(13,033)(16,262)
    In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $11.6 million and $8.0 million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively.

    ICON Development Solutions Limited pension plan

    One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022, December 31, 2021 and December 31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'. The plan has been closed to new entrants with effect from July 1, 2003.
    Funded status
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(19,558)$(41,813)
    Fair value of plan assets26,050 36,198 
     Funded status$6,492 $(5,615)

    The funded status as at December 31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December 31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.
    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of year$41,813 $43,988 
    Service cost117 134 
    Interest cost672 665 
    Plan participants' contributions19 23 
    Benefits paid(514)(489)
    Actuarial gain(18,636)(2,097)
    Foreign currency exchange rate changes(3,913)(411)
     
    Benefit obligation at end of year
    $19,558 $41,813 

    Change in plan assets
     
    December 31, 2022December 31, 2021
     (in thousands)
    Fair value of plan assets at beginning of year$36,198 $34,612 
    Expected return on plan assets1,258 1,171 
    Actual return on plan assets(7,305)1,176 
    Employer contributions70 91 
    Plan participants' contributions19 23 
    Benefits paid(514)(489)
    Foreign currency exchange rate changes(3,676)(386)
     Fair value of plan assets at end of year$26,050 $36,198 

    The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.
    The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Service cost$117 $134 $100 
    Interest cost672 665 746 
    Expected return on plan assets(1,258)(1,171)(1,214)
    Amortization of net loss228 625 160 
    Net periodic benefit cost$(241)$253 $(208)
        
    The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

    December 31, 2022December 31, 2021December 31, 2020
    Discount rate1.8 %1.5 %2.1 %
    Rate of compensation increase3.7 %3.4 %3.3 %
    Expected rate of return on plan assets3.8 %3.4 %4.0 %

    Other comprehensive income
     
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Actuarial (gain)/loss - benefit obligation$(18,636)$(2,097)$5,294 
    Actuarial loss/(gain) – plan assets7,305 (1,176)(878)
    Actuarial loss recognized in net periodic benefit cost(228)(625)(160)
     Total$(11,559)$(3,898)$4,256 

    The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.3 million and $Nil respectively.

    Benefit Obligation

    The following assumptions were used in determining the benefit obligation at December 31, 2022 and December 31, 2021:
    December 31, 2022December 31, 2021
    Discount rate4.9 %1.8 %
    Rate of compensation increase3.6 %3.7 %

    A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.

    Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in the discount rate.
    Plan Assets

    The Company's pension plan asset allocation is as follows:
    Asset Category
     
    December 31, 2022December 31, 2021
    Government Bonds88 %— %
    Diversified Bonds12 %— %
    Equities— %24 %
    Corporate Bonds (including 50% high yield bonds)— %37 %
    Secured Loans and Multi Asset Credit— %39 %
     100 %100 %

    During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company’s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December 31, 2022 and December 31, 2021, respectively.


    Plan Asset Fair Value Measurements
     December 31, 2022December 31, 2021
    (in thousands)
    Government Bonds$22,887 $— 
    Diversified Bonds$3,163 $— 
    Equities$— $8,782 
    Corporate Bonds (including 50% high yield bonds)$— $13,434 
    Secured Loans and Multi Asset Credit$— $13,982 
     $26,050 $36,198 

    The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.

    Cash Flows
        
    The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2023.

    The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.
    (in thousands)
    2023$302 
    2024371 
    2025402 
    2026703 
    2027643 
    Years 2028 - 20323,614 

    The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.
    Aptiv Solutions pension plan

    On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 and December 31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'.

    Funded surplus/(deficit)
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(5,806)$(7,643)
    Fair value of plan assets5,681 6,964 
     Funded deficit$(125)$(679)

    The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

    The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 were 2.3% and 0.4%, respectively.

    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of year$7,643 $8,620 
    Service cost146 150 
    Interest cost30 12 
    Plan participants' contributions82 95 
    Settlement(218)(483)
    Prior service cost(23)(82)
    Benefits paid and transferred balances(182)76 
    Actuarial gain(1,527)(484)
    Foreign currency exchange rate changes(145)(261)
    Benefit obligation at end of year$5,806 $7,643 

    Change in plan assetsDecember 31,December 31,
    20222021
    (in thousands)
    Fair value of plan assets at beginning of year$6,964 $7,601 
    Expected return on plan assets29 15 
    Actual return on plan assets(987)(238)
    Scheme contributions114 128 
    Plan participants' contributions82 95 
    Benefits paid and transferred balances(182)76 
    Settlement(218)(483)
    Foreign currency exchange rate changes(121)(230)
    Fair value of plan assets at end of year$5,681 $6,964 

    The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.
    PRA Switzerland AG pension plan

    On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'.

    Funded surplus/(deficit)
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(5,345)$(4,990)
    Fair value of plan assets4,059 3,017 
     Funded deficit$(1,286)$(1,973)

    The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

    The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 was 2.3% and 0.4%, respectively.

    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of period$4,990 $4,890 
    Service cost404 207 
    Interest cost20 19 
    Plan participants’ contributions2,396 135 
    Settlement(844)— 
    Benefits paid(946)(113)
    Actuarial (gain)/loss(627)
    Foreign currency exchange rate changes(48)(149)
    Benefit obligation at end of year$5,345 $4,990 

    Change in plan assets
     
    December 31, 2022December 31, 2021
    (in thousands)
    Fair value of plan assets at beginning of period$3,017 $2,849 
    Expected return on plan assets29 15 
    Actual return on plan assets87 — 
    Scheme contributions325 135 
    Plan participants’ contributions2,396 135 
    Benefits paid(946)(113)
    Settlement(844)— 
    Foreign currency exchange rate changes(5)(4)
    Fair value of plan assets at end of year$4,059 $3,017 

    The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.
    XML 52 R30.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges
    12 Months Ended
    Dec. 31, 2022
    Share-Based Payment Arrangement [Abstract]  
    Equity Incentive Schemes and Stock Compensation Charges Equity Incentive Schemes and Stock Compensation Charges
    Share Options

    On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.
    On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.
     
    An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.
     
    Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant.

    PRA Equity Incentive Plans

    The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.
    Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.
    PRA Health Sciences, Inc. 2020 Stock Incentive Plan (the "2020 Plan”), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021.
    The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.
    The 2018 Stock Incentive Plan (the “2018 Plan”), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).
    On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.
    On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.
    The following table summarizes the transactions for the Company's share option plans for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

     Options Granted
    Under Plans
    Weighted Average Exercise Price
    Outstanding at December 31, 2019656,107 $87.80 
    Granted107,737 $159.83 
    Exercised(193,417)$68.19 
    Canceled(16,681)$92.21 
    Outstanding at December 31, 2020553,746 $108.53 
    Assumed through business combinations *2,177,130 $108.78 
    Granted100,299 $177.76 
    Exercised(1,065,529)$111.29 
    Canceled/expired(70,186)$128.46 
    Outstanding at December 31, 20211,695,460 $110.38 
    Granted108,643 $229.94 
    Exercised(348,286)$102.87 
    Canceled/expired(77,698)$143.08 
    Outstanding at December 31, 20221,378,119 $119.86 
    Vested and exercisable at December 31, 20221,047,803 $102.29 
    *Represents stock options issued as replacement awards in connection with the Merger.

    The weighted average remaining contractual life of options outstanding and options exercisable at December 31, 2022, was 4.69 years and 4.25 years respectively (2021: 5.39 years and 4.55 years respectively).

    Outstanding and exercisable share options:

    The following table summarizes information concerning outstanding and exercisable share options as of December 31, 2022:

    Options OutstandingOptions Exercisable
    Range Exercise
    Price
    Number of
    Shares
    Weighted
    Average
    Remaining
    Contractual Life
    Weighted Average Exercise PriceNumber of
    Shares
    Weighted Average Exercise Price
    14.88 - 96.15
    494,565 2.70— 494,565 — 
    103.81 - 124.00
    226,489 5.58— 203,605 — 
    125.74 - 147.26
    386,518 5.65— 303,054 — 
    159.33 - 231.68
    270,547 6.24— 46,579 — 
    14.88 - 231.68
    1,378,119 4.69$119.86 1,047,803 $102.29 
     
    Options outstanding include both vested and unvested options as at December 31, 2022. Options exercisable represent options which have vested at December 31, 2022. From the date of grant, substantially all options vest over a five year period.
    Fair value of Stock Options Assumptions

    The weighted average fair value of options granted during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:
     Year Ended
    December 31, 2022December 31, 2021December 31, 2020
    Weighted average fair value$68.42 $49.15 $42.43 
    Assumptions:
    Expected volatility31 %30 %30 %
    Dividend yield— %— %— %
    Risk-free interest rate1.86 %0.78 %0.57 %
    Expected life5.0 years5.0 years5.0 years

    The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:

    July 1, 2021
    Weighted average grant date fair value$107.21 
    Assumptions:
    Expected volatility30 %
    Dividend yield— %
    Risk-free interest rate0.56 %
    Expected life3.5 years
        
    Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.

    Restricted Share Units and Performance Share Units

    On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.

    On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months.
    The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December 31, 2022:
    PSU Outstanding
    Number of Shares
    PSU
    Weighted Average
    Grant Date
    Fair Value
    RSU Outstanding
    Number
    of Shares
    RSU
    Weighted Average
    Grant Date Fair Value
    Outstanding at December 31, 2021154,190 $160.23 572,785 $191.20 
    Granted64,682 $229.79 302,307 $216.85 
    Shares vested(46,087)$140.48 (195,029)$174.35 
    Forfeited(20,365)$185.90 (97,451)$205.25 
    Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 

    The fair value of RSUs vested for the year ended December 31, 2022 totaled $34.1 million (2021: $83.5 million). The share price range for the year was $137.47 - $265.96 (2021: $115.11 - $206.71).

    The fair value of PSUs vested for the year ended December 31, 2022 totaled $6.5 million (2021: $5.1 million). The share price range for the year was $137.47 - $166.51 (2021: $115.11 - $125.74).

    The PSUs vest based on service and specified EPS targets over the period 2021 – 2023 and 2022 – 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional 76,210 PSUs may also be granted.

    Non-cash stock compensation expense

    Income from operations for the year ended December 31, 2022 is stated after charging $70.5 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:

     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Direct costs$22,854 $18,551 $8,557 
    Selling, general and administrative47,669 41,457 17,714 
    Transaction and integration related *— 73,836 — 
    Total compensation costs$70,523 $133,844 $26,271 
    * Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger

    The income tax expense for the year ended December 31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December 31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December 31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $2.5 million.
    XML 53 R31.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information
    12 Months Ended
    Dec. 31, 2022
    Segment Reporting [Abstract]  
    Business Segment and Geographical Information Business Segment and Geographical Information
    The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.

    The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 'Segment Reporting'. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.
    The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries.

    Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.

    ICON Ireland acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts.

    ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.

    The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland.

    There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.

    Reportable geographic information at December 31, 2022 and December 31, 2021 and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 is as follows:
     
    a) The distribution of revenue by geographical area was as follows:

     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland$1,984,567 $1,365,909 $1,181,292 
    Rest of Europe1,618,350 1,175,515 416,884 
    U.S.3,574,610 2,581,007 925,563 
    Other563,859 358,395 273,549 
     
    Total
    $7,741,386 $5,480,826 $2,797,288 

    b) The distribution of income from operations (including Restructuring) by geographical area was as follows:

     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland *$218,088 $131,961 $276,478 
    Rest of Europe253,799 177,863 35,765 
    U.S.254,849 39,132 58,018 
    Other68,501 29,573 21,239 
     
    Total
    $795,237 $378,529 $391,500 
    * Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.
    c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:

    December 31, 2022December 31, 2021
     (in thousands)
    Ireland$143,025 $118,253 
    Rest of Europe99,721 121,174 
    U.S.213,311 239,828 
    Other48,095 55,312 
     
    Total
    $504,152 $534,567 
    XML 54 R32.htm IDEA: XBRL DOCUMENT v3.22.4
    Net Income Per Ordinary Share
    12 Months Ended
    Dec. 31, 2022
    Earnings Per Share [Abstract]  
    Net Income Per Ordinary Share Net Income Per Ordinary Share
    Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
        
    Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares.
        
    There is no difference in net income used for basic and diluted net income per ordinary share.
        
    Basic and diluted net income per ordinary share attributable to the Group for the year ended December 31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.
        
    The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
    December 31, 2022December 31, 2021December 31, 2020
    Weighted average number of ordinary shares outstanding for basic net income per ordinary share81,532,320 67,110,186 52,859,911 
    Effect of dilutive share options outstanding936,043 958,125 423,674 
    Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,468,363 68,068,311 53,283,585 
    The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Net income attributable to the Group$505,304 153,185 $332,331 
    Noncontrolling interest adjustment to redemption amount— — (4,522)
    Net income attributable to the Group (including NCI redemption adjustment)505,304 153,185 327,809 
    December 31, 2022December 31, 2021December 31, 2020
    Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):
    Basic $6.20 $2.28 $6.20 
    Diluted $6.13 $2.25 $6.15 
    XML 55 R33.htm IDEA: XBRL DOCUMENT v3.22.4
    Accumulated Other Comprehensive Income
    12 Months Ended
    Dec. 31, 2022
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income
    Year ended
    December 31, 2022December 31, 2021
     (in thousands)
    Currency translation adjustments$(175,369)$(85,840)
    Actuarial gain/(loss) on defined benefit pension plan (note 21)7,559 (5,098)
    Loss on cash flow hedge(3,728)— 
    Amortization of loss on cash flow hedge— 
     Total$(171,538)$(90,937)
    XML 56 R34.htm IDEA: XBRL DOCUMENT v3.22.4
    Supplemental Disclosure of Cash Flow Information
    12 Months Ended
    Dec. 31, 2022
    Supplemental Cash Flow Elements [Abstract]  
    Supplemental Disclosure of Cash Flow Information Supplemental Disclosure of Cash Flow Information
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Cash paid for interest$210,918 $106,205 $13,062 
    Cash paid for income taxes (net of refunds)$116,322 $55,105 $27,604 
    XML 57 R35.htm IDEA: XBRL DOCUMENT v3.22.4
    Related Parties
    12 Months Ended
    Dec. 31, 2022
    Related Party Transactions [Abstract]  
    Related Parties Related Parties
    Subsidiaries of the Company earned revenue of $2,000 (December 31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December 31, 2022 (December 31, 2021: $12,000). 

    Subsidiaries of the Company earned revenue of $235,000 (December 31, 2021: $551,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December 31, 2022 (December 31, 2021: $197,000). 

    Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December 31, 2022.
    On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December 31, 2022 (December 31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December 31, 2022 (December 31, 2021: $264,000). During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December 31, 2022 accrued interest of $183,000 remained outstanding.

    The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.
    XML 58 R36.htm IDEA: XBRL DOCUMENT v3.22.4
    Subsequent Events
    12 Months Ended
    Dec. 31, 2022
    Subsequent Events [Abstract]  
    Subsequent Events Subsequent EventsThe Company has evaluated subsequent events from the Balance Sheet date through February 24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.
    XML 59 R37.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies (Policies)
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    Basis of Consolidation
    Basis of consolidation

    The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.
    Use of Estimates
    Use of estimates

    The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.
    Disclosure of Fair Value of Financial Instruments
    Disclosure of fair value of financial instruments

    Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.

    Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

    Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.

    Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

    Level 3: Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
    The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements – quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.
    Business Combinations
    Business combinations

    The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

    The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

    The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.
    Transaction and integration-related expenses

    Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.
    Foreign Currencies and Translation of Subsidiaries
    Foreign currencies and translation of subsidiaries

    The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income.

    Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:

    Year ended
    December 31,
     202220212020
    (in thousands)
     
    Amounts (credited)/charged
    $(25,997)$(14,316)$5,979 
    Revenue recognition
    Revenue recognition

    The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years.

    ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.
    Clinical trial service revenue

    A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.

    Laboratory services revenue

    Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer.

    Contracting services revenue

    The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff.

    Consulting services revenue

    Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs.

    Data services revenue

    The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.

    When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.

    Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.

    The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above.
    At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract.

    Commissions

    Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.
    Reimbursable expenses and Direct costs
    Reimbursable expenses

    Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.

    Direct costs

    Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.

    Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.
    Cash and Cash Equivalents
    Cash and cash equivalents

    Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.
    Investment in Debt, Equity and Other
    Investments in debt, equity and other

    Available for sale investments

    The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification

    Long term investments

    The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2021 and December 31, 2022 qualify for the NAV practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy.

    Equity method investments

    The Company’s investments that are not consolidated are accounted for under the equity method if the Company exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.
    Accounts Receivable, Net and Unbilled Revenue
    Accounts receivable, net and unbilled revenue    
        
    Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.

    Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.

    Accounts receivable early payment discounting
    Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 'Transfers and Servicing' (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows.
    Property, Plant and Equipment
    Property, plant and equipment

    Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: 
     Years
    Building  40
    Computer equipment and software
    2-8
    Office furniture and fixtures8
    Laboratory equipment  5
    Motor vehicles5
        
    Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter.
    Leases
    Leases

    The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December 31, 2022 and December 31, 2021, the Company did not account for any leases as finance leases.
        Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.
    The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.
    Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations.

    In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.
    ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, Property, Plant, and Equipment – Overall, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.
    Intangible Assets
    Intangible assets

    Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist.

    Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

    Estimated Useful Life
    Customer relationships23 years
    Order backlog3 years
    Trade names3 years
    Patient database7 years
    Technology assets5 years

    The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.
    Impairment of goodwill and long-lived assets
    Impairment of goodwill and long-lived assets

    Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.

    Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.
    Debt Issuance Costs
    Debt issuance costs

    Debt issuance costs relating to the Company’s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company’s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.
    Derivative Financial Instruments
    Derivative financial instruments

    The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts.

    Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income
    and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.

    The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.
    Income Taxes
    Income taxes

    The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.
    Government grants
    Government grants

    Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.

    Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.
    Research and development credits
    Research and development credits

    Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.
    Pension Costs
    Pension costs

    The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.

    The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 'Defined Benefit Plans – Pension'. These plans are presented in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.
    Share-Based Compensation
    Share-based compensation

    The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 'Compensation – Stock Compensation'. Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.
    Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on
    the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.
    Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.

    Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled.

    Replacement awards

    In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.
    Transaction and Integration-related Expenses
    Business combinations

    The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.

    The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.

    The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership.
    Transaction and integration-related expenses

    Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.
    Restructuring
    Restructuring

    Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company’s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset’s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.
    Redeemable non-controlling interests and equity
    Redeemable noncontrolling interests and equity

    The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 'Distinguishing Liabilities from Equity'. On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova.
    Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020.
    Net Income per Ordinary Share
    Net income per ordinary share

    Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.
    Reclassifications
    Reclassifications
    Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period’s presentation.
    Impact of Recently Issued or Adopted Accounting Standards
    Impact of Recently Issued or Adopted Accounting Standards 
    No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company’s consolidated financial statements.
    XML 60 R38.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies (Tables)
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    Adjustments resulting from foreign currency translations Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:
    Year ended
    December 31,
     202220212020
    (in thousands)
     
    Amounts (credited)/charged
    $(25,997)$(14,316)$5,979 
    Estimated useful lives of assets Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: 
     Years
    Building  40
    Computer equipment and software
    2-8
    Office furniture and fixtures8
    Laboratory equipment  5
    Motor vehicles5
    Schedule of Finite-Lived Intangible Assets
    Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

    Estimated Useful Life
    Customer relationships23 years
    Order backlog3 years
    Trade names3 years
    Patient database7 years
    Technology assets5 years
    The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
    Cost(in thousands)
    Customer relationships$4,076,435 $4,056,642 
    Order backlog536,934 528,022 
    Trade names & brands204,621 204,685 
    Patient database170,238 170,525 
    Technology assets120,984 121,507 
    Total cost5,109,212 5,081,381 
    Accumulated amortization(830,553)(370,538)
     
    Net book value
    $4,278,659 $4,710,843 
    XML 61 R39.htm IDEA: XBRL DOCUMENT v3.22.4
    Disaggregation of Revenue (Tables)
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    Schedule of Disaggregation of Revenue
    Revenue disaggregated by customer profile is as follows:
    Year ended
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Top client$683,546 $441,173 $337,904 
    Clients 2-51,506,087 1,291,946 754,906 
    Clients 6-101,112,636 752,325 350,865 
    Clients 11-251,585,739 1,077,073 501,643 
    Other2,853,378 1,918,309 851,970 
    Total$7,741,386$5,480,826$2,797,288
    XML 62 R40.htm IDEA: XBRL DOCUMENT v3.22.4
    Contract Balances (Tables)
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    Schedule of Contracts with Customers, Asset and Liabilities
    Accounts receivable and unbilled revenue are as follows:
    December 31, 2022December 31, 2021
    (in thousands)
    Billed services (accounts receivable)$1,751,950 $1,349,851 
    Allowance for credit losses (note 5)(20,562)(7,081)
    Accounts receivable (net)1,731,388 1,342,770 
    Unbilled services (unbilled revenue)$957,655 $623,121 
    Accounts receivable and unbilled revenue, net$2,689,043 $1,965,891 

    Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:
    (in thousands, except percentages)December 31, 2022December 31, 2021$ Change% Change
    Unbilled services (unbilled revenue)$957,655 $623,121 $334,534 53.7 %
    Unearned revenue (payments on account)(1,507,449)(1,323,961)(183,488)13.9 %
    Net balance$(549,794)$(700,840)$151,046 21.6 %
    XML 63 R41.htm IDEA: XBRL DOCUMENT v3.22.4
    Allowances for Credit Losses (Tables)
    12 Months Ended
    Dec. 31, 2022
    Accounts Receivable, after Allowance for Credit Loss [Abstract]  
    Schedule of Provision for Credit Losses
    The Company does business with most major international pharmaceutical companies. Provision for credit losses at December 31, 2022 and December 31, 2021 comprises:
    December 31, 2022December 31, 2021
     (in thousands)
    Opening provision$7,081 $7,149 
    Amounts used during the year(3,913)(116)
    Amounts provided during the year17,800 705 
    Amounts released during the year— (544)
    Foreign exchange(406)(113)
     
    Closing provision
    $20,562 $7,081 
    XML 64 R42.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations (Tables)
    12 Months Ended
    Dec. 31, 2022
    Business Combinations [Abstract]  
    Schedule of Business Acquisitions, by Acquisition
    The Merger Date fair value of the consideration transferred consisted of the following:

     (in thousands)
    Fair value of cash consideration5,308,646 
    Fair value of ordinary shares issued to acquiree stockholders5,658,126 
    Fair value of replacement share-based awards issued to acquiree employees209,399 
    Repayment of term loan obligations and accrued interest *865,800 
    12,041,971 
    * This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.
    Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed
    The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:

    July 1,
    2021
    (in thousands)
    Cash and cash equivalents$259,971 
    Accounts receivable and unbilled revenue934,308 
    Other current assets125,156 
    Fixed assets156,851 
    Operating lease right-of-use assets180,601 
    Goodwill *8,084,314 
    Intangible assets4,919,000 
    Deferred tax assets25,190 
    Other assets33,928 
    Accounts payable(50,259)
    Accrued expenses and other current liabilities(380,048)
    Current portion of operating lease liabilities(36,506)
    Unearned revenue(739,278)
    Non-current portion of operating lease liabilities(147,204)
    Deferred tax liabilities(1,119,762)
    Other non-current liabilities(204,291)
    Net assets acquired$12,041,971 

    * The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.
    Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination
    The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):
    Estimated Fair ValueEstimated Useful Life
    Customer relationships3,938,000 23 years
    Order backlog500,000 3 years
    Trade names202,000 3 years
    Patient database168,000 7 years
    Technology assets111,000 5 years
    4,919,000 
    Schedule of measurement period adjustments In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:
    Measurement period adjustments
    (in thousands)
    Cash and cash equivalents$— 
    Accounts receivable and unbilled revenue— 
    Other current assets14,465 
    Fixed assets(6,137)
    Operating lease right-of-use assets(11,744)
    Goodwill70,436 
    Intangible assets *44,000 
    Deferred tax assets(147,039)
    Other assets(1,166)
    Accounts payable— 
    Accrued expenses and other current liabilities(37,496)
    Current portion of operating lease liabilities1,865 
    Unearned revenue **19,623 
    Non-current portion of operating lease liabilities10,454 
    Non-current deferred tax liabilities193,837 
    Other non-current liabilities(151,098)
    * In the year ended December 31, 2022, the Company incurred $2.2 million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.

    ** The unearned revenue measurement period adjustment also includes $16.0 million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.
    XML 65 R43.htm IDEA: XBRL DOCUMENT v3.22.4
    Fair Value (Tables)
    12 Months Ended
    Dec. 31, 2022
    Fair Value Disclosures [Abstract]  
    Fair Value, Liabilities Measured on Recurring Basis
    As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,713 — — — 1,713 
    Available for sale investments (long-term) (b)— — — 32,663 32,663 
    Derivative instruments (c)— 12 — — 12 
    Total assets$1,713 $12 $— $32,663 $34,388 
    Liabilities:
    Derivative instruments (c)— 3,670 — — 3,670
    Total Liabilities$— $3,670 $— $— 3,670

    As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,712$— $— — 1,712
    Available for sale investments (long-term) (b)— $— $— 20,57920,579
    Total assets$1,712 $— $— $20,579 $22,291 

    (a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

    (b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

    (c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.
    Fair Value, Assets Measured on Recurring Basis
    As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,713 — — — 1,713 
    Available for sale investments (long-term) (b)— — — 32,663 32,663 
    Derivative instruments (c)— 12 — — 12 
    Total assets$1,713 $12 $— $32,663 $34,388 
    Liabilities:
    Derivative instruments (c)— 3,670 — — 3,670
    Total Liabilities$— $3,670 $— $— 3,670

    As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):

    Level 1Level 2Level 3Investments Measured at Net Asset ValueTotal
    Assets:
    Available for sale securities (short-term) (a)1,712$— $— — 1,712
    Available for sale investments (long-term) (b)— $— $— 20,57920,579
    Total assets$1,712 $— $— $20,579 $22,291 

    (a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.

    (b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.

    (c) Represents the fair value of interest rate cap and interest rate swap agreements. The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.
    XML 66 R44.htm IDEA: XBRL DOCUMENT v3.22.4
    Investments (Tables)
    12 Months Ended
    Dec. 31, 2022
    Investments, Debt and Equity Securities [Abstract]  
    Equity Method Investments
    The following table represents our equity method investments at December 31, 2022:
    Ownership PercentageCarrying ValueCarrying Value
    December 31, 2022December 31, 2022December 31, 2021
    (in thousands)
    Oncacare Limited49 %$— $2,373 
    XML 67 R45.htm IDEA: XBRL DOCUMENT v3.22.4
    Property, Plant and Equipment, net (Tables)
    12 Months Ended
    Dec. 31, 2022
    Property, Plant and Equipment [Abstract]  
    Schedule of Property Plant and Equipment, Net
    The carrying amount of Property, Plant and Equipment for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Cost  
    Land$3,724 $3,724 
    Building70,880 82,017 
    Computer equipment and software500,135 506,322 
    Office furniture and fixtures50,600 107,507 
    Laboratory equipment59,946 29,210 
    Leasehold improvements65,167 70,123 
    Motor vehicles41 65 
     750,493 798,968 
    Less accumulated depreciation and asset write offs(400,173)(462,524)
    Property, plant and equipment (net)$350,320 $336,444 

    Property, Plant and Equipment depreciation expense is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Depreciation expense$106,426 $75,484 
    XML 68 R46.htm IDEA: XBRL DOCUMENT v3.22.4
    Goodwill (Tables)
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Schedule of Goodwill
    The change in the carrying amount of Goodwill for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Opening goodwill$9,037,931 $936,257 
    Current year acquisitions (note 6)— 8,120,006 
    Prior period acquisition (note 6)(35,692)— 
    Foreign exchange movement(30,569)(18,332)
    Closing goodwill$8,971,670 $9,037,931 
    XML 69 R47.htm IDEA: XBRL DOCUMENT v3.22.4
    Intangible Assets (Tables)
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Schedule of Finite-Lived Intangible Assets
    Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:

    Estimated Useful Life
    Customer relationships23 years
    Order backlog3 years
    Trade names3 years
    Patient database7 years
    Technology assets5 years
    The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
    Cost(in thousands)
    Customer relationships$4,076,435 $4,056,642 
    Order backlog536,934 528,022 
    Trade names & brands204,621 204,685 
    Patient database170,238 170,525 
    Technology assets120,984 121,507 
    Total cost5,109,212 5,081,381 
    Accumulated amortization(830,553)(370,538)
     
    Net book value
    $4,278,659 $4,710,843 
    Schedule of Future Intangible Asset Amortization Expense
    Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows:
     Year Ended
    December 31, 2022
    (in thousands)
    2023$460,711 
    2024339,940 
    2025223,674 
    2026209,681 
    2027198,300 
     $1,432,306 
    XML 70 R48.htm IDEA: XBRL DOCUMENT v3.22.4
    Other Liabilities (Tables)
    12 Months Ended
    Dec. 31, 2022
    Other Liabilities Disclosure [Abstract]  
    Schedule of Other Liabilities
    The carrying amount of Other Liabilities for the years ended December 31, 2022 and 2021 is as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    General trade and overhead liabilities*$530,204 $459,814 
    Personnel related liabilities395,862 413,185 
    Operating lease liabilities43,657 49,949 
    Facility related liabilities16,896 12,055 
    Other liabilities12,852 7,204 
    Restructuring liabilities5,512 7,377 
    Short term government grants42 45 
     $1,005,025 $949,629 

    *includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December 31, 2022 and $323.6 million at December 31, 2021.
    XML 71 R49.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities (Tables)
    12 Months Ended
    Dec. 31, 2022
    Debt Disclosure [Abstract]  
    Schedule of Long-term Debt Instruments
    The Company had the following debt outstanding as of December 31, 2022 and 2021:

    Principal amount
    Interest rate as ofInterest rate as ofDecember 31,December 31,
    (in thousands)December 31, 2022December 31, 202120222021Maturity Date
    Credit Facilities:
    Senior Secured Term Loan7.092 %2.750 %$4,201,213 $5,001,213 July 2028
    Senior Secured Notes
    2.875 %2.875 %500,000 500,000 July 2026
    Total debt4,701,213 5,501,213 
    Less current portion of long-term debt and debt issuance costs(55,150)(55,150)
    Total long-term debt4,646,063 5,446,063 
    Less long-term portion of debt issuance costs and debt discount
    (47,026)(64,901)
    Total long-term debt, net$4,599,037 $5,381,162 
    Schedule of Financing Cost
    Year ended
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Interest expense on drawn facilities$209,189 $93,809 $13,406 
    Amortization of financing costs17,749 12,890 523 
    Transaction and one time financing costs— 75,391 — 
    Other financing costs/(credits)2,793 333 (910)
    Total financing costs$229,731 $182,423 $13,019 
    Schedule of Maturities of Long-term Debt
    As of December 31, 2022, the contractual maturities of the Company's debt obligations were as follows:

    Current maturities of long-term debt:(in thousands)
    202355,150 
    202455,150 
    202555,150 
    202655,150 
    2027 and thereafter4,480,613 
    Total$4,701,213 
    XML 72 R50.htm IDEA: XBRL DOCUMENT v3.22.4
    Derivatives (Tables)
    12 Months Ended
    Dec. 31, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
    The fair value of the Company’s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:

    December 31, 2022
    AssetLiabilityNotional
    (in thousands)
    Derivatives designated as hedging instruments:
    Interest Rate CapsOther Assets and Liabilities$12$3,3632,100,606
    Interest Rate SwapOther Assets and Liabilities$—$3071,100,606
    Total derivatives designated as hedging instruments$12$3,6703,201,213
    XML 73 R51.htm IDEA: XBRL DOCUMENT v3.22.4
    Operating Leases (Tables)
    12 Months Ended
    Dec. 31, 2022
    Leases [Abstract]  
    Lease Cost
    Lease costs recorded under operating leases as of December 31, 2022 and 2021 were as follows:
    Year ended
    December 31, 2022December 31, 2021
    (in thousands)
    Operating lease costs$53,880 $51,200 
    Income from sub-leases(1,165)(1,338)
    Net operating lease costs$52,715 $49,862 
    Schedule of Operating Lease Maturity
    Future minimum lease payments under non-cancelable leases as of December 31, 2022 were as follows:
    Minimum rental
    payments
    (in thousands)
    2023$47,479 
    202434,400 
    202525,045 
    202620,430 
    202717,249 
    Thereafter45,065 
    Total future minimum lease payments 189,668 
    Lease imputed interest(14,367)
    Total$175,301 
    XML 74 R52.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current other liabilities (Tables)
    12 Months Ended
    Dec. 31, 2022
    Payables and Accruals [Abstract]  
    Non-current other liabilities
    The carrying amount of Non-current other liabilities for the years ended December 31, 2022 and 2021 is as follows:

    December 31, 2022December 31, 2021
     (in thousands)
    Defined benefit pension obligations, net (note 21)$13,033 $16,262 
    Other non-current liabilities25,227 26,334 
     $38,260 $42,596 
    XML 75 R53.htm IDEA: XBRL DOCUMENT v3.22.4
    Restructuring charges (Tables)
    12 Months Ended
    Dec. 31, 2022
    Restructuring and Related Activities [Abstract]  
    Schedule of Restructuring Charges
     Year Ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Restructuring charges$31,143 $31,105 $18,089 
     
    Net charge
    $31,143 $31,105 $18,089 
    Schedule of Restructuring Reserve by Type of Cost
    Year Ended
    December 31, 2022December 31, 2021
    (in thousands)
    Opening provision$10,311 $4,675 
    Additional provision in the year4,364 11,273 
    Utilization(8,653)(5,637)
    Ending provision$6,022 $10,311 
    XML 76 R54.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes (Tables)
    12 Months Ended
    Dec. 31, 2022
    Income Tax Disclosure [Abstract]  
    Summary of Components of Income Before Provision for Income Taxes
    The components of income before income tax expense are as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland$432,963 $231,893 $280,310 
    United States(270,440)(278,413)41,950 
    Other405,328 243,200 58,945 
     
    Income before income tax expense
    $567,851 $196,680 $381,205 
    Summary of Components of Provision for Income Taxes
    The components of income tax expense are as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Income tax expense:   
    Current tax expense:   
    Ireland$53,248 $18,469 $28,963 
    United States60,753 35,478 3,022 
    Other70,395 48,003 14,963 
     
    Total current tax expense
    184,396 101,950 46,948 
    Deferred tax (benefit)/expense:   
    Ireland(6,166)553 1,654 
    United States(118,475)(52,717)4,577 
    Other(344)(8,452)(5,304)
     
    Total deferred tax (benefit)/expense
    (124,985)(60,616)927 
    Income tax expense allocated to continuing operations59,411 41,334 47,875 
    Income tax expense was allocated to the following components of other comprehensive income:   
    Currency impact on long term funding7,211 1,776 68 
    Total$66,622 $43,110 $47,943 
    Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)$70,980 $24,586 $47,651 
    Rate differential from amortization of intangible assets(59,330)(31,228)(2,298)
    Foreign and other income taxed at higher rates52,464 51,273 10,241 
    Research & development tax incentives(2,608)(3,120)(1,243)
    Movement in valuation allowance(777)3,101 3,581 
    Effects of change in tax rates(300)(128)108 
    Change in unrecognized tax benefits8,392 5,246 (1,672)
    Impact of stock compensation(8,756)(9,083)(5,150)
    Other(654)687 (3,343)
     
    Income tax expense
    $59,411 $41,334 $47,875 
    Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities
    The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:
    December 31, 2022December 31, 2021
     (in thousands)
    Deferred tax liabilities:  
    Property, plant and equipment$10,927 $19,606 
    Operating right-of-use-assets23,260 33,449 
    Goodwill37,150 33,354 
    Intangible assets1,078,302 1,201,086 
    Other9,054 1,761 
     
    Total deferred tax liabilities recognized
    1,158,693 1,289,256 
    Deferred tax assets:  
    Operating loss and tax credits carryforwards88,697 86,893 
    Property, plant and equipment6,010 5,846 
    Operating lease liabilities27,593 36,106 
    Intangible assets3,602 4,596 
    Accrued expenses and unbilled revenue64,016 69,198 
    Stock compensation21,862 25,557 
    Deferred compensation 2,917 3,445 
    Unearned revenue66,565 64,924 
    Other9,155 602 
    Total deferred tax assets290,417 297,167 
    Valuation allowance for deferred tax assets(43,379)(45,495)
    Deferred tax assets recognized247,038 251,672 
     
    Overall net deferred tax asset/(liability)
    $(911,655)$(1,037,584)
    Schedule of Expected Expiry Dates of NOL's The expected expiry dates of the US NOLs are as follows: 
    Federal
    NOL's
    State
    NOL's
     
    (in thousands)   
    2023-2036$5,268 $249,530 
    2033-2041— 145,632 
    Indefinite95 6,736 
     $5,363 $401,898 
    Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits
    A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Unrecognized tax benefits at start of year$202,065 $19,078 $20,156 
    Increase related to acquired tax positions170,047 — 
    Increase related to prior year tax positions16,098 204 401 
    Decrease related to prior year tax positions(5,442)(1,695)(1,271)
    Increase related to current year tax positions5,701 18,613 2,931 
    Settlements— (844)(369)
    Lapse of statute of limitations(838)(3,338)(2,770)
     
    Unrecognized tax benefits at end of year
    $217,584 $202,065 $19,078 
    XML 77 R55.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits (Tables)
    12 Months Ended
    Dec. 31, 2022
    Retirement Benefits [Abstract]  
    Schedule of Amounts Recognized in Balance Sheet The balances recorded to the balance sheet are as follows:
    December 31, 2022December 31, 2021
    Other receivables$6,492 $— 
    Non-current other liabilities (note 16)(13,033)(16,262)
    Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan
    Funded status
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(19,558)$(41,813)
    Fair value of plan assets26,050 36,198 
     Funded status$6,492 $(5,615)

    The funded status as at December 31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December 31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.
    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of year$41,813 $43,988 
    Service cost117 134 
    Interest cost672 665 
    Plan participants' contributions19 23 
    Benefits paid(514)(489)
    Actuarial gain(18,636)(2,097)
    Foreign currency exchange rate changes(3,913)(411)
     
    Benefit obligation at end of year
    $19,558 $41,813 

    Change in plan assets
     
    December 31, 2022December 31, 2021
     (in thousands)
    Fair value of plan assets at beginning of year$36,198 $34,612 
    Expected return on plan assets1,258 1,171 
    Actual return on plan assets(7,305)1,176 
    Employer contributions70 91 
    Plan participants' contributions19 23 
    Benefits paid(514)(489)
    Foreign currency exchange rate changes(3,676)(386)
     Fair value of plan assets at end of year$26,050 $36,198 
    Funded surplus/(deficit)
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(5,806)$(7,643)
    Fair value of plan assets5,681 6,964 
     Funded deficit$(125)$(679)

    The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

    The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 were 2.3% and 0.4%, respectively.

    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of year$7,643 $8,620 
    Service cost146 150 
    Interest cost30 12 
    Plan participants' contributions82 95 
    Settlement(218)(483)
    Prior service cost(23)(82)
    Benefits paid and transferred balances(182)76 
    Actuarial gain(1,527)(484)
    Foreign currency exchange rate changes(145)(261)
    Benefit obligation at end of year$5,806 $7,643 

    Change in plan assetsDecember 31,December 31,
    20222021
    (in thousands)
    Fair value of plan assets at beginning of year$6,964 $7,601 
    Expected return on plan assets29 15 
    Actual return on plan assets(987)(238)
    Scheme contributions114 128 
    Plan participants' contributions82 95 
    Benefits paid and transferred balances(182)76 
    Settlement(218)(483)
    Foreign currency exchange rate changes(121)(230)
    Fair value of plan assets at end of year$5,681 $6,964 
    The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 'Defined Benefit Plans – Other Postretirement'.
    Funded surplus/(deficit)
     
    December 31, 2022December 31, 2021
     (in thousands)
    Projected benefit obligation$(5,345)$(4,990)
    Fair value of plan assets4,059 3,017 
     Funded deficit$(1,286)$(1,973)

    The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.

    The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 was 2.3% and 0.4%, respectively.

    Change in benefit obligation
     
    December 31, 2022December 31, 2021
     (in thousands)
    Benefit obligation at beginning of period$4,990 $4,890 
    Service cost404 207 
    Interest cost20 19 
    Plan participants’ contributions2,396 135 
    Settlement(844)— 
    Benefits paid(946)(113)
    Actuarial (gain)/loss(627)
    Foreign currency exchange rate changes(48)(149)
    Benefit obligation at end of year$5,345 $4,990 

    Change in plan assets
     
    December 31, 2022December 31, 2021
    (in thousands)
    Fair value of plan assets at beginning of period$3,017 $2,849 
    Expected return on plan assets29 15 
    Actual return on plan assets87 — 
    Scheme contributions325 135 
    Plan participants’ contributions2,396 135 
    Benefits paid(946)(113)
    Settlement(844)— 
    Foreign currency exchange rate changes(5)(4)
    Fair value of plan assets at end of year$4,059 $3,017 
    Schedule of Components of Net Periodic Benefit Cost
    The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Service cost$117 $134 $100 
    Interest cost672 665 746 
    Expected return on plan assets(1,258)(1,171)(1,214)
    Amortization of net loss228 625 160 
    Net periodic benefit cost$(241)$253 $(208)
    Summary of Assumptions Used in Calculating Pension Benefit Obligations
    The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

    December 31, 2022December 31, 2021December 31, 2020
    Discount rate1.8 %1.5 %2.1 %
    Rate of compensation increase3.7 %3.4 %3.3 %
    Expected rate of return on plan assets3.8 %3.4 %4.0 %
    The following assumptions were used in determining the benefit obligation at December 31, 2022 and December 31, 2021:
    December 31, 2022December 31, 2021
    Discount rate4.9 %1.8 %
    Rate of compensation increase3.6 %3.7 %
    Schedule of Amounts Recognized in Other Comprehensive Income (Loss)
    Other comprehensive income
     
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Actuarial (gain)/loss - benefit obligation$(18,636)$(2,097)$5,294 
    Actuarial loss/(gain) – plan assets7,305 (1,176)(878)
    Actuarial loss recognized in net periodic benefit cost(228)(625)(160)
     Total$(11,559)$(3,898)$4,256 
    Schedule of Underlying Asset Split of Fund
    The Company's pension plan asset allocation is as follows:
    Asset Category
     
    December 31, 2022December 31, 2021
    Government Bonds88 %— %
    Diversified Bonds12 %— %
    Equities— %24 %
    Corporate Bonds (including 50% high yield bonds)— %37 %
    Secured Loans and Multi Asset Credit— %39 %
     100 %100 %
    Schedule of Plan Asset Fair Value Measurements
     December 31, 2022December 31, 2021
    (in thousands)
    Government Bonds$22,887 $— 
    Diversified Bonds$3,163 $— 
    Equities$— $8,782 
    Corporate Bonds (including 50% high yield bonds)$— $13,434 
    Secured Loans and Multi Asset Credit$— $13,982 
     $26,050 $36,198 
    Schedule of Annual Benefit Payments which Reflect Expected Future Service
    The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.
    (in thousands)
    2023$302 
    2024371 
    2025402 
    2026703 
    2027643 
    Years 2028 - 20323,614 
    XML 78 R56.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges (Tables)
    12 Months Ended
    Dec. 31, 2022
    Share-Based Payment Arrangement [Abstract]  
    Schedule of Transactions for Company's Share Option Plans
    The following table summarizes the transactions for the Company's share option plans for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:

     Options Granted
    Under Plans
    Weighted Average Exercise Price
    Outstanding at December 31, 2019656,107 $87.80 
    Granted107,737 $159.83 
    Exercised(193,417)$68.19 
    Canceled(16,681)$92.21 
    Outstanding at December 31, 2020553,746 $108.53 
    Assumed through business combinations *2,177,130 $108.78 
    Granted100,299 $177.76 
    Exercised(1,065,529)$111.29 
    Canceled/expired(70,186)$128.46 
    Outstanding at December 31, 20211,695,460 $110.38 
    Granted108,643 $229.94 
    Exercised(348,286)$102.87 
    Canceled/expired(77,698)$143.08 
    Outstanding at December 31, 20221,378,119 $119.86 
    Vested and exercisable at December 31, 20221,047,803 $102.29 
    *Represents stock options issued as replacement awards in connection with the Merger.
    Summary of Information Concerning Outstanding and Exercisable Share Options
    The following table summarizes information concerning outstanding and exercisable share options as of December 31, 2022:

    Options OutstandingOptions Exercisable
    Range Exercise
    Price
    Number of
    Shares
    Weighted
    Average
    Remaining
    Contractual Life
    Weighted Average Exercise PriceNumber of
    Shares
    Weighted Average Exercise Price
    14.88 - 96.15
    494,565 2.70— 494,565 — 
    103.81 - 124.00
    226,489 5.58— 203,605 — 
    125.74 - 147.26
    386,518 5.65— 303,054 — 
    159.33 - 231.68
    270,547 6.24— 46,579 — 
    14.88 - 231.68
    1,378,119 4.69$119.86 1,047,803 $102.29 
    Summary of Weighted Average Fair Values and Assumptions Used The weighted average fair values and assumptions were as follows:
     Year Ended
    December 31, 2022December 31, 2021December 31, 2020
    Weighted average fair value$68.42 $49.15 $42.43 
    Assumptions:
    Expected volatility31 %30 %30 %
    Dividend yield— %— %— %
    Risk-free interest rate1.86 %0.78 %0.57 %
    Expected life5.0 years5.0 years5.0 years

    The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:

    July 1, 2021
    Weighted average grant date fair value$107.21 
    Assumptions:
    Expected volatility30 %
    Dividend yield— %
    Risk-free interest rate0.56 %
    Expected life3.5 years
    Summary of RSU and PSU Activity The following table summarizes RSU and PSU activity for the year ended December 31, 2022:
    PSU Outstanding
    Number of Shares
    PSU
    Weighted Average
    Grant Date
    Fair Value
    RSU Outstanding
    Number
    of Shares
    RSU
    Weighted Average
    Grant Date Fair Value
    Outstanding at December 31, 2021154,190 $160.23 572,785 $191.20 
    Granted64,682 $229.79 302,307 $216.85 
    Shares vested(46,087)$140.48 (195,029)$174.35 
    Forfeited(20,365)$185.90 (97,451)$205.25 
    Outstanding at December 31, 2022152,420 $192.29 582,612 $207.73 
    Schedule of Non-cash Stock Compensation Expense Non-cash stock compensation expense has been allocated as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Direct costs$22,854 $18,551 $8,557 
    Selling, general and administrative47,669 41,457 17,714 
    Transaction and integration related *— 73,836 — 
    Total compensation costs$70,523 $133,844 $26,271 
    * Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger
    XML 79 R57.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information (Tables)
    12 Months Ended
    Dec. 31, 2022
    Segment Reporting [Abstract]  
    Schedule of Distribution of Net Revenue by Geographical Area
    Reportable geographic information at December 31, 2022 and December 31, 2021 and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 is as follows:
     
    a) The distribution of revenue by geographical area was as follows:

     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland$1,984,567 $1,365,909 $1,181,292 
    Rest of Europe1,618,350 1,175,515 416,884 
    U.S.3,574,610 2,581,007 925,563 
    Other563,859 358,395 273,549 
     
    Total
    $7,741,386 $5,480,826 $2,797,288 
    Schedule of Distribution of Income from Operations by Geographical Area The distribution of income from operations (including Restructuring) by geographical area was as follows:
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Ireland *$218,088 $131,961 $276,478 
    Rest of Europe253,799 177,863 35,765 
    U.S.254,849 39,132 58,018 
    Other68,501 29,573 21,239 
     
    Total
    $795,237 $378,529 $391,500 
    * Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger.
    Schedule of Distribution of Long-lived Assets, Net, by Geographical Area The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:
    December 31, 2022December 31, 2021
     (in thousands)
    Ireland$143,025 $118,253 
    Rest of Europe99,721 121,174 
    U.S.213,311 239,828 
    Other48,095 55,312 
     
    Total
    $504,152 $534,567 
    XML 80 R58.htm IDEA: XBRL DOCUMENT v3.22.4
    Net Income Per Ordinary Share (Tables)
    12 Months Ended
    Dec. 31, 2022
    Earnings Per Share [Abstract]  
    Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share
    The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:
    December 31, 2022December 31, 2021December 31, 2020
    Weighted average number of ordinary shares outstanding for basic net income per ordinary share81,532,320 67,110,186 52,859,911 
    Effect of dilutive share options outstanding936,043 958,125 423,674 
    Weighted average number of ordinary shares outstanding for diluted net income per ordinary share82,468,363 68,068,311 53,283,585 
    Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share
    The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:
    December 31, 2022December 31, 2021December 31, 2020
    (in thousands)
    Net income attributable to the Group$505,304 153,185 $332,331 
    Noncontrolling interest adjustment to redemption amount— — (4,522)
    Net income attributable to the Group (including NCI redemption adjustment)505,304 153,185 327,809 
    December 31, 2022December 31, 2021December 31, 2020
    Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):
    Basic $6.20 $2.28 $6.20 
    Diluted $6.13 $2.25 $6.15 
    XML 81 R59.htm IDEA: XBRL DOCUMENT v3.22.4
    Accumulated Other Comprehensive Income (Tables)
    12 Months Ended
    Dec. 31, 2022
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Schedule of Accumulated Other Comprehensive Income
    Year ended
    December 31, 2022December 31, 2021
     (in thousands)
    Currency translation adjustments$(175,369)$(85,840)
    Actuarial gain/(loss) on defined benefit pension plan (note 21)7,559 (5,098)
    Loss on cash flow hedge(3,728)— 
    Amortization of loss on cash flow hedge— 
     Total$(171,538)$(90,937)
    XML 82 R60.htm IDEA: XBRL DOCUMENT v3.22.4
    Supplemental Disclosure of Cash Flow Information (Tables)
    12 Months Ended
    Dec. 31, 2022
    Supplemental Cash Flow Elements [Abstract]  
    Schedule of Supplemental Disclosure of Cash Flow Information
     Year ended
    December 31, 2022December 31, 2021December 31, 2020
     (in thousands)
    Cash paid for interest$210,918 $106,205 $13,062 
    Cash paid for income taxes (net of refunds)$116,322 $55,105 $27,604 
    XML 83 R61.htm IDEA: XBRL DOCUMENT v3.22.4
    Description of business (Details)
    12 Months Ended
    Dec. 31, 2022
    Employee
    Country
    Location
    Jul. 01, 2021
    Employee
    Product Information [Line Items]    
    Number of employees | Employee 41,100 38,000
    Number of locations in which company operates | Location 111  
    Number of countries in which company operates | Country 53  
    Geographic Concentration Risk | United States | Net Revenue    
    Product Information [Line Items]    
    Percentage of company revenue (in percent) 46.20%  
    Geographic Concentration Risk | Europe | Net Revenue    
    Product Information [Line Items]    
    Percentage of company revenue (in percent) 46.50%  
    Geographic Concentration Risk | Rest of World | Net Revenue    
    Product Information [Line Items]    
    Percentage of company revenue (in percent) 7.30%  
    XML 84 R62.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Foreign Currency [Abstract]      
      Amounts (credited)/charged $ (25,997) $ (14,316) $ 5,979
    XML 85 R63.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)
    12 Months Ended
    Dec. 31, 2022
    Building    
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 40 years
    Computer equipment and software | Minimum  
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 2 years
    Computer equipment and software | Maximum  
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 8 years
    Office furniture and fixtures  
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 8 years
    Laboratory equipment    
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 5 years
    Motor vehicles  
    Property, Plant and Equipment [Line Items]  
    Estimated useful lives 5 years
    XML 86 R64.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)
    12 Months Ended
    Dec. 31, 2022
    Customer relationships  
    Indefinite-lived Intangible Assets [Line Items]  
    Amortization period 23 years
    Order backlog  
    Indefinite-lived Intangible Assets [Line Items]  
    Amortization period 3 years
    Trade names & brands  
    Indefinite-lived Intangible Assets [Line Items]  
    Amortization period 3 years
    Patient database  
    Indefinite-lived Intangible Assets [Line Items]  
    Amortization period 7 years
    Technology assets  
    Indefinite-lived Intangible Assets [Line Items]  
    Amortization period 5 years
    XML 87 R65.htm IDEA: XBRL DOCUMENT v3.22.4
    Summary of Significant accounting policies - Narrative (Details)
    Mar. 09, 2020
    MeDiNova  
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
    Business combination acquisition percentage (in percent) 100.00%
    XML 88 R66.htm IDEA: XBRL DOCUMENT v3.22.4
    Disaggregation of Revenue (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Disaggregation of Revenue [Line Items]      
    Revenue $ 7,741,386 $ 5,480,826 $ 2,797,288
    Top client      
    Disaggregation of Revenue [Line Items]      
    Revenue 683,546 441,173 337,904
    Clients 2-5      
    Disaggregation of Revenue [Line Items]      
    Revenue 1,506,087 1,291,946 754,906
    Clients 6-10      
    Disaggregation of Revenue [Line Items]      
    Revenue 1,112,636 752,325 350,865
    Clients 11-25      
    Disaggregation of Revenue [Line Items]      
    Revenue 1,585,739 1,077,073 501,643
    Other      
    Disaggregation of Revenue [Line Items]      
    Revenue $ 2,853,378 $ 1,918,309 $ 851,970
    XML 89 R67.htm IDEA: XBRL DOCUMENT v3.22.4
    Contract Balances (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Revenue from Contract with Customer [Abstract]      
    Billed services (accounts receivable) $ 1,751,950 $ 1,349,851  
    Allowance for credit losses (note 5) (20,562) (7,081) $ (7,149)
    Accounts receivable (net) 1,731,388 1,342,770  
    Unbilled services (unbilled revenue) 957,655 623,121  
    Accounts receivable and unbilled revenue, net 2,689,043 1,965,891  
    Unearned revenue (payments on account) (1,507,449) (1,323,961)  
    Net balance (549,794) $ (700,840)  
    Change in unbilled receivables 334,534    
    Change in unearned revenue (payments on account) (183,488)    
    Change in advance payments netted against unbilled contracts receivable $ 151,046    
    Change in unbilled receivables (in percent) 53.70%    
    Change in unearned revenue (payments on account) (in percent) 13.90%    
    Change in advance payments netted against unbilled contracts receivable (in percent) 21.60%    
    XML 90 R68.htm IDEA: XBRL DOCUMENT v3.22.4
    Contract Balances - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
    Amounts due to third parties for reimbursable expenses $ 406,300 $ 323,600
    Change in unbilled receivables 334,534  
    Change in unearned revenue (payments on account) 183,488  
    Increase in advance payments netted against unbilled contracts receivable 151,046  
    Bad debt expense 17,800 900
    Revenue, remaining performance obligation, amount $ 13,700,000 $ 13,300,000
    Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01    
    Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
    Revenue, remaining performance obligation (in percent)   48.00%
    Revenue, remaining performance obligation, expected timing of satisfaction, period   12 months
    Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01    
    Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
    Revenue, remaining performance obligation (in percent) 52.00%  
    Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months  
    XML 91 R69.htm IDEA: XBRL DOCUMENT v3.22.4
    Allowances for Credit Losses (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
    Opening provision $ 7,081 $ 7,149
    Amounts used during the year (3,913) (116)
    Amounts provided during the year 17,800 705
    Amounts released during the year 0 (544)
    Foreign exchange (406) (113)
      Closing provision $ 20,562 $ 7,081
    XML 92 R70.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations - Narrative, PRA Acquisition (Details)
    $ / shares in Units, $ in Thousands
    12 Months Ended
    Jul. 01, 2021
    Employee
    $ / shares
    shares
    Dec. 31, 2022
    USD ($)
    Employee
    Dec. 31, 2021
    USD ($)
    Dec. 31, 2020
    USD ($)
    Business Acquisition [Line Items]        
    Number of employees | Employee 38,000 41,100    
    Transaction and one time financing costs   $ 0 $ 75,391 $ 0
    PRA Health Sciences, Inc        
    Business Acquisition [Line Items]        
    Business acquisition, share price (in USD per share) | $ / shares $ 80      
    Business acquisition, number of shares issued (in shares) | shares 0.4125      
    Transaction and integration related (Note 6)   39,700 198,300  
    Acquisition related costs   800 57,100  
    Transaction and one time financing costs     $ 86,700  
    Gross debt issuance costs   $ 76,200    
    XML 93 R71.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Jul. 01, 2021
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Business Acquisition [Line Items]        
    Fair value of cash consideration   $ 0 $ 5,914,475 $ 47,931
    PRA Health Sciences, Inc        
    Business Acquisition [Line Items]        
    Fair value of cash consideration $ 5,308,646      
    Fair value of ordinary shares issued to acquiree stockholders 5,658,126      
    Fair value of replacement share-based awards issued to acquiree employees 209,399      
    Repayment of term loan obligations and accrued interest 865,800      
    Consideration transferred 12,041,971      
    Payments to settle debt obligations that existed prior to acquisition date $ 401,600      
    XML 94 R72.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) - USD ($)
    18 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Jul. 01, 2021
    Dec. 31, 2020
    Business Acquisition [Line Items]        
    Goodwill $ 8,971,670,000 $ 9,037,931,000   $ 936,257,000
    PRA Health Sciences, Inc        
    Business Acquisition [Line Items]        
    Cash and cash equivalents     $ 259,971,000  
    Accounts receivable and unbilled revenue     934,308,000  
    Other current assets     125,156,000  
    Fixed assets     156,851,000  
    Operating lease right-of-use assets     180,601,000  
    Goodwill     8,084,314,000  
    Intangible assets     4,919,000,000  
    Deferred tax assets     25,190,000  
    Other assets     33,928,000  
    Accounts payable     (50,259,000)  
    Accrued expenses and other current liabilities     (380,048,000)  
    Current portion of operating lease liabilities     (36,506,000)  
    Unearned revenue     (739,278,000)  
    Non-current portion of operating lease liabilities     (147,204,000)  
    Deferred tax liabilities     (1,119,762,000)  
    Other non-current liabilities     (204,291,000)  
    Net assets acquired     12,041,971,000  
    Goodwill, expected tax deductible amount     $ 0  
    Cash and cash equivalents $ 0      
    XML 95 R73.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) - PRA Health Sciences, Inc
    $ in Thousands
    Jul. 01, 2021
    USD ($)
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 4,919,000
    Customer relationships  
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 3,938,000
    Estimated Useful Life 23 years
    Order backlog  
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 500,000
    Estimated Useful Life 3 years
    Trade names  
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 202,000
    Estimated Useful Life 3 years
    Patient database  
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 168,000
    Estimated Useful Life 7 years
    Technology assets  
    Business Acquisition [Line Items]  
    Estimated Fair Value $ 111,000
    Estimated Useful Life 5 years
    XML 96 R74.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) - PRA Health Sciences, Inc - USD ($)
    $ in Thousands
    12 Months Ended 18 Months Ended
    Dec. 31, 2022
    Dec. 31, 2022
    Business Acquisition [Line Items]    
    Cash and cash equivalents   $ 0
    Accounts receivable and unbilled revenue   0
    Other current assets   14,465
    Fixed assets   (6,137)
    Operating lease right-of-use assets   (11,744)
    Goodwill   70,436
    Intangible assets   44,000
    Deferred tax assets   (147,039)
    Other assets   (1,166)
    Accounts payable   0
    Accrued expenses and other current liabilities   (37,496)
    Current portion of operating lease liabilities   1,865
    Unearned revenue   19,623
    Non-current portion of operating lease liabilities   10,454
    Non-current deferred tax liabilities   193,837
    Other non-current liabilities   $ (151,098)
    Amortization adjustment $ 2,200  
    Accounting Standards Update 2021-08    
    Business Acquisition [Line Items]    
    Unearned revenue $ 16,000  
    XML 97 R75.htm IDEA: XBRL DOCUMENT v3.22.4
    Fair value - Narrative (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total assets $ 34,388 $ 22,291
    Long-term debt at fair value 4,650,300 5,507,200
    Level 3    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total assets 0 $ 0
    Fair value, nonrecurring    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Identifiable intangible assets, net 4,278,700  
    Fair value, nonrecurring | Level 3    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total assets 13,250,400  
    Goodwill $ 8,971,700  
    XML 98 R76.htm IDEA: XBRL DOCUMENT v3.22.4
    Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Available for sale investments (Note 8a) $ 1,713 $ 1,712
    Available for sale investments (long-term) (b) 32,663 20,579
    Total assets 34,388 22,291
    Total Liabilities 3,670  
    Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative instruments (c) 12  
    Derivative instruments (c) 3,670  
    Level 1    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Available for sale investments (Note 8a) 1,713 1,712
    Available for sale investments (long-term) (b) 0 0
    Total assets 1,713 1,712
    Total Liabilities 0  
    Level 1 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative instruments (c) 0  
    Derivative instruments (c) 0  
    Level 2    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Available for sale investments (Note 8a) 0 0
    Available for sale investments (long-term) (b) 0 0
    Total assets 12 0
    Total Liabilities 3,670  
    Level 2 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative instruments (c) 12  
    Derivative instruments (c) 3,670  
    Level 3    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Available for sale investments (Note 8a) 0 0
    Available for sale investments (long-term) (b) 0 0
    Total assets 0 0
    Total Liabilities 0  
    Level 3 | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative instruments (c) 0  
    Derivative instruments (c) 0  
    Fair Value Measured at Net Asset Value Per Share    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Available for sale investments (Note 8a) 0 0
    Available for sale investments (long-term) (b) 32,663 20,579
    Total assets 32,663 $ 20,579
    Total Liabilities 0  
    Fair Value Measured at Net Asset Value Per Share | Interest rate cap and interest rate swap | Total derivatives designated as hedging instruments    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Derivative instruments (c) 0  
    Derivative instruments (c) $ 0  
    XML 99 R77.htm IDEA: XBRL DOCUMENT v3.22.4
    Investments - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Jul. 24, 2020
    Related Party Transaction [Line Items]        
    Available for sale investments $ 1,713 $ 1,712    
    Short term investments average maturity period 2 years 9 months 18 days 2 years 8 months 12 days    
    Debt securities, available for sale, cumulative amount advanced under subscription agreements $ 20,600 $ 16,900    
    Increase (decrease) in equity securities, FV-NI 6,300 3,200    
    Carrying value of long-term investments in equity 32,600 22,600    
    Commitment to acquire future long-term investments 23,300      
    Equity method investments $ 0 2,373   $ 4,900
    Majority investor, ownership percentage 51.00%      
    Period majority voting share capital can be sold to the company 18 months      
    Loss on equity method investments $ 3,136 2,161 $ 366  
    Oncacare        
    Related Party Transaction [Line Items]        
    Ownership Percentage 49.00%      
    Loss on equity method investments $ 3,100 2,200    
    Increase (decrease) in equity method investments (2,300)      
    Oncacare        
    Related Party Transaction [Line Items]        
    Loan granted tp related party   $ 10,000    
    Related party, loan interest rate   1.60%    
    Equity method investment, decrease in loan receivable 800      
    Loans and Leases Receivable, Related Parties $ 9,200      
    XML 100 R78.htm IDEA: XBRL DOCUMENT v3.22.4
    Investments - Equity Method Investments (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Jul. 24, 2020
    Debt Securities, Available-for-sale [Line Items]      
    Equity method investments $ 0 $ 2,373 $ 4,900
    Oncacare      
    Debt Securities, Available-for-sale [Line Items]      
    Ownership Percentage 49.00%    
    XML 101 R79.htm IDEA: XBRL DOCUMENT v3.22.4
    Property, Plant and Equipment, net (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Abstract]    
    Land $ 3,724 $ 3,724
    Building 70,880 82,017
    Computer equipment and software 500,135 506,322
    Office furniture and fixtures 50,600 107,507
    Laboratory equipment 59,946 29,210
    Leasehold improvements 65,167 70,123
    Motor vehicles 41 65
    Property, plant and equipment, gross 750,493 798,968
    Less accumulated depreciation and asset write offs (400,173) (462,524)
    Property, plant and equipment (net) 350,320 336,444
    Depreciation expense $ 106,426 $ 75,484
    XML 102 R80.htm IDEA: XBRL DOCUMENT v3.22.4
    Goodwill - Schedule of Goodwill (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill [Roll Forward]    
    Opening goodwill $ 9,037,931 $ 936,257
    Current year acquisitions (note 6) 0 8,120,006
    Prior period acquisition (note 6) (35,692) 0
    Foreign exchange movement (30,569) (18,332)
    Closing goodwill $ 8,971,670 $ 9,037,931
    XML 103 R81.htm IDEA: XBRL DOCUMENT v3.22.4
    Goodwill - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill and Intangible Assets Disclosure [Abstract]    
    Goodwill impairment charge $ 0 $ 0
    XML 104 R82.htm IDEA: XBRL DOCUMENT v3.22.4
    Intangible Assets - Summary of Intangible Assets (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost $ 5,109,212 $ 5,081,381
    Accumulated amortization (830,553) (370,538)
      Net book value 4,278,659 4,710,843
    Customer relationships    
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost 4,076,435 4,056,642
    Order backlog    
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost 536,934 528,022
    Trade names & brands    
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost 204,621 204,685
    Patient database    
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost 170,238 170,525
    Technology assets    
    Acquired Finite-Lived Intangible Assets [Line Items]    
    Total cost $ 120,984 $ 121,507
    XML 105 R83.htm IDEA: XBRL DOCUMENT v3.22.4
    Intangible Assets - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended 18 Months Ended
    Jul. 01, 2021
    Dec. 31, 2022
    Dec. 31, 2022
    Customer relationships      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period   23 years  
    Order backlog      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period   3 years  
    Trade names & brands      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period   3 years  
    Patient database      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period   7 years  
    Technology assets      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period   5 years  
    PRA Health Sciences, Inc      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired $ 4,919,000    
    Amortization of intangible assets   $ 453,600 $ 677,100
    PRA Health Sciences, Inc | Minimum      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period 3 years    
    PRA Health Sciences, Inc | Maximum      
    Indefinite-lived Intangible Assets [Line Items]      
    Amortization period 23 years    
    PRA Health Sciences, Inc | Customer relationships      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired $ 3,938,000    
    PRA Health Sciences, Inc | Order backlog      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired 500,000    
    PRA Health Sciences, Inc | Trade names & brands      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired 202,000    
    PRA Health Sciences, Inc | Patient database      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired 168,000    
    PRA Health Sciences, Inc | Technology assets      
    Indefinite-lived Intangible Assets [Line Items]      
    Value of intangible assets acquired $ 111,000    
    XML 106 R84.htm IDEA: XBRL DOCUMENT v3.22.4
    Intangible Assets - Future Intangible Asset Amortization Expense (Details)
    $ in Thousands
    Dec. 31, 2022
    USD ($)
    Goodwill and Intangible Assets Disclosure [Abstract]  
    2023 $ 460,711
    2024 339,940
    2025 223,674
    2026 209,681
    2027 198,300
    Finite lived intangible assets, amortization expense, net, total $ 1,432,306
    XML 107 R85.htm IDEA: XBRL DOCUMENT v3.22.4
    Other Liabilities (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Other Liabilities Disclosure [Abstract]    
    General trade and overhead liabilities $ 530,204 $ 459,814
    Personnel related liabilities 395,862 413,185
    Operating lease liabilities 43,657 49,949
    Facility related liabilities 16,896 12,055
    Other liabilities 12,852 7,204
    Restructuring liabilities 5,512 7,377
    Short term government grants 42 45
    Other liabilities 1,005,025 949,629
    Amounts due to third parties for reimbursable expenses $ 406,300 $ 323,600
    XML 108 R86.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Jul. 01, 2021
    Debt Instrument [Line Items]      
    Total debt $ 4,701,213 $ 5,501,213  
    Less current portion of long-term debt and debt issuance costs (55,150) (55,150)  
    Total long-term debt 4,646,063 5,446,063  
    Less long-term portion of debt issuance costs and debt discount (47,026) (64,901)  
    Total long-term debt, net $ 4,599,037 $ 5,381,162  
    Credit Facilities: | Senior Secured Term Loan      
    Debt Instrument [Line Items]      
    Debt instrument, interest rate (in percent) 7.092% 2.75% 1.00%
    Total debt $ 4,201,213 $ 5,001,213  
    Senior Secured Notes | Senior Secured Notes      
    Debt Instrument [Line Items]      
    Debt instrument, interest rate (in percent) 2.875% 2.875% 2.875%
    Total debt $ 500,000 $ 500,000  
    XML 109 R87.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 30, 2022
    Sep. 30, 2022
    Jun. 30, 2022
    Mar. 31, 2022
    Dec. 29, 2021
    Sep. 27, 2021
    Jul. 01, 2021
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Debt Instrument [Line Items]                    
    Total financing costs               $ 229,731 $ 182,423 $ 13,019
    Cash paid for interest               210,918 106,205 $ 13,062
    Long-term debt at fair value               4,650,300 5,507,200  
    PRA Health Sciences, Inc                    
    Debt Instrument [Line Items]                    
    Total financing costs               $ 17,700 $ 86,700  
    Senior Secured Term Loan | Minimum                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               0.50%    
    Senior Secured Term Loan | London Interbank Offered Rate (LIBOR)                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)             2.25%      
    Senior secured revolving loan facility | Variable rate component one | Base rate                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               0.60%    
    Senior secured revolving loan facility | Variable rate component one | Base rate | Maximum                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               1.00%    
    Senior secured revolving loan facility | Variable rate component one | Base rate | Minimum                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               0.25%    
    Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR)                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               1.60%    
    Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Maximum                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               2.00%    
    Senior secured revolving loan facility | Variable rate component two | London Interbank Offered Rate (LIBOR) | Minimum                    
    Debt Instrument [Line Items]                    
    Basis spread on variable rate (in percent)               1.25%    
    Credit Facilities: | Senior secured credit facility and senior secured notes                    
    Debt Instrument [Line Items]                    
    Debt discount paid             $ 27,600      
    Credit Facilities: | Senior Secured Term Loan                    
    Debt Instrument [Line Items]                    
    Debt instrument, face amount             $ 5,515,000      
    Debt instrument, interest rate (in percent)             1.00% 7.092% 2.75%  
    Repayments of senior debt $ 200,000 $ 200,000 $ 100,000 $ 300,000 $ 500,000 $ 13,800        
    Cash paid for interest 66,100 53,600 39,400 35,100 40,800 $ 40,400        
    Payments of debt restructuring costs $ 1,800 $ 1,900 $ 900 $ 3,200 $ 5,600          
    Credit Facilities: | Senior Secured Revolving Credit Facility                    
    Debt Instrument [Line Items]                    
    Remaining borrowing capacity               $ 300,000    
    Line of credit | Senior secured revolving loan facility | Revolving loan facility                    
    Debt Instrument [Line Items]                    
    Maximum borrowing capacity             $ 300,000      
    Senior Secured Notes | Senior Secured Notes                    
    Debt Instrument [Line Items]                    
    Debt instrument, face amount             $ 500,000      
    Debt instrument, interest rate (in percent)             2.875% 2.875% 2.875%  
    XML 110 R88.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Debt Disclosure [Abstract]      
    Interest expense on drawn facilities $ 209,189 $ 93,809 $ 13,406
    Amortization of financing costs and debt discount 17,749 12,890 523
    Transaction and one time financing costs 0 75,391 0
    Other financing costs/(credits) 2,793 333 (910)
    Total financing costs $ 229,731 $ 182,423 $ 13,019
    XML 111 R89.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)
    $ in Thousands
    Dec. 31, 2022
    USD ($)
    Debt Disclosure [Abstract]  
    2023 $ 55,150
    2024 55,150
    2025 55,150
    2026 55,150
    2027 and thereafter 4,480,613
    Total long-term debt, net $ 4,701,213
    XML 112 R90.htm IDEA: XBRL DOCUMENT v3.22.4
    Derivatives - Narrative (Details)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    USD ($)
    Nov. 29, 2022
    USD ($)
    instrument
    Dec. 31, 2021
    USD ($)
    tranche
    Derivative [Line Items]      
    Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net $ (3,300)    
    Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax 100    
    Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax $ 100    
    Derivative, Fair Value, Net     $ 0
    Derivative, number of instruments held | tranche     0
    Interest Rate Caps | Total derivatives designated as hedging instruments      
    Derivative [Line Items]      
    Number of interest rate derivatives held | instrument   2  
    Derivative, notional Amount   $ 2,101,000  
    Derivative, fixed interest rate   0.42%  
    Interest Rate Caps | Total derivatives designated as hedging instruments | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate      
    Derivative [Line Items]      
    Derivative, variable interest rate, reference rate in excess of   4.75%  
    Interest Rate Swap      
    Derivative [Line Items]      
    Derivative, notional Amount   $ 1,101,000  
    Derivative, fixed interest rate   3.40%  
    XML 113 R91.htm IDEA: XBRL DOCUMENT v3.22.4
    Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) - Total derivatives designated as hedging instruments
    Dec. 31, 2022
    USD ($)
    Interest Rate Caps  
    Derivative [Line Items]  
    Derivative Asset $ 12,000
    Derivative Liability 3,363,000
    Notional 2,100,606,000
    Interest Rate Swap  
    Derivative [Line Items]  
    Derivative Asset 0
    Derivative Liability 307,000
    Notional 1,100,606,000
    Interest rate cap and interest rate swap  
    Derivative [Line Items]  
    Derivative Asset 12,000
    Derivative Liability 3,670,000
    Notional $ 3,201,213,000
    XML 114 R92.htm IDEA: XBRL DOCUMENT v3.22.4
    Operating Leases - Lease Costs (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Leases [Abstract]    
    Operating lease costs $ 53,880 $ 51,200
    Income from sub-leases (1,165) (1,338)
    Net operating lease costs $ 52,715 $ 49,862
    XML 115 R93.htm IDEA: XBRL DOCUMENT v3.22.4
    Operating Leases Operating Leases - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
    Net operating lease costs $ 52,715 $ 49,862
    Right-of-use assets obtained in exchange for lease obligations 28,700 10,200
    Impairment of long lived assets $ 24,800 $ 15,400
    Weighted average remaining lease term 6 years 10 months 24 days 6 years 10 months 28 days
    Weighted average discount rate (in percent) 2.45% 2.51%
    Operating lease liabilities $ 43,657 $ 49,949
    Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other liabilities (Note 12) Other liabilities (Note 12)
    Selling, general and administrative    
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
    Net operating lease costs $ 48,300 $ 47,500
    Cost of Sales    
    New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
    Net operating lease costs $ 4,400 $ 2,400
    XML 116 R94.htm IDEA: XBRL DOCUMENT v3.22.4
    Operating Leases Operating Leases - Operating Lease Maturity (Details)
    $ in Thousands
    Dec. 31, 2022
    USD ($)
    Leases [Abstract]  
    2023 $ 47,479
    2024 34,400
    2025 25,045
    2026 20,430
    2027 17,249
    Thereafter 45,065
    Total future minimum lease payments 189,668
    Lease imputed interest (14,367)
    Total $ 175,301
    XML 117 R95.htm IDEA: XBRL DOCUMENT v3.22.4
    Non-current other liabilities (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Payables and Accruals [Abstract]    
    Defined benefit pension obligations, net (note 21) $ 13,033 $ 16,262
    Other non-current liabilities 25,227 26,334
    Other Liabilities, Noncurrent $ 38,260 $ 42,596
    XML 118 R96.htm IDEA: XBRL DOCUMENT v3.22.4
    Commitments and Contingencies - Narrative (Details)
    Dec. 31, 2022
    Commitments and Contingencies Disclosure [Abstract]  
    Non-cancelable operating leases for facilities expiration period 12 years
    XML 119 R97.htm IDEA: XBRL DOCUMENT v3.22.4
    Share Capital (Details)
    12 Months Ended
    Feb. 18, 2022
    USD ($)
    shares
    Jul. 01, 2021
    shares
    Dec. 31, 2019
    USD ($)
    shares
    Jul. 22, 2016
    Dec. 31, 2022
    USD ($)
    vote
    $ / shares
    shares
    Dec. 31, 2021
    USD ($)
    $ / shares
    shares
    Dec. 31, 2020
    USD ($)
    $ / shares
    shares
    Dec. 31, 2019
    USD ($)
    Dec. 31, 2018
    USD ($)
    shares
    Jan. 08, 2019
    shares
    Oct. 03, 2016
    USD ($)
    Equity, Class of Treasury Stock [Line Items]                      
    Number of votes | vote         1            
    Total proceeds from exercise of stock options by employees | $         $ 35,844,000 $ 118,589,000 $ 13,203,000        
    Ordinary shares redeemed, value | $         $ 99,983,000   $ 175,000,000        
    Buyback program                      
    Equity, Class of Treasury Stock [Line Items]                      
    Stock repurchase program, authorized amount | $                     $ 400,000,000
    Ordinary shares redeemed (in shares) 420,530   35,100       1,235,218   4,026,576    
    Ordinary shares redeemed, value | $ $ 100,000,000   $ 5,300,000       $ 175,000,000 $ 141,600,000 $ 372,100,000    
    Number of shares authorized to be repurchased (in shares)                   1,000,000  
    Maximum | Buyback program                      
    Equity, Class of Treasury Stock [Line Items]                      
    Stock repurchase program, authorized percentage (in percent)       10.00%              
    Employee Stock Option                      
    Equity, Class of Treasury Stock [Line Items]                      
    Options exercised by employees (in shares)         348,286 1,065,529 193,417        
    Average exercise price of option per share (USD per share) | $ / shares         $ 102.87 $ 111.29 $ 68.19        
    Total proceeds from exercise of stock options by employees | $         $ 35,800,000 $ 118,600,000 $ 13,200,000        
    Restricted Stock Units (RSUs)                      
    Equity, Class of Treasury Stock [Line Items]                      
    Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)         195,029 446,404 144,172        
    Performance Share Unit (PSUs)                      
    Equity, Class of Treasury Stock [Line Items]                      
    Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)         46,087 44,132 63,516        
    Ordinary Shares                      
    Equity, Class of Treasury Stock [Line Items]                      
    Options exercised by employees (in shares)         348,286 1,065,529 193,417        
    Issue of shares associated with a business combination (in shares)   27,372,427       27,372,427          
    Ordinary shares redeemed (in shares)         420,530   1,235,218        
    Ordinary shares redeemed, value | $         $ 28,000   $ 82,000        
    XML 120 R98.htm IDEA: XBRL DOCUMENT v3.22.4
    Restructuring charges - Narrative (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Restructuring Cost and Reserve [Line Items]      
    Restructuring charges $ 31,143 $ 31,105 $ 18,089
    Restructuring reserve 6,022 $ 10,311 $ 4,675
    2021 Restructuring Plan      
    Restructuring Cost and Reserve [Line Items]      
    Restructuring charges 31,100    
    Severance costs 2,700    
    Other restructuring costs 24,500    
    Fixed asset impairment 4,000    
    Lease Liability      
    Restructuring Cost and Reserve [Line Items]      
    Restructuring reserve 1,400    
    Restructuring reserve, current 900    
    Restructuring reserve, noncurrent 500    
    Workforce reductions      
    Restructuring Cost and Reserve [Line Items]      
    Restructuring reserve $ 4,600    
    XML 121 R99.htm IDEA: XBRL DOCUMENT v3.22.4
    Restructuring charges - Summary of Restructuring Charges (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Restructuring and Related Activities [Abstract]      
    Restructuring charges $ 31,143 $ 31,105 $ 18,089
    XML 122 R100.htm IDEA: XBRL DOCUMENT v3.22.4
    Restructuring charges - Restructuring Provision (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Restructuring Reserve [Roll Forward]    
    Opening provision $ 10,311 $ 4,675
    Additional provision in the year 4,364 11,273
    Utilization (8,653) (5,637)
    Ending provision $ 6,022 $ 10,311
    XML 123 R101.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Components of Income Before Provision for Income Taxes (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]      
      Income before income tax expense $ 567,851 $ 196,680 $ 381,205
    Ireland      
    Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]      
      Income before income tax expense 432,963 231,893 280,310
    United States      
    Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]      
      Income before income tax expense (270,440) (278,413) 41,950
    Other      
    Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]      
      Income before income tax expense $ 405,328 $ 243,200 $ 58,945
    XML 124 R102.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Components of Provision for Income Taxes (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Current tax expense:      
    Current tax expense $ 184,396 $ 101,950 $ 46,948
    Deferred tax (benefit)/expense:      
    Deferred tax (benefit)/expense (124,985) (60,616) 927
    Income tax expense allocated to continuing operations 59,411 41,334 47,875
    Income tax expense was allocated to the following components of other comprehensive income:      
    Currency impact on long term funding 7,211 1,776 68
    Total 66,622 43,110 47,943
    Ireland      
    Current tax expense:      
    Current tax expense 53,248 18,469 28,963
    Deferred tax (benefit)/expense:      
    Deferred tax (benefit)/expense (6,166) 553 1,654
    United States      
    Current tax expense:      
    Current tax expense 60,753 35,478 3,022
    Deferred tax (benefit)/expense:      
    Deferred tax (benefit)/expense (118,475) (52,717) 4,577
    Other      
    Current tax expense:      
    Current tax expense 70,395 48,003 14,963
    Deferred tax (benefit)/expense:      
    Deferred tax (benefit)/expense $ (344) $ (8,452) $ (5,304)
    XML 125 R103.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Income Tax Disclosure [Abstract]      
    Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%) $ 70,980 $ 24,586 $ 47,651
    Rate differential from amortization of intangible assets (59,330) (31,228) (2,298)
    Foreign and other income taxed at higher rates 52,464 51,273 10,241
    Research & development tax incentives (2,608) (3,120) (1,243)
    Movement in valuation allowance (777) 3,101 3,581
    Effects of change in tax rates (300) (128) 108
    Change in unrecognized tax benefits 8,392 5,246 (1,672)
    Impact of stock compensation (8,756) (9,083) (5,150)
    Other (654) 687 (3,343)
    Income tax expense allocated to continuing operations $ 59,411 $ 41,334 $ 47,875
    XML 126 R104.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Deferred tax liabilities:      
    Property, plant and equipment $ 10,927 $ 19,606  
    Operating right-of-use-assets 23,260 33,449  
    Goodwill 37,150 33,354  
    Intangible assets 1,078,302 1,201,086  
    Other 9,054 1,761  
      Total deferred tax liabilities recognized 1,158,693 1,289,256  
    Deferred tax assets:      
    Operating loss and tax credits carryforwards 88,697 86,893  
    Property, plant and equipment 6,010 5,846  
    Operating lease liabilities 27,593 36,106  
    Intangible assets 3,602 4,596  
    Accrued expenses and unbilled revenue 64,016 69,198  
    Stock compensation 21,862 25,557  
    Deferred compensation 2,917 3,445  
    Unearned revenue 66,565 64,924  
    Other 9,155 602  
    Total deferred tax assets 290,417 297,167  
    Valuation allowance for deferred tax assets (43,379) (45,495) $ (32,800)
    Deferred tax assets recognized 247,038 251,672  
      Overall net deferred tax asset/(liability) $ (911,655) $ (1,037,584)  
    XML 127 R105.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Narrative (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Valuation allowance for deferred tax assets $ 43,379,000 $ 45,495,000 $ 32,800,000
    Net change in the total valuation allowance 2,100,000 (12,800,000)  
    Deferred tax liabilities, undistributed foreign earnings 1,600,000 800,000  
    Unrecognized tax benefit, potentially expire in 2021 37,900,000    
    Total unrecognized tax benefits net of potential benefits 217,600,000 202,100,000 19,100,000
    Interest and penalties recognized as an expense 7,100,000 1,900,000 $ 600,000
    Total accrued interest and penalties 22,600,000 15,500,000  
    Acquired entity      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Net change in the total valuation allowance   (9,300,000)  
    Provision for income taxes      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Net change in the total valuation allowance 800,000 (4,400,000)  
    Other Comprehensive Income      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Net change in the total valuation allowance 1,300,000 $ (900,000)  
    Foreign Country      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Other non-U.S subsidiaries operating loss carryforwards for income tax 37,900,000    
    Foreign Country | Tax Year 2022 to 2028      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Additional operating loss carryforward 14,800,000    
    Foreign Country | Tax Year 2029 to 2038      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Additional operating loss carryforward 18,200,000    
    Ireland | Foreign Country      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Ireland subsidiaries additional tax credit carryforward for income tax 16,600,000    
    United States      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    U.S. Federal net operating loss carry forwards currently available for offset 3,500,000    
    Alternative minimum tax credit carry forwards 800,000    
    United States | Federal NOL's      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Net operating loss carryforwards 5,363,000    
    U.S. federal net operating loss carry forwards 5,300,000    
    Tax credit carry forward 93,000,000    
    Other non-U.S subsidiaries operating loss carryforwards for income tax 95,000    
    United States | State NOL's      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Net operating loss carryforwards 401,898,000    
    Other non-U.S subsidiaries operating loss carryforwards for income tax 6,736,000    
    Other | Foreign Country      
    Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
    Ireland subsidiaries additional tax credit carryforward for income tax $ 4,700,000    
    XML 128 R106.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Expected Expiry Dates of NOL's (Details) - United States
    $ in Thousands
    Dec. 31, 2022
    USD ($)
    State NOL's  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, not subject to expiration $ 6,736
    Net operating loss carryforwards 401,898
    State NOL's | 2023-2036  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, subject to expiration 249,530
    State NOL's | 2033-2041  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, subject to expiration 145,632
    Federal NOL's  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, not subject to expiration 95
    Net operating loss carryforwards 5,363
    Federal NOL's | 2023-2036  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, subject to expiration 5,268
    Federal NOL's | 2033-2041  
    Operating Loss Carryforwards [Line Items]  
    Net operating loss carryforwards, subject to expiration $ 0
    XML 129 R107.htm IDEA: XBRL DOCUMENT v3.22.4
    Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
    Unrecognized tax benefits at start of year $ 202,065 $ 19,078 $ 20,156
    Increase related to acquired tax positions 170,047 0
    Increase related to prior year tax positions 16,098 204 401
    Decrease related to prior year tax positions (5,442) (1,695) (1,271)
    Increase related to current year tax positions 5,701 18,613 2,931
    Settlements 0 (844) (369)
    Lapse of statute of limitations (838) (3,338) (2,770)
      Unrecognized tax benefits at end of year $ 217,584 $ 202,065 $ 19,078
    XML 130 R108.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Narrative (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    May 07, 2014
    Other retirement plans        
    Defined Benefit Plan Disclosure [Line Items]        
    Non-current other liabilities (note 16) $ 11,600,000 $ 8,000,000    
    ICON Development Solutions Limited pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Expected rate of return on plan assets 3.80% 3.80%    
    Aptiv Solutions pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Discount rate 2.30% 0.40%    
    PRA Switzerland AG pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Discount rate 2.30% 0.40%    
    United States        
    Defined Benefit Plan Disclosure [Line Items]        
    Participant's contributions percentage of annual compensation (in percent) 4.50%      
    Defined contribution plan, cost $ 30,200,000 $ 23,700,000 $ 17,000,000  
    United Kingdom | ICON Development Solutions Limited pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Non-current other liabilities (note 16) 19,558,000 $ 41,813,000 $ 43,988,000  
    Net loss that will be amortized 300,000      
    Net prior service cost for defined benefit pension plan that will be amortized $ 0      
    Pension plan period 19 years      
    Expected rate of return on plan assets 3.80% 3.40% 4.00%  
    Contribution to pension fund in the year ending December 31, 2021 $ 100,000      
    Retirement period used as a basis to estimate expected cash flows 10 years      
    Discount rate 4.90% 1.80%    
    Switzerland | Aptiv Solutions pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Non-current other liabilities (note 16) $ 5,806,000 $ 7,643,000 $ 8,620,000  
    Switzerland | Aptiv Solutions pension plan | Aptiv Solutions        
    Defined Benefit Plan Disclosure [Line Items]        
    Percentage of share capital acquired (in percent)       100.00%
    Switzerland | PRA Switzerland AG pension plan        
    Defined Benefit Plan Disclosure [Line Items]        
    Non-current other liabilities (note 16) $ 5,345,000 $ 4,990,000 $ 4,890,000  
    XML 131 R109.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Summary of plan assets and liabilities (Details) - Pension Plan - United States - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Defined Benefit Plan Disclosure [Line Items]    
    Other receivables $ 6,492 $ 0
    Non-current other liabilities (note 16) $ (13,033) $ (16,262)
    XML 132 R110.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Funded Status (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    United Kingdom | ICON Development Solutions Limited pension plan      
    Defined Benefit Plan Disclosure [Line Items]      
    Projected benefit obligation $ (19,558) $ (41,813)  
    Fair value of plan assets 26,050 36,198 $ 34,612
     Funded status 6,492 (5,615)  
    Switzerland | Aptiv Solutions pension plan      
    Defined Benefit Plan Disclosure [Line Items]      
    Projected benefit obligation (5,806) (7,643)  
    Fair value of plan assets 5,681 6,964 7,601
     Funded status (125) (679)  
    Switzerland | PRA Switzerland AG pension plan      
    Defined Benefit Plan Disclosure [Line Items]      
    Projected benefit obligation (5,345) (4,990)  
    Fair value of plan assets 4,059 3,017 $ 2,849
     Funded status $ (1,286) $ (1,973)  
    XML 133 R111.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Change in Benefit Obligations (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    United Kingdom | ICON Development Solutions Limited pension plan      
    Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]      
    Benefit obligation at beginning of year $ 41,813 $ 43,988  
    Service cost 117 134 $ 100
    Interest cost 672 665 746
    Plan participants' contributions 19 23  
    Benefits paid 514 489  
    Actuarial gain (18,636) (2,097)  
    Foreign currency exchange rate changes (3,913) (411)  
      Benefit obligation at end of year 19,558 41,813 43,988
    Switzerland | Aptiv Solutions pension plan      
    Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]      
    Benefit obligation at beginning of year 7,643 8,620  
    Service cost 146 150  
    Interest cost 30 12  
    Plan participants' contributions 82 95  
    Settlement (218) (483)  
    Prior service cost (23) (82)  
    Benefits paid and transferred balances (182) 76  
    Actuarial gain (1,527) (484)  
    Foreign currency exchange rate changes (145) (261)  
      Benefit obligation at end of year 5,806 7,643 8,620
    Switzerland | PRA Switzerland AG pension plan      
    Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]      
    Benefit obligation at beginning of year 4,990 4,890  
    Service cost 404 207  
    Interest cost 20 19  
    Plan participants' contributions 2,396 135  
    Settlement (844) 0  
    Benefits paid 946 113  
    Actuarial gain (627) 1  
    Foreign currency exchange rate changes (48) (149)  
      Benefit obligation at end of year $ 5,345 $ 4,990 $ 4,890
    XML 134 R112.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Change in Plan Assets (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    United Kingdom | ICON Development Solutions Limited pension plan      
    Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
    Fair value of plan assets at beginning of year $ 36,198 $ 34,612  
    Expected return on plan assets 1,258 1,171 $ 1,214
    Actual return on plan assets (7,305) 1,176  
    Employer contributions 70 91  
    Plan participants' contributions 19 23  
    Benefits paid (514) (489)  
    Foreign currency exchange rate changes (3,676) (386)  
     Fair value of plan assets at end of year 26,050 36,198 34,612
    Switzerland | Aptiv Solutions pension plan      
    Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
    Fair value of plan assets at beginning of year 6,964 7,601  
    Expected return on plan assets 29 15  
    Actual return on plan assets (987) (238)  
    Scheme contributions 114 128  
    Plan participants' contributions 82 95  
    Benefits paid and transferred balances 182 (76)  
    Settlement (218) (483)  
    Foreign currency exchange rate changes (121) (230)  
     Fair value of plan assets at end of year 5,681 6,964 7,601
    Switzerland | PRA Switzerland AG pension plan      
    Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]      
    Fair value of plan assets at beginning of year 3,017 2,849  
    Expected return on plan assets 29 15  
    Actual return on plan assets 87 0  
    Employer contributions 325 135  
    Plan participants' contributions 2,396 135  
    Benefits paid (946) (113)  
    Settlement (844) 0  
    Foreign currency exchange rate changes (5) (4)  
     Fair value of plan assets at end of year $ 4,059 $ 3,017 $ 2,849
    XML 135 R113.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Components of Net Periodic Benefit Cost (Details) - United Kingdom - ICON Development Solutions Limited pension plan - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Defined Benefit Plan Disclosure [Line Items]      
    Service cost $ 117 $ 134 $ 100
    Interest cost 672 665 746
    Expected return on plan assets (1,258) (1,171) (1,214)
    Amortization of net loss 228 625 160
    Net periodic benefit cost $ (241) $ 253 $ (208)
    XML 136 R114.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) - ICON Development Solutions Limited pension plan - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Defined Benefit Plan Disclosure [Line Items]      
    Expected rate of return on plan assets 3.80% 3.80%  
    United Kingdom      
    Defined Benefit Plan Disclosure [Line Items]      
    Discount rate 1.80% 1.50% 2.10%
    Rate of compensation increase 3.70% 3.40% 3.30%
    Expected rate of return on plan assets 3.80% 3.40% 4.00%
    Other comprehensive income        
    Actuarial (gain)/loss - benefit obligation $ (18,636) $ (2,097) $ 5,294
    Actuarial loss/(gain) – plan assets 7,305 (1,176) (878)
    Actuarial loss recognized in net periodic benefit cost (228) (625) (160)
     Total $ (11,559) $ (3,898) $ 4,256
    XML 137 R115.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) - United Kingdom - ICON Development Solutions Limited pension plan
    Dec. 31, 2022
    Dec. 31, 2021
    Defined Benefit Plan Disclosure [Line Items]    
    Discount rate 4.90% 1.80%
    Rate of compensation increase 3.60% 3.70%
    XML 138 R116.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) - ICON Development Solutions Limited pension plan
    Dec. 31, 2022
    Dec. 31, 2021
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 100.00% 100.00%
    Government Bonds    
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 88.00% 0.00%
    Diversified Bonds    
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 12.00% 0.00%
    Corporate Bonds (including 50% high yield bonds)    
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 0.00% 37.00%
    Equities    
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 0.00% 24.00%
    Secured Loans and Multi Asset Credit    
    Defined Benefit Plan Disclosure [Line Items]    
    Actual plan asset allocations 0.00% 39.00%
    XML 139 R117.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Plan Asset Fair Value Measurements (Details) - Level 1 - ICON Development Solutions Limited pension plan - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets $ 26,050 $ 36,198
    Government Bonds    
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets 22,887 0
    Diversified Bonds    
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets 3,163 0
    Equities    
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets 0 8,782
    Corporate Bonds (including 50% high yield bonds)    
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets 0 13,434
    Secured Loans and Multi Asset Credit    
    Defined Benefit Plan Disclosure [Line Items]    
    Fair value of plan assets $ 0 $ 13,982
    XML 140 R118.htm IDEA: XBRL DOCUMENT v3.22.4
    Employee Benefits - Annual Benefit Payments (Details) - United Kingdom - ICON Development Solutions Limited pension plan
    $ in Thousands
    Dec. 31, 2022
    USD ($)
    Defined Benefit Plan Disclosure [Line Items]  
    2023 $ 302
    2024 371
    2025 402
    2026 703
    2027 643
    Years 2028 - 2032 $ 3,614
    XML 141 R119.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) - USD ($)
    $ / shares in Units, $ in Thousands
    12 Months Ended 24 Months Ended 252 Months Ended
    Feb. 14, 2017
    May 11, 2015
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Dec. 31, 2020
    Dec. 31, 2017
    May 18, 2020
    May 16, 2019
    May 31, 2018
    Feb. 13, 2017
    Sep. 23, 2013
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Weighted average contractual term of options outstanding     4 years 8 months 8 days 5 years 4 months 20 days                
    Exercisable - weighted average remaining contractual life     4 years 3 months 4 years 6 months 18 days                
    Total compensation costs     $ 70,523 $ 133,844 $ 26,271              
    Income tax benefit related to stock compensation     12,900 22,700 6,900              
    Cash tax benefit related to stock options exercised     $ 7,700 23,900 $ 2,500              
    The 2018 Legacy PRA Plan                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares)                   2    
    2013 Legacy PRA Plan                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares)                       2,052,909
    Percentage of outstanding shares authorized                       12.50%
    The 2020 Legacy PRA Plan                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares)               2,500,000        
    Consultants Stock Plan, 2008 Plan                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares) 1,000,000                   400,000  
    Limit of shares issued or to be issued pursuant to options granted (in shares) 1,000,000                      
    Employee Stock Plan, 2008 Plan                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares) 6,000,000                      
    Maximum number of shares per employee (in shares) 400,000                      
    Option Plans 2008 | Minimum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Percentage of option price for fair value of ordinary share (in percent) 100.00%                      
    Employee Stock Option                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Shares vesting period     5 years                  
    Employee Stock Option | Award date, prior to 2018                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Shares expiration period             8 years          
    Shares vesting period             5 years          
    Restricted Stock Units 2013                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares)   4,100,000                    
    Additional number of ordinary shares which have been reserved for issuance (in shares)   2,500,000                    
    Consultants Restricted Stock Units 2019                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Ordinary shares which have been reserved for issuance (in shares)                 250,000      
    Consultants Restricted Stock Units 2019 | Non-executive director                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Shares vesting period           12 months            
    Restricted Stock Units (RSUs)                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Fair value of stock units vested     $ 34,100 $ 83,500                
    Restricted Stock Units (RSUs) | Minimum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Share price of equity instruments other than options, vested in period (in USD per share)     $ 137.47 $ 115.11                
    Restricted Stock Units (RSUs) | Maximum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Share price of equity instruments other than options, vested in period (in USD per share)     $ 265.96 $ 206.71                
    Performance Share Unit (PSUs)                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Fair value of stock units vested     $ 6,500 $ 5,100                
    Performance Share Unit (PSUs) | Minimum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Share price of equity instruments other than options, vested in period (in USD per share)     $ 137.47 $ 115.11                
    Performance Share Unit (PSUs) | Maximum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Share price of equity instruments other than options, vested in period (in USD per share)     $ 166.51 $ 125.74                
    PSUs Based on Service and EPS Targets | Maximum                        
    Compensation Related Costs Share Based Payments Disclosure [Line Items]                        
    Stock units to be granted (in shares)     76,210                  
    XML 142 R120.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) - Stock Option and Award Plans - $ / shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Options Granted Under Plans      
    Beginning balance (in shares) 1,695,460 553,746 656,107
    Assumed through business combination (in shares)   2,177,130  
    Granted (in shares) 108,643 100,299 107,737
    Exercised (in shares) (348,286) (1,065,529) (193,417)
    Canceled/expired (in shares) (77,698) (70,186) (16,681)
    Ending balance (in shares) 1,378,119 1,695,460 553,746
    Vested and exercisable at end of period (in shares) 1,047,803    
    Weighted Average Exercise Price      
    Beginning balance (USD per share) $ 110.38 $ 108.53 $ 87.80
    Assumed through business combination (USD per share)   108.78  
    Granted (USD per share) 229.94 177.76 159.83
    Exercised (USD per share) 102.87 111.29 68.19
    Canceled/expired (USD per share) 143.08 128.46 92.21
    Ending balance (USD per share) 119.86 $ 110.38 $ 108.53
    Vested and exercisable at end of period (USD per share) $ 102.29    
    XML 143 R121.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) - $ / shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Dec. 31, 2019
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Minimum Range Exercise Price (USD per share) $ 14.88      
    Maximum Range Exercise Price (USD per share) 231.68      
    Range 1        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Minimum Range Exercise Price (USD per share) 14.88      
    Maximum Range Exercise Price (USD per share) 96.15      
    Range 2        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Minimum Range Exercise Price (USD per share) 103.81      
    Maximum Range Exercise Price (USD per share) 124.00      
    Range 3        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Minimum Range Exercise Price (USD per share) 125.74      
    Maximum Range Exercise Price (USD per share) 147.26      
    Range 4        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Minimum Range Exercise Price (USD per share) 159.33      
    Maximum Range Exercise Price (USD per share) $ 231.68      
    Stock Option and Award Plans        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Number of Shares (in shares) 1,378,119      
    Weighted Average Remaining Contractual Life 4 years 8 months 8 days      
    Weighted average exercise price (USD per share) $ 119.86 $ 110.38 $ 108.53 $ 87.80
    Number of Shares (in shares) 1,047,803      
    Vested and exercisable at end of period (USD per share) $ 102.29      
    Stock Option and Award Plans | Range 1        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Number of Shares (in shares) 494,565      
    Weighted Average Remaining Contractual Life 2 years 8 months 12 days      
    Number of Shares (in shares) 494,565      
    Stock Option and Award Plans | Range 2        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Number of Shares (in shares) 226,489      
    Weighted Average Remaining Contractual Life 5 years 6 months 29 days      
    Number of Shares (in shares) 203,605      
    Stock Option and Award Plans | Range 3        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Number of Shares (in shares) 386,518      
    Weighted Average Remaining Contractual Life 5 years 7 months 24 days      
    Number of Shares (in shares) 303,054      
    Stock Option and Award Plans | Range 4        
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Number of Shares (in shares) 270,547      
    Weighted Average Remaining Contractual Life 6 years 2 months 26 days      
    Number of Shares (in shares) 46,579      
    XML 144 R122.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) - Employee Stock Option - $ / shares
    12 Months Ended
    Jul. 01, 2021
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
    Weighted average fair value (USD per share) $ 107.21 $ 68.42 $ 49.15 $ 42.43
    Assumptions:        
    Expected volatility (in percent) 30.00% 31.00% 30.00% 30.00%
    Dividend yield (in percent) 0.00% 0.00% 0.00% 0.00%
    Risk free interest rate (in percent) 0.56% 1.86% 0.78% 0.57%
    Expected life 3 years 6 months 5 years 5 years 5 years
    XML 145 R123.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)
    12 Months Ended
    Dec. 31, 2022
    $ / shares
    shares
    Performance Share Unit (PSUs)  
    Outstanding number of shares [Roll Forward]  
    Outstanding at beginning of period (in shares) | shares 154,190
    Granted (in shares) | shares 64,682
    Shares vested (in shares) | shares (46,087)
    Forfeited (in shares) | shares (20,365)
    Outstanding at ending of period (in shares) | shares 152,420
    Weighted Average Fair Value  
    Outstanding at beginning of period (USD per share) | $ / shares $ 160.23
    Granted (USD per share) | $ / shares 229.79
    Shares vested (USD per share) | $ / shares 140.48
    Forfeited (USD per share) | $ / shares 185.90
    Outstanding at end of period (USD per share) | $ / shares $ 192.29
    Restricted Stock Units (RSUs)  
    Outstanding number of shares [Roll Forward]  
    Outstanding at beginning of period (in shares) | shares 572,785
    Granted (in shares) | shares 302,307
    Shares vested (in shares) | shares (195,029)
    Forfeited (in shares) | shares (97,451)
    Outstanding at ending of period (in shares) | shares 582,612
    Weighted Average Fair Value  
    Outstanding at beginning of period (USD per share) | $ / shares $ 191.20
    Granted (USD per share) | $ / shares 216.85
    Shares vested (USD per share) | $ / shares 174.35
    Forfeited (USD per share) | $ / shares 205.25
    Outstanding at end of period (USD per share) | $ / shares $ 207.73
    XML 146 R124.htm IDEA: XBRL DOCUMENT v3.22.4
    Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Total compensation costs $ 70,523 $ 133,844 $ 26,271
    Direct costs      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Total compensation costs 22,854 18,551 8,557
    Selling, general and administrative      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Total compensation costs 47,669 41,457 17,714
    Transaction and integration related      
    Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
    Total compensation costs $ 0 $ 73,836 $ 0
    XML 147 R125.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information - Narrative (Details)
    12 Months Ended
    Dec. 31, 2022
    segment
    Segment Reporting [Abstract]  
    Number of reporting segments 1
    XML 148 R126.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Segment Reporting Information [Line Items]      
    Revenue $ 7,741,386 $ 5,480,826 $ 2,797,288
    Ireland      
    Segment Reporting Information [Line Items]      
    Revenue 1,984,567 1,365,909 1,181,292
    Rest of Europe      
    Segment Reporting Information [Line Items]      
    Revenue 1,618,350 1,175,515 416,884
    U.S.      
    Segment Reporting Information [Line Items]      
    Revenue 3,574,610 2,581,007 925,563
    Other      
    Segment Reporting Information [Line Items]      
    Revenue $ 563,859 $ 358,395 $ 273,549
    XML 149 R127.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Segment Reporting Information [Line Items]      
    Income from operations, excluding restructuring and other items $ 795,237 $ 378,529 $ 391,500
    Ireland      
    Segment Reporting Information [Line Items]      
    Income from operations, excluding restructuring and other items 218,088 131,961 276,478
    Rest of Europe      
    Segment Reporting Information [Line Items]      
    Income from operations, excluding restructuring and other items 253,799 177,863 35,765
    U.S.      
    Segment Reporting Information [Line Items]      
    Income from operations, excluding restructuring and other items 254,849 39,132 58,018
    Other      
    Segment Reporting Information [Line Items]      
    Income from operations, excluding restructuring and other items $ 68,501 $ 29,573 $ 21,239
    XML 150 R128.htm IDEA: XBRL DOCUMENT v3.22.4
    Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Segment Reporting Information [Line Items]    
    Long-lived assets $ 504,152 $ 534,567
    Ireland    
    Segment Reporting Information [Line Items]    
    Long-lived assets 143,025 118,253
    Rest of Europe    
    Segment Reporting Information [Line Items]    
    Long-lived assets 99,721 121,174
    U.S.    
    Segment Reporting Information [Line Items]    
    Long-lived assets 213,311 239,828
    Other    
    Segment Reporting Information [Line Items]    
    Long-lived assets $ 48,095 $ 55,312
    XML 151 R129.htm IDEA: XBRL DOCUMENT v3.22.4
    Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) - shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Earnings Per Share [Abstract]      
    Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares) 81,532,320 67,110,186 52,859,911
    Effect of dilutive share options outstanding (in shares) 936,043 958,125 423,674
    Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares) 82,468,363 68,068,311 53,283,585
    XML 152 R130.htm IDEA: XBRL DOCUMENT v3.22.4
    Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) - USD ($)
    $ / shares in Units, $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Earnings Per Share [Abstract]      
    Net income attributable to the Group $ 505,304 $ 153,185 $ 332,331
    Noncontrolling interest adjustment to redemption amount 0 0 (4,522)
    Net income attributable to the Group (including NCI redemption adjustment) $ 505,304 $ 153,185 $ 327,809
    Net income per Ordinary Share attributable to the Group (Note 24):      
    Basic (USD per share) $ 6.20 $ 2.28 $ 6.20
    Diluted (USD per share) $ 6.13 $ 2.25 $ 6.15
    XML 153 R131.htm IDEA: XBRL DOCUMENT v3.22.4
    Accumulated Other Comprehensive Income (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2022
    Dec. 31, 2021
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]    
    Currency translation adjustments $ (175,369) $ (85,840)
    Actuarial gain/(loss) on defined benefit pension plan (note 21) 7,559 (5,098)
    Loss on cash flow hedge 3,728 0
    Amortization of loss on cash flow hedge 0 1
     Total $ (171,538) $ (90,937)
    XML 154 R132.htm IDEA: XBRL DOCUMENT v3.22.4
    Supplemental Disclosure of Cash Flow Information (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Supplemental Cash Flow Elements [Abstract]      
    Cash paid for interest $ 210,918 $ 106,205 $ 13,062
    Cash paid for income taxes (net of refunds) $ 116,322 $ 55,105 $ 27,604
    XML 155 R133.htm IDEA: XBRL DOCUMENT v3.22.4
    Related Parties (Details) - USD ($)
    $ in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Related Party Transaction [Line Items]    
    Majority investor, ownership percentage 51.00%  
    Oncacare    
    Related Party Transaction [Line Items]    
    Ownership Percentage 49.00%  
    DS Biopharma Limited | Subsidiaries    
    Related Party Transaction [Line Items]    
    Revenue earned from related parties $ 2 $ 30
    Amounts due from related parties 12 12
    Afimmune Limited | Subsidiaries    
    Related Party Transaction [Line Items]    
    Revenue earned from related parties 235 551
    Amounts due from related parties 263 197
    Corvus Pharmaceuticals | Subsidiaries    
    Related Party Transaction [Line Items]    
    Revenue earned from related parties 428  
    Amounts due from related parties 231  
    Oncacare    
    Related Party Transaction [Line Items]    
    Expenses incurred from related party transactions 451 465
    Loan granted tp related party   $ 10,000
    Related party, loan interest rate   1.60%
    Interest receivable, related party loans 183  
    Oncacare | Subsidiaries    
    Related Party Transaction [Line Items]    
    Amounts due from related parties $ 715 $ 264
    XML 156 iclr-20221231_htm.xml IDEA: XBRL DOCUMENT 0001060955 2022-01-01 2022-12-31 0001060955 dei:BusinessContactMember 2022-01-01 2022-12-31 0001060955 2022-12-31 0001060955 2021-12-31 0001060955 2021-01-01 2021-12-31 0001060955 2020-01-01 2020-12-31 0001060955 us-gaap:CommonStockMember 2019-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2019-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001060955 us-gaap:RetainedEarningsMember 2019-12-31 0001060955 2019-12-31 0001060955 iclr:RedeemableNoncontrollingInterestMember 2019-12-31 0001060955 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001060955 iclr:RedeemableNoncontrollingInterestMember 2020-01-01 2020-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001060955 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2020-01-01 2020-12-31 0001060955 us-gaap:CommonStockMember 2020-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2020-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001060955 us-gaap:RetainedEarningsMember 2020-12-31 0001060955 2020-12-31 0001060955 iclr:RedeemableNoncontrollingInterestMember 2020-12-31 0001060955 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001060955 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001060955 us-gaap:CommonStockMember 2021-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2021-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001060955 us-gaap:RetainedEarningsMember 2021-12-31 0001060955 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001060955 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2022-01-01 2022-12-31 0001060955 us-gaap:CommonStockMember 2022-12-31 0001060955 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001060955 iclr:OtherUndenominatedCapitalMember 2022-12-31 0001060955 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001060955 us-gaap:RetainedEarningsMember 2022-12-31 0001060955 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001060955 srt:EuropeMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001060955 iclr:OtherGeographicLocationsMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-12-31 0001060955 us-gaap:BuildingMember 2022-01-01 2022-12-31 0001060955 srt:MinimumMember iclr:ComputerEquipmentAndCapitalizedSoftwareMember 2022-01-01 2022-12-31 0001060955 srt:MaximumMember iclr:ComputerEquipmentAndCapitalizedSoftwareMember 2022-01-01 2022-12-31 0001060955 us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001060955 us-gaap:EquipmentMember 2022-01-01 2022-12-31 0001060955 us-gaap:VehiclesMember 2022-01-01 2022-12-31 0001060955 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001060955 us-gaap:OrderOrProductionBacklogMember 2022-01-01 2022-12-31 0001060955 us-gaap:TradeNamesMember 2022-01-01 2022-12-31 0001060955 us-gaap:DatabasesMember 2022-01-01 2022-12-31 0001060955 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-01-01 2022-12-31 0001060955 iclr:MeDiNovaResearchMember 2020-03-09 0001060955 iclr:TopClientMember 2022-01-01 2022-12-31 0001060955 iclr:TopClientMember 2021-01-01 2021-12-31 0001060955 iclr:TopClientMember 2020-01-01 2020-12-31 0001060955 iclr:Clients25Member 2022-01-01 2022-12-31 0001060955 iclr:Clients25Member 2021-01-01 2021-12-31 0001060955 iclr:Clients25Member 2020-01-01 2020-12-31 0001060955 iclr:Clients610Member 2022-01-01 2022-12-31 0001060955 iclr:Clients610Member 2021-01-01 2021-12-31 0001060955 iclr:Clients610Member 2020-01-01 2020-12-31 0001060955 iclr:Clients1125Member 2022-01-01 2022-12-31 0001060955 iclr:Clients1125Member 2021-01-01 2021-12-31 0001060955 iclr:Clients1125Member 2020-01-01 2020-12-31 0001060955 iclr:OtherCustomersMember 2022-01-01 2022-12-31 0001060955 iclr:OtherCustomersMember 2021-01-01 2021-12-31 0001060955 iclr:OtherCustomersMember 2020-01-01 2020-12-31 0001060955 2023-01-01 2022-12-31 0001060955 2022-01-01 2021-12-31 0001060955 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember 2022-01-01 2022-12-31 0001060955 iclr:PRAHealthSciencesIncMember 2021-01-01 2021-12-31 0001060955 iclr:PRAHealthSciencesIncMember 2022-12-31 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:CustomerRelationshipsMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:CustomerRelationshipsMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:OrderOrProductionBacklogMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:OrderOrProductionBacklogMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:TradeNamesMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:TradeNamesMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:DatabasesMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:DatabasesMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember 2021-07-01 2022-12-31 0001060955 us-gaap:AccountingStandardsUpdate202108Member iclr:PRAHealthSciencesIncMember 2022-01-01 2022-12-31 0001060955 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001060955 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001060955 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001060955 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 iclr:InterestRateCapAndInterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001060955 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001060955 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001060955 us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2021-12-31 0001060955 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001060955 us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001060955 2020-07-24 0001060955 iclr:OncacareMember 2022-12-31 0001060955 iclr:OncacareMember 2021-01-01 2021-12-31 0001060955 iclr:OncacareMember 2022-01-01 2022-12-31 0001060955 iclr:OncacareMember 2021-01-01 2021-12-31 0001060955 iclr:OncacareMember 2022-01-01 2022-12-31 0001060955 iclr:OncacareMember 2022-12-31 0001060955 us-gaap:CustomerRelationshipsMember 2022-12-31 0001060955 us-gaap:CustomerRelationshipsMember 2021-12-31 0001060955 us-gaap:OrderOrProductionBacklogMember 2022-12-31 0001060955 us-gaap:OrderOrProductionBacklogMember 2021-12-31 0001060955 us-gaap:TradeNamesMember 2022-12-31 0001060955 us-gaap:TradeNamesMember 2021-12-31 0001060955 us-gaap:DatabasesMember 2022-12-31 0001060955 us-gaap:DatabasesMember 2021-12-31 0001060955 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-12-31 0001060955 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-12-31 0001060955 srt:MinimumMember iclr:PRAHealthSciencesIncMember 2021-07-01 2021-07-01 0001060955 srt:MaximumMember iclr:PRAHealthSciencesIncMember 2021-07-01 2021-07-01 0001060955 iclr:PRAHealthSciencesIncMember 2021-07-02 2022-12-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-12-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2021-12-31 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2022-12-31 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2021-12-31 0001060955 iclr:SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember us-gaap:SecuredDebtMember 2021-07-01 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2021-07-01 0001060955 us-gaap:RevolvingCreditFacilityMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LineOfCreditMember 2021-07-01 0001060955 iclr:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-07-01 2021-07-01 0001060955 srt:MinimumMember iclr:TermLoanFacilityMember 2022-01-01 2022-12-31 0001060955 srt:MaximumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2022-01-01 2022-12-31 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2022-01-01 2022-12-31 0001060955 srt:MinimumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:BaseRateMember iclr:VariableRateComponentOneMember 2022-01-01 2022-12-31 0001060955 srt:MaximumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember iclr:VariableRateComponentTwoMember 2022-01-01 2022-12-31 0001060955 iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember iclr:VariableRateComponentTwoMember 2022-01-01 2022-12-31 0001060955 srt:MinimumMember iclr:SeniorSecuredRevolvingLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember iclr:VariableRateComponentTwoMember 2022-01-01 2022-12-31 0001060955 iclr:SeniorSecuredRevolvingCreditFacilityMember us-gaap:SecuredDebtMember 2022-12-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-12-30 2022-12-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-09-30 2022-09-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-06-30 2022-06-30 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2022-03-31 2022-03-31 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2021-12-29 2021-12-29 0001060955 iclr:TermLoanFacilityMember us-gaap:SecuredDebtMember 2021-09-27 2021-09-27 0001060955 iclr:SeniorSecuredNotesMember us-gaap:SeniorSubordinatedNotesMember 2021-07-01 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-11-29 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-11-29 0001060955 us-gaap:InterestRateSwapMember 2022-11-29 0001060955 us-gaap:InterestRateCapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001060955 us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001060955 us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001060955 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001060955 iclr:PerformanceShareUnitMember 2022-01-01 2022-12-31 0001060955 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001060955 iclr:PerformanceShareUnitMember 2021-01-01 2021-12-31 0001060955 us-gaap:CommonStockMember 2021-07-01 2021-07-01 0001060955 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001060955 iclr:PerformanceShareUnitMember 2020-01-01 2020-12-31 0001060955 srt:MaximumMember iclr:BuybackProgramMember 2016-07-22 2016-07-22 0001060955 iclr:BuybackProgramMember 2016-10-03 0001060955 iclr:BuybackProgramMember 2018-01-01 2018-12-31 0001060955 iclr:BuybackProgramMember 2019-01-08 0001060955 iclr:BuybackProgramMember 2019-01-01 2019-12-31 0001060955 iclr:BuybackProgramMember 2019-12-31 2019-12-31 0001060955 iclr:BuybackProgramMember 2020-01-01 2020-12-31 0001060955 iclr:BuybackProgramMember 2022-02-18 2022-02-18 0001060955 iclr:A2021RestructuringPlanMember 2022-01-01 2022-12-31 0001060955 iclr:LeaseLiabilityMember 2022-12-31 0001060955 us-gaap:EmployeeSeveranceMember 2022-12-31 0001060955 country:IE 2022-01-01 2022-12-31 0001060955 country:IE 2021-01-01 2021-12-31 0001060955 country:IE 2020-01-01 2020-12-31 0001060955 country:US 2022-01-01 2022-12-31 0001060955 country:US 2021-01-01 2021-12-31 0001060955 country:US 2020-01-01 2020-12-31 0001060955 iclr:RestOfEuropeAndOtherCountriesMember 2022-01-01 2022-12-31 0001060955 iclr:RestOfEuropeAndOtherCountriesMember 2021-01-01 2021-12-31 0001060955 iclr:RestOfEuropeAndOtherCountriesMember 2020-01-01 2020-12-31 0001060955 country:IE us-gaap:ForeignCountryMember 2022-12-31 0001060955 country:US us-gaap:InternalRevenueServiceIRSMember 2022-12-31 0001060955 country:US us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001060955 country:US 2022-12-31 0001060955 country:US us-gaap:InternalRevenueServiceIRSMember iclr:TaxYear2023To2036Member 2022-12-31 0001060955 country:US us-gaap:StateAndLocalJurisdictionMember iclr:TaxYear2023To2036Member 2022-12-31 0001060955 country:US us-gaap:InternalRevenueServiceIRSMember iclr:TaxYear20332041Member 2022-12-31 0001060955 country:US us-gaap:StateAndLocalJurisdictionMember iclr:TaxYear20332041Member 2022-12-31 0001060955 us-gaap:ForeignCountryMember 2022-12-31 0001060955 us-gaap:ForeignCountryMember iclr:TaxYear2022To2028Member 2022-12-31 0001060955 us-gaap:ForeignCountryMember iclr:TaxYear2029To2038Member 2022-12-31 0001060955 iclr:OtherCountriesMember us-gaap:ForeignCountryMember 2022-12-31 0001060955 iclr:IncomeTaxBenefitMember 2022-01-01 2022-12-31 0001060955 us-gaap:OtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001060955 iclr:AcquiredEntityMember 2021-01-01 2021-12-31 0001060955 iclr:IncomeTaxBenefitMember 2021-01-01 2021-12-31 0001060955 us-gaap:OtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001060955 country:US 2022-01-01 2022-12-31 0001060955 country:US 2021-01-01 2021-12-31 0001060955 country:US 2020-01-01 2020-12-31 0001060955 country:US us-gaap:PensionPlansDefinedBenefitMember 2022-12-31 0001060955 country:US us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0001060955 iclr:OtherRetirementPlansMember 2022-12-31 0001060955 iclr:OtherRetirementPlansMember 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2022-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2020-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2022-01-01 2022-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2021-01-01 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2020-01-01 2020-12-31 0001060955 iclr:GovernmentBondsMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 iclr:GovernmentBondsMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 iclr:DiversifiedBondsMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 iclr:DiversifiedBondsMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:DefinedBenefitPlanEquitySecuritiesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:DefinedBenefitPlanEquitySecuritiesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:CorporateDebtSecuritiesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:CorporateDebtSecuritiesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-01-01 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-01-01 2022-12-31 0001060955 iclr:GovernmentBondsMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 iclr:GovernmentBondsMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 iclr:DiversifiedBondsMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 iclr:DiversifiedBondsMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:DefinedBenefitPlanEquitySecuritiesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2022-12-31 0001060955 us-gaap:FairValueInputsLevel1Member iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember 2021-12-31 0001060955 iclr:ICONDevelopmentSolutionsLimitedPensionPlanMember country:GB 2022-12-31 0001060955 iclr:AptivSolutionsMember iclr:AptivSolutionsPensionPlanMember country:CH 2014-05-07 0001060955 iclr:AptivSolutionsPensionPlanMember country:CH 2022-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember country:CH 2021-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember 2022-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember 2021-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember country:CH 2020-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember country:CH 2022-01-01 2022-12-31 0001060955 iclr:AptivSolutionsPensionPlanMember country:CH 2021-01-01 2021-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember country:CH 2022-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember country:CH 2021-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember 2022-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember 2021-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember country:CH 2020-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember country:CH 2022-01-01 2022-12-31 0001060955 iclr:PRASwitzerlandAGPensionPlanMember country:CH 2021-01-01 2021-12-31 0001060955 iclr:ConsultantsStockPlan2008PlanMember 2017-02-13 0001060955 iclr:ConsultantsStockPlan2008PlanMember 2017-02-14 0001060955 iclr:EmployeeStockPlanTwentyZeroEightPlanMember 2017-02-14 0001060955 iclr:ConsultantsStockPlan2008PlanMember 2017-02-14 2017-02-14 0001060955 iclr:EmployeeStockPlanTwentyZeroEightPlanMember 2017-02-14 2017-02-14 0001060955 srt:MinimumMember iclr:OptionPlans2008Member 2017-02-14 2017-02-14 0001060955 iclr:AwardDateAllYearsExcluding2018Member us-gaap:EmployeeStockOptionMember 1997-01-01 2017-12-31 0001060955 iclr:The2020LegacyPRAPlanMember 2020-05-18 0001060955 iclr:The2018LegacyPRAPlanMember 2018-05-31 0001060955 iclr:A2013LegacyPRAPlanMember 2013-09-23 0001060955 iclr:StockOptionAndAwardPlansMember 2019-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2020-01-01 2020-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2020-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2021-01-01 2021-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2021-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2022-01-01 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember 2022-12-31 0001060955 iclr:Range1Member 2022-01-01 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range1Member 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range1Member 2022-01-01 2022-12-31 0001060955 iclr:Range2Member 2022-01-01 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range2Member 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range2Member 2022-01-01 2022-12-31 0001060955 iclr:Range3Member 2022-01-01 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range3Member 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range3Member 2022-01-01 2022-12-31 0001060955 iclr:Range4Member 2022-01-01 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range4Member 2022-12-31 0001060955 iclr:StockOptionAndAwardPlansMember iclr:Range4Member 2022-01-01 2022-12-31 0001060955 us-gaap:EmployeeStockOptionMember 2021-07-01 2021-07-01 0001060955 iclr:RestrictedStockUnitsTwentyThirteenMember 2015-05-11 2015-05-11 0001060955 iclr:RestrictedStockUnitsTwentyThirteenMember 2015-05-11 0001060955 iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember 2019-05-16 0001060955 iclr:NonexecutiveDirectorMember iclr:ConsultantsRestrictedStockUnitsTwentyNineteenMember 2019-01-01 2020-12-31 0001060955 iclr:PerformanceShareUnitMember 2021-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001060955 iclr:PerformanceShareUnitMember 2022-12-31 0001060955 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001060955 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001060955 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001060955 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001060955 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001060955 srt:MinimumMember iclr:PerformanceShareUnitMember 2022-12-31 0001060955 srt:MaximumMember iclr:PerformanceShareUnitMember 2022-12-31 0001060955 srt:MinimumMember iclr:PerformanceShareUnitMember 2021-12-31 0001060955 srt:MaximumMember iclr:PerformanceShareUnitMember 2021-12-31 0001060955 srt:MaximumMember iclr:PerformanceBasedGrantsMember 2022-12-31 0001060955 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001060955 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001060955 iclr:TransactionAndIntegrationExpenseMember 2022-01-01 2022-12-31 0001060955 iclr:TransactionAndIntegrationExpenseMember 2021-01-01 2021-12-31 0001060955 iclr:TransactionAndIntegrationExpenseMember 2020-01-01 2020-12-31 0001060955 iclr:RestOfEuropeMember 2022-01-01 2022-12-31 0001060955 iclr:RestOfEuropeMember 2021-01-01 2021-12-31 0001060955 iclr:RestOfEuropeMember 2020-01-01 2020-12-31 0001060955 iclr:OtherCountriesMember 2022-01-01 2022-12-31 0001060955 iclr:OtherCountriesMember 2021-01-01 2021-12-31 0001060955 iclr:OtherCountriesMember 2020-01-01 2020-12-31 0001060955 country:IE 2022-12-31 0001060955 country:IE 2021-12-31 0001060955 iclr:RestOfEuropeMember 2022-12-31 0001060955 iclr:RestOfEuropeMember 2021-12-31 0001060955 country:US 2021-12-31 0001060955 iclr:OtherCountriesMember 2022-12-31 0001060955 iclr:OtherCountriesMember 2021-12-31 0001060955 iclr:DSBiopharmaLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2022-01-01 2022-12-31 0001060955 iclr:DSBiopharmaLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2021-01-01 2021-12-31 0001060955 iclr:DSBiopharmaLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2022-12-31 0001060955 iclr:DSBiopharmaLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2021-12-31 0001060955 iclr:AfimmuneLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2022-01-01 2022-12-31 0001060955 iclr:AfimmuneLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2021-01-01 2021-12-31 0001060955 iclr:AfimmuneLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2022-12-31 0001060955 iclr:AfimmuneLimitedMember us-gaap:SubsidiaryOfCommonParentMember 2021-12-31 0001060955 iclr:CorvusPharmaceuticalsMember us-gaap:SubsidiaryOfCommonParentMember 2022-01-01 2022-12-31 0001060955 iclr:CorvusPharmaceuticalsMember us-gaap:SubsidiaryOfCommonParentMember 2022-12-31 0001060955 iclr:OncacareMember us-gaap:SubsidiaryOfCommonParentMember 2022-12-31 0001060955 iclr:OncacareMember us-gaap:SubsidiaryOfCommonParentMember 2021-12-31 shares iso4217:USD iso4217:EUR shares iso4217:USD shares iclr:Employee iclr:Location iclr:Country pure iclr:instrument iclr:tranche iclr:vote iclr:segment false 2022 FY 0001060955 http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent 20-F false true 2022-12-31 --12-31 false false 333-08704 ICON PLC L2 South County Business Park, Leopardstown, Dublin 18, D18 X5R3 IE Brendan Brennan South County Business Park Leopardstown Dublin 18 D18 X5R3 D18 X5R3 IE Brendan.Brennan@iconplc.com 353 1 291-2000 ORDINARY SHARES, PAR VALUE €0.06 EACH ICLR NASDAQ 81723555 Yes No Yes Yes Large Accelerated Filer false true U.S. GAAP false 1116 KPMG Dublin, Ireland 288768000 752213000 1713000 1712000 1731388000 1342770000 957655000 623121000 63658000 56760000 137094000 114323000 48790000 50299000 3229066000 2941198000 350320000 336444000 8971670000 9037931000 4278659000 4710843000 153832000 198123000 70790000 70557000 21380000 18637000 76930000 48392000 0 2373000 32631000 22592000 17185278000 17387090000 81194000 90764000 1507449000 1323961000 1005025000 949629000 41783000 59433000 55150000 55150000 2690601000 2478937000 4599037000 5381162000 131644000 159483000 38260000 42596000 239188000 172109000 988585000 1085976000 0 0 8687315000 9320263000 6 6 100000000 100000000 81723555 81723555 81554683 81554683 6649000 6640000 6840306000 6733910000 1162000 1134000 -171538000 -90937000 1821384000 1416080000 8497963000 8066827000 17185278000 17387090000 7741386000 5480826000 2797288000 5527045000 3972612000 1979883000 778753000 585330000 342449000 569513000 314987000 66126000 39695000 198263000 -759000 31143000 31105000 18089000 6946149000 5102297000 2405788000 795237000 378529000 391500000 2345000 574000 2724000 229731000 182423000 13019000 567851000 196680000 381205000 59411000 41334000 47875000 508440000 155346000 333330000 -3136000 -2161000 -366000 505304000 153185000 332964000 0 0 633000 505304000 153185000 332331000 6.20 2.28 6.20 6.13 2.25 6.15 81532320 67110186 52859911 82468363 68068311 53283585 505304000 153185000 332964000 -89530000 -60617000 46526000 0 0 -231000 12657000 4266000 -4138000 0 -113000 910000 -3728000 778000 -905000 424703000 97725000 373306000 0 0 633000 424703000 97725000 372673000 53622206 4635000 577961000 1052000 -75819000 1110226000 1618055000 39510000 332331000 332331000 633000 46526000 46526000 -231000 -231000 -4138000 -4138000 910000 910000 -905000 -905000 372673000 193417 13000 13176000 13189000 207688 14000 14000 25981000 25981000 14000 14000 1235218 82000 -82000 175000000 175000000 140000 140000 -4522000 -4522000 4522000 -44665000 52788093 4580000 617104000 1134000 -35477000 1262895000 1850236000 0 52788093 4580000 617104000 1134000 -35477000 1262895000 1850236000 153185000 153185000 -60617000 -60617000 4266000 4266000 -113000 -113000 778000 778000 97725000 1065529 77000 118512000 118589000 328634 23000 23000 133553000 133553000 853000 853000 27372427 1960000 5656195000 5658155000 209399000 209399000 81554683 6640000 6733910000 1134000 -90937000 1416080000 8066827000 81554683 6640000 6733910000 1134000 -90937000 1416080000 8066827000 505304000 505304000 -89530000 -89530000 12657000 12657000 -3728000 -3728000 424703000 348286 21000 35807000 35828000 241116 16000 16000 70606000 70606000 17000 17000 420530 28000 -28000 99983000 99983000 17000 17000 81723555 6649000 6840306000 1162000 -171538000 1821384000 8497963000 505304000 153185000 332964000 569513000 314987000 66126000 28767000 20037000 5411000 45215000 45339000 28480000 -3136000 -2161000 -366000 17749000 12890000 523000 70523000 133844000 26271000 0 -14434000 0 0 -59460000 0 -124985000 -60616000 927000 13009000 6054000 -5979000 -11324000 -4480000 7859000 420695000 -113513000 175040000 332592000 17656000 5748000 192944000 -69121000 291844000 10121000 108259000 -2209000 563315000 829142000 568035000 142160000 93750000 40885000 0 5914475000 47931000 0 2450000 2450000 0 10000000 0 481000 497000 47902000 482000 480000 0 1906000 500000 87000 5612000 4077000 3299000 -145867000 -6024235000 -46576000 0 30328000 1554000 75000000 5905100000 350000000 875000000 877780000 350000000 0 0 43923000 35844000 118589000 13203000 17000 853000 14000 99983000 0 175000000 17000 0 140000 0 0 905000 -864173000 5114728000 -208333000 -16720000 -7727000 6870000 -463445000 -88092000 319996000 752213000 840305000 520309000 288768000 752213000 840305000 Description of Business <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON plc and its subsidiaries ("the Company" or "ICON") is a clinical research organization ("CRO"), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support all stages of the clinical development process from compound selection to Phase I-IV clinical studies. Our mission is to improve the lives of patients by accelerating the development of our customers' drugs and devices through innovative solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe that we are one of a select group of CROs with the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. At December 31, 2022 we had approximately 41,100 employees, in 111 locations in 53 countries. During the year ended December 31, 2022, we derived approximately 46.2%, 46.5% and 7.3% of our revenue in the United States, Europe and Rest of World, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON’s ordinary shares are traded on the NASDAQ Global Select Market under the symbol “ICLR”.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We began operations in 1990 and have expanded our business through internal growth, together with a number of strategic acquisitions to enhance our capabilities and expertise in certain areas of the clinical development process. We are incorporated in Ireland and our principal executive office is located at: South County Business Park, Leopardstown, Dublin 18, Republic of Ireland. The contact telephone number of this office is +353 1 2912000.</span></div> 41100 111 53 0.462 0.465 0.073 Summary of Significant Accounting Policies<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The accounting policies noted below were applied in the preparation of the accompanying financial statements of the Company and are in conformity with accounting principles generally accepted in the United States.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements – quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2021 and December 31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s investments that are not consolidated are accounted for under the equity method if the Company exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building  </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December 31, 2022 and December 31, 2021, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment – Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company’s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company’s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation – Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company’s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset’s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period’s presentation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company’s consolidated financial statements.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The consolidated financial statements include the financial statements of the Company and all of its subsidiaries. All significant intercompany profits, transactions and account balances have been eliminated. The results of subsidiary undertakings acquired in the period are included in the Consolidated Statement of Operations from the date of acquisition.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates. The principal management estimates and judgments used in preparing the financial statements relate to revenue recognition and intangible assets acquired in a business combination.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Disclosure of fair value of financial instruments</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents, other receivables, available for sale investments, accounts receivable, accounts payable, investigator payments and income taxes payable have carrying amounts that approximate fair value due to the short term maturities of these instruments. Other liabilities' carrying amounts approximate fair value based on net present value of estimated future cash flows. Debt is measured at historical cost.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments are measured in the Consolidated Balance Sheet at amortized cost or fair value using a fair value hierarchy of valuation inputs. The fair value hierarchy prioritizes the inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels, which is determined by the lowest level input that is significant to the fair value measurement in its entirety. These levels are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1: Inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3: Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.</span></div>The Company classifies its investments in short term debt or equity investments as available for sale, as it does not actively trade such securities nor does it intend to hold them to maturity. The fair value of short term investments are represented by level 1 fair value measurements – quoted prices in active markets for identical assets. The unrealized movements in fair value are recognized in equity until disposal or sale, at which time, those unrealized movements from prior periods are recognized in the Consolidated Statement of Operations. Losses other than temporary, which reduce the carrying amount below cost are recognized in Consolidated Statement of Operations. <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Business combinations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The cost of a business combination is measured as the aggregate of the fair value of assets received, liabilities assumed and equity instruments issued in exchange for control. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records and allocates to its reporting units the excess of the cost over the fair value of the net assets acquired, known as goodwill. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where a business combination agreement provides for an adjustment to the cost of the acquisition which is contingent upon future events, the amount of the estimated adjustment is recognized at the acquisition date at the fair value of the contingent consideration. Any changes to this estimate outside the measurement period will depend on the classification of the contingent consideration. If the contingent consideration is classified as equity it shall not be re-measured and the settlement shall be accounted for within equity. If the contingent consideration is classified as a liability any adjustments will be accounted for through the Consolidated Statement of Operations or Other Comprehensive Income depending on whether the liability is considered a financial instrument.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The assets, liabilities and contingent liabilities of businesses acquired are measured at their fair values at the date of acquisition. In the case of a business combination which is completed in stages, the fair values of the identifiable assets, liabilities and contingent liabilities are determined at the date of each exchange transaction. When the initial accounting for a business combination is determined provisionally, any subsequent adjustments to the provisional values allocated to the identifiable assets, liabilities and contingent liabilities are made within twelve months of the acquisition date and presented as adjustments to goodwill in the reporting period in which the adjustments are determined.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company allocates a share of net income to the noncontrolling interest holders based on percentage ownership. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Transaction and integration-related expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Transaction and integration-related expenses are the incremental costs directly attributable to the completion and integration activities associated with the Company’s recent acquisitions. The costs consist of investment banking fees, advisory costs, retention agreements with employees, accelerated share compensation charges, contingent consideration valuation adjustments and ongoing integration activities. The Company accounts for these transaction and integration-related costs as expenses in the period in which the costs are incurred and the services are received.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Foreign currencies and translation of subsidiaries</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's financial statements are prepared in United States dollars. The financial statements of subsidiaries with other functional currencies are translated at period end rates for the Consolidated Balance Sheets and average rates for the Consolidated Statements of Operations. Translation gains and losses arising are reported as a movement on accumulated other comprehensive income. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Transactions in currencies other than the functional currency of the subsidiaries of the Company are recorded at the rate ruling at the date of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency of the subsidiaries of the Company are translated into the functional currency of that entity at exchange rates prevailing at the Balance Sheet date. Adjustments resulting from these translations are charged or credited to income. Foreign currency gains and losses on intercompany transactions classified as long-term investments are reported in other comprehensive income as currency translation adjustments. Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> Amounts charged or credited to the Consolidated Statements of Operations for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts (credited)/charged</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,997)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,316)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,979 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 25997000 14316000 -5979000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company earns revenues by providing a number of different services to its customers. These services, which are integral elements of the clinical development process, include clinical trials management, consulting, contract staffing, data services and laboratory services. These services, which are described below, can be purchased collectively or individually as part of a clinical trial contract. There is not significant variability in how economic factors affect these services. Contracts range in duration from a number of months to several years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ASC 606 requires application of five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies the performance obligation(s), which have been applied to revenue recognized from each service described below.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Clinical trial service revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A clinical trial service is a single performance obligation satisfied over time, i.e. the full-service obligation in respect of a clinical trial (including those services performed by investigators and other parties) is considered a single performance obligation. Promises offered to the customer are not distinct within the context of the contract. ICON is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support the clinical research projects. The transaction price is determined by reference to the contract or change order value (total service revenue and pass-through/ reimbursable expenses) adjusted to reflect a realizable contract value. Revenue is recognized over time as the single performance obligation is satisfied. The progress towards completion for clinical service contracts is measured based on an input measure being total project costs incurred (inclusive of pass-through/ reimbursable expenses) at each reporting period as a percentage of forecasted total project costs.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Laboratory services revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the products or services are transferred to the customer. Revenue for laboratory services is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Where contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on the estimated relative selling price of the promised good or service. Service revenue is recognized over time as the services are delivered to the customer based on the extent of progress towards completion of the performance obligation. The determination of the methodology to measure progress requires judgment and is based on the nature of services provided. This requires an assessment of the transfer of value to the customer. The right to invoice measure of progress is generally related to rate per unit contracts, as the extent of progress towards completion is measured based on discrete service or time-based increments, such as samples tested or labor hours incurred. Revenue is recorded in the amount invoiced since that amount corresponds to the value of the Company's performance and the transfer of value to the customer. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Contracting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has availed of the practical expedient which results in recognition of revenue on a right to invoice basis. Application of the practical expedient reflects the right to consideration from the customer in an amount that corresponds directly with the value to the customer of the performance completion to date. This reflects hours performed by contract staff. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Consulting services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our consulting services contracts represent a single performance obligation satisfied over time. The transaction price is determined by reference to contract or change order value. Revenue is recognized over time as the performance obligation is satisfied. The progress towards completion for consulting contracts is measured based on total project inputs (time) at each reporting period as a percentage of forecasted total project inputs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Data services revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company provides data reports and analytics to customers based on agreed-upon specifications, including the timing of delivery, which is typically either weekly, monthly, or quarterly. If a customer requests more than one type of data report or series of data reports within a contract, each distinct type of data report is a separate performance obligation. The contracts provide for the Company to be compensated for the value of each deliverable. The transaction price is determined using list prices, discount agreements, if any, and negotiations with the customers, and generally includes any out-of-pocket expenses. Typically, the Company bills in advance of services being provided with the amount being recorded as unearned revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">When multiple performance obligations exist, the transaction price is allocated to performance obligations on a relative standalone selling price basis. In cases where the Company contracts to provide a series of data reports, or in some cases data, the Company recognizes revenue over time using the “units delivered” output method as the data or reports are delivered. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the services performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain arrangements include upfront customization or consultative services for customers. These arrangements often include payments based on the achievement of certain contractual milestones. Under these arrangements, the Company contracts with a customer to carry out a specific study, ultimately resulting in delivery of a custom report or data product. These arrangements are a single performance obligation given the integrated nature of the service being provided. The Company typically recognizes revenue under these contracts over time, using an output-based measure, generally time elapsed, to measure progress and transfer of control of the performance obligation to the customer. Expense reimbursements are recorded to revenue as the expenses are incurred as they relate directly to the service performed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company enters into contracts with some of its larger data suppliers that involve non-monetary terms. The Company issues purchase credits to be used toward the data supplier's purchase of the Company's services based on the fair value of the data obtained. In exchange, the Company receives monetary discounts on the data received from the data suppliers. The fair value of the revenue earned from the customer purchases is recognized as services are delivered as described above. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At the end of the contract year, any unused customer purchase credits may be forfeited or carried over to the next contract year based on the terms of the data supplier contract. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Commissions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Incremental costs of obtaining a contract are recognized as an asset on the Consolidated Balance Sheet in respect of those contracts that exceed one year. Where commission costs relate to contracts that are less than one year, the practical expedient is applied as the amortization period of the asset which would arise on deferral would be one year or less.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reimbursable expenses</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses comprise investigator payments and certain other costs which are reimbursed by clients under terms specific to each contract to the investigators. The Company includes reimbursed expenses in revenue and direct costs as the Company is primarily responsible for fulfilling the promise to provide the specified service, including integration of the related services into a combined output to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Direct costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Direct costs consist of compensation, associated employee benefits and share-based payments for project-related employees and other direct project-related costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reimbursable expenses are presented within direct costs. This presentation is to align the presentation of costs with our assessment that our clinical trial service is a single performance obligation satisfied over time. Reimbursable expenses are recorded once the activity which forms the basis for the cost has occurred. Payments are made based on predetermined contractual arrangements. Timing of payments may differ from the timing of the expense.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash and highly liquid investments with initial maturities of three months or less and are stated at cost, which approximates market value.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Investments in debt, equity and other</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Available for sale investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies short-term investments as available for sale. The investments are reported at fair value, with unrealized gains or losses reported in a separate component of shareholders' equity. Any differences between the cost and fair value of the investments are represented by accrued interest and unrealized gains/losses. Realized gains and losses are determined using specific identification</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Long term investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company classifies its interests in funds having considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2021 and December 31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. Any increases or decreases in fair value are recognized in net income in the period. These are therefore measured at Level 3 of the fair value hierarchy. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Equity method investments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s investments that are not consolidated are accounted for under the equity method if the Company exercises significant influence that is considered to be greater than minor. These investments are classified as equity method investments on the accompanying Consolidated Balance Sheet. The Company records its pro rata share of the earnings/losses of these investments in Share of equity method investments in the Consolidated Statement of Operations. The Company reviews these for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Accounts receivable, net and unbilled revenue</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are recorded at fair value less an estimate of the credit losses expected to be incurred on the Company's accounts receivable portfolio. The Company's estimate of expected credit losses considers historical credit loss information that is adjusted, where necessary, for current conditions and reasonable and supportable forecasts. Historical credit loss experience provides the basis for the estimation of expected credit losses. The Company's receivables and unbilled services are predominantly due from large and mid-tier pharmaceutical and biotechnology companies that share similar risk characteristics. The Company monitors their portfolio of receivables and unbilled services for any deterioration in current or expected credit quality (for example, expected delinquency level), and adjusts the allowance for credit losses as required.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in the allowance for credit losses are recorded as a provision for (or reversal of) credit loss expense in the Consolidated Statement of Operations. Losses are charged against the allowance when management believes the uncollectibility of a previously provisioned amount is confirmed.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts receivable early payment discounting</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Where the Company enters into an agreement to sell certain portfolios of its accounts receivable balances, the sale is accounted for in accordance with ASC Topic 860 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Transfers and Servicing'</span> (ASC 860). Agreements which result in true sales of the transferred receivables, as defined in ASC 860, which occur when receivables are transferred without recourse to ICON, are excluded from amounts reported in the Consolidated Balance Sheet. Cash proceeds received from such sales are included in operating cash flows. <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Property, plant and equipment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, plant and equipment is stated at cost less accumulated depreciation. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building  </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div>Leasehold improvements are amortized using the straight line method over the estimated useful life of the asset or the lease term, whichever is shorter. Depreciation of property, plant and equipment is computed using the straight line method based on the estimated useful lives of the assets as listed below: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building  </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2-8</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment  </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td></tr></table> P40Y P2Y P8Y P8Y P5Y P5Y <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception and reassess if there are changes in terms and conditions of the contract. Finance leases, if any, are depreciated on the same basis as property, plant and equipment. At December 31, 2022 and December 31, 2021, the Company did not account for any leases as finance leases. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Operating leases are included in operating right-of-use assets, other liabilities and non-current operating lease liabilities on our Consolidated Balance Sheet with the lease charge recognized on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date or date of transition. Our lease terms may also include options to extend or terminate. The Company actively reviews options to extend or terminate leases and adjusts the ROU asset and lease liability when it is reasonably certain the option will be exercised. The ROU asset is adjusted for any prepayments made at the date of commencement and any initial direct costs incurred. As most of the Company's leases do not provide an implicit rate, the discount rate used is based on the rate of traded corporate bonds available at the commencement date adjusted for country risk, liquidity and lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for lease and non-lease components separately with lease components flowing through the Consolidated Balance Sheet and non-lease components expensed directly to the Consolidated Statements of Operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of the depreciable lives of the corresponding fixed assets or the lease term including any applicable renewals. Certain property leases include variable lease payments resulting from periodic rent increases based on an index which cannot be reasonably estimated at the lease commencement date. These costs are expensed as incurred on the Consolidated Statements of Operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some cases, the Company enters into sublease agreements and becomes both a lessee and a lessor for the same underlying asset. Subleases are accounted for as operating leases separately from the lease they relate to, but similar in manner as all other leases.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ROU assets for operating leases are occasionally reduced by impairment losses. The Company uses the long-lived assets impairment guidance in Subtopic 360-10, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant, and Equipment – Overall</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, to determine whether an ROU asset is impaired, and if so, the amount of the impairment loss to recognize.</span> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Intangible assets</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are measured at their fair value when acquired and amortized on the straight line basis over their respective useful lives. The Company has no indefinite life intangibles other than goodwill. The Company evaluates its intangibles for impairment when indicators of impairment exist. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company periodically assesses the useful lives of intangible assets to evaluate whether what was established at acquisition continues to be appropriate.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets are amortized on a straight-line basis over the expected useful life, as set forth in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P23Y P3Y P3Y P7Y P5Y <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Impairment of goodwill and long-lived assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill is tested for impairment annually or more frequently if an event or circumstance indicates that an impairment loss may have been incurred. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also chose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Fair value is determined through various valuation techniques including discounted cash flow models and third-party independent appraisals, as considered necessary. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured at the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of are reported at the lower of the carrying amount of the asset or fair value less selling costs.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Debt issuance costs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Debt issuance costs relating to the Company’s long-term debt are recorded as a direct reduction of long-term debt; these costs are deferred and amortized to interest expense using the effective interest method, over the respective terms of the related debt. Debt issuance costs relating to the Company’s revolving credit facilities are recorded as an asset; these costs are deferred and amortized to interest expense using the straight-line method. Early repayment of debt facilities can result in modification of the debt and the acceleration of the amortization of debt issuance costs.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments to reduce exposures to interest rates and foreign currencies. Derivatives are recorded on the balance sheet at fair value at each balance sheet date utilizing pricing models for non-exchange-traded contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our accounting policies for derivative financial instruments are based on whether they meet the criteria for designation as cash flow or fair value hedges. A designated hedge of the exposure to variability in the future cash flows of an asset or a liability, or of a forecast transaction, is referred to as a cash flow hedge. A designated hedge of the exposure to changes in fair value of an asset or a liability is referred to as a fair value hedge. The criterion for designating a derivative as a hedge includes the assessment of the instrument's effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction and the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the gain or loss from the effective portion of the hedge as a component of Other Comprehensive Income </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and within the same Consolidated Statement of Operations line item as the impact of the hedged transaction. For derivatives with fair value hedge accounting designation, we recognize gains or losses from the change in fair value of these derivatives, as well as the offsetting change in the fair value of the underlying hedged item, in earnings. Fair value gains and losses arising on derivative financial instruments not qualifying for hedge accounting are reported in our Consolidated Statement of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The company has entered into certain put and call arrangements to purchase equity in unconsolidated entities at a future date. These arrangements are accounted for at fair value at the balance sheet date.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company applies the asset and liability method of accounting for income taxes. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance to the amount that is more likely than not to be realized. The Company recognizes the effect of income tax positions only if those positions will more likely than not be sustained. Recognized income tax positions are measured at the largest amount of tax benefit that is greater than 50 percent likely of being realized upon settlement. Interest and penalties related to income taxes are included in income tax expense and classified with the related liability on the Consolidated Balance Sheet. The Company accounts for the impact of GILTI (“global intangible low-taxed income”) in the period it arises and has therefore not provided for deferred taxes in respect of this item.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Government grants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Government grants received relating to capital expenditures are shown by deducting the grant from the asset's carrying amount and crediting them to income on a basis consistent with the depreciation policy of the relevant assets. Grants relating to categories of operating expenditures are shown as deferred income and credited to income in the period in which the expenditure to which they relate is charged.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the grant agreements amounts received may become repayable in full should certain circumstances specified within the grant agreements occur, including downsizing by the Company, disposing of the related assets, ceasing to carry on its business or the appointment of a receiver over any of its assets. The Company has not recognized any loss contingency having assessed as remote the likelihood of these events arising.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Research and development credits</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits are available to the Company under the tax laws in certain jurisdictions, based on qualifying research and development spend as defined under those tax laws. Research and development credits may be recognized as a reduction of income tax expense. However, certain tax jurisdictions provide refundable credits that are not wholly dependent on the Company's ongoing income tax status or income tax position. In these circumstances the benefit of these credits is not recorded as a reduction to income tax expense, but rather as a reduction of operating expenditure.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Pension costs</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company contributes to defined contribution plans covering all eligible employees. The Company contributes to these plans based upon various fixed percentages of employee compensation and such contributions are expensed as incurred.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates, through certain subsidiaries, a defined benefit plan for certain employees located in the United Kingdom and Switzerland. The Company accounts for the costs of these plans in accordance with ASC 715-30 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Pension'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. These plans are presented in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company also maintains various retirement plans across the Group, many of which are required by local employment laws.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Share-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company accounts for its share options, Restricted Share Units ("RSUs") and Performance Share Units ("PSUs") in accordance with the provisions of ASC 718 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Compensation – Stock Compensation'.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation expense for equity-settled awards made to employees and directors is measured and recognized based on estimated grant date fair values. These equity-settled awards include employee share options, RSUs and PSUs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense for share options awarded to employees and directors is estimated at the grant date based on each option's fair value as calculated using the Black-Scholes option-pricing model. Share-based compensation for RSUs and PSUs awarded to employees and directors is calculated based on the market value of the Company's shares on </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the date of award of the RSUs and PSUs. The value of awards expected to vest is recognized as an expense over the requisite service periods. Forfeitures are estimated on the date of grant and revised if actual or expected forfeiture activity differs materially from original estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimating the grant date fair value of share options as of the grant date using an option-pricing model, such as the Black-Scholes model, is affected by the Company's share price as well as assumptions regarding a number of complex variables. These variables include, but are not limited to, the expected share price volatility over the term of the awards, risk-free interest rates and the expected term of the awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liability classified awards are measured at the fair value of the award on the grant date and remeasured at each reporting period at fair value until the award is settled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Replacement awards</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In connection with the completion of the Merger, the company issued replacement awards to the holders of PRA equity awards on July 1, 2021. An exchange of share-based compensation awards in a business combination is treated as a modification under ASC 718. The replacement awards and the original acquiree awards are measured at fair value at the acquisition date and calculated using the fair-value-based measurement principles in ASC 718. Amounts attributable to pre-combination vesting are accounted for as part of the consideration transferred for the acquiree. Amounts attributable to post-combination vesting are accounted for separate from the business combination and are recognized as compensation cost in the post-combination period.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Restructuring charges reflect certain one-time costs arising from reorganization programs announced by Company management. These programs generally result in asset impairments and workforce reductions in order to optimize the Company’s structure and facilitate improved long-term performance. Impairment charges are taken when the value-in-use of the asset is less than the asset’s carrying value. Workforce related charges are taken when an approved reorganization program is communicated to the relevant employee groups.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Redeemable noncontrolling interests and equity</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company acquired a majority ownership interest in MeDiNova during the year ended December 31, 2019. Included in the purchase agreement were put and call option arrangements with the noncontrolling interest holders that required (put option) or enabled (call option) the Company to purchase the remaining minority ownership at a future date. The option was accounted for as temporary equity, which is presented separately as redeemable noncontrolling interest on the Consolidated Balance Sheet. This classification reflects the assessment that the instruments are contingently redeemable in accordance with ASC 480-10-S99 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Distinguishing Liabilities from Equity'. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 9, 2020, ICON exercised its option to call the remaining shares and took 100% ownership of MeDiNova. </span></div>Redeemable noncontrolling interests are accreted to their redemption value over the period from the date of issuance to the first date on which the option is exercisable. The change in the option's redemption value is recorded against retained earnings. In a computation of earnings per share, the accretion of redeemable noncontrolling interests to their redemption value is a reduction of net income attributable to the Group. Basic and diluted net income per ordinary share attributable to the Group includes the adjustment to reflect the accretion of the noncontrolling interest to its redemption value until the redemption of the noncontrolling interest on March 9, 2020. 1 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:112%">Net income per ordinary share</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Company has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. There is no difference in net income used for basic and diluted net income per ordinary share. Basic and diluted net income per ordinary share attributable to the Company includes the adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Most notably, the Company has presented transaction and integration-related expenses as a separate line in the Consolidated Statement of Operations and reclassified certain costs incurred in the year ended December 31, 2020 within this line. These costs consist of transaction and integration-related expenses and contingent consideration valuation adjustments related to ICON's prior period acquisitions. These costs were previously presented in the selling, general and administrative expenses but have been reclassified to transaction and integration-related expenses to conform to the current period’s presentation.</span></div> <div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Impact of Recently Issued or Adopted Accounting Standards</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective has had, or is expected to have, a significant impact on the Company’s consolidated financial statements.</span></div> Disaggregation of Revenue<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Our customers have similar profiles and economic characteristics, and therefore have similar degrees of risk and growth opportunities.Contract Balances<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,046 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. We record assets for amounts related to performance obligations that are satisfied but not yet billed and/or collected. These assets are recorded as unbilled revenue and therefore contract assets rather than accounts receivable when receipt of the consideration is conditional on something other than the passage of time. Liabilities are recorded for amounts that are collected in advance of the satisfaction of performance obligations or billed in advance of the revenue being earned. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services/revenue balances arise where invoicing or billing is based on the timing of agreed milestones related to service contracts for clinical research. Contractual billing arrangements in respect of certain reimbursable expenses (principally investigators) require billing by the investigator to the Company prior to billing by the Company to the customer. As there is no contractual right of set-off between unbilled services (contract assets) and unearned revenue (contract liabilities), each are separately presented gross on the Consolidated Balance Sheet. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is the contract principal in respect of both direct services and in the use of third parties (principally investigator services) that support a clinical trial. The progress towards completion for clinical service contracts is measured based on total project costs (including reimbursable costs). Amounts owed to investigators and others in respect of reimbursable expenses at December 31, 2022 and December 31, 2021 were $406.3 million and $323.6 million (see</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> note 12 - Other liabilities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services as at December 31, 2022 increased by $334.5 million as compared to December 31, 2021. Unearned revenue increased by $183.5 million over the same period resulting in a decrease of $151.0 million in the net balance of unbilled services and unearned revenue or payments on account between December 31, 2021 and December 31, 2022. These fluctuations are primarily due to the completion of the Merger on July 1, 2021 but are also partially due to timing of payments and invoicing related to the Group's clinical trial management contracts. Billings and payments are established by contractual provisions including predetermined payment schedules which may or may not correspond to the timing of the transfer of control of the Company's services under the contract. Unbilled services arise from long-term contracts when a cost-based input method of revenue recognition is applied and revenue recognized exceeds the amount billed to the customer. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit loss expense recognized on the Group's receivables and unbilled services was $17.8 million and $0.9 million for the twelve months ended December 31, 2022 and 2021, respectively.</span></div>As of December 31, 2022 approximately $13.7 billion of revenue is expected to be recognized in the future in respect of unsatisfied performance obligations compared to $13.3 billion as of December 31, 2021. As of December 31, 2022 the Company expects to recognize revenue on approximately 52% of the unrealized performance obligation over the next twelve months compared to 48% as of December 31, 2021, with the remainder recognized thereafter over the duration of the customer contracts. <div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue disaggregated by customer profile is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.126%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.206%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.062%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top client</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">683,546 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">441,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">337,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 2-5</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506,087 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,291,946 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 6-10</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,636 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">752,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clients 11-25</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,585,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077,073 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853,378 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,918,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">851,970 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$7,741,386</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5,480,826</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,797,288</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 683546000 441173000 337904000 1506087000 1291946000 754906000 1112636000 752325000 350865000 1585739000 1077073000 501643000 2853378000 1918309000 851970000 7741386000 5480826000 2797288000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable and unbilled revenue are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Billed services (accounts receivable)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,751,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,349,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for credit losses (note 5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,081)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable (net)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,731,388 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,342,770 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689,043 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,965,891 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unbilled services and unearned revenue or payments on account (contract assets and liabilities) were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unbilled services (unbilled revenue)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">957,655 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue (payments on account)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,507,449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,323,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183,488)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(549,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(700,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,046 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 1751950000 1349851000 20562000 7081000 1731388000 1342770000 957655000 623121000 2689043000 1965891000 957655000 623121000 334534000 0.537 1507449000 1323961000 183488000 0.139 -549794000 -700840000 151046000 0.216 406300000 323600000 334500000 183500000 151000000 17800000 900000 13700000000 13300000000 0.52 P12M P12M 0.48 Allowance for Credit Losses<div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December 31, 2022 and December 31, 2021 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company does business with most major international pharmaceutical companies. Provision for credit losses at December 31, 2022 and December 31, 2021 comprises:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,149 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts used during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts provided during the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts released during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing provision</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,562 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,081 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7081000 7149000 3913000 116000 17800000 705000 0 544000 -406000 -113000 20562000 7081000 Business Combinations<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Health Sciences, Inc. Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021 (the "Merger Date"), the Company completed the Acquisition of PRA by means of a merger whereby Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON, merged with and into PRA Health Sciences, Inc., the parent of the PRA Health Sciences ("the Acquisition" and "the Merger"). The combined Group has retained the name ICON and brought together approximately 38,000 (as at the Merger date) employees across the globe, creating the world's largest clinical research organization with a singular focus on clinical research and commercialization. The Merger was accounted for as a business combination using the acquisition method of accounting in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The combined Company leverages its enhanced operations to transform clinical trials and accelerate biopharma customers’ commercial success through the development of much needed medicines and medical devices. The new ICON has a renewed focus on leveraging data, applying technology and accessing diverse patient populations to speed up drug development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Upon completion of the Merger, pursuant to the terms of the Merger Agreement, PRA became a wholly owned subsidiary of the ICON Group. Under the terms of the Merger, PRA shareholders received per share $80 in cash and 0.4125 shares of ICON stock. The trading of PRA common stock on NASDAQ was suspended prior to market open on July 1, 2021. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the years ended December 31, 2022 and 2021, the Company incurred Merger-related expenses of $39.7 million and $198.3 million, respectively, which were accounted for separately from the business combination and expensed as incurred within the “Transaction and integration related” line item of the Consolidated Statement of Operations. These costs consist primarily of investment banker fees, advisory fees, legal costs, accounting and consulting fees, share-based compensation expense, and employee retention bonuses. Included in transaction and integration costs in the years ended December 31, 2022 and 2021 are acquisition related costs (as defined by ASC 805) of $0.8 million and $57.1 million, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company also incurred approximately $86.7 million of Merger-related financing fees which are included in the “Interest expense” line item in the Consolidated Statement of Operations for the year ended December 31, 2021. During the year ended December 31, 2021, the Company deferred </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$76.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> of financing costs incurred as a result of the Senior Secured Credit Facility and Senior Secured Notes. These costs will be amortized over the term of the related debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At June 30, 2022, the Company completed its review of the July 1, 2021 acquisition balance sheet of PRA and completed the final valuation associated with certain assets acquired and liabilities assumed. In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December 31, 2022, the Company incurred $2.2 million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0 million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div> 38000 80 0.4125 39700000 198300000 800000 57100000 86700000 76200000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Merger Date fair value of the consideration transferred consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of cash consideration</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,308,646 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of ordinary shares issued to acquiree stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,658,126 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of replacement share-based awards issued to acquiree employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan obligations and accrued interest *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">865,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* This represents the portion of PRA debt paid by ICON. PRA also paid $401.6 million from available cash to settle debt obligations that existed at the Merger Date.</span></div> 5308646000 5658126000 209399000 865800000 12041971000 401600000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the consideration transferred based on the Merger Date fair values of assets acquired and liabilities assumed, with the excess of the purchase price over the estimated fair values of the identifiable net assets acquired recorded as goodwill:</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.782%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.018%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259,971 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">934,308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,156 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">156,851 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,084,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,190 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,928 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(739,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,119,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(204,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,041,971 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* The goodwill in connection with the Merger is primarily attributable to the assembled workforce of PRA and the expected synergies of the Merger. None of the goodwill recognized is deductible for income tax purposes.</span></div> 259971000 934308000 125156000 156851000 180601000 8084314000 4919000000 25190000 33928000 50259000 380048000 36506000 739278000 147204000 1119762000 204291000 12041971000 0 <div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes the fair value of identified intangible assets and their respective useful lives as of the Merger Date (in thousands, except for estimated useful lives):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:44.434%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.132%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.134%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,938,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,919,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div> 3938000000 P23Y 500000000 P3Y 202000000 P3Y 168000000 P7Y 111000000 P5Y 4919000000 In the period since the Merger Date, the Company recognized certain measurement period adjustments as shown in the table below:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.515%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement period adjustments</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,039)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,865 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue **</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,623 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,454 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193,837 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151,098)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> * In the year ended December 31, 2022, the Company incurred $2.2 million amortization which related to the year ended December 31, 2021 due to the timing of when the measurement period adjustment was identified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** The unearned revenue measurement period adjustment also includes $16.0 million as a result of the early adoption of ASU 2021-08 'Business Combinations (Topic 805) - Accounting for Contract Assets and Contract Liabilities from Contracts with Customers' in Quarter 4 2021.</span></div> 0 0 14465000 -6137000 -11744000 70436000 44000000 -147039000 -1166000 0 -37496000 1865000 19623000 10454000 193837000 -151098000 2200000 16000000 Fair Value<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company records certain assets and liabilities at fair value. Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy that prioritizes the inputs used to measure fair value is described below. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 1 — Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">Level 3 — Unobservable inputs that are supported by little or no market activity. This includes certain pricing models, discounted cash flow methodologies, and similar techniques that use significant unobservable inputs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable, unbilled services, contract assets, accounts payable, and unearned revenue approximate fair value due to the short maturities of these instruments. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-recurring Fair Value Measurements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain assets and liabilities are carried on the accompanying Consolidated Balance Sheet at cost and are not re-measured to fair value on a recurring basis. These assets include finite-lived intangible assets that are tested for impairment when a triggering event occurs and goodwill that is tested for impairment annually or when a triggering event occurs. As of December 31, 2022, assets carried on the balance sheet and not re-measured to fair value on a recurring basis totaled approximately $13,250.4 million and are identified as Level 3 assets. These assets are comprised of goodwill of $8,971.7 million and identifiable intangible assets, net of $4,278.7 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the fair value of total debt approximated $4,650.3 million and $5,507.2 million, respectively, as determined under Level 2 measurement for these financial instruments.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the fair value of the major classes of the Company's assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,713 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,663 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,388 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivative instruments (c)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,670</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2021, the fair value of the major classes of the Company's assets measured at fair value on a recurring basis were as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments Measured at Net Asset Value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale securities (short-term) (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available for sale investments (long-term) (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,712 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,579 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,291 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a) Represents the fair value of investments in highly liquid investments with maturities of greater than three months and a minimum "A-" rated fixed term deposits and are based on quoted market prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b) To determine the classification of its interests in long-term investments, the Company considered the nature of its investment, the extent of influence over operating and financial decisions and the availability of readily determinable fair values. The Company determined that the interests in funds at December 31, 2022 and December 31, 2021 meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 and December 31, 2021 qualify for the Net Asset Value (NAV) practical expedient in ASC 820 'Fair value measurements and disclosures'. Any increases or decreases in fair value are recognized in net income in the period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c) Represents the fair value of interest rate cap and interest rate swap agreements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The fair value of the agreements are the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities or using market inputs with mid-market pricing as a practical expedient for bid-ask spread. The Company held no derivative instruments at December 31, 2021.</span></div> 1713000 0 0 0 1713000 0 0 0 32663000 32663000 0 12000 0 0 12000 1713000 12000 0 32663000 34388000 0 3670000 0 0 3670000 0 3670000 0 0 3670000 1712000 0 0 0 1712000 0 0 0 20579000 20579000 1712000 0 0 20579000 22291000 13250400000 8971700000 4278700000 4650300000 5507200000 Investments<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(a)     Available for sale investments (short-term)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company held $1.7 million of available for sale investments at both December 31, 2022 and December 31, 2021. The Company classifies its investment in short term investments as available for sale. Short term investments comprise highly liquid investments with maturities of greater than three months and minimum "A-" rated fixed term deposits. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Short term investments at December 31, 2022 have an average maturity of 2.8 years compared to 2.7 years at December 31, 2021. The contractual maturity of certain investments in the portfolio is greater than 12 months; however, classification as short-term investments reflects the Company practice and intention in respect of these investments. The Company recognizes the unrealized losses at fair value in equity as these unrealized losses on short term investments have been considered as temporary.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(b)    Available for sale investments (long-term)</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company entered into subscription agreements with a number of funds. Capital totaling $20.6 million had been advanced under the terms of the subscription agreements at December 31, 2022 (December 31, 2021: $16.9 million). The Company determined that the interests in the funds meet the definition of equity securities without readily determinable fair values. The Company concluded that the interests held at December 31, 2022 qualify for the NAV practical expedient in ASC 820 '</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value measurements and disclosure</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">s'. These are therefore measured at Level 3 of the fair value hierarchy. There was an increase in fair value of $6.3 million (December 31, 2021: $3.2 million) recognized in net income during the year bringing the carrying value of the subscriptions to $32.6 million at December 31, 2022 (December 31, 2021: $22.6 million).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span>December 31, 2022, the Company had committed to future investments of $23.3 million in respect of these funds.<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(c)     Equity method investments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company’s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Consolidated Statement of Operations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December 31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued development of the business operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. The outstanding balance of the Company's loan receivable with Oncacare at December 31, 2022 is $9.2 million.</span></div> 1700000 1700000 P2Y9M18D P2Y8M12D 20600000 16900000 6300000 3200000 32600000 22600000 23300000 4900000 0.49 0.51 P18M 0.51 <div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table represents our equity method investments at December 31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.813%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ownership Percentage</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Oncacare Limited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,373 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div> 0.49 0 2373000 10000000 0.016 -3100000 -2200000 -2300000 800000 9200000 Property, Plant and Equipment, net<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December 31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment depreciation expense is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company regularly updates its register of property, plant and equipment and during the year ended December 31, 2022 and the year ended December 31, 2021, certain fully depreciated assets were written off as they were no longer used in the Company.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Property, Plant and Equipment for the years ended December 31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,724 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Building</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">506,322 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,210 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Motor vehicles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">750,493 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">798,968 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation and asset write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(400,173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(462,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment (net)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">350,320 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">336,444 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property, Plant and Equipment depreciation expense is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,426 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,484 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3724000 3724000 70880000 82017000 500135000 506322000 50600000 107507000 59946000 29210000 65167000 70123000 41000 65000 750493000 798968000 400173000 462524000 350320000 336444000 106426000 75484000 Goodwill<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of Goodwill for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There were no goodwill impairment losses for the years ended December 31, 2022 and 2021.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in the carrying amount of Goodwill for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year acquisitions (note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,120,006 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior period acquisition (note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,692)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange movement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Closing goodwill</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971,670 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,037,931 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 9037931000 936257000 0 8120006000 -35692000 0 -30569000 -18332000 8971670000 9037931000 0 0 Intangible Assets<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Intangible Assets for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,076,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,056,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Order backlog</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">536,934 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">528,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade names &amp; brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient database</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,238 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,525 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,109,212 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,081,381 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370,538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net book value</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,278,659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,710,843 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, ICON plc announced the completion of its Merger with PRA Health Sciences, Inc. The Merger resulted in the recognition of Customer relationships of $3,938.0 million, Order backlog of $500.0 million, Trade names of $202.0 million, Patient database of $168.0 million and Technology assets of $111.0 million. These assets will be amortized over their expected useful lives of between 3 and 23 years. The valuation of these assets were finalized in June 30, 2022. In total, $677.1 million has been amortized in the period since the date of acquisition, $453.6 million has been amortized in the year ended December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,432,306 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4076435000 4056642000 536934000 528022000 204621000 204685000 170238000 170525000 120984000 121507000 5109212000 5081381000 830553000 370538000 4278659000 4710843000 3938000000 500000000 202000000 168000000 111000000 P3Y P23Y 677100000 453600000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future intangible asset amortization expense for the years ended December 31, 2023 to December 31, 2027 is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460,711 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339,940 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,300 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,432,306 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 460711000 339940000 223674000 209681000 198300000 1432306000 Other Liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December 31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December 31, 2022 and $323.6 million at December 31, 2021.</span></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Other Liabilities for the years ended December 31, 2022 and 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General trade and overhead liabilities*</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">530,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">459,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personnel related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">395,862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413,185 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,657 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Facility related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,896 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,852 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,512 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short term government grants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,005,025 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949,629 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*includes amounts due to third parties in respect of accrued reimbursable investigator expenses of $406.3 million at December 31, 2022 and $323.6 million at December 31, 2021.</span></div> 530204000 459814000 395862000 413185000 43657000 49949000 16896000 12055000 12852000 7204000 5512000 7377000 42000 45000 1005025000 949629000 406300000 323600000 Non-current Bank Credit Lines and Loan Facilities<div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December 31, 2022 and 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less long-term portion of debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company paid a $27.6 million debt discount in connection with the Senior Secured Credit Facility and Senior Secured Notes on July 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company incurred interest costs from various financing arrangements during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 as set out in the table below. These costs have been charged in the interest expense line of the Consolidated Statement of Operations. In the years ending December 31, 2022 and December 31, 2021, the Company expensed $17.7 million and $86.7 million of transaction related financing costs (inclusive of the amortization of financing fees which were previously capitalized) associated with the debt facilities used to finance the Merger.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,701,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's primary financing arrangements are its senior secured credit facilities (the "Senior Secured Credit Facilities"), which consists of a senior secured term loan and a revolving credit facility, and the senior secured notes (the "Senior Secured Notes").</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In conjunction with the completion of the Merger Agreement, on July 1, 2021, ICON entered into a credit agreement providing for a senior secured term loan facility of $5,515 million and a senior secured revolving loan facility in an initial aggregate principal amount of $300 million (the "Senior Secured Credit Facilities"). The proceeds of the senior secured term loan facility were used to repay in full (i) PRA’s existing credit facilities and (ii) the Company's notes and fund, in part, the Merger. The senior secured term loan facility will mature in July 2028 and the senior secured revolving loan facility will mature in July 2026. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The credit agreement governing the Senior Secured Credit Facilities provides that borrowings denominated in U.S. Dollars will bear interest based on LIBOR or the base rate (as elected by the borrower), plus an applicable margin. On the 29th of November 2022, the Company agreed with its lenders to the early adoption of Term SOFR as the reference rate within the Credit Agreement ahead of the June 2023 USD LIBOR cessation date. LIBOR is no longer an applicable reference rate available to the Company under the terms of the Credit Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Borrowings under the senior secured term loan facility amortize in equal quarterly installments in an amount equal to 1.00% per annum of the principal amount, with the remaining balance due at final maturity. The interest rate margin applicable to borrowings under the senior secured term loan facility is USD Term SOFR and a Term SOFR Adjustment depending on the interest period chosen plus an applicable margin of 2.25%. The senior secured term loan facility is subject to a floor of 0.50%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The interest rate margin applicable to borrowings under the revolving loan facility will be, at the option of the borrower, either (i) the applicable base rate plus an applicable margin of 1.00%, 0.60% or 0.25% based on ICON’s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively, or (ii) Term SOFR plus a Term SOFR Adjustment on the interest period chosen plus an applicable margin of 2.00%, 1.60% or 1.25% based on ICON’s current corporate family rating assigned by S&amp;P of BB- (or lower), BB or BB+ (or higher), respectively. In addition, lenders under the revolving loan facility are entitled to commitment fees as a percentage of the applicable margin at the time of drawing and utilization fees dependent on the proportion of the facility drawn. At December 31, 2022, $300.0 million remained undrawn under the senior secured revolving loan facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Borrowers’ (as defined in the Senior Secured Credit Facility) obligations under the Senior Secured Credit Facilities are guaranteed by ICON and the subsidiary guarantors. The Senior Secured Credit Facilities are secured by a lien on substantially all of ICON’s, the Borrowers’ and each of the subsidiary guarantor’s assets (subject to certain exceptions), and the Senior Secured Credit Facilities will have a first-priority lien on such assets, which will rank pari passu with the lien securing the Senior Secured Notes, subject to other permitted liens. The Company is permitted to make prepayments on the senior secured term loan without penalty. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $66.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.8 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 30, 2022, the Company repaid $200.0 million of the senior secured term loan facility and made a quarterly interest payment of $53.6 million. This repayment resulted in an additional charge associated with previously capitalized fees of $1.9 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On June 30, 2022, the Company repaid $100.0 million of the senior secured term loan facility and made a quarterly interest payment of $39.4 million. This repayment resulted in an additional charge associated with previously capitalized fees of $0.9 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On March 31, 2022, the Company repaid $300.0 million of the senior secured term loan facility and made a quarterly interest payment of $35.1 million. This repayment resulted in an additional charge associated with previously capitalized fees of $3.2 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December 29, 2021, the Company repaid $500.0 million of the senior secured term loan facility and made a quarterly interest payment of $40.8 million. This repayment resulted in an additional charge associated with previously capitalized fees of $5.6 million. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 27, 2021, the Company repaid $13.8 million of the senior secured term loan facility and made a quarterly interest payment of $40.4 million. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Notes</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In addition to the Senior Secured Credit Facilities, on July 1, 2021, a subsidiary of the Company issued $500 million in aggregate principal amount of 2.875% senior secured notes due 2026 in a private offering (the “Offering”). The Senior Secured Notes will mature on July 15, 2026. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Debt</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated fair value of the Company’s debt was $4,650.3 million and $5,507.2 million at December 31, 2022 and December 31, 2021, respectively. The fair values of the Senior Secured Credit Facilities and Senior Secured Notes were determined based on Level 2 inputs, which are based on rates at which the debt is traded among financial institutions.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company had the following debt outstanding as of December 31, 2022 and 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest rate as of</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.092 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,201,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,001,213 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2028</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Secured Notes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">500,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2026</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,701,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,501,213 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less current portion of long-term debt and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,646,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,446,063 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less long-term portion of debt issuance costs and debt discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term debt, net</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,599,037 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,381,162 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div> 0.07092 0.02750 4201213000 5001213000 0.02875 0.02875 500000000 500000000 4701213000 5501213000 55150000 55150000 4646063000 5446063000 47026000 64901000 4599037000 5381162000 27600000 17700000 86700000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense on drawn facilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">209,189 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,809 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,749 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">523 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and one time financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing costs/(credits)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total financing costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229,731 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,019 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 209189000 93809000 13406000 17749000 12890000 523000 0 75391000 0 2793000 333000 -910000 229731000 182423000 13019000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2022, the contractual maturities of the Company's debt obligations were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current maturities of long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,480,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,701,213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 55150000 55150000 55150000 55150000 4480613000 4701213000 5515000000 300000000 0.0100 0.0225 0.0050 0.0100 0.0060 0.0025 0.0200 0.0160 0.0125 300000000 200000000 66100000 1800000 200000000 53600000 1900000 100000000 39400000 900000 300000000 35100000 3200000 500000000 40800000 5600000 13800000 40400000 500000000 0.02875 4650300000 5507200000 Derivatives<div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company has entered into interest rate cap and swap agreements for purposes of managing its exposure to interest rate fluctuations. These financial derivative agreements are designated as Cash Flow Hedges.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into two interest rate cap agreements ("2022 Caps") with an initial total notional value of $2,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Caps began accruing on December 30, 2022 and the interest rate cap expires on December 31, 2024. The Company pays a fixed rate of 0.42% and receives a variable rate equal to the amount that the three-month SOFR rate exceeds 4.75%.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">On November 29, 2022, the Company entered into an interest rate swap agreement ("2022 Swap") with an initial notional value of $1,101 million to limit its exposure to changes in the variable interest rate on its Senior Secured Credit Facilities. Interest on the 2022 Swaps begins accruing on December 31, 2024 and the interest rate swap expires on December 31, 2026. The Company pays a fixed rate of 3.4% and receives a variable rate of interest equal to the three-month SOFR on the 2022 Swap.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The critical terms of the caps and swap are substantially the same as the underlying borrowings. The interest rate caps and swap are accounted for as cash flow hedges as these transactions were executed to hedge the Company's interest payments and for accounting purposes are considered highly effective. As such, the effective portion of the hedges is recorded as unrealized gains (losses) on derivatives in Accumulated Other Comprehensive Income.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of these cash flow hedges represents the present value of the anticipated net payments the Company will make to the counterparty, which, when they occur, are reflected as interest expense on the consolidate statement of income. </span></div><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company’s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"/><td style="width:20.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,201,213</span></td></tr></table></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">During 2023, the Company estimates that an additional $3.3 million will be reflected as interest expense in the consolidated statements.</span></div><div style="text-align:justify;text-indent:14.4pt"><span><br/></span></div><div style="text-align:justify;text-indent:14.4pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">At December 31, 2021 the fair value of the Company's derivative financial instruments was $nil as the Company had no outstanding derivative financial instruments. </span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The Company recognized $0.1 million of gain within OCI and reclassified $0.1 million of gain from OCI to the income statement for the year end December 31, 2022.</span></div> 2 2101000000 0.0042 0.0475 1101000000 0.034 <div style="text-indent:14.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The fair value of the Company’s derivative financial instruments, on a gross basis, and the line items on the accompanying consolidate balance sheets to which they were recorded are summarized in the following table:</span></div><div style="text-indent:14.25pt"><span><br/></span></div><div style="text-indent:14.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.081%"><tr><td style="width:1.0%"/><td style="width:20.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Notional</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Caps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,363</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2,100,606</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest Rate Swap</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Other Assets and Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$—</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$307</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">1,100,606</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Total derivatives designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$12</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">$3,670</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3,201,213</span></td></tr></table></div> 12000 3363000 2100606000 0 307000 1100606000 12000 3670000 3201213000 -3300000 0 0 100000 100000 Operating Leases<div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases as of December 31, 2022 and 2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Of the total cost of $52.7 million incurred in the year ended December 31, 2022, $48.3 million is recorded within selling, general and administration costs and $4.4 million is recorded within direct costs. Of the total cost of $49.9 million incurred in the year ended December 31, 2021, $47.5 million is recorded within selling, general and administration costs and $2.4 million is recorded within direct costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Right-of-use assets obtained, in exchange for lease obligations, net of early termination options now reasonably certain to be exercised, during the years ended December 31, 2022 and December 31, 2021 totaled $28.7 million and $10.2 million, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and December 31, 2021, impairments of operating right-of-use assets were recognized within restructuring charges for $24.8 million and $15.4 million, respectively, as part of an office consolidation program (see </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 19 - Restructuring Charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining lease term and weighted-average discount rate at December 31, 2022 were 6.90 years and 2.45%, respectively. The weighted average remaining lease term and weighted-average discount rate at December 31, 2021 were 6.91 years and 2.51%, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December 31, 2022 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,668 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities are presented as current and non-current. Operating lease liabilities of $43.7 million and $49.9 million have been included in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_4e96e968-9c11-40fd-a303-2bb58d8fbc29"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU0YWJhNjU0NzRjYTQ5ZjE4ZDI5YjM4ZDcxN2ZiNWQ0L3NlYzplNGFiYTY1NDc0Y2E0OWYxOGQyOWIzOGQ3MTdmYjVkNF8yMzgvZnJhZzo4M2FmNjkyMmFlODQ0MGQ4OTI5YjcyMjEwYzI5OWExYy90ZXh0cmVnaW9uOjgzYWY2OTIyYWU4NDQwZDg5MjliNzIyMTBjMjk5YTFjXzE1MTM_7797f20c-d0da-447d-8e1d-a6a60da2da46">other liabilities</span></span> as at December 31, 2022 and December 31, 2021, respectively.</span></div> <div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Lease costs recorded under operating leases as of December 31, 2022 and 2021 were as follows:</span></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,880 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from sub-leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating lease costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,715 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,862 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 53880000 51200000 1165000 1338000 52715000 49862000 52700000 48300000 4400000 49900000 47500000 2400000 28700000 10200000 24800000 15400000 P6Y10M24D 0.0245 P6Y10M28D 0.0251 <div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable leases as of December 31, 2022 were as follows: </span></div><div style="margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Minimum rental </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,479 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total future minimum lease payments </span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,668 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175,301 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 47479000 34400000 25045000 20430000 17249000 45065000 189668000 14367000 175301000 43700000 49900000 Non-current other liabilities<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The carrying amount of Non-current other liabilities for the years ended December 31, 2022 and 2021 is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Defined benefit pension obligations, net (note 21)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,262 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,260 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,596 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 13033000 16262000 25227000 26334000 38260000 42596000 Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not expect any litigation to have a materially adverse effect on our financial condition or results of operations. However, from time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has several non-cancelable operating leases, primarily for facilities, that expire over the next twelve years. These leases generally contain renewal options and require the Company to pay all executory costs such as maintenance and insurance. See </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">note 15 - Operating leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for rental expense pursuant to ASC 842 for the years ended December 31, 2022 and December 31, 2021 and future minimum rental commitments as of December 31, 2022.</span></div> P12Y Share CapitalHolders of ordinary shares are entitled to receive such dividends as may be recommended by the Board of Directors of the Company and approved by the shareholders and/or such interim dividends as the Board of Directors of the Company may decide. On liquidation or a winding up of the Company, the par value of the ordinary shares are repaid out of the assets available for distribution among the holders of the ordinary shares of the Company. Holders of ordinary shares have no conversion or redemption rights. On a show of hands, every holder of an ordinary share present in person or proxy at a general meeting of shareholders shall have one vote, for each ordinary share held with no individual having more than one vote. <div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Employee share based payments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, 348,286 options were exercised by employees at an average exercise price of $102.87 per share for total proceeds of $35.8 million. During the year ended December 31, 2022, 195,029 ordinary shares were issued in respect of certain RSUs and 46,087 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, 1,065,529 options were exercised by employees at an average exercise price of $111.29 per share for total proceeds of $118.6 million. During the year ended December 31, 2021, 446,404 ordinary shares were issued in respect of certain RSUs and 44,132 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. In accordance with the terms of the Merger Agreement, the Company issued 27,372,427 shares of the Company’s ordinary share capital at par value in exchange for all outstanding PRA shares of common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    During the year ended December 31, 2020, 193,417 options were exercised by employees at an average exercise price of $68.19 per share for total proceeds of $13.2 million. During the year ended December 31, 2020, 144,172 ordinary shares were issued in respect of certain RSUs and 63,516 ordinary shares were issued in respect of PSUs previously awarded by the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.02pt">Share Repurchase Program</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A resolution was passed at the Company’s Annual General Meeting (“AGM”) on July 22, 2016, which authorized the Directors to purchase (buyback) up to 10% of the outstanding shares in the Company. This authorization was renewed at the Company's AGM on each of July 25, 2017, July 24, 2018, July 23, 2019, July 21, 2020, July 20, 2021 and July 26, 2022. On October 3, 2016, the Company commenced a share buyback program of up to $400 million. The share buyback program was completed during the year ended December 31, 2018 with a total of 4,026,576 ordinary shares redeemed for a total consideration of $372.1 million. On January 8, 2019, the Company commenced a further share buyback program of up to 1.0 million ordinary shares which was completed during the year ended December 31, 2019. These shares were redeemed by the Company for a total consideration of $141.6 million. On October 22, 2019, the Company commenced a further share buyback program. At December 31, 2019, 35,100 ordinary shares were redeemed by the Company for a total consideration of $5.3 million. During the year ended December 31, 2020, 1,235,218 ordinary shares were redeemed by the Company under this buyback program for a total consideration of $175.0 million. On February 18, 2022, the Company commenced a share buyback program which was fully complete at March 31, 2022. Under this buyback program, 420,530 ordinary shares were redeemed by the Company for total consideration of $100.0 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All ordinary shares that were redeemed under the buyback program were canceled in accordance with the Constitution of the Company and the nominal value of these shares transferred to other undenominated capital as required under Irish Company law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Under the repurchase program, a broker purchased or may purchase the Company's shares from time to time on the open market or in privately negotiated transactions in accordance with agreed terms and limitations. The program was and may be in the future designed to allow share repurchases during periods when the Company would ordinarily not be permitted to do so because it may be in possession of material non-public or price-sensitive information or due to applicable insider trading laws or self-imposed trading blackout periods. The Company's instructions to the broker in such cases were or may in the future be irrevocable and the trading decisions in respect of the repurchase program were made or will be made independently of and uninfluenced by the Company. The Company confirms that on entering the share repurchase plans it had no material non-public, price-sensitive or inside information regarding the Company or its securities. Furthermore, the Company will not enter into additional plans whilst in possession of such information. The timing and actual number of shares acquired by way of the redemption will be dependent on market conditions, legal and regulatory requirements and the other terms and limitations contained in the program. In addition, acquisitions under the program may be suspended or discontinued in certain circumstances in accordance with the agreed terms. Therefore, there can be no assurance as to the timing or number of shares that may be acquired under the program.</span></div> 1 1 348286 102.87 35800000 195029 46087 1065529 111.29 118600000 446404 44132 27372427 193417 68.19 13200000 144172 63516 0.10 400000000 4026576 372100000 1000000 141600000 35100 5300000 1235218 175000000 420530 100000000 Restructuring Charges<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A restructuring charge of $31.1 million was recognized during the year ended December 31, 2022 under a restructuring plan adopted following a review of operations. The restructuring plan reflected resource rationalization across the business to improve employee utilization and an office consolidation program to optimize the Company's office footprint. The restructuring plan resulted in a charge of $2.7 million relating to workforce reductions, an impairment of right-of-use assets and associated unavoidable costs totaling $24.5 million and fixed asset impairment of $4.0 million. It is company policy to disclose operating right-of-use asset impairment as a restructuring charge when it is part of a coordinated program to decommission space.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2022, a total liability of $6.0 million was recorded on the Consolidated Balance Sheet relating to restructuring activities. The total liability included $1.4 million of facilities related liabilities of which $0.9 million is included within other liabilities and $0.5 million is included within non-current other liabilities. The remaining provision of $4.6 million relates to workforce reduction and is included within other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table></div> 31100000 2700000 24500000 4000000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net charge</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,143 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,105 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,089 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 31143000 31105000 18089000 31143000 31105000 18089000 6000000 1400000 900000 500000 4600000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.106%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Opening provision</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional provision in the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,364 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Utilization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending provision</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,022 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr></table> 10311000 4675000 4364000 11273000 8653000 5637000 6022000 10311000 Income Taxes<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States and Irish based subsidiaries file income tax returns in the United States and Ireland respectively. Other foreign subsidiaries are taxed separately under the laws of their respective countries.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ireland's statutory income tax rate is 12.5%. The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,016 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2022 Ireland subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available for offset against future tax liabilities, if any, of $16.6 million.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2022 U.S. subsidiaries had U.S. federal and state net operating loss ("NOL") carryforwards of approximately $5.4 million and $401.9 million, respectively. These NOLs are available for offset against future taxable income and the expiry dates are shown in the table below. Of the $5.4 million U.S. federal NOLs, approximately $3.5 million is available for offset against future U.S. federal taxable income in 2023. The subsidiaries' ability to use the remaining U.S. federal and state NOL carryforwards is limited on an annual basis due to change of ownership in 2014, 2017, and 2019, as defined by Section 382 of the Internal Revenue Code of 1986, as amended. Of the U.S. federal NOLs, $5.3 million are limited by Section 382 for the years 2023 - 2036. As of December 31, 2022, U.S subsidiaries also had disallowed interest carryforwards of $93.0 million that can be carried forward indefinitely. These carryforwards are available for offset against future taxable income in the event that the U.S subsidiaries have excess capacity for interest deductions in future years. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected expiry dates of the US NOLs are as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023-2036</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,268 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033-2041</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,736 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, we also have general business tax credit carryforwards of approximately $0.8 million that are available to reduce future U.S. federal and state income taxes. The general business tax credits are non-refundable and are due to expire between the years 2026-2038.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">At December 31, 2022 other than those in the U.S. and Ireland, we had operating loss carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future taxable income, if any, of approximately $37.9 million. At December 31, 2022 those subsidiaries also had additional operating loss carryforwards of $14.8 million which are due to expire between 2023 and 2029 and operating loss carryforwards of $18.2 million which are due to expire between 2030 and 2039. In addition, at December 31, 2022 those subsidiaries had tax credit carryforwards for income tax purposes that may be carried forward indefinitely, available to offset against future tax liabilities, if any, of $4.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowance at December 31, 2022 was approximately $43.4 million. The valuation allowance for deferred tax assets as of December 31, 2021 and December 31, 2020 was $45.5 million and $32.8 million respectively. The net change in the total valuation allowance was a decrease of $2.1 million during 2022 and an increase of $12.8 million during 2021. Of the total decrease of $2.1 million in 2022, $0.8 million was recognized within income tax expense and a decrease of $1.3 million was recognized in Other Comprehensive Income. Of the total increase of $12.8 million in 2021, $9.3 million was in respect of an acquired entity, $4.4 million was recognized within income tax expenses, and $0.9 million was recognized in Other Comprehensive Income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The valuation allowances at December 31, 2022 and December 31, 2021 were primarily related to operating losses and tax credits carried forward that, in the judgment of management, are not more likely than not to be realized. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, loss utilization, projected future taxable income and mitigation strategies in making this assessment. In respect of deferred tax assets not subject to a valuation allowance, management considers that it is more likely than not that these deferred tax assets will be realized on the basis that there will be sufficient reversals of deferred tax liabilities and taxable income in future periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has recognized a deferred tax liability of $1.6 million (2021: $0.8 million) for investments in foreign subsidiaries where the Company does not consider the earnings to be indefinitely reinvested. For the deferred tax liability not recognized in respect of temporary differences related to investments in foreign subsidiaries which are considered to be indefinitely reinvested, it is not practicable to calculate the exact unrecognized deferred tax liability, however it is not expected to be material as Ireland allows a tax credit in respect of distributions from foreign subsidiaries at the statutory tax rate in the jurisdiction of the subsidiary so that no material tax liability would be expected to arise in Ireland in the event these earnings were ever remitted. In addition, withholding taxes applicable to remittances from foreign subsidiaries would not be expected to be material given Ireland’s tax treaty network and the EU parent subsidiary directive.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The relevant statute of limitations for unrecognized tax benefits totaling $37.9 million could potentially expire during 2023. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in the balance of total unrecognized tax benefits at December 31, 2022 were potential benefits of $217.6 million, which if recognized, would affect the effective rate on income tax from continuing operations. The balance of total unrecognized tax benefits at December 31, 2021 and December 31, 2020 included potential benefits which, if recognized, would affect the effective rate of income tax from continuing operations of $202.1 million and $19.1 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties recognized during the year ended December 31, 2022 amounted to a net charge of $7.1 million (2021: $1.9 million, 2020: ($0.6 million)) and are included within the income tax expense. Total accrued interest and penalties as of December 31, 2022 and December 31, 2021 were $22.6 million and $15.5 million respectively and are included in closing income taxes payable at those dates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our major tax jurisdictions are Ireland and the United States. We may potentially be subjected to tax audits in both our major jurisdictions. In Ireland, tax periods open to audit include the years ended December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. In the United States, tax periods open to audit include the years ended December 31, 2016, December 31, 2017, December 31, 2018, December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022. During such audits, local tax authorities may challenge the positions taken by us in our tax returns.</span></div> <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The components of income before income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">432,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,310 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(270,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(278,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,950 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">405,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Income before income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">567,851 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,680 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381,205 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 432963000 231893000 280310000 -270440000 -278413000 41950000 405328000 243200000 58945000 567851000 196680000 381205000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The components of income tax expense are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,469 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,753 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,478 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,003 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,963 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current tax expense</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184,396 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,950 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,948 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax (benefit)/expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,475)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,717)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,577 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Total deferred tax (benefit)/expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,985)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,616)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">927 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense allocated to continuing operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense was allocated to the following components of other comprehensive income:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency impact on long term funding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,776 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,110 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,943 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 53248000 18469000 28963000 60753000 35478000 3022000 70395000 48003000 14963000 184396000 101950000 46948000 -6166000 553000 1654000 -118475000 -52717000 4577000 -344000 -8452000 -5304000 -124985000 -60616000 927000 59411000 41334000 47875000 7211000 1776000 68000 66622000 43110000 47943000 The Company's consolidated reported income tax expense differed from the amount that would result from applying the Irish statutory rate as set forth below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,980 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,586 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate differential from amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign and other income taxed at higher rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,464 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,273 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,241 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research &amp; development tax incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,243)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Movement in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,101 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,581 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effects of change in tax rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in unrecognized tax benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,392 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact of stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,756)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,083)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,411 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,334 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,875 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 70980000 24586000 47651000 -59330000 -31228000 -2298000 52464000 51273000 10241000 2608000 3120000 1243000 -777000 3101000 3581000 -300000 -128000 108000 8392000 5246000 -1672000 -8756000 -9083000 -5150000 -654000 687000 -3343000 59411000 41334000 47875000 <div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,927 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating right-of-use-assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,449 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,354 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078,302 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,201,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,761 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> <br/>Total deferred tax liabilities recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158,693 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,289,256 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss and tax credits carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,697 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,893 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,846 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,593 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,596 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and unbilled revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,016 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,445 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,565 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,924 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,155 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,417 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297,167 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance for deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,379)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,495)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets recognized</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247,038 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,672 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Overall net deferred tax asset/(liability)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911,655)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,037,584)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10927000 19606000 23260000 33449000 37150000 33354000 1078302000 1201086000 9054000 1761000 1158693000 1289256000 88697000 86893000 6010000 5846000 27593000 36106000 3602000 4596000 64016000 69198000 21862000 25557000 2917000 3445000 66565000 64924000 9155000 602000 290417000 297167000 43379000 45495000 247038000 251672000 911655000 1037584000 16600000 5400000 401900000 5400000 3500000 5300000 93000000 The expected expiry dates of the US NOLs are as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Federal<br/>NOL's</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">State<br/>NOL's</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023-2036</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,268 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,530 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2033-2041</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,736 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401,898 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 5268000 249530000 0 145632000 95000 6736000 5363000 401898000 800000 37900000 14800000 18200000 4700000 43400000 45500000 32800000 -2100000 12800000 -2100000 -800000 -1300000 12800000 9300000 4400000 900000 1600000 800000 <div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of total unrecognized tax benefits is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at start of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to acquired tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,047 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to prior year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Decrease related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,442)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,701 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,613 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,931 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lapse of statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,770)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrecognized tax benefits at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">217,584 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,065 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,078 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 202065000 19078000 20156000 170047000 0 16098000 204000 401000 5442000 1695000 1271000 5701000 18613000 2931000 0 844000 369000 838000 3338000 2770000 217584000 202065000 19078000 37900000 217600000 202100000 19100000 7100000 1900000 600000 22600000 15500000 Employee Benefits<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Defined contribution or profit sharing style plans ("the Plans") are offered in a number of countries. In some cases, these plans are required by local laws or regulations. Certain employees are eligible to participate in the Plans and participants in the Plans may elect to defer a portion of their pre-tax earnings into a pension plan, which is run by an independent party. The Company matches participant's contributions up to certain levels of the participant's annual compensation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's United States operations maintain retirement plans (the "U.S. Plans") that qualify as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code. Participants in the U.S. Plans may elect to defer a portion of their earnings, up to the Internal Revenue Service annual contribution limit. The Company matches participant's contributions at varying amounts, subject to a maximum of 4.5% of the participant's annual compensation. Contributions to this U.S. Plan are recorded, in the year contributed, as an expense in the Consolidated Statement of Operations. Contributions for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 were $30.2 million, $23.7 million and $17.0 million respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Pension and Postretirement Benefit Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company maintains various retirement plans across the Group, many of which are required by local employment laws. The balances recorded to the balance sheet are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition to the specific defined-benefit schemes shown separately below, the Company maintains several other retirement plans which have a cumulative total net obligation of $11.6 million and $8.0 million recorded to non-current liabilities as of December 31, 2022 and December 31, 2021, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICON Development Solutions Limited pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">One of the Company's subsidiaries, ICON Development Solutions Limited, operates a defined benefit pension plan in the United Kingdom for its employees. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022, December 31, 2021 and December 31, 2020, consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> 'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The plan has been closed to new entrants with effect from July 1, 2003.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December 31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December 31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) – plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The estimated net loss and prior service cost for the defined benefit pension plan that will be amortized from accumulated other comprehensive income into net periodic benefit cost over the next year are $0.3 million and $Nil respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit Obligation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December 31, 2022 and December 31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A single discount rate is used which, when used to discount the projected benefit cash flows underlying a pension scheme with a 19 year duration, gives the same result as a full AA corporate bond yield curve.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Actuarial gains on the benefit obligation during 2022 resulted from changes in the assumptions compared to those adopted at December 2021. Changes in the assumptions reflect the changes in market conditions from December 2021 to December 2022 and the actuarial gain is primarily due to the change in</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> the discount rate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Assets</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">During 2022, the scheme's asset strategy changed to align the plan assets more closely with government and diversified bonds. There is no self-investment in employer related assets. The Company’s assumption for the expected return on plan assets was determined by the weighted average of the long-term expected rate of return on each of the asset classes invested as of the balance sheet date. The expected long-term rate of return on assets is 3.8% at December 31, 2022 and December 31, 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plan Asset Fair Value Measurements</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of assets held by the plan are represented by quoted prices in active markets for identical assets and are therefore classified as level 1 investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company expects to contribute $0.1 million to the pension fund in the year ending December 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2028 - 2032</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,614 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected cash flows are estimated figures based on the members expected to retire over the next 10 years assuming no early retirements, withdrawals or commutation of pension for cash. At the present time it is not clear whether annuities will be purchased when members reach retirement or whether pensions will be paid each month out of scheme assets. The cash flows above have been estimated on the assumption that pensions will be paid monthly out of scheme assets. If annuities are purchased, then the expected benefit payments will be significantly different from those shown above.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Aptiv Solutions pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On May 7, 2014 the Company acquired 100% of the common stock of Aptiv Solutions ("Aptiv"). The Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 and December 31, 2021 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 were 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">PRA Switzerland AG pension plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 1, 2021, the Company completed the Acquisition of PRA. PRA Switzerland AG, a subsidiary of the Company has a defined benefit plan covering its employees in Switzerland as mandated by the Swiss government. Benefits are based on the employee's years of service and compensation. Benefits are paid directly by the Company when they become due, in conformity with the funding requirements of applicable government regulations. The plan is managed externally and the related pension costs and liabilities are assessed in accordance with the advice of a professionally qualified actuary. Plan assets at December 31, 2022 consist of units held in independently administered funds. The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 was 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants’ contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants’ contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of the assets above do not include any of the Company's own financial instruments, property occupied by, or other assets used by, the Company.</span></div> 0.045 30200000 23700000 17000000 The balances recorded to the balance sheet are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current other liabilities (note 16)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 6492000 0 13033000 16262000 11600000 8000000 <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded status</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41,813)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,492 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded status as at December 31, 2022 is included in other long-term receivables on the Consolidated Balance Sheet. The funded status as at December 31, 2021 is included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,913)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,558 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,813 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,612 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(489)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rates used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 were 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,620 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">146 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,806 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,643 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,601 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants' contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid and transferred balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(483)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,681 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,964 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The pension costs of this plan are presented in the following tables in accordance with the requirements of ASC 715-60 <span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Defined Benefit Plans – Other Postretirement'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funded surplus/(deficit)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Projected benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,990)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Funded deficit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,973)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The funded deficit at December 31, 2022 and December 31, 2021 are included in non-current other liabilities on the Consolidated Balance Sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in benefit obligation is presented in the following table. The discount rate used in calculating the benefit obligation in years ended December 31, 2022 and December 31, 2021 was 2.3% and 0.4%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in benefit obligation<br/> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,890 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants’ contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(627)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,345 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,990 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.659%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.521%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in plan assets</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,849 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scheme contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plan participants’ contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(844)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,059 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,017 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 19558000 41813000 26050000 36198000 6492000 -5615000 41813000 43988000 117000 134000 672000 665000 19000 23000 514000 489000 18636000 2097000 3913000 411000 19558000 41813000 36198000 34612000 1258000 1171000 -7305000 1176000 70000 91000 19000 23000 514000 489000 -3676000 -386000 26050000 36198000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following amounts were recorded in the Consolidated Statement of Operations as components of the net periodic benefit cost:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,214)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 117000 134000 100000 672000 665000 746000 1258000 1171000 1214000 -228000 -625000 -160000 -241000 253000 -208000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used at the commencement of the year in determining the net periodic pension benefit cost for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following assumptions were used in determining the benefit obligation at December 31, 2022 and December 31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.018 0.015 0.021 0.037 0.034 0.033 0.038 0.034 0.040 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial (gain)/loss - benefit obligation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,097)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss/(gain) – plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,305 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss recognized in net periodic benefit cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,559)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,898)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,256 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 18636000 2097000 -5294000 7305000 -1176000 -878000 228000 625000 160000 -11559000 -3898000 4256000 300000 0 0.049 0.018 0.036 0.037 P19Y <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's pension plan asset allocation is as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Asset Category</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 0.88 0 0.12 0 0 0.24 0 0.37 0 0.39 1 1 0.038 0.038 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Government Bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,887 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diversified Bonds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,782 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Bonds (including 50% high yield bonds)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured Loans and Multi Asset Credit</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,050 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table> 22887000 0 3163000 0 0 8782000 0 13434000 0 13982000 26050000 36198000 100000 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following annual benefit payments, which reflect expected future service as appropriate, are expected to be paid.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Years 2028 - 2032</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,614 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 302000 371000 402000 703000 643000 3614000 P10Y 1 5806000 7643000 5681000 6964000 -125000 -679000 0.023 0.004 7643000 8620000 146000 150000 30000 12000 82000 95000 218000 483000 -23000 -82000 -182000 76000 1527000 484000 145000 261000 5806000 7643000 6964000 7601000 29000 15000 -987000 -238000 114000 128000 82000 95000 182000 -76000 218000 483000 -121000 -230000 5681000 6964000 5345000 4990000 4059000 3017000 -1286000 -1973000 0.023 0.004 4990000 4890000 404000 207000 20000 19000 2396000 135000 844000 0 946000 113000 627000 -1000 48000 149000 5345000 4990000 3017000 2849000 29000 15000 87000 0 325000 135000 2396000 135000 946000 113000 844000 0 -5000 -4000 4059000 3017000 Equity Incentive Schemes and Stock Compensation Charges<div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Share Options</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 21, 2008 the Company adopted the Employee Share Option Plan 2008 (the "2008 Employee Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any employee, or any Director holding a salaried office or employment with the Company or a Subsidiary for the purchase of ordinary shares. On the same date, the Company also adopted the Consultants Share Option Plan 2008 (the "2008 Consultants Plan"), pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may grant options to any consultant, adviser or non-executive Director retained by the Company or any Subsidiary for the purchase of ordinary shares.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On February 14, 2017 both the 2008 Employee Plan and the 2008 Consultants Plan (together the "2008 Option Plans") were amended and restated in order to increase the number of options that can be issued under the 2008 Consultants Plan from 0.4 million to 1.0 million and to extend the date for options to be granted under the 2008 Option Plans.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An aggregate of 6.0 million ordinary shares have been reserved under the 2008 Employee Plan, as reduced by any shares issued or to be issued pursuant to options granted under the 2008 Consultants Plan, under which a limit of 1.0 million shares applies. Further, the maximum number of ordinary shares with respect to which options may be granted under the 2008 Employee Option Plan, during any calendar year to any employee shall be 0.4 million ordinary shares. There is no individual limit under the 2008 Consultants Plan. No options may be granted under the 2008 Option Plans after February 14, 2027.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each option granted under the 2008 Option Plans is an employee stock option, or Nonqualified Stock Option ("NSO"), as described in Section 422 or 423 of the Internal Revenue Code. Each grant of an option under the 2008 Options Plans is evidenced by a Stock Option Agreement between the optionee and the Company. The exercise price is specified in each Stock Option Agreement, however option prices are not less than 100% of the fair market value of an ordinary share on the date the option is granted. Share option awards are granted with an exercise price equal to the market price of the Company's shares at date of grant. Share options typically vest over a period of five years from date of grant and expire eight years from date of grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">PRA Equity Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following represent the PRA equity incentive plans, that have been terminated as of July 1, 2021, as to grants of future awards.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the Merger Agreement, effective on July 1, 2021, each stock option and restricted stock unit under the PRA Plans was assumed by the Company and converted into a stock option or Restricted Share Unit exercisable for or payable in Ordinary Shares based on the ratio of the average trading price per Ordinary Share for the ten days prior to July 1, 2021, and the corresponding value of the Merger consideration for each PRA Share. Accordingly, the plans as detailed below were assumed by the Company.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PRA Health Sciences, Inc. 2020 Stock Incentive Plan (the "2020 Plan”), 2018 Stock Incentive Plan (the "2018 Plan"), 2014 Omnibus Incentive Plan (the "2014 Plan"), and 2013 Stock Incentive Plan (the "2013 Plan") were amended and restated and assumed by the Registrant effective as of July 1, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2020 Stock Incentive Plan, was approved by the PRA stockholders at their annual meeting on May 18, 2020. The 2020 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2020 Plan authorized the issuance of 2.5 million shares of common stock plus all shares that remained available under the prior plan on May 18, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2018 Stock Incentive Plan (the “2018 Plan”), was approved by the PRA stockholders at their annual meeting on May 31, 2018. The 2018 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws. The 2018 Plan authorized the issuance of 2 million shares of common stock plus all shares that remained available under the 2014 Plan on May 31, 2018 (which included shares carried over from the 2013 Plan).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On November 23, 2014, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2014 Plan for Key PRA Employees. The 2014 Plan allowed for the issuance of stock options, stock appreciation rights, restricted shares and restricted stock units, other stock-based awards, and performance compensation awards as permitted by applicable laws.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On September 23, 2013, the PRA Health Sciences, Inc. Board of Directors approved the formation of the 2013 Plan for Key Employees of Pinnacle Holdco Parent, Inc. and its subsidiaries. The 2013 Plan allowed for the issuance of stock options and other stock-based awards as permitted by applicable laws. The number of shares available for grant under the 2013 Plan was 12.5% of the outstanding shares at closing on a fully diluted basis. The 2013 Plan authorized the issuance of 2,052,909 shares of common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047,803 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average remaining contractual life of options outstanding and options exercisable at December 31, 2022, was 4.69 years and 4.25 years respectively (2021: 5.39 years and 4.55 years respectively).</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Outstanding and exercisable share options:</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December 31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.88 - 96.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.70</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.24</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.88 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,378,119</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.69</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047,803</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102.29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding include both vested and unvested options as at December 31, 2022. Options exercisable represent options which have vested at December 31, 2022. From the date of grant, substantially all options vest over a five year period.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Fair value of Stock Options Assumptions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December 31, 2022, December 31, 2021 and December 31, 2020 was calculated using the Black-Scholes option pricing model. The weighted average fair values and assumptions were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of our common stock over a period equal to the expected term of the options; the expected life represents the weighted average period of time that options granted are expected to be outstanding given consideration to vesting schedules and our historical experience of past vesting and termination patterns. The risk-free rate is based on the U.S. government zero-coupon bonds yield curve in effect at time of the grant for periods corresponding with the expected life of the option.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Restricted Share Units and Performance Share Units</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 23, 2013 the Company adopted the 2013 Employees Restricted Share Unit and Performance Share Unit Plan (the "2013 RSU Plan") pursuant to which the Compensation and Organization Committee of the Company's Board of Directors may select any employee, or any Director holding a salaried office or employment with the Company, or a Subsidiary to receive an award under the plan. On May 11, 2015 the 2013 RSU Plan was amended and restated in order to increase the number of shares that can be issued under the RSU Plan by 2.5 million shares. Accordingly, an aggregate of 4.1 million ordinary shares have been reserved for issuance under the 2013 RSU Plan. The shares are awarded at par value and vest over a service period. Awards under the 2013 RSU Plan may be settled in cash or shares at the option of the Company. No awards may be granted under the 2013 RSU Plan after May 11, 2025.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On April 30 2019, the Company approved the 2019 Consultants and Directors Restricted Share Unit Plan (the “2019 Consultants RSU Plan”), which was effective as of May 16, 2019, pursuant to which the Compensation and Organization Committee of the Company’s Board of Directors may select any consultant, adviser or non-executive Director retained by the Company, or a Subsidiary to receive an award under the plan. 250,000 ordinary shares have been reserved for issuance under the 2019 Consultants RSU Plan. The awards are at par value and vest over a service period. Awards granted to non-executive directors during 2020 and 2021 vest over twelve months. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has awarded RSUs and PSUs to certain key individuals of the Group. The following table summarizes RSU and PSU activity for the year ended December 31, 2022:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(195,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of RSUs vested for the year ended December 31, 2022 totaled $34.1 million (2021: $83.5 million). The share price range for the year was $137.47 - $265.96 (2021: $115.11 - $206.71).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of PSUs vested for the year ended December 31, 2022 totaled $6.5 million (2021: $5.1 million). The share price range for the year was $137.47 - $166.51 (2021: $115.11 - $125.74).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The PSUs vest based on service and specified EPS targets over the period 2021 – 2023 and 2022 – 2024. Depending on the actual amount of EPS from 2021 to 2024, up to an additional 76,210 PSUs may also be granted.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Non-cash stock compensation expense</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations for the year ended December 31, 2022 is stated after charging $70.5 million in respect of non-cash stock compensation expense. Non-cash stock compensation expense has been allocated as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The income tax expense for the year ended December 31, 2022 reflects a net income tax benefit of $12.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2022 was $7.7 million. The income tax expense for the year ended December 31, 2021 reflects a net income tax benefit of $22.7 million in connection with stock compensation (including excess tax benefits) and the total tax benefit in connection with stock options exercised during 2021 was $23.9 million. The income tax expense for the year ended December 31, 2020 reflects a net income tax benefit of $6.9 million in connection with stock compensation (including excess tax benefits) and the total tax benefit realized in connection with stock options exercised during 2020 was $2.5 million.</span></div> 400000 1000000 6000000 1000000 400000 1 P5Y P8Y 2500000 2 0.125 2052909 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">The following table summarizes the transactions for the Company's share option plans for the years ended December 31, 2022, December 31, 2021 and December 31, 2020:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.860%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Granted<br/>Under Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656,107 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.80 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,737 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.83 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(193,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.21 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,746 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.53 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumed through business combinations *</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,177,130 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108.78 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,299 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177.76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,065,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.29 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695,460 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.38 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,643 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.94 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(348,286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled/expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143.08 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,378,119 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.86 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested and exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,047,803 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.29 </span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Represents stock options issued as replacement awards in connection with the Merger.</span></div> 656107 87.80 107737 159.83 193417 68.19 16681 92.21 553746 108.53 2177130 108.78 100299 177.76 1065529 111.29 70186 128.46 1695460 110.38 108643 229.94 348286 102.87 77698 143.08 1378119 119.86 1047803 102.29 P4Y8M8D P4Y3M P5Y4M20D P4Y6M18D <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following table summarizes information concerning outstanding and exercisable share options as of December 31, 2022:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.298%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Exercisable</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Range Exercise<br/>Price</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual Life</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.88 - 96.15</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.70</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,565 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.81 - 124.00</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203,605 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.74 - 147.26</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,518 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.65</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,054 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159.33 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">270,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.24</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,579 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.88 - 231.68</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,378,119</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.69</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">119.86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047,803</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">102.29</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 14.88 96.15 494565 P2Y8M12D 494565 103.81 124.00 226489 P5Y6M29D 203605 125.74 147.26 386518 P5Y7M24D 303054 159.33 231.68 270547 P6Y2M26D 46579 14.88 231.68 1378119 P4Y8M8D 119.86 1047803 102.29 P5Y The weighted average fair values and assumptions were as follows:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average fair value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.15 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42.43 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.57 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0 years</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted average fair value of options assumed on the date of the Merger was calculated using the Black-Scholes option pricing model. The weighted average fair values on the date of the Merger and assumptions used were as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">July 1, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average grant date fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.21 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.56 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5 years</span></td></tr></table></div> 68.42 49.15 42.43 0.31 0.30 0.30 0 0 0 0.0186 0.0078 0.0057 P5Y P5Y P5Y 107.21 0.30 0 0.0056 P3Y6M 2500000 4100000 250000 P12M The following table summarizes RSU and PSU activity for the year ended December 31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU Outstanding<br/>Number of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSU<br/>Weighted Average<br/>Grant Date <br/>Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU Outstanding<br/>Number<br/>of Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU<br/>Weighted Average<br/>Grant Date Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,190 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160.23 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">191.20 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">229.79 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">302,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216.85 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,087)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.48 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(195,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.35 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185.90 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(97,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,420 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192.29 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582,612 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207.73 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table> 154190 160.23 572785 191.20 64682 229.79 302307 216.85 46087 140.48 195029 174.35 20365 185.90 97451 205.25 152420 192.29 582612 207.73 34100000 83500000 137.47 265.96 115.11 206.71 6500000 5100000 137.47 166.51 115.11 125.74 76210 70500000 Non-cash stock compensation expense has been allocated as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Direct costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,854 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,551 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,557 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,457 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration related *</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,836 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total compensation costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,523 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133,844 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,271 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Represents the post combination portion of the accelerated vesting of awards following the completion of the Merger</span></div> 22854000 18551000 8557000 47669000 41457000 17714000 0 73836000 0 70523000 133844000 26271000 12900000 7700000 22700000 23900000 6900000 2500000 Business Segment and Geographical Information<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company has the expertise and capability to conduct clinical trials in most major therapeutic areas on a global basis and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated "full-service" solution. The Company has expanded through internal growth, together with a number of strategic acquisitions to enhance its expertise and capabilities in certain areas of the clinical development process.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company determines and presents operating segments based on the information that is internally provided to the chief operating decision maker, the (‘CODM’) in accordance with ASC 280 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">'Segment Reporting'</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. The Company determined that the CODM was comprised of the Chief Executive Officer and the Chief Financial Officer.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company operates as one reporting segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenues are allocated to individual entities based on where the work is performed in accordance with the Company's global transfer pricing model. Revenues and income from operations in Ireland are a function of our global contracting model and the Group’s transfer pricing model.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland acts as the Group entrepreneur under the Company’s global transfer pricing model given its role in the development and management of the Group, its ownership of key intellectual property and customer relationships, its key role in the mitigation of risks faced by the Group and its responsibility for maintaining the Company’s global network. ICON Ireland enters into the majority of the Company’s customer contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ICON Ireland remunerates other operating entities in the ICON Group on the basis of a guaranteed cost plus mark-up for the services they perform in each of their local territories. The cost plus mark-up for each ICON entity is established to ensure that each of ICON Ireland and the ICON entities that are involved in the conduct of services for customers, earn an appropriate arms-length return having regard to the assets owned, risks borne, and functions performed by each entity from these intercompany transactions. The cost plus mark-up policy is reviewed annually to ensure that it is market appropriate. The integration of entities acquired through the Merger into this global network and global transfer pricing model remains ongoing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The geographic split of revenue disclosed for each region outside Ireland is the cost plus revenue attributable to these entities. The residual revenues of the Group, once each ICON entity has been paid its respective intercompany service fee, generally fall to be retained by ICON Ireland. As such, revenues and income from operations in Ireland are a function of this global transfer pricing model and comprise revenues of the Group after deducting the cost plus revenues attributable to the activities performed outside Ireland. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There have been no changes to the basis of segmentation or the measurement basis for the segment results since the prior year.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December 31, 2022 and December 31, 2021 and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b) The distribution of income from operations (including Restructuring) by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,765 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c) The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> 1 <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Reportable geographic information at December 31, 2022 and December 31, 2021 and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 is as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a) The distribution of revenue by geographical area was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,984,567 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,365,909 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181,292 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,618,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416,884 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,574,610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,581,007 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925,563 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,859 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">273,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,741,386 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,480,826 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,797,288 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1984567000 1365909000 1181292000 1618350000 1175515000 416884000 3574610000 2581007000 925563000 563859000 358395000 273549000 7741386000 5480826000 2797288000 The distribution of income from operations (including Restructuring) by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland *</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218,088 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,478 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,799 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,765 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254,849 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,018 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,501 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,573 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,239 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">795,237 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">378,529 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,500 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>* Includes the full amount of the amortization charge associated with the intangible asset acquired in the Merger. 218088000 131961000 276478000 253799000 177863000 35765000 254849000 39132000 58018000 68501000 29573000 21239000 795237000 378529000 391500000 The distribution of long-lived assets (property, plant and equipment and operating right-of-use assets), net, by geographical area was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ireland</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,253 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,174 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,311 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239,828 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,095 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">504,152 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,567 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table> 143025000 118253000 99721000 121174000 213311000 239828000 48095000 55312000 504152000 534567000 Net Income Per Ordinary Share<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic net income per ordinary share attributable to the Group has been computed by dividing net income available to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted net income per ordinary share is computed by adjusting the weighted average number of ordinary shares outstanding during the period for all potentially dilutive ordinary shares outstanding during the period and adjusting net income for any changes in income or loss that would result from the conversion of such potential ordinary shares. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There is no difference in net income used for basic and diluted net income per ordinary share.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic and diluted net income per ordinary share attributable to the Group for the year ended December 31, 2020 includes an adjustment to reflect the accretion of the noncontrolling interest in MeDiNova to its redemption value. The noncontrolling interest was acquired in the year ended December 31, 2020 and therefore no adjustment has been required in the years ended December 31, 2022 and December 31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div> <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation of the number of shares used in the computation of basic and diluted net income per ordinary share is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for basic net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,532,320 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,110,186 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,859,911 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">936,043 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">423,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of ordinary shares outstanding for diluted net income per ordinary share</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,468,363 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68,068,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,283,585 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 81532320 67110186 52859911 936043 958125 423674 82468363 68068311 53283585 <div style="margin-bottom:9pt;margin-top:4pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The reconciliation between net income attributable to the Group per the Consolidated Statement of Operations and the net income used to calculate net income per ordinary share attributable to the Group is as follows:</span></div><div style="margin-bottom:9pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest adjustment to redemption amount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to the Group (including NCI redemption adjustment)</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">505,304 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153,185 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,809 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per Ordinary Share attributable to the Group (including NCI redemption adjustment):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.28 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.20 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div> 505304000 153185000 332331000 0 0 4522000 505304000 153185000 327809000 6.20 2.28 6.20 6.13 2.25 6.15 Accumulated Other Comprehensive Income<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan (note 21)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial gain/(loss) on defined benefit pension plan (note 21)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,559 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of loss on cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(171,538)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,937)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> -175369000 -85840000 -7559000 5098000 -3728000 0 0 1000 -171538000 -90937000 Supplemental Disclosure of Cash Flow Information<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">210,918 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,205 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,062 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes (net of refunds)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,322 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,105 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,604 </span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 210918000 106205000 13062000 116322000 55105000 27604000 Related Parties <div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Subsidiaries of the Company earned revenue of $2,000 (December 31, 2021: $30,000) from DS Biopharma Limited (formerly Dignity Sciences Limited) during the year. Dr. John Climax is Executive Chairman and a Director and shareholder of DS Biopharma Limited. $12,000 was recorded as due from DS Biopharma Limited at December 31, 2022 (December 31, 2021: $12,000). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $235,000 (December 31, 2021: $551,000) from Afimmune Limited during the year. Dr. John Climax is Chief Executive Officer and a Director and shareholder of Afimmune Limited. $263,000 was recorded as due from Afimmune Limited at December 31, 2022 (December 31, 2021: $197,000). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subsidiaries of the Company earned revenue of $428,000 from Corvus Pharmaceuticals during the year. Dr. Linda Grais serves as a Director and shareholder of Corvus Pharmaceuticals. $231,000 was recorded as due from Corvus Pharmaceuticals at December 31, 2022. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On July 24, 2020, a subsidiary of the Company, ICON Clinical Research Limited, entered into an agreement to jointly establish a new company, Oncacare, with a third party. The Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare. The Company provided corporate support services to Oncacare to the value of $451,000 during the year ended December 31, 2022 (December 31, 2021: $465,000). $715,000 was recorded as due from Oncacare at December 31, 2022 (December 31, 2021: $264,000). During the year ended December 31, 2021, the Company provided a loan of $10 million to Oncacare in order to fund the continued start up of the business' operations. The loan accrues annual interest at 1.6% and the loan is repayable on June 30, 2025. The Company has recorded losses of $3.1 million and $2.2 million representing its pro rata share of the losses in Oncacare during the year ended December 31, 2022 and December 31, 2021, respectively. The carrying value of the Company's investment in Oncacare was reduced by $2.3 million of pro rata losses. The remaining $0.8 million in pro rata losses served to reduce the carrying value of the Company's loan receivable from Oncacare. At December 31, 2022 accrued interest of $183,000 remained outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The majority investor in Oncacare has the right to sell the 51% majority voting share capital exclusively to the Company in an eighteen month period, commencing January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.</span></div> 2000 30000 12000 12000 235000 551000 263000 197000 428000 231000 4900000 0.49 451000 465000 715000 264000 10000000 0.016 -3100000 -2200000 -2300000 800000 183000 0.51 0.51 Subsequent Events<span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">T</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">he Company has evaluated subsequent events from the Balance Sheet date th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">rough February 24, 2023, the date at which the consolidated financial statements were available to be issued. The Company has determined that there are no items to disclose.</span> EXCEL 157 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 159 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 160 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 341 623 1 false 117 0 false 12 false false R1.htm 0000001 - Document - Cover Sheet http://www.iconplc.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.iconplc.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME Sheet http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - Description of business Sheet http://www.iconplc.com/role/Descriptionofbusiness Description of business Notes 9 false false R10.htm 0000010 - Disclosure - Summary of Significant accounting policies Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies Summary of Significant accounting policies Notes 10 false false R11.htm 0000011 - Disclosure - Disaggregation of Revenue Sheet http://www.iconplc.com/role/DisaggregationofRevenue Disaggregation of Revenue Notes 11 false false R12.htm 0000012 - Disclosure - Contract Balances Sheet http://www.iconplc.com/role/ContractBalances Contract Balances Notes 12 false false R13.htm 0000013 - Disclosure - Allowances for Credit Losses Sheet http://www.iconplc.com/role/AllowancesforCreditLosses Allowances for Credit Losses Notes 13 false false R14.htm 0000014 - Disclosure - Business Combinations Sheet http://www.iconplc.com/role/BusinessCombinations Business Combinations Notes 14 false false R15.htm 0000015 - Disclosure - Fair Value Sheet http://www.iconplc.com/role/FairValue Fair Value Notes 15 false false R16.htm 0000016 - Disclosure - Investments Sheet http://www.iconplc.com/role/Investments Investments Notes 16 false false R17.htm 0000017 - Disclosure - Property, Plant and Equipment, net Sheet http://www.iconplc.com/role/PropertyPlantandEquipmentnet Property, Plant and Equipment, net Notes 17 false false R18.htm 0000018 - Disclosure - Goodwill Sheet http://www.iconplc.com/role/Goodwill Goodwill Notes 18 false false R19.htm 0000019 - Disclosure - Intangible Assets Sheet http://www.iconplc.com/role/IntangibleAssets Intangible Assets Notes 19 false false R20.htm 0000020 - Disclosure - Other Liabilities Sheet http://www.iconplc.com/role/OtherLiabilities Other Liabilities Notes 20 false false R21.htm 0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities Non-current Bank Credit Lines and Loan Facilities Notes 21 false false R22.htm 0000022 - Disclosure - Derivatives Sheet http://www.iconplc.com/role/Derivatives Derivatives Notes 22 false false R23.htm 0000023 - Disclosure - Operating Leases Sheet http://www.iconplc.com/role/OperatingLeases Operating Leases Notes 23 false false R24.htm 0000024 - Disclosure - Non-current other liabilities Sheet http://www.iconplc.com/role/Noncurrentotherliabilities Non-current other liabilities Notes 24 false false R25.htm 0000025 - Disclosure - Commitments and Contingencies Sheet http://www.iconplc.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 25 false false R26.htm 0000026 - Disclosure - Share Capital Sheet http://www.iconplc.com/role/ShareCapital Share Capital Notes 26 false false R27.htm 0000027 - Disclosure - Restructuring Charges Sheet http://www.iconplc.com/role/RestructuringCharges Restructuring Charges Notes 27 false false R28.htm 0000028 - Disclosure - Income Taxes Sheet http://www.iconplc.com/role/IncomeTaxes Income Taxes Notes 28 false false R29.htm 0000029 - Disclosure - Employee Benefits Sheet http://www.iconplc.com/role/EmployeeBenefits Employee Benefits Notes 29 false false R30.htm 0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges Equity Incentive Schemes and Stock Compensation Charges Notes 30 false false R31.htm 0000031 - Disclosure - Business Segment and Geographical Information Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation Business Segment and Geographical Information Notes 31 false false R32.htm 0000032 - Disclosure - Net Income Per Ordinary Share Sheet http://www.iconplc.com/role/NetIncomePerOrdinaryShare Net Income Per Ordinary Share Notes 32 false false R33.htm 0000033 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 33 false false R34.htm 0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information Sheet http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation Supplemental Disclosure of Cash Flow Information Notes 34 false false R35.htm 0000035 - Disclosure - Related Parties Sheet http://www.iconplc.com/role/RelatedParties Related Parties Notes 35 false false R36.htm 0000036 - Disclosure - Subsequent Events Sheet http://www.iconplc.com/role/SubsequentEvents Subsequent Events Notes 36 false false R37.htm 0000037 - Disclosure - Summary of Significant accounting policies (Policies) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies Summary of Significant accounting policies (Policies) Policies 37 false false R38.htm 0000038 - Disclosure - Summary of Significant accounting policies (Tables) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables Summary of Significant accounting policies (Tables) Tables http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies 38 false false R39.htm 0000039 - Disclosure - Disaggregation of Revenue (Tables) Sheet http://www.iconplc.com/role/DisaggregationofRevenueTables Disaggregation of Revenue (Tables) Tables http://www.iconplc.com/role/DisaggregationofRevenue 39 false false R40.htm 0000040 - Disclosure - Contract Balances (Tables) Sheet http://www.iconplc.com/role/ContractBalancesTables Contract Balances (Tables) Tables http://www.iconplc.com/role/ContractBalances 40 false false R41.htm 0000041 - Disclosure - Allowances for Credit Losses (Tables) Sheet http://www.iconplc.com/role/AllowancesforCreditLossesTables Allowances for Credit Losses (Tables) Tables http://www.iconplc.com/role/AllowancesforCreditLosses 41 false false R42.htm 0000042 - Disclosure - Business Combinations (Tables) Sheet http://www.iconplc.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.iconplc.com/role/BusinessCombinations 42 false false R43.htm 0000043 - Disclosure - Fair Value (Tables) Sheet http://www.iconplc.com/role/FairValueTables Fair Value (Tables) Tables http://www.iconplc.com/role/FairValue 43 false false R44.htm 0000044 - Disclosure - Investments (Tables) Sheet http://www.iconplc.com/role/InvestmentsTables Investments (Tables) Tables http://www.iconplc.com/role/Investments 44 false false R45.htm 0000045 - Disclosure - Property, Plant and Equipment, net (Tables) Sheet http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables Property, Plant and Equipment, net (Tables) Tables http://www.iconplc.com/role/PropertyPlantandEquipmentnet 45 false false R46.htm 0000046 - Disclosure - Goodwill (Tables) Sheet http://www.iconplc.com/role/GoodwillTables Goodwill (Tables) Tables http://www.iconplc.com/role/Goodwill 46 false false R47.htm 0000047 - Disclosure - Intangible Assets (Tables) Sheet http://www.iconplc.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.iconplc.com/role/IntangibleAssets 47 false false R48.htm 0000048 - Disclosure - Other Liabilities (Tables) Sheet http://www.iconplc.com/role/OtherLiabilitiesTables Other Liabilities (Tables) Tables http://www.iconplc.com/role/OtherLiabilities 48 false false R49.htm 0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables) Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables Non-current Bank Credit Lines and Loan Facilities (Tables) Tables http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities 49 false false R50.htm 0000050 - Disclosure - Derivatives (Tables) Sheet http://www.iconplc.com/role/DerivativesTables Derivatives (Tables) Tables http://www.iconplc.com/role/Derivatives 50 false false R51.htm 0000051 - Disclosure - Operating Leases (Tables) Sheet http://www.iconplc.com/role/OperatingLeasesTables Operating Leases (Tables) Tables http://www.iconplc.com/role/OperatingLeases 51 false false R52.htm 0000052 - Disclosure - Non-current other liabilities (Tables) Sheet http://www.iconplc.com/role/NoncurrentotherliabilitiesTables Non-current other liabilities (Tables) Tables http://www.iconplc.com/role/Noncurrentotherliabilities 52 false false R53.htm 0000053 - Disclosure - Restructuring charges (Tables) Sheet http://www.iconplc.com/role/RestructuringchargesTables Restructuring charges (Tables) Tables 53 false false R54.htm 0000054 - Disclosure - Income Taxes (Tables) Sheet http://www.iconplc.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.iconplc.com/role/IncomeTaxes 54 false false R55.htm 0000055 - Disclosure - Employee Benefits (Tables) Sheet http://www.iconplc.com/role/EmployeeBenefitsTables Employee Benefits (Tables) Tables http://www.iconplc.com/role/EmployeeBenefits 55 false false R56.htm 0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables Equity Incentive Schemes and Stock Compensation Charges (Tables) Tables http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges 56 false false R57.htm 0000057 - Disclosure - Business Segment and Geographical Information (Tables) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables Business Segment and Geographical Information (Tables) Tables http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation 57 false false R58.htm 0000058 - Disclosure - Net Income Per Ordinary Share (Tables) Sheet http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables Net Income Per Ordinary Share (Tables) Tables http://www.iconplc.com/role/NetIncomePerOrdinaryShare 58 false false R59.htm 0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome 59 false false R60.htm 0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) Sheet http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables Supplemental Disclosure of Cash Flow Information (Tables) Tables http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation 60 false false R61.htm 0000061 - Disclosure - Description of business (Details) Sheet http://www.iconplc.com/role/DescriptionofbusinessDetails Description of business (Details) Details http://www.iconplc.com/role/Descriptionofbusiness 61 false false R62.htm 0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details) Details 62 false false R63.htm 0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details) Details 63 false false R64.htm 0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details) Details 64 false false R65.htm 0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details) Sheet http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails Summary of Significant accounting policies - Narrative (Details) Details 65 false false R66.htm 0000066 - Disclosure - Disaggregation of Revenue (Details) Sheet http://www.iconplc.com/role/DisaggregationofRevenueDetails Disaggregation of Revenue (Details) Details http://www.iconplc.com/role/DisaggregationofRevenueTables 66 false false R67.htm 0000067 - Disclosure - Contract Balances (Details) Sheet http://www.iconplc.com/role/ContractBalancesDetails Contract Balances (Details) Details http://www.iconplc.com/role/ContractBalancesTables 67 false false R68.htm 0000068 - Disclosure - Contract Balances - Narrative (Details) Sheet http://www.iconplc.com/role/ContractBalancesNarrativeDetails Contract Balances - Narrative (Details) Details 68 false false R69.htm 0000069 - Disclosure - Allowances for Credit Losses (Details) Sheet http://www.iconplc.com/role/AllowancesforCreditLossesDetails Allowances for Credit Losses (Details) Details http://www.iconplc.com/role/AllowancesforCreditLossesTables 69 false false R70.htm 0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details) Sheet http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails Business Combinations - Narrative, PRA Acquisition (Details) Details 70 false false R71.htm 0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) Sheet http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details) Details 71 false false R72.htm 0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) Sheet http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details) Details 72 false false R73.htm 0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) Sheet http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details) Details 73 false false R74.htm 0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) Sheet http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details) Details 74 false false R75.htm 0000075 - Disclosure - Fair value - Narrative (Details) Sheet http://www.iconplc.com/role/FairvalueNarrativeDetails Fair value - Narrative (Details) Details 75 false false R76.htm 0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) Sheet http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details) Details 76 false false R77.htm 0000077 - Disclosure - Investments - Narrative (Details) Sheet http://www.iconplc.com/role/InvestmentsNarrativeDetails Investments - Narrative (Details) Details 77 false false R78.htm 0000078 - Disclosure - Investments - Equity Method Investments (Details) Sheet http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails Investments - Equity Method Investments (Details) Details 78 false false R79.htm 0000079 - Disclosure - Property, Plant and Equipment, net (Details) Sheet http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails Property, Plant and Equipment, net (Details) Details http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables 79 false false R80.htm 0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details) Sheet http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails Goodwill - Schedule of Goodwill (Details) Details 80 false false R81.htm 0000081 - Disclosure - Goodwill - Narrative (Details) Sheet http://www.iconplc.com/role/GoodwillNarrativeDetails Goodwill - Narrative (Details) Details 81 false false R82.htm 0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details) Sheet http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails Intangible Assets - Summary of Intangible Assets (Details) Details 82 false false R83.htm 0000083 - Disclosure - Intangible Assets - Narrative (Details) Sheet http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails Intangible Assets - Narrative (Details) Details 83 false false R84.htm 0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details) Sheet http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails Intangible Assets - Future Intangible Asset Amortization Expense (Details) Details 84 false false R85.htm 0000085 - Disclosure - Other Liabilities (Details) Sheet http://www.iconplc.com/role/OtherLiabilitiesDetails Other Liabilities (Details) Details http://www.iconplc.com/role/OtherLiabilitiesTables 85 false false R86.htm 0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details) Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details) Details 86 false false R87.htm 0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details) Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails Non-current Bank Credit Lines and Loan Facilities - Narrative (Details) Details http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables 87 false false R88.htm 0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details) Details 88 false false R89.htm 0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details) Sheet http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details) Details 89 false false R90.htm 0000090 - Disclosure - Derivatives - Narrative (Details) Sheet http://www.iconplc.com/role/DerivativesNarrativeDetails Derivatives - Narrative (Details) Details 90 false false R91.htm 0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) Sheet http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details) Details 91 false false R92.htm 0000092 - Disclosure - Operating Leases - Lease Costs (Details) Sheet http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails Operating Leases - Lease Costs (Details) Details 92 false false R93.htm 0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details) Sheet http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails Operating Leases Operating Leases - Narrative (Details) Details 93 false false R94.htm 0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details) Sheet http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails Operating Leases Operating Leases - Operating Lease Maturity (Details) Details 94 false false R95.htm 0000095 - Disclosure - Non-current other liabilities (Details) Sheet http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails Non-current other liabilities (Details) Details http://www.iconplc.com/role/NoncurrentotherliabilitiesTables 95 false false R96.htm 0000096 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 96 false false R97.htm 0000097 - Disclosure - Share Capital (Details) Sheet http://www.iconplc.com/role/ShareCapitalDetails Share Capital (Details) Details http://www.iconplc.com/role/ShareCapital 97 false false R98.htm 0000098 - Disclosure - Restructuring charges - Narrative (Details) Sheet http://www.iconplc.com/role/RestructuringchargesNarrativeDetails Restructuring charges - Narrative (Details) Details 98 false false R99.htm 0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details) Sheet http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails Restructuring charges - Summary of Restructuring Charges (Details) Details 99 false false R100.htm 0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details) Sheet http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails Restructuring charges - Restructuring Provision (Details) Details 100 false false R101.htm 0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details) Sheet http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails Income Taxes - Components of Income Before Provision for Income Taxes (Details) Details 101 false false R102.htm 0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details) Sheet http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails Income Taxes - Components of Provision for Income Taxes (Details) Details 102 false false R103.htm 0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) Sheet http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details) Details 103 false false R104.htm 0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) Sheet http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details) Details 104 false false R105.htm 0000105 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.iconplc.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 105 false false R106.htm 0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details) Sheet http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails Income Taxes - Expected Expiry Dates of NOL's (Details) Details 106 false false R107.htm 0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) Sheet http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details) Details 107 false false R108.htm 0000108 - Disclosure - Employee Benefits - Narrative (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails Employee Benefits - Narrative (Details) Details 108 false false R109.htm 0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails Employee Benefits - Summary of plan assets and liabilities (Details) Details 109 false false R110.htm 0000110 - Disclosure - Employee Benefits - Funded Status (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails Employee Benefits - Funded Status (Details) Details 110 false false R111.htm 0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails Employee Benefits - Change in Benefit Obligations (Details) Details 111 false false R112.htm 0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails Employee Benefits - Change in Plan Assets (Details) Details 112 false false R113.htm 0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails Employee Benefits - Components of Net Periodic Benefit Cost (Details) Details 113 false false R114.htm 0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details) Details 114 false false R115.htm 0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details) Details 115 false false R116.htm 0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details) Details 116 false false R117.htm 0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails Employee Benefits - Plan Asset Fair Value Measurements (Details) Details 117 false false R118.htm 0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details) Sheet http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails Employee Benefits - Annual Benefit Payments (Details) Details 118 false false R119.htm 0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details) Details http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables 119 false false R120.htm 0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details) Details 120 false false R121.htm 0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details) Details 121 false false R122.htm 0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details) Details 122 false false R123.htm 0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details) Details 123 false false R124.htm 0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) Sheet http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details) Details 124 false false R125.htm 0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails Business Segment and Geographical Information - Narrative (Details) Details 125 false false R126.htm 0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details) Details 126 false false R127.htm 0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details) Details 127 false false R128.htm 0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) Sheet http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details) Details 128 false false R129.htm 0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) Sheet http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details) Details 129 false false R130.htm 0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) Sheet http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details) Details 130 false false R131.htm 0000131 - Disclosure - Accumulated Other Comprehensive Income (Details) Sheet http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income (Details) Details http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables 131 false false R132.htm 0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) Sheet http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails Supplemental Disclosure of Cash Flow Information (Details) Details http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables 132 false false R133.htm 0000133 - Disclosure - Related Parties (Details) Sheet http://www.iconplc.com/role/RelatedPartiesDetails Related Parties (Details) Details http://www.iconplc.com/role/RelatedParties 133 false false All Reports Book All Reports iclr-20221231.htm exhibit121-2022.htm exhibit122-2022.htm exhibit22-2022.htm exhibit231-2022.htm exhibit25-2022.htm iclr-20221231.xsd iclr-20221231_cal.xml iclr-20221231_def.xml iclr-20221231_lab.xml iclr-20221231_pre.xml iclr-20221231_g1.jpg iclr-20221231_g10.jpg iclr-20221231_g11.jpg iclr-20221231_g2.jpg iclr-20221231_g3.jpg iclr-20221231_g4.jpg iclr-20221231_g5.jpg iclr-20221231_g6.jpg iclr-20221231_g7.jpg iclr-20221231_g8.jpg iclr-20221231_g9.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 162 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "iclr-20221231.htm": { "axisCustom": 1, "axisStandard": 40, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1502, "http://xbrl.sec.gov/dei/2022": 47 }, "contextCount": 341, "dts": { "calculationLink": { "local": [ "iclr-20221231_cal.xml" ] }, "definitionLink": { "local": [ "iclr-20221231_def.xml" ] }, "inline": { "local": [ "iclr-20221231.htm" ] }, "labelLink": { "local": [ "iclr-20221231_lab.xml" ] }, "presentationLink": { "local": [ "iclr-20221231_pre.xml" ] }, "schema": { "local": [ "iclr-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 938, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://xbrl.sec.gov/dei/2022": 4, "total": 6 }, "keyCustom": 98, "keyStandard": 525, "memberCustom": 60, "memberStandard": 54, "nsprefix": "iclr", "nsuri": "http://www.iconplc.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.iconplc.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Summary of Significant accounting policies", "menuCat": "Notes", "order": "10", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies", "shortName": "Summary of Significant accounting policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000100 - Disclosure - Restructuring charges - Restructuring Provision (Details)", "menuCat": "Details", "order": "100", "role": "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails", "shortName": "Restructuring charges - Restructuring Provision (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iclr:IncomeBeforeIncomeTaxTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000101 - Disclosure - Income Taxes - Components of Income Before Provision for Income Taxes (Details)", "menuCat": "Details", "order": "101", "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "shortName": "Income Taxes - Components of Income Before Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iclr:IncomeBeforeIncomeTaxTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000102 - Disclosure - Income Taxes - Components of Provision for Income Taxes (Details)", "menuCat": "Details", "order": "102", "role": "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "shortName": "Income Taxes - Components of Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000103 - Disclosure - Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)", "menuCat": "Details", "order": "103", "role": "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails", "shortName": "Income Taxes - Consolidated Reported Provision for Income Taxes Differed from Statutory Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000104 - Disclosure - Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)", "menuCat": "Details", "order": "104", "role": "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails", "shortName": "Income Taxes - Tax Effects of Temporary Differences That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000105 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "105", "role": "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0f29ad522a3c4db2af1974c2d81a85e6_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000106 - Disclosure - Income Taxes - Expected Expiry Dates of NOL's (Details)", "menuCat": "Details", "order": "106", "role": "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "shortName": "Income Taxes - Expected Expiry Dates of NOL's (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i243aa952befc42c99e33d30e034ad490_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000107 - Disclosure - Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)", "menuCat": "Details", "order": "107", "role": "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9c028363c21c48d5bdb88ba826d38299_I20191231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "if733533a187d46cfb46437f0574bd48b_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000108 - Disclosure - Employee Benefits - Narrative (Details)", "menuCat": "Details", "order": "108", "role": "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "shortName": "Employee Benefits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "if733533a187d46cfb46437f0574bd48b_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia4f00760e31240959ce3972bf544992d_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000109 - Disclosure - Employee Benefits - Summary of plan assets and liabilities (Details)", "menuCat": "Details", "order": "109", "role": "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails", "shortName": "Employee Benefits - Summary of plan assets and liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia4f00760e31240959ce3972bf544992d_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Disaggregation of Revenue", "menuCat": "Notes", "order": "11", "role": "http://www.iconplc.com/role/DisaggregationofRevenue", "shortName": "Disaggregation of Revenue", "subGroupType": "", "uniqueAnchor": null }, "R110": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i825154864e984f849f9034999b633fbe_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000110 - Disclosure - Employee Benefits - Funded Status (Details)", "menuCat": "Details", "order": "110", "role": "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "shortName": "Employee Benefits - Funded Status (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i825154864e984f849f9034999b633fbe_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i8e37e3b18efc4c54890a23af49e0fa65_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000111 - Disclosure - Employee Benefits - Change in Benefit Obligations (Details)", "menuCat": "Details", "order": "111", "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "shortName": "Employee Benefits - Change in Benefit Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i8e37e3b18efc4c54890a23af49e0fa65_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000112 - Disclosure - Employee Benefits - Change in Plan Assets (Details)", "menuCat": "Details", "order": "112", "role": "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "shortName": "Employee Benefits - Change in Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000113 - Disclosure - Employee Benefits - Components of Net Periodic Benefit Cost (Details)", "menuCat": "Details", "order": "113", "role": "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "shortName": "Employee Benefits - Components of Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ie835ce8081ec4f4ca739bd71e6565c20_D20220101-20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000114 - Disclosure - Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)", "menuCat": "Details", "order": "114", "role": "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "shortName": "Employee Benefits - Net Periodic Pension Benefit Cost Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia71f12b8513d4a2b995929f5b9d3c336_D20220101-20221231", "decimals": "3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i825154864e984f849f9034999b633fbe_I20221231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000115 - Disclosure - Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)", "menuCat": "Details", "order": "115", "role": "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "shortName": "Employee Benefits - Assumptions Used in Determining Benefit Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i825154864e984f849f9034999b633fbe_I20221231", "decimals": "3", "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0bc40275d8744c9793904bf596955616_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000116 - Disclosure - Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)", "menuCat": "Details", "order": "116", "role": "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "shortName": "Employee Benefits - Expected Rate of Return and Actual Plan Asset Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0bc40275d8744c9793904bf596955616_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9862be84bb6f492bb811a70c03726aeb_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000117 - Disclosure - Employee Benefits - Plan Asset Fair Value Measurements (Details)", "menuCat": "Details", "order": "117", "role": "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "shortName": "Employee Benefits - Plan Asset Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9862be84bb6f492bb811a70c03726aeb_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0784352491d144cd972226c028844591_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000118 - Disclosure - Employee Benefits - Annual Benefit Payments (Details)", "menuCat": "Details", "order": "118", "role": "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "shortName": "Employee Benefits - Annual Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0784352491d144cd972226c028844591_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000119 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)", "menuCat": "Details", "order": "119", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Contract Balances", "menuCat": "Notes", "order": "12", "role": "http://www.iconplc.com/role/ContractBalances", "shortName": "Contract Balances", "subGroupType": "", "uniqueAnchor": null }, "R120": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i940aa8c093bc4589896acef14854ea63_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000120 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)", "menuCat": "Details", "order": "120", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i7c67eb08e5524f1389812b02c4f529e7_I20191231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000121 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)", "menuCat": "Details", "order": "121", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Outstanding and Exercisable Share Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000122 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)", "menuCat": "Details", "order": "122", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Weighted Average Fair Values and Assumptions Used (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i0b9d345e9ee145ed8c6cf6f4477d5927_D20210701-20210701", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i50c7dd932b404320af63f5c9a2cf9cd5_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000123 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)", "menuCat": "Details", "order": "123", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Summary of RSU and PSU Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i50c7dd932b404320af63f5c9a2cf9cd5_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000124 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)", "menuCat": "Details", "order": "124", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "shortName": "Equity Incentive Schemes and Stock Compensation Charges - Schedule of Non-cash Stock Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i82cb0ef605764df78f456f39f2da3b44_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000125 - Disclosure - Business Segment and Geographical Information - Narrative (Details)", "menuCat": "Details", "order": "125", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails", "shortName": "Business Segment and Geographical Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000126 - Disclosure - Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)", "menuCat": "Details", "order": "126", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "shortName": "Business Segment and Geographical Information - Distribution of Net Revenue by Geographical Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "iafa7e4e2e42d410c8242fd736b98d48d_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000127 - Disclosure - Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)", "menuCat": "Details", "order": "127", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "shortName": "Business Segment and Geographical Information - Distribution of Income from Operations, Excluding Restructuring, by Geographical Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "iclr:OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R128": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000128 - Disclosure - Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)", "menuCat": "Details", "order": "128", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "shortName": "Business Segment and Geographical Information - Distribution of Long-lived Assets, Net, by Geographical Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000129 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)", "menuCat": "Details", "order": "129", "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails", "shortName": "Net Income Per Ordinary Share - Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "0", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AllowanceForDoubtfulAccountsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Allowances for Credit Losses", "menuCat": "Notes", "order": "13", "role": "http://www.iconplc.com/role/AllowancesforCreditLosses", "shortName": "Allowances for Credit Losses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AllowanceForDoubtfulAccountsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000130 - Disclosure - Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)", "menuCat": "Details", "order": "130", "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails", "shortName": "Net Income Per Ordinary Share - Reconciliation of Net Income Attributable to the Group Per the Statement of Operating Income and Net Income Used For Net Income Per Ordinary Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iclr:ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R131": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000131 - Disclosure - Accumulated Other Comprehensive Income (Details)", "menuCat": "Details", "order": "131", "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails", "shortName": "Accumulated Other Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000132 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)", "menuCat": "Details", "order": "132", "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails", "shortName": "Supplemental Disclosure of Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncomeTaxesPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "2", "first": true, "lang": "en-US", "name": "iclr:EquityMethodInvestmentMajorityOwnershipPercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000133 - Disclosure - Related Parties (Details)", "menuCat": "Details", "order": "133", "role": "http://www.iconplc.com/role/RelatedPartiesDetails", "shortName": "Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i45448a33be2443fd93dedd1a7d14df2a_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Business Combinations", "menuCat": "Notes", "order": "14", "role": "http://www.iconplc.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Fair Value", "menuCat": "Notes", "order": "15", "role": "http://www.iconplc.com/role/FairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Investments", "menuCat": "Notes", "order": "16", "role": "http://www.iconplc.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Property, Plant and Equipment, net", "menuCat": "Notes", "order": "17", "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnet", "shortName": "Property, Plant and Equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Goodwill", "menuCat": "Notes", "order": "18", "role": "http://www.iconplc.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "19", "role": "http://www.iconplc.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0000002 - Document - Audit Information", "menuCat": "Cover", "order": "2", "role": "http://www.iconplc.com/role/AuditInformation", "shortName": "Audit Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Other Liabilities", "menuCat": "Notes", "order": "20", "role": "http://www.iconplc.com/role/OtherLiabilities", "shortName": "Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Non-current Bank Credit Lines and Loan Facilities", "menuCat": "Notes", "order": "21", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities", "shortName": "Non-current Bank Credit Lines and Loan Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Derivatives", "menuCat": "Notes", "order": "22", "role": "http://www.iconplc.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Operating Leases", "menuCat": "Notes", "order": "23", "role": "http://www.iconplc.com/role/OperatingLeases", "shortName": "Operating Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Non-current other liabilities", "menuCat": "Notes", "order": "24", "role": "http://www.iconplc.com/role/Noncurrentotherliabilities", "shortName": "Non-current other liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "25", "role": "http://www.iconplc.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Share Capital", "menuCat": "Notes", "order": "26", "role": "http://www.iconplc.com/role/ShareCapital", "shortName": "Share Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Restructuring Charges", "menuCat": "Notes", "order": "27", "role": "http://www.iconplc.com/role/RestructuringCharges", "shortName": "Restructuring Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "28", "role": "http://www.iconplc.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Employee Benefits", "menuCat": "Notes", "order": "29", "role": "http://www.iconplc.com/role/EmployeeBenefits", "shortName": "Employee Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "3", "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges", "menuCat": "Notes", "order": "30", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges", "shortName": "Equity Incentive Schemes and Stock Compensation Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Business Segment and Geographical Information", "menuCat": "Notes", "order": "31", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation", "shortName": "Business Segment and Geographical Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Net Income Per Ordinary Share", "menuCat": "Notes", "order": "32", "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShare", "shortName": "Net Income Per Ordinary Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Accumulated Other Comprehensive Income", "menuCat": "Notes", "order": "33", "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome", "shortName": "Accumulated Other Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AccumulatedOtherComprehensiveIncomeLossTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Supplemental Disclosure of Cash Flow Information", "menuCat": "Notes", "order": "34", "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation", "shortName": "Supplemental Disclosure of Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Related Parties", "menuCat": "Notes", "order": "35", "role": "http://www.iconplc.com/role/RelatedParties", "shortName": "Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "36", "role": "http://www.iconplc.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Summary of Significant accounting policies (Policies)", "menuCat": "Policies", "order": "37", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies", "shortName": "Summary of Significant accounting policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:ForeignCurrencyDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Summary of Significant accounting policies (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables", "shortName": "Summary of Significant accounting policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:ForeignCurrencyDisclosureTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Disaggregation of Revenue (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.iconplc.com/role/DisaggregationofRevenueTables", "shortName": "Disaggregation of Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "eurPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "eurPerShare", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Contract Balances (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.iconplc.com/role/ContractBalancesTables", "shortName": "Contract Balances (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Allowances for Credit Losses (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.iconplc.com/role/AllowancesforCreditLossesTables", "shortName": "Allowances for Credit Losses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:AllowanceForDoubtfulAccountsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Business Combinations (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.iconplc.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Fair Value (Tables)", "menuCat": "Tables", "order": "43", "role": "http://www.iconplc.com/role/FairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "44", "role": "http://www.iconplc.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Property, Plant and Equipment, net (Tables)", "menuCat": "Tables", "order": "45", "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables", "shortName": "Property, Plant and Equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Goodwill (Tables)", "menuCat": "Tables", "order": "46", "role": "http://www.iconplc.com/role/GoodwillTables", "shortName": "Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "47", "role": "http://www.iconplc.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Other Liabilities (Tables)", "menuCat": "Tables", "order": "48", "role": "http://www.iconplc.com/role/OtherLiabilitiesTables", "shortName": "Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Non-current Bank Credit Lines and Loan Facilities (Tables)", "menuCat": "Tables", "order": "49", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables", "shortName": "Non-current Bank Credit Lines and Loan Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "5", "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Derivatives (Tables)", "menuCat": "Tables", "order": "50", "role": "http://www.iconplc.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Operating Leases (Tables)", "menuCat": "Tables", "order": "51", "role": "http://www.iconplc.com/role/OperatingLeasesTables", "shortName": "Operating Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Non-current other liabilities (Tables)", "menuCat": "Tables", "order": "52", "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables", "shortName": "Non-current other liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Restructuring charges (Tables)", "menuCat": "Tables", "order": "53", "role": "http://www.iconplc.com/role/RestructuringchargesTables", "shortName": "Restructuring charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "54", "role": "http://www.iconplc.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "iclr:IncomeBeforeIncomeTaxTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Employee Benefits (Tables)", "menuCat": "Tables", "order": "55", "role": "http://www.iconplc.com/role/EmployeeBenefitsTables", "shortName": "Employee Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Equity Incentive Schemes and Stock Compensation Charges (Tables)", "menuCat": "Tables", "order": "56", "role": "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables", "shortName": "Equity Incentive Schemes and Stock Compensation Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Business Segment and Geographical Information (Tables)", "menuCat": "Tables", "order": "57", "role": "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables", "shortName": "Business Segment and Geographical Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Net Income Per Ordinary Share (Tables)", "menuCat": "Tables", "order": "58", "role": "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables", "shortName": "Net Income Per Ordinary Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000059 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "menuCat": "Tables", "order": "59", "role": "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables", "shortName": "Accumulated Other Comprehensive Income (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "menuCat": "Statements", "order": "6", "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000060 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)", "menuCat": "Tables", "order": "60", "role": "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables", "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "0", "first": true, "lang": "en-US", "name": "dei:EntityNumberOfEmployees", "reportCount": 1, "unitRef": "employee", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000061 - Disclosure - Description of business (Details)", "menuCat": "Details", "order": "61", "role": "http://www.iconplc.com/role/DescriptionofbusinessDetails", "shortName": "Description of business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "INF", "lang": "en-US", "name": "iclr:NumberOfLocations", "reportCount": 1, "unique": true, "unitRef": "location", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000062 - Disclosure - Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)", "menuCat": "Details", "order": "62", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails", "shortName": "Summary of Significant accounting policies - Adjustments Resulting from Foreign Currency Translation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000063 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)", "menuCat": "Details", "order": "63", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails", "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Property Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i780da3ac80704e9a9f4584c0471959ae_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i423bdb53508049b790b135a49d542ab9_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000064 - Disclosure - Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)", "menuCat": "Details", "order": "64", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails", "shortName": "Summary of Significant accounting policies - Estimated Useful Lives of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000065 - Disclosure - Summary of Significant accounting policies - Narrative (Details)", "menuCat": "Details", "order": "65", "role": "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails", "shortName": "Summary of Significant accounting policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "iclr:StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i4e046e6a7e2e4fb8a81cc5a28f2ad352_I20200309", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000066 - Disclosure - Disaggregation of Revenue (Details)", "menuCat": "Details", "order": "66", "role": "http://www.iconplc.com/role/DisaggregationofRevenueDetails", "shortName": "Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i8b703a470aec45d6b7cc535d913a035b_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BilledContractReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000067 - Disclosure - Contract Balances (Details)", "menuCat": "Details", "order": "67", "role": "http://www.iconplc.com/role/ContractBalancesDetails", "shortName": "Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BilledContractReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "iclr:OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000068 - Disclosure - Contract Balances - Narrative (Details)", "menuCat": "Details", "order": "68", "role": "http://www.iconplc.com/role/ContractBalancesNarrativeDetails", "shortName": "Contract Balances - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iclr:AllowanceForDoubtfulAccountsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000069 - Disclosure - Allowances for Credit Losses (Details)", "menuCat": "Details", "order": "69", "role": "http://www.iconplc.com/role/AllowancesforCreditLossesDetails", "shortName": "Allowances for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "iclr:AllowanceForDoubtfulAccountsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ib7e5ed959ca1442c959fca1bf9fa7721_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME", "menuCat": "Statements", "order": "7", "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ib7e5ed959ca1442c959fca1bf9fa7721_I20191231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "id34237e03be942cc9cc2d0552e1de455_I20210701", "decimals": "-3", "first": true, "lang": "en-US", "name": "dei:EntityNumberOfEmployees", "reportCount": 1, "unitRef": "employee", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000070 - Disclosure - Business Combinations - Narrative, PRA Acquisition (Details)", "menuCat": "Details", "order": "70", "role": "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "shortName": "Business Combinations - Narrative, PRA Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701", "decimals": "INF", "lang": "en-US", "name": "iclr:BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000071 - Disclosure - Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)", "menuCat": "Details", "order": "71", "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "shortName": "Business Combinations - Fair Value of Consideration Transferred, PRA Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i2c7d61df1af34f86ba89d912d3f9d7ec_D20210701-20210701", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000072 - Disclosure - Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)", "menuCat": "Details", "order": "72", "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "shortName": "Business Combinations - Schedule of Acquisitions, PRA Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701", "decimals": "-3", "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9351c9d02ef249de88d6a39e2bdb6b06_I20210701", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000073 - Disclosure - Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)", "menuCat": "Details", "order": "73", "role": "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "shortName": "Business Combinations - Fair Value of Identified Intangible Assets Acquired, PRA Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i050bc2a0894b4b519c23ad5dce7c546e_D20210701-20210701", "decimals": null, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000074 - Disclosure - Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)", "menuCat": "Details", "order": "74", "role": "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails", "shortName": "Business Combinations - Schedule of Pro-Forma Information, PRA Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ie2a5ecab1da44652af4540e1ac699283_D20210701-20221231", "decimals": "-3", "lang": "en-US", "name": "iclr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000075 - Disclosure - Fair value - Narrative (Details)", "menuCat": "Details", "order": "75", "role": "http://www.iconplc.com/role/FairvalueNarrativeDetails", "shortName": "Fair value - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9eac6e85f2054a39b9b4982e267fcdef_I20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000076 - Disclosure - Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)", "menuCat": "Details", "order": "76", "role": "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "shortName": "Fair Value - Measurement of Fair Value of Major Asset and Liability classed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000077 - Disclosure - Investments - Narrative (Details)", "menuCat": "Details", "order": "77", "role": "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "shortName": "Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "lang": "en-US", "name": "iclr:ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000078 - Disclosure - Investments - Equity Method Investments (Details)", "menuCat": "Details", "order": "78", "role": "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "shortName": "Investments - Equity Method Investments (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000079 - Disclosure - Property, Plant and Equipment, net (Details)", "menuCat": "Details", "order": "79", "role": "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails", "shortName": "Property, Plant and Equipment, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "8", "role": "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i3bdf1ab44b5e470db76e3745541d3db7_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000080 - Disclosure - Goodwill - Schedule of Goodwill (Details)", "menuCat": "Details", "order": "80", "role": "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails", "shortName": "Goodwill - Schedule of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000081 - Disclosure - Goodwill - Narrative (Details)", "menuCat": "Details", "order": "81", "role": "http://www.iconplc.com/role/GoodwillNarrativeDetails", "shortName": "Goodwill - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillImpairmentLoss", "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000082 - Disclosure - Intangible Assets - Summary of Intangible Assets (Details)", "menuCat": "Details", "order": "82", "role": "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "shortName": "Intangible Assets - Summary of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i423bdb53508049b790b135a49d542ab9_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000083 - Disclosure - Intangible Assets - Narrative (Details)", "menuCat": "Details", "order": "83", "role": "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "shortName": "Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000084 - Disclosure - Intangible Assets - Future Intangible Asset Amortization Expense (Details)", "menuCat": "Details", "order": "84", "role": "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails", "shortName": "Intangible Assets - Future Intangible Asset Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherSundryLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000085 - Disclosure - Other Liabilities (Details)", "menuCat": "Details", "order": "85", "role": "http://www.iconplc.com/role/OtherLiabilitiesDetails", "shortName": "Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OtherSundryLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000086 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)", "menuCat": "Details", "order": "86", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails", "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000087 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)", "menuCat": "Details", "order": "87", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "shortName": "Non-current Bank Credit Lines and Loan Facilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i7b720d0c635c4b45ac4c627c84de8d89_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000088 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)", "menuCat": "Details", "order": "88", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails", "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Finance Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "iclr:DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000089 - Disclosure - Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)", "menuCat": "Details", "order": "89", "role": "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails", "shortName": "Non-current Bank Credit Lines and Loan Facilities - Schedule of Maturities of Long-term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Description of business", "menuCat": "Notes", "order": "9", "role": "http://www.iconplc.com/role/Descriptionofbusiness", "shortName": "Description of business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000090 - Disclosure - Derivatives - Narrative (Details)", "menuCat": "Details", "order": "90", "role": "http://www.iconplc.com/role/DerivativesNarrativeDetails", "shortName": "Derivatives - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "if27a87a7700d4f5fa4a149e379b8f150_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000091 - Disclosure - Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)", "menuCat": "Details", "order": "91", "role": "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "shortName": "Derivatives - Effect of Derivative Financial Instruments on Statement of Financial Position (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "if27a87a7700d4f5fa4a149e379b8f150_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000092 - Disclosure - Operating Leases - Lease Costs (Details)", "menuCat": "Details", "order": "92", "role": "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails", "shortName": "Operating Leases - Lease Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LeaseCost", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000093 - Disclosure - Operating Leases Operating Leases - Narrative (Details)", "menuCat": "Details", "order": "93", "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails", "shortName": "Operating Leases Operating Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000094 - Disclosure - Operating Leases Operating Leases - Operating Lease Maturity (Details)", "menuCat": "Details", "order": "94", "role": "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails", "shortName": "Operating Leases Operating Leases - Operating Lease Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000095 - Disclosure - Non-current other liabilities (Details)", "menuCat": "Details", "order": "95", "role": "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails", "shortName": "Non-current other liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000096 - Disclosure - Commitments and Contingencies - Narrative (Details)", "menuCat": "Details", "order": "96", "role": "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails", "shortName": "Commitments and Contingencies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "ia06e61e30b434302889007f7159b05f5_I20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "iclr:NumberOfVotes", "reportCount": 1, "unique": true, "unitRef": "vote", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000097 - Disclosure - Share Capital (Details)", "menuCat": "Details", "order": "97", "role": "http://www.iconplc.com/role/ShareCapitalDetails", "shortName": "Share Capital (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "iclr:NumberOfVotes", "reportCount": 1, "unique": true, "unitRef": "vote", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000098 - Disclosure - Restructuring charges - Narrative (Details)", "menuCat": "Details", "order": "98", "role": "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails", "shortName": "Restructuring charges - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i9f1c69ab13d0496aadcb84ce20aed759_D20220101-20221231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "iclr-20221231.htm", "contextRef": "i5cb1aceebcb948c8b64b9c78e8fc4fd7_D20220101-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000099 - Disclosure - Restructuring charges - Summary of Restructuring Charges (Details)", "menuCat": "Details", "order": "99", "role": "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails", "shortName": "Restructuring charges - Summary of Restructuring Charges (Details)", "subGroupType": "details", "uniqueAnchor": null } }, "segmentCount": 117, "tag": { "country_CH": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SWITZERLAND", "terseLabel": "Switzerland" } } }, "localname": "CH", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "domainItemType" }, "country_IE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IRELAND", "terseLabel": "Ireland" } } }, "localname": "IE", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States", "verboseLabel": "U.S." } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/DescriptionofbusinessDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r941", "r942", "r943" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r941", "r942", "r943" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r941", "r942", "r943" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r942", "r943" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]", "terseLabel": "Business Contact" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelEmailAddress": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Email address of contact personnel.", "label": "Contact Personnel Email Address", "terseLabel": "Contact Personnel Email Address" } } }, "localname": "ContactPersonnelEmailAddress", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name", "terseLabel": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r942" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard", "terseLabel": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r941", "r942", "r943" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r937" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement", "terseLabel": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r942" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report", "terseLabel": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r944" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r939" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity common stock, shares outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r939" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r939" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filler Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r945" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityNumberOfEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of persons employed by the Entity", "label": "Entity Number of Employees", "terseLabel": "Number of employees" } } }, "localname": "EntityNumberOfEmployees", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "decimalItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r939" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r939" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r946" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r941", "r942", "r943" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r938" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r940" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.iconplc.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "iclr_A2013LegacyPRAPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2013 Legacy PRA Plan", "label": "2013 Legacy PRA Plan [Member]", "terseLabel": "2013 Legacy PRA Plan" } } }, "localname": "A2013LegacyPRAPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_A2021RestructuringPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2021 Restructuring Plan", "label": "2021 Restructuring Plan [Member]", "terseLabel": "2021 Restructuring Plan" } } }, "localname": "A2021RestructuringPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_AccountsReceivableCreditLossExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Credit Loss Expense", "label": "Accounts Receivable, Credit Loss Expense", "terseLabel": "Amounts provided during the year" } } }, "localname": "AccountsReceivableCreditLossExpense", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AccountsReceivableCreditLossReversal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accounts Receivable, Credit Loss Reversal", "label": "Accounts Receivable, Credit Loss Reversal", "negatedLabel": "Amounts released during the year" } } }, "localname": "AccountsReceivableCreditLossReversal", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AccumulatedOtherComprehensiveIncomeLossTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income Loss [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncome" ], "xbrltype": "textBlockItemType" }, "iclr_AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax", "label": "Accumulated Other Comprehensive Loss, Amortization Of Cash Flow Hedges, Effect Net of Tax", "terseLabel": "Amortization of loss on cash flow hedge" } } }, "localname": "AccumulatedOtherComprehensiveLossAmortizationOfCashFlowHedgesEffectNetOfTax", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AcquiredEntityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquired Entity", "label": "Acquired Entity [Member]", "terseLabel": "Acquired entity" } } }, "localname": "AcquiredEntityMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, After Tax", "label": "Acumulated Other Comprehensive Loss, Cash Flow Hedge, Loss, Reclassification, after Tax", "negatedTerseLabel": "Loss on cash flow hedge" } } }, "localname": "AcumulatedOtherComprehensiveLossCashFlowHedgeLossReclassificationAfterTax", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AdjustmentToRetainedEarningShareRepurchaseCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment to Retained Earning Share Repurchase costs", "label": "Adjustment to Retained Earning Share Repurchase costs", "negatedLabel": "Share repurchase costs" } } }, "localname": "AdjustmentToRetainedEarningShareRepurchaseCosts", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "iclr_AdvancePaymentsNettedAgainstUnbilledContractsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advance Payments Netted Against Unbilled Contracts Receivable", "label": "Advance Payments Netted Against Unbilled Contracts Receivable", "terseLabel": "Net balance" } } }, "localname": "AdvancePaymentsNettedAgainstUnbilledContractsReceivable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AfimmuneLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Afimmune Limited", "label": "Afimmune Limited [Member]", "terseLabel": "Afimmune Limited" } } }, "localname": "AfimmuneLimitedMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "iclr_AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments", "label": "Allowance For Doubtful Accounts Foreign Currency Translation Adjustments", "terseLabel": "Foreign exchange" } } }, "localname": "AllowanceForDoubtfulAccountsForeignCurrencyTranslationAdjustments", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_AllowanceForDoubtfulAccountsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance for Doubtful Accounts, Table", "label": "Allowance for Doubtful Accounts [Table Text Block]", "terseLabel": "Schedule of Provision for Credit Losses" } } }, "localname": "AllowanceForDoubtfulAccountsTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesTables" ], "xbrltype": "textBlockItemType" }, "iclr_AllowanceForDoubtfulAccountsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Allowance For Doubtful Accounts [Text Block]", "label": "Allowance For Doubtful Accounts [Text Block]", "terseLabel": "Allowances for Credit Losses" } } }, "localname": "AllowanceForDoubtfulAccountsTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLosses" ], "xbrltype": "textBlockItemType" }, "iclr_AptivSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aptiv Solutions [Member]", "label": "Aptiv Solutions [Member]", "terseLabel": "Aptiv Solutions" } } }, "localname": "AptivSolutionsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_AptivSolutionsPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aptiv Solutions Pension Plan", "label": "Aptiv Solutions Pension Plan [Member]", "terseLabel": "Aptiv Solutions pension plan" } } }, "localname": "AptivSolutionsPensionPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://www.iconplc.com/20221231", "xbrltype": "stringItemType" }, "iclr_AwardDateAllYearsExcluding2018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award Date, Prior to 2018 [Member]", "label": "Award Date, All Years Excluding 2018 [Member]", "terseLabel": "Award date, prior to 2018" } } }, "localname": "AwardDateAllYearsExcluding2018Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held", "label": "Business Combination, Consideration Transferred, Cash Payment To Shareholders, Per Share Held", "terseLabel": "Business acquisition, share price (in USD per share)" } } }, "localname": "BusinessCombinationConsiderationTransferredCashPaymentToShareholdersPerShareHeld", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" ], "xbrltype": "perShareItemType" }, "iclr_BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date", "label": "Business Combination, Consideration Transferred, Payments To Settle Debt Obligations That Existed Prior To Acquisition Date", "terseLabel": "Payments to settle debt obligations that existed prior to acquisition date" } } }, "localname": "BusinessCombinationConsiderationTransferredPaymentsToSettleDebtObligationsThatExistedPriorToAcquisitionDate", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Consideration Transferred, Shares Issued, Per Current Share Held To Shareholders", "label": "Business Combination, Consideration Transferred, Shares Issued To Shareholders, Per Share Held", "terseLabel": "Business acquisition, number of shares issued (in shares)" } } }, "localname": "BusinessCombinationConsiderationTransferredSharesIssuedToShareholdersPerShareHeld", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" ], "xbrltype": "sharesItemType" }, "iclr_BusinessCombinationIntegrationRelatedCostsCredits": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Integration Related Costs (Credits)", "label": "Business Combination, Integration Related Costs (Credits)", "terseLabel": "Transaction and integration related (Note 6)" } } }, "localname": "BusinessCombinationIntegrationRelatedCostsCredits", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable and Unbilled Revenue", "terseLabel": "Accounts receivable and unbilled revenue" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsReceivableAndUnbilledRevenue", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses and Other Current Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Current Portion of Operating Lease Liabilities", "terseLabel": "Current portion of operating lease liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentPortionOfOperatingLeaseLiabilities", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Assets", "terseLabel": "Deferred tax assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxAssets", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill", "terseLabel": "Goodwill" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Deferred Tax Liabilities", "terseLabel": "Non-current deferred tax liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentDeferredTaxLiabilities", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Non-Current Portion of Operating Lease Liabilities", "terseLabel": "Non-current portion of operating lease liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNonCurrentPortionOfOperatingLeaseLiabilities", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use assets", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssets", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Non-Current Liabilities", "terseLabel": "Other non-current liabilities" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherNonCurrentLiabilities", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Unearned Revenue", "terseLabel": "Unearned revenue" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentUnearnedRevenue", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 16.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Contract With Customer, Liability, Current", "negatedTerseLabel": "Unearned revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractWithCustomerLiabilityCurrent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-of-Use Asset", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Asset", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAsset", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 13.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Operating Lease Liability", "negatedLabel": "Current portion of operating lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentOperatingLeaseLiability", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Operating Lease Liability", "negatedLabel": "Non-current portion of operating lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNoncurrentOperatingLeaseLiability", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_BuybackProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Buyback Program [Member]", "label": "Buyback Program [Member]", "terseLabel": "Buyback program" } } }, "localname": "BuybackProgramMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "iclr_CapitalGovernmentGrantsCurrent": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Government Grants Current", "label": "Capital Government Grants Current", "terseLabel": "Short term government grants" } } }, "localname": "CapitalGovernmentGrantsCurrent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable", "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable", "terseLabel": "Increase in advance payments netted against unbilled contracts receivable", "totalLabel": "Change in advance payments netted against unbilled contracts receivable" } } }, "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails", "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent", "label": "Change in Advance Payments Netted Against Unbilled Contracts Receivable, Percent", "terseLabel": "Change in advance payments netted against unbilled contracts receivable (in percent)" } } }, "localname": "ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivablePercent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "percentItemType" }, "iclr_Clients1125Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clients 11-25 [Member]", "label": "Clients 11-25 [Member]", "terseLabel": "Clients 11-25" } } }, "localname": "Clients1125Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "iclr_Clients25Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clients 2-5 [Member]", "label": "Clients 2-5 [Member]", "terseLabel": "Clients 2-5" } } }, "localname": "Clients25Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "iclr_Clients610Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clients 6-10 [Member]", "label": "Clients 6-10 [Member]", "terseLabel": "Clients 6-10" } } }, "localname": "Clients610Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "iclr_CommitmentToAcquireLongTermInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Commitment To Acquire Long-Term Investments", "label": "Commitment To Acquire Long-Term Investments", "terseLabel": "Commitment to acquire future long-term investments" } } }, "localname": "CommitmentToAcquireLongTermInvestments", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation Related Costs Share Based Payments Disclosure [Line Items]", "label": "Compensation Related Costs Share Based Payments Disclosure [Line Items]", "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Line Items]" } } }, "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureLineItems", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "iclr_CompensationRelatedCostsShareBasedPaymentsDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation Related Costs Share Based Payments Disclosure [Table]", "label": "Compensation Related Costs Share Based Payments Disclosure [Table]", "terseLabel": "Compensation Related Costs Share Based Payments Disclosure [Table]" } } }, "localname": "CompensationRelatedCostsShareBasedPaymentsDisclosureTable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "iclr_ComputerEquipmentAndCapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Equipment and Capitalized Software [Member]", "label": "Computer Equipment and Capitalized Software [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentAndCapitalizedSoftwareMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "iclr_ConsultantsRestrictedStockUnitsTwentyNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultants Restricted Stock Units Twenty Nineteen [Member]", "label": "Consultants Restricted Stock Units Twenty Nineteen [Member]", "terseLabel": "Consultants Restricted Stock Units 2019" } } }, "localname": "ConsultantsRestrictedStockUnitsTwentyNineteenMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_ConsultantsStockPlan2008PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultants Stock Plan, 2008 Plan [Member]", "label": "Consultants Stock Plan, 2008 Plan [Member]", "terseLabel": "Consultants Stock Plan, 2008 Plan" } } }, "localname": "ConsultantsStockPlan2008PlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_ContractsReceivableGross": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 1.0, "parentTag": "iclr_ContractsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contracts Receivable", "label": "Contracts Receivable, Gross", "totalLabel": "Accounts receivable (net)" } } }, "localname": "ContractsReceivableGross", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_ContractsReceivableNet": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contracts Receivable, Net", "label": "Contracts Receivable, Net", "totalLabel": "Accounts receivable and unbilled revenue, net" } } }, "localname": "ContractsReceivableNet", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_CorvusPharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corvus Pharmaceuticals", "label": "Corvus Pharmaceuticals [Member]", "terseLabel": "Corvus Pharmaceuticals" } } }, "localname": "CorvusPharmaceuticalsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "iclr_DSBiopharmaLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DS Biopharma Limited [Member]", "label": "DS Biopharma Limited [Member]", "terseLabel": "DS Biopharma Limited" } } }, "localname": "DSBiopharmaLimitedMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "iclr_DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements", "label": "Debt Securities, Available For Sale, Cumulative Amount Advanced Under Subscription Agreements", "terseLabel": "Debt securities, available for sale, cumulative amount advanced under subscription agreements" } } }, "localname": "DebtSecuritiesAvailableForSaleCumulativeAmountAdvancedUnderSubscriptionAgreements", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DeferredTaxAssetContractWithCustomerLiability": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Asset, Contract With Customer, Liability", "label": "Deferred Tax Asset, Contract With Customer, Liability", "terseLabel": "Unearned revenue" } } }, "localname": "DeferredTaxAssetContractWithCustomerLiability", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration", "label": "Deferred Tax Assets, Additional Tax Credit Carryforwards Not Subject to Expiration", "terseLabel": "Ireland subsidiaries additional tax credit carryforward for income tax" } } }, "localname": "DeferredTaxAssetsAdditionalTaxCreditCarryforwardsNotSubjectToExpiration", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DeferredTaxAssetsOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Operating Lease, Liability", "label": "Deferred Tax Assets, Operating Lease, Liability", "terseLabel": "Operating lease liabilities" } } }, "localname": "DeferredTaxAssetsOperatingLeaseLiability", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards", "label": "Deferred Tax Assets Operating Loss And Tax Credits Carryforwards", "terseLabel": "Operating loss and tax credits carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossAndTaxCreditsCarryforwards", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost", "label": "Defined Benefit Plan, Actuarial Losses to be Amortized and Reclassified from Accumulated Other Comprehensive Income (Loss) to Net Pension Cost", "negatedLabel": "Actuarial (gain)/loss - benefit obligation" } } }, "localname": "DefinedBenefitPlanActuarialLossesToBeAmortizedAndReclassifiedFromAccumulatedOtherComprehensiveIncomeLossToNetPensionCost", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Plan Period", "terseLabel": "Pension plan period" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationPlanPeriod", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "durationItemType" }, "iclr_DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid And Increase (Decrease) For Balance Transfers", "terseLabel": "Benefits paid and transferred balances" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaidAndIncreaseDecreaseForBalanceTransfers", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid And Increase (Decrease) For Balance Transfers", "terseLabel": "Benefits paid and transferred balances" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaidAndIncreaseDecreaseForBalanceTransfers", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DefinedBenefitPlanSchemeContributions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Scheme Contributions", "label": "Defined Benefit Plan, Scheme Contributions", "terseLabel": "Scheme contributions" } } }, "localname": "DefinedBenefitPlanSchemeContributions", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "iclr_DerivativeVariableInterestRateReferenceRateInExcessOf": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Variable Interest Rate, Reference Rate In Excess Of", "label": "Derivative, Variable Interest Rate, Reference Rate In Excess Of", "terseLabel": "Derivative, variable interest rate, reference rate in excess of" } } }, "localname": "DerivativeVariableInterestRateReferenceRateInExcessOf", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "percentItemType" }, "iclr_DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure Of Detailed Information About Financing Cost", "label": "Disclosure Of Detailed Information About Financing Cost [Table Text Block]", "terseLabel": "Schedule of Financing Cost" } } }, "localname": "DisclosureOfDetailedInformationAboutFinancingCostTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "iclr_DiversifiedBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified Bonds", "label": "Diversified Bonds [Member]", "terseLabel": "Diversified Bonds" } } }, "localname": "DiversifiedBondsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "iclr_EmployeeStockPlanTwentyZeroEightPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Plan, 2008 Plan [Member]", "label": "Employee Stock Plan, 2008 Plan [Member]", "terseLabel": "Employee Stock Plan, 2008 Plan" } } }, "localname": "EmployeeStockPlanTwentyZeroEightPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_EquityMethodInvestmentDecreaseInLoanReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Decrease In Loan Receivable", "label": "Equity Method Investment, Decrease In Loan Receivable", "terseLabel": "Equity method investment, decrease in loan receivable" } } }, "localname": "EquityMethodInvestmentDecreaseInLoanReceivable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_EquityMethodInvestmentMajorityOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Majority Ownership Percentage", "label": "Equity Method Investment, Majority Ownership Percentage", "terseLabel": "Majority investor, ownership percentage" } } }, "localname": "EquityMethodInvestmentMajorityOwnershipPercentage", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "iclr_EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company", "label": "Equity Method Investment, Period Majority Voting Share Capital Can Be Sold To The Company", "terseLabel": "Period majority voting share capital can be sold to the company" } } }, "localname": "EquityMethodInvestmentPeriodMajorityVotingShareCapitalCanBeSoldToTheCompany", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "durationItemType" }, "iclr_ExpectedRetirementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected Retirement period", "label": "Expected Retirement period", "terseLabel": "Retirement period used as a basis to estimate expected cash flows" } } }, "localname": "ExpectedRetirementPeriod", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "durationItemType" }, "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finite Lived Intangible Assets, Amortization Expense, Net", "label": "Finite Lived Intangible Assets, Amortization Expense, Net", "totalLabel": "Finite lived intangible assets, amortization expense, net, total" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNet", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "iclr_ForeignCurrencyDisclosureTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign Currency Disclosure", "label": "Foreign Currency Disclosure [Table Text Block]", "terseLabel": "Adjustments resulting from foreign currency translations" } } }, "localname": "ForeignCurrencyDisclosureTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" ], "xbrltype": "textBlockItemType" }, "iclr_GainLossOnIssuanceOfDebt": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) On Issuance Of Debt", "label": "Gain (Loss) On Issuance Of Debt", "negatedTerseLabel": "Loss on issuance of debt" } } }, "localname": "GainLossOnIssuanceOfDebt", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "iclr_GovernmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Bonds", "label": "Government Bonds [Member]", "terseLabel": "Government Bonds" } } }, "localname": "GovernmentBondsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "iclr_GovernmentGrantsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Grants, Policy", "label": "Government Grants [Policy Text Block]", "terseLabel": "Government grants" } } }, "localname": "GovernmentGrantsPolicyTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "iclr_ICONDevelopmentSolutionsLimitedPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ICON Development Solutions Limited Pension Plan", "label": "ICON Development Solutions Limited Pension Plan [Member]", "terseLabel": "ICON Development Solutions Limited pension plan" } } }, "localname": "ICONDevelopmentSolutionsLimitedPensionPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "iclr_IncomeBeforeIncomeTaxTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Before Income Tax, Table", "label": "Income Before Income Tax [Table Text Block]", "terseLabel": "Summary of Components of Income Before Provision for Income Taxes" } } }, "localname": "IncomeBeforeIncomeTaxTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Noncontrolling Interest", "totalLabel": "Income before share of earnings from equity method investments" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "iclr_IncomeTaxBenefitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income Tax Benefit [Member]", "label": "Income Tax Benefit [Member]", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxBenefitMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Contract with Customer, Liability, Gross, Current, Percent", "label": "Increase (Decrease) In Contract With Customer, Liability, Gross, Current, Percent", "terseLabel": "Change in unearned revenue (payments on account) (in percent)" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiabilityGrossCurrentPercent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "percentItemType" }, "iclr_IncreaseDecreaseInContractsWithCustomersLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 2.0, "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Contracts With Customers, Liability, Current", "label": "Increase (Decrease) In Contracts With Customers, Liability, Current", "negatedTerseLabel": "Change in unearned revenue (payments on account)", "terseLabel": "Change in unearned revenue (payments on account)" } } }, "localname": "IncreaseDecreaseInContractsWithCustomersLiabilityCurrent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails", "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrent": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 1.0, "parentTag": "iclr_ChangeinAdvancePaymentsNettedAgainstUnbilledContractsReceivable", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current", "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current", "terseLabel": "Change in unbilled receivables" } } }, "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails", "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent", "label": "Increase (Decrease) In Contract with Customer, Asset, Gross, Current, Percent", "terseLabel": "Change in unbilled receivables (in percent)" } } }, "localname": "IncreaseDecreaseInContractwithCustomerAssetGrossCurrentPercent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "percentItemType" }, "iclr_IncreaseDecreaseInEquityMethodInvestments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Equity Method Investments", "label": "Increase (Decrease) In Equity Method Investments", "terseLabel": "Increase (decrease) in equity method investments" } } }, "localname": "IncreaseDecreaseInEquityMethodInvestments", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_InterestExpenseCreditOther": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest Expense (Credit), Other", "label": "Interest Expense (Credit), Other", "terseLabel": "Other financing costs/(credits)" } } }, "localname": "InterestExpenseCreditOther", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" ], "xbrltype": "monetaryItemType" }, "iclr_InterestRateCapAndInterestRateSwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Cap And Interest Rate Swap", "label": "Interest Rate Cap And Interest Rate Swap [Member]", "terseLabel": "Interest rate cap and interest rate swap" } } }, "localname": "InterestRateCapAndInterestRateSwapMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "iclr_InterestReceivableRelatedPartyLoans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest Receivable, Related Party Loans", "label": "Interest Receivable, Related Party Loans", "terseLabel": "Interest receivable, related party loans" } } }, "localname": "InterestReceivableRelatedPartyLoans", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_LeaseLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Liability", "label": "Lease Liability [Member]", "terseLabel": "Lease Liability" } } }, "localname": "LeaseLiabilityMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limit of Shares Issued or To Be Issued Pursuant to Options Granted", "label": "Limit Of Shares Issued Or To Be Issued Pursuant To Options Granted", "terseLabel": "Limit of shares issued or to be issued pursuant to options granted (in shares)" } } }, "localname": "LimitOfSharesIssuedOrToBeIssuedPursuantToOptionsGranted", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "iclr_LongTermDebtCurrentMaturitiesGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term Debt, Current Maturities, Gross", "label": "Long-term Debt, Current Maturities, Gross", "negatedTerseLabel": "Less current portion of long-term debt and debt issuance costs" } } }, "localname": "LongTermDebtCurrentMaturitiesGross", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "iclr_LongTermDebtExcludingCurrentMaturitiesGross": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term Debt, Excluding Current Maturities, Gross", "label": "Long-term Debt, Excluding Current Maturities, Gross", "terseLabel": "Total long-term debt" } } }, "localname": "LongTermDebtExcludingCurrentMaturitiesGross", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "iclr_LongTermDebtMaturityYearFiveAndThereafter": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Maturity, Year Five And Thereafter", "label": "Long-Term Debt, Maturity, Year Five And Thereafter", "terseLabel": "2027 and thereafter" } } }, "localname": "LongTermDebtMaturityYearFiveAndThereafter", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "iclr_MeDiNovaResearchMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MeDiNova Research [Member]", "label": "MeDiNova Research [Member]", "terseLabel": "MeDiNova" } } }, "localname": "MeDiNovaResearchMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_NonexecutiveDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-executive Director [Member]", "label": "Non-executive Director [Member]", "terseLabel": "Non-executive director" } } }, "localname": "NonexecutiveDirectorMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_NumberOfLocations": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Locations", "label": "Number of Locations", "terseLabel": "Number of locations in which company operates" } } }, "localname": "NumberOfLocations", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "integerItemType" }, "iclr_NumberOfVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Votes", "label": "Number Of Votes", "terseLabel": "Number of votes" } } }, "localname": "NumberOfVotes", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "integerItemType" }, "iclr_OncacareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oncacare", "label": "Oncacare [Member]", "terseLabel": "Oncacare" } } }, "localname": "OncacareMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "iclr_OperatingIncomeByGeographyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Income by Geography.", "label": "Operating Income by Geography [Table Text Block]", "terseLabel": "Schedule of Distribution of Income from Operations by Geographical Area" } } }, "localname": "OperatingIncomeByGeographyTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "xbrltype": "textBlockItemType" }, "iclr_OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses", "label": "Operating Income (Loss) Before Restructuring Charges, Transaction And Integration Expenses", "terseLabel": "Income from operations, excluding restructuring and other items" } } }, "localname": "OperatingIncomeLossBeforeRestructuringChargesTransactionAndIntegrationExpenses", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails" ], "xbrltype": "monetaryItemType" }, "iclr_OperatingLossCarryforwardsUSFederal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, US Federal", "label": "Operating Loss Carryforwards, US Federal", "terseLabel": "U.S. Federal net operating loss carry forwards currently available for offset" } } }, "localname": "OperatingLossCarryforwardsUSFederal", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "iclr_OptionPlans2008Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Plans 2008 [Member]", "label": "Option Plans 2008 [Member]", "terseLabel": "Option Plans 2008" } } }, "localname": "OptionPlans2008Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax", "label": "Other Comprehensive Income, Amortization of Net Actuarial Gain (Loss), Net of Tax", "negatedLabel": "Actuarial loss recognized in net periodic benefit cost" } } }, "localname": "OtherComprehensiveIncomeAmortizationOfNetActuarialGainLossNetOfTax", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "monetaryItemType" }, "iclr_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Countries [Member]", "label": "Other Countries [Member]", "terseLabel": "Other" } } }, "localname": "OtherCountriesMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_OtherCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Customers [Member]", "label": "Other Customers [Member]", "terseLabel": "Other" } } }, "localname": "OtherCustomersMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "iclr_OtherGeographicLocationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Geographic Locations [Member]", "label": "Other Geographic Locations [Member]", "terseLabel": "Rest of World" } } }, "localname": "OtherGeographicLocationsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "iclr_OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses", "label": "Other Liabilities, Amount Payable To Third Parties For Reimbursable Expenses", "terseLabel": "Amounts due to third parties for reimbursable expenses" } } }, "localname": "OtherLiabilitiesAmountPayableToThirdPartiesForReimbursableExpenses", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails", "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_OtherRetirementPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Retirement Plans", "label": "Other Retirement Plans [Member]", "terseLabel": "Other retirement plans" } } }, "localname": "OtherRetirementPlansMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_OtherUndenominatedCapital": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other undenominated capital.", "label": "Other Undenominated Capital", "terseLabel": "Other undenominated capital (Note 18b)" } } }, "localname": "OtherUndenominatedCapital", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "iclr_OtherUndenominatedCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other undenominated capital.", "label": "Other Undenominated Capital [Member]", "terseLabel": "Other Undenominated Capital" } } }, "localname": "OtherUndenominatedCapitalMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "domainItemType" }, "iclr_PRAHealthSciencesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PRA Health Sciences, Inc", "label": "PRA Health Sciences, Inc [Member]", "terseLabel": "PRA Health Sciences, Inc" } } }, "localname": "PRAHealthSciencesIncMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_PRASwitzerlandAGPensionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PRA Switzerland AG Pension Plan", "label": "PRA Switzerland AG Pension Plan [Member]", "terseLabel": "PRA Switzerland AG pension plan" } } }, "localname": "PRASwitzerlandAGPensionPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_PaymentsForShareRepurchaseCosts": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for Share Repurchase Costs", "label": "Payments for Share Repurchase Costs", "negatedLabel": "Share repurchase costs" } } }, "localname": "PaymentsForShareRepurchaseCosts", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "iclr_PerformanceBasedGrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Grants [Member]", "label": "Performance Based Grants [Member]", "terseLabel": "PSUs Based on Service and EPS Targets" } } }, "localname": "PerformanceBasedGrantsMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_PerformanceShareUnitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Share Unit [Member]", "label": "Performance Share Unit [Member]", "terseLabel": "Performance Share Unit (PSUs)" } } }, "localname": "PerformanceShareUnitMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "iclr_Range1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 1 [Member]", "label": "Range 1 [Member]", "terseLabel": "Range 1" } } }, "localname": "Range1Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "domainItemType" }, "iclr_Range2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 2 [Member]", "label": "Range 2 [Member]", "terseLabel": "Range 2" } } }, "localname": "Range2Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "domainItemType" }, "iclr_Range3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 3 [Member]", "label": "Range 3 [Member]", "terseLabel": "Range 3" } } }, "localname": "Range3Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "domainItemType" }, "iclr_Range4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range 4 [Member]", "label": "Range 4 [Member]", "terseLabel": "Range 4" } } }, "localname": "Range4Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "domainItemType" }, "iclr_ReconciliationOfProvisionOfIncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation of Provision of Income Taxes [Line Items]", "label": "Reconciliation of Provision of Income Taxes [Line Items]", "terseLabel": "Reconciliation of Provision of Income Taxes [Line Items]" } } }, "localname": "ReconciliationOfProvisionOfIncomeTaxesLineItems", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "iclr_ReconciliationOfProvisionOfIncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reconciliation of Provision of Income Taxes [Table]", "label": "Reconciliation of Provision of Income Taxes [Table]", "terseLabel": "Reconciliation of Provision of Income Taxes [Table]" } } }, "localname": "ReconciliationOfProvisionOfIncomeTaxesTable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "iclr_RedeemableNoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redeemable Noncontrolling Interest, Increase From Business Combination", "label": "Redeemable Noncontrolling Interest, Increase From Business Combination", "terseLabel": "Noncontrolling interest adjustment to redemption amount", "verboseLabel": "Noncontrolling interest adjustment to redemption amount" } } }, "localname": "RedeemableNoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "iclr_RedeemableNoncontrollingInterestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable Noncontrolling Interest [Member]", "label": "Redeemable Noncontrolling Interest [Member]", "terseLabel": "Redeemable Noncontrolling Interest" } } }, "localname": "RedeemableNoncontrollingInterestMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "domainItemType" }, "iclr_ResearchandDevelopmentCreditsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research and Development Credits [Policy Text Block]", "label": "Research and Development Credits [Policy Text Block]", "terseLabel": "Research and development credits" } } }, "localname": "ResearchandDevelopmentCreditsPolicyTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "iclr_RestOfEuropeAndOtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest Of Europe And Other Countries [Member]", "label": "Rest Of Europe And Other Countries [Member]", "terseLabel": "Other" } } }, "localname": "RestOfEuropeAndOtherCountriesMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "iclr_RestOfEuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest Of Europe [Member]", "label": "Rest Of Europe [Member]", "terseLabel": "Rest of Europe" } } }, "localname": "RestOfEuropeMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" ], "xbrltype": "domainItemType" }, "iclr_RestrictedStockUnitsTwentyThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Units Twenty Thirteen [Member]", "label": "Restricted Stock Units Twenty Thirteen [Member]", "terseLabel": "Restricted Stock Units 2013" } } }, "localname": "RestrictedStockUnitsTwentyThirteenMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_RestructuringReserveUtilizations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve Utilizations", "label": "Restructuring Reserve Utilizations", "negatedLabel": "Utilization" } } }, "localname": "RestructuringReserveUtilizations", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" ], "xbrltype": "monetaryItemType" }, "iclr_RestructuringReserveandOtherLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve and Other Liabilities, Current", "label": "Restructuring Reserve and Other Liabilities, Current", "terseLabel": "Restructuring liabilities" } } }, "localname": "RestructuringReserveandOtherLiabilitiesCurrent", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "iclr_ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Adjusted Earnings Per Share, Basic and Diluted [Table Text Block]", "label": "Schedule Of Adjusted Earnings Per Share, Basic And Diluted [Table Text Block]", "terseLabel": "Reconciliation of net income attributable to the group per the statement of operating income and net income used for net income per ordinary share" } } }, "localname": "ScheduleOfAdjustedEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" ], "xbrltype": "textBlockItemType" }, "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]", "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]", "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]" } } }, "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "iclr_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]", "label": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]", "terseLabel": "Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]" } } }, "localname": "ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "iclr_ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Measurement Period Adjustments", "label": "Schedule Of Measurement Period Adjustments [Table Text Block]", "terseLabel": "Schedule of measurement period adjustments" } } }, "localname": "ScheduleOfMeasurementPeriodAdjustmentsTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "iclr_ScheduleOfNonCashStockCompensationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Non Cash Stock Compensation Expense.", "label": "Schedule of Non Cash Stock Compensation Expense [Table Text Block]", "terseLabel": "Schedule of Non-cash Stock Compensation Expense" } } }, "localname": "ScheduleOfNonCashStockCompensationExpenseTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" ], "xbrltype": "textBlockItemType" }, "iclr_ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]", "label": "Schedule Of Share Based Compensation Restricted Stock Units Performance Stock Units Award Activity [Table Text Block]", "terseLabel": "Summary of RSU and PSU Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsPerformanceStockUnitsAwardActivityTableTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" ], "xbrltype": "textBlockItemType" }, "iclr_ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Useful Lives For Property Plant Equipment", "label": "Schedule Of Useful Lives For Property Plant Equipment [Table Text Block]", "terseLabel": "Estimated useful lives of assets" } } }, "localname": "ScheduleOfUsefulLivesForPropertyPlantEquipmentTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" ], "xbrltype": "textBlockItemType" }, "iclr_SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Credit Facility And Senior Secured Notes", "label": "Senior Secured Credit Facility And Senior Secured Notes [Member]", "terseLabel": "Senior secured credit facility and senior secured notes" } } }, "localname": "SeniorSecuredCreditFacilityAndSeniorSecuredNotesMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_SeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Notes", "label": "Senior Secured Notes [Member]", "terseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSecuredNotesMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "iclr_SeniorSecuredRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Revolving Credit Facility", "label": "Senior Secured Revolving Credit Facility [Member]", "terseLabel": "Senior Secured Revolving Credit Facility" } } }, "localname": "SeniorSecuredRevolvingCreditFacilityMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_SeniorSecuredRevolvingLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Revolving Loan Facility", "label": "Senior Secured Revolving Loan Facility [Member]", "terseLabel": "Senior secured revolving loan facility" } } }, "localname": "SeniorSecuredRevolvingLoanFacilityMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Per Share", "terseLabel": "Share price of equity instruments other than options, vested in period (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodFairValuePerShare", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed Through Business Combination", "terseLabel": "Assumed through business combination (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedThroughBusinessCombination", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "iclr_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Outstanding Shares Authorized", "terseLabel": "Percentage of outstanding shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingSharesAuthorized", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "percentItemType" }, "iclr_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price", "label": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Assumed In Business Combination, Weighted Average Exercise Price", "terseLabel": "Assumed through business combination (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInBusinessCombinationWeightedAverageExercisePrice", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "iclr_ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short Term Available For Sale Investments Average Remaining Maturity Period", "label": "Short Term Available For Sale Investments Average Remaining Maturity Period", "terseLabel": "Short term investments average maturity period" } } }, "localname": "ShortTermAvailableForSaleInvestmentsAverageRemainingMaturityPeriod", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "durationItemType" }, "iclr_StockOptionAndAwardPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Option And Award Plans [Member]", "label": "Stock Option And Award Plans [Member]", "terseLabel": "Stock Option and Award Plans" } } }, "localname": "StockOptionAndAwardPlansMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "iclr_StockRepurchaseProgramAuthorizedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program Authorized Percentage", "label": "Stock Repurchase Program Authorized Percentage", "terseLabel": "Stock repurchase program, authorized percentage (in percent)" } } }, "localname": "StockRepurchaseProgramAuthorizedPercentage", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "iclr_StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy", "label": "Stockholders' Equity Note, Redeemable Non-Controlling Interest, Policy [Policy Text Block]", "terseLabel": "Redeemable non-controlling interests and equity" } } }, "localname": "StockholdersEquityNoteRedeemableNonControllingInterestPolicyPolicyTextBlock", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "iclr_TaxYear2022To2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2020 to 2026 [Member]", "label": "Tax Year 2022 to 2028 [Member]", "terseLabel": "Tax Year 2022 to 2028" } } }, "localname": "TaxYear2022To2028Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_TaxYear2023To2036Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2023 to 2036", "label": "Tax Year 2023 to 2036 [Member]", "terseLabel": "2023-2036" } } }, "localname": "TaxYear2023To2036Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" ], "xbrltype": "domainItemType" }, "iclr_TaxYear2029To2038Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2027 to 2036 [Member]", "label": "Tax Year 2029 to 2038 [Member]", "terseLabel": "Tax Year 2029 to 2038" } } }, "localname": "TaxYear2029To2038Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_TaxYear20332041Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tax Year 2033-2041", "label": "Tax Year 2033-2041 [Member]", "terseLabel": "2033-2041" } } }, "localname": "TaxYear20332041Member", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" ], "xbrltype": "domainItemType" }, "iclr_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility", "label": "Term Loan Facility [Member]", "terseLabel": "Senior Secured Term Loan" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "iclr_The2018LegacyPRAPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2018 Plan", "label": "The 2018 Legacy PRA Plan [Member]", "terseLabel": "The 2018 Legacy PRA Plan" } } }, "localname": "The2018LegacyPRAPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_The2020LegacyPRAPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2020 Legacy PRA Plan", "label": "The 2020 Legacy PRA Plan [Member]", "terseLabel": "The 2020 Legacy PRA Plan" } } }, "localname": "The2020LegacyPRAPlanMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_TopClientMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Top Client [Member]", "label": "Top Client [Member]", "terseLabel": "Top client" } } }, "localname": "TopClientMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "iclr_TransactionAndIntegrationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction And Integration Expense", "label": "Transaction And Integration Expense [Member]", "terseLabel": "Transaction and integration related" } } }, "localname": "TransactionAndIntegrationExpenseMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "iclr_TransactionAndOneTimeFinancingCosts": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": { "order": 4.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction And One Time Financing Costs", "label": "Transaction And One Time Financing Costs", "terseLabel": "Transaction and one time financing costs" } } }, "localname": "TransactionAndOneTimeFinancingCosts", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" ], "xbrltype": "monetaryItemType" }, "iclr_VariableRateComponentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component", "label": "Variable Rate Component [Axis]", "terseLabel": "Variable Rate Component [Axis]" } } }, "localname": "VariableRateComponentAxis", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "iclr_VariableRateComponentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component [Domain]", "label": "Variable Rate Component [Domain]", "terseLabel": "Variable Rate Component [Domain]" } } }, "localname": "VariableRateComponentDomain", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_VariableRateComponentOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component One", "label": "Variable Rate Component One [Member]", "terseLabel": "Variable rate component one" } } }, "localname": "VariableRateComponentOneMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_VariableRateComponentTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Rate Component Two", "label": "Variable Rate Component Two [Member]", "terseLabel": "Variable rate component two" } } }, "localname": "VariableRateComponentTwoMember", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "iclr_VehiclesGross": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 7.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Vehicles, Gross", "label": "Vehicles, Gross", "terseLabel": "Motor vehicles" } } }, "localname": "VehiclesGross", "nsuri": "http://www.iconplc.com/20221231", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r418", "r911", "r1007", "r1131" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r471", "r472", "r473", "r474", "r627", "r827", "r861", "r890", "r891", "r907", "r926", "r936", "r1001", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/ShareCapitalDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r471", "r472", "r473", "r474", "r627", "r827", "r861", "r890", "r891", "r907", "r926", "r936", "r1001", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r418", "r911", "r1007", "r1131" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r471", "r472", "r473", "r474", "r570", "r627", "r664", "r665", "r666", "r826", "r827", "r861", "r890", "r891", "r907", "r926", "r936", "r994", "r1001", "r1125", "r1126", "r1127", "r1128", "r1129" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/ShareCapitalDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r471", "r472", "r473", "r474", "r570", "r627", "r664", "r665", "r666", "r826", "r827", "r861", "r890", "r891", "r907", "r926", "r936", "r994", "r1001", "r1125", "r1126", "r1127", "r1128", "r1129" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/ShareCapitalDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r415", "r416", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r910", "r935", "r1007" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/DescriptionofbusinessDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r415", "r416", "r875", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r910", "r935", "r1007" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/DescriptionofbusinessDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r976", "r1120" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate202108Member": { "auth_ref": [ "r721", "r722" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2021-08 Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.", "label": "Accounting Standards Update 2021-08 [Member]", "terseLabel": "Accounting Standards Update 2021-08" } } }, "localname": "AccountingStandardsUpdate202108Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as noncurrent at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Noncurrent [Text Block]", "terseLabel": "Non-current other liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureNoncurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/Noncurrentotherliabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r14", "r934" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]", "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]" } } }, "localname": "AccountsReceivableNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r420", "r421" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for credit losses (Note 4)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r2", "r256", "r277" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r4", "r256", "r277" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Non-current income taxes payable" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedUtilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Utilities, Current", "terseLabel": "Facility related liabilities" } } }, "localname": "AccruedUtilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r107", "r303" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and asset write offs" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": { "auth_ref": [ "r27", "r32", "r1049" ], "calculation": { "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": { "order": 3.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax", "negatedLabel": "Actuarial gain/(loss) on defined benefit pension plan (note 21)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r316", "r319", "r320", "r321", "r762" ], "calculation": { "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": { "order": 4.0, "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "terseLabel": "Currency translation adjustments" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r29", "r31", "r32", "r311", "r855", "r869", "r873" ], "calculation": { "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income (Note 25)", "totalLabel": "Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeDetails", "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r28", "r32", "r217", "r814", "r864", "r865", "r956", "r957", "r958", "r970", "r971", "r972" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Estimated Useful Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r9" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r673", "r674", "r675", "r970", "r971", "r972", "r1108" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r356", "r357", "r358", "r359", "r368", "r423", "r424", "r429", "r430", "r431", "r432", "r433", "r434", "r673", "r674", "r675", "r705", "r706", "r707", "r708", "r721", "r722", "r723", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r788", "r789", "r793", "r794", "r795", "r796", "r809", "r810", "r811", "r812", "r813", "r814", "r832", "r833", "r834", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Accounting Standards Update [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.", "label": "APIC, Share-Based Payment Arrangement, Other, Increase for Cost Recognition", "terseLabel": "Replacement share-based awards issued to acquiree employees" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r175", "r176", "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r132", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedLabel": "Share issue costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r312", "r422", "r435", "r436", "r439" ], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 2.0, "parentTag": "iclr_ContractsReceivableGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedTerseLabel": "Allowance for credit losses (note 5)", "periodEndLabel": "Closing provision", "periodStartLabel": "Opening provision" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails", "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r438" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedLabel": "Amounts used during the year" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AllowancesforCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r37", "r501", "r791", "r964" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of financing costs and debt discount" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r58", "r94", "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember": { "auth_ref": [ "r981", "r1030" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced with cash flows derived financial assets that are being securitized for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans. Excludes mortgage-backed securities.", "label": "Asset-Backed Securities, Securitized Loans and Receivables [Member]", "terseLabel": "Secured Loans and Multi Asset Credit" } } }, "localname": "AssetBackedSecuritiesSecuritizedLoansAndReceivablesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r254", "r276", "r307", "r347", "r400", "r405", "r410", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r727", "r731", "r764", "r934", "r999", "r1000", "r1122" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r298", "r313", "r347", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r727", "r731", "r764", "r934", "r999", "r1000", "r1122" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r237" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current Assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r82", "r440" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Debt Securities, Available-for-Sale, Current", "terseLabel": "Available for sale investments (Note 8a)", "verboseLabel": "Available for sale investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": { "auth_ref": [ "r82", "r301", "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.", "label": "Debt Securities, Available-for-Sale, Noncurrent", "terseLabel": "Available for sale investments (long-term) (b)" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]", "terseLabel": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]", "terseLabel": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r639", "r640", "r641", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BilledContractReceivables": { "auth_ref": [ "r829" ], "calculation": { "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 1.0, "parentTag": "iclr_ContractsReceivableGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amounts due for billed services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the Company and, at a minimum, one other party. An example would be amounts billed to customers under contracts or programs but not paid as of the balance sheet date.", "label": "Billed Contracts Receivable", "terseLabel": "Billed services (accounts receivable)" } } }, "localname": "BilledContractReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r106" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Building" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r719", "r920", "r923" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r193", "r194", "r719", "r920", "r923" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "verboseLabel": "Percentage of share capital acquired (in percent)" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Goodwill, expected tax deductible amount" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r205", "r206", "r207" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r205", "r206" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Fair value of ordinary shares issued to acquiree stockholders" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r204", "r205", "r206", "r725" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Repayment of term loan obligations and accrued interest" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r208" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Fair value of replacement share-based awards issued to acquiree employees" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r212", "r720" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIntegrationRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.", "label": "Business Combination, Integration Related Costs", "terseLabel": "Transaction and integration related (Note 6)" } } }, "localname": "BusinessCombinationIntegrationRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": { "auth_ref": [ "r198" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": { "auth_ref": [ "r198" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment", "terseLabel": "Fixed assets" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": { "auth_ref": [ "r718" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.", "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period", "terseLabel": "Amortization adjustment" } } }, "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 15.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "verboseLabel": "Accounts receivable and unbilled revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 10.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 12.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedNetLabel": "Accrued expenses and other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets", "verboseLabel": "Deferred tax assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r195", "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "netLabel": "Estimated Fair Value", "terseLabel": "Intangible assets", "verboseLabel": "Value of intangible assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 11.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedTerseLabel": "Other non-current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r195", "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 14.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "verboseLabel": "Fixed assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r196" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.", "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage", "terseLabel": "Business combination acquisition percentage (in percent)" } } }, "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r189" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations", "verboseLabel": "Transaction and Integration-related Expenses" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r1134" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Capitalized Computer Software, Gross", "terseLabel": "Computer equipment and software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r60", "r300", "r893" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r55", "r60", "r63" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r55", "r243" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease)/increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Supplemental Disclosure of Cash Flow Information" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.", "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]", "terseLabel": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan" } } }, "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r138", "r139", "r140", "r141" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r23", "r263", "r283" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 17)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r119", "r469", "r470", "r877", "r998" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r970", "r971", "r1108" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value (in EUR per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Ordinary shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Ordinary shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r132" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Ordinary shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r8", "r934" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary shares par value 6 euro cents per share; 100,000,000 shares authorized, (Note 18). 81,723,555 shares issued and outstanding at December 31, 2022 and 81,554,683 shares issued and outstanding at December 31, 2021." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Reimbursable expenses and Direct costs" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r34", "r325", "r327", "r335", "r851", "r858" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "terseLabel": "Total comprehensive income attributable to the Group", "totalLabel": "Total comprehensive income attributable to the Group" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r214", "r215", "r218", "r325", "r327", "r334", "r850", "r857" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Less net income attributable to noncontrolling interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r213", "r218", "r325", "r327", "r333", "r849", "r856" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r70", "r71", "r241", "r242", "r418", "r876" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r70", "r71", "r241", "r242", "r418", "r874", "r876" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r70", "r71", "r241", "r242", "r418", "r876", "r1133" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r70", "r71", "r241", "r242", "r418" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "verboseLabel": "Percentage of company revenue (in percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r70", "r71", "r241", "r242", "r418", "r876" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r216", "r896" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Basis of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r1005" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Contracts with Customers, Asset and Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetCreditLossExpense": { "auth_ref": [ "r437", "r541", "r908" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense" } } }, "localname": "ContractWithCustomerAssetCreditLossExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetGrossCurrent": { "auth_ref": [ "r1003", "r1004" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.iconplc.com/role/ContractBalancesDetails": { "order": 2.0, "parentTag": "iclr_ContractsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, before Allowance for Credit Loss, Current", "netLabel": "Unbilled services (unbilled revenue)", "terseLabel": "Unbilled revenue (Note 4)" } } }, "localname": "ContractWithCustomerAssetGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r520", "r521", "r543" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "negatedTerseLabel": "Unearned revenue (payments on account)", "terseLabel": "Unearned revenue (Note 4)" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/ContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r916", "r918", "r1132" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate Bonds (including 50% high yield bonds)" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r42", "r830" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Direct costs (excluding depreciation and amortization)" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Direct costs", "verboseLabel": "Cost of Sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r38" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy": { "auth_ref": [ "r114", "r115", "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.", "label": "Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]", "terseLabel": "Restructuring" } } }, "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r188", "r702", "r712", "r967" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current tax expense" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current tax expense:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DatabasesMember": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal rights granted to the owner or licensee of collections of information stored in electronic form (such as on computer disks or files).", "label": "Database Rights [Member]", "terseLabel": "Patient database" } } }, "localname": "DatabasesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r1", "r2", "r3", "r255", "r259", "r273", "r351", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r792", "r902", "r903", "r904", "r905", "r906", "r965" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate (in percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r3", "r259", "r273", "r503" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "terseLabel": "Total debt" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r245", "r247", "r486", "r792", "r903", "r904" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r20", "r487" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument, interest rate (in percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r21", "r351", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r792", "r902", "r903", "r904", "r905", "r906", "r965" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r21", "r133", "r134", "r135", "r136", "r244", "r245", "r247", "r271", "r351", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r792", "r902", "r903", "r904", "r905", "r906", "r965" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r244", "r247", "r1002" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt discount paid" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r246", "r492", "r504", "r903", "r904" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedTerseLabel": "Less long-term portion of debt issuance costs and debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Debt Issuance Costs" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r246" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Gross debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r682", "r683" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax asset (Note 20)" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r58", "r188", "r703", "r711", "r712", "r967" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred tax (benefit)/expense" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred tax (benefit)/expense:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r5", "r6", "r257", "r272", "r696" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Total deferred tax liabilities recognized" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r682", "r683" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability (Note 20)" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r59" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred tax (benefit)/expense" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "terseLabel": "Intangible assets" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r697" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r1102" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax assets recognized" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "totalLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Other non-U.S subsidiaries operating loss carryforwards for income tax", "verboseLabel": "Net operating loss carryforwards, not subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Additional operating loss carryforward", "verboseLabel": "Net operating loss carryforwards, subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax": { "auth_ref": [ "r184", "r186", "r1103" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible alternative minimum tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax", "terseLabel": "Alternative minimum tax credit carry forwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other", "terseLabel": "Stock compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.", "label": "Deferred Tax Assets, Tax Deferred Expense, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "terseLabel": "Accrued expenses and unbilled revenue" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r698" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance for deferred tax assets", "terseLabel": "Valuation allowance for deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r177", "r1102" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Overall net deferred tax asset/(liability)" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": { "auth_ref": [ "r186", "r210", "r211", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.", "label": "Deferred Tax Liabilities, Goodwill", "terseLabel": "Goodwill" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "terseLabel": "Operating right-of-use-assets" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.", "label": "Deferred Tax Liabilities, Other Finite-Lived Assets", "terseLabel": "Intangible assets" } } }, "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r186", "r1103" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "terseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTaxEffectsofTemporaryDifferencesThatGiveRisetoSignificantPortionsofDeferredTaxAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r1103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Deferred tax liabilities, undistributed foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r4", "r145", "r146", "r148" ], "calculation": { "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Defined benefit pension obligations, net (note 21)" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r561", "r918" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedTerseLabel": "Actuarial gain" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r548", "r586", "r612", "r918", "r919" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "negatedLabel": "Amortization of net loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r548", "r587", "r613", "r918", "r919" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Prior service cost" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "auth_ref": [ "r253", "r275", "r546", "r547", "r569", "r918" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.", "label": "Assets for Plan Benefits, Defined Benefit Plan", "verboseLabel": "Other receivables" } } }, "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate", "terseLabel": "Discount rate" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r595", "r617" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets", "verboseLabel": "Expected rate of return on plan assets" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase", "terseLabel": "Rate of compensation increase" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation", "periodEndLabel": "Benefit obligation at end of year", "periodStartLabel": "Benefit obligation at beginning of year", "terseLabel": "Non-current other liabilities (note 16)" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r556", "r620" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid", "terseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant", "terseLabel": "Plan participants' contributions" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r598", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]", "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]", "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r563", "r573", "r616", "r916", "r917", "r918", "r919" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r916", "r918" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan, Equity Securities [Member]", "terseLabel": "Equities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear": { "auth_ref": [ "r1056" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount included in accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan expected to be recognized in net periodic benefit (cost) credit for fiscal year following most recent annual statement of financial position.", "label": "Defined Benefit Plan, Expected Amortization of Gain (Loss), Next Fiscal Year", "terseLabel": "Net loss that will be amortized" } } }, "localname": "DefinedBenefitPlanExpectedAmortizationOfGainLossNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear": { "auth_ref": [ "r1056" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount included in accumulated other comprehensive (income) loss for prior service cost (credit) expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.", "label": "Defined Benefit Plan, Expected Amortization of Prior Service Cost (Credit), Next Fiscal Year", "terseLabel": "Net prior service cost for defined benefit pension plan that will be amortized" } } }, "localname": "DefinedBenefitPlanExpectedAmortizationOfPriorServiceCostCreditNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years", "terseLabel": "Years 2028 - 2032" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One", "terseLabel": "2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five", "terseLabel": "2027" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four", "terseLabel": "2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three", "terseLabel": "2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r580" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two", "terseLabel": "2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": { "auth_ref": [ "r581", "r919" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year", "terseLabel": "Contribution to pension fund in the year ending December 31, 2021" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r548", "r585", "r611", "r918", "r919" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r560", "r571", "r573", "r574", "r916", "r917", "r918" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan, Plan Assets, Amount", "periodEndLabel": "Fair value of plan assets at end of year", "periodStartLabel": "Fair value of plan assets at beginning of year", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Foreign currency exchange rate changes" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r546", "r569", "r918" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "totalLabel": "Funded status" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r548", "r552", "r584", "r610", "r918", "r919" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r582", "r608", "r918", "r919" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": { "auth_ref": [ "r1058" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation", "negatedLabel": "Projected benefit obligation" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r565", "r1070" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan, Plan Assets, Benefits Paid", "negatedTerseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r564" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant", "terseLabel": "Plan participants' contributions" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r562" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency exchange rate changes" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r550", "r583", "r609", "r918", "r919" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsBenefitObligation": { "auth_ref": [ "r551" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease to benefit obligation of defined benefit plan from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Includes, but is not limited to, lump-sum cash payment to participant in exchange for right to receive specified benefits, purchase of nonparticipating annuity contract and change from remeasurement.", "label": "Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement", "negatedTerseLabel": "Settlement" } } }, "localname": "DefinedBenefitPlanSettlementsBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "auth_ref": [ "r568" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.", "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement", "negatedTerseLabel": "Settlement" } } }, "localname": "DefinedBenefitPlanSettlementsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": { "auth_ref": [ "r1029" ], "lang": { "en-us": { "role": { "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage", "terseLabel": "Actual plan asset allocations" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Defined contribution plan, cost" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.", "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent", "terseLabel": "Participant's contributions percentage of annual compensation (in percent)" } } }, "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r58", "r105" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r58", "r105" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r58", "r397" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r1104", "r1105", "r1106" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset, Notional Amount", "terseLabel": "Notional" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r314", "r315", "r763", "r895" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative instruments (c)", "verboseLabel": "Derivative Asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "auth_ref": [ "r763" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.", "label": "Derivative, Fair Value, Net", "terseLabel": "Derivative, Fair Value, Net" } } }, "localname": "DerivativeFairValueOfDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Derivative, fixed interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r225", "r226", "r228", "r230", "r895" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r236", "r738" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivatives" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r314", "r315", "r763", "r895" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative instruments (c)", "verboseLabel": "Derivative Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1105", "r1106" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "auth_ref": [ "r220", "r222" ], "lang": { "en-us": { "role": { "documentation": "The number of derivative instruments of a particular group held by the entity.", "label": "Derivative, Number of Instruments Held", "terseLabel": "Derivative, number of instruments held" } } }, "localname": "DerivativeNumberOfInstrumentsHeld", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r219", "r221", "r222", "r223", "r224", "r227", "r228", "r231", "r233", "r234", "r738" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r219", "r221", "r223", "r224", "r232", "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Total derivatives designated as hedging instruments" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r542", "r909", "r910", "r911", "r912", "r913", "r914", "r915" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r1007" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DisaggregationofRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r638", "r669", "r670", "r671", "r677", "r927" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Equity Incentive Schemes and Stock Compensation Charges" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r261", "r285", "r310", "r477", "r478", "r479", "r483", "r484", "r485", "r818", "r968" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due from Related Parties", "terseLabel": "Amounts due from related parties" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net income per Ordinary Share attributable to the Group (Note 24):" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r336", "r360", "r361", "r362", "r363", "r364", "r369", "r372", "r375", "r376", "r377", "r381", "r749", "r750", "r852", "r859", "r898" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r336", "r360", "r361", "r362", "r363", "r364", "r372", "r375", "r376", "r377", "r381", "r749", "r750", "r852", "r859", "r898" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net income per Ordinary Share attributable to the Group (Note 24):" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r378", "r379", "r380", "r382" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income Per Ordinary Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r779" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate movements on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Personnel related liabilities" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r668" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "terseLabel": "Income tax benefit related to stock compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": { "auth_ref": [ "r672" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit", "terseLabel": "Cash tax benefit related to stock options exercised" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Workforce reductions" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Laboratory equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r132", "r294", "r329", "r330", "r331", "r352", "r353", "r354", "r357", "r365", "r367", "r383", "r432", "r519", "r673", "r674", "r675", "r707", "r708", "r748", "r780", "r781", "r782", "r783", "r784", "r786", "r814", "r864", "r865", "r866" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r90", "r401", "r948" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails", "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r308", "r761", "r894" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "verboseLabel": "Carrying value of long-term investments in equity" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r753", "r754", "r759" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r237", "r238" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r494", "r573", "r574", "r575", "r576", "r577", "r578", "r754", "r823", "r824", "r825", "r903", "r904", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r753", "r754", "r755", "r756", "r760" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r494", "r573", "r578", "r754", "r823", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r494", "r573", "r578", "r754", "r824", "r903", "r904", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r494", "r573", "r574", "r575", "r576", "r577", "r578", "r754", "r825", "r903", "r904", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r237", "r238" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": { "auth_ref": [ "r573", "r752", "r760" ], "lang": { "en-us": { "role": { "documentation": "Fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Measured at Net Asset Value Per Share [Member]", "terseLabel": "Fair Value Measured at Net Asset Value Per Share" } } }, "localname": "FairValueMeasuredAtNetAssetValuePerShareMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r494", "r573", "r574", "r575", "r576", "r577", "r578", "r823", "r824", "r825", "r903", "r904", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails", "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r753", "r754", "r755", "r756", "r757", "r760" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Fair value, nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r239", "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Disclosure of Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Amortization period" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r305", "r452" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r101" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": 1.0, "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r101" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": 5.0, "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r101" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": 4.0, "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r101" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": 3.0, "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r101" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails": { "order": 2.0, "parentTag": "iclr_FiniteLivedIntangibleAssetsAmortizationExpenseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsFutureIntangibleAssetAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r450", "r451", "r452", "r453", "r831", "r835" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": { "auth_ref": [ "r1109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets, Fair Value Disclosure", "terseLabel": "Identifiable intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r99", "r835" ], "calculation": { "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Total cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r95", "r98" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r99", "r831" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible assets, net (Note 11)", "totalLabel": "Net book value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Country" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency [Abstract]", "terseLabel": "Foreign Currency [Abstract]" } } }, "localname": "ForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r773", "r775", "r776", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "negatedTerseLabel": "Amounts (credited)/charged" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesAdjustmentsResultingfromForeignCurrencyTranslationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r59", "r1111", "r1112" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), Unrealized", "negatedTerseLabel": "Unrealized foreign exchange (gain)/loss" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r787" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currencies and Translation of Subsidiaries" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignPlanMember": { "auth_ref": [ "r1071", "r1072", "r1073" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Foreign Plan [Member]", "terseLabel": "Foreign Plan [member]" } } }, "localname": "ForeignPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesGross": { "auth_ref": [ "r106" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures, Gross", "terseLabel": "Office furniture and fixtures" } } }, "localname": "FurnitureAndFixturesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Office furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r58", "r125", "r126" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r69", "r876" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r304", "r441", "r848", "r901", "r934", "r983", "r990" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Closing goodwill", "periodStartLabel": "Opening goodwill", "terseLabel": "Goodwill", "verboseLabel": "Goodwill (Note 10)" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r443", "r901" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Current year acquisitions (note 6)" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r446", "r447", "r449", "r901" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "Goodwill Disclosure [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillFairValueDisclosure": { "auth_ref": [ "r1109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Fair Value Disclosure", "terseLabel": "Goodwill" } } }, "localname": "GoodwillFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange movement" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r58", "r442", "r444", "r448", "r901" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment charge" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r190", "r989" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Prior period acquisition (note 6)" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillScheduleofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r223", "r736" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "auth_ref": [ "r58", "r104", "r109" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).", "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairment of long lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of goodwill and long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r400", "r404", "r409", "r412", "r900" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "terseLabel": "Income before income tax expense" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r35", "r58", "r90", "r265", "r287", "r398" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Loss on equity method investments", "terseLabel": "Share of equity method investments" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r40", "r958" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax", "totalLabel": "Income before income tax expense" } } }, "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r455", "r459" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails", "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r348", "r686", "r694", "r701", "r709", "r713", "r715", "r716", "r717" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity": { "auth_ref": [ "r684" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of the tax effects of all items occurring during the period that have been charged or credited directly to other comprehensive income or to related components of shareholders' equity.", "label": "Income Tax Effects Allocated Directly to Equity", "totalLabel": "Total" } } }, "localname": "IncomeTaxEffectsAllocatedDirectlyToEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r349", "r366", "r367", "r399", "r684", "r710", "r714", "r860" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "iclr_IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterest", "weight": -1.0 }, "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity", "weight": 1.0 }, "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax expense (Note 20)", "totalLabel": "Income tax expense allocated to continuing operations" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails", "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Income tax expense:" } } }, "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r328", "r680", "r681", "r694", "r695", "r700", "r704" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Movement in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r679", "r685" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Effects of change in tax rates" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign and other income taxed at higher rates" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r685" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Taxes at Irish statutory rate of 12.5% (2021:12.5%; 2020:12.5%)" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAmortization": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible amortization.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount", "terseLabel": "Rate differential from amortization of intangible assets" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "terseLabel": "Impact of stock compensation" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "auth_ref": [ "r1100" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount", "negatedLabel": "Research & development tax incentives" } } }, "localname": "IncomeTaxReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes (net of refunds)" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivable": { "auth_ref": [ "r262", "r286", "r953" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Current", "terseLabel": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesReceivableNoncurrent": { "auth_ref": [ "r274", "r951" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.", "label": "Income Taxes Receivable, Noncurrent", "terseLabel": "Income taxes receivable" } } }, "localname": "IncomeTaxesReceivableNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r57" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [ "r963" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedLabel": "Unbilled revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r828", "r963" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Unearned revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": { "auth_ref": [ "r339", "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Increase (Decrease) in Equity Securities, FV-NI", "terseLabel": "Increase (decrease) in equity securities, FV-NI" } } }, "localname": "IncreaseDecreaseInEquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r963" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase (Decrease) in Other Current Liabilities", "terseLabel": "Other net assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-Lived Intangible Assets [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r246", "r267", "r332", "r396", "r790" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 }, "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense (Note 13)", "terseLabel": "Total financing costs", "totalLabel": "Total financing costs" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r45", "r499", "r506", "r905", "r906" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense on drawn facilities" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofFinanceCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r338", "r342", "r344" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCapMember": { "auth_ref": [ "r932" ], "lang": { "en-us": { "role": { "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.", "label": "Interest Rate Cap [Member]", "terseLabel": "Interest Rate Caps" } } }, "localname": "InterestRateCapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net", "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified euring next 12 months, net" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r932" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesEffectofDerivativeFinancialInstrumentsonStatementofFinancialPositionDetails", "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalRevenueServiceIRSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.", "label": "Internal Revenue Service (IRS) [Member]", "terseLabel": "Federal NOL's" } } }, "localname": "InternalRevenueServiceIRSMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r44", "r395" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r427", "r1130" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investment in Debt, Equity and Other" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r89", "r252", "r270", "r290", "r892" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_Land": { "auth_ref": [ "r950" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r806", "r933" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Net operating lease costs", "verboseLabel": "Net operating lease costs" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails", "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r1117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r106" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 6.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements, Gross", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r800" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r1118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Operating Lease Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r807" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Lease imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r1116" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Non-cancelable operating leases for facilities expiration period" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CommitmentsandContingenciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r808" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Operating Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r347", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r728", "r731", "r732", "r764", "r899", "r999", "r1122", "r1123" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Liabilities, Total" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r13", "r260", "r281", "r934", "r966", "r982", "r1110" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r299", "r347", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r728", "r731", "r732", "r764", "r934", "r999", "r1122", "r1123" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r237" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Total Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairValueMeasurementofFairValueofMajorAssetandLiabilityclassedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-current Liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Remaining borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r1", "r255" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of Credit, Current", "terseLabel": "Current bank credit lines and loan facilities (Note 13)" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableRelatedParties": { "auth_ref": [ "r249", "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.", "label": "Loans and Leases Receivable, Related Parties", "terseLabel": "Loans and Leases Receivable, Related Parties" } } }, "localname": "LoansAndLeasesReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableRelatedPartiesAdditions": { "auth_ref": [ "r249", "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the amount of new advances made to related parties in the form of loan and lease receivables.", "label": "Loans and Leases Receivable, Related Parties, Additions", "terseLabel": "Loan granted tp related party" } } }, "localname": "LoansAndLeasesReceivableRelatedPartiesAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR)" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-Lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Distribution of Long-lived Assets, Net, by Geographical Area" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r3", "r259", "r279", "r493", "r505", "r903", "r904" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total long-term debt, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "terseLabel": "Long-term debt at fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/FairvalueNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r123", "r351", "r497" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r123", "r351", "r497" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r123", "r351", "r497" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r123", "r351", "r497" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofMaturitiesofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r309" ], "calculation": { "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "totalLabel": "Total long-term debt, net" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long-Term Debt [Text Block]", "terseLabel": "Non-current Bank Credit Lines and Loan Facilities" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r21", "r121", "r122" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit, Noncurrent", "verboseLabel": "Non-current bank credit lines and loan facilities (Note 13)" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r21", "r124" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r106" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 5.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Laboratory equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r384", "r389" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Description of business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/Descriptionofbusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r341" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in)/provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r341" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r55", "r56", "r59" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r36", "r59", "r266", "r288", "r297", "r324", "r326", "r331", "r347", "r356", "r360", "r361", "r362", "r363", "r366", "r367", "r373", "r400", "r404", "r409", "r412", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r750", "r764", "r900", "r999" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income attributable to the Group", "verboseLabel": "Net income attributable to the Group" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "auth_ref": [ "r41" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest", "negatedTerseLabel": "Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r360", "r361", "r362", "r363", "r369", "r370", "r374", "r377", "r400", "r404", "r409", "r412", "r900" ], "calculation": { "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income attributable to the Group (including NCI redemption adjustment)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "auth_ref": [ "r66", "r292", "r293", "r294", "r295", "r296", "r355", "r356", "r357", "r358", "r359", "r362", "r368", "r381", "r423", "r424", "r429", "r430", "r431", "r432", "r433", "r434", "r673", "r674", "r675", "r705", "r706", "r707", "r708", "r721", "r722", "r723", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r788", "r789", "r793", "r794", "r795", "r796", "r809", "r810", "r811", "r812", "r813", "r814", "r832", "r833", "r834", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873" ], "lang": { "en-us": { "role": { "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]" } } }, "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Impact of Recently Issued or Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r416" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets", "terseLabel": "Long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NontradeReceivablesCurrent": { "auth_ref": [ "r953" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Nontrade Receivables, Current", "terseLabel": "Other receivables" } } }, "localname": "NontradeReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries in which company operates" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfInterestRateDerivativesHeld": { "auth_ref": [ "r220", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date.", "label": "Number of Interest Rate Derivatives Held", "terseLabel": "Number of interest rate derivatives held" } } }, "localname": "NumberOfInterestRateDerivativesHeld", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r975" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of reporting segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r400", "r404", "r409", "r412", "r900" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r801", "r933" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease costs" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r1115" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Operating Lease, Impairment Loss", "terseLabel": "Impairment of long lived assets" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r798" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "verboseLabel": "Total" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesOperatingLeaseMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r798" ], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities", "verboseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails", "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r799" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r798" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease liabilities (Note 15)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r797" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating right-of-use assets (Note 15)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r964" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Amortization Expense", "terseLabel": "Reduction in carrying value of operating right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r805", "r933" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate (in percent)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r804", "r933" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "U.S. federal net operating loss carry forwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order or Production Backlog [Member]", "terseLabel": "Order backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r17" ], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r306" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other receivables" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r26", "r29", "r590" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax", "terseLabel": "Actuarial gain/(loss) on defined benefit pension plan", "verboseLabel": "Actuarial gain (loss) on defined benefit pension plan" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": { "auth_ref": [ "r25", "r30", "r774", "r777", "r785" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxEffectsAllocatedDirectlyToEquity", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax", "terseLabel": "Currency impact on long term funding" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location in other comprehensive income.", "label": "Other Comprehensive Income Location [Axis]", "terseLabel": "Other Comprehensive Income Location [Axis]" } } }, "localname": "OtherComprehensiveIncomeLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in other comprehensive income.", "label": "Other Comprehensive Income Location [Domain]", "terseLabel": "Other Comprehensive Income Location [Domain]" } } }, "localname": "OtherComprehensiveIncomeLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "auth_ref": [ "r317", "r319" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 5.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "terseLabel": "Loss on cash flow hedge", "verboseLabel": "(Loss)/gain on cash flow hedge" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r317", "r319", "r733", "r734", "r737" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification and tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r319", "r322" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 6.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "negatedLabel": "Amortization of cash flow hedge" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "auth_ref": [ "r319", "r322", "r735" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r25" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 4.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income, net of tax", "verboseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r29", "r33", "r323", "r590" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Actuarial loss/(gain) \u2013 plan assets" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax": { "auth_ref": [ "r29", "r33", "r323", "r590" ], "calculation": { "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for transition asset (obligation) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Transition Asset (Obligation), Reclassification Adjustment from AOCI, after Tax", "totalLabel": "Total" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetTransitionAssetObligationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Tax [Abstract]", "terseLabel": "Income tax expense was allocated to the following components of other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeLossTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesComponentsofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeMember": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.", "label": "Other Comprehensive Income (Loss) [Member]", "terseLabel": "Other Comprehensive Income" } } }, "localname": "OtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r318", "r319" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "verboseLabel": "Unrealized capital loss - investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r17", "r934" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other liabilities (Note 12)", "totalLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]", "terseLabel": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "Other Liabilities Disclosure [Text Block]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Non-current other liabilities (Note 16)", "totalLabel": "Other Liabilities, Noncurrent" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other liabilities.", "label": "Other Liabilities [Table Text Block]", "terseLabel": "Schedule of Other Liabilities" } } }, "localname": "OtherLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLongTermInvestments": { "auth_ref": [ "r284", "r949" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term investments classified as other.", "label": "Other Long-Term Investments", "terseLabel": "Investments in equity-long term (Note 8b)" } } }, "localname": "OtherLongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r59" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Other non-cash items" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Non-current other liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentotherliabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.", "label": "Other Restructuring Costs", "terseLabel": "Other restructuring costs" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesCurrent": { "auth_ref": [ "r17", "r120" ], "calculation": { "http://www.iconplc.com/role/OtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.", "label": "Other Sundry Liabilities, Current", "terseLabel": "General trade and overhead liabilities" } } }, "localname": "OtherSundryLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r4", "r258", "r278" ], "calculation": { "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentotherliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForHedgeFinancingActivities": { "auth_ref": [ "r343", "r962" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.", "label": "Payments for Hedge, Financing Activities", "negatedTerseLabel": "Settlement of cash flow hedge" } } }, "localname": "PaymentsForHedgeFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r52" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of ordinary shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtRestructuringCosts": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.", "label": "Payments of Debt Restructuring Costs", "terseLabel": "Payments of debt restructuring costs" } } }, "localname": "PaymentsOfDebtRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r54" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedTerseLabel": "Financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r54" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Share issue costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r47", "r81", "r337" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-Sale", "negatedTerseLabel": "Purchase of available for sale investments" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r48", "r724" ], "calculation": { "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 }, "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "negatedLabel": "Purchase of subsidiary undertakings (net of cash acquired)", "terseLabel": "Fair value of cash consideration" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r48" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedTerseLabel": "Investment in equity method investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLongtermInvestments": { "auth_ref": [ "r961" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.", "label": "Payments to Acquire Long-Term Investments", "negatedLabel": "Purchase of investments in equity - long term" } } }, "localname": "PaymentsToAcquireLongtermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r49" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": { "auth_ref": [ "r960", "r1119" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.", "label": "Payments to Fund Long-Term Loans to Related Parties", "negatedTerseLabel": "Loan to equity method investment" } } }, "localname": "PaymentsToFundLongtermLoansToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r54" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Purchase of noncontrolling interest" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r570", "r572", "r578", "r597", "r599", "r600", "r601", "r602", "r603", "r618", "r619", "r621", "r634", "r918" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Employee Benefits" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r4", "r546", "r547", "r569", "r918" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "negatedTerseLabel": "Non-current other liabilities (note 16)" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementPlansPolicy": { "auth_ref": [ "r153", "r158", "r159", "r160", "r161" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.", "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]", "terseLabel": "Pension Costs" } } }, "localname": "PensionAndOtherPostretirementPlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r143", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r595", "r596", "r598", "r601", "r604", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r621", "r622", "r633", "r918", "r919", "r923", "r924", "r925" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plan" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r598", "r916", "r917", "r918" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Defined Benefit Plan, Plan Assets, Category [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088", "r1089", "r1090", "r1091", "r1092", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r954" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepayments and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r947" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r51", "r965" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Drawdown of credit lines and facilities" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r46", "r81", "r337" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from Sale of Debt Securities, Available-for-Sale", "terseLabel": "Sale of available for sale investments" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfLongtermInvestments": { "auth_ref": [ "r959" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.", "label": "Proceeds from Sale of Long-Term Investments", "terseLabel": "Proceeds from investments in equity - long term" } } }, "localname": "ProceedsFromSaleOfLongtermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r50", "r174" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from the exercise of equity compensation", "verboseLabel": "Total proceeds from exercise of stock options by employees" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]", "terseLabel": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r297", "r324", "r326", "r340", "r347", "r356", "r366", "r367", "r400", "r404", "r409", "r412", "r428", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r726", "r729", "r730", "r750", "r764", "r853", "r900", "r930", "r931", "r958", "r999" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": { "order": 3.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income", "totalLabel": "Net Income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r110", "r878", "r879", "r880" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r106", "r302" ], "calculation": { "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r108", "r282", "r854", "r934" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment (net)", "verboseLabel": "Property, plant and equipment, net (Note 9)" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/PropertyPlantandEquipmentnetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r108", "r878", "r879" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property Plant and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/PropertyPlantandEquipmentnetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r977", "r978", "r979", "r980" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable, Net and Unbilled Revenue" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r128", "r129", "r130", "r131" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r598", "r817", "r818" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r291", "r817", "r818", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r248" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Expenses incurred from related party transactions" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.", "label": "Related Party Transaction, Rate", "terseLabel": "Related party, loan interest rate" } } }, "localname": "RelatedPartyTransactionRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r598", "r817", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r847", "r1121" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r815", "r816", "r818", "r819", "r820" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r53", "r965" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedTerseLabel": "Repayment of credit lines and facilities" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "terseLabel": "Repayments of senior debt" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r456", "r458", "r461", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Charges" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r58", "r462", "r464", "r995" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Additional provision in the year" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r457", "r458", "r464", "r465" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCosts": { "auth_ref": [ "r58" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs", "terseLabel": "Restructuring charges", "verboseLabel": "Restructuring (Note 19)" } } }, "localname": "RestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails", "http://www.iconplc.com/role/RestructuringchargesSummaryofRestructuringChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r458", "r463" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Ending provision", "periodStartLabel": "Opening provision", "terseLabel": "Restructuring reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails", "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r952", "r996", "r997" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Current", "terseLabel": "Restructuring reserve, current" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveNoncurrent": { "auth_ref": [ "r955", "r996", "r997" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "Restructuring Reserve, Noncurrent", "terseLabel": "Restructuring reserve, noncurrent" } } }, "localname": "RestructuringReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesRestructuringProvisionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r10", "r137", "r280", "r868", "r873", "r934" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r294", "r352", "r353", "r354", "r357", "r365", "r367", "r432", "r673", "r674", "r675", "r707", "r708", "r748", "r864", "r866" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r926", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r926", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanSponsorLocationAxis": { "auth_ref": [ "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r594", "r595", "r596", "r598", "r601", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r1071", "r1072", "r1073" ], "lang": { "en-us": { "role": { "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Axis]", "terseLabel": "Retirement Plan Sponsor Location [Axis]" } } }, "localname": "RetirementPlanSponsorLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanSponsorLocationDomain": { "auth_ref": [ "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r594", "r595", "r596", "r598", "r601", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r1071", "r1072", "r1073" ], "lang": { "en-us": { "role": { "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Retirement Plan Sponsor Location [Domain]", "terseLabel": "Retirement Plan Sponsor Location [Domain]" } } }, "localname": "RetirementPlanSponsorLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r143", "r144", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r595", "r596", "r598", "r601", "r604", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r621", "r622", "r623", "r633", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r143", "r144", "r546", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r593", "r595", "r596", "r598", "r601", "r604", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r621", "r622", "r623", "r633", "r918", "r919", "r920", "r921", "r922", "r923", "r924", "r925" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r393", "r394", "r403", "r407", "r408", "r414", "r415", "r418", "r540", "r542", "r830" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/DisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r545", "r897" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r522", "r523", "r524", "r525", "r526", "r527", "r530", "r531", "r544", "r545" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Disaggregation of Revenue", "verboseLabel": "Contract Balances" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalances", "http://www.iconplc.com/role/DisaggregationofRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Distribution of Net Revenue by Geographical Area" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r39", "r289", "r477", "r478", "r479", "r483", "r484", "r485" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "terseLabel": "Revenue earned from related parties" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r528" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r1006" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Revenue, remaining performance obligation (in percent)" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ContractBalancesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving loan facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r803", "r933" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r418", "r974" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Net Revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r32", "r1113", "r1114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule of Allocation of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Plan Asset Fair Value Measurements" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.", "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Balance Sheet" } } }, "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.", "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.", "label": "Defined Benefit Plan, Assumptions [Table Text Block]", "terseLabel": "Summary of Assumptions Used in Calculating Pension Benefit Obligations" } } }, "localname": "ScheduleOfAssumptionsUsedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r83", "r84", "r85", "r86", "r87", "r88", "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-Sale Securities [Table]", "terseLabel": "Schedule of Available-for-sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsEquityMethodInvestmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": { "auth_ref": [ "r918", "r1058" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefit obligation and plan assets for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block]", "terseLabel": "Schedule of Underlying Asset Split of Fund" } } }, "localname": "ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r193", "r194", "r719" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofConsiderationTransferredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsNarrativePRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofAcquisitionsPRAAcquisitionDetails", "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r193", "r194" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of Supplemental Disclosure of Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SupplementalDisclosureofCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Summary of Components of Provision for Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r21", "r133", "r134", "r135", "r136", "r244", "r245", "r247", "r271", "r903", "r905", "r969" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of Deferred Tax Assets and Deferred Tax Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r153", "r154", "r155", "r156", "r157" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsAnnualBenefitPaymentsDetails", "http://www.iconplc.com/role/EmployeeBenefitsAssumptionsUsedinDeterminingBenefitObligationDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinBenefitObligationsDetails", "http://www.iconplc.com/role/EmployeeBenefitsChangeinPlanAssetsDetails", "http://www.iconplc.com/role/EmployeeBenefitsComponentsofNetPeriodicBenefitCostDetails", "http://www.iconplc.com/role/EmployeeBenefitsExpectedRateofReturnandActualPlanAssetAllocationDetails", "http://www.iconplc.com/role/EmployeeBenefitsFundedStatusDetails", "http://www.iconplc.com/role/EmployeeBenefitsNarrativeDetails", "http://www.iconplc.com/role/EmployeeBenefitsNetPeriodicPensionBenefitCostAssumptionsDetails", "http://www.iconplc.com/role/EmployeeBenefitsPlanAssetFairValueMeasurementsDetails", "http://www.iconplc.com/role/EmployeeBenefitsSummaryofplanassetsandliabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r973" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of Number of Shares Used in Computation of Basic and Diluted Net Income Per Ordinary Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Consolidated Reported Provision for Income Taxes and Statutory Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule of Expected Benefit Payments [Table Text Block]", "terseLabel": "Schedule of Annual Benefit Payments which Reflect Expected Future Service" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r95", "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsTables", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r901", "r983", "r984", "r985", "r986", "r987", "r988", "r989", "r990", "r991", "r992", "r993" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Components of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]", "terseLabel": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DescriptionofbusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Summary of Estimates of Fair Values of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r250", "r251" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/InvestmentsNarrativeDetails", "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r457", "r458", "r459", "r460", "r464", "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r112", "r113", "r116" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring Charges" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r111", "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r75", "r76", "r77", "r93" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r635", "r637", "r639", "r640", "r641", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Summary of Information Concerning Outstanding and Exercisable Share Options" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r163", "r166", "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Transactions for Company's Share Option Plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Summary of Weighted Average Fair Values and Assumptions Used" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Intangible Asset Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Credit Facilities:" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r1107" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r390", "r391", "r392", "r400", "r402", "r406", "r410", "r411", "r412", "r413", "r414", "r417", "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segment and Geographical Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofIncomefromOperationsExcludingRestructuringbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofLonglivedAssetsNetbyGeographicalAreaDetails", "http://www.iconplc.com/role/BusinessSegmentandGeographicalInformationDistributionofNetRevenuebyGeographicalAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r43" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/OperatingLeasesOperatingLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorSubordinatedNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A senior subordinated note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated notes are junior to Senior Notes and Senior bond holders.", "label": "Senior Subordinated Notes [Member]", "terseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSubordinatedNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesScheduleofLongtermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r58" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Severance costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r57" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Total compensation costs", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r927" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Shares vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r656" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r654" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at ending of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Outstanding number of shares [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r651", "r652" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at end of period (USD per share)", "periodStartLabel": "Outstanding at beginning of period (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Shares vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r658" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Shares vested (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]", "terseLabel": "Assumptions:" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield (in percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility (in percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r666" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rate (in percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofNoncashStockCompensationExpenseDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "The highest quantity of shares an employee can purchase under the plan per period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee", "terseLabel": "Maximum number of shares per employee (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional number of ordinary shares which have been reserved for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r929" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Ordinary shares which have been reserved for issuance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Stock units to be granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r649" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Canceled/expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Weighted average fair value (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Options Granted Under Plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Ending balance (USD per share)", "periodStartLabel": "Beginning balance (USD per share)", "terseLabel": "Weighted average exercise price (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Vested and exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Vested and exercisable at end of period (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r639", "r640", "r641", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r663", "r664", "r665", "r666", "r667" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofRSUandPSUActivityDetails", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r648" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Average exercise price of option per share (USD per share)", "verboseLabel": "Exercised (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r650" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Canceled/expired (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r647" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r642", "r661", "r662", "r663", "r664", "r667", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]", "terseLabel": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit", "terseLabel": "Minimum Range Exercise Price (USD per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Number of Shares (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r164" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "terseLabel": "Number of Shares (in shares)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit", "terseLabel": "Maximum Range Exercise Price (USD per share)" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r928" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Shares expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r663" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesScheduleofWeightedAverageFairValuesandAssumptionsUsedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average contractual term of options outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable - weighted average remaining contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Percentage of option price for fair value of ordinary share (in percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r169" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Remaining Contractual Life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesOutstandingandExercisableShareOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r65", "r345" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant accounting policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": { "auth_ref": [ "r179" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit", "terseLabel": "Unrecognized tax benefit, potentially expire in 2021" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]", "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "A summary of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return for which the resultant tax benefit has not been recognized in the financial statements because it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.", "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]", "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table]" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State NOL's" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r24", "r132", "r294", "r329", "r330", "r331", "r352", "r353", "r354", "r357", "r365", "r367", "r383", "r432", "r519", "r673", "r674", "r675", "r707", "r708", "r748", "r780", "r781", "r782", "r783", "r784", "r786", "r814", "r864", "r865", "r866" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r352", "r353", "r354", "r383", "r830" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r7", "r8", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issue of shares associated with a business combination (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r7", "r8", "r132", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Ordinary shares issued in respect of certain RSUs previously awarded by the Company (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r7", "r8", "r132", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issue of restricted share units / performance share units (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Ordinary shares issued in respect of certain PSUs previously awarded by the Company (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r7", "r8", "r132", "r137", "r648" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Exercise of share options (in shares)", "verboseLabel": "Options exercised by employees (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/EquityIncentiveSchemesandStockCompensationChargesSummaryofStockOptionActivityDetails", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r24", "r132", "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issue of shares associated with a business combination" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r7", "r8", "r137", "r167" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issue of restricted share units / performance share units" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r24", "r132", "r137" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of share options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Number of shares authorized to be repurchased (in shares)" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r7", "r8", "r132", "r137" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedLabel": "Repurchase of ordinary shares (in shares)", "terseLabel": "Ordinary shares redeemed (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r7", "r8", "r132", "r137" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedLabel": "Repurchase of ordinary shares", "terseLabel": "Ordinary shares redeemed, value" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME", "http://www.iconplc.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r8", "r11", "r12", "r80", "r934", "r966", "r982", "r1110" ], "calculation": { "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Shareholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r142", "r346", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r739" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Share Capital" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r802", "r933" ], "calculation": { "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "negatedLabel": "Income from sub-leases" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/OperatingLeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r821", "r822" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOfCommonParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to an entity under the control of the same parent as another entity (that is, a sister company).", "label": "Subsidiary of Common Parent [Member]", "terseLabel": "Subsidiaries" } } }, "localname": "SubsidiaryOfCommonParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "auth_ref": [ "r179", "r181", "r182" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.", "label": "Summary of Income Tax Contingencies [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Beginning and Ending Amount of Total Unrecognized Tax Benefits" } } }, "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary of Operating Loss Carryforwards [Table Text Block]", "terseLabel": "Schedule of Expected Expiry Dates of NOL's" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Cash Flow Elements [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r0", "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "terseLabel": "Fixed asset impairment" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carry forward" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]", "terseLabel": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]", "terseLabel": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesExpectedExpiryDatesofNOLsDetails", "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Technology assets" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Exercise of call option on noncontrolling interest shares" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "auth_ref": [], "calculation": { "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.", "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedTerseLabel": "Noncontrolling interest adjustment to redemption amount" } } }, "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNetIncomeAttributabletotheGroupPertheStatementofOperatingIncomeandNetIncomeUsedForNetIncomePerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net income" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITYANDCOMPREHENSIVEINCOME" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names & brands", "verboseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsFairValueofIdentifiedIntangibleAssetsAcquiredPRAAcquisitionDetails", "http://www.iconplc.com/role/IntangibleAssetsNarrativeDetails", "http://www.iconplc.com/role/IntangibleAssetsSummaryofIntangibleAssetsDetails", "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r356", "r357", "r358", "r359", "r368", "r423", "r424", "r429", "r430", "r431", "r432", "r433", "r434", "r673", "r674", "r675", "r705", "r706", "r707", "r708", "r721", "r722", "r723", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r788", "r789", "r793", "r794", "r795", "r796", "r809", "r810", "r811", "r812", "r813", "r814", "r832", "r833", "r834", "r862", "r863", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Accounting Standards Update [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/BusinessCombinationsScheduleofProFormaInformationPRAAcquisitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r457", "r458", "r464", "r465" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/RestructuringchargesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r678", "r688" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits at end of year", "periodStartLabel": "Unrecognized tax benefits at start of year" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r689" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedLabel": "Decrease related to prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r691" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedLabel": "Settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r687" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Total accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r687" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense", "terseLabel": "Interest and penalties recognized as an expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.", "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition", "terseLabel": "Increase related to acquired tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r690" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increase related to current year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r689" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increase related to prior year tax positions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r1101" ], "calculation": { "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "terseLabel": "Change in unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesConsolidatedReportedProvisionforIncomeTaxesDifferedfromStatutoryRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r692" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedLabel": "Lapse of statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesReconciliationofBeginningandEndingAmountofTotalUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r693" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Total unrecognized tax benefits net of potential benefits" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r72", "r73", "r74", "r385", "r386", "r387", "r388" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r699" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedTerseLabel": "Net change in the total valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/DerivativesNarrativeDetails", "http://www.iconplc.com/role/NoncurrentBankCreditLinesandLoanFacilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Motor vehicles" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/SummaryofSignificantaccountingpoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r973" ], "calculation": { "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "terseLabel": "Effect of dilutive share options outstanding (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r371", "r377" ], "calculation": { "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of ordinary shares outstanding for diluted net income per ordinary share (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average number of ordinary shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r369", "r377" ], "calculation": { "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of ordinary shares outstanding for basic net income per ordinary share (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.iconplc.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.iconplc.com/role/NetIncomePerOrdinaryShareReconciliationofNumberofSharesUsedinComputationofBasicandDilutedNetIncomePerOrdinaryShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1006": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1007": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1008": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1009": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1011": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1012": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1013": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1014": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1015": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1016": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1017": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1018": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1019": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1021": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1022": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1023": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1024": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1025": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1026": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1027": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1028": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1029": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1031": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1032": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1033": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1034": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1035": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1036": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1037": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1038": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1039": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1041": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1042": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1043": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1044": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1045": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1046": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1047": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1048": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1049": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1051": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1052": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1053": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1054": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1055": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1056": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1057": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1058": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1059": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1061": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1062": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1063": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1064": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1065": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1066": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1067": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1068": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1069": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1071": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1072": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1073": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1074": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1075": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1076": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1077": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1078": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1079": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1081": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1082": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1083": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1084": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1085": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1086": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1087": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1088": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1089": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1110": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1131": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1133": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3,4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(b)(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r236": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.7(e))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5)(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(f))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5(c))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3581-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.18)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "https://asc.fasb.org/topic&trid=2175745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "https://asc.fasb.org/topic&trid=2134446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=SL65897772-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "832", "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r892": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r937": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r938": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r939": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r941": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r942": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r943": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r944": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r945": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r946": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r954": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r955": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "210-10-S99-1(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r957": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r968": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r969": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r971": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r972": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r973": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r974": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r975": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r976": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r998": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" } }, "version": "2.2" } ZIP 163 0001060955-23-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001060955-23-000007-xbrl.zip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Ð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ʉ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

    9D7_^W0%YF5%2+<6.FDB)VMV23BMZ-N8Y/"MECLRT -YT'S, MF/FO&1W\)3VT&)]:#9$:I3;0Y1_XRON<'6$B:0@>@#_)K'-Y\NRA[T>CXYLP M/JQP]WC3\)CR21F"1Y%O%*>L*CU2Y4-N7_C!N9=5>KV MLL)&DHSNVMG+GP'F9%XJ ';)B,BH7"^I25=&ORA>YHRIZ:0:H=UUZ^$65F*6 M,$I03C)*/]XX,C5N&\XINAH_D(HV\_BLD\@?\65E&N%+ BC,(*^-M'2=G!2R M?#F:&HT-/50B5F+E)0YN*-$#JPE^@+G&(6XS8EQ/ 2!;C!4ZD.U;\ M78/J=>?S*^_^B5Z,6C)]=,U*-VLJ@<=6L#*!N62E>LSJ7''&GPT%#V&MEX6Q M_GE;$+9F\4>_)R5_U@TWJBA38LZW7/?P9,)7\YL)GEQD"%IQ@<9/]J]/1Z9B MY-*_0C9A>GZFR/G[0LFO4K5':_:63F*(H];\E7H_]A\_/G0B,D21L^:3M"XS MMJ!GJ. H_3SG7V)^Z2/LS8AY\ N^Q&+%5+Y&/@Y;,,C%''C4*@F#"(SXM,E*W215T1I MK]<#8N*G2+Q(C1U&XD0OC\O!SKDN/&:267:E6ZK]Z)'^]+,=U=G;I?3PG"!I MK5=C;<-Y^TH_AF 2RT6+4N$5K4^=:#'&/KCTC#$>$_RKHIOEH2"X:GDH"GDEC146ZF&9\)O3 7'ZS#^M'''ZZR8RZ M)465>%)VTIHF4C'R*++LV,AJB?DIL\\C.5Y9]47+-@;Q2]B(>4;-V_22(T<&GC74FE B'P7F\*MG*&9"5C5^[RN]8;4SM7.)O\.?VSG \_9: MN3DFI5 \>0B6)#XA6UXYM*4=TX<5JT\. M=>-!G[Q-VACYV5;]G6Y=3QN\^T2&;;A+AK(,WFY]NVU%%Y$ZLQ' MV,/K0@:YC$6Y'S2HF/VIS(^.(93D8&(*6TKP(/XB <^Q[U S(PN3W?0_] WO M&U^-@@#!1VJ<&W-+NG-A:W4R19TFA 'K>O5%%%,)VJ2]_G/,85"Y8D$*@J-Q M9+KD0$_/VZRZ8 B]@+BC2DT":,Z[DN.#0E2F2+N: %(ND%;"S&Q\U40T4EZ_ MP]_*Z84')$-Y[UTP,L9QQV"L:*^2<+O++&QY9EF0_9?R%PZ')_0? D)-73?% M;?/-]&;$,X;JI%D=/TNL'YS%IB5]K#1T1XM4YRXL5C+AN9RLL#B47J< 0RW6 M-\>Y%)MFD&(8F'=L(?2,LD21^L9KCZUX"-6PEBFCFK+8V'C$D%+4C8%M[6H[ MDYE[8CW3XI)G0F2R\-PO?!Q1KHCG9%K._?UU:1;&V"4'Y_1SZ?&QF''9N9+< MZM^F)?;/D])V\\E<^RKV/(2CF_%R[4OF3F[+F\ L/MS5O8R_K M\I4(*/(HV5^.CO_"9NW-890853_76\7KG5]OFIG#(RXW/FJ=&I@1#ZM:Q#.# M.]//U]>/-[-M,RS/@]83<5?/'H::U%SZFK?!T@_L?WS1^N@ RH1]@QKM@-"K M:@HG+@)N*\D39,S ,5"!31!KI>-HH\[W3>+E MT<5]RVTSC_G;BP\_L)R95X0/;FM8%JSC>;!#S'[7DY>S=QRJ^'G Y9-RZI8_ MFC$-@J.;0);XA/@8PY]4?GJ&/5.R'2LQ5 UFPDUF7#B^>&)Z=9J2;H734WQ8;>*TB M.J^==N#U"GD-$KWA+@\LIF;F;!:LE6*Y+T?W"!4%B!6L)@130S?\P$3:"IP* MUL KU?#\O"MK=^]73?/Z>!B[!0?3,M/&0.!DV^(TKF612E(U@P:KV9[.9]Q@ M44E0%Q7Z"*O>5KQQ\E3?R40MNYFV9B?W-#T,LF3C=%.Z9/D*-6'!&=RI!159 M0?PN)(NFCZU ;V]/X#HY$:@2O.*5"T(SV4ZXVW=6(G8]N17!!V/=L0%'X(+% MC)'+/*![L&AZN!ME(AJ^-@*]!8THS(\7?XCX4J NCNM)6#)D6 MG)4[WZ7GYVRS<+]PD_IN\;U6<]R"F[GEC+=)BZI73+?KWE9&*KC:$,\L/&15 MWS#9?&'[Y=8KW<]\[:G916X].U&!L19J"?KM(OMYRXB;4'GH@+HZX:M\1BEV MMBU@,MQQODI@>^Z4#73F)+-^DX;FXU,E^-;5PNTSM8P(N>FB_5VW_:(]KN>E M5G>$8HTV>UM"U*M^VU:D5DY*$-:PA(U5*YVE!9.XQ.(WB=\5A\7;R:2TOJ8G M9Q7VSY'Y$06:CTCGC*)9?@L7_HX:TJC\?! T(-J7LY2.K?$R#CR@Q< 5QL!+ M;S, =_YH'P&Q2D9<2]2CI^Q.*MIK+U1>#:ILI!ZMI#\(_(& FQRJ&H;PK%[# MI7Y<;;+/F%LYJT!??6<\\%K&$+AXC(M'[F.OD(#?AYGSIRD"/!/R#KO\"S6> M>$!_P MXX>_EK2G)/$\%D3YRKF/4-"D)"WE#*X?AKS'EN%D8*W7B3+$T1K.24XH;UJ[ M.NA3R$QS?;'3Q:%]'1Z!YW4\K7?$TQDN5IWEX)AAK6+J_,0N/?="6@12 ETN M/5"\V$8S_2D:5*&5<(4?^KQB*1Y!PW%TS+'ZM.+>>(I47SG8!NG.Z!F4?*_> MH-@4D^L&.K$K/QXO06JQFZ="H__D^D%.N)>P5FX\#<[0VL8OM*V8Z8VJ@T>] M[K7J<&5HUI4-V=LWJM[O"/D))5A83:XM[HJ0[7<;VX03-U1-%T9]73U3%5IY M-$K1.#JM@^9A=OPGD.XVR(7X5A1NPI!FEED':6PD ?WX[DC5ZSV'_O5'<.W" M^4YQQ?ENIP,/]T*G Q*@!;N3P4$"GB!"87P.R>ZL04JHIK6Q4QEKS6<2>]DB M$\]\[L(XX?P3B*6PQ8J%?*\1C6\[,R[5'AS5-2IBJYA#AG1EST!?N"7/&F?3 MZO"INFS+W#HK"7 L-G =Z)7>6W-%@YF>P6>+Q8FT)BA*@V?1,T[OX8UE86P[ M,M)I73)!I0B;&P3Q\>8_?_$D3Z3""Z;>]'(/L^%QSE))L+XM/):MN',^EWA$F[CU$L*%( 9*B%87@8YQH3N7$#3;,\6% M2N:(9_@H;O_6>97E&[$&%!(O7UZ IA [$:C;A@Q!UQHKT#2=XK,07M3V5YPQ'%Q2L5-;'<=G>_O[]]]>KN0Z,6X.+K ).= MOHX-CH*21[C"/E@C02^L\4JO3$\!MG RKWK=+!)J-$%NS"'TK4]UV:.9;BJ6 M;L9_\NZN:-'G?7L"T 47=2Z6ARK&86[F7_V&JG[$ZI@2ZG@BS"W*.'&\5V( M)MK>P]_GC)C^_07 SVF/J[A\Y/Z)\9U##[PW8R:<2$>#3L2XU=?7U?Q:1=>$ M/WUJ-U;)/8,,\9&9?;/>Y='38L\-ODDICZO3"N"VZJVB[JVR_GQZPHYU3=SP M]-[@,BC$>92[X_6< S;Q__Z,C<[R)D?\KR0'VY!L;RH3U[-;V"J<6) \=K>N M$;+DSKASPG@#DU9(.S 2Y_R:57JIK5&Z@P2@[L1-;W0HZDNH5>>H05K*:?L^$O%IW+3C5T7HR!QIZ XNT;& 5MIS+VC]<;33.*.+E0$^94# MY^9*MN"K6&IW<=EIOX*70XWB.XSG8M6-JC3^+_;>,ZC)[NT7C0]8$!!%Z24J M5:K2I<7R" +2>XU*!P$!*5(2&Z!4!06ID28B)5)"Z)$N76F!A!J:E$!""8&T M$_[[S)XSY_UT]IPS9_;,^V%-/F3N=:_[6E?Y_=:ZUK5Z1':>:^_!;Q^G:['" M:#"(T+#P!)3S6=(=KR'\4>VHC^'JC%18"@$;W^#YD9?)M<'*&5SSR9$W'2H, M \&X-.HEJ!5$,$J"?'%1,47P@.3Y.NI&17CJ[F5-.X?:LG,1 L*<5?"F\SH; M>[(D'28=.3%C&A)0$>4Q+H9$6@B'AQG4SXC#-H>#FJ4W;>0[7WY0E)0QU93P,KF42'P)Y"K%A0#.5_U6UN]:/)OED(V\).?I^>9>.DX MRQ=:::D&2ZD&XJF^C^-EN_V0H9 NDYQ'/&=D)0J,_LUP8_J'DR?_9UVZ_V[_ MW?Z[_7?[[_;?[;_;_RX-& -$AN'#B*[MP#IPYXRB 1E&O&@TJL( 7'"Y[>OM MC=/Z=;DNR>V*^06WL]]/WP+\4]_$E

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�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

    !LUED>*QU M/$?[JKOBF66)9C[3("CQ:(\UF)0?&[8AI.3K$15N4*-TL@Z&D^$ZOSU*I[HLJ<(O<0R7G@+$HF9K?!5VU'W M'D_>A"R+\UE^RE'@%G8,B=C)+W\PJ^,R&VI0$E5F8K\0J>K=%EZBR(C?69]T MK#>EJH\!20P$^EQ8L:NP_I :@-&2OW&"79;VX2M#E$Z"[:W>N'+;=D^QF9?X MX$]>>2BEC1;RV2&^!FN&*8,?XE;G5U 'IB1 ;1/6OAKFF8'/&MI>I5[G]+QB MC>)\;6QW33BM(KS]Q0W'AU7)T!7N+)5+:/T+C69[!Y2N>7,8D^AU4Z MVLJJ:3_E2VR4[GL6Y SSVP;R3:[OK:PU0_XPRNYTI,O11]E=HNT\@_ M\#:K@;^R6G/ U%-GB7X([$W>=[[=YK3"\H:Y)HL[^]%;3BK\1LJXNH/2@1LW MGUM$T%DE6/648H!=T6>=,[,EUI7$8<]673?S#Z P>#CJO#SV0Z3>W#2?4%C3 M9R6T>#K0JV!$7&MXN:%K05)2EA@X 6%M3F^\EE^%$PJ.'8QI$2FA63OQ,1P9 MX1UIYHV+GXY]7ZV(1[I":6TY7I0&B)RLO.?'*WB-C3-<8E+/UZI,XGOWHU(P MG/(VO#A55=EX*69P;!0U,%"V/,=JE##]=5RO\:F5K)>I%%HH)#X'V1NWL^!F MSD24MAUG7=]B"3,>URIQO+A0C+F0A5%>0)[XFRBI[((X"M,;X>4TNUVK*+Y5 M2T!5WIK\,/6 WC4YR+[7-*KO7">]<.ZX;]&4N XB:F))-XRI5U-DN+5[K;(I M<*IM*N!ZAE#X-357'5U(NWUNL5MQG$W7UGH0I*@I5)&?H-!7*8-2M_"Q0RQU MV\Y9T'(5M[,JJMVY9$"=QI]XB1 +9:]. SO:C"48G"4=U;?>$' M52R&A2;MBI.E>Z'VW:6L"*9O'2]%YL7U()83AR%U!Q+?1U?MA3.*%^V #V'; MV=(>W^>H:$'V]"WPMKV<-8QCEKN[YFXUO/01<=Q7U%^G9URI!\PRJ2"E@0[4 M]@'>ZE$*2R1\O)=_)0'H&9XDCE5QS!+DRHGRE/#TKN%'-W!OR[^<^(61%HT87TI(/ M^]+F(L@F8=IXME6F!X=IY>$7B&V\C\%!_65%ROY*U6R%A?YKRB;>YV*X>QW, MG?VOT]$TG0SP0/GB.$(AUO9RC:ISYOQ:U$B^ULMG'.RW5*; MF6;\;BYW.0.GF9<*.\/'I+M?/8$;X5L;#.*\3C@HJ%N;CNFA!71>)L])@JU].U-7>QR&:NW>N?S6(,WSR4%W^Y M.#9HC\$TE\D)!:\.O5)I=]+T$9@70WR2WD XI\7/V=X(?<+23-"* 7X>,AT= M>N'.P5 -6C9G!H,F+T@9E/0^\:_QNN\E$6+]F'T-W1FXIR[GT.09('[0_<,U!7WPWB;BD)KO'%;&E8#)=LNH_Y8@1;JAF&I!7M_C2[C3Y MZN%4.(LG#? ;VZ.];]]=2G,OUJ:>F*9O![OCIY&^W2 :E+PNZC!";KD^_.J% M-'NVRM/!]-KTGX-8K2(\N0;9E%PF\T>$.&)_U*A$BR.[I=QBLU7<+.N',D"8 M0^=*^*HED^;Z5-2UZW:>S,?<\V>=WZP':8W\PL=NDO[8'(=V'H!MQM,(L=:Z;)#Q\U,L0D*KS M[FRX"**U+7(\>E-IOV$I:7G.A\*>!#C)@4,>1HEX1-:1 %0$>X'3U ZNJR>% MKE]YU^K3UZA<;5W4T[?I#K;3S^@L-Q'^N&XAO1GDY.'YQ$FZ)>)M M=%I"4<0J3V5LI,.\4X9O%_- Y('BDOF%U))>DUO]$I8#EI]3($4"-9SW@0[# M!=2HDZH=GKGLP<"NU$"X^N=>@SEW7_MM E52PQQCJ$Y&'JWSCM.#L'TER1XS MU9+=Q,;/!S?MC+56#A!@R?!Q#7M*O?Y8HYCG[XE]!2?";B K'-J4*^EY9.:J M:*?9U@E\Z"'*&@@5=*T(16=:$BKQ"1W,."J??6^<\\JGQHVJ<"KPX)O^=N]Z MV<#@(AO';?7E=K5]GVK+AKYV\1[[!ZD"]9'O .>3 ,=+;6=?S1K0A$7I)6"( M-L;-:(U#'841'MK!]'=(S51G!+]:*(O7;9B4>,0FY"QQ!3ZCFQ(,[%-\R'^K M)Q5!-VO[[&2([@&Z,2T3J=52-Y:>Z^G@%>7J=^3<^.D;X>O^6099\IVPO:2!:0OE4>*H$6= M%W(@,O.N2#7GQO>J_KY94Y]/U.-(ERT]/?C9CR\S([5>;=\?I@K*#LQF[N.: MEJ[(B-=07$3J*DP3V4].:8FMFF,#P2+$'QWKJ^9XE=C5>'15A1O9+OAFUT+D M!!O@&!J%Z=5S/&(-RON+SC!8>\;/OO?FYZU-.>"EX$I*&Y32##E\G"N@:/BV MKC4I3!SF6[Q2(3JSK4[Y+' MB;JGY>+,-0/UR2RK@C)!#7[#Q2L8K6.W.KU")M -5>H3AO7M8@W&\I*Z2[+: M'QK8,&*U8\^T:!W.MO@N)[UU"9Y=0++3A,!E-8$Q[N7K/NM+%JR]E[-[ZK.@ M2;'"G,OL&A:.F@$E@96.61XJC9?L,!HSF.?9=C*E?MYN_-TB'4XKSK:/I=#:&=3;\!DH*8^2[0F MWMXP?6H'+2I:C-J;LQ^N;!^]0_&=,]UKR7=,\7KE0_B O!A9 8^KY\]FS\NR MIF[WC?=BF\CL+#/&,?/G,?DREZOET,X.-[N9F9G0OIXZWW1B7D#01B5QS'AL M/=5F5#)W9=?0*Y&R?CQ8=K=1F&'$+NE:'W>?*\MK6F] -C-5>5#JV2R9;X"+ MJDNJ2% (!^.V5FB),2LF3?*&5."6MP_-D+UV]/U+:Q@3%Q$A]X2/;U: H8@4 M$L" GYBM+)^0IQZKY!#RO>E ET$7DQ7-6I6MZ>[N3)YV##E:[-7TF@2P(P%H M/$"UE[U.)6=X:"\5_M+294A!T'&CS4AXZ#U@1O4E!01%DS0XO&]OF8A\.T-4#F;05E5:[C-[]=+S4&QC$]OTSO4VB3+KCN M@'*?&3>L4& >48W3K_/13/>4=5,;'!6,]"[,R8G/S\_OVH4-@51Q#= WE;=R MP0K] ML::F//_/6P"3NM,GV"9W&@F"8:0'TNW2E6L@&S!#FQ;?[>>!VZU_T]<"C*#VA"MDOIP=K3=DHE Y6J*-N=Y5 E[TSUE_YLTFZAYAE[&EZ75!P>XTS(%@-DJ.0S?"*?W\1?9008.MZC9;(56Y<1,X+Y^] M= /&>-7-VJ/N0&4ZL-&1VFQ!UBPUR]2N/'$LF1Z97M I8L1MHSCEYW&AD]4P MU[?;>"E:I=P-[7Q"*_?IBM-@1,<,^RT*3"5MG1E_ MOSQ3MDJF]7XT,=*'\:K0BS7V,Q_83Y]/HX8A[^38&29=[9NKZA/*=40)L;PJ M&%'K:>5;C'G.%;F-NEULMJ2?EEB5J*"SW!:I;M:RN^Y25SO?73>9IWG6;/Q2 MPK.U*#W6J'3+"F=;3 77N.F7OTK+>NF,['U_0:>MI/K+>WRB.^$+7/UG.0+IC$G3:?Y2>'5SKY5OP-?Y,3VV= M$ASA1Y:![4=.WY-:55J9?81^[I-W_TP69(>Y_K;C- M38$$D$7D@U\.V_NO(X(IU?@U?J<))A[5VK-1?VQRY![^V?GTI[_YE@Y%7'B: M6;0H@/SS;]GKS&[3U[>L^:7TI\/YW5].5YJ+40_@LW]D_CF[9O0D[R$4WE#] M>N>O\:]W_T44BDBD[">8%TQ7L.6W2QBPK*/G^A]K(X\4DYAB\I\//Y?U3MJ6 M]\NYOZ4#D@=%^"3YG0]_IS5&L]V[:/OLR'7][]S#5Z^6;,E+.'(S_VUA_\8Q MS1^?)0NFG"/PJ3]!-I,I[U?[/Z%/60GY9^T,'/J?139B<88'!ULJ6U(!), & MM_G4!\--B@,%$J#%L1)( E@F<1S*#VX=_L/_K/UAU;#;%Z[""&F%&NYS]&[3 M:9O+^^39W2,!H#$D@/M^<$_.Z&^_Y&' MTX0EV6FQLT>Q6?YD4VCVJN^%(_>P)0D %]1$0[+_BQ-Z1Q2TBXI4M H!S9@= M:A^(_ ^.Y5"R&BT#FF6'D5^]DHB'D :Q=LK_;,#1*XJH_4GD#=42GL<8>@B MT[08\\+Y>O%HMP*/R #ZG"0X, )_":'( M;*06J/FV9U$6IL^E]?2FRJ[06/3&(<3\Y9ALDC PV2R^NP8<9V WTZNRY]]4 MIO "%93WB7^I0X*K?[]1HT5X_C*LC(1WVK\8LISP>[GNS6@A\:'?/V?%_Z= M#YSV>L.6S,;S!'[+O%=$+O4C)%0QJSN;$IW>Y=\; MF *IJMT717_I5Z+ROR0-7]^/Q7Z:$T0E&KA M:;H;_[A"X^CV<@+N1\<5$@^ M7/Y3CAZA^O<;PG^3OBM!03*1^G B^8W$[[O"OZH$'>'A]XMSJ+Q( #_/F^VX M$(-(Q[5!Y8^J6]<]3A-5-E!YV?-H/,]NGJM/Y&EF>5 =NS66<\ RF#[18/G@9Y6DJ? MX$*LB2K+^=V:B"-D'Y*54TOH9=^V,6X[!:^&M-Z9#\@DQ/&8HDHV91:\"9OV M5V4J;3_(4_[BO%0C?*!&7.>#PN+J@E+3_!HGFE96_^[H-R=\[%9*UA48FQ02WL M5/#A8YP[@39V@@0(66>>TCK3!&^;F/EAVOX"]M9V^)1"S%?(9#_Z-&2!#0F9 MZ% [-(:%&,FG>M:F^'Z$'#@1QDT6.ANHX_66M2,6]C+05%;PLT9[WDJ^ MR9"Z;-]+)$"7G#&9Q@E1_PG6/VR&Q,")Q]%[5TB ]S93Z+T]%1* D8" $'" MUJ@^8;RK8RW'/J6=.5XL OIW((1)>*./;/X9D@!<'#A!>?)?$"\),.%"Y@VK MV57Z_71IT_'HR)( $$MPDG(!OG8H^EM@&QN!!(I040# M7S-M\TP(=FG]+6CKP@ $:\7-\2<@C \>^B^(0_[">Y9^G[S[+N;^Q'/4ZA?> M_P%3F_P3;ZI_X5U)QIL$F.P?)R/.DD.F1X<:Z._0%/#W1_L J2_$F1,(R23 MFTX2(!H6ZX]4-8>3 -@E$N#?*!-DFR8Y#BF*8 0F516"THO8/5O(!%DF1-#N MB^-,2(#8*!!6AJQ$%6P0@P]OD@"!#PF<), 7MP+R5N7C_2<E_AVX5JQ.* )AR;S63$E05[D,Z6SA M^(OEW,F2>!_R'_32@>*YH;570#,L.3^_(XX^WWR6K B^1A'O.2[T-C@2S<@4 M^S9/EG2=K?L_Y[;$AA#?E#?]B^'_!/Z8^QR1&Q8"^DUW-)GNH,D!\]/HA7_- M\W?@[T0OP%G]2?0MPR5*@FSK),,AA2N4P-2L\G?@#X)3X6-\!4@ V'\2W A\ MC4Q@ASPR@65X_PG_0? C;NUL@/WF5O-N\TP.[++P6W/RUP;]Y-8_@3^)!9HR MPA<0??\7B87PY9\9_]]>\OWX_ZM+1D1"_C=7+.KXO[=B,GMD:/S!FJ _61.B MY/L%4I=330WIDGKXES#\&U2OUXS^MRS\SSV!ZJ/"N\;6"N^?6N;XERS\$PC^ M+/6'2!$@&/TI4@[I]]^0MT0^7NEH2UC\$BG_ 5/K7O]#I/R?X6S^9__/^\RO M7/=]_H-&1V($5DO6(6[\A'4>$/Y_?# 19 MF\=#V;Y_XU,J19J4I073CE3:).M4DG"C2+(UE22$LLMP5;(D2^5&$5-)2$QV ME8PU125[B+$D.S/68:ZYYCFOL:3N^_-Y[N_W>5Z_Y_>\GL\?>KTN7<=Y',?[ M>!_+.:XY+X8FL(#%T7C\M^L3;$S1L0]L3!C$"5L@U&;B&H=X@MOR.E W/CZ7 M&JF;JS+FUXL-/CIPVBQK=BCJ37=0^W]J $H;%7$$L&TZA.%BDF@((9H<-)0V MK$UE:53UCJ1 +?<)2ZK/6*)J3PY 7-W724Q;M6K64Z+RYN-N+0Y M)O5/F_ =^TE>:B0-$;U%BYDR^5=9?)NXN6C<5 ANK2(#CS"T]19'7YD:W$&:B9QK&]09 QA;QL;

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

    A/=^\?=%;1IATWBA73R)9"W[TVTK849^$=$+>LO/FC\*9<<9=^4($PW> M/X1/OXJ37!JL@XXL];8+B'O2:A13753MOPXUQG-C8&'!#"C7O?$^4-S""O/59J^H88DD(%(A_',,9J_C\,/247\8LP# M!5K:/_4D&998/]N,I'UJC/1H?QYPI2M'=KCXY9O^]Q6195%EET["0$).MSKJ M*YF [3*>E/$>\]73_W63V;#+R[^5I9[DZ< M;HH>&;38XY!]< Z)?6!D#M=DBT")'FL48BU]YL&8F=-%??VJ\Z]J0F8;;9_P M&;" E*=6&TCL*Q2BTCI)HBNVJHM=4*AA9WS]"ST$=KX7Z"+*O_"FY\F.S$K< M'-E/_"52!]T"FI1S96-U9'N9+O_GE6'%9F6S2UVK<0_I87N+-/,+%]5[1FMM M#W;*&HNF).?ANVYES:,$ VU6BPG^2_]?HN3_I\:&"OX!K"&4'C\B>?^"LA1\ M3]M=W^576Y[RF;GSMJ4Z">5Z_@Y6Y(* :N6E5F."S$GARY-DI',<8V^9@[^X M-8L@>WWTK%50X*/\<. "YY5OZ%0 SM#KCT]WN9!%J$79P"&8-#F&__OZ&X^7 MZ0]G75D/DY4$=="@_YNZV?K6NMNZW<' D_1@5K=T-?K(+NEK))WH7BT/X=8W MBRX*8SX#7J,]K.(-+M>WZ&-CG3)R\9D$!QQ[-^/TPO'B2L?LD.=M_KO-\(OORJ%D3IE?1Z87[BA #.A;2'1S2U)#_<(3+V1+%R MI>5^!M$-29V89 ZRL"T!?G08E'"^.->/2.QZ(4,>S?(B9B16^$,F?9^MDW>6 M<]+KMKXW-&CMQ;YB8=]T,^!\5_B8?E#*$H,U;/(<3GZVAY*/?O7'S/;+P?@N MZIPK/P/F)(?T!HSXO6"(O^12SAA>:>\"+;EJ2$X3/-?MY/>,?J#OMJSYYBG@ M):'I)/XO69+WN=@LI (JU?2TMM_'PQS]PQ'5MT#78+?_?F']F _*]KX MFOR+:^)O4I&-FQK;<.0IH :Q7*?;5+4+KG]P,S'N.R_D^64J?\3K$:"[L0"9 M)DDD&HDQAW+#JDAW#?F/>5L4LX6A+M]/ :[)C/)_OJG._O$\_GS%0@>HU&U2 M)A0:DT+ QR*$/.RH![DK6(R7I9S&T0,[5_AN?A#ZJ"\+,LM^L--K,5IH-J24 M\>?#L]?;?&9@/])Q7EOTR2(3;CMC.JQV#JCO\F:1_ M;-(HL<%P=^ N,R8Z-+O%-X1AZBUE"*> 2!"WAKT]QIB7Q$[T_4QTL\R6$!@G MB3L*9Y>N79P+RQJD^,B%'[X^/T<+ ?H=[=>4EOY4/QS66Y[$*)?.'KPUDB[[P?E0H-C-F:AI@X6V:HE ")@HJ-.T1KA39.<' MY<,=] W/BG>TL>#-8ERM+GT!TT]\S7F@@1(;6'3@QCIZ[_86AZB]: 3-L*.7 M5S8/\0W="W1MJ9Y2&K>AA+SGS??Q)ZM+?1[?S:IF%3>!N ?@PP>17:A_%L6+ MW>:$IC-%=QF0;8Q,DD=(]$4Y&TURF!9D2I1,(X\#2QWDGK>+(DF;4[LB8UZQ M1AZ(_HRLMH%O3N/E4*:X\K@2J#K>M77A'80S2[MVT=K\Y0K4HV]H]WGL#C4$+K 1SP\=H0H=P:+57D8W)DPQ#35L_139RY;/GL8"G6OU(2,XW0?6B"@ M /S?%#S6''^P>8!U*_'8U-"NM%V J#]NI(IC?,K<7^<[H^KSY-UXS;G!I;/D M,W(:%[^<91<**8 8=V4LEZ>IU$<$]D5[^/%$AU#A9F<=I,Q3XQY'W'76XRNVA MH-$A5QT#QGLII8H< ^8N@CDS]97SV>FILU:@91#C2'*./+NM@NA 02Y=KZE' M3]F,K-%(W 0J.]F3<)C3"B1TG63.$AX2#\L@;'7O$)JI]+5Q$$G- 4&YSF2T M\,%Q,SY[#JO"*SX6+/44$D#0(29AC-_GT.#@$5 S-"R*ZP)HS4HYUIVAE.'C MG59H%^,5#?[J+.'Y&2/\AYM_ZUPZZC.,S8]^ M[ZU[U;/3?,"*Q):TMHJ.FE2GF&>YZEFN9I1\L/*P%?5KUA3(:XL]:2*QYZX' M7R#JXD4ZCY0^Y:W9*N%^UR/KQSSR0Q8DC89(92GUBF;F+P8".=7U_K3Z=B-K M&D)S*9H!E@J]%%58W&,HTO4*SE3ISUC=*^U8E?/WB:S"V\!WIG/Y[B)46RH\ M7*NEW;5V.G$N=\D[T#B8N&&OX:&._O $3RV$G\6"+:KK<>FUDC%"U(9+,9M* MR>& U,9(/N:U^.KV[^..)L8(F)-T+(I%0R]_3:US]>B)+?^OW'$/TS^R)0M* M5-]C+^_>-+O"^(ACL:Y%>*H"+W@6J*PZ'>B\.T:VU _$JW\U++K[VX1TC" MRX3G<;7&"JZZ63LLB0583]D0&G7SX5S:FOS+JGIZ=X7 KXTTML2GA3C69X.M M5P^_M@B8%_'EB%4\'0O[O*[7?)SXF.#M(3CKF^PJJ[^M6S=SZ!E]M(MAC"/S MDU$+M\"1"S>( 6A8!%EJ2L ?M_)>0\CAZ$VMA6MX,G>,Q\_*A-J0KJP<&:/U M(8K@7I'.CT"#L(C88'9\8>4G=P7891 -0EJ2&5.K9]<8)=@8XR7D$ ?](8>> M]&^,5A URQ'.#%LK:>#EQ8HXWJH+*D/]W/ P.^C$.3ZTO1DF8Y9OFNUTJ_>5 MZVA88)9#=I9-^?87EZ+,FH;!(U8:_XKIGIO;\7HC-GH"7A+G>'P/+:I@'=ID M1D@0FG\K%2M-0S3OJ9V_H*_TX'H])EHH3VV;Q"X..DT]+,UN"K"&&5DQ 8*)L3I_!IH1-,>,,X& M$$SQU%NJ%/='AIA5+\F0@IEGD-3'1!H%UQ$QB MK,:UP0AJQ 4V7?:FO_11P!2IO!\:T,M\;)2:3 M>Y6F-+24M<0'+* R^)W.9LA2_*L$#D1>QZ*(57*9B@K(X:!!9TKGV+-I(Q#O'NA:_D \)>G= MH04( :H;[J!!GEUB5DN_4T1$'!$2J#*@(;C?A@*Z;G\4])/O+&MQ+(7-5?,4,Q&WG4(GMJ79C=&IF97-X*MV'M;LGS"Y6]Y/ M(2+Z<&5I^52L\+Z%B?E8Q?'O4#*M(@;!;4F2PL$ZI4.#F4H:=$(QGW^S""X-IB*7N]I,>Z/C%IUN> M5/U-%[N MZ]PLKO0J578%#;SSN7159:;@]ER:8,8&_M"(F*SCR;TCA9H-V.48LA(I.*?8$RECS)] MJUM3EFLKEL&M^4M0T5)CEO ?.RI#]^J%DY_\W 0M-5H$H8 M'5B(^(Z"70K-*=W,P$^,H8K:<86J@E;]7I*!FK\ZJ3&VLA2X[4"VW=!4BO,' M\J^BF&K<.$4(.XYLL?#W1482?M\]\JP9D)U6*E^UHOE:RNB'@Z96^#,(.&) M;:+ AA.9IN8_8IF6$$1!95*!%F;[I!NY-QT ,J>,FD%Q2[H/6-W7#8O<"F)K M*U4JOCWV^;GCM0/SQ-FH\]Z)%33]:\GG>G5\D,^!1&'E&*0C_TS? SPL?A_$ M8/G;)<'7*;^L])Y# ],D.E^I;KG3S64U) MZ_A!*D:P N6_,[[W]9.PLFR7UZ0T-8.KGV-@OP?WD]" +5QMRT3\8S(MS3^N MLH 4&,Y>SY'$#>7$O2E5CM@JO_(ZR]3@4C^;GDK\?0_4];ZA^!:+<=#_?B ) M5."LWI9[\+Q5^DF(!&S/$E$/1)L*8"$/' ZM>A1_KD[2GH(:+&Y?KC!F(VG8/W%]R M1A#^WNL.C"$]B Y+U6#>R(J-)J@@T;5MS.E8?8BF<>01#XCV%% +K!G"LMGS MJ->_*?O^1/80UO/586M5;[$Q@7C#:4LQ%ZJ*3X]JN5"Y8+56#2E%-X\6Y]SE M,O#F<'"6@\RM#SQQ2@[S><"Z!21?ML92G>1/+F!-1N"8\M<).5,AF/"Y>KN& MP)L2GLRIA\J>[:KN.9&3/QW3)WY6>2UR*E[NE(INUI\\R'+?3R7LMF7P4=.7 M+T32.^YB+HL:^0M6,8QXDA8VG?S]&:SGRRPM4390)*&4*(IKP.INI6)X^='Q M=<7#!1#".K=;L_4#P7AZKETS[=YO-:M/2H NQAU=5VOEER&-6#9W@ MWS6$+9P$BJ["H;$*=WN)/?BZ?UM03X:Q0F"B@+S,E<0E[Q$XM= #?GU8A\XI MX 6O+IF67224+ P5G520]+ VL-&\G[P]&.],E2#AF3 089ZF[>LM[NZ+#ZSYA=26;[0Y7Q%[J\GGWB&K^5 M5"F9SZ+GOODYL%30G9:=TW3C.W?-V?5X*^A?P1]S5JMI0)P^B"@,?Z_ S[3! MY3$5U_*T(;G#Z4IFR^SL1V: P.-=#>^;-UZU4[OP>')B8.@%7SC1^M_*8>W* MFG%C6@98N2&.IF(I :]]>]>4$6*O&H8KAD'T>E)R_:XO\CFP0OJ>3=$&"X3' MRSX&1DX5)VRU52/D'TB<"9#&!57G +S4(HF;,AB%X/EX=+!'_LT,P:>%< M,6WT%@A-[/Y*/X[UL#[Y"G-!G"V<-%GSKALZ(9S,WSC58G]YJBZHWOZ"%HOZ MG:J.\)NW>T4_AG>&=&^IEV'ATU0K9-IP#/*8Q^D4,)(\50SK@ *7<%#EL[SR M"'(:RJ)"BK=#@AS/,#P]D;>L."0=K-?J6($*GM*-)IXY*V:RJLD?WM3QZ JI M^F@=>+NJ:?M,.\^T9M:\SLFF"+V.J(ZQT46#W[6)KC89YGSZXCJ%HW EF?<% MS1&+,]9A4E/>S#UFF24]3\'\S<4K+[*_K\AO M&?.;M69OSKA@KXX ZE.%Q?VU). 47- M31NG 'M4?/#UL_H+V3,6D<'LD"YC'+('>'&-<&1G4/+\(U7]+)>G'M,IP%_B MAN['JUO!ZCQ$[YX7IX")+ZSC2/^MK)>SR<_27YEZMWP -UL[)Q2DT5T@-[]8 M;Y0&[_NKN>A(?INUO"?G*O5J9ML&/)$!N^P_.$R\=1"N88"1C@-1*2*HYKH\ MA:LFI/R:8Y[?58?Y*HR(ZB4F>G%$F/K(7 9*PCID80Y(NIYC"&2LTU:S86S? M0ZO=16V-H&QGQ3V=W_ADEU33%6[\4?3[88? ,J) DQ?"3R@=J;T-MB'6X0>U M<(R1>S&^LHT-([5EO5A.)^%YDT=7WNU>DWR7 $I .DB?(X()4R?5+6;*T9I" MD'0MO-#^(,B9JR7H1*;-RD2U^RYOAG. M>EG),V.3&A,^DEV#Y[BFNI!,Y%]<$;FX8;WQ6MY+?P6#XN1VOEMFTK5\366^ MWN?J54X-N/8< +!836AGC$35;7V">+BD\'.DR64I75/]FFI5ETS0>BW YG+=LK=,X!3"73/5X[3^T"5#Q,3,/ MAV@;*A>6&BFU2%;^7+OMI_M]@1;OO_U6P[Y@8\8]QR@_;Z$+YKH"%*Q226*D MXN/4O2>^;Z]]THI\B9P=QI#A!22SNC&_-Z;GOI7OUR5S;!7:U&"4F%UGL+?X/$WZ<]!3.KLLV(Z%RT?'J^ M0.9ZR%T.Q#AXQIC 0 RB*/\Y(CT&P0JE36AOXVZJ=1$Z/VP4W2D^D?38CUWS MGJ=>O@,'0['G"L^EH: Y?YX+B(@T]9R<"IU:WF_\3OFHXI_#ODM0\=),"6$E M5:>:BH)G7_?93O*V>8<$V] M!%,;+8/L2+%"[,EB+(_G O&[NO%UDMZQ,KDOHZ\'.9L\A@'':(ZX^3N5&"FN M,'OZ1\];+LV<&.%RS9!K>3FI!^DD%C<"(QZX>3%H$<%)TL*_BK0OF%LKHG'W MJ)RON$%W$SCS,FF"52U,[/.%[N*L+(O!'(:3IA9E"CY9(]I$$^:(RD_;WBA9 MSDB&664ZUEEG^?,KN(A^_SG?_M:83]@@XZ5/FCI]:"5>-EP)8SJS._L 5;8P MTVJJF1_EHY$F.X#_%L'V?,6TVNS6;E#;S[\[WC-BA-;D44/U:?E5V$P-F98% M R.*&'<_#68G*1/!F.D;HQ*+:KF22V*'7P2?MCVR_-T[L+G#K.?=L93C1#@F MTJ"E9^ $_JJ3SRUTGVE\QJT$[:\#E%..:KG[;@>.%!MMPO9/_?= M>>=&IJ4P'JI6/'C+!+]-OJ;;]4:KZZ@M<['9X&73+CC,C;N/^5YU_ML!?*US MI)AO(D25:CUXEHL0?GSI['AI#Q7B5FY)86 3%1?AJ=S0#H=ORLH6%VGFJM)< MF.CLA2(TUR[T#ZZ$Q Q^698'LXOVS6P(SS1LJXX%B32DE1Q=F>$LU,[\M4CK M'0\RRFH-78[6-R#:#A6^FD$%Z0]61)[=4<8#T9F@?]U1?ALF*I?]^[U7DS2% M$@R36.P7TT_"]\$GBC,6\#.*#;_J-\^]R-@-HI][IL50B+#\O6#9NW/1I:?F M&0V;+OZJB'G[TD41CGXNIZL?<-\6HY%(0]*'%)C/^!)F/2E".GQN'AE@ YV3 M:"-L0OO.THPKGZ49OP8[\M4_@I/I4A8'$\Z1Q_AI_0<5(@R&KGU'M:><'ZGI M\>/5 MP5TX]%A\8O%N$L2,PI/7!:F,<@B)<88X7;@K_U [$*?Z,GI0UHJI2\TS9<\6G?*13H 6># MQ)!I(I5[2VM/ 8R(Z/RJEJ9KI51=QO/T>_7K2IP//]YZ"U_P'[[; ^WX1SZ_ MB2_!(T"\V:+5K'.M*VY?:M_\<8G5W_ZGVR32?COR M %[+3V*R@W)CILO_3&Z[[ZM?U'/\G?33G[/HR:N.&7TY_OQH_#!1 -G)ZX26 M)K%J]=DRX<];]Y4[MS'GB!>&@)047S:-S=DUXSK;/"/X+VA=R#(M^N"J8\9L M8Z8H!#Y^1=!LYHP9DK6,9)BJ$-6/Q>B;ON&UN#0+6W ]!40MPNK G;.(.!3N M"8P%HC-$*DM@(E9)4!4XW*DTL=+:+$O3' 0Y!(_SUQ:?9=9*FG$*)S'AMMNM M;A-:84Z$CBTDXS@3Y.]*$XG*$]Z,IHX'3^L?169N/ M3AFG"C;O8#/."0QRY^_DIA8FV7!?8:!^=.= 7L\D]6%]O(NX':_0&ZL8N%AU MBOF:&VCXQ^%(*KRZ-JXB(8)\'>))ER)@%3KFV>*QV-.21J?B./]G8:X]\1P7_!,VBEENZRW#J,JK0B$.*OI]6M5R97)AUKQR&9YRS8 M.)8G\RT:5I]/P=?-<5C_F_2'O/L":[J$TTOA8$"R*]JW0B M($@'BS]UJ,:=[/9,3^OR%"H?_/T85U&,G, M\R(%WI5#,C\&Z9,CT%Z?D9ZF52-$3,UY^98A:V6&@+IU#=#IK?^-5VG?Y)MI M'S*ZD/_,TGG(Y<7-Z1R5V[8]RE.IZ;ZMQ:36*9[,W3!7@H]J6X$!LNZ^BDG8 MRY=/CVS 8MP_1X9[K*G"#B$C?R8Z09.(:AM6AO,Q!0ECD+ M0QWZ0!Q>'+44?ZTQ_Y6D]ZO*BIZCN\*ZR/8#=X8B9MX.^JIQO^-A!L,LK#;";,SZATYOR.)ZO#2]T2 M^4$?T3_"CM&$GMG:)5*>OZE9L6U\QD)Z\O/).#93KY)EW'*1E-1&(YH9IK-3 M>\Q:S9";* ^C#X'( 91;EUQBV;4U\=I' 0FU&/A&J4'O)JTR-SW6&#,[ DIL M^Q]7SO^_ ^899$LZ_ :9=%A@:KL0ZS]?-JLXUN0UOR'CO;.'9,P4VX>!L_;_7/GZ028XEMX[P7QBXW- M2X]Q\BV>5!V)UZ,7H3^\E&_$:AIS\90,9$FI[2JI&+EQPWMEY4)O[QDS?9] MO^T>9'IG4:JK>,1>Q(>VSS5U5T"EM0U^MT3WFUG6Q>>XC/J;+). M30K&PNVL?C+'?KBL\@\O6.!J/NKTZ_66JPR'5 ER;YUX KNR^L<_XL4++:S>H_KVU[W?!/U_7("<)-Y.G% /6YN8N29\SV:ZC)EEB%L M(QY;)JF0*ILMA8$?W]C>C-PR>W,?-9_()'M!.*PHMN7TE743E)AT6F:)KC(6 MN)R49$3%291 :R/WJFX6"<. 2_W/O?*B4JR]\MQ-\J1V?:2*>+X4<6Y9&ZNK M..Z['ME'_\G!2Q"-2'/S()1J&M2?[NC-_-$:0;N\(,T? M]*>1%KVU_[Q]I7>ZP'NNQJ4-PPP'G0\2)@=^XS-O$?P59.7C5;#>P#\P4AA? MK+VKT$'LB?Y78U3(_/(,]TS[BFGR6LFHD[&28HR'>J-R$AC+-8P([B]R#"J_ M'7'=.,LEO*.M;+5T0-[4$FKB(9.?GR>>-+D/+JWZYHI!-_D+OP7-9V?SD\IC MY%[1@&16O%]]_GVV'L*I0FG0K M[NT\J&N0PY!TV$;G)W>'TRX5*Z9R*7_?FXQZG?_N86V<43]"$\*F75$1Q;&2 MR"08(G[P(J3V"WBHP0 :APTJQATN>;IX#/2X!ZAZ,!U\R-D\PG\6N!^3_-G- MS;5>==!$K'Z1S KB@5$THCC'G MCGWV8B*I1X'@%8^\5)UYNM_L[_$]BH0N)9;JA^36(Y]+*8('&$VVWIZ$V11T M-E$5J6EV/^9+GXP]H.]<@MW4*+F8-&/ES/.@V0AV MM5AQO_(@5BS4<.-I*XW=9;XUX@3@*H?;;6_A('MD^QJQFF*;W3YQ7_UF*%96 M>9V5'WA1X>T$D\ ;8!MP?9 BFGXSE&0J?+FD)/?+&,""WT)O4F+^U'#3]@&D MB@)?F&'JLK]-":M-WZ3SUH2Y:G$EKGU2WY_&8'U2^%'RK!]?B5P[_,X49X5: M)9"ONIL:9/'KP,L*+%QKH+&:IV9O7=:VK M,]QD/2Q*&RNA+C$3>B3_A8T@&TK] HQ%;/@W-JHFT$C,XT'(8^SMGPF>P(1& M#QI!1'4=N'8"F.P[>$,J(D+(&=J40#SD=>A%Q%XHNVVH"WHN0K'XQ3'$:%;? MBC:_:?-$&OP$)3?_LG62O0--E:7/R2,%FU08J9I#,5NUAC39,KXW6#.]%B&C M]X.JDQ?Q#V_]M##367-"-!*UWE!DG5;I57K>1PQ9/=+0$+ Y7HPQG$:I7'QB M9ZLLLL&"#$BYD^%^VPAL-5GDXB9>-C)B@^N.H/E3GIP 6,P(>M%-U^1:&8QK M@7=,5G&NYD@(@@LJDFIU7I[*=.&/NP-/PF!. ' CV,-C3*@'_V 8#A86(DSQ M(P>Y^#]-7\[(RPC6W0^:@*;N/%SLK]%6^\9[;=R%@7TV"ZV;8X0+VV=I=RAZ MI,-.7,A;D;6)]$/4,]$Q.:6H]\1$1_ZA)Z;?B#CUQR@73A[-G:8O)H5K:N/) M'.G&4F*T_M6TVY-BP7N52C_K;)@A[%%E%2S9?)P"-Z8=IQ+]GZ-\/1-LTHT* M:M&-PE)#,'!0, 4VWXHZ 50YAO*V"*T6+_ J-ALI>G(B/:3LX3;@?+LA.YLJ M[XH6OV0)P/MSM\![,:T7@Z0H]ZCL05R4!#SFO-OLC7$/M!)0PTZ(TT9I0C9D MG%+7G,*AF?"=KR1<--'1Y-#'VAQOX%5TKA@\8/;B2''9S,2[:GQ*9ANNN.T@ MKV9I>=E8N9XLP[GOLEE $#Y/'YVK MQD8WR6.0$M^U^+&4K%RME-S"K$+1YY30A]&G#EXB^AB4_,/ 3CZW/^^&/1/I M<+ZPBK =EPY[)8)-O.1Q GAD)Z3_V\=3(F/IA\WDK0ZJ5/FZ6K[MNEF'7D*; M?%(C1#=K9L(Y/21M/1[(WKYK_F7B>[]%K%5OYK/TH"$WT9$Q'RE=P_&I0J\] M:$7(K/I*>(T'>F>M_FYO+@N?<8[=VF! KJ?S> M1DBBW^,*5K9WX?[<0HY9V>OK!R'!@W**W\N$%,JY;ILM)L4K3$[B-OHJ]B5H M[#D'?B36>(0FF ")X?*>04H8-GS])7.#6V$J:O_"5%BLS8L'Z,B':4\RG^P. MR-M+4,$T_H;CG!!-2NEW[#VL*U]8*OFV;^KI76T)VF5QW1/ :VA#R-_F-NT: M(?TPYI:+4Q4QIG&CE,&.DOP(JN^O&QP>3/T<@4EKU=2Q08HDHHZR3])8D.LV MM #+:FH7LK(BHR;4^&++ERX>;2TX=H6&EQ]&MR0L M4OCLU$:=:=M"W:N3789A<6::M:BK'?,$EA31Q.6T:KJHS<9F9G&G7W5C5<1Q MC-9%)*A3Z!PEBWRA.]WN,%)3@S1B7/-AC6LBUMF7/Z;86C*E )9ESO$L99^I M]I+<*T:\T>2H#B%3?[@C7LB<(WP78B>++6]OUM5(M";VGD>D6Z5XB)WZ@$VY M?O9=7]-EK\%?PA7=Q'L'/K:1Y+(%G>#X=E@Q0Q&!%X F"6('86N8%(KX)NCS B^]:HW#YK[>1JB,5R M%!;RL2F#5R7G!OO2?"'_#3W>HSI"E_,CBIY"IZ[L7I+)X5ZT.0&XLSG;-%%# M[Q_8;)7J+3J.>9N,)U@;F!U/-"MO&'/Y4)*?U:MY]AT0*W;CB?<(H BZ.%FP M)J<]!S!-D1W13\7/+N.#O8,-C!Y[F B@$@'7KP&=S-_[,Z)S, WZ*Y6N1L(2 MW:@F%.>^+IPG@SR&A[!_37SD:]C*ZC8WZ35]/WQ1'/+Q\,'B^7:'V&^$Z)&F MXP;-ZP4;.VXM@I13I#@(2UD;$.DKHV#3;XU\?=W?[J,*,\\5,,O+?;=)A1Y;>*#@0*2\3UDCZ4[,O7D,W7VLR6XF54^"=U MB69A")[2@N#%K8G;];M^Z;\*\SPF+C1,ZQ=:K*3\�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�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�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

    'RV=FNCB+CU&B**A80A3N+TB=P1>"YM@6GM*[M5M0?T-#4_\V\/ MEU,-PY+K%@!>F.%#@&8 M2"C\4='P+NL/][7]F!]U81W_] 6+")6:Z(K@8I/^@@0%9NS;8'I_?;70IA2M M;=%#WW6 %1:O+,.1KT.$X;/;<<U#3Y#)40'_ET"+!V+IHP=/$"CJKS_X6_%1;GY3.-_FM^H0B@ M.E%:OI^?UMG(+&8Y(#075O/DGT MG6._%G?DU^F3C_Y<32Y=R:OVL&$RDFM54/>;TV<.^,0>Y9NG2#>A$8'!&Y.8 MPJF@%,A#1,O%9B%7$ OWW!M'1G9N 056'21(S25E5+_6O8K]&@(%[<%%@[I) M=EV_LH]R0<@=2TR$*(P-H\I_M?1"WH8(8QFY. \BVK:E68 44OW.E>?W:CP: M7F@>!U.EY/SC9&"!&.T]_Y1@Y.%H("ZP#'1T$209)#SX,D29OBCW^0 M95L:G!OD1U*K-$M_N@LF7[Q27YL1KN]L8 M\AW\H07S1AV[7%)R>9JNA7YZ"%#>V6S,% _!(%H>X^>*$.*@IYA)/RN2:>LA M0$27Q>/.6+G5\$Y.K*F$E3C)U?''K,7B)\^^GGN!=N-] >%G) M;!]H0=[;$ 6VPLX:%HYW7F+ESBF)SZ5"N5;\DA_G?>[@O%_?W/2V6N[E(K^W MO"0VL)2=618P(S(ALS>>":OT6:%9_9$USDW;WC',5J,IL'2369 7#<**\5FJ M&YG8_^T0(* INK!A-MM:I1O\:6+2?J7?YV(K/^6/;:>HWHIDB4N9VN.P4&T; M1@[>F>$TK[\!)-]I">!"E5)#.^?[<@-JU2PI,*6:\HC@6!_MKW?=L+E3/\+/ MS+DD0@SH(D,(9^YQ/^*E#/)%[CCM\]05HB)'CPHG1^N!7]CF*U'O8. U0R^5 MWFO;@_= W5V7N80XT8%,=A^RY>0"6V<_(;83PB,'JD'[H"((AX"HW4E11T?; M=K74VNM?\Y[FJ)Y&5!9.JF2Z=YY9=;Q6/>7V!:UN!U/P3'1[-3T!,5EW$4G, M6S*+LXE/3<5.'\AXHOS)+&7#B=.%SKG2317>H/7GB\HL?Z@\JTAY[N +=HXR MJ7WRLJ*>(_-=G%=+"8J3U7%[%[3HJ]LRQ['^9OK-M-SUMRJZ?;GV)Z_Y"W)&.EZ:%FOY#2@V6@;Y$1&GW;/91PN&?-!J#P951+VC/6 >,S.N^!G](Y'$ MJYR2^C@R5]&)!!34.SCP%?&FQP;13?HC4M?B@:',3S !S\&\# 62'LZ.]Q/Q M$4Q)>SMX22>"+4A[Y@8)$^TY^7UXH3)"UW9-??D\;H#_Q1HN"=TM!3@!C RY MAF.$(>;2'?[VP+.,-/*MA9 FA),;44679IF8,RX0XXJVBNN4JN6,2/2_JM1B M\01(N&$\4FMK=\U*4QUCXC-OE5\W^AEIFI(WL!#=]K*I)_S[U83;%4$G'(^T8"I! MAL#>(U788LVT;XU88X#<^%5+^U@2<=F)CL,.YJ,&(H,X8?TX6= M,O5[W@ES%+%)2B32%(P_$Q M>@C/$@R?V^ J4V)HAUO$8555J5ZO*53\F;J# M_%?>S]\$9,JE1@6JC':D+UN$XASSV:VT1EF,U/DHI;O5Z7C92.VMH9%\] M4Q0>,_9U@)IM?\P&V6INATYW_^%T=1RW7M;+D^'Y;9LR18#/V1_)_E+*!!7?-V^74_?X/QK[^R1\:9 _A:MC8,H;3=ANUCU+UB;6MP-!LX)#'.@[D5#A=$^LN:67A7)>^9".T*95J+JDG8FE3[!*AWZE&"YCDV$R M6CU]QV#8HT\:VU0;Z)]S"/ 7.PF,0A^G/B1^//_3&<()?Y-+?I!8#19Y->GS M(N'ACXI)VD;9Z:R/+<DW='=Z:UL;2(TEI;5#3JFXKFO: MSJ-XX X'3WD[824K0U;??_]S(92E#%O8SCLEVFCTKV^1C[5FGT:V-42^"7)Z M,M_]S],13V7;#Z698F+1'X]*Y.*]("^9[8< ;%ITR/F_OB4@5VZ^(#UR/)GM^".T_E7JB=XWM M7@RH6LD.*W]J)ON@$>1C;*(\@#Y@S.^FCZ;D-$WOSAJO%+H,[TNVAIP6\XN-#.LB)RIUD9/D8A45U@ MZ*"[9#UT+C6W755$X7/.U$SC[VWKZ:E.F!R'"^H"7^]+ 0N G8)2S,OO)88_ M!F+]D>>]],M8TS!TW;[R/G^%FZ1H"8J-[9Y5??FLM MKBP_?O8W= TVV4CI)H^U( @E'=E'J& B\FR0(HG[M4]L%K?13YQBL9U;3=&B M@5.J]?'[!6Y2*?83BW(ACV^\/L$*4>@'J"!$!.&,F(A=.(D;L*-.=MJQ7=^HXRJ6I+?>Z_^<^<6V]TZH[9=<[*3!J=''0'1PIOO8USLV+^ ,$ M(U1;51NG#7O47G[2#,AV7#*0O'K]E,I.+5T P]3#3*0QNQ#A^)U;Q;O<5'G, M1@OYV#QB@[Q@R@9G:[/I;%T3OT737C"O(^TNIOO,-/I?RGK^+3 ZQSF109T5O\M7;043K./-/Y9C3:V M&2Z[L61C9:OU?7N!]N5U!?U$ J:EBGQ$GJ1\6P MY[N]-7\4RUZMO!J .V6;_S&Z&_[BN^&18$-I;47Z@U'\7#:H MG"4HQT=1R. MA(S7EG<]UL&4)8N',5"/&K!UB:G?!J^,\>J>[HAKNR":<>94[[$!L8Z\G$\Y M3;G)\9B"]%H6MFTW3>-^2,8D&UT)'(,&*Z^MP+;_:%O4,3*9%VR"=)#?O.'< M'0_AQ58SCP90NO7V.@/\C>5A+A]N%U?QU0*NR+RQ\PC)0+2<1G@JGJ.#&975 ML&-TPU$5(%!N=&^,*3JLTAO1/*PLNUO[[OO/*8-[H>IHW"Y\C\?@-J"E?]D$ M&MYND>4_OZ8K(R#X:A.EIK8?O*><:_.RZ*JWY9+ARNC>(>!\3HSL@,;_FG/[ M9,%?F]E'M*7AD_JDY4A70@26R/%;>5I[Q-JBS/-2HE/,-:OP$UGOG[X[Z7_Q M?5Y2X\GULN_%LFLHJI?B!O@0<)=%OA7L@8> I!*U#@A)%T2 LBCS6Q7[0$NJ M"\5>YFY5.I/B112_:GKIU+MN20_CI!_A9B\^)<"\*A;AK![_5/5/I]?3KKEK MY]\%\N@(LYU/A'",30-).F<+@4B$$+Z&QBB25;H?Q.X:DZH5Y_7(2/ M2<0O,EL0?R8I6#H.Q!181&#-@HX8*(.H9O)DG[QI$*63?FEV@O8/8S:9@JCD MPJ_YP0X!3N)K9^3/"&+O9XNF[ 1%V_[Z&:-,HJ^EIJ!"'N'YHB!O0M00O"L! MEUFD(:&BS+K]RTK-,4/4AD9X*:Y34VE]6LJ4KO"IQ/=2$5V':DN$O6V8I;C$ MX-0QSCJU*=T)0C?E"@:]!\6Q^\%]#104&ANY$XIOO7"?/XX^LIF5S#F-A M8=EB32,^TQ>?58\HSK%?GR0P/I]*O! _ZD<(OU-]"%#=**E-)'%WF/*%C.-) MAEO( ;K1*%91V!UT:E>1>TU"9,0'&M$X+)=]L&D,C?J^S2>IYW1G._7\.0I MPSK%ST@HNN6RX9?-K=)Z<\)D$Z:F^4[$U9*W[G5EEH.S]O885A+;<6]#+ZBC4JF\E M/G(>G@?-R5Z.E[J/\U_/V>SZ%7,0.-\9MP5ZC*%>*HP,N0#7!=^CHLBM]L-R M\IIW)ZU]@U5(:9'P+"UMD!L1%LGD';*;_*TM M3AHM5$TK7%%UWX^1CCGW8!U@UD?[."G7ENP0 HXI^VW6.A SF*+F._MHI'I' M_85/L<:+_./5;^UG_]K\D*"35ZHGNSTV+Z3.$ 6O2)E= ,=''N?Q/QX@,DH2 M;#7E#;(8 QN3\)&[>%YW6 _!S??ZS/VIA;?QU@WDP68T [T;R2A'S&5GLU/W MRNYX:E^ (]I?TK7("KD"#=^8D@]=%38\"PB?;5P7&$-J8$,TR:U)4+YL"XHMKDF?=B!D<0AF)M+4A:>N%<88RKH[T,]+D8" M4PFN;T2*:\"'T9VU8PB;C13#1>0_282EI1H)1^:FZL=8F2WUQZ<S4N%MF"Y^&"=>[+['Z5_LJO&CFE/30[PM(U_)(+$! MYQPE"7"2T:Q=1QP"+K]GE./7,&&(G?61K""GI5=K+=YZCPY6MDRDI:L&9O5' M?.X.EZW//Y0M!)H\+66R;LZ^(RA2^T)&"X5YT9[-!L8]#3D$.+<4Q5[AS!P+ MO,/XZ#Q944"XX_]XLZ5/R29;@X&B^Y,:[V!'-$WF4()P/Y/F(^BR72T)8A_' MZP!^?QY9E_%TVITY4.>&\;]GIXA-4<-T0D>"3!0[U.6JX^];I1J^NC*K9S;V MX&1/-"XE7?HEN^G-ROD4*S4F.Y!F2==EY".>WP*^1?%JNA&10"HWT3>M:,6F MXR-1W,S#Z%KT$Z\727=^W=@W8PM_T9W0_,G1_9G%PFGL>T%I-=G5S6$?WZ': MX%F/;_#BXAM??EI-)%5INC(2]M[&(/!:0.L5&]F9-3_LTO'$NNUX<$QLD230]U1V$ MUGJOT?%1*];NME \.3K%&./1*CG37,Z:)Q?=A*P? 9K+RSY!"D9&J]!,.=S' M1/+2(Y!08^ ^C7")F%? MZI$T>,TLEOJ\<2]M87;QI=[A([&?X(7S(+J>@YV@BPZ6!7FC(\_+ MY?SPF_QVH_7&E/\_,K="RULP'Z$[Q[[BJT!MB@ 63W)"MF@?)T=&XTQH.O!P M3ZS@P*OHK?2AVT/=V[R0*T(=SG728U(P/:T7[G_<>_B#L]:7AV%83..^WH9_ M2OR77-,DRK(O;8^6T@=BGFZH8 Z$<%"-:49N%%]*+]E43\,E^F(-L+%F=%VH MY8K6L*%(D:[F1J2Z^LEFI0C!^H].\3:&4H^+BZ]_-_V'#1T2']*#KX2TA M2":S"V:$;KLB*0>CL8A*GSK_.TTU=^#'4>2#/ZQ^.?EO81 MD6W$>/:VXH0YY3PUD:8S,4Z8@J_XK)D>@U\_6)V^A+S3D,KG[>,;-5?T0:=: MTFE1:O>,KM=C\D"NWJ,KA/N\#V-,?61?KI5%WP*1JE#<4?$:GID^7KXV.X'0 MQ>I]H"IUB.)+#2/-MKZ#2EPD*<95BU_\?8R3DILS19@T8O\Z*17%_Z?S9'/R MWS=/X4XI$AOF*&[RZRS)')^0?9;L[J[& M4NR:8.(:NQ6:$DTT,?( &P[/>4J%0JT_YBHU).4!3K&%J+ V]$N:?1/W448USF]ABU!%&2&?0Q,5CZQ*B%+?$&-+;KEI M*GH43.F_2HYU/1^C4OO.O\-0X&RYGE7W.W6!A8"^>/_Y'XY;IL/R"L]5.-BS M9Y8)Q$LQ4/^',3C/N".6EL=Y_CD?RAD2PQR?W:Z,8/U+I\ZWH)VT>Q@D8NX3 M:#L$(HI8#QE#["QH05.=^.>-WCL]7>EP2*M!723Y[.>>DG;N014F_M(H?.VS MP?TMP $?F+,Z&G"N[H]^P>J-B6[Q@D\_RZWO7D^LO!WWS^.\#:EC,14DVCPL MNED>BIC(%B M-Q$]C$6;N_-6MF?Z$SY._'U OPO<>/-O*T0BUC!Q^)UU[#!S M!B*N:7$(.$Y#M8( (0)K-IA6:I#\9RL(M>K!0"%4W!@R6O;8>BD)&M65UJN; M*" Y'<[BB IB-T12>,-OEKE<03M$W[XOCV^]ORX9DXD64O2O5Y35)1P"TF:< M68*5OUEB#<&-GRM%<%P@3E(!,W<($#;-J6DL8R3Y2_Z4JJGW]XC\@&^,+W#LIO59 M'15,IQDS3_G0O. E"Y"-C'G\"?K]$<4@?V75O;T9P9'=C_$S13GVL89W>](4 M[J'/U'0\'K@A,%5Q#8#1/DMC<>L>:=!SQ8.UN5G&+17_$5D3Q^) N"QS'E: ME7Y6$^! V6S(3;60*C$FR"-\<@4SO8O!C@0&'=LC4M^[YU3FCK6=7DP)X)M M4F57YMNLX!3S*X)T'\1--R9E0I^031>>57UQ2_>+.BW;G^,Z*NV8Y>%W97LI MU;?50)T $+IZ:A'Q#$6]"D'B.!8^HD.NPL/:(8+:(O!0@CVHS4&8?+)((5]\ MH[&H):KOQV(/LF+D9U'/+N;A@A+?W#3>N'.G 5OS)/.IP6_^./)H4QKE++430<(\HB9R M?\,?@V>TS0K@=%W3$:'86[<$FNM((U7W3(:95N"+?F'NFLP64Z;725\KYT*7_'YB!@9W7A;&R**L70SQ=V'Y561 :O7Z&I MNJ.J?VVHSV5Q@4[#(]N80K"S;N^H'U92O7M2-8)JO?(&3>3N7)-)6PXAI1P[ MONBD4D+S8?8V_%K_03.%=XC"CE(S6B78D>T!X6GAR[CR1F/;7KBGW=URNWO< M*%IYY M?*9Z7WND[D(E#@.4H_AF(*J>"#PT2),HC6IE 2.Q/N.?FI.GP)2S2 MK"+6EJ>4K_@:;X?Y^=Q%GC8_E1Y691AIWZ"V=J)J!=M0W&O96FQ-LM?!4&$3]/\G !!)0P#O"EGC')\ T,HN$0\"G7+*_B M]"Q'_"$ T=2L2*U:&-N $@\!Y^"_OL'F8 +N@[8(5U>8FTJ)5;5O>5MC M;L9>C/U9N\U5B-:I,M-O^"I8&T2<:N2!N$/BCE?).CGEF696\7/34_ZB<(?- MH]MA[_0OX>_BW2!O9D2I/UB29YW:%+R@I86%G:2KD]8=5$9+;V!AGRI^KEL[ M.H6J*F-X'NN=7O3#(+4E$2WF(5K40P#QS,$ZD _W9/Y+T$\/Y7ANBPS3P1WJ M>^:FT$:.,]+Q,L>?*U+<'[+=K]WL2;D\%'&.W8;'!_8^\]HYJ* MOK?!6!$0D5X%E-Y$I4F-BH"(@-*+@ I($Y#>0J(B1:J @(" 4J4+)'02Z5(C M-1)*0N@]$0B!%-[XG[5FWK7F-_.^:\J'66L^Y$-6G#R!=+W3?[E+[9).<^4LFCCWVT'A_R[A(;'[I\ .C>8&E]XKB?/^-E!T*7$ZZ1@ M\OU9=V(#^'8+RKN-8]&NXH$E;V#%GV\\W*A$?BF++.RLF.CNY1L WAIS.G!E MT/X(W20QXQ>)(7C,FP-#Y/D-V\8.Y"6'C9:=%$5;CTS\V72O;?#O]P\^]FYJ M;-_[AH;D!$W.U!#3;6[?^\*C]"6M=?3V;A7,'HHR:G$_*!O,N)E4!=TA>AZ? M **U&>CPV=B-80Q$;"&Y0OP=\"/%B1CG2>C1J]*^1ULI%HB'2'Q?]&Z;"\X( MJ#^V7=0V ?/\O+4MO\@7NI+R[MJI#>LWVC BZ@WX5D@.L8<^7!,0.!EG"2L+ M&7Q"TB\+@5CCIRHJGBK/?W,^1/G9/=5S_9C%K\@O_*D6T/CCS $FVMY@W)C M$N1.Z#*-YI,#7UH'>HZE!LQ=&6D/;&%1T60;Z6>>%;[KA>0J\ATG6@CBFK%' MK_(2H5^\-H/!AUXR48+@[ MUIGPZX6BA:U%/AZ7WQA"A^ M@AE,M<7$P26XQM(_PC*GAM?\H66R181W-2AQ3IA&]<7(W2 M%!>J6E2S,OY-@7Q;O[&>W9ORO?]OQVKLNSY?YGX8TPV #Y)L2$#T*D1EU_P\ M <31Q/#>S?Q]E2&.IOF/6B\$2Z=*,[&7MGQQ%L)&FE$ND*TH"JSGJ3%#9!_B M=O(T,6)7<9NQ4>BH)R*&[$W"= !9$-@6N!P*5L,X'[+9%6;9[.5[_:W'=V2Y M0Z*VH)YYM*4C[.\O\QT+F;O]U9^+WW>W!%BU8)<'&HSEY14*VHDSAH?*R3L> M3>.VMQM]E+U:'6C9PN)NCO6LW36<)#-R^"-2Z&*NH0Z3X(9*"\O$U%OC!]H> MWQX)"OFC:^%"% F"50^2H^'# O B*;+[>*QW#!:=5FH4'L#VFJ^M:3*'.24M MX6(VNO^:-2H_*._9- M';V70BOHY@R>I!B2;]/^.# 3,J,H1JK1%/=%1(RZ<7/-QCS[!,NGX,;QT-^S M@YP-0]\*TZO2_Y9ZK@:K]4NO6(A;/&D3+,JQ3-^:A(:!U;U^Z/!(FTR3JZ#; MKN'*L_00AZW"_)A U-5LF^!^402PK!QK$*8 S!8YG,64'J<3U592!QA2=)=: MT[\,C8%:26J B\] T_B]!JL@[;ZGL-!P1 M3Q_S-@FYR)Q/DF+M5CC7CT.R]V-G_(N?ZGYM*%4;OY9)5IENK&K8E5)9@]Z;..$[%*]H[#$8( M9S:'W(G]*RQO=@70>UO0)61YW\.\WB_N,*?.,%VCX< +0?+7U+Y6]'IB6=:^ MN"+,"S5$0O8!+VGJXA$VM&&"2F152/#CWMVZC:!;:*-D^U0IG[%:S_UXG&,7 M:YR#.'WA&X#L,A?S6EUQ1L$+\[4%'F >56T1*$HY4=R[VG)L02);VB55JDC? MOO;7]!P'J-!'. >VMDS"5.K9.5P?&5E?RQW?]UP)7/ 5FM2"!HU;U(5%K*Z7 M4@0."1IW20IX.^)'@OZ'*I&6WZ]XNBR//Z?KR$S//G6\JR9R\#C)ND9O.HX4 M3)RBYKE0TX$>^8(AC&U3L-^!:NR=-MH'/3DX.W>MPWN$/,5^Y7T3"D<-[4GN MOXIUHO]5L]=P>G;VWDU7;\:SH/KUA/ SR]P [9MGJGVMH:' MALM"=C15H"9-"(R$:Y-:2Y_.AYC\I"D0=(M3ZY^:%*VA>&I_\I0%)?)*\?$A M'ZXH&UW?O#_QLKZ]L:F^M<%?\(<)7]*#SX&69K]$?Z/&A:$H"N +@I#%NVH*SOI/>Z)5I-Q8Z=:T$7#F5(HYBO MKKJ++-5*3ED/W5=S=6#4,Y*_@O;1C9 [J N:/IS=L8Y+@9:+I;G[E,-1X_#\ M%5 VAI%BGL'/,A[BVGT:U>/@2A3K,\X9G-)LG):8ZV"((\39 M"0#-T8MI8.CP0=QZ_O]/GG0;9E:,,X01XQ9]Q!L+M1[Z9AP$Q-2N;4QM^6)-ETE4:4@>WJ M")"!=I/4U8&IQ?0J7%AW8,NTPD,22D?M[%'@?LV4-7:[IVT-74..<[WC-YVI MJW*GF(?#5K?HHO3LWI2V#*T3**CI7@92(%27XN(%O$X[QNSUE3K6$-\TM:=< M7X(E NS:[G&(,9X^C^0[GT8$G@ ^/03_<3Q =2".@SRV3@#/D6@-G% ^_72- MU#+G1L)JHDA:A^4\>WS7L%"C7^E=&V7I5%WHU1/ :)=,^8]D[SL O&P^GVUY MHF,%6MZB)*=UBH9L+#?I9XLM4RK=@H(()A$^_;0@L'X76 Z?5(558'=P.U[) M_.[6 L^]&KW32YO>WO%Z&JB?^-/E^=H=Y7%(EQ)%_P3P7H#&GDRRHJG\2X/F MHZ%HG2WD2S=;M8.&<]4VQ[./!6B,>Q?YH72)=P)P\Q'644TZ8'W?(J=>7+!I MIH7#>&;64_,&[$K2?-.?3&(N^MF8KR[7T"<;4PP>%<;_^*_TZJB>14PCM73; MT94VF4D&!ODW;H62M9%$S7;XY+JF\37_@+4>!Y45+VCU6)"E2:'Q+GQHG3CI M(LGD[NXY=P#;0@P16%E(/J:$S%@Y:*ZP2?MDH/W#@ 9H7?W;TJ:6]%_F2;W&$Z)98].:;-%E+?S:,^H2+$0^#:GQ=(P)+41X92?F'=EU NDY4.HMQWW@7EI#ZO8ZE;:;*3< M!>&_\]X/EB*'=BD*[CGXT)&'A]K<]OP;Q8^4CB_]J5[R#0N)/C9N+U_/S';X M? )P2;-O"BU*.L81=4^MNN M6@54O/UBU?3AC63#UOWZ>H>P/ W"S*)P@J8/68["B:]N7> +<&0A76=Y#M*H M:B\BT"FRSI5A=+^:C?!2RO.4(/!NE-S=)=1YQ&F*-TU\;/\)%L-UQ>EI??R3 M\5?GTX#H0&:;T*00I^F6!_DD^[N66T81"N17OG2/JZ,F C=]"XNSJ1'G(A!8X80\"6HM!)N& M$2XDI5=Y.-R: +-M. A/:2J7;Z!8@K_;M!_,9J#8LI8D]!)Z8Y;E[LAO ?I( MP8O,R#^J-,;B!4RL-IOP-(0#KKJ)(JKDB9H[PMSYY=]:E\1-Q@[Y&;[^X\Z3 M6BC(92G0=[/,U?B)PZAA*FJTD4MV'M4HVSIV;&=F4O5P1#X;A4[IQ M%;5EU?#WT=#O04&$RV!Y>&.+D_D:P(W0J]P/G%(F?I/E;O!473!"X/\C="6.P'4 MLM,!TI@_$#R/PO%0!*S^I2CAD&0V!>#^0JG5]C98LL_QKS)DX0,>=)=&HE[^ M#Q4M]JG_N^2OIWR7)B-X-L!VO<)_%R=I,?M474XKI/ KV_^MM(7J?Y?S51T7 MSG6Y($[VWO^5![X7P__7]*[4_Z[B1=-0YW^H:('9^,_Y7^T)R=3-)606#GG$ M@S '#T'^4T+7(O _U+\(#41\4+ ,_^.(U1D%Z^]=)8?_RZ"CN-%-N_N4_I_W M!TN3F\!&!"7?I#>9+'2 I-XV<3!R'/TC?.@!67!,!=IVG0"8M./_,DD5M"3& MPP7QVX?Q%)WG1>M!]8X>ML5#01D9H]?7KTO0!:;4CDTL("R;FHRWHG#X$.ET MZ9T5#9D=G(!P*W3ZM]?@<9?C5TOBSE>R\=RVEZM;*7O4VMC !:Q@KP #5I@D M*ARSO\L!Z3 &L\]L)-7.Z)<]M?_FO=?EZJMTAI!]NV\"-9J/]T=\@,G6H'=_ MVFJF#@6$"S,4+T.=\^5=LXGK$L_4G2LOG]DJ@%O=+K-B^VPZ^%SU G19 NKE MZ9P_:-;3]S#0]T:G].V2ZNW6OQ36 FV.D' B%WV0M4\W'-CPB+=;%#;0J<+\3QPH,[E67T$8^DN^C53$E/V8M?G/% %E H3B':0?4'2E.RW*-%(;;2 M)C%W)T>Q*Y#YUBV57I//+C:?%K^+6=;T(N+AZJ117'B$&>Y\.TZ!;9.;6.%Y M;@KF*W;(" A^S@_-TCBC\5'=)6<"]=(Q8ZH#QQ]E)6,$NA7L?J3=2WHJMV8! MJO=F>77@?B1< L3[HK96\8?8X"[AJ$,A)KQP)$C8][M'YNB<08%; SI\MKR' MS<*?2?H9H]B9+\ZH 034^0M<]N_Z&GPE%; M(6\&*\.V6=HGM$E6A<=!!)5O&5M1?"]&:\8O G0"$-8A5,=1R^A.#Y%3,K*B M,5H17J*ZYUTIHIG:XE/7)D$-,B< 9Z]K/XW>J3$,RO]:J4=@/V/PEC47:6/" M4*/,GSG 2&TV/.2-IJY7('>RY\N"1\PA0A&-#\P&/[4]AML!=GJ#796W+7$R MM;DA8U^7OK<[WK*U/9ST6:XIPY@I9:?K,@4_GIM'0^Q9^X7?.MP8I0E1O/'> M")R\A!:DZUBHV>6[1]C3%+'^,MN>UZE&IPRT]=BOU:7[?-KI6%3>RL>; M&1 M"X[;!@36KI;2SOSH#,>+ <.JQIYV,[)>*B,]WBNWZAD?-)RRWK[J-TM8=Y@A MWZK%'9]7/)/X7<8 M]D#(99 S?J<6M^UQDU.;?UP>ZELVTXM1--3HMC[_\?GIT[P*([ZY1> /M*[\ M!I,^A1F&15A^)"68K+)&$R))!F2:%D_N1GM7.8U/7OO4M?>T]MU+]YM\UHMG M0Q-" %/-&8%FS-+H]$6NH-E//L74F=*A$X IP>;]]T8W^^M5Q1#CU276+:T% M,BLW&)U_0:G*LA=I-G8 %'";RLP(?ETY=?BZ'\+4YB=ZNCJAJ(R.E \TK5 G M@'^-&X'G09>IW]I._0\;-UH T9Y8'CJNO3P!D!1*WVAJ8:DJ5P3NYO32>":> M_WCC%4U'2%@HNS*-$],4)2AUFQ? 1*?GV-7=([4:N@XCRAF< (K]K'A06G#7 MJ(KS$Z[GMS=:/D\MS]X.VYB3B='_ZI*65\]D6[\YQ@>]2."47PU$V2YS]&A@=' M+N1\ /Z00$%SKPX9_44Z<:4/I9Q)8MI]=V;]HRSX:H^EV;?(0DD>2TL_NZ*J M\-#6[)?IY?YFWXQF.MDDAAW&EDLQ'LY+6OCL9NN;W0KJ- M<\'T4XY1T7AP^W%^](35MCY%@.KY#0/ID '+Z^!\%&ELS6T&E1)5/SYBG-6U MWN2<]<]7"#;V3*4F(+"P>6;2. %SCR3[G<*%3XX!(H.XP<91ZAAJH_$OQ3CK9;K:*J\9 M0N*8KN@IK+\>RFX+DV0A% XTDNA%1034G">=1_:/@L7EJ^:CG)IS7ZTT-7D& M-3#PH26>?E]ZGW+>@.OX#(&CXR^D0Y#&$0+L@IR&N%+]<:BD UG_Z[5T&#F_ ML>"#M7H/EC@Q&P%T%0YZ%2F?'[T&(+>XF) +NY=JZ&S>K> M=,4'4G?'K?RG'>8;(U@[T;+$'&([-;,2B"U"X(US_7&]-?@84Q*0D-\1A+)* MLYU;KW/?VS@]?;]>EE$T<37:NE'IU6"SF(#.9>'@?SGZ/R##02> )@;:TB:? MKQCW^6IYG?F2,=^6.2@TU4BY:KR6526N:Z3Q>FV0!\W=&ZPWZEB:#VNDZ\,$XUZU%?,W"$ KB!FW%TRIPNU"=BYF',W'#BL_Y=C@?\#JW)-UX(_)T MFIH%]$)&8^I-MKXM4(6)/B2U"I ^:3KG><5&6$R41!NKWV/H&.-5IYOF'\OU MV3EYGX4M->H3>T6GPRUBPEIEH5#841%MX&_PRWS'LOZ1,BV'[*I6>-_R9'@I MA<.1Z/P;\@HR8]S\NLPZ M8'SCM?XFBB*B3I\##XVQ>?$$P [^C6%0 IXE'8\@G^08IP0TUL,3O;:Y#<.A M>_%/[X&&UYY@5JR/!.RX" H4 23Y94CA FI;K8#"4_OCMPL>T[@G_&5NER^/UG:\8NL0-$-Z6/W$B>MQYRJ-'Z89ZI<'3KMTRT2O?"JVMIV?[ M5*J43.>XLT6VF/4%/=^8\#[IJPJD\5&AVHSN$+Q1F3;7/.C*N#=85KEX2';1 MK/"/\L^4W:(\%?)=8;>CYR[Q:K^8W_X\#:=3HLC($X#/+A^D.A//Z$"ME&J8._<^LDL.2B/==Q(#VR MJ%)CP4(;PF9C7H%4G@[Y *49YJ;[^#L-09O^_D&CJOVRYY[%"HO< M4NL-NK$/G*Z@,;]=2)[A(4:.:K.3_K6 ?>]%$R9U[KNUW->U)%2ZY+8U<5LO MFB<;@2=GI]+I\8$Y/]Q(K:EZ>,[-;4O$_3RLN=3O,>4HCML#4139\)= ML9GTV'>=6]9%[SAAF"C2-.']84.!J:DPYX\&;QQ[_6^]''NX%B!S790.P,8KITH:;7A!MTE\ :'] N MT V6P/^N-Y(UF7 R&!OCNP]W^17UEZ]11LKOTL@?.5GE[KC;'I,59K[IDJX" MI15H9"VSRL-/&^917ZYDMY\ ./:8XJA-4\!7F$1M9D)&Z<() &U&M!I7=GS? M\-B$?S;$JLNG2N?EYR/>S(P'_!(_SZ8P\C$ $F'T.T1^.$?B>4S:Q84G1[_V MF(*?:VE3=".BO[S0J+#^LR?&,H^_N(J;3]OM-Z:D2_V(9I-(B=X#J&1'PP>I6M. M\#>Z9TJ0VD,)GL3P'!W"?;#V\[)-;8Z-,9\L!3+X3;E;O:9>VIL>S([.[PHC_@ M,+7;]J;O,/0(<33_ MWF>-.=2^VCA94PW[P,<"V[+$#U[[^?$6M[N!(U:$G1NAL5;(ECE1/BL.]#NL MMTJ=(IK"X\CN@:-;7#?&\UN6=^;)GAA]R.]_1;US%^)K$NE6.P%L:^$SNVJ< M_!=WKUB'!&W>&5MMBYL\N.L"D6MD%'@X4-S9\E%QQ)-^R-Z"O0[6YP/$#?C> MM@16 KI)6J]T\UVC"4[Z'#RH6JS/DZ8,MG*V)F:)9N"TXJJK 5*O#7I JKI& M3QO, JU4TMRWZQ]*!]8[;+0TM&QP=#;[5ZS+:K54A&Z73!WEVW@*XQ_YQ J? M!=WUP=4D9Z*!;RB2KP8C_/W]<;):^N93BV;Y$@/,H46I-D6]D_(P'HVL-^?_ M%=-O%6*9$*.V'B3'/NGS4HVD25BO'R=''_ J7,U5EKHZ7B62_C-Q.NW5]\&] MJ)%;M]1J$KY7E$965O2Q6;I#O[PJ='%U+:DJ#6AI5[]6> \\:OZEQGFRRL75 M1[4ZSW7>$6_'^B9/BI1"6.UVA&I'NCI5@$0(K]3OC,/(]L93YJ'\G;QM)1^< M]W1B/G0(W+C=SUD#-TJ-S<88>VQLIHLR&L.JZ2M2L332XV9\ M9F>VY2AZ:A>11?2AJ.BJ!IL3/GSLFJ0$X?]C/=/G;>!6 ME)[8:RC$>+$RJ)>N%!)-E'<;:GM>$>'8EC+P-'*%48&/4I5 EI>K:WP M.;FVQ*LQF>I?YM"C[CX(*\A/\B#QB,2(2T8[$>U(H@37G\0@;1&\0A?FO:WV M6YSAFK*&19I^6[V[:+;T5?>S62S7L#*I>L8W9)F).81V5%<-23)Y2ZW:?>R: M1YYP?H]Z;I/6D\4I^:7$V'VY_"06D(6NJXG<)W-1:?M[1E7JRN*N-8>-==O> M17U,8W'>&_*P4KWL>A22/HQZ8@8UH0:"+3P!<._"KX.1C?RL'Q8(*\I&/IWU MFPU!ZJCHP--OYO3E@EDOIXJ*!-N877VK^#1D7QF+)"0P]V6$4L.I-GM8G38;;S.A*4,' =.0S!9APA$!T2,5X^KF] ]HYK-KCC>-[5%3_RM4L M#5]E@PWYO3M]D^&9YF)ICY+52]E+FU)-K0^OK^]694\&&JFTA.5,%FR(N[[, M':>U91V?(U^CC8#_/0>VI1A,:(N @J8"A,^MW5A/LYDC"9/U!JTG0?Z"H[D9 M$*%]64V MOO)Z0V1/R$VS)7!<#Y/):SZSW"*;E.=H>CNYRMA]8"HH,OL(=4^'3Z.DD M*)?NZ"7M63\V@(DX ? <6=FS MPJ_OUGQ8J^Y?"*V]7 .),K!#J"HL#Y)RV0O#4LHBTAPC$+]D-^G26JRRXGPB M^;%FPG<$OH#R(.X:P M]EKE7VKS+R!%&KL8Z=Q%1#Z!.8VZ1.NFL%+W"^!_J'1W?4'5H3$9$<+V<*BM M0Y487"P%U&4V!9)4:79UJ2)Y/G8YOZ(FVI1Z5,-B?:!#]$UW7%0L:52AI?0G:H5* 4)<\'WQ% X@,3'I+1O MI$C[WX$FB<(\T'T\;BU;I?C25SCW6%M/ZOJN>"STA4U#N9Q']]OH?K[3R3_C M[5F)6&JD$IU[ _$?U_*ND+[A9QR:Z8/BAD5<2<^/E?,YG5-Q>R7M0B:SS ? MRU/1#$9#^8)6;> AN!+I9C5(&J5YCN!H.*DD4*7S.-ETM"VPP*9JF9BZH-G8 MT/0VZ]%4I?8KT?-6JU\2VVXG"'XSFFC]=/2I.F-D:DQU6IZ_'=T.4]MX[)NL M-9,^WN(HWVI70C[03J"^0V#SLE%;A60/BC**=MNH@/2DD/X53XL\7^]:YI&] M31F[9G=+WTNLX+9H*+=KQKW"5\_U#,NJ?-Y9W:S9_O<."//G7^\D\/K=@)K6 M97'812F&V8\,5:'(CD17HCOUO6:X$T%4EY190_$EQ,3@5,/.Q_.\=_T=L*9\ M^KVN^,3X@'VJA$8M;[_+%5U0("Z??3X$V7V<\:]&(G]T5:#\\D35E(VSWT[? M1G?V8A)W]?6B55/C$6G[GAYWV77NW3T?N_7:!+<1:+&T:IU5O;U/01AU!='A M%:R+1_0J,&XXB-=[&79E!]6[!I:C%>9;H :C)0FOP?O/8W2FX!O45L1S8"*F M(;@/R0FZCW=H_PIZ0+(H>\H\+& 5TS-UP_U8//[-\X80UUR6Y@\/+!]'?C29 M%[-:C>#:?'$#)FFIO&X@+395D64#6ZG5Y:9+#9A9B&Q-95?0OE-9""> MGW/J>[0+J.H0@9_:UT8IH=6@&Z0$N RA:B0WG'UZYGY \XM0KT>5B;YG719B MPA20UWX]OK50,03Q"K6B7?$G\_R^9 6^8E=^-3-:)C,2''QNW2^GWF^F+(5^TR1G*'4:)!5BC M!^]3H1@UWH-A$(1\>B0#T^C:82/FDG2;$OJM7E%0YNWW.P:28VT9<2-Y]OU\ M?3DX R]8>FP23[J!8T#F;&6X H73G(L*IRF[)I.JE>FB-*T.505&_ZVAJ*\2 ME9/]CN(9$@1+P,]*S2,9A&(8&. LH+>ZG@?"6#*F*W@&$MBWW'Y,5-C8G44M M4 (\#[1_T8-=_:\Z$H+HGFBME$)AP]>I1V;HS06\UG=Z=TFKY^4)H"/0U3"9 M))/?HY>8H:I'7S6Z<40?-&#+)$7R:'BUY] MM9?_R0M#N!+!A??L%CX%EP>='=?D(G"0S1;R$Z#,@Q\JV[P*UX'HCQX->U?F M=:EU+0]L50#Z8LX+QA<6Y:-%&61DT7<;CF:KT[<#70/#^X,;VL/X)K]BFR=W MAR.XM@-GRO=1.]H_Z4;1 />D@?L@C4E1"CV).KIC($B$)\3U:XC#H'G#A(]\ M+"QK1\$;/;>4="&#=RG1XK-&VQQ KV;0EJS3 >&$GZ&;#:B4S.WI>+$M%,>: M .%0KA):U1E55M-4O?ZVF!1Z_7&?\OQTD7O1%[T'=P".GU>GX K%&;V5%1/= M1HU#!;#XI-D9W8V,]L#V+F:^EM0*V8U4](RC\X&A _RY+J=54]A=7<['I_[O M?NYXE8J^4^>7^LJHC5*E[*?1CI4$RGB?]5]E^#[KH2X%J&D!8M^IGT/%GP#< M%.+IFH$?6>[IR BK8):Z&,_7E&<8+W[_7"P@;?8CH/\V()OD$+?4]]SAVOOO MI9X'=!'& E04U!7V-!IOKXX(/P%<$J:60]8^]]'9J$3:":!?>14!;:1P""P& M;[W%_P5R@73P'F[\%U$IZ^M^RO$"5>,MK3*OHEW!][W]$RX&UIPMJ"LUX2_* M?9CB6?[8G4K9P?@K)MP41'U*1W2B:+/('T!LS9Y<-G)KI7Q@F/4GXJ)8'*L4 M9EV?X3%#5.W)$4B-Q.%UK>XV=E:'I$Z=$KTS;6.J]GTE23O/;=)O!' M;9<_Z/IU(LU&V@O<4 NTH X41V1#_!^1F;&/LH6W:\E,ZR> L\L$[@\+-1_R M697)N9Z=9VS;[#2N@$>V]=&ON%T[]7U7I0+G[[R*$NX>Y(E$8+/RKE&S0*%% MI$+BNR;\X1L05^&P4+%R*?$@G5:&$T^(L3.4#7=W?AGZ@R?\K^*I1F^VY^X?E8!;T+\R\_$! M=/V=N6Q>Z!6B/.Q^<'.!4W?89!O.:1#7O,YH=&RC2#9P0C26-R-R1SR M\;INUJW"'9RM=&G6#F,W:R288LB-K0[ZI!%\!A;U#-(AH0TDF1 =J6T4@<5D M 0^O0I*/;LP3LL7 C*'?@,N/ICAE1O;ZU#'UFD<7ESZ>4MZ+"OWSE"5,N5GZ MX2QTO7='U7@D>&S3HM1>H6I?;6UAPZQLD 'ZHGHJ";5G2SG.MP7_@8OC=[?6 MR4(D56(PGAX[H8[5P+^"3IC98PKU,(CQ< M+TU'SB/K5-W[_7JM>6Q^(2R@8Q1JVP@*/&EI9Q3[')2ICJ<87!;6"H M/:;]L&6;]H!V:5?MN.,9OY6C$P7W2G2J35=MVIR@)$IMWS;$;"G'[6, M3]W>YR)0.0WE/^'F#!R,'WNA!WZGIAHXZA9NS%<=G>ELEE@Z\*9[FV6V :0C M/-\1,U!&/Q%?;6*6I8&VNF)YVMZM1,:W(F&G[R";RC'X>V5C&!I3*;ZJR"71 MT*.<6?"T<5H8X#CUCM *W*"@W,8_0PAVR0?G[^G5G-ZZ^7R0.Q<>85VC=7\>'!6%R<8;Q 14BCXF5./I>[ M:>/*RPA8S%8$@9D().16YQ+.Z"3KY3\U\%%:2:+-;RN(L'/NF7?N1HGYMKJ+ M1,;];9']]MRY5GO^UFB/;D605X7&.D%CC::7U_NP!FH2D';D, >BC(P3_4G2 M9>!1S!6*)-9><$,OUQ^?3":#N0S.R+OLXGLY!R1#2X%UJ!0QR M@2)..$S0%* [R4)[%2(2&J]UQKZIMC%;@^MF6Z5(H WOX I@5>RK\>MS(#-= MKA^^%?869>5Q[A(M#=6T99>2[$,9ZT#U./])\<:T(U@))@L M*$3"KY!0BWU;M56DF ?XI+1%+0]D'^(B;/O>XN"8:.[O.KOA&[^LE][IG!X M/QYE]WL8>52OZ_?BUF?C4FCISEJ#O9FQPM+N1HZ^UJ.+3X\*2PLV//#>R M#JSI0*-#,<2?&RZI(-PC=^2S@,X/KSP-23T!=#?P^&H"*+UHYM"B;-R]4]/\ M$C8_;F]H($CR*XU?0V(65W_.()CZ?%EC)$D&"T=*OZY?4)Q!0P^33QLDG8G- M4G2\B"H&#VJ?(X4N(F/'=0FR.$[,I8 KVJCMVGG=;R85_=\?I79K_RIC/*\2 M@M9C5_UU\9EP&\LC/,S)]';YWLJ2R8.>@[]MN2> "OE[YB4E%>;I1SX%]I3J M.60%$%N2SUFES4#'N/ #5CX/-@.5_ 43]A GJY:DFYDA7VO'BU\CMKG,DD$6 MPNA#&F,B@7DQ?YMY$1DGS%K3QH%#1@LIH;S;='QP 03+7%=75ZXEY&M3K,DM M P'=]O2W]\ ZO2$U>71G_8J!MM=L1Y*=27NXZ_E>ONXEI&CB32>NSJC/=G?/ M!OW.9'IPR2F*$?"%7<_$;#$P@_6,+:?; /N3+\]YH9-3@\,>^?F_1I*$BMS' M?8-2XXPWJ&VCAZH4SGPC?$T,$$N_0OVE&.SV"R";&^U*"T$[]WK51;W;R@*P MO-%JE]C+ OV*2GDVSYA%3.^,R"#[3-Y90?"6(9K"!($%O6]?-_+9<^[5C6JZ M8LES#AB3"?B<)^][AYGXF/L9\]93P);N;P#!U [PY8+&THR'7T2W5G=[^N%BEP@ZO-%\HN;7[=&OL&3,%;],?D4&_;EM.^:[!+3O][,XFKF9:8[QCDSNOV2 MLO)!X=[;\%:. S4UM0%;N$/^P&Y)N\D/.& N!$*>9X(\GH[%C)!UZZ!IJHGYN\V1( MA+C7+B"8*,#?(E[WUTJ[N3.S,^,_7[V!MNUQ5VQF5YEMECF]M'0QA6#/U?9# MV4K)W7SY?8Z7G47$D?UD#;QL8U\I)+3B^\/^(\]J8O#XCNN<8ZU* 480^ (3 MC[D$Y]VT!;X!RY/2>E2.N[EO>6R6P!$%[YUI@PU-'VMN#O3$U2=NW-'T5D). M5Q"Y4, 7$/3X3R%%ZE=8!,-/E6.%#TKD"B]YV*"1CM6DM_;O: FVF4&1I+,O MQ#)L; #W1;Q?/@;S%A24V)L>B#*B%3&&@\[0=.)X.?A1UG.74*F! ;OUZJGY M$T"A=B^)O#"(G(ZG,3]GC05Y?'17U^KKD0*YNQSFW6)G#V3_%O/)A<_1Q;6$ MEKU.RB_.IQ.M;>6OM&%'O /D0W9IG&A3&U[_@]*,#W-(NM>E=W?OUT99/ M(M,$HOR^LH/J"M,<>*KHKL8/E]Y$%^\4XW?V.H"7X4)%[PPA7']"2HVCA[UF M*8GJAK<,F-\>_B[K.GU^R^K7OJ7Y+33TZKE[[LJ\/7/VVA;.= :-L-JKY<37 ME124#9JG!EL9SWD%NNYI5U ;*1$+)N\Q]3%T:)S>[8"+C%.>S;--7&_3Q\V% M&V4.C_O PJ/8*E5JWJ[HGQ5]_O'U4UU9;OU+2WG=^;>I=3MX8_K@!+#U1.8$T%4->?7]4.'S[Q"M3M<5&66# MO[YKMVZ%.ULIDZVDJ/1@YHR,0C LR K5UMQ#L(&>KR7(K%3Q7\; B(^GI5*,%%]>A+=G'&SW6I1VL<= .-P!GG@"BM3R) MYW+E$=[(=W4/!@5]27LZ+U_>MCCS^$VJ27'$6S*(;EY!B!N2KI4AW34\(:X+ M?SVTA0GGVWW#GP<$;JL(:TOXI#<8O*YNWG_&"@/[C1JR15;)W>M^G!V_O#QU MW=YG[ E34UA2#>Q]ZABZXNA0?PX"0#@G7_Q7XQPN8DTQ)1WB$(P&%2&W+"8" M@ "W,*AZ7FV%QTW*[]"5:Z,SG:E>?EL/-&[2!OWS\<80M),)P9'"*=J3IT28 M;RT)\>D1O@P=]M#BZ;8JTG=9V/;;Y_#QZW['KCS8RWHJN$;DC*/ Z!.Y>K0> M&!W\"24_5F=89WLP.==Z,-:9P9I]BYC:F@HC*XB? %C]-VN$Z6.2IJFB/:IP MR7%AJ&A-K07/+"'/9+[-O!M0>&-S@B"T]L)*ZLI"3GE!K_V',X#L32"V3NAR M(R'F/>T4Y0'>>UMG 4*1S97M5 \J5AX2=N,)J@K:]E&261XS_[ HYPN]*1JD M)[N0+:U_SGXRRC;-).-8:MJFAJ 5-$7\>_7YAG^O7^IX75W]43ND0C@4TO%* M^W1((4Z_+Y\-_/N8)3>I"A_9\V/]C#%J.U##YLF2YX47?[/%TX8O"4F>??5S M4>QEJ_",(=&>E$)7ZI M7T&'OF"BO:CG.TWYF=3AN><7UYMG9?E%6H_#JJ0R)W&R,J,BR[-DO;K%X]'K MM(1GG](7"\8-W5O@Q][9^\ '0-?\Z7=7.(BGJ$5P%A*DV^$*(:;7/@QU;ZH& M6B5KT1@NJ^&I=><17GR\I4<)WUMOH)!APZGIQI0AOCSF<'TL7]98^;[@V.7/M_=J&RS4Y[ MVEV5?U1S.:1^]9) V#]+[\^T@UQT7>WD5RVJ9-5@8MOXIN]%E(/$XR"FS\8N M&EK.XPY&8IG5*&TZSWQ73/$:I]T$H]##F3%+>-@8?@<4BC+4WPL4F6^K!U,^AHN%B% V46*85U$WSKI-+Q#<=41\5U(^G@QP]8G8- M:>\N A?F(#"/II ,A>MFP=Q9JM-MX!4@5/M9O&;>4KX="R.FW='BU>5-TY# M3P!J8!O)/>M?RP87[CKX,9)H<4W//%5YI\J&>:%CL!Q/;]?@<)\"VZ3;H:W2 M ^NAGB6H8!3\@_"S_Y-MF3^C=+Q\DVYF0RWDRK(H(?'@ A(-EF>HG/\+8+. M(+JL\CXL+15=]I9$Q@4[ MT_JYTH:I93+QKS:4^E$Y1W@Z&5?:4_/F!,"?11$M!MT?2XXZ".^0"Y9>F#/F M.SL5;,H[*)>B+Z'SZA7@Z!>3.P*_? )(P+C1?N]I"YT .IE7CR#X;$BG2\D) MX/E1"#(7,;(7Y'54N[S3YW&D$N?7@4J8>ZAH,#"+2AQWMUWWE]5PK_#4W;O" M'_?T=ZK1;O$DN2J 8@(76'1]3[&G.] %ZB<:/TAK0FR*PH7WL1W=UXAX6CTQ MM>L\X91-_*O<:RF9=NKNR#U7,3;'&S2,63%R>YI0_F#:.- ;4":#V?L4)X%(SM:YP%NYT M%WO(F/_Y^Z1D?]_77_W;*9;:9VW7((T,6WRE%+X3P/N8^_C='M9H],%(_<)M M6,7:5B7EKE,(YYQ-G]+G^TTVY@_.W+AX0]W;F81K7R2Z$$H[$OT7C)NQ"G'' M#F5?YSSXWX=E)"Y6L0_[*$ S&9?;8=T7!U["GN\]Y[V%T%SR&N2(?&U6Q3WC M;VIIY3'Z!'U<(1D JW?WT'VE$?=IM?!?023)$AA9BH9& ML 2> )(XW."<;@=D*0KP:T?E](9M22M$*39C*&7&0"KIPKQNUO+'[S.\3U(W M/)=]9HBZ.<0=TM3 P,"\%NJ!R!(;]9M6^/\+^^#(,_SU/89L3QJ:3:>NRP;M MQZ.,=\/7:WD#U2P#72)2IZO;.5"[4D]TN7;ROO[_/5G^O]:317WW#8(7IC"] MNV@5!?(MK/3S<.":%)G )IDTW_S0Q3M#S024]=UVO-9*?;N!:2NKMI7EME M:VVR8M$GEKI2Y\#!WXU"ZH]7JC )\$TA1=S?19V MZK(SWE9Z9 M]X^V< M2AIBKI":++UNT^=ZK$CTI#'2[7'6N)$>KL$@2Y\$1VY*Z$(HJH.X9_0B8^C% M>&76HAMZ!1<>9=*2-&,NU75YINZK,)*5)-NX7>%"]@=/\Y=^4%)--6%:"ZI= M"Q-HV5+E)BBVFD#?Z&?)I=Z853TG=>GFVP4,^PG 35B(XL:6S$N:Z9F7N_S1 MB7^DUA?R(^GSGGWMQ'ZU7O-?2DGE306^A#*DZ92EI4$H)"M#X-SM2>+!\K"L MC;MS"EGZ!,"@!^F7).G38[,77=+=[]*G<,[0+ Y)DB> 9_F,D/4?5DN[/0IH M11Q/GX"A!H2?M-OK<"/2)"AU2LO'MGF"??HS8.B=Z[.B-Z=$^7X6=M/QQ[5; M00"D78O/@"TB^#QH7..FO%O[GG,>*XLF4&LK9T/!2RM*%Q R;PK=L,^LN'EB M/$P+HXM6$(&2DJO!$1>EEE/?2]\=Q 8? *T1V&BZ4\0 DQR)W/2(N=_OXL@. MZ6"$+,M@Z/%W1_X$4!*./EK\B?EWS6BA2W#\;G1;\*+")1+$/%2L;5QIV&-E M;&2[2#=)+Y5W5C1#UT+\[ MZO9+&<%!Y-'"B-1>G>JEEV;O;E7>Q69O)9DHU7IF@8^)?UL\'=NFG[EX#-"I M!T6I]O@N'9$NG0#28VD")X _2"Q])4C!*B!X/R),E3YXS_PHVT0X!NI.$R8_ M"H^V\G-HO4AVMEJ5C(6KA"![3@!L\FW/*T):NX]+X^66H\,CO'?-\R+T&*^* M=*Z_'G*V3"A/OUI7=-&)$_28-+T(3#S.A1TF:MKC(#SS-CU+=K.>847'[W_H MI\ZP%;^4:1;#^J:9Q?2[&C<(%:9Z?%%SS,MH*GOFPC>>!KGHM0$>_->@$'R* MSA'.]5$_P@4I=TD:E6Z'_(?1_,%I>BUMYFY&8W>).3:.1?Z]>#T]_#>4W(6+ MK6W<)B0QUR[A/SY$-@(P">BVOKW3!KEEC.;.*MF\I0?W39!O+X^27?WE?#3[ M72;6H)_)".Q%T2#5XFK>\_=/@"1Q/I=#'!\_CPPL\E"T'M+7]/GPZ5"+/ &Y MK"T5DH,;:4*7QK7I5H?DF#Z/#"['#(:J">_^&L)4N<3\(IA?^S%1@8X+-E ( M0R'D=QMSJW4UX3"ELGO%7W.)J/9J\ ](1X.Z8_1+$@_AQ:Y.LG[:XD557:_L M(W.HBMXT>.ANW^=KGFDWTGP8V%8_PN9H7?D,D%?Q"C.>]PBNV^<6-:HD.RP5 MY]Z/KQ"N?*Y'>:_ LGF?O1N;)+(S'WVSYQ$R$/&NZ:EA) U:XR^U7BK[YM&2 M$5\VLSK0^J,YW!V'/+2_\)S$OQ98@U;%\<12?)QP7CI]>8H(@D2F2 ;2LGEJ MQP4.]1TMS/K2HMKRT5/3E76RPA;V8$3E>]6NWM^D#*C]ON,U3Y?Z7(-^Y=WJ M\FWWT5GJ.7K4B.WMIZ]+-I"R7.4WBM'"Z:+D-NW15[> E_47#.@_ "']PR!5 M.H%X84*5345H:5H0-OLW)2F61'4R*D2XW'(PQ^5]8'R*\&L M->MR8>H@+'I*C5>9IX]M+#?Y;G@V5+Z6 MW_)%1:HQ Y_R>%1_N6E53/D2(O"2U6IQM:?^&2GC+S,D4:?/-3,^?R(7#[M, M2+*E%(YY#!:8#(L-0 BYJP>H^\:VZ ??A)W90D=5[X@]*X>_4-!\<($)F]^= MG3JVX\G\??6=P=5L;E;!E%I+/<%W%Y;8-NV/2BP$O6Y7N_+US-^RYQM/Z*B\ MS]Z>'6Q2#WP"4J:C,2)D&GZU3ZB6H- YN*"M+_BK M(XPR)]M,-]X0#0VD+\B7R#^T/N)SDE6$:T1( _'8X7M#:N5@H/MB3H7LOO15Y[=1^V>0./PKP4/I5@ MK=;LO;&9)!.Q ^65\7Y?9<_.ZN=VN7?GQ"IK1A%_U43?5*BGY$F 9O\;>^\9 MU%07]XO&QXHTI4H-"E(%I'?RH-)$1$!ZB8IT(8"4 "%1D-X$!*1&14!JI$9I MH5@(9 0KCQ?3_<>^:<.Z?,N7?NA_MAS60R>^^L^BLK:___#9_3 MZW:'L8MDE9Y[HS#COV\=DDN*MJ8873]Z"(I-[-3Q3$=:>R$-OMK8I[6>812$ MXIOB2738"+\$NT_VI+A!];M:A"P03*[,CA Y9CJ):?V.G7DZ%/.9[\ M\W%:S_H[0&:;>UD=1-!GQ2K@]CI8R3=ENTU8R)D]<&;"7HR2L;E=ZO"#\3]E MGD8#=6GZM4G*23S\&E$!SN=U!B3.OM6%N[D#:TTZ65G)+":7IZ%;W9;:U]Y? M%4V!5-CW/!72TGEMKX>XZNC%Q"5?*<7#R[YBEOJ0V)+H76=[\FNE.!JE/C&A MYE>T4[H_#_2D@XD+",(LUH4AF$,N0N/;5"RSNU!M&576NTLIS\/WCQ>VY_NJ MOEJDVST/Z_ZU^.4&1@?A 8P!"X \D]_D,Y(3*4+4!S^71_8J^CVRC2?JD2() M.W7O,K]%@67<#CE319U[^O4>OJ22IXP)4\OZ"7 F#S-'**@K7Y20M]+Q(NT7 M-I+>O7255^?\$@4LY*5 MR02P8K$N$$VY3_N!_$I"XTV2@+7=.87D",=ZI$DU 9Z%T[JQ48=0^B<8Z+;O M].3?0'E-CP'>?9Y8P &&X'F1.@6AO$+L/L1(- 40N3N!'$H;2F!VSX;AF#K# MFI8#\^;47=R^H5KPM:J5M*EF#ZK4R0?-8(+LSB+A#91.SLRT\7W:[$ETN;W[ M*>#%_F$PW#5U"^-].-NHNC"]Z>'A0RW,'&\OT;WOI?'E2Z%+7GE=J/?LTUMU M38I?YATM9T1JW7^?W$=P(U;*H06T]BG$L=K6803I,R&HBV]O6A@WE$?A;,GT M_#@WV^ZP+7.K B)6=9LYD;^&,]99-DWJ@DU0TOF8BD]8DV8,[0?L*UR5:?YC9:N(F8>*I*L>-S>]N-D,&N7(7U MRM^)$W:J KJ!+ED/B([]CU*;54(-'66-/"KK?WDEM/6CA>,=]_0JD:6@(,QS MDZA%#AK=L[2I:\NX@W@T+53BM$7 =A['B3OEV-X)F5KKPC%3H;I 2^<',0D? MK^QTSO"G@=/^9FD#7K&!NM(NIQ&*EA\U1(TRR"@QZ@:S6*VFO#U]'>X=TEO>#L84H;R-'754\$M#IP5_I.+6DH*!9G]DOZ;V M@C\A0? [OMD3%TTM)=(U[),\NK$SXXNC%A(S=^X2%?"RX5,=<"%R[')%:,>7 M1Y697[:FK"SOF[_KE+UNDHGF#RPE8>BB10H8V=-*H$NJ1V2)E )MH+''JG]U MQ?7TS.TV:CD/@Y_R?F=^TSCB&?YFY,?H$J40\X0TPZUK97;CR"\6_NZC[S*_ MB]",_H#H4+,4 1;0%"86D/3(F11%D0)Q5[T27$R5=>JI:ZEENO@EJ3! MXJU["ND7;X*%GEY+,)F.IEWB)IHO[>UDX9 .D! M\13/X#0@\'#F<52E>4\PMZE>W)^[\6]9_X'=-E<^TO?E\)[JV<[0+5 M<7<.\T--_04\\6))=8DL2N(- :3F %^WTI#7[+WF@M-EJ+1GG+;5[1:FB>!8 MI5 -F[K2Q1^E[WE+7_J[.FOMHB"*82"Z.%DYJ:1J4"SA,\0>G-2LEWD'[>+H MV#WC.PLZM[@/!5^D#HH\5'5K"TBX8B"J_,3@*=B!/ME&D/N&M*MT"6;WZ!0P M>&I@',) MKO]4//?@O%V9=NAV &EL,#H81VW3;$Q]0LPQ0[].GM'QF8[1_?PT-<2T'9AN MWFZFPS+IV.Y]DJRI0+':RA>Q \4[BI,]B4YWP1HZ\09-7'Z.[2-Y0Y47WP>J M4S>CKU]2I;M?X%GX"/)*RS6H.J6CA9>XF-"D@3LQ74D]>#"F5)9CI%&?PJ7& M:^#DDV3#^3CCHN0'00!GG_7B<)&COJ^78OWAE:_0U=A^S1?J5_2%*''":1,F M5\4?KP;8NF-):+W\I*6O"@_+S- :#6-.AT$TAAX<HBE4NC2_LB,9G*H8\_ M?]A!&G,9<71CPR^;G-U&6Y7]PUAR!<6<%73A:8=J8-_0\O*"V$DI7!PZV[Y\ M=[)%!'IH-6)QGUG[L),[B.NCB>EJ4Z1/F)P]YRWTS0P@YRT'?0[L:JWP@,!> M4-FXM?VYDLF 0L\Z3UV;D.-(NNV]'S)"MZFOZ1__/?__5N$<T'3"8\YX MY$N.4L7P7D;MQU)'(4E5GH7#2I$13Q_.%%O(=?ML^OS0)OSA_#'>;3@O]O5= MVK1X!>0LE-&!C,3G.+!VV,I4X*4]R%_KQWX/J,GL5BJ7!,YP/*EY:O%^B1]@ MHO,(6M#>4/R:JAM(/2)>)^58EEZI:@/7&)5;/K MS#[>K)^QGN/Y\X/[9H8.$>[>ST=LL>!7 3LOVT.*,,Z?-J>RN:((/24>MVWZ M;A;EC\E9OQE]72V_?>E1I[?0Z^R^CX9:X5M_MSY:Q3_5-5U=$@C%0V)P(U25 M3YL+0A.55U?B>HQK4G?7=._)K#HE<%TWM8D]^^IS_GD)PYN!TFR-\FZ?ZBNT M^:%QIX!6M*-XA,YD$6$PL7_&?I,X#K^6?![=LVEX0B1=A8[]\405\8 MG>OZ%/<+?ITJ0@2W2\UJ@+F@KIW:W-_&O3+V1Z7M'F;W[7YX=F> M[?4AN'< M!9YS$8-B(GDY$]'RS4DA<=,$[H[A*[#'1(OZ2%P8JS51% WEG]TX=GB7F6G^ MQFRG6KQ#P\O"197_O-B'\FB]Q/ZODOT^.OP1)EF.\_IA+VYR5BPE [86V6'Z M+,FX9FY+XH4*GV012W6OW,P@>'D-5S#OCU5GV"%'T_I_9B>V<[[VO+B6YW]D,?C%0^11)',LJ^%9G+DO.2; MGQH1L: :4&=RA*W? K0#=PI(I$JXK9Q'6O^L+'=Z]O "[V/3/ORW.)]^? M=ILBN7FDNB+_)WJD?M3*>=OL4_F6NM)ZM%)\,^A1[?>OX[=$0T-S/&.R)2I6 M]22)#;?/VUA?T:&+7R7;Q#\Z:QR6]6CZ/.S0YA_YDVBD.U%[(M8I<2O;XL]@ M;HJ=AR?[]MLV84#U&T1Z''LMP<>-&/0J8"_Z8+H'Y=90'RM:XLQ5Z)))\K-3 MFB__\+XX094/[\-@95_F%.X1C"!1-'\8I9^O>LW1]QFFA9RCVM53< MB[-L&7+6$\$,,PWZ2$[6GX"!*MRWN;9,QBM$ZAKJ;]X%$ W.2DCVZ_W;*W18 M7FJ:ZO&+O:'ALI2='8&E&8=D<3ON+ORTB86GX3DRC"6/UX8,*NJ48DD&3U)> MV=P!]7)?4+0A8=WF[[0!L% M\BM)#?,-*J$Z$-&VTL/QFA8BTO6&+W9>:=_ACVBPDFRZ,ANT%'ZFW/=:S$C1 MYK#S2=C>QSS;N%S^U6K-9!RZ%<-'="C MZQ+BB@>009.QL$;W(]FSG;T^#5(\&[%?UL0GZ'ZIS<4IO/,M!S_KOR?I&.]9 M(#8)>X #[NC@.:>:N,MGY@2 W;P-)P46A(#C;D>UU.4+5HG]V^*=*]4KD7.L M3%76_;ZDFJ+O(9]G4\$!.?M@T:%@2Q3GL'A9X,.]_1HX^*5KI[_E5'2+H*>@ M,G%%FX^P$SD5JQ3?F%%74S^*"RV1S66GE3SF>O*OR!/_M>:!'B#!D!4+PDV] M1N!$)K39R8G^=8E%+ST(CO9WX@^SEJ+TLP#\U%[5<[\Y9ZRX[Z29EBAQD8P+ M$48Y0W6JBL4BJ'FDVH@=F 4NN 7D:D)\(H,[2$@L[UX,ZN.8/P6B=IVBVUG) MIK@H+"EC\VK@RH7@&\VA."LJN_!R3W>O4E:3 F'1>MRKEF\@47L75X1&HRGW M6)PRQ%)14Z.%#7LDLJUKZ;54*4S^) M;I&A6I,KRJ# ?\FA>,\]3C=IM/E7S[MGW8O1^:->!F@$0^"91I>"D\^G@&=[ M<>!JEH_N$"*P+005!:KER9@,?O 2.U>][/>9J-#Y0Y[A3&S;Q4+9BD! K&?QHLA9U90N%RU,K MOV^B-?GI;?G./ZWESGA1UF\?'KBN+2U_(9\"Z&IICSQ!D2'K,2-ZP*Q_$EEU M\U*TL8)\7YZXXM@L(^?N_/"-3'-7X_<3AS9<]LC);IQQ .\"ZXL*^WZ@L.OQ MD^APS;,HF#&17QT4]=O!KI.WKETSQ7JCWL]AKO=+Y%RY;WBGI)2--[35=@+D9'J*),-:_Z@IZPEOZ7(=;M MJRI=*";X%"\C3& L8QD?D J60;K[?96X5O?>_A\T4\GWIP=P2[7>UG-+EG[= MH^EJ_6_P<^:;Y/I M=RZ0AY=8DQ:ND1&E9.D75)OEUD->EOR&B@C&Z3:GE!L/GB5':FK(/DQ'DHJ M6VP=:B+XM!"4!BK5*BSM ;+2C%29YK$!#E@_LMT;)X1(_1:F70ZC/[6%.-6! MB 0SPTP^4%5&_1U86T\!C+]CJ %!3B^+6T>VSA3:E8A:O-7Z41AW5I+AK&^4 MD"\1UFW:;E9A@BRJF+(I+6D<[[(7R>A\6J[4.^ '.#Y2P?33K-TD">/F."A)86DG.BF M>E!4L7#,7\&Y@P1BEG(Q?!CG4P"3#18*P#:IOKO9GGN7+-XL#W)E[V9EZH:=)RK0&"PH=V!"Y&"QN"8= L:Q M;N3IFSF36_(Z04J?[ZJENCU-68W]]UR&_R. F"KGP0Z'+T>9C(>\F:,QJ%=B M(E(7JG@B0">"BL1;_ZUX4?^;RC]?Z7J#Z3_UQG]93ACI5M?C%+!R#+.A(\/- M=5JNXN9),ZI3EJR,HID4=R%)-QP1&QT/4;-8JDD29H5^;0?[$CGBA'@LA%J[ M2 H]!;Q;A%K1!C1!Q\&HC6/,>^#,'LT\# >FW"*< C;6OLD+E![+CE/1":#5 MGK(3UHWC.'%4OO9TW6=$SP"B\437W=([Y10 E*;M_>$L=. @25[7Y;",_%\1 M]-<.P<0#,4K/T7C S2DJK(]&I 4(^&9%PNG8TS:!V'^+N7 *F-&HIMNWC&(P M9H)\]A1PT8)NZ^Y0Z>;N^>[ *>"A;5XH#Y RU8=4Z$+NR\*_G+RG6S\_1+^6 M]MF_]]*;1,OQVIHIZT8LY2+WDTU>G0)(#ZETPUHT&T+RV-]"L#F6'W[%M$9_ MHB:OW24=G@+2-L@CIP"G!3HR%#-L]95-(B"((VUD(I"DM84\]LEORL84? 7M MCI\"VC$B\+IH&D<8]PI]T +X_L^V64T/4#2H/"=QVHQ0[DX0[V^Z=#X%]"Q> M]?],9,G#"LP_&=.DEIAE_=TN= M_[,/5AZ5J[!5W*X()!F0U^(HKCBKUP@7X.QA]UX9//?HR3.)@T2@H!^K7T1/NWU ?Z35[ P& =F MGO?@=8WQW^(1X99ZR6]^+X=70EC,JS5A1?D2_XJ/;]13'@DQ!@E=<$;_3K!- M+:D^.>S'^G- :]#(;?C#'FXO898=]/O5&XG./&K-H7= MTMQH+SPY=)X!@7K74#&1$GH*E(>+A/6U$PZK7\-4=G8:0P=A>9EUVYAX%G^Q M,T^@SBO4;$S)<_CBOY!=KP=7W+^>SR?>,[O1^VD-ZG3]$/ (]DU:[VE2843A MCL?"E)'Q[BF@#"-R+?>>^-W\L)V/1X.Z'%:^H_^Y?!V11(@E&1Q*T89)H0D9 MF24VU'LU\>:"J@U9J\I3/Z8D7SS0^>Q\_ND"W[,/0_(,:S6YW^TM7 M']H-*WC5!Z'?/Q:3C>P#^3N)]4J8EEW^:EY<^O2A:6YP 1U&.$L*P^-21PKL MOB64-0@M?5M/']:2HL_O%\SFN/PZBAXY=6MI-Z?$'<@BZOFR8&:Q-M$70%&\ M\Z1;/X7@RI;RO0^K_]-ET]:#*Z1H;\S(?7.ON$ L9V$5?>1/:SD8I$/2S[+_ M>FE;C?S-F0U\19=E?PJI4 C'AM>7OB5,I/I4[&]7NZRGRB&1Z-2GF8/[L/QZ>\??AP+.F#BK=R$CUXE94?(LHP:7V8P"8<3.(UWER ML6&8(Y)1MK1>Y>S<%<]QQ%+.*:#&)8WRB#;1().(?[D*!=Y%?R.RQA7+:WI> MR'2+LD&KP_HK[^A_-Q#^T2MT8&O1.5:L.X6X;#56?PR/'*IU,AX/M5U_8_HW M2?/34X"KR07: !#-58=C/?.K@CZ+6; ;DRI7K>OFIO3$4L^['JT%O]D MF;,:J'WJ>[73-!'J)9+=TKR :YM!7./%[Z(*I[ M;Z0]_.PJZ+;-834&K@[:+ERRP;@BKL)\R'W!>'&XX*_LK=9O1( .0U38L6IC0U*F9EINL2U6'O M71C3ZEHLS>3UK(3>ZFBK./A[WJE0LLQI""D("1!6+>EQH:])#^O_."/BB*3P M;RXR_C;!LNI^(_<5;MKV=-3%_?*PK&>5G&OD<[]WGLE/;\8F07_OS"N_2[W: M3VU*,W,B\V,U?@>UQ _:@1^;J#0M0_:W3L+:_H<8C_,7LD9V>T]L1XGXSW+' MQK))=,M9BE+\HH!^MWKO:.WA96+QN^H=KU'D[2NOGI=^_U74O$X38%9*(&*FA97H2BKZT#@Q.R@7;$BIJCE?T^:\G$U0QT;=R',[& O2 M>[>IYYG-!ZP $O0AL;:L=#Y%S0-MU^@\5!Q*I8037=EDL2[M2 M*B06R^:N+2J7UQ6PHRK=M-W*FCF8<*]?341"E'G6)MOP9 M/!0>:&]Y<&_1T!"5;8AJ/P7X:1G1+EG@!D 1MEV'W<;/YI^'&74>RW;(,C%< M9%OT"/*)[[MR"H#SW;$..*=VSFH00[ 'AE@NDTH/+N8WY+'05W"-)Y94NH) M7<>[OE?1"5Y"L;EIBQ)?W T/:+Y/6W!)TIG_\.J3!&T[?0@,XQS]&^Z7K&KT MF)"/YFSN3@E;GFW,Z14#-3;$S8@TN-F-&UR?2:)4+51UX#E\T^7&9MK-P+AX M2\KHVE'6:&EZ\#/GFGB$R&_*X5'^14(:C2&(2%G.?+5,!$7!KVU-97,0RW\Z MV&LJW]FY]JKB\M"OT8B4\-?N/'/C7.\=S+%FE$&'^A(#]YJ:TJR^*HQ(2C4V\G^7 MEI0YT5%^S;UX1*PH;^$4\'H?L[U#Y^YM\@S%BAQ6!P%0M2;K M!J\;B6-UW'V<$)8H()5SY_!:Z!;Z+:-.F :!3))\ID(->L#ULG%4X%G# M(J@8+F\+:M>1S<34YUPX.X/_QRFY:-UM($--S(>G]9$6BL9@2M$G1W0M5B-W ME A[M@U(Z[%:\)L&6LDGX\!N&T5_3X0,?H%;38JCLW7US&P#X-^^9WX]EEV/ MVT+=_?8'TK%#&\H-"X.'EH[-ZU?-:K^$ZGMJN$\X5*)K#D: ,C"^<;BD+;P' MS/.!4)>K +O=D'D/S&\/K,F2GO&>*9=K?O-!\>A<]V=_IG]O? ?2UUV-?C+& M?8]]H( *(N37X2ONS)]+*TPXGSIAV.K^7-5@_.V_,JWL76'_5=(?NY-JF$48 M10[>L?@/G MJ&32RK2U$MM$,PS?&2UPVQ#/LB?B>,V] 9@G%:;6 __4QF%-P M -MG5Y@EBA>*:8!'-_S&XQ/WXGE#Y7<0I(+0Y:1,]!,3O"?U,J MD0M(LAOJ5L37_H_?7J_$6B_AC/[Q@2Y-Y5!5R,YX MV01'^1K"7J2_L4FG^MJ'+J_M%]+8X-76ONN/V5^=$?D-8//Y*SB<,;.R]B?9 M_K*\T+#R9:)*!"SLTW#!)O;\]G9]TA HR+_@W"VBRH^D"SIB^>]W$4M(V^@N MHV$ U9HPU8ZX+-U=@=^1Q/8\)OIB>!'4&\BP6%1476)YQ3MP=#)4.G2^T6[*,0K<"22+ MK.]<)72TF9.CK'>UX'U1N*M9B;_-"+) M0CW40A4+&)?!=8\5L.R4O.TPIPK<+?&55 MKT)-\61R-\T!&'@*4#CH;QFBNYWG"[+=K#.9I RRK,J[ VA\^]FN[#N8!97L MQ^$0:1#VK3SM:OX,*L%S$;.4">0M(%^DP*@*4Y7/D[24EZV,Q1[))W21/+N4 MJS,%)BR]Z,+MC&.WN_$PH[;Q5%/SLZ-,?-+V<_LO YD!I7]L4;VKIX"GJ' @ M8118?[$#>:[66*FRN7*V)Z14'MZ;N#;''WHG%=C>\C=P&C\&X@+\83 MQ&W"M !N8V8U^^D?^G[6-0U1,L?'R!!\;JES7UE]7XVS#=&FODCC6MP^I.C! MKJ=\/(#I+OTANJ16RZRI8#7;E_2YST6GUZ+58VY M\E\*,#;NJB@9/J%>.SRV&EH0/,FF!N#IW!P"BJM%,B_^#:2K=( +4]N.LS<) M+KF4 :X1N=3]K$O 0$,Y=XG-3VJ!:J)"E6 E"R.C_'_"\LR7@Y*\ X(OJ;K[ M#\K(>W5[3&E/\<;Z^,&A6.?R>X'S M;AO:*8S&(LRYGY,Y9+D(\EQ6;1ET\W MD':^"4P=._B^NEASN+U.,8#W NLSP_U/ 8QD/6,@?JWP\[S',4M>F'1.GW1! M6P!'Y8!(OBTZDW.([0YP]9JCE58/][N9V'H9E% +$4>#Z['@);*,*RRLKN5 MD,JU9$MWT6_IGU/O^ ]4&[J(I/TIWR-?EZ46VN' )UV8W\.AUFL64I+6[XLY MQ4>-^\101,5%(SMC?Z_F0#%.,UBZ4^$X>S/RL(E:N_/R[3CH.3@)6#6\XTJ8 MG(0PZGRB_COY)]38J)T+A7#R%9AO;3"%I*;6&C!]U!-Q%OS&V4=&+R&[0,FG M '[:;<=%-X0W,?K-R@359#EFU-,-5$/-R:#X-P9%/DE3.WHVYWNH4X^J^-?W4E%UNOG^I\IG- MQQ3NE=YY&\-'E]_J\%RH[W*2>KHR:_J.7O'LYE5/[^T6B ,LOB(F3W0A MZ;X&=M[+:R&Z7UO@;WH.VDB+%-FG1:J*;(1WKPT69M=O[$O:?2SU3=ZV)C[J MG)]R]\L4L/8F;UAW&D*K8IS==MZV=\28Z8N90=Y#'AN3ZZ__)ERU,BVB0HD9 MF<0XUIBKY#3KM.ZWX$0#3[9YS4R(#U\@Z6W>8/X;]G!Y=5\P'#Z"J7&-HLG2 M+54/B!#IL$&*_[#%.Q%5]@6KS,4WV/#8:NK2S-:ZO#9N(B&:/_M7OGJEH->S M%U.WBC]YS-4W3#12;;6TF)UC\B24+ =MFCGKZR9W*4^7MV7]KU!5;5YP&F/-G*H'=R.J>3F TB,D; MYH0B@Q^-4$&N>&Y"WH^IR.O9LX\-8*2ZU L0M6OZ!\YO);9?=KG#ITX!M<.Q M( \@5JK3\?9D'2/:_0\#HL:K:?*JNW+IREW(Y=^)IO\D 402/CF1!VR8FEI55/P\(I(^H?JA;K<,/Q .U2 MV_G$J9U,$8\&=V(:U,E"^Z(GD0>=#.9:PV(&F2KL0HIAIS04%0LDCUF0[[881LV.]U2$^9QUS#8UR\:9OE3>R2F-\@W MX6UCI#CQ=X_D!E7/&OG<,QB M#7)'_10@J+3'N05D^8V\O&";@L^)K80/X*L4GW7S.2D_"/K'N"W]-K=$$T ' MB/QS>+CSFMC1B218HF8\9GNRI6=MR)FX8%=B\BO_=:GG1"-A^DCC;CD^X-Y? MFW-8[L^-[(.\0[S S.1#I@](*42QCO@*[^%.*T<^-[;0+6M;\<_!TLOOOUB* M4%MJ/\^')YMEIJ1BG#VK\O<1,X% MA\&3$6U^&$]4W.(ET-)'1Z$133&B0L\"S\C3,<4CX:^C33I!KEY\2@T93_G] MSI_+-SR;!LY5.O[[#E)4/,D",IOI2$?J*K&>56(R*2PY5U.TP83D%M\+EH5@ M%:Y[84)5>3:VS+/N,_+I#K%X9H314'CFXPW\0"VW,2K2P:@"]BP2:CTJX=!MUZYM<3 M'8UH)#R3X;F%83@$>H!E]DB;QEJ,BV60I.4%0B4A[7WFLF*_=,(8?\\\) M_V:$E!E>2T\3B7RB!HBR[+B%(#Q(YMU$LFGJ4.RA\;:-J:< ZZD61BC*M.4[ MHME7LX(I5:V'YU8G<L\]+Q^U@LW.:,=B]_;U[(=R"VUS@RU2 MIXP:]YQG@!Q3HXB:BZW)7'3#2'B,> -G)M:G8H&QBL.\O]@<;)0ZS6MOV,4' M%PS<^Y$EUY#K*JRJJL9YX Q/A<_LWUHD^(E%S=C8V'4[7I74Z17N'3OB_.5R M+5:W0> F X9Z,5WV1"(/FET!X:COIWOCO)&+S^/450]]']HS0#01M@ZIXPF\FU76U>:.HA*8=> M+0.JW1C,(D"[)(C ;3E2E\SH:-^W9N)^H+F1/%#MKSR[8H)QS[/L #T/1V* M)WUNW<(XF1RO+@-/U'4F+X(VOA[LK35]U2DQBOY"/=S&WW4X!]D],IH-A 8I%@-?EX$N$RZ3Q7 ML&05Q6 6DC@%LU2]G%M=S"CM:N=8.I:QT&S8,5Z3X-54? HH5!AL8: #^VV: M%GQ$^V)R9_Y5LF>%!R]SIV- \T[G5^NNP*SNIRIL^FLK!,WF&2T%1_-EV2C' M&V0-H@!5 U_!;DX@?2\>BO=U0GC_-.$R$$I_PG))*.)G^*5>%!KD!8IN %(Y MMO#;(#9M3JHE01HS6[O%9ZUY%N]@[V8;'EH@O9I2]A):GOFH&/BP MBC89D?:)%[OBP6PP-0*XVX2A/AZ/ FS6)=66L \DIR)A]MH?.]O4(P@YT23=(D)3\:YIOB5[__ZV$IPO$O167KW[ R^ MI>P4$/$:K@2-Z*+KPD]^^UA5M3E30Z"[8Q_.;;\<,[/*2T(;A7?OK;Q4XW97#);]S [8PD MWU"0F$=_P!9\X!S(>";'\?6]JX:?X1WEFH8F_Z!FI%&95%"8;[M%R67%W J7 M3Q45I!&ZB8YL<4V$!=*-I3V\'WQN!P9V90(R[WR:M&M-*YX9L)=R^(B9=:*;.%%[$E.RU4\#&Z.4MT!+J%,#;I ,A MH$A>!.;FW_4M?&E_4S($Y)1!63-DUY]GB!Q4T:J>6<_>K6RK;@FMH(,/$#FQY&%*&_CEZ+992593:B%Q:P&BWN/Y UF9NFQ/-27>: MZJ+Q*N%U$*:*@]K *;;M_$EY6SN!3'^WY56N(MM)MPP.+%<4(!@ M%1T 8?<,NNS@I4@)S/XW@B>PYW*$\*U.\6$1JW%D=65ST/(P602XH_MABYMM MD]% 1SXWC=([WIH>74B496'U+9N-ND<<&S M1I,M6N1,\QS[\9V;,P&BR"+YV9YG#L'66'UYSJ7'$6]1X=8QRIH613/)AU@V[+ M(64;AX[BXUZU>>HFM79&GM+S;8Q,K#ZIBG(:&==L!$PJ;WMV:P8LY9GC4(EU MR73*2BS><@2V((W'I6W2L[%X'EXUIYN&9A8343I"R^&>&V"R,&*'LQ)VY:0) M=K9H9MY8.6)9Z]FL[H1_S[-)--P_[FU_W]B/*"?^+^2Y0O57!MIT.#E_YA20 MMD^>/04XD1KIZ,*S9:\M?*7*A-5VT&]A0RG,J\9[,52QV!)53[*0KMNMW<)N M[ZN+?VJ^^_6_N]7\/U&DMO?(HE'S")+:"4I3RXG1""\U? [K$4@1>(-TJLW7 M:SRC_\C2X.!WSTOPM:D2>/=BW<,J"A\,/JKI^]EV=M,4&UT[7CN03#Z<*'?F MSZT[D\-[;G5*OBHU%'D%4/J] M'DOO)40XL'8]9A9,UB%VM&)87RBY>,;"I(F"F\:"80Q#-A^-/J3J:CI]XE^_ M=J[&+X0U*E^.;$J7%5]__AEF@T)Z&D!=>\GMQ75>,9Q[BK;2>C"BJOHS/D!PQ-=C>!#;)U-)JI_ZV0T=Z!X?6_N5 M'7ITA# HI&AA/1!58"K[UK)^IY=L7S4Y)73Y&OR:[6;]&(.,HGB&Z+?FT. K MU*)'G^3$:;\D7X(E85+D5?QB.)*]O,D9EQ=J/MIDZ.0C8T:2F/V1CG9^$PUJ MLOS5/\/$<(Y_J@[>A:B5C0#C@I);F*A6+4VC3>S$&W9A>K.=/JV'?F17*[18 M?X/;N]U4" 9) [),(*?L&0:4P'9ZRW M_GAJ[X8YK>0%-?)V[_+JO/!3P^$?9\J=S#@D+9)N*J_\/K1;LR^QL=&J&UN? M7/,P+98H[=\UJ0FRM$6TG@(4QN%R4%9]PBF RN5*"B-:1A=AW>K!G)5-PLN9 M8Q51T]O%S=\2?GSTN[^;H1)63 OQD8L[VJ)=#B8&V9-?4X*I#XP:^PIJ":@X M)0&@05UDTS?%:>G*E=ASXM^L]Q\U>@$R YU2#;7R,G>BBV@CBP1+1-0IX KJ M1A4!$N&?S.EFF1W0O-K?!?GDKORR/>6H6L/+7B]R+@/+DW/Q&HKKI+[)N)@\ M1AHD?R]W5ZG'9J250<=LFJL;T6\-F04$*/-11L*X9A*O435)V#N$5V: M)0&IG@UO2'B@]D:T@OJM:V9'6(&J\2DQBMIF)O@*8BD)7)N45C9O[[A!.S/9 M)%?^Z]%]2IK)]X:F4)L9A;R/GT2NR/6)?1_6HJ]X37(R74?%8$VVUT\!EVC? M/V^!IQ$7:IF%S;A4W#7<#]\>X>V"PU.=TN7E$\/E66[K JL7.Q&L9%<:0S3% M'(HPG5+,$0CM'",_B6&9*94J*9=NV9&"Q<\>C]E^LZ/-VZ3GK),N#[ M2R?N[SMIP!' M'NCMZLH]G&2W'?!2Z#RR?/YL6N2YRS?&Q1@:D,Y)4C9D?(.QQ!.LG?3."L9%;K;;_M5H2S38\RT4CF8 M.'\_J,#"+AC^A8"Z1(4076*)&!/BN+;0A$G\Q_$Q4]IX:*9GEMC!62Y7,>FT M<<%+(H)2OZ=:6ZY6$?2I @)?;#8(1\H')@%?Y!->*@U'\ZZY+%-&^W?(AZA^ M9HGPS8RN+(M[9:D/ 2L!2L=A[A0]*@A,5N.BX,\0T9$77YL)T\WK15(Y<"81 MW6%T9M:W<0"R>/9:FYKW!6/'@(3J(@>PR71JC[-# .)3<'&PUG7T*&/4Z MGCZB^U6C4X"$)=GJ%. +.5%8F.K#8JB1WI@MNLQ1<#RA@U8!>0^W.%-,N\Q M6.]VE&JD#1-H.2\#(,'^CZMGI0?3NTI[I\_M6&89/?$Y4ZE"JCC)O7Z22WWJ MZ@DA7L3U=$J%/5.3P3<0DFI."@6J@R,MO+4M]@N%F6MRSTXV+LO8MUM1'L4Y M!KZ$[#90AM*EGCD<=]FMK")^D!;_IAD)_WOHAW)=FY=F/O4=2B$]&*\SF69? M2GX%TR#F+"6W-[-V.O(E=SO>J"/JQR.J]F#&0; ?(TUQ52HY3'*2G?(^/-97 MWUUHRB$-C%!E*7;P 0P#7 @:A'?M"-/>PB$Z!!3:0WHBZ[SLL9X'\S,:!6'9 MZZDEG_/R117JW,G:@*745@[DBOQ8CN&WTTE0STI M\2GQC$SVPL& K'OH.7E]WMB"O$>[EN?"H2^87&C#H)JASXL$PT6F+APX#GP9 MSNX!YOZS1") M=Y7QQ>'R6: :=!=K]"F@%K@=+-:*BFD1C6X-Z7Y=V8=G/4?^M,\@.O;!_>W- MP&KZPH/VMY7KC-.S+[CS.X"/:\GJN86I@2NW)Y %P^A30?0JX M3#7!F\0(\I!KW(O("&-R[).^0G+&K!$[\**'%'W:I71&^,W6/_"N6MK!JIX5 MAG9@NVL_KZK6IGEHHB>V&VJ;\DA33HZ. 6K**]E&NI#&1C"!]CJV(;O/",B84=*R>1UHZ_KW*FF!L8OGRO2NYH@)BUQ M)5!?5B#:#9<=G$QYO2J39/>*OG-Q]0XP)QWQ-+UC,KRQ4TTH]V$WO_V$B2&XZCC1$4I\>7:VX]3,!6GM']=-I(9F5ZO2 MPR/?K@LK[2?O,!"U@8E(P2:O9:DP+?\R!.<6NJ'3TD.'J\Q7HU^X=VF'.2'I M6^5V2UE>,"C6)G2N4C:HH"5I=MYVUGJCX['?EX5CZ1=3 S5'+WQ_F^J&ZG_X M?_!,W/]M^?]S-/Y_-T=C>)S4/(A>);*$2C=D>JSU<(&?#,'_:M(HV%09++&_ MXQ_*5Y\1F*0Z ,GGAGDE7O@9F,!VP5",=[3T8XB$RDQ]YL([C+!ZDGMHK,K: MSC&HE] @M;5(1ES<,3\%Z*J#J**_D30]%,O)%\0+8 RR'I*@>!**UVMIN3Y1 MVRA7//OPEG0Y]=O9VASE-EZ)H[PD ['\NDC>]V@-RS=FNT6SE%SN-=>'%K.' M^-1]KU/ 3MF!YE#+YA1%/^GQG*QOIEB]S%0EBSBVKES PIS(%CU+++"I0UQ4\D6 M:&2;MK#^1.UAXIM8L=19FYN6E^^4*42UGM6T )-ORKXY!> 0B#8KF$8AU7+4 MJBO(MK.AA[2#C)4^/S9G7XGT'USON2WVPX:#_^M<^0>"+C1Y.Y* P!=W#B\!I'U>>*7]^>W%[Y4:-(9F8FH/R9-^ M10),BZCS=?#.=BF:L>U'PS=!+).4P;.3:^RHMO=&0N(4Z)2:7&W4W M]TI]/:<.D2N)DOH9S???.AY*>DXM:)P"8H'UX';DS$!W2'$X_!J5@6R%WV/\ M52.@#KD"Q;9[@2VGLL4Z,\7QS^T"WI9(5J$NZS](YX?LI!$@;>I[;:"S5&^R M<\$P#L$$'=WJOM".*B T&YAGAYP/VQH%VQR,'BO:O+DG[R.B+\MX7\ M0 131!Q(@.I*D8 I?".O$J_6,9MWJ[\YWHF.<"&L)B$#BFV[>*($[@0+&:Q< M ,OK&LS+U;*GZG'SR]8EWE>P+S%"U;[+3<^9:9/5F+?SKA=-UG1FD/*U>OG!#NO.F35 MG7=LYC5!J?\^##KRAB06E3Y^ W2$]!XY]0!KUF.HK!3=31#C2IUG,J?UUB!N M/%SN% !4T4:DYFC=K1\M_O847 J\1'4H_@6JO]@Y'$$#9JO!5 ABI)"))LGD MJR?SDQ_7I@<0+Y.&#NB+\X?#^9?'K%&*2"#L'B%Y9_"++=8!BM CA\J@47>O M.U23Z]NL'L:QE>J8WZK@B'D(FG!MAK)2KT9W'BXH_\TD=<=3O; S,R2C@I#6 M&81^B5G(=I=Y,3]'R7B&X-WWG8Z.[^CW.P5D^M:< OCR B ,/>B7@"GLGIP A0P7C45>C^_GX/#MU^PF5RE9R ]7T)CVN[ M7AW9<"NM]TZX;R1S. MSX")A'P@X*:9PTW@\EURI0OD(:FA8TAX%T=NM? KP M.%IPS4I>GDDX0&M.(,FBPG>)KCA$#RK\D8.M+30-CX[R*B+\RNMT?809\V8> MM1'.3Y3/;!61F!GV.$JC<>K'@7!/$>UTCW)I]SM=?II@X3TG*20>[?EU5T%P M6B*E9I8'Y333WB):[LM,J:]NM+71]N*=/+3:\(X.*S KGW#,H']G%Z:YBUH) M<_>EW("JX-!4#ED2M)G0+QO3?^5E@Q'E ME1?A/#9^AGT5K-AH4B893.&%3P"O:@H3]I80[9AK=XO)$:;H\0 @[X:9QW47 M%1G;R:&9FTE2UM+[3QY<"+P*Z=^]K#',H0EBP'A@ICV7WAU:9L)%R.8E&P?0 MF'_Q=XL7-VW+54R>[ZK72K(+L14@!+:6,61Q5BHRLWN1 JQ;/%$=ME=5;3)V M*QVLZ]TIL[+?T6VT/4Q$#JUKG=]Q:2[P\FMII&!5]L=_[Y'%(>W LWT$Q!*F M&Q5-$TAN"S'I.M%X9'<*8.E0&(04>_"&]:*_01E78IZ[]%?"'9IK7H]0;1&L M="M0A=CV)?(9$X"O_N0%DJ&5QHX"3GI&\> KP=S$KLL+GW8\7_/VM@4IZ_,O M/2NA30/W8TVF#VD-Y+^GXP?T=ZI. >+_E_SF%A)J>I%JRE.U)0(+)9(EHH"=/H^[WN".H3=(M_]< IHKR2K@W!/8((_ZTQVKN(P MY/=0R* \>J:V#S;\V]-_]DTR5>OJF*=DU%&>H+864>Q+=9/'T"KFV^4<47SIZ9=1JP1GL4&7B<-J MC%%M(]C[LVF"T_U,3@<>57[;\@#8VH(G(=<@ -W)+]I424J M0KC?4$V6XGEJ&\5E,^1'9N=GCE)%4NY;N0=T2 CSIW:PTAA<*2IN((X681B4 MD)Q<49NGI2@;G?VY9G%36<)_02![87_"N3'FROT!MN!OS]LV%<(]__[U9 QC M'X<]I=A"77LR/QD+MX(8(>Q=@L+$\^W5UAL_L7"RL&$"=TKZ8Z$!Y>7N,ZC[ M)^%P(7UB/+YGIQ#_T?MK#Q[Q9D%^DDO@U:6FH^7W3"P75%CRY&R=9.\K??F9 MMGI?-G0?+9.Y6[Z#MO.P@/@^Y)BMR\S+.X8U(++PH%K@CA3AL&?AVACU*F$= MQQH%X\/-JSP.7Y/VVPL[C*W3X34$'AL/",2E'N4[=?"^82E)XKA,D1PC^9'A MBP0_Z<..@R7D9> _3?HT"?I@?0'5< =%9;RL7X1D8%I$=5[=GDO@I;:-@E:D MZ%3I8'X4=^)7?0I(_[)["MAZ>PH8-Y9\Z4:YU,^10^.T:O2FK:$A/MVR+KE/ M$>%ACK3=XNY'\#D0,_S<)EJ;BV#5"GY#4R!$YL0;*J%XW,4G?ODR'?KR= M9?9S('R W^#>DU=&2VEW:9=E*=+0(-S>#NN2"=E2/6 0&463)X,-B"X1!49R MV0[_!WOO'=54%+T+QH*(( A*+U%!>I&.M*A(%Y N-2H@0H0(2 ]$5$ Z@H"" M@'2I47H/)8!2I0L((:'W!"1<20@3WGNSYKV9WYHUOUDSLV:MF3_N/TE6[KWG M[/WM[SOG[+T5UGG?>RA_[WNB_4/H,_T9$6[41]CVSLPHG@G)$"I#[0H53U=, M!S-11 A/RX@?F/D?I>OKM<^ON&I--+F;'[9>S_[NN6O6,N/OYN!XY.DA2A;_ M_G+'+W,_:/4I)1A(($Q2&;X3+VS@H&]#V2G*0 $^@7FF !6-L%R 0BH@DL)>-Y]53-@C]1/A MT2G.8\W\1/']9DOEDW87S4? [F(WP]W-\*"X+PMT^B23,&P5J8%&HLY[ MD76 -YA+?87V 1,KG?X(WNP,?+KTOLA#9"K&>NY*C7'S:XD] M__H35$R()E\F*1*4TFA>3SH'O"=FZ!,,(TGV1T443K(+)8B ZD!SA@[2](("F,M1.KYN[N+PRHAOIFA_ ME]6J/0.T?S?F'%Q63P*L[GH+2KB/G:K2HL'E:XPM0HH8D9P/H/1^[4,O/4NK M34_Y[&\UZ>$&"PKK][RPJ'XG;/W\6;Y7L.J39"/J!+I:=TN0; .(BU*,?/,! M>N/)O_\H]Z8=,V"YSX9MRSM.P67KHE5^?GH7+OC$L#KGA3<,1N*A0\Z?=&=% M_B8NR!QQ%EL/XHM493$C"4WDPLW\)=>*Q@+7M<4AI>H"(\O7HW\\?]95M&P] M#7@)KF/IA(:IE@^%-[,3.'&06,JUI_@1(UBW[ RE3T^T\<5AXYMY1Q1M_FR.M+_-,U(-6+1 MSFC3^_=[;P:14VT_NV'+/.0JT@$0">Z0BP6_> M44A*H;G*TYL!BNL61?L((XB3WV)!<.WV2&/+(;9X_,192/Y-QHDQ1!LCAU%'*IILFM M.@1B#^CC+\IK16S=-]L0K:6Z#&!$7SB*/K3+2;S85 &BOQJVC"\>I@[&7QO8 MZTO=WK&:;G0G[12T8"7X:O),UDM0\LM^$SO6OC2/*?I!.4#1I,9\QH'W;V2[ M$O+YVOQ[7#J_3*>W[G7^LEAIN-Y5TM5)##MIDG*Y[!C4787VD"&?!7R.009P MV.]!]"QZZQ!YZ"T2JF8+43D&K>F=Z,T"&RUBD1Y@2;[K1NQ_=;UCZ-C#H;O(VDLKM2F4P6D!QZ>6"+R,0X];MTQ(K;#WY MMF#E!RD:9C9*;9U9%B]WJ\_1R,4K2\\I<8/=#S%VS M@A0G[6E4&S_]+TC=9#N2B4KS"L(+U\AFS@7>,#BN)?#E#SC]1R>R\#AGN9L3#4^-0=>5H^_22\-=:]WOU(>;!Y3E1SKNY'KT:+!V=_'LC-2 MQ.@X;#PP%;36-+JT)X>>S\6>07WF!(R[0RQ%W MF?0_3&^]54N0V1HGGT/,\+^G1JORVZ _(:63710KS<-6T<2>3%"\)DGU'Y"9X%7N(V MTUI+W"YCVPL);NGJ>*&$ -Y*O5MTP=#?V2<'&%R.09,R],BUD:!Q EUK>^OB*C720CF4[O[\I\0B9:L_:9))""-D. ">ALR.HHCS7T3 W(+EMVJ)1?5IQMJ4A2:0>*KN0 M+N+\N[WM9Z+/9Z=VR"/P%*H3PMMLOL!RF7*[OK4.@!/J[J9A@@YMT&D^Q1Z/ M$A]BCD%M>S_N;B^$/[J0=)X,H9YO(FLC0H]RCT$T@L7BGB5"U"GF[.2]')!V M4ZJ,Q^K]USF-SQV\#W,C5/"ICQ.4G[RV].A[Y'&NU8N&$8]_UW7+O$56B[3; M,93CB"88%..,X[-+/SIN*?(.R"W.AL0K07K$.><3F4=,S@AFSUCD;HS$+)E: MD)+39!32DYL,!K2A,*G^EOR9/S- ^B!'Q[_BK]68 85'GJ?O_5Y\_.IL^GX"(#JYJ8PK MAY'V@%.$;-Q;6^V4R%AUQIS.HU(W)_[&=>T*Z85D\T^"%P1T(VZ\'[*:F50D M0EZWG@OHQ(.[[.!GU@1X)Z2;[7Q?2DX:D"4*^KT73_-SG>&RIW1]N^*MQW[X MF&Q,N7.2OHL"))0WX[ZZ\[3$+;_!(2,:!>*\2DLC:X,#>4TKE8,3*%4S,I^: M*LX%37R<>;S1N5Z^YSTPO35;D#?>BD9FQF!L4[0W'6N3:W;*JY$3*_VT0 UY MC@Z'5*7%[INJ+^>N$FO>3K>6HQ1,HJ1-,3]J-ZZ963HY M7HG_)*Z"G1&9Q[[VQ;X.I0=F"7VZV1U4+F+!^$1,&>"U+; .8=G@P#F,<$.7 MGPG'8=YQ)=4_'KW0ND1^>*)*(,]14_0+K4WS'JYX]O$2MS1O[4+C.>HEA?AOT9 MEG,#N#Y^S0WCFFAY)M6WN[??_V!J=8Y^W^CT3$0H5BR<]+U8!Y8BYDM*2DZJ M"E:YL1)<:CO[7%R=^$&H'.7X]%_U5M\>6NO;$\]P03# ^] GP9Z MNN?D *6Z\_L<57%03MD V&N_/-1HQ>)$K$/LP<;B(@(V-K! M2V>MLVBC\ BY*$%6/@9-,1!Z]IIR^Z@/1/R/02Z_D6OA$JHO:9]_'5]&C"09 MS6[.6&%AB,.=8MF$[1RUIKJGVZ2FT>T[X'.O%7EA8^["J,M(19DO8X!0?<(6W7*B">_Y*>-CT.,>.@0+B>$HDR)% MI#VP+-$5(P;/ WP(55KP2[!$&TB:3TG=Q^]VO[MICCK:V^[O]8KW+-OYO]#_ M=:Z(,H75%7\0K:[F1*QK0[/LQX2PX*UCU17/%>%N%40PV-($DE'*,OFZ9.\/ MYU0Q%]#-F=TDKVK66G'S3G)0@+]SGM'ZW.>1I.36VF$H3PB4'\,_.5)@OAYXKB]/\KS7=9[L MB( MX9\U3DZE 2'/IOOO7C""- /JF+SB33JQ!&OTC'47DJV? "NS<)DB7+U[?M9$T]2#$7TVRUA*^DOKG0L7-6UY9TW'BQ;:0IHS* MS_FSJ4D3XA,[(?"):2>[K,_"*6D-(B["A\_V#>;J)A<1-?1;G83)>>-2'QR< M#D$'F"Q SMO45R?;$E,S-7-0L.BXR,;+#"E23/62WS%O=*C9Z=.A&3'/%?IY7F9_D&0B[><:FSL9$]-(#^7>8?N>SAR(+<2Z%8P2\A>#O$B"U-'LQD1KN1K MZ]BJ@^Y2U*4 _TX/_ VB=23%-&_FJ,+H^L'/77Z1-V6)'Z1UVNSDE$U2TAX@ MVZ^7424O8>FH&@A!(%.HWVK&(..!JG"=S^@I#^$_.OIGEE_(8ROD$6#RM55T M]0'ELKD)4;F#1G_B3/#HSA;/93#/M,V PF%J7F&OK2$LOU;:,DFC0W[IZA/6 MJ,$1V-*L"(X6=5%L/7F_5X.ZYKX+O5;9?%259)B*F!>-T\'[A+V23Q_,5!0; M2^7)>V.&&'93#"7-"I?]36KTK_D1"Q?KC?WC,#M:9;WCL8]]Z0^NL8X,E42H M$@LSYK$Q;GB8@UW[X4O;IY]<2GM'I%*BG>^E;B65@]HO.-U0N2H@L6K"/T?1 MI,V%$Q#[+;-T M15*Y?J@XP 'QV&G46Z33T%1:.X15.&EA 1SY-\Y@Q=;P$V9R@@=Q<.'YHWI/ MNQ=1%G1.*;+UZSZ./VE3!Z+=*Y4ZG'U1"G&9*(%#Q@E5 89$WLX)ZXDACR]N MDZF'5KF)9R:LLF? MS4<)-1Z$!"[9^EYA,QC**-6O_CLNDC?^^U^5_7 S/3D@M)^J3H1'JM/E(!2! M D+%H!3,O)*PFJK!BPDRU/MN=-U.#3*U');)M>515A;TV>.O!)8>P7-RT.;L M[E%6J&1 7[LJ-'K_Z.Z0W;?J7]? 4QMXB9JQ@M,[IEE7A5)YGZ5<$?:7-^1) MNG2S5#;T=W8->(N?S(PP(]9AP-&[S[*9/?X>@S;5G.L)J1_+\>2,PMVLCCGM M")$'@G,C^MQ/PH($#/X-;:%X$H ;=9ON,]8^6@N7C&]==4]\%%JT5YQ0_0%W MU[N2%&F8%-KT^+[MW2^9R9IECM,3/K45J-GN=$/D'R /*D M_J-RB@<.S!9 CQL*=P+:<<75$.;.0C44%]:GU,H5IHE6<^HN'I3,C0 #K.%%37RW/]^;TLMI_F25Z],<+Y2 M]RFFR!(G8O!&'$ME^PDL6*VO4\8MC]-%V 1#F;Y,KIG$4&0+*(+ /Z(@"3WB M04E@VG"DB^P*O?(OI1G%!G,G/95\OZ?.R1@B 9++L3CD^2O++L#L83[M92!! MWKC7ZH:BT%45EIL\%NDCI:0!J3$[C>1X. E)0'5@X[()CKPL=&L"#(3,GDZI MBS(497BA9AK\1D6NY,O2=]/KEK\Y;!SQ2A\,[CCM\B6=0J4=@QY!I](ZL?^' M-P&"()1+?E89U MYA*793[,+XS'R?$G(RNU_BO24R_1]0!VA\.GL+5?1G[Z9CQJ7=BLV MG)C&_NC.>]FPP%G]&)6RF+%?FZ^$)IAB(^7<95?]H978=@A@7;@8F$J8GDU@ M90Q]>]%Z<$]] -U5?3JP)\B5!G%/3"*.05R0^2][@'*[YBT/K?E-*[: P@T' M,X$-PY'<6IHLD?-*4)5CNB58;"68)+%B)#*?$*LX%&T*7)_LY%ELO9FZL:FE M2[X2$R0\J,3UXT^^_P\0LS%=R"B9&3 T/'J#GB_F077,RO18^<"RKA/")]\L M3;K4QMJN'A[UL_9_J_ O?5>1&\^7Z']+W/IK^??W$3R7 VPT/?75'&H*6K;@ M):N'_V:,)':'8U[:H27\FD)J-DHHB*%KXY#Y'/3%YELE?3D E.0"J"F_$LQP M=K*O;F@BLH^!V/\<1F8VWN+BQUY/+#^:I_."UL$W]W'(\,.5U\V/"0=;OQ"W M %1N15/N#%3/)5OWO?,SSS+G9*IMH%SQJ7\W3G8V-+L6L(!$PE8YH0'59?)-$U6HN,*G\=?L\TQOZEDFYX FG+T7$-)L7E ]=YV0U*>PALN\J_Q[@Z^2)9U; MA__;[]5L4, ME8&7F(R#OZ/R QFXR.X6OTYM CK2MPD2#;>=G1YJ9=AC8V;LN+N8NU M^$\[%)0.*$7O;K@\*#8HD'[:4##@VQCD<=/KPPW&%H>=J=40>D(?Z?TQ M*+R&%I6T"9%=$ ZHW5KM838F3MD>7=_P09])>B\B+I=<'JLV]S5ZF&$YV'-YPE_0\6*(E#RBF6*7(&0T<\>YG MZSX%J^RIL7__&KUW[0HB]Q_N00L:/!9#DHE.)#7 FFP4< RR(V([L/'9%]0% M<9E!_N-"A)UX1>YJ#^N[@78O4WNS+&)>?.V?N?_<^PO+Q[B>=T=?0Z_1%-8= M'#(RE %0T\A^5Y-PQE&_'!8*H?9QC&[8)LMQX>ND6^%34J3'6GSR;#/(J%:/ MW,(LJ&C]WIBWZ92:7VVY%$T<*/N)XM)AZ48%E:/$[9!VXB@NNQ,"B/EC;%I% M 5U\72\A88->NW%.E_WJ$BR!R=, M<4(!$;(0Y=)13O-E3@R<&6CJT90$'I?W>*'N7*L>7OAP]UKM2#7ILU!:\OV] MYMC>5T_.=[R)%-S+BE[),ELR_*V:\-ZVSSA^S7'2S8ZR[2IY^04),91F**7J M@=I?\5E'3L'QD$B*/"TF=QX5-T.^;J0;Q;?@W2BB"G%*P=6&+88_QK+T8V4O MM][A0?1;7/H2NW"]AB*X (]$UREOHN:S(UL5B(7)A"&\:T=UM@F!U%"N*SN\ M?R1GO<G";G/JUI"=9)M\6B M<_*_%=<)37M@1^^AA4(^T5S[&'2!YN=95!ZB'QK/\@YZ,50>H=0F8T0<> MX_F=,+59HB.^+98N#O+6N[A=H_ _7WE[M2$M5N(Z>)-'+#^JS0/A"F#UF60W MK!&?7V5-^=+R/NEHVXM*=OYJ!05DM*//0N9; MS0-F'@#O";LT89EU=9Q&_@+V9_@]E4>WKJ'KT$E+M#YDXO_:Z?95U"SOWZ/X.F_DMR<;++R6XQTP&8[F-0]P/?^ MF[.+BKCNU6@7]LWR>" [#TV@0=%T51N$#>*$OH@-T,+82AHX*!QP5:'B2;7.,G_9N#9\+J\]A_+%(^T6Q@'5B#DU6H,V#F9INO1E=4 M-2K*4H-*^W4_U"I?G;'G'**[9]9T*> ?K.L92IXE9;0@/)5=K2B$K"&U:V7X M:ZGHS5O11@F+'6 -D&(IA;B)=N@L2[L>@ MW_BMB[M3<=RYY#N1:AC'QPS-L1SS?,NM#W-+N-TMBD>:#GC\UZ?GJ.5_!,,- M6,.IG$AKVML<9E//U_V7/V2 S.>UGB&R1-<,B'2F61,UOX M)S?"_YIW?^\75Z%O9X0F-?Z3)Y-16<]*RM,Z2DO[L3O7.-ZOASS96C6SE MH>\:_8EE?>3Q)M!*Q'U?<0U*'ZH$J!D=E=.&(>[I0IX ]:R-_YU,7DXQMC07B@_R@9X=?CC1>U11(^+OC'*N]3\&O7)5YTW# M[->@><-#VFFPRGB$4M@!(=M=X:$W UBLAIMM"E?KTI7R8%Y%KY&* M%32?.X%!U)\&<-"'S M%EV-Q/##>M!,5'6*."'A[?[4C&7&;6+FUF!:Z:J)Q';2^/6'SIS7N#^*Q<5; M,-O1#860;=Q#3YULC D!)IUHEFVXHI3@;:"&)%CFT.:Q2.3O6+-FLW"I<6[0-A)M. HH6AS2+RO8!<V:XN/Z#6.2"(9BMYT\ M1X?O=$OWFDSD9AWJOFM+G_+4@ TA83O3!_H %L=R#F!I:V6'GRRV(?E6#$:? M-I(=MK;Z-WF"^XI??PV$@D#G+CF?>=,39\+RKEC5-%OQR^A!P_.R;$NB9MKT M)-P\0J&D]T$L:KMIPS.F$7NX'J =$D)P[4$R'X-@T-\G1Z7I*#X+,$@$51;P M*G5T%V">V'^V&,)!FMY/V9:L$%!\&M;\RYGMDG6=>30-- ]DN7QM):P^.XPZ M",R^G*JF?%H=R]MBFQA0*PP9)JL%!+=!" ;8J!BBF@/P<_X8]*Y58=@CWX&Q M \M<T^G:9/[[@&1UB2:4AD((F06MB)>8!P),"C MJV=A>D"ST&1%=>08+MN:T$*N]7Q>D6/>8NHLTNN=XW#SW-UM>,9JA6U@EW"OMDE[L7AA1:+KE_:2Z^K'UV2>X&97V#?BV,/^*P.&WE95$5%[5ZH=C)C9BG> M?PO][MH)G=K *&E*$>MZX.&:RH2L[*LM"5J$IWF:.16P#%XQ]RQ$[$43F2'ID8-4212F-"<)43(/.HN9RY@7"/]Y&^) MS+(-F;FBTXN+8:W.H3_+ PA'XU-MEV3K;Y6[D#.WK+ V(*6U. M8N&[FJM')9JG$6)'#>AGQR#N "QNLMLD(O1,RWB-8<-^W.7NQOQT!,3-ADMC M(!./(?S1>J&;GB?>]D-'-LS>I/L8%"5P]B@5[11G.)_0N<,Y1;E-%$E0A'E8 M]VA>'WV9BYM?V.=3GQ.SA8?-3:2\3-\6+G%-_YPI MG/1KJMT8@'GI7A@Q]?:0L'$;A1V"S:F3V:P4")Y&/#@WLW%;RO8COA?].Q\$ M?%T_#*F9-O0I^'?X0>9\YI74V,92N0A0HOQ(-2U0_(,J!?%O4C?SE^Z:"N^MO3]34SK M(/P8=,8#W;BD>R'9I(IFFFV9QR#SS:&8[.\['9!IGQZ>HOA6-HH[H#4/8=RX MY\X&V'4K[Z[64052B,LS]UYSZB_H2%I@0K=!L[%92-(6L#"_Y82+I-G+VU96 MHE8 %?S6S_\[-N#[5M8T[QI*6O#C3-N-TR95,V]_5P!_5$%?7)=4QTU@-EJ^0^2H(:S.$Z$J]8$Z4@!): M:PJ &*U6#T6/&GZE->ER3Z8@AWR3RGLW'DKDB5U]GZ*HD89!LAR#.E-0ZH)' M#?D)["RQI:7'(*>,:LZ!IR]=8K9.\^W(!KXJ)-SD?>T3_>])=$G@2Z>[*8QK M)JESB!)LE&E'@?&5'<(,0;/H"'620X1!$XQEIB"=TYX-^>L\.Q%?B*;C?\FP MZM05P[U]44=653$I;E\K%Z935UT+P"=$X!T5#,24(NAH(X&DS>/0)OB-(_^( MXN7'?FD2+H&X5." B,T8*IR23"D#[<^'W1G]E\:]6B]\7W M]\ZSOG.[("%Q\X$>O8;XY.8&41EWL,5*YNLC2.!%HLH19\H"_.V2,9H,1.U- MMH&BO/MATL^EF[_9JOQYM7'5[(RO.ATRN70.\A0Z'=,^=P$PK4 H MGS_L3( M,-^MNQJV$N5R:\]]!\[M7^Z3G[G?V]L[3"F_\L9M?I%O1=*8/E6^F+'AEIB; M\ZB^KN'J7]NB1@]6.^:1#WE^,R:&#L]2TT9=ZLQ7L;_!)'<@D"P2.HV]Z"O# MAC"CA0A#S"0-?Q,BJR&GL8;%,UT:F"CPC(RTK>B(4)B0VUE8P_2]VR_.3/9" MZS(W;1.V^HA9> :.AY[J_A7ZO"A=\Z_&=\"FCK,$,NG;42;$:>!% 'I^\C55 M+" &+U6>UY._+J#1^HU\+M)'R.5BK]UTTQ+&2P\'/.4 MD2Y,PJ^OZZ2[V2_E^PE575[7%ZYL&RXCRF$LT!UI+2XA=L-2:17EV!]#+,:> MI:5J6Q[/T73?+UXQ=<2M_=_9#Z/AP7^K"DSG3-.89TYJ!#.F_)0?Z##(US6C50[<\EBSB!SWT'MLX./P/,C24'Z'_ MFU:;04/_04O.OW[T1]/9@/5BPL2W8U!'0B[E=;1H1=ZC__FM4'H /1F*,#E* MDQ9!1E)5B)SA>8U>0B22O^YF'=.Y,^I2'V=?S7.8:0>VL&<:O"@6,(A2G%J/ M^B!XH^_&RQ#6$]3M(VLC/ F;Z2;O-,6!UT::SYJC'G^+OWCS_N[A<^ M;^H_QS/#?H;240*(KIOC1+F>;D>&\0PMHO#'9%U84"W1^%?4DP#GCMZR3[)- M3 N"M[BN\BP^*WO\NK.#^2UUR<[-KF5">>M-^9IJ&@;. M"F;%/DL=<'45^UY;(WMOT"%L5_ VYKM0E4N4!JQ_M?Q&9.%RB4J%2U5MZ?"' MU:Z^S +?L0/L6RC! IZ /=W, (Y R!/5'*M^X=YIT97WOX!*Y3*Q/[0-F,UE M# OCMO?KHID%)CN*>AWH69 8N@2@[,?5M2N@WV Q6W=Q%2)I?"";*)4SK^A! M3""ZQZ:F)O0ZGV?U[@@?N EA2Z^\(,1X1^NCKU:,XH>V&!? \4&Z;S<1EN6: MY;#Y$ &I,_=TZB)DOOWNPKQ85C CZ_)^KGIT*DLB)K?N)7XZV;:\N>7B+JK"XRM*,^DB__6N3Z5)E MA,3[=!3!A!1.3-A<*=VPGF.:R-9N)'(D>'UQEZXE#)$RN$F?'E^W>*1\1:OA M]B.+2]I>+ZW@+/I% I9N[G]MT9J+P5Q3I5+^PJ.^$G&\IG7-5?7I$]L3VND, M.!^^Q,9$RY1(\;97=_A>2ZQB 03]EM0QZ+P,11!-J&LV.LJ.#6QZ1/:_C^S! MII'B,RF#S?O+K<]S"VN9PV'!S\3L8/E;!]&% I>!D="2E3OSZ.BLJ[1@H'6? M6)A6/ ".5H@ST'@R^2#3:EF[2?]LJ3R#EF1<\SFUSM-!RR4!&]W311@4+TQ M<%)ZYL%$\YT0S8*O#G(E-0.8$86D'W=??:FJX@.!AD!6ENQ%50G*BC4SB]95 MUFCS"J)K3P)'P I.YFTS8\GZ0" .>KIE,9T]JBXJM,USD>W/$VU30?H7O,S] MI]9BT]4]B M=V:PT2JW6WCA8-IG%2SCMT//%)B1+=-*$TRRJ0M/YP;;C;0;I MA[&@FRH5.M$&X8HP[6Y,C*!.V5O1 D1S#S>W((Q7$8Z6HW M])8 C.R:1![4;KD))WO!X"_8V/!:?-X_>0UY/$%;NJ9=WL>@4S05BP2']FN* MI#T$D/@!6$=C>,?YE6#NWH*1V,3*;N\D4:%$?CWZ=-S7KP]5&0S$+XR,K]:$ MAE"=CQPYW'N'0I3W-;))\33*$(EP.RI_&5:$N V\*8EN((7ITL;&L2E6N(]38[Q#/V$[B#^GDC%S%JB 5SA'^G3 ME_[HKC//[2L]GC.=EH.]SWWW6+0CN_(M6X)S2NO6:Y4 '?4H";_:-U\RRXOT M+T?&O1$35!&<;GD,\4R(_DX=W:,\A7+H'X,8Y7 V4%LR7<4F+[223WLI4(*< MD/CXG&JL .SGLY+BR")(O-CJ1,FAQF1>9>.ZQ==N*!O:)/F/! HHI+ M(L,27?-T/(_P- J.&^#C# MNPNN,IK-SH>>:[Y($Z7*G=-!H3U8S@IU7\**Q7>;2?V&B>KZ?3!S/_$IGC%& M;8+QC$34^8"(D?./O/T%(*1LHE\#68G:E7U)_091HL!_H6^X",S[;.NS/E/Z]TE)E)4!J4O6YODC>TLF25(I@QO(?E/ MZ#^8%^T6HF583RS"&/E8>'"LJVV(YK ^G)FQU[D3[Q(Q*YC0;R8']KPSI)[N M<@RB7)%8X"@F:[MA.2K47170EZHSSA3:PBX630>^O_TXB:T5FK*4O-1W=&U*;6R'?&N'2M9=]MWU;;3M/-(7GH MEUO-Z60-*/L%6Y_4BZ6[#$R115(Z:G#4FF_ WDM:I[^5=?83,\Z.X MA18_@)*';(?&T)[8F&EL#,*R8EU ?:)&PZZ[D:XG?#\X9B3-2//3+7.I$@;V MMZ)=G$@+ N)T3 Z',JN[ MX/C/V(9 .M&7'M75$ND^UD5HC['1N[[C>"F98?-[62Y_^VJ22H5T])S% BT< M^JXLE9"S"@?%2@W-*P!VXDH7NDJWZZ)R=RC]Q(U?",/\?Z\GB-?B/5[K32O3 M"5GIT-E$<.NM:-Q6' +2,/YSLD2!G-+U-#.LNVUY?UJ:/]OG%LR(K+^?9ADF M>;]$P8ST8'FEM@E:WL0X5>'I6>1%;"(E$WNV>(FFS1X+4J$+5D1S(=9CT+,R M6=L?9\4YKI\5C^:^F_"1*4E.7WVR_*2]'A3I9H@%*49)^ETV'H5SD7G(3CN* M#G)J=P=GGR76DM&F7-=IEJ:?+EH K:;?4RZ++;3H2^JR[/@NE&CD1'$$B/BA M!&5-<$97>I7[2("U5@UA.24C((:(KL-\=H* ).!+&.K6O#A<\[2*@$T8&=$([=LDZC6^ MJODP -]33;N;Q';G;O[BF_==+Z%5_EL%1$.2%KJQ'O!9,++K//UOPC CP,\( MYMU[WBK@AG74[].W)?/QS:W1WIUFGUVXNQ2EME-;%'=RH2\,8H72DVQW"E>J M \C4"]>(57AD5PM+C^H*!G[)$F8L4EZ/..\A%U.+-.FTRMA J]JFH*86]<;5Q[H,/Z5=/9LDX./K^QH' M.$X*.^_"01OJM"XNFXEB/%GV5^7)I7:8#Q]GW[,W=%8<6]:98'>/8RFQ*2B"2LL;9,'3WY0#XM:Z@%Q/#$&S9]J.P,Z]=#"VE?] M!I?^V%LVN%^2T6%5KL)CS@&N?.S[2<1_PG+>M:H'5+*$F2/D'6S0./H,>P'! MD)LS&&OR[3LD+Y5D^$>6E-TMIBOS;'+R]G'LN9TT]9EB\[R\+J>H,B[I^R2" M\>164Z5XEX38YLNE2I%X(UGA^(E]#WQF#AN&\#,\Q4;.R8^[6\?[YFW%@=7I M\95(Q6 '+9.FQF_HRA37NH:ZE-QTABM+#OQZ)T2'_FITJ3:T*OQ/>>GPH<3, M'C(87!6W,W:H=K()V1@Z8COT6C=R6U,*R-B\QA3Z_ EM:A-/G=MRXJ17X7<^ M0 D"(L1C4#>X"M5E:,(;H&R;K$NT?/?YSE>NZPWOU5>SQ(QO6)OU)ZG\Y.;^ M<75^DE?;I_-,Y%O[:^<+I$8,AB8;/KP8PW]V8G=MS3@,]\6R4]4#JA9"ZL)Q M1..RZ>I0IE];E%MYGG71@JY%[?6=YYPLI3F#'V?[/)I/#J.-S?#F?V61<2'I MGILD?D$2&6C)I0[693/@B 6+V2P['M,C1L+XB;EYH1N8")6E)*54A3^GIN/S MHHGKHL5%.IEJ9)4"?W\76.M.TQ6QNYQ+5@W#"!F@#I_P.E0JTI& ?%>#8H)9 MS9.UN\:D'0?0##PFEQJ@I=O5V R][\I"D%,X0=@S2N5U9% M;Q1"%G"/V0ZHQZ 61+NVJQU]9-F_DM'8['23/>%"@13=P"Z(Q:<M8M MXL4Y5+F[]71KZ5<]EX;FELRB^GH?BO&FH>R!< LOZ<51?:@D]<<0A"*!YMMP MY*UK3#12S'>1EEQ". 7;]:-8GX.4V0?/J5I_&+8V9S'.U_B,_QRLZ'O ;.$D MNOM3..'>T1<,S"STQ&A>I\@3_-_X9MJ@U)7GSS8EW*XDJYM69$D77+9'_,CYT_R*S?X[ M%^B1%VWP93O-HPUD]74]E-:*/'C)73RR^D*I&8%T0><:R.;_15-4#<81"LF8 M-'\P"P42>IB5G?I+>G]HE'YXG-Q\]))O8KG\=>6EF\J'Z& M_=VN0YZZ@:Q/?WF-)>S&:ED(-PX-2,"W^'&0,S*1SZF20#)928&!U_B;_2P& M)*YD_Y/7N/YL0DH/^[RF$%&Z@!8&]RS'=W84C,;/VX?P_Q=K:+9M)Z/)P)O6K.^<+0G_\IU1>(&<72XR ,#"U()'- M&H!V'&\VK'"DNPQU5Y;QD@_GLOR#22Q1N4 3>G0^?_]'D7<>A^/VT1%3/ND. M]#+C_\P"Q/_5%^/_Y4L^0>#-8;(8< PB=1"/>L*I?$!(LWZ%[>_6 L5OS74U MK#-Y/;QZCH&L-WD>=BL[I_)99UG/( E:\'\2$#[T9AP,>ZC:6^\C>6_U<9%M M9D5M*[9HV0=?TILIHK(=[T_E,R1;'H.&)8]!?6FZQZ#%$D+"-"/)#(@CBV], M',(Q,O0;CNP-S683 _XHC>;TZZD0= M5 F_;,:F*'DW]O-W%=#D6\3):7ZW .S\2D>F5H^MZ[M6/L1]0FB,T(/U:508 M15?@.W/B[J.KGT$5GX28M@0U"'>4PP?$C+S'D\R6/WBLB;#O^3FBGGQ=N"8E M/.(/V_:0:?XW%[U]#')-F$)U0VN4$TPBU=GS:XM#+E;-S?;N%K149#[_B/7R MDD]\?Z^!^ZE@$NCG5?!S"$'?A ]&DA=Y@P@A6..-6^#P&_U9 H2BV"_H<5)/ M??U# ]3'MFMJ3D^%G+B%SDS:\4<62!LDZU,=6UJ?CLM>^?+/5>C3;A?[:O89 MY%,X:^@O)>HM#PXC38;F4[B-!#;W2XX*40H$+4E3]19X9+_O"/;[,[WT^ M,XH(/7JC#B/?1$B,-NLO!.\P/&M,+?"E:P1L:CX6$-D;#:\DE>W9"M\W#>.R MFFM/R=<69U I?K):3!:Y,3#S==;=W3YNXS?15F)- @+QLP5/;.;=YR4^ETGHW\^ M?6BUM<6)W:/4_!U+*!]N:7B_U\+^MR<>,I^JJ4(XZ)1RZG+D)?IW(*-JLWBK M/+1LJPG6T;CQG9*;!T:*N9K0\F7=;6MB;331-4!+C?9LVYB^)8R+T9O)6\=OD()*X2K19 M3%)2)?8'3A15/$-E$%N("^IV)L 36B]0]"?+MQ8;DCOGKA _<$ZW_C[@9&2P MW.,Z*_+\.2;62>A5Z)/OPS**1D_YE28&UQ<>U'_RR*V)%@XL2,EP[_YZ#M_U M[M3MG^J6IEW#Y4A7H2UTXMIDD=JN1G2U]7@BLOU:0,1V@OP.R,/.'R'TS/_RG!L.XV%:_P>TNL'(/BCD%GU&W(*HC[8\W@!0^. MC=M$CB2/>QN3\KT9BO/B.R?2I,0**=GX)I2">$"T)7^. MT*!Q]*%_!YA@8"( !O#V:$+OYF!3 M4V"8!K$KL*@'\GNO&UL%Q<1Q=K8JUGP?-L?122]-,>3B?I9AAJIRU>FWT#MIM9ZH3 ZTT MZ>'WP1V#HEL[A6N^-#_1+W-V\_ TTTMZN!0U95$IIYIH\&;P_%E6*X6$J00, M#VJSH0SA (N3'NIH-&ZACU@PC!*R*]F&;G(!I?=JB (I&>\* M.=-#!A>8YKO[01YQN[5T<&B,2<1T0J<%$(770^@=3KYZ66[7 MF< ^EL;X.,]P^2AUJ)/$5=%3#TR8?-)70Z_0,$H!X46DQ\UEXP>0&"AS M* > M ^O4 A&\0?$2W'7?&P3\6V^SV-M3I%\(.%\26^Y82&VB$>VV!;F6.JZ M-C;P1)!+; P&W=!:"=HHH#WO#TTZ+:)L=>HQZ*U R O 2U'6BQ6Z=8H^ZY'L M]MZIW5:/KKN?+S'K2(Q3K]+N+:&>#<>K"I1P80K00Z8M)O8HQ)^ M3^R#S^UT76^');34'W>##Z+[WK__'/;&EX#%"R$))J503N6H:\BWNP'_JE-^ M:8]E.0?]^"9W]+6SJJ^]KI>>V>[K-+W0X=:M_-4!Q?[D?Z53=N7I+&4Z^JK> M=@6',V.X5AG$>:)K&RR;I1,_<*/ZD[IEKBV08#" ,6<W*X?BD02[IOP J5MC9!W%%-\0@3D MPDLTZ_11G9ZF*E'2]MYA08-9G\(#W-+N#%A"[M746>=+Q@&(;A86GO'IF)1C MD'+EG_2 K^0;9GD&*X,*UJ6AH]G?B^+0SFL*-LWZ N^_/@L5CEH9]MVZ;)I@ M-N+KK#--O4],8C#3LI",ZF<6C%1-F(Y!'?(+,U*Z M#QQT=LPYE!J9.)3%/.2Q ZKY#]X(O;L,:T 0?UQO%%!C_E)RJ\(ZUW^XQ0%- M?\ 3\B0I.CFI:N;P'UAC&'KO/Q^(-$T)@O,L,2>EWZ*40MD(FE&^*%A=>^:C M=R5"IB@IR219!CY8M\,/TT3Y)#I+=1>&45^G&[UU(2W!B [%M5YIMU(I2HNQ M:O1AR0Z5@75A2\LX"7(!P,X/86389KHD1P&[#JI"+7KRZL,P.1;!"_ROSF[% M?:KOEN]"]!4&6%M,-)LPQ[@50>TW.)6O#TIPS3^M3_*>.7OWIC*G5/_=-P>9]=CWT%W(MU0A@)?(:$$HBJD.'J#'J"JT&BVE](8) M&;W2%;SVH9B)6]_J["6]JR,Y<3DVNR/I\+XZI.+*-W.,^=G'>(5X>W1S;(,G;59,?,D.J5OBS).&+6 MQOMT,HHD0W._L-63?LE;-O/@TQO0*NAFE5L^4/KPC4EC>E_;^336[I6S.8$V M6D%L^<'6S,KL5F_M<2:?A&;&I5J,$=INH_;#<2/6?RA_'T';( MM!U>Y,U+]%0>R;)^5%T0[V&H79VZT79^M.]BS=BW/#TK2[.E!VQWPS[/,Z<0 MCD'QE >M*L3NJG+I3P6KI650DZ!&OT\,$;UM^H*0Y--L!OR'5[.U+08@5D<_+W 7F3J:%JYWY"LS;X/V:PC+'12A4_R5*EC7(5MX(!5VN87]4O*3:%B$Z7:M.?-4Z6=UKO!=XL M 'M=^O>'ZZ^XJGS[_+@&FYU41H-[2?_< M7<6C]+5IY%NK0Q1E M01$SI"58^R-=D!J"[!(3X<#Z?K*NY!P7[UL/7AH=7V M9;7+1B7>Y3_DY1;2U<:%NEA2)&2@GU:((?B;+-?]2N)4JQNLHQR"'D_;$ M%RZ(YK[Z?\.E5@XG08&3\\0_%Z0,<=CXZF,0_4_XQ6E8G>K%,5M8I^P=IM>X M/-8/B3_"[/QX@Q9NL7=,;OMOU1R#Q&=6T:2K@/PQ2'?-\M\-@A/I'%!#OHM@ M([)@X/2 "1G:WLH>_''?2(ML/(C=+(>?MK^O7NQB8_?<3!#QSN/O$W098TN9OX2M(9_A))>V MG)[M[$AI^/[:.!SG51ZLQEKFX,:L[Q"P..MWFM((PQ$$&+1Z4J A;CP0QA@?E/&'[5 MKC_U3L1M@;T)961A\3E-?EQB?3+8TVWK>L&/:;1G MT6=3J#9"]J0!4>@PE O!U"KT*Y1]8]2-[9YPM%UQ^:9SO582CTK1>Z'$2W(7 MQ'X(CEF_0V@#'GB6MXYRK82=: 4/P]N3"I.[V\_A7YZYOET0%.]4N?J:Y>YY MP>NYJ=+A^BKFZ1Z>R48H"U&K(J4%!N')I_\3;>\9U-0;=8_&!B(BHM*%*%6Z M4D0!B8!T 0&E%Q61$F/H-20JTIN @-(B M*)=*FA(UTZA!)"$2F1!#0<2>'F M]WZ[=^Z']W]G[H,D673W[>W#;Q M6&>)Y"LHQ9[!QM1:)ZM2NYQ)9@I@&\0#0&=Y'A^=^7./SC?VT0WHNU@V#$Z3(,G,:&03I:A,BA<5#!*[6 M-;:.*\?-4V6BF8F524O.U,W687PRO:L8GG;9#?3OH>\6]Z*GGT-PR=),2DTU MGB93]LM[8JADTE^4!2-,M-W$%@4@-LCL!'2,YH6@3!/>'B1X1N-&>6><6+I M77R]M7G9V3*^M4>/3Z]=N,T=Y7P7U7'_+SX.*4(O5S%&)^#DLS[1[MZ\&1?H M\934(G,^.ECN@VN:HB5_5]A=%7 '&!"?Z)_.)FH MM*8L?AH=/IU[SR.*E>7ZG,;9S#]2JQY]G *S,;VJQO:5]FW#OYN%S+MU+1Y) MUV(VBOIS675#>Y.9V?L.;%<@KI-1\9:$WWG03T%L&%[G],.]Z8&P6[AV2;1_ MRWCY<+V$E>"#WR=A"]!AQAG&Z-)->C["EAZU[,R^[20]Q:TQ=V6"F.DLK@9/ M;MN2#UKH/DNVU^?7-K*(GS#'/RK"/)T*@=TL*&^8@5LF?6Y+)V_0N#8HZ0"< MD%?FZE)/**;9&[I=J@B#7O00BY V/$G!UA9!=N@WB, M:@N@>@ZQK_^@N1%RI.%%8E+T$:A.-Z>GW%(S!Y*28G=_?KT;PW;*Y7%%>')M M\J#SS>A[Q "3L% MN1':F,Z%3;C1Y?%A 07_LKYF[D6*_D7-?VL)YX3=>X_)[;OQG4R,7KUFE%K^ MI9'7OBR,*E"NJ\KI7E"QM(4/WE"V;@0D&6PEY,$5A>@6QR_N>$Y_X_X6-G]O METH32ES0SDY1PV@.+\Y)ZVSBIV?E+_M.ZC3Z\&[%;03!E6U^ZP@K* M;2T[.-&'K0UDSO0S-'!5_TW;U2"S'0CI71"J7?,B56'^\?XG.FF"B/=YYK:6 M1AYE96G3I[_%+B^CX\ 7_VOA= I0[;.#O/WKR-F;.?PEVK6J-F5D:\ XYMZ- M[Q4_%:NCDHUEI,043H7,]!/V%WI;U=)^C31#OZ3/Y@<(3(<_HG 1>HN0REC?(V:!APG[E4>& $\ZFF_LEG%@0 MK=&I D;J-D;?9!T:L$]_+KD!9V$ZXLM8CR3A(-^#UL5>@GH>OI%_+N-G8?JX",:J7J/G^5V]M9FS8 MW/X=[@7$77J61C I:R4"_8;VB!!FV844GQ2/E8'>L;CAML%O(W(]1?OB$Y<$ M:OW9R\GAB?F40OIKAARR)R"32747-408@E'=9LHAB'#SVE9;W)7(NR8MU2^N M&'S#QZ^MWKI%/)P2=N_+<;*7J0A3IR6B8::;OC*M=?B)QM4_UK6($\SU&()X M3"]JX]X6ODDR>PNI:Y'Y-"S+>QC?5)$6[Z5A+EOM[:W\HL/%_^G#\THS&A;N M:)(9*EY3C)YY%>@H FY"1Z,R3D;7W:ICUTNQI-2X1=1?H'^J^B8(XEK+U=-7 M4>Q[\K[1T6!I\V5#J(+UV$OC;@O3$>/0EPW$K: >[C_63- LIX)KW<*1O/VK M',8$_>B*/[=$E(9T.L07N")DARAE5[_I@BX8Z]W +()M>3Q-A]:G4(?%+SFH>34(?O\ MQ+K%3ZM0*#9O]9+UN$ #[8(@)>4'XW)#;&7;!2#VCL2MH9'/QH&MNJ 4D\_? M7[* -FZ03?[KD^_ZTTY(5"6SB]HZN6=[AKYL,A.*U[NG2&:'%!IOU64K8[ M9FH44 #3+NI;5DW78B\CK@'.A 36=DUNTDX-$+MQ+\YT_'.D[L?9YO8*P8%. MQ9;2&WW"4R3]':;J.TD!QJA6FS+% "OA=V/E)EST7N;K/:)LSLSNM=P @WZA M62_ MMZYJM\*Q[5S!FEQX35^HB"S%3$'R\;>87)'NXW<74XZ)7K%.G2DTJE.KVB@2 M%U]4Q[1O11@,^VHM!I_BGD5PT]$M,*H>4$/E;&_CG6YY5"H=7*U5-*_<9N2' M%PV;=" W1O.OM&;UH4GZ:)P] 1O96U&"$)\IJ+FAW$?57)DQ_W@)U.=GM= ?!L)BGV0(;N6NH/3]/C<"J9XT%.05Y&S MX/-PA QIMVMXA2/4M"K5HK$6.A^JQ-UD>/G^>J580E"PBZ#6XKY?NUC@$>@< M9/D]ME:R!W,1BC-]31JU:OE&&J8=.N7)+.+F<;K^[)?2Q1I3'D5:6?%IVM=Q M>\]ZPGH+#;[4!7K83TI&%[)Z],L$NO_[&;N-5$&<)D?M;*R6M"BM)IW;0O+/ M7-$2M5OJJ 4;9P4&4S)0FZU2+/NSYDL/, MDY6ZF@22:9?&[^27[2.+WT=2NL<2(# I<>$#*RI%^M&G_!%<0^CF0;9S M)Q-T2"4 7[(P"RAT:DJ2P]:SG<*Z!20R-/-DN=;D#VS28BL-^#6>34M&:T!0 MA#LA5*.I%W#E8JUPHX#[-\[@@HL+'19X_.Y,FF;S$&\ M.@+U_T/ _NLQZG@$FHC_^Y/@ZPQ/+(F,R':Y-&%Z@%WV,>\-O7^ON'?:4/V@ M<@N.>7?=(/S< WB%UL6F/G#@^8O,DAN\I&]]/ M_AZ;ISSLK&:XAW5+]>9.\#^B%Q.S/>E.;X,+H:TO4B "-!AIOQO,H9(^T6*8 MMRT,GN1-KYLL+ZC[$$!- :&,^C#SHW.[C#-<)"B#_1CU5E!1!TJ(:099@L". M$^=E?9VWKG><1A?Z/,1= @QC52=;I&>\3$1SRWRX&CMJ6L=F,_ZL)[Y,&$LTV" ^-3FEJBH!.98MEKN M.-_W4"G+I=W%FJW<.%ILETMV8[Z31J+Z=E'%*/ASZV@'A&1BENC,A=!=(2KI M :&E3B;+QF5Q0C[P6OL^-]<[;8A?;>-[IY_YGQ!W";AU)7[-[1UP@BI.,Z*7 MU EF.4R%79G/?&-ISY=T)OR[).MX*J7Q0DZ%67??7SAE* MP>J4;5\JQRM.A%E%Y8PY:R,\F4!XB/R!KL%'_O9/XD8HS,#\RJZ9# ]/O:\_ MS+8:BU]?@]J*G69A$Z]ZW=_^\QMX+I5B KRFN@![^UT0CC^<@,'?04'6*.O<6R>#1%$BAQH>HP$7SF)8V_A+D_K^(VYUJPU&)5X9OV_&S* M]T$N;:ZO5$I.P8E,T<0NPV^]!2_3ELIT%[<;/LB:2. L[*!-LWL#,I1Y2@E.GH&8&&[/"=6D>!^XLSR*5/"AJ M!46[O- +5P8^X/]GC%/]6R!<,'T6D- MN3Z+4+)+CR9_&\DYYJ\>ZB^7MJ ^12MQ\4EL?I]VZ['>_[1(2Y(: MN;9*D+)8DBMS5-TNTO_1Q9I8%&/2E8\[ B7E84D8"HJ\T6?6@.KD6D;S!@U2 M%0:I<(IPDG=Q6-+0XOJ_7*.;P_/@ESMN+BYYE8,1G=$S2A.M S.4 MG#_C25!6V@R<^@KUV_2;&2Z4P;Y+GE]&$Y^0.3N;GFF>;OQ!$UU9-#:JC=PV M"@B&$3%B,3SZM@]3S$%BC_<,>H+K?%_XD?]Z!=EY(V+4ZZKGR4IY M>E)[\X&P<8BJQI-E&)SPNQH'CU8.L]29%.6'.FJ/&]N^]UN_S+(3&E#>1.]E MIG LB8,QCB(9@#EH#Z=KMQT5NL?MF-(BOCRKZ(TQ^5CNF',E7MKZJ=K%XRF* M+!#)MO_$(T13 3GNS*HR&BW,3DJBS+Q%J*IT"S#=+Z4PK6$N]_2%8/T,Y7Y1 M6.R]%Z7O?%^GG!;ZZ!1H=C'2?]LNIV#E]Y^FG<7F'#ZF,"T)-80YN@.I-F9_CZQ2:VXBGK*H%: ]D)=_=3E0YYW^L1B, M\_P$);?OHZ\=I:U^%T;\&4 UV/=Q= [U;PB]?"? VKD&W2T#CNCJNQC$V?L MD$I^)GPE[,*Z7W7%E1A[HKA&.?_INX$^W4R_4_D+3S) XXR[P>>L>ZRP; B# MP_O),>:VRXE_)U^U5^0;R)_3XNM&S/RR[MGFKQT%;O*H0S^X-GQKF%#^51C[ M\!I9#8@$/7J]=E[KI'#:ZFI-DU^AD?)EM^%;'7-+,W^VM[Q6E$YW=%AZ6J?$ MS4#1\9/6P50(8\@)0B^A.1SR=N'/;"U)3>9IB?5[\.T1WV6SI.N)W)K,/18 MROQ#AS+8Y*CW@@)7ZA.6R_"1=H5MV!4NJ8DT#$RSW^]IS)=DJ]UAJB99H :F MR+),SI69*$GLFL@0-THVG:GQ4 ]L<*FTB35'5*>838'5S!T#^U"O-67H'QG2 M6VVGR?5I]+B5!-Y^*BP#]Z1Q#S%KX7X$"F9O@7U8T_MGLQIP[O25D(TN,"#6 M1^0F1[4/KIBP$IQ:;R:+:;L7-F4N]1J_O7TU/S;X@N&Q$U<^9[^YHZOV84CC M2NF(MWGHS7%3.OI!NLC[IT528KDC6WTCM=:/*A'GR8$1;;)]RX[V78?IJ2N; M"D\G>C/"P'-N%P<&JDKVKX.>#D:*R9]F^E\J_S(>$%M?1].X*N&L6V#6%@%\ M[0F;)9$12I-#9E$FKJ!:E^DT.'I\*1:OP.H1G6LN,*^?ME-G+WSY.;'A\;(> M!1WS1[II*H!-W\1EX#S@$]@\(%4WQ'5FQY>LQIF$2^J<;1$LVQ+6''?H"R[P M&&@8;]*XF]68YZ';J7'AS[?VYV2R?'_N"Y@E;U)O[F/-& Y..=M>!A MI7=J%BJS3GPO$^^(T0P^Z6F\X_RQ?MD'*A%K,64CW#>#)?5"JAOHP@]1@*<_ MG*%NFZM$3T8]#^/L.*S[G4RUUZ_8F@[P-7,M0G563\FUX=7RW G[=MI5NX]Y M@T_*[^2F[55P;^B?<%1ON#_X-0>]3G/U0_\YCFB#+;U3K0^!]V'AK M@;0XSY P;.<=3^.R&[=?+7;+RQKW_ 09O7Q@[74R?J,.H>#\@$D?,E@/,"MR M&'R>(84/FG@8)C'3C>?P1W%ZC,N5SPC[_]E],7;OGF=/X.GLEX\O77Z66%L3 MZU,27G):8MY>[D"[3W?@;?ZEEZBN)\C^(] ?-T4487KJ" 3$KF(]F+MK,@@7 MX(X;J:\=>>('\@)-H:Z-,9ZJ,_[;M?G;Y.\0V8Q BR<;TJ#>AS[';N.RD+Z? M*W.MM14M#[+L*CV,##4IJ9Z,QU_])M_7!?R>I\UK3M.K$;!2#RQ)?W>.M^N' MDXEP4MGP2MSVX*.G%U:@809BLEUM'=XW(7B5+&8QC&A,V<)3/HRON4B@_4DZ MW:J*\ZHW^F7U\ ,^K:H2![B0A#[N'N2D,Y@F2>:EG*5G(CCS/1."5\RBO@)) M5.3\SGAOO<0>0PHV$UILR*X7D=C9[L7&&@M9S@8S?T)B?PC\6)*=G#=.ZG4^ MHX(_ZV$J5YAM5NSPCX4O*;W\H6IZ5RCHTZJ8/T:.4(IRFWP3]],WJZX.U0*# M- T'7\X=<+9Z#\,HH?XIT=G!5=:O&:)!^&7.GAPEG1D-\#(J,F3%Q@[HZA$6 M2=TAWZTR&N^ 7BJMD-%(R.ZY<,/[U0(7VIC^5O,LXB+@1H71Y+Y%K58NA-W3CKI0?Z_]4FE#?W\Q<9&% ;YRLS2YUQ.:**HXXXYPAB]]NX_WAWXKDO/1K27Q<]M2^1\@;'4H@[_7C&&4YWKM%TCYW^[]O(2\" M6(HW_4V;*N#2ZR1 ;HA&JFTW:99!O>%2I,E,EK3">V+.:@&)'@+0N(BDH!B] M;MOKW?4_"GJHMFJ31+'UT&M]AJ$ECOU?,!-^XW;RE=#;#;>VLG"#^H5U :C, M.^$4+?))+"MJ^1.VX69%WCRNSYL /@/@J*:Q!ET][+BM&#%GF>.G+07>G=XX MCE6M:WVYW]W4,YU7O.B =\8;32PX+!@\2P_F6\^9J[:-$4L)EFC;J:=_T3Q' M4Z47'X$\1R]Z0,Y+D%EBR%D$?(S(V$_8\=]C,U93;A?E<\W3DG[O:>74Z\U* M)AX#)!H&\L1O3[ZW:XK$ EW3.H,:(*D?&U2 M;^E/G,U)@8B&W.?1P;&%;_[%JA9+FWJ9V9>E*[D)8.U_\ MD@LKQ!VB* ;UBC$!_X(O)#2SLZR=/_WS:U$$>NJ:5L^F,JX>UQ#X[V/O^]:$ M6_,>D@U9ZF#@JO01R!W58:PA6#!D^V/+0E4">*(&K*0^B=#*(Z1/M):!R0U*I7>N M7)L4,QHQ-MAJO:Z4MX_'LDOX3DJ+WGWF6_G7C6[1#&Q.EZL>W5O,;OB0] M6;DT96@H4Z932/%I-BZS0[)^0G:"6339:$KT>@;/@@YYFMJ32=.4FLC_6DTZ M>"O_N:[I6_ 4MUA34\J%Y)>N9ZTD!]+;-W/1%!O2$IJ0!,B,$@57V.W5#160 M/'VK*"X@9,#@;?1!>L-%_>.E[[2>7>!Q^'/CS;F[E:P$"--_N8%G9591D1JN M!(Q@4-1J97/^5GT#SQZ:P_"3A]U#;=W](O>?R5^^?;,YB'[_0C?UK#'LC+>F M)&-:C75G^PAT2F6J31$A219#G5>&!5JWS/Q>;AT7G_B; M]1O_FKU,^10&9%(*U:8VS'4^EEAZW):WKZ4 CS#(4NJ\"[]>H:'13&!"VE03 ML;IAZ!^\VTFDC1R #2W=RL@0B"PL,3U0M59J#'XI'B [,A0L:RB&#J%R4KB! MN KD/*0!NX/_1+MO+T-4Z+S6Y)3EZ^L>Z(R;TU<9.G^_3^2Q^-UP4?!MUI+R M,#CAOUY$8)LF\J.DGEUAFN:$O#@OYW(SFD6S$,6R8MP%#[W?II83VDV\:DOK_"OI,N7-^#H*A+;^BE<'G-;4Q7^ M,'5:K48^Y0. P2"\F,!;Y>0.R@R-^5OA]NA;[NH(1!ERF_T\N+/XTQ7S]C.@ M36<=FOSDSSX!TV*_#*I).BI;>_&Z]W%Y:;ZF*IW$?J9EE=] M]_U[;( (*%6.,;MT?5(C.(PLVHTZ1M.JA$^J8#F-"?S^5#:%[-_O9X?A(I<2 M9FM.I>FQ0?P>6U^D/D!.,%BK@6,%3(Y6A58HO-KQ5\) ,W_6G/7:,54ZS'?LQ+#Z00UY M.>6)>5WX'31,H7$2N<#K3!K'5R5U0!*2T[]-^S4' O"5S9-A"K(90]5I\Q"E M8<^U%.^AH(TZ,^!:V!@ )KDL8]N#'MHO!JEJ"TN2U4"/LFRFM!>"?4Y,Y=5? M_Z3AM69Y!%K^@*\UZU(X,0]TM4,$%2IE&9>!-X[JW>?[N;,;$GB*BAS%2O@, MIC[J=K,$V5;%&[/U*VS;S?ZK7TL;C & M)":%7^N:"L1/B\[V:QK!:@\U82E,N^GC9'">/M/&R(JJP=NRK[5;#" C^2P.FZ>+QMK-V# M[Z^+0^$N[9/I*&.0"=<)]IGR69HN$/SE?ZX9N">=IMVIFD(1>"?^PL_-=ZP( M.8E'4GOLLC/?F'C]5!'3N>1E?T_TK1+W@Z$^WVS$9O!_Q0;&1/W[6L"A*4LU MD7>E.2CG#QDF/SEQ!*HV^?I^L&&P_SUQEJ_AY#M6E32^ =_L/!8L(J=B(D6M M;1'_LBG5=,_'P_X@Y@BT5F;9S/2K=;,.GDM,9P*#P=::FYH ,,$][_6EFOL[ M!UH/CO6+O;NN]K,<.8T_)H_P)4<]($L2NA";N1 MRMM3N2,V>2:69IFV!:_*B]N>EBD>;[_T(ON"3"GPMP@Y@*_#=..Y$)89J_KQ M2,$MIVN-:I6%!)G14R;E#G&-IO^FEWY+60A%#'+OWWB%.N875B'M]_[]YY3T M4HUQDWX/J+ID*W'"?[)H]'3G9H5PB>-N_;<*UFG5EE6D"#7G>)QH5_6JUWB?;F8K.3/%QGGO%B4(JBN0?B'$ZCE M)'RU:M2GEDPYL'56#^],>FFWOK=*6\$%GB=X]V]9_(Q_)2W!U/LT3J"(.3T_ M9]K._<)%5I&.0(SSJ$L*L1K238F9AVD;\3:V_2 MSL,Q<7;UY;.F!OH7Y4:;_B)'IA7D&)H>'O(QYFK86\"8]+=2_1)HN99 M!$D:U^[*1FPMFP;Z?-!,+PX5KJ+^04]>SJ^N#OKE 3#0IQSE<@IRW8$KWEJ( M&>;R_TB$5W9%O9'DYU]P#DA%P+P2<#'RALFNA&EO?+_>C:A[FM=2+SA[BI5? MM,(-V8.M]&/A'=-95F5VT.\[4,8+@*$1RLG'6TPK3\[FW2?,K MYZI(^2LL<2MPSL5^EXI?JE7.LZ/\_SYGJIXM6GCFHQX?2[5FL/FOS"%5F=G0 M0UZE&9$+>]$$]$4/Y*69%B=Y2\-@EYI)C4*]1OL'@>HBH[+48X/%P)9SK),BT(2[U_6@FN0GS)FJ&^R6T* CM+@P7OO\3H?Q/R-# M_E4 .LS@1W7<;;%<1LU7PA,S*.DAO26E6X&J=FT9DH-0%-2GXO)T=OC;/?33 MWQRUI1<$+V_'_NR9*!&X[K%7%Y!M#]\I% \-A)M4A!F7+P;U:]^1"ZC8FT*U MWP%;T]__UYCYO&>#Z@R^/JUG_>]:Q9V>;B87^W\4S]43JZGA]QDR%$OMEZAA M,E,1]@*#GZ9+.NB815PD7VV3"HKK;!-B7 6^OZ3=E-K[R/W19J M%QN/0%/QN;KR-:1 BBZYM\Q[!099M4Y$>5Q3M_M?>Q\%.7S&,H=PQ,$-R8]C_ EH*,@G'Y^/S24BAP-Q)JN ML[BE_"1DK"L-B_*&M9QC,3R5&!1D&A1MG%G0""?KW3#:FA[G@J\1"W<_MUA8 MI-D,[ 6T;8K5,F/"]L^2SUS[W/;JK_;_AWZM_]N-\P<6N(EAF!7UH"DB3JC- M+E/,/(ZF?00*]V02Y"'"]@CT5'R#D:V\16_%= /;##T,[88F9S0$#_Y\AO$8 MY8;]9W(0@=JIZ3H"%64RT&7_7M-SCT#KJDO<3#H>Y63D0L.OXC"?Z6:#05T, MAQ#L#P:Z^'/LOU5BG)T^#=% Q4Y:I3W?!)/W\+^/0.9VC\;,GGZ^9*[K_M]; M94#_A]NQ)/\C$%@1U8+*T;=P1/4-H7?!&^8S_!^LESEI0M9'("EV$IR>VJQ MO^WI3Z4[OX*0_)UI!0H=6(KI#O;/>LE,5?)_3_E]W-=@QBURL)4TEP1(2M+R M)Y8A]%0LYQ%HLWZI-;/%C<'6?P2Z]@=@?O-LEQGY(:P!\QPCWT 6WQH-9:>= M#E'XSG@&@:/^::(3P)0[V^A#K]R6S%8WRL$1*'43^*\3Q!(3_K8-BJ _AM32O61M_M7:F]1%<062R0WZWR8U>$D'?<+R$\3G5(T# M-?D(_V*=L\TZP2_(HJ=@Y44G-TX*_^V:"28U4[X 622=KGT/378@9C6)S2.0 MER-0+C>ATF&V0VRH-%+/(.=AXT-=63VO6/4SO0UU:_1AS$8H\N3#C89&Z+\< M5IHZ4WB.TKD4XM" OB>$]OQ;$K-.LB">D(QM&B9:/ B0"X#^@Z8HXG7%P6H^&(\N"<6VZ<]I?"%$;*]=3+& T]"KQQZ_*S5!OS0SQDMQ&V M'LJ0>$AOI5/M!S9N_$]'^,HCT/LXFN 1J"IWY@BDC3F&03+KF#5J0)?!<02: M'84>@?(LAR"+3-Q&.J<*RP!*?U#)(TRZNXM:H[4Q:]\LG7F*S=Z00YU5MUXI M['(*+O M4ABA,.$GJ!!KX5YO=Q"OX5+LP8.+S(<'^_)]E)5#_$V^&GEM3E%[ MO9^C@Q6B^O]V,E7*3P"\D@1<>XL4HG_2O/3KL"@)2[@R]D(9S[<9HMOLY)EY MK@9VO$.D'RZ\>=]"S'WSBL7I_EO?1S,LD_LX+^N3%OS;1JP<2OXT].2/4[9= M8A$MM6G.;W"4UC0,0-N!+*/_&VN%76!%:/ MD-9FVZU,2HWO"2V!/KC$W#WS@L3=JP] '?P=79#E;#0OS9 DRF#+ISH ^9UJ M==,1*^Q/Q:8(^^]J+F*'*UIOS0ZD]D+.BS.E5"()K3:DLLMP) MI40S#1HE,4%E_2M:ER2K'AO<_XWO=QVH*[&JVRMX%8G:$2)E69$S.N$Q^%J) MO.4[+JN!B;5T)P[!KI![3<\.AZSMRK;CQ=^#NH:H" MN^54*9L OS=5B79W,C^\FUT9A_ZO@?!2?VK1EDEZJDG:J*9)_^;HN1"EX,=^ MSE\K\U97J2JT)_0LKPI?VST2-2KP1/&0?X84+*_G6TWIYQO#[,/L2J1Z+U@"ORNI MO71U^:3ZMB+#94@"OLZZ&\ZWV03NW7W%D ?"26V']ZHG:[.P$16N] SW(1T3 M#V6>Y!;%[LO5];_+^AE7S1ALJ]3;1Z N650' J9YV5 L(QTIU#(->QP\^;*Q M+DSZIX%M^ZH<>Z_!9@KT(R!*FJ L 1EDBU%=,FL\UAU^[-=Y XGI%JT5N5"K M\3]$D6'.W4J!X#6;><_(*\<#N?KX1:$,MHP5$X4>-,F1+D'5(:O&:KA^KOM= MPQ'9N**^&EJR]56_<%'_\H31(V.>AR==M=AK76(W,.X_NO6RWCB-6#]HQ< $ M?^4RX)7?1XJ:34N3Y!J%)@/VPC#8DO7SJ Y;C6"2[Z/&'XSS.,"Y_0C$49%M MC_NEWU7/6U%BKX>7P3N8L)MHC!]KTEO*]Q7*8P%E,,X4DO!=2!Z 3)KIU;PT M]J)%P97LV]ZDD"BO',K7'=#D.C7K+>M53+"\$=G>?BJ+CP^3"MU! ]*C-!R& M_FZ7_0A$]*2(1Q7J\!K/EOE*26Y\#CD(W/JK3L^6FHX2J=M%W5$[8*[YY1*D M( D;#5EN"OF9L;+]=@(!+@:BNMY!,X[1DD]EIZL%?7OWC8H5O2TWGSH-"]"G\"D0 !B2,)T7(,OW6$9Z.NX:>T$GJZM?2J'LT]E_YAI8*2< M5;C W__/5.8=$^[H($@'$WBHY:;<:S]:PLJ=@D([U7H8"6[%6P'E<>)O^O/G MI >,RZX]\HF(N2S_.P?*V84^B869S=:LO&_C U!0I=7 M-RO#?.K!+V /0)A +#.(-S3W23;GCX,\ZOM]C#'D&7I3 MVQ6:T[2&2E@^[4F462+#.!1JPL*>I7"VX_Q3T?,MZG(GI3]T*7G==LG.G)]_ M4%K2ZV&?LHU3KW"L3&O]6=&6J;(P@;/,C$VQ6L>V_&&._@^^KCD#LOQINNTZ M/<.5GLVX8PN\["- >CEY/#+#MZVL,N]9C76%N8G<:X"YB2A[]ROS7ALIO)%K M%)[JJ$_C[J,< K5X=LWS@ -0PQ!#M9Z!2V^2& M2@.ZS?5N'6], J0".RO,]/_GQ8E#Z">M&;WUFNRHB[- G/-$^-(FQ7K?>9XG MYO?=:RB$>,+E^CG$Y^\VOC9HDN5NA/ U((H$IWB1Z\,)K:%V)&02R5*[:E*E M3)#MI>P+R0;%@K%AQ1*# :5B]>_K3&DJJE?P=;\TU?,1-XXH.5 W9:^7H:,F MG9USVT3231R3&F!'^96(HLS&H @SD*KR9NLA=XW'\<"_V 2+LV3L%UYEXOB$9C<:K'K M/8(2!@Z-5[]=21U ,FW87IS"[ 2C,:B/R8WOK,VIO@A.LC[MDC;D'.,'^(Q? MF&4?GO3.O5X 'N_7*K*(43%AM:U__3CY64.2WQ>I"\I^[Z1./LM^YO8Y_M/J MZ15(Y(;5P1S6_9_E)M19OW!\V\7@5AVW->%G#M7YXW_7U$>Z&&RTIUF,,U-% M08/$NR__6F.E($'^BD4414'&\X^4?K0 MTF/!KM_JH_I,Z?]>164\_I=5M$^!RJS2 ^*0%PJ'V\MXNKJ*J8CR@J1I%*EQ M4QR6NN$P<'/>U+$^<-NK9&#UFB5P.Z^^?U]FGC1?,8*A0)BH^830!C:IND&< MA*1N>\@IH)D0%5_7#.%5[H.F,HJ.=H:[J"=';@VHLB MFI/J1Y=11!4R>TF%;:,8;$SM);E. M,F;T$9F$:7K]$5/J%-'0,[T8JK *FBZ7WGK_CH"?]TC.I7Q>]MI:ZS;*;B7= MM/1!@H9./'>JO?R!QLO8:YC'?_[_,C#_:Z.SL#L/93QJ&$/M:)'<&$GC94R; M$HY /,P]Q4RB'>WAC%A=XN$=J"8.[+Q8 M9?DV"HA&$?E)!X0HVH6,5;3^OO7WT6P"H>M^FF/PN.FZZ=#0XOZJ%(:EUECLN2O<*] 6W BA061^N";D+"YQ6P4K] M*O_^>^+@,?#Z$TV.F98TVLV9%I.*3>'+/W90M8R)XJV,Y#F<_>XX1M1D[[NV M_(:K>8KB$&@M]@\*D,83#0M_H4C6[,XQ>$Z:[N>@3'Q7E-ZDG$)M%H"1DTQ9 M%'V>-)3PT30@[4GNFL!?[[G[TL^5NL:C9%UU*[@S5&_F6H\)?8B_Y!J;=DVO MO^OS^,'$GOX4J@J]Z3:LV#,SB!/TA'HE#)SZ)2@YN[,H8##O@C$I0:U=#14\:?@!^6#R)%) MXNV%+[87?(K>&([RVU&5*$/,H[,00B3X3OCJJ& 0>(7WU5\S(:BF0.*@25W5 M-/'9U-S:4CTA+V'H4_N!S_>'2:D''_LDL-RHY5Q4_:G1'16J%>"[[#Z0>,5N).0S]V%N%PEASF8['/%!,3]U$?<*J:J8[\P"JU_ M]Q4[.UM#_*7K/'R*,2DSNY!G$"A^KHPR#510]1>"P@F8'C0H2*'#[D4_/:Y MA3A>\SE"]L!=]IFA[>R%1Q_?2YU13UT#D[P#=_:%FZE7 =85IP9HP3SM+HF^ M7I]>\05']:V1JK8^4>]Q *2 MD%<,8=I5@ @G6??B."+1GB4V\C#ZC>;M(![[VYE'H&ZX?W!PIOT.#""10;N([7$^35,G1],"R '-,!2LJ"[_ MWW2ZWL]C+"=D^B_='%ON7X^Q_?B1G-!=Z1E?\NA!'JOD*-*PZQ&FNU0^I^ZJ MI5=FPJWZ?YB!U=(9I"O#S96YV%R!B56%_XR:1)O"MMU!G(9)!51-/K]\?G/F MX+#@0-6*JR??ML7P4F)/_L. YP\*3LD:=*B0=FE<-2N86,T;J XG) ]46)XL MT;I283\P=84:4%5L'.:[7ID<5J?1;YOEWM\^PF(2>D [GTK! L8$SCF9%=4. M?#12<9QV,73%T>KW;YD*T\T7R]_JFZO>3%%,)'^G_6@W%8I$]+3?NK4/F=-O M!Y^!/$D"Y'B[0L,NKFQ$T,R732!FK4U-Y(>XPFR[L)8)CT#R/S.U[T\L^'I; MVHQO"1EP+^Y,J7TX-.4P,D]-:LYWP+A!X3]^K9NG2YQ3JR46&?NIP0$IL\X$ MU=4,&B^^D\$U?7%X[._VXO'I0XW5D5=]_,E*\SXL#M294E1'V!$(OAN#JM[H MP9ZD*0&P2K/E!%X&UZ^ZCQOC^382V;7[\WT@!"*YM_[?Z2RM_=O?S[ .8DE6 MNSBC$0@@<\F9JTT B-,AR[A#9F<.71EI@3QY'G+#37H=JGJVSN>:;7VW.,)@ MU/O('T>@JB0:]\5V3=X9AFQ063?^K(9MGKUB:U.'>%O^<=4A$OSFA*[W>2^C M]XX+?[1[H!"7:[+<(7\6-GMY/.2A1H/6X.VG85E)7TLLSIF;UU6$J@>H[\ZA M*!5D26(X)B1:%%9C($>B!C87$E(# MW;ZQ$;^,R&,>#B>/$KEAU-M 5Q?D!(,7\%P9M6OY"$? 2Q<%]>H:W:UN3?%] MO[H8X!9DU2P>2VA$&"]C &,-DR/0:3@EX*,W/9Q> J&X?5R3V:7> MW)4)V,U2]\T-F9EVKHWJ-M%AL)DSX[@/^*#9A]3THQ%..%C%='F5S%!&8+V/ MDZ.C/.'-1O^-O,=&5^_>OJL?@>KP:@,C. "M!3A2X+W8MF!N)Z,9 \*&R$! M\JBF,?V1A:CBCO5^Z@M$FE0'OYA?Q>Y<*F4+ %.#_KO]LG9T[@BT>A"]1M)L M)&2%ACHJ.+R/KEBW=]TCNAE&7ZLN0#4G/P>II>AB:YM?_*LI.&,CP-Y M/;#)V-[?N 31,NLII_NMI](5+D>HOGS4XVIOMI24%/)1F^ZVE,HXX0=[=R6?FQY8$C]/0)6!C M>;!\C*O0^L_3N#LB*X(5Y*2<*U:O,_E<%$]Y""W4GX=9Z$V3T,#54:+UYQZF M0A #TL@75P+C$"J$8(TGA&'3K16J]>35B0K7EF^3.VXW1(T&&MO?E9[(*?:Z M7L==W/2NU[I+J_?]YQ0K3Z*_,>.8RI5U@;]2NL7*Y170MDTA)FV &>Q7R1>7 M=XDJJ_]U(F.'5"$4"'>._PR5TQK)N#0C4+;'7SF(S;B_ I?#J$>8BU<&SXQY.F$UFN=[@029S'!(0&"9POU-.(_>_C/_381<0M((P,9YPN8KKM M+CRWAJ$W 7QL2_@8J8'RI>+4D-6XW8O$3@-OL1@1^GBGJ)>M:"R= MWME64<0PZ@.:$EF5=OZ$(>EE%OEB>U-4O"C)[&T%6+M^IL)U,L7]^<3]L2S_ M=]^%;PBF.S8Z)F0_GEEU1'PQ?O\(HU>=9CMAZF-E96UEM]5$W--XP<+B?U5Y MXUJEV^=Q*K@ +<#$T)>F#6(6<[9,2>"8-BZ:.EQ8X?5R9E]GR,U"?LLPKPZ< M_;]+U_?J28.-K[2.JW-?>;V#!R,%D#.:$& 8N@H'TX))G#OX?!$=:7>/U9B* MY8;(ZSR&/(LH?R]CJ:=BJ2>_.:R^)BO0N.(HK:2,G2=4C_F@U-ZMJR1&5<&" M>ZHGV$VI/F6\Q4*N_=&IJ@\!-QX8&-J'C[=ET^O_NT-FSF4%0Q0J0WB058DF M15LA\EB_S(2^2.6L9U/^MZ>X]>>>IMPVUN:3Z+F@??RXHI>2_5,2J>MI7E2$ MIHT>C\6:+]S1XA?:O@Y0,IK,-ZKUT+L9FY"Z[@,?K*8F:3&)[_.?7[R$W4Y! M\EEHJ'!A<6?-ZQCNLUXW'/[VWH686QV!7L!,4,L%>)(6D75%L7HI"-/NW5'B MW#"T1_\\F65/["M>%%3>N,UW)FS[+?-LD2@/LRAL;5&[\]O#J-GAXL M^172F^T/$-W^Y;G/N^:LO?C6<4&VOHO_LHR7;Q_'&95K:Y/> 8@_SQ:;YC]^ M:7/?*#)]T#Y1 ?-HIF%*U4:3FIJ8-*.&7<8SEP:@QV,/X4%8U"8NN5R*$%\L M?MG4)'\CM7J&+M0$L@T6#5]B]((%_IK-C3(XIB=HL,\Z4/DZ EW!.K=]04\L M43"\8K' )^VQ#M]B6KOHR4\8)HDOKSKC3)!2C-DF^*M::D2J/N#V1:XEN;>] MMV'FJFL6WVIT1#4733;^UFWN;? YK/MH5#V$]-*D[_5/,C[\";G,(^2M2]=N MA;U\L6U=__HCZ@V4JH3B98Z6$M8BE4?7+7./1Q@E-Y?9*64XBJ,ZIZE]LNKI M ME?*C=4)'_M C;,PH-WGF]8*6+::?@*;Y3FE:#J(U!/^LTF![NZ,OPI#YCX M?O>+X@$6KO!XS-T'L+[;^[M18)(%*NZ_3CLO"TD*-+$9MN5K"._@Y=F66]%Q M13VN9\?M^NJOYT.3Y)R]-KQZ U)D1IAA+H(3?"[!_D3*,T&C+6N:^&_\9IL=ZJ'/@(4\"LS%0[M W;FRB\S$5F M9@VR?1[97K'*R,,YW3^G:J*9 M[_U4;$1=_[(.=A'3AH4YSUFNMI60!CN0Q^D?:8^6L1%(+A*Q*#G K>E;76OJ M\[&SYLI6X\2[)Y1N+H\,C^@%(CV9V4"BW!7. 0<4"DD_EB$U!97F]ZSZ'2XD710)K+VFU6#--6UHED67B*S MIZM.;:&$"29,4>7[-#:G*,H2#+ZBL-OEAXXH*\T4 $L5HVD#9',$ MP[VR3)<]$_=D>-C:>\:O8(U0\V:]P?9["%SN<%I1=2AM+31?'M>Q2I("Y M8N2(,^GE-'H5)B$87(?B]+#KZ45O=(LERJ16.!8HIKT4'$Q.(X6\QR2BH,RE M@>P] E5;[_2%+>-!"SKDLI7I B3[/A\E\_V.WI+V9T"LN.\;O3W$YZ* M"_4/$?F>RV?^->%[!?#MHX \\6?4,M'7GC22A$$X5==.EM_/;T16\/D&1+M,2FCPVS>LD< $]]B3L"?W@P49FNNC=VW MF\S[VI#B@GK18KIA4_*UL)>1< M7#%IB#XU_=$K@\MI7BOXTM#39#;KA6(OK2LS=9<%$EVC(V[9*7ZI-=8[ LGD M#+RQ*:V*]_,F%HY6H);7DQ(T%4G.O68L@)L^V2VF%LVQO<27034SJIZ2;*B: M]/450:MQ/TYQO0N^KG'6NIFF"F"7T?,8!MOHLD(4]C12W9[&3:X/?U(TWP^# M(615+J4O+72)UUQ)N6W'+_9XZ<7]0&X+WW3+]2,0R2;+;&Z#L@,\T)1Q1PG] M]Y(B-MYPQ!V-D.>OSQ5ZROM'XG_J\S /H@NC(0@V*U&5>G].=!K:+^;$V.6W^]"VU=SXW9OKS];+W MMLZ8OW5K77Y92;N6='N0P49Z(F]I;&AWVOZ- Z2&Q$D.I:HSV M-GF26>+_Q=Y[1S451>^"451$!*0W(2I5JM)[Q!8! 47I3:43 >DM)"H"TA4$ M!)1($^DBA$B-=.G2)?0$I 82A'@A(4QX\]Z\6?-^L];\YH^9M6;>'W?#8G'/ MO?ON<[[]??>><_93&B>Y]\>WR;X)NEAX:6^_OT'DQ10W+H')QIC[%^!&-6>K M?A>!D\>HG&7T2? I['R6(\GD$,0+%R-M=8J1ISIP1/1!;B?FV=C6RYST3 MK%C.'GOU@M?1P^_.'@GQ@\&C3.&2 (:$(A3%7@2*J-"08'S@#"51[BU@,MB1 M"LM0XY)O/[;YWCCR=$(JYT.S5WV:\V[+#%D/)D:1PO%N-&Y%JX./62+2D!#A#"==8\*G<+IBS2R%L+D MQ!*#OLB7>/0]T^V6(E>R,IQ.1+;8-*O +S-^?1U2:DS*B*MHA"P@CZT[.J&' MY%-4:QJW>S*S J>H(RK1MR6^74-O$7 MWF'7,>(]Y>M5-_[8&V;'<)LJ;\XE/'<4T#;ANL"!%+O0@3V96/P M_)R :=%:QK ]- ]F@8NK>G0O<"?,34-((I?X Q8AKR=Q75(P> M+\V37(AJJSP?8B%P?(W_'Z?UQ>^8V#RC+]Z2!R,L8H.9W$HI?=?.BUEF1.7? M=P$,TSXMF7"EOGLZ2YQ$3R**)(3\K3RYBOD(?)OER_F8MQ@&RE&/9@_0Q1 C M#NIDU$N]B[ ,!SDO\%U[V[NC6^8VFY-W>\]_K?ET?*V#\$@@1>VSN=RB565@,5Y_^.-7GP9&^]9;/ "0-3H5@.%[+Z5A3/>&.8P&EZ[JF M1J,TK[*9R5F;N]6V,VT2M+Z4VVN&]4IO6MZ]T3_AZS!N^.FOX:Y[2R?[5?2$ M/(TXS$ ODPUFV8[1CQK?.PJ]Y 'P)\:?8$&8S[:,#-GQN0]+UJP?J6G(?K#J MPY,AJPX_V/.B!JUITR ,$B_PB]$Q&3_/ TT^E66_]G+41A4<0[SF7+)6"U\G M*4GK@93=,?K$R/U?NYJ:U[]\Z.+6;#U M6RW[Q,VGYQ_1BV@&Y(D-14:C[D+!<3J/\:4^(&#,:YPUTP',L<%)8V?+AV2Q)?@1]+GZF1J[$>^;8F3\ M="B3>A71"B:9'H*FI#HS9D4!GU"\*9?GOM?;4>_'?W?C5>- JX)/_G8(N07$ MJ45^7WQSA>5\)8V+=4$OGB1%9_4A#[;,GL>D3UPGS<6H:@L+%*1]#HA5E5**!-9TTF4SOJL4DTX<(02^OAW3L[ M!ZY_;6HC39O=1E7^W8H+\CT?E2;RW$+S=/LSMA"S=)D \I4#0F048; TK# \ M@K+N9:I)M10JG?7U'I3'X0LTUG^-)\&;LR# M60'N5O^R/Q"PPYIQTS;![@F(U029-<,0N74 M(+ZY*G?-!E%5L.9PJ2YG>+]S04&^(E^^K>L25UE1U8FX S[ B&H 9SMH1LZ_ M:Q8$Q/"*\4*F+3Z<(<$FW[XV\Y>E?^T;OW8RE4O'=QJJ-B0F_4;]?:@@D]YG M1193MN>Y&RM%P?R2^"4O/SUHTY&;*8IK!85&S,U,X5U.T4T+L4% M;!)=!/#ORH*T^R0[B )SQ78-$:,#5!!_>_>;-D_P":WYQ ++ M/B3IIFG\+#MPD?&0K@*%)2$-G7JA]_2V,,4:1;[8 MZ0D:;RD!VHH"I&/B:N980DK6V^C\)%$T1=N>:U+,UFA0KCBSR![;I'S'^8FM M.#/AA&OSJ(X."\9%;.UR\;<86-/+_2"E:QBV&"AQU6>J?%9_?1] MR7XE9/80-*NZ5_J?""YUD,ZN?=2A:;Z "ZEYKL5!F^23(#6R:[2JD#^D6NJE M3TS+>RVK$?7[B_@YELYGL)']A,OXK^P?Y#=[LWJII7CJ[++C&.',=[?34] ( MG70&#)G:'Q42H@62L2^1\S'@TW#;/*"WPP8:AY97;.-R@*G9H#N:^_3M9.E)+%<@<86ZW:CFXJ5%0J*BHH2'IL*4F^ZY;:OR@WT^?V7 ME5CB$QM;K_04Z(-(TGT.0,*Q;2Y*5 9@)*+H>DS43KGD\*ZJ[O79 ?SLG]9C MWG=LHV^E:QY//RDPK[6XR.F8A.0,D 6STO0G:OH5#E3M%4U&O>6?;MU/2]_F M>9LF<3+DXKM3/PDYLM51PX5"-1+\@L6UF^7Y8;#1.:E_/*MH#\G]@!5$&6.X ME8'_VF,WCQV"ZK1,<6*4_H-7<$'JW9"UP0[LL4;'LA"L 5F7IM6_[T'Y:SOG M" V\D/-(]"!8K$?DZT\E#ADM2PE&$L(A?HDR ?P,W$'1N9'"(= 6+ [U&_F$ M/CTNOW,(J@U%XO3<,I:UMJ::U+T&U"O"XHAZJ@PF@G4&)\X)Z=@2C Y!N-)6 M2C!"8;Q2M2$^',GGWFS'X:_=]S/J_<=/=4R:&L<;GSI[0#7:3;D'!=#"&OZP MS8HN=K&W3B6&E4HVMND'&4[?CRI1P#4< 6E3&G=XVQQ_,Q]0?=_Q.'"[?S=W M(1IM)>^=&Y7%XH(KK9.J-4\+JE9YS-M*%,]H8YPG? CJ.4_71/ZV=3P$C4BD MN1Q-+"#=![]P_&9)X^Y9IX0#POA3Y(_CN06#N1)]7 >?665A16\K_F3-RW0Q M0ED-JCI[*A4B#0)K,5H[0Y^=.TMGIUTA+[<<@N+"QI)C=I \L[7Y+OY?P#*= MRP,8(]A[B?=./1*77K]LORR\]R!Q$LH:2__YP8FY5R@C#C;KV[0YX0@@HCT3 M'8L-I!LNV\O"8"@(LH4%N20S=^80M"E_"/H MWN#(!-R>:.\^\2,M)20/\Y([:4G\N\&ID#ZGE1#PI.5"QL;1-X.U@V\[(N$& MP(P'H3_\80Z,33J>:KJ!8M-7,6-1\*Z\MR?^^N^YO='4RWN:/:%S1+>C.LZD M?T?;QYQLB<=W10=Z274VT4Y1C6[VQ# MSY^Q5/2Y&'Z?#EA[["01IG"Y9FQFJ_#@:8#%.[) K&%*V(B'O6WQ6T:#1^.K MAN9)&B0.X2O9 -E.(4RDCO:\T4*1]>3DZ0FBTFV>;I7)!W^V4C4L>E[AU!:K M?$HA7H[)#+9VJF+((*;D:\X3K\0D+&I?U+,IGU+V\=VE$?]0_OX>\ M6EX:/>K#LYB(\ RLBP^7 2,0#/86B?1IE@Z1'.C7<2NS^6@"FWS$E5Y7-VK1 M<_DT)$2?.]?\:<6B^$O!%]N.1Q!.X^G"=W4Z3EV?^.&@1U8]!"4&(+DF9Z:G M:O.X# )*OSSVN%FE-UU2 Q-W.39%_7%-0+.2<1F&''Z9 +^*HDB-(1G!3/XZ M9P7O/SUQVRF(Y?E[9V00&O().TDW!3*IVEM #Q$\LX MF9A6 /C,1Z/QJ%@'-;)7^;39NE"J3RUIZ<,SG4TQG^K6P@)W@FF:]7/7WDKI M+7YCLZ*$:,GX=XM+$K+V?E.FX46*/F_-/^4*D4N-Z]1P0<,SJJL^ +,R>&,F MGSX,)OEAD@GDDQ^;VABCPN 6!P4*.OJD"?S@GIX#9^2>-D&BTQ? MS[$SVJED16(RU;F;RL5 .B3-B7QFEH-HK]2]L\YF,\QWLL)+?&@C/Y-GD>/J MZ>E/;]0[CQ$N-8D1!AD7$42VZ-.E'>$.U0>Y*H>@F&W8E&+@C!#E#VX ;_ R M^4H7;[>EM=7EF:^&A0.6%Q;2#%4?M(T7D\*E"_9T\TQZUB:&F@]!EUQ,/$:* M%6/>2FS^%2>BZ\,^3M#.*Y/4G*BR-$V@"BZG@HV=Y1Y]NK-./;B8R=M7I?P] MSHSO>I5=N]"E'[SLRV>LQB?:*I.:U1EM1?IYZ_BJ)S2:JR=:&HV*BUZ(L%E M7^NM,.7"X(SVZCB?/]]6V)\Y#(*W!^,+O M]<%C'YU.5]W^5CNL7#>K+Q3MU:!W+SCB:&H&X2"_^30\C-%-[AA0]8"_>(MX MTI95G"R5M5C5Z'=9K('/8F-<2(Y?E49?KJ'WS#OOYY&V%BTFZ=8Q?@D%^?>- MK":_K$=PIV+2]LO99!XOG950&_$PUK4HA@UOW8ABM'H",4,_"022Q? V-!OR MR]_ 2)>2M2GS:QHTS)&X?J:G_"S&_RJNS8^SZ?FCJQ^^\.Y &:@\:43Y"DB0 MN>^1_[6!<4PW /)"0^'[6_E M75]RNR&^LQIL> 7XC=>GO6[621P@:FV&7+P M5E5Q$D().?B$D&*H]H)F,'DPRK7^)FFY7;%:8L,C^YGX/5+HBX=5/5K>YB[: M7S5%QZC\-/:##\CY[#D&!UOPU*J< M[3W?TVP(7RF[FG _ZT$RIM3FG4MHIUI"\=_;8>YYXU4;E*]/"& /S19(J*R4 M<+%'GOW]O0YJP)J#S#@6AA1Q")EKH>@QD;W^%+B.U=AJ3,H3*P1Y&CXOP\N* M_C5$*F$RZTR&9;M+YR#SG['H]&PJ##&9(T.FQ#KY/LZ=#>4+\[,#2:6G:=7FN*@:=NE%0-3\.2\-LUPZ;^RVO+:)WGN MV\=<^T\L=+#*N9<7)RTMG1<'8AQR"O?^6Q&5#9[[MXX]JBPIQ\[GB_("Y46K M4H2,%D4VFMV$BI'T#J *H'L'.=8RWG1&7>+WL^7"G(UT9^\1B *E^,&6;&11 MG%%%-K-#GK4>-1/YQI#VSL+3#P'LJ1'J>%$]?<01PS;1!8[.4F_;.AL"N0:X MD0;U&R,,Y]IP.JEW%2H%@R(^KX5:=>ODZEWK$GB08!EU_Y:61HA9LH2JRX'W M;/G>UZ+;5^RJSDCGU58523.\L&8^LCW_=4_>%]9'#K3^S[4N__];Z_+?W#(_ M^CA4^I $>5VVF\AOAAW:]5(SSQFF]"P0-^6='WH[V\OEYO@:N +%?F=TM=G()YB()XU3.)O M'^2"RTQ8/B1A7ZMBV=;N7,&$V>_4^E=J+A!D$A;LN1G EMPB:-1J+9_CL-MUS7_\;QA6D3%"H)[3$58'F91 M_0O=%6UL9/)R^PY1]514_$W7U^=2>)X8IC-[B"=8&/,T??#J]6*A>([?Q"%R M?0OF6@)A*N,8BV]R7_NYWZ5(/4AS>?SST;4+2?J\A?A#T&O$!2 2OT?3KX1E M==95VFMUJQ5^<>CV#U66/F9=Z&?WAO>:. FT4Q8F?53Q2N]6^,>,1(@[ZC6$ M2T?S5#)>422DUV%8_MJYWVM:8_UC-1?.)U;]7(+JD&0Y6D3U)A""0)*(4UO8 M>/G"@<.,J$9ES52WO(*3Y?4DOCL_'PD*OGL>>E9_?MR85R:!)]3,8L.TVL!: M_GBMC@&9M5U4R5@B,-'?:BQ#OSK9=.3DTF)JHA9.R5"?'0__/IIR78&'ZYEF M69C,GL627\7GRL3&P'*:(?G6;!U>U\FBW+M M,E\$I4#'<)@=1=P-O%14HQ#]_(A..,%8NVV8K;(0MQY\9?+KSI725[JFWKL= M0P]DKGC<*G0V*N(K?VR/@\JU5U_MEBI6Q0U2C6C0.I(4[=(P_!JY)D>@D(A,?IJ0J@PK?E#0(5DG(2A$I#6^G!D>KH60.%AD&-V(19@3MC;$(?MP/KO M0\-T\Z\Y+M1O*L<::WTGXQ;-B6*$RD0:A+3]MU5-5(ELGOQJ]WQ\$]^VI^V>U\S M&5+=:\G],R9-0.E.4@&ORZ/3%UZ>/O$P1YRLD$]0/.>PANO,#2]9JW^WY1\< M'JIMZALHFS(HGG)5;J,]Q2K%0+/DX8,E2^S][=)I1G+*>_G_\L3?H\/8CG$G M.?>/BM!#I?\#F]&HC#?:.@6DFHZK-&3*[(&"#J, M-6R\P1!!;XY>$C]E$+$5-53-X(\#)X<)'U6[+Q\1Z7H)T$ M<.:EE\P.<^]W+$^IR^;'^:89%4-=LXT=(^[WOFYI17_ V*IL3/112RF]#-+5 MX@'AAKC\I)^F"0+!'&W@&"Y01LG?V(H* M=>LUF40()*9$"2]N0>\4_*TO//KRTG/3J.$1VI5+[2L\*X5*N \6>VP-BZ^V'?_:L(J48 M4][\-QR?W%[N1)!J3PSOR#H8G%*MY)SK_S+;GYB[E-9;R^S2_4,$!+)@X[$, M\/A285XU)#!YE._->RRE_P_W^C]8WAN,!,&KDW?D0M*]_VZ_!#%,T3N[W%L\ M]WO._X?6G+WE%L_#[?AWC.>B>>._6JH_G66.$VH2NGZ? U/=76K]?%O?VF_*+LLZ,]'^Q-GOV:*, >A^DZL-^;155AP8: MWSD$\7FF>SU5!7,ZGKLHIS_5W]^[9_WPR=O&\%J"&&CBCQH+).^^>+TH0\?/N[.2 XCOJSHR<'OCS>KT>Y.--KCM;$86+-X<\:] M9I3[M>V?'=F>2;RWG_$\ X&>R:+RXG;S3_+D\SHG_>[L^<>HF:>_ 5OS;R>E M*W*OEWV9F)8Z[W0S9?T]0_6ALVT=@MZ]!WSH+4(9]%359W_>Q_YJ-2\W#>E MK[T=3"B6"9 RTRZ8)$OP;H*_;FT8E""FLQB"526"PRQEPH:4_*I2Q]C)120# MYVB3Q1S+U6WZ/L?VSO!S\!_0O->RV) .^&B73\ >K^LPUQH,KCD$M5$=8S,L M99WXDOEBO]AY@#V\3T MSER@ O8_!5E6NA+2JN5T->O]O-<#4H.PELX[?W_+ M/"F^;B*_AOGFLPWM#BPG($'K&-^"Q*]W#M6O%8K[4-ZQM723P'R MYY]?.9M0QG(^^L0SV A-DZK@WLQR4!2X%0,6:O0Y!)UY"U<;F9KUC+R!LKO_ M+"KH4MLQ2^>W)DNIGZ=%\#7![<.]MZXW*"EQD:'1P\8H1; MB7U"(#H9P_JRFU!I:'1Y1>7GC&G:W[SF@F'D_$<'$N/R5=UVOGE67TF-VZ=E[3B(MZB":Y!J3,P.F,9,=_O^3GYCN1J//4RO9*KN7UKJS9I M< @WN#CIVV'VKNX!3025/TG+)*A8COZ7]1".:SFZ@")IN:N78,QTC509O]-T MPWQ"-2*0+1VU$(!N@MU,+#Q+])7;P#;.FU))G4IIP);%H-0^7:4W1,XO9[;QZ\;&8%&BS1I#_) M5'- 8;DS. /L]')\N;7^8T6J7)>[N5 D6[;U^^=+5SO#XTBH<_0^NAIIB\CI M3_IL?.8/H(G,8YWI<]:_F(\9MYHEA0FY=^OR3:67?L0 ML+4E4933%GWIP\>,BN)R[;7T&.9;$5XER!8=/5Z:>G,]:3D9Z7$(.@[XX$^6 MRBFM4$3!HZKQPM;=;3=T:8:7$M^0?ENJ M(L7$[&H,[^G8%N&,RCW^:<'C.H6GG.-ATS>7@A*_7UB^X'4I+\?INO>0#XRF M9&E4YMVT10W")\E\J+'L MN[WKHTI3N$*,7ORYV6'%;%?HJ@:%'!3$8+_6GU#.FYK8.;;8)]9_Y(AJ\(T=S\<1;:EV/O$.%;'_' 4 M\9Q5JO_^BRZK5H)UHK*JT\1\)QVZ3O0][XW%Q/R]<@)>P?&O-(,U4^Z65J"> MJ(>JFR#,1+%NS976[E1'4P5 M1@QI#;Y04'5OU/=R$FF:196V,;_E*X;I7)9[(./M5*' MJKKUK]/8U,%>2U#'%!RM8B^U\=) -?:F)"RVF!C9SRC]7*HM54("490SB? CTSFBS!MR9= AJ M.8"V6XC='PG@SG. 976]Z;EKZGOR^_%I@R3U6M_1XVXN/X$1M;/>"YS!9ZL>(FSSGWT\'K)@("X[T29O WX83 M\ZMW@JKWU&[Z/BQ4>,@8]&XK%*1D2'^$,E*.5&!KW#KQ_=2I&S&)2;S=+2=>9.VY-D\=E&&7SH"_)1]$ MT8P9TDLXKDNIW$+AG71OVH"%]\1(NNF.&*^9[[,$D;J/#3L^.U*3T[C11AB;WM:UIV:I),N\*>U#S&P>B@XN#@GG-48 (E=5C5AK0+:!!@5RR MK#YP8QYR;M;8)6_6P6-"JYQ>^TNM-Z:V!G,2IX%:='.])YP<5DF]26\;/P2= MI7.VD647&-FRQC$.R^8\BOSF-E;VM&AD2Z4AKR%%NT$S&@A.KF_)--':;D@F MGF$OJF[&U Y,$/N];?<<_OW20YMFI]!MM1W1%&S:X/&\YC< ]]%>-(RFW<&3 M?G/XH R\O.+=D<=DW8&H_1HZ>E@V$JD[2]A.5>J\9-5;S@\-!4&QFXE'X(\.9@ GZ[QA*_]!1ZS(J.!V<(&#(Q5I,M?G=\S#+ MS'O+5GR1.-NM[J,;7_SZE0KRI<]VW;8Q[RH*+;51A/>95.Q*QT%>@^^.EJ%A M-T=KO& &WZD6F176V.GOF PFOYQ7YP1$\]^8UH=,T5G,'Y,R;I# <3I>9/\V M.AN )/B<\N_GJ PC=N093#*!X_X?;FZ37)>&VC8P]TVC@$ M.DT<^<:-9V?* JZ0&ISIW\[D'Y;3^N+L\Q_ DQB*8BK!M,W+"<\< MI_/X$TT5\/@T]SG5%R]B(5B!&(&OB/.ECY-DC71:E1N_,+$.N"?I1181'PQ3 M)F+;]70!"-GQ%M"V M@&)^C\40DJ'U0X'V"IK"GM.J!7N*IS;/QG4)+IY5FX52[ [B=Y&X&S0*A @3C*>4+ M4U*C/C6,T>NN548A?_)PKHF>!]=L+*:9";/^$(^"R%N\AYMK32RNUGM\;GI@ M0#_YH/P,BL-4$C6]JTNE>!V\*#@HT#O/(!^WL8)Z3"$\$15&CAMS_"$8JO+] MO>,HY9YMU#^OANA!#1W+LG[&#>B3=;'/GY#M4")8USLT1=UE2H!-6\CX_:+N MP!KL&RFJ8KH+KFR*R?N'E O^58$AN"X9SG7"J98.Q\5X)L)S8SL&/D@HE5K MEF*Q9".%W-:\JH?CBD_8\9)/CTE C(*_]J&J.5YL!'8":!(4?WQV3C[Y=Z,@ MOI)H.^4W])/^]&WHG9N.#3)VSJ>

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�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end

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�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Þ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�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